Comparison (group1/group2),UniProtIds,ProteinDescriptions,Genes,Log2 Ratio,Standard Deviation,Pvalue,Qvalue, -log10(qvalue),GO Biological Process,GO Molecular Function,GO Cellular Component,# of Ratios,# Unique Total Peptides,# Unique Total EG.Id,EG.Id
SEN / CTL,P09341;P19875;P19876,Growth-regulated alpha protein;C-X-C motif chemokine 2;C-X-C motif chemokine 3,CXCL1;CXCL2;CXCL3,4.60,1.28,1.79E-02,4.67E-03,2.33E+00,"chemotaxis,inflammatory response,immune response,signal transduction,G-protein coupled receptor signaling pathway,nervous system development,cell proliferation,negative regulation of cell proliferation,actin cytoskeleton organization,response to lipopolysaccharide,intracellular signal transduction,positive regulation of catalytic activity,cell chemotaxis,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis;response to molecule of bacterial origin,chemotaxis,inflammatory response,immune response,G-protein coupled receptor signaling pathway,response to lipopolysaccharide,regulation of cell proliferation,cell chemotaxis,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis;inflammatory response,immune response,G-protein coupled receptor signaling pathway,neutrophil chemotaxis,response to lipopolysaccharide,regulation of cell proliferation,chemokine-mediated signaling pathway,positive regulation of neutrophil chemotaxis","receptor binding,chemokine activity,enzyme activator activity,growth factor activity,CXCR chemokine receptor binding;chemokine activity,CXCR chemokine receptor binding;chemokine activity,CXCR chemokine receptor binding","extracellular region,extracellular space,intracellular;extracellular region,extracellular space;extracellular region,extracellular space",3,1,2,SPGPHC[CAM]AQTEVIATLK.3|SPGPHC[CAM]AQTEVIATLK.2
SEN / CTL,Q8NBJ7,Sulfatase-modifying factor 2,SUMF2,4.33,0.81,1.20E-02,3.29E-03,2.48E+00,post-translational protein modification,metal ion binding,"endoplasmic reticulum,endoplasmic reticulum lumen",3,14,22,SVLWWLPVEK.2|LEHPVLHVSWNDAR.4|LEHPVLHVSWNDAR.3|LEHPVLHVSWNDAR.2|QPAGPGSGIR.2|ERLEHPVLHVSWNDAR.4|ERLEHPVLHVSWNDAR.3|GASWIDTADGSANHR.3|GASWIDTADGSANHR.2|RLPTEEEWEFAAR.3|RLPTEEEWEFAAR.2|EATVKPFAIDIFPVTNKDFRDFVR.5|EATVKPFAIDIFPVTNKDFR.4|C[CAM]AADAGRPPGEL.2|FLMGTNSPDSR.2|FLM[Oxi]GTNSPDSR.2|EATVKPFAIDIFPVTNK.3|EATVKPFAIDIFPVTNK.2|PFAIDIFPVTNK.2|LPTEEEWEFAAR.2|MGNTPDSASDNLGFR.2|M[Oxi]GNTPDSASDNLGFR.2
SEN / CTL,P01889,"HLA class I histocompatibility antigen, B-7 alpha chain",HLA-B,4.13,1.00,1.59E-02,4.18E-03,2.38E+00,,,,3,4,4,AYLEGEC[CAM]VEWLR.2|RAYLEGEC[CAM]VEWLR.3|GHDQYAYDGK.2|GHDQYAYDGKDYIALNEDLR.4
SEN / CTL,Q9Y287,Integral membrane protein 2B,ITM2B,3.98,0.51,5.84E-03,1.73E-03,2.76E+00,"nervous system development,negative regulation of amyloid precursor protein biosynthetic process,cellular protein metabolic process","beta-amyloid binding,protein binding,ATP binding","Golgi membrane,extracellular region,extracellular space,Golgi apparatus,plasma membrane,endosome membrane,membrane,Golgi-associated vesicle membrane,integral component of organelle membrane,intracellular membrane-bounded organelle,extracellular exosome",3,6,6,NLLELLINIK.2|FAVETLIC[CAM]S.2|VTFNSALAQK.2|IENIDHLGFFIYR.3|AGTYLPQSYLIHEHMVITDR.4|IFEEEEVEFISVPVPEFADSDPANIVHDFNK.3
SEN / CTL,P26022,Pentraxin-related protein PTX3,PTX3,3.77,1.12,5.33E-09,4.71E-09,8.33E+00,"response to yeast,inflammatory response,opsonization,negative regulation by host of viral exo-alpha-sialidase activity,negative regulation by host of viral glycoprotein metabolic process,innate immune response,positive regulation of nitric oxide biosynthetic process,negative regulation of viral entry into host cell,positive regulation of phagocytosis,negative regulation of exo-alpha-sialidase activity,negative regulation of glycoprotein metabolic process","complement component C1q binding,(1->3)-beta-D-glucan binding,protein binding,identical protein binding,virion binding","extracellular region,extracellular space",15,7,7,LTSALDELLQATR.2|ALAAVLEELR.2|SWLPAGC[CAM]ETAILFPMR.2|LAESLARPC[CAM]APGAPAEAR.3|ADLHAVQGWAAR.3|ETGGAESC[CAM]HIR.3|MEGAEAQRPEEAGR.3
SEN / CTL,P03956,Interstitial collagenase,MMP1,3.72,1.13,3.10E-08,2.43E-08,7.61E+00,"proteolysis,viral process,extracellular matrix disassembly,collagen catabolic process,positive regulation of protein oligomerization,cellular protein metabolic process,leukocyte migration","endopeptidase activity,metalloendopeptidase activity,serine-type endopeptidase activity,calcium ion binding,zinc ion binding","extracellular region,proteinaceous extracellular matrix",12,6,6,AFQLWSNVTPLTFTK.2|DGFFYFFHGTR.3|SQNPVQPIGPQTPK.2|TYFFVANK.2|MIAHDFPGIGHK.3|VTGKPDAETLK.2
SEN / CTL,P17096,High mobility group protein HMG-I/HMG-Y,HMGA1,3.59,1.10,2.35E-02,5.95E-03,2.23E+00,"DNA unwinding involved in DNA replication,nucleosome disassembly,regulation of transcription, DNA-templated,transcription from RNA polymerase II promoter,protein complex assembly,negative regulation of cell proliferation,response to virus,negative regulation of chromatin silencing,senescence-associated heterochromatin focus assembly,negative regulation of transcription, DNA-templated,positive regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,nuclear transport,establishment of integrated proviral latency,oncogene-induced cell senescence,positive regulation of cellular senescence","transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,DNA binding,AT DNA binding,chromatin binding,transcription factor activity, sequence-specific DNA binding,protein binding,transcription factor binding,enzyme binding,ligand-dependent nuclear receptor transcription coactivator activity,retinoic acid receptor binding,peroxisome proliferator activated receptor binding,retinoid X receptor binding","nucleus,nucleoplasm,transcription factor complex,cytosol,focal adhesion,senescence-associated heterochromatin focus,RNA polymerase II transcription factor complex",3,9,13,KQPPVSPGTALVGSQKEPSEVPTPK.4|KQPPVSPGTALVGSQKEPSEVPTPK.5|KQPPVSPGTALVGSQKEPSEVPTPK.3|SSQPLASKQEK.3|SSQPLASKQEK.2|SSQPLASK.2|EPSEVPTPK.2|KQPPVSPGTALVGSQK.3|KQPPVSPGTALVGSQK.2|SSQPLASKQEKDGTEK.3|QPPVSPGTALVGSQK.2|KLEKEEEEGISQESSEEEQ.3|QPPVSPGTALVGSQKEPSEVPTPK.3
SEN / CTL,Q6UVY6,DBH-like monooxygenase protein 1,MOXD1,3.48,1.94,6.97E-02,1.57E-02,1.80E+00,oxidation-reduction process,"copper ion binding,protein binding,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen","endoplasmic reticulum membrane,integral component of membrane",3,2,2,LVLSLPVNVR.2|ELHTC[CAM]DINDK.2
SEN / CTL,P02765,Alpha-2-HS-glycoprotein,AHSG,3.32,3.73,3.83E-02,9.30E-03,2.03E+00,"skeletal system development,ossification,platelet degranulation,pinocytosis,acute-phase response,negative regulation of endopeptidase activity,regulation of bone mineralization,negative regulation of bone mineralization,negative regulation of phosphorylation,negative regulation of insulin receptor signaling pathway,regulation of inflammatory response,positive regulation of phagocytosis,negative regulation of biomineral tissue development","endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,kinase inhibitor activity","extracellular region,extracellular space,extracellular matrix,platelet alpha granule lumen,extracellular exosome,blood microparticle",9,15,28,C[CAM]NLLAEK.2|C[CAM]DSSPDSAEDVR.2|C[CAM]DSSPDSAEDVRK.3|C[CAM]DSSPDSAEDVRK.2|EHAVEGDC[CAM]DFQLLK.4|EHAVEGDC[CAM]DFQLLK.3|EHAVEGDC[CAM]DFQLLK.2|HTFMGVVSLGSPSGEVSHPR.5|HTFMGVVSLGSPSGEVSHPR.4|HTFM[Oxi]GVVSLGSPSGEVSHPR.4|HTFMGVVSLGSPSGEVSHPR.3|HTFM[Oxi]GVVSLGSPSGEVSHPR.3|HTFMGVVSLGSPSGEVSHPR.2|QLKEHAVEGDC[CAM]DFQLLK.4|QLKEHAVEGDC[CAM]DFQLLK.3|TVVQPSVGAAAGPVVPPC[CAM]PGR.4|TVVQPSVGAAAGPVVPPC[CAM]PGR.3|TVVQPSVGAAAGPVVPPC[CAM]PGR.2|EHAVEGDC[CAM]DFQLLKLDGK.4|EHAVEGDC[CAM]DFQLLKLDGK.3|HTLNQIDEVK.2|QLKEHAVEGDC[CAM]DFQLLKLDGK.4|VWPQQPSGELFEIEIDTLETTC[CAM]HVLDPTPVAR.5|VWPQQPSGELFEIEIDTLETTC[CAM]HVLDPTPVAR.4|AALAAFNAQNNGSNFQLEEISR.3|AQLVPLPPSTYVEFTVSGTDC[CAM]VAK.3|HTLNQIDEVKVWPQQPSGELFEIEIDTLETTC[CAM]HVLDPTPVAR.5|QPNC[CAM]DDPETEEAALVAIDYINQNLPWGYK.3
SEN / CTL,P78417,Glutathione S-transferase omega-1,GSTO1,3.25,1.38,5.76E-05,2.81E-05,4.55E+00,"glutathione metabolic process,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,L-ascorbic acid metabolic process,methylation,xenobiotic catabolic process,oxidation-reduction process,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,cellular response to arsenic-containing substance,cellular oxidant detoxification,glutathione derivative biosynthetic process","glutathione transferase activity,oxidoreductase activity,glutathione dehydrogenase (ascorbate) activity,methylarsonate reductase activity","cytoplasm,cytosol,extracellular exosome",9,28,41,VPSLVGSFIR.2|MILELFSK.2|M[Oxi]ILELFSK.2|GIRHEVININLK.3|KLLPDDPYEK.3|KLLPDDPYEK.2|LNEC[CAM]VDHTPK.3|LNEC[CAM]VDHTPK.2|SQNKEDYAGLK.3|LWMAAMK.2|GSAPPGPVPEGSIR.3|GSAPPGPVPEGSIR.2|EDYAGLKEEFR.3|EDYAGLKEEFR.2|SQNKEDYAGLKEEFR.4|SQNKEDYAGLKEEFR.3|FC[CAM]PFAER.2|LEEVLTNK.2|EFTKLEEVLTNKK.3|EFTKLEEVLTNKK.2|LLPDDPYEKAC[CAM]QK.3|LEEVLTNKK.2|HEVININLK.2|LLPDDPYEK.2|NKPEWFFK.2|SLGKGSAPPGPVPEGSIR.3|LKLWMAAMKEDPTVSALLTSEK.4|M[Oxi]ILELFSKVPSLVGSFIR.3|MILELFSKVPSLVGSFIR.3|EDPTVSALLTSEK.2|EFTKLEEVLTNK.2|LWMAAMKEDPTVSALLTSEK.3|LWM[Oxi]AAMKEDPTVSALLTSEK.3|LWMAAM[Oxi]KEDPTVSALLTSEK.3|LWMAAMKEDPTVSALLTSEK.2|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.5|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.4|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.5|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGKK.4|NPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGK.4|KNPFGLVPVLENSQGQLIYESAITC[CAM]EYLDEAYPGK.4
SEN / CTL,Q15904,V-type proton ATPase subunit S1,ATP6AP1,3.16,1.16,2.99E-02,7.46E-03,2.13E+00,"insulin receptor signaling pathway,ATP hydrolysis coupled proton transport,proton transport,transferrin transport,ion transmembrane transport,positive regulation of osteoblast differentiation,positive regulation of bone resorption,pH reduction,positive regulation of exocytosis,establishment of organelle localization,positive regulation of ERK1 and ERK2 cascade,positive regulation of osteoclast development","transporter activity,ATP binding,Rab GTPase binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism","endosome membrane,integral component of membrane,proton-transporting two-sector ATPase complex,proton-transporting V-type ATPase, V1 domain,extracellular exosome",3,9,11,LGASPLHVDLATLR.3|LGASPLHVDLATLR.2|DVAVVAGGLGR.2|LFGTTVTFK.2|GPTISLTQIV.2|NVLLFLQDK.2|SEDVPYTAALTAVRPSR.3|EVLTGNDEVIGQVLSTLK.3|EVLTGNDEVIGQVLSTLK.2|LPYTASSGLMAPR.2|LSIEDFTAYGGVFGNK.2
SEN / CTL,Q99988,Growth/differentiation factor 15,GDF15,3.08,0.59,9.53E-03,2.66E-03,2.57E+00,"signal transduction,transforming growth factor beta receptor signaling pathway,cell-cell signaling,positive regulation of pathway-restricted SMAD protein phosphorylation,regulation of apoptotic process,regulation of MAPK cascade,cell development,SMAD protein signal transduction,positive regulation of myoblast fusion","cytokine activity,transforming growth factor beta receptor binding,protein binding,growth factor activity","extracellular region,extracellular space,nucleus,cytoplasm,extracellular exosome",3,7,7,ASLEDLGWADWVLSPR.2|ASFPGPSELHSEDSR.3|RYEDLLTR.2|AALPEGLPEASR.2|LSPPPSQSDQLLAESSSARPQLELHLRPQAAR.5|TDTGVSLQTYDDLLAK.2|LKPDTVPAPC[CAM]C[CAM]VPASYNPMVLIQK.3
SEN / CTL,P04156,Major prion protein,PRNP,2.97,1.37,4.23E-02,1.01E-02,2.00E+00,"negative regulation of protein phosphorylation,cellular copper ion homeostasis,response to oxidative stress,cell cycle arrest,learning or memory,metabolic process,negative regulation of interferon-gamma production,negative regulation of interleukin-17 production,negative regulation of interleukin-2 production,regulation of protein localization,cellular response to drug,negative regulation of apoptotic process,negative regulation of sequence-specific DNA binding transcription factor activity,negative regulation of activated T cell proliferation,response to cadmium ion,negative regulation of T cell receptor signaling pathway,protein homooligomerization,negative regulation of calcineurin-NFAT signaling cascade,cellular response to copper ion,regulation of potassium ion transmembrane transport","copper ion binding,lamin binding,microtubule binding,tubulin binding,identical protein binding,ATP-dependent protein binding,ion channel binding,chaperone binding","nucleus,cytoplasm,endoplasmic reticulum,Golgi apparatus,plasma membrane,cell surface,extrinsic component of membrane,anchored component of membrane,membrane raft,extracellular exosome",3,4,5,VVEQMC[CAM]ITQYER.2|VVEQM[Oxi]C[CAM]ITQYER.2|PIIHFGSDYEDR.3|ESQAYYQR.2|HMAGAAAAGAVVGGLGGYMLGSAMSR.3
SEN / CTL,P20962,Parathymosin,PTMS,2.94,1.39,5.35E-02,1.26E-02,1.90E+00,"immune system process,DNA replication",zinc ion binding,"nucleus,cytosol",3,5,8,SVEAAAELSAK.2|AAEEEDEADPKR.3|AAEEEDEADPKR.2|RAAEEEDEADPK.3|RAAEEEDEADPK.2|RAAEEEDEADPKR.3|RAAEEEDEADPKR.2|AAEEEDEADPK.2
SEN / CTL,Q06323,Proteasome activator complex subunit 1,PSME1,2.94,1.76,5.89E-02,1.36E-02,1.87E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,positive regulation of endopeptidase activity,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of G1/S transition of mitotic cell cycle",endopeptidase activator activity,"proteasome complex,nucleoplasm,cytoplasm,cytosol,proteasome activator complex,extracellular exosome",3,26,39,NAYAVLYDIILK.2|NAYAVLYDIILK.3|IVVLLQR.2|VFELMTSLHTK.3|VFELM[Oxi]TSLHTK.3|VFELMTSLHTK.2|VFELM[Oxi]TSLHTK.2|LMVMEIR.2|LM[Oxi]VMEIR.2|LMVM[Oxi]EIR.2|VDVFREDLC[CAM]TK.3|VDVFREDLC[CAM]TK.2|EPALNEANLSNLK.3|EPALNEANLSNLK.2|QLVHELDEAEYRDIR.4|QPHVGDYR.2|QLVHELDEAEYR.3|QLVHELDEAEYR.2|APLDIPVPDPVKEK.3|ISELDAFLK.2|KGEDEDKGPPC[CAM]GPVNC[CAM]NEK.4|KGEDEDKGPPC[CAM]GPVNC[CAM]NEK.3|LEGFHTQISK.2|KISELDAFLK.2|APLDIPVPDPVK.2|KISELDAFLKEPALNEANLSNLK.4|KISELDAFLKEPALNEANLSNLK.3|NAYAVLYDIILKNFEK.3|TENLLGSYFPK.2|YFSERGDAVTK.2|IEDGNNFGVAVQEKVFELMTSLHTKLEGFHTQISK.6|VDVFREDLC[CAM]TKTENLLGSYFPK.4|VDVFREDLC[CAM]TKTENLLGSYFPK.3|GEDEDKGPPC[CAM]GPVNC[CAM]NEK.3|GPPC[CAM]GPVNC[CAM]NEK.2|LKPEIKDVIEQLNLVTTWLQLQIPR.4|LKPEIKDVIEQLNLVTTWLQLQIPR.3|IEDGNNFGVAVQEK.2|ISELDAFLKEPALNEANLSNLK.3
SEN / CTL,P30048,"Thioredoxin-dependent peroxide reductase, mitochondrial",PRDX3,2.92,1.48,5.93E-02,1.36E-02,1.87E+00,"response to reactive oxygen species,maternal placenta development,apoptotic process,response to oxidative stress,mitochondrion organization,positive regulation of cell proliferation,peptidyl-cysteine oxidation,myeloid cell differentiation,response to lipopolysaccharide,negative regulation of kinase activity,cellular response to oxidative stress,cellular response to reactive oxygen species,response to hydrogen peroxide,hydrogen peroxide catabolic process,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,positive regulation of NF-kappaB transcription factor activity,regulation of mitochondrial membrane potential,cellular oxidant detoxification","protein binding,protein C-terminus binding,thioredoxin peroxidase activity,alkyl hydroperoxide reductase activity,kinase binding,protein kinase binding,identical protein binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process","cytoplasm,mitochondrion,mitochondrial matrix,early endosome,cytosol,myelin sheath,extracellular exosome,IkappaB kinase complex",3,19,41,GLFIIDPNGVIK.2|HLSVNDLPVGR.3|HLSVNDLPVGR.2|SVEETLR.2|DLSLDDFK.2|KNGGLGHM[Oxi]NIALLSDLTK.4|KNGGLGHMNIALLSDLTK.3|KNGGLGHM[Oxi]NIALLSDLTK.3|KNGGLGHMNIALLSDLTK.2|DYGVLLEGSGLALR.3|DYGVLLEGSGLALR.2|QISRDYGVLLEGSGLALR.4|QISRDYGVLLEGSGLALR.3|GTAVVNGEFK.2|GTAVVNGEFKDLSLDDFKGK.4|GTAVVNGEFKDLSLDDFKGK.3|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.6|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.5|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASK.3|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.6|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.5|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.4|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPR.3|NGGLGHMNIALLSDLTK.3|NGGLGHM[Oxi]NIALLSDLTK.3|NGGLGHMNIALLSDLTK.2|NGGLGHM[Oxi]NIALLSDLTK.2|SVEETLRLVK.2|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPRK.6|ANEFHDVNC[CAM]EVVAVSVDSHFSHLAWINTPRK.4|GLFIIDPNGVIKHLSVNDLPVGR.4|GLFIIDPNGVIKHLSVNDLPVGR.3|GTAVVNGEFKDLSLDDFK.3|GTAVVNGEFKDLSLDDFK.2|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.6|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.5|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIK.4|AFQYVETHGEVC[CAM]PANWTPDSPTIK.3|AFQYVETHGEVC[CAM]PANWTPDSPTIKPSPAASKEYFQKVNQ.6
SEN / CTL,P07585,Decorin,DCN,2.90,1.29,1.14E-19,3.93E-19,1.84E+01,"kidney development,placenta development,negative regulation of protein kinase activity,skeletal muscle tissue development,aging,response to mechanical stimulus,animal organ morphogenesis,positive regulation of autophagy,negative regulation of endothelial cell migration,positive regulation of phosphatidylinositol 3-kinase signaling,positive regulation of macroautophagy,negative regulation of angiogenesis,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,response to lipopolysaccharide,wound healing,positive regulation of transcription from RNA polymerase II promoter,negative regulation of JAK-STAT cascade,positive regulation of mitochondrial depolarization,positive regulation of mitochondrial fission,negative regulation of vascular endothelial growth factor signaling pathway","protein kinase inhibitor activity,protein binding,collagen binding,glycosaminoglycan binding,poly(A) RNA binding,protein N-terminus binding,extracellular matrix binding","extracellular region,collagen type VI trimer,extracellular space,cytoplasm,Golgi lumen,lysosomal lumen,extracellular matrix",45,22,33,VSPGAFTPLVKLER.3|ASYSGVSLFSNPVQYWEIQPSTFR.3|KVTFNGLNQMIVIELGTNPLK.3|NLHALILVNNK.3|NLHALILVNNK.2|VSPGAFTPLVK.2|KASYSGVSLFSNPVQYWEIQPSTFR.3|KASYSGVSLFSNPVQYWEIQPSTFR.4|KASYSGVSLFSNPVQYWEIQPSTFR.5|VVQC[CAM]SDLGLDKVPK.3|VVQC[CAM]SDLGLDKVPK.2|NLHALILVNNKISK.3|YIQVVYLHNNNISVVGSSDFC[CAM]PPGHNTK.4|YIQVVYLHNNNISVVGSSDFC[CAM]PPGHNTK.3|VVQC[CAM]SDLGLDK.2|VTFNGLNQMIVIELGTNPLK.3|VTFNGLNQM[Oxi]IVIELGTNPLK.3|VTFNGLNQM[Oxi]IVIELGTNPLK.2|VTFNGLNQMIVIELGTNPLK.2|DLPPDTTLLDLQNNK.3|DLPPDTTLLDLQNNK.2|LTRVPGGLAEHK.3|VPGGLAEHK.2|AHENEITK.2|VDAASLKGLNNLAK.3|VDAASLKGLNNLAK.2|ELHLDNNK.2|SAIQLGNYK.2|TLQELRAHENEITK.3|ITEIKDGDFK.2|SSGIENGAFQGMK.2|SSGIENGAFQGM[Oxi]K.2|LGLSFNSISAVDNGSLANTPHLR.3
SEN / CTL,P04632,Calpain small subunit 1,CAPNS1,2.71,0.33,5.89E-03,1.73E-03,2.76E+00,"proteolysis,positive regulation of cell proliferation,regulation of macroautophagy,extracellular matrix disassembly","calcium-dependent cysteine-type endopeptidase activity,calcium ion binding","cytosol,plasma membrane,membrane,extracellular exosome",3,18,39,THYSNIEANESEEVR.3|THYSNIEANESEEVR.2|LGFEEFK.2|VVTRHPDLKTDGFGIDTC[CAM]R.5|VVTRHPDLKTDGFGIDTC[CAM]R.4|VVTRHPDLKTDGFGIDTC[CAM]R.3|THYSNIEANESEEVRQFRR.5|THYSNIEANESEEVRQFRR.4|YLWNNIK.2|THYSNIEANESEEVRQFR.4|THYSNIEANESEEVRQFR.3|TDGFGIDTC[CAM]R.2|HPDLKTDGFGIDTC[CAM]R.3|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.6|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.5|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.5|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.4|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.4|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAM[Oxi]R.3|GGGGGGGGGGGLGGGLGNVLGGLISGAGGGGGGGGGGGGGGGGGGGGTAMR.3|ILGGVISAISEAAAQYNPEPPPPR.4|ILGGVISAISEAAAQYNPEPPPPR.3|SMVAVMDSDTTGK.2|SM[Oxi]VAVMDSDTTGK.2|SMVAVM[Oxi]DSDTTGK.2|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIRR.5|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIRR.4|SMVAVMDSDTTGKLGFEEFK.3|YSDESGNMDFDNFISC[CAM]LVR.3|YSDESGNM[Oxi]DFDNFISC[CAM]LVR.2|YSDESGNMDFDNFISC[CAM]LVR.2|RYSDESGNMDFDNFISC[CAM]LVR.3|LFAQLAGDDM[Oxi]EVSATELMNILNK.3|LFAQLAGDDMEVSATELM[Oxi]NILNK.3|LFAQLAGDDMEVSATELMNILNK.3|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNM[Oxi]IIR.4|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIR.4|SGTIC[CAM]SSELPGAFEAAGFHLNEHLYNMIIR.3|RLFAQLAGDDMEVSATELMNILNK.3
SEN / CTL,Q9UHL4,Dipeptidyl peptidase 2,DPP7,2.71,2.36,2.34E-01,4.76E-02,1.32E+00,proteolysis,"serine-type carboxypeptidase activity,serine-type peptidase activity,dipeptidyl-peptidase activity","lysosome,Golgi apparatus,cytosol,cytoplasmic, membrane-bounded vesicle,vesicle,intracellular membrane-bounded organelle,extracellular exosome",3,18,27,GHTELLTVEQALADFAELLR.3|KLEATIIGEWVK.3|KLEATIIGEWVK.2|LYHSC[CAM]ADPTGC[CAM]GTGPDAR.4|LYHSC[CAM]ADPTGC[CAM]GTGPDAR.3|LYHSC[CAM]ADPTGC[CAM]GTGPDAR.2|ASHPEDPASVVEAR.3|ASHPEDPASVVEAR.2|APDPGFQER.2|AASNIIFSNGNLDPWAGGGIR.4|AASNIIFSNGNLDPWAGGGIR.3|AASNIIFSNGNLDPWAGGGIR.2|LDHFNFER.2|NLSASVIAVTIQGGAHHLDLR.4|GALLVFAEHR.2|SLPFGAQSTQR.2|DLTQLFMFAR.2|DLTQLFM[Oxi]FAR.2|LEATIIGEWVK.2|DVTADFEGQSPK.2|DLFLQGAYDTVR.2|YC[CAM]LDTWGVWPR.2|YPHLVAGALAASAPVLAVAGLGDSNQFFR.4|YPHLVAGALAASAPVLAVAGLGDSNQFFR.3|NAFTVLAMMDYPYPTDFLGPLPANPVK.4|NAFTVLAMMDYPYPTDFLGPLPANPVK.3|WEFGTC[CAM]QPLSDEK.2
SEN / CTL,Q9UNW1,Multiple inositol polyphosphate phosphatase 1,MINPP1,2.63,0.66,7.16E-05,3.40E-05,4.47E+00,"ossification,polyphosphate metabolic process,dephosphorylation,bone mineralization,inositol phosphate metabolic process","acid phosphatase activity,phosphohistidine phosphatase activity,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,bisphosphoglycerate 3-phosphatase activity,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,inositol phosphate phosphatase activity,inositol hexakisphosphate 2-phosphatase activity","endoplasmic reticulum,endoplasmic reticulum lumen,extracellular exosome",6,12,13,LASLFPALFSR.2|SGLIVPYASNLIFVLYHC[CAM]ENAK.3|DKEPLTAYNYK.3|VLEYLNDLK.2|TGPEMQNILK.2|SSC[CAM]TLFQDIFQHLDK.3|SSC[CAM]TLFQDIFQHLDK.2|DPVASSLSPYFGTK.2|SPWC[CAM]DVFDIDDAK.2|DILQSC[CAM]QTSEEC[CAM]ELAR.2|YEDVNPVLLSGPEAPWR.2|VLPLAYSQETVSFYEDLK.2|TRYEDVNPVLLSGPEAPWRDPELLEGTC[CAM]TPVQLVALIR.4
SEN / CTL,Q08629,Testican-1,SPOCK1,2.62,0.17,1.47E-03,5.01E-04,3.30E+00,"regulation of cell growth,neuron migration,cell adhesion,signal transduction,nervous system development,negative regulation of cell-substrate adhesion,negative regulation of endopeptidase activity,negative regulation of neuron projection development,central nervous system neuron differentiation,neurogenesis","serine-type endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,calcium ion binding,metalloendopeptidase inhibitor activity","proteinaceous extracellular matrix,extracellular space,cytoplasm,postsynaptic density,sarcoplasm,neuromuscular junction,node of Ranvier",3,2,2,SLLGAFIPR.2|ATQC[CAM]HGSTGQC[CAM]WC[CAM]VDK.3
SEN / CTL,P01033,Metalloproteinase inhibitor 1,TIMP1,2.62,1.29,5.00E-15,9.50E-15,1.40E+01,"cell activation,platelet degranulation,aging,positive regulation of cell proliferation,response to hormone,negative regulation of endopeptidase activity,extracellular matrix disassembly,response to cytokine,wound healing,negative regulation of apoptotic process,negative regulation of catalytic activity,response to peptide hormone,negative regulation of membrane protein ectodomain proteolysis,cartilage development,negative regulation of trophoblast cell migration,regulation of integrin-mediated signaling pathway","protease binding,cytokine activity,protein binding,growth factor activity,metalloendopeptidase inhibitor activity,metal ion binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,platelet alpha granule lumen,extracellular exosome",33,7,11,TYTVGC[CAM]EEC[CAM]TVFPC[CAM]LSIPC[CAM]K.3|LQDGLLHITTC[CAM]SFVAPWNSLSLAQR.3|GFQALGDAADIR.2|LQSGTHC[CAM]LWTDQLLQGSEK.3|LQSGTHC[CAM]LWTDQLLQGSEK.2|EPGLC[CAM]TWQSLR.2|FVYTPAMESVC[CAM]GYFHR.3|FVYTPAMESVC[CAM]GYFHR.2|FVYTPAMESVC[CAM]GYFHR.4|FVYTPAM[Oxi]ESVC[CAM]GYFHR.3|SEEFLIAGK.2
SEN / CTL,Q9Y646,Carboxypeptidase Q,CPQ,2.54,0.82,3.66E-04,1.48E-04,3.83E+00,"proteolysis,thyroid hormone generation,tissue regeneration,peptide catabolic process","carboxypeptidase activity,protein homodimerization activity,metal ion binding,metallodipeptidase activity","extracellular space,cytoplasm,lysosome,endoplasmic reticulum,Golgi apparatus,extracellular exosome",6,10,10,LALLVDTVGPR.2|AIINLAVYGK.2|VHLEPVRIPHWER.4|VGALASLIR.2|GEESAVMLEPR.2|IVVYNQPYINYSR.2|LVLWTAEEQGGVGAFQYYQLHK.3|SVASFSIYSPHTGIQEYQDGVPK.3|AIQIMYQNLQQDGLEK.2|TYPDTDSFNTVAEITGSK.2
SEN / CTL,P39059,Collagen alpha-1(XV) chain,COL15A1,2.52,1.37,7.05E-08,5.10E-08,7.29E+00,"angiogenesis,cell adhesion,signal transduction,cell differentiation,collagen catabolic process",extracellular matrix structural constituent,"extracellular region,collagen type XV trimer,extracellular space,endoplasmic reticulum lumen,integral component of membrane,extracellular exosome,extracellular matrix",18,14,24,NLVTAFSNMDDMLQK.2|AFLSSHLQDLSTIVR.3|AFLSSHLQDLSTIVR.2|DSTEFFIR.2|FTGSLQQLTVHPDPR.3|FTGSLQQLTVHPDPR.2|GGVLFAITDAFQK.2|IILYYTEPGSHVSQEAAAFSVPVMTHR.4|IILYYTEPGSHVSQEAAAFSVPVMTHR.5|IILYYTEPGSHVSQEAAAFSVPVM[Oxi]THR.4|IILYYTEPGSHVSQEAAAFSVPVMTHR.3|PALHLAALNM[Oxi]PFSGDIR.4|PALHLAALNMPFSGDIR.3|PALHLAALNM[Oxi]PFSGDIR.3|PALHLAALNMPFSGDIR.2|AAGLLSTYR.2|AHLVIEGTFIYLR.3|AHLVIEGTFIYLR.2|YSLPIVNLK.2|TADTAVTGLASPLSTGK.3|TADTAVTGLASPLSTGK.2|LSGVEDGHQR.2|AFLSSHLQDLSTIVRK.3|LVDNYC[CAM]EAWR.2
SEN / CTL,P23284,Peptidyl-prolyl cis-trans isomerase B,PPIB,2.50,1.54,2.54E-06,1.48E-06,5.83E+00,"protein peptidyl-prolyl isomerization,positive regulation of multicellular organism growth,positive regulation by host of viral process,positive regulation by host of viral genome replication,protein stabilization,bone development,chaperone-mediated protein folding,regulation of post-translational protein modification","peptidyl-prolyl cis-trans isomerase activity,protein binding,protein complex binding,peptide binding,poly(A) RNA binding,unfolded protein binding,RNA polymerase binding,collagen binding","nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,focal adhesion,membrane,macromolecular complex,endoplasmic reticulum chaperone complex,melanosome,perinuclear region of cytoplasm,extracellular exosome",15,28,56,TVDNFVALATGEK.2|TVDNFVALATGEK.3|VLEGMEVVR.2|VLEGM[Oxi]EVVR.2|VIKDFMIQGGDFTRGDGTGGK.4|VIKDFM[Oxi]IQGGDFTRGDGTGGK.4|VIKDFMIQGGDFTRGDGTGGK.3|VIKDFMIQGGDFTR.3|VIKDFM[Oxi]IQGGDFTR.3|VIKDFMIQGGDFTR.2|IEVEKPFAIAK.3|IEVEKPFAIAK.2|IGDEDVGR.2|LKHYGPGWVSMANAGK.4|LKHYGPGWVSMANAGK.3|VIFGLFGK.2|FPDENFK.2|FPDENFK.1|IEVEKPFAIAKE.3|IEVEKPFAIAKE.2|DKPLKDVIIADC[CAM]GKIEVEKPFAIAK.6|DKPLKDVIIADC[CAM]GKIEVEKPFAIAK.5|DKPLKDVIIADC[CAM]GKIEVEKPFAIAK.4|DTNGSQFFITTVK.3|DTNGSQFFITTVK.2|DVIIADC[CAM]GK.2|HYGPGWVSMANAGK.3|HYGPGWVSM[Oxi]ANAGK.3|HYGPGWVSM[Oxi]ANAGK.2|HYGPGWVSMANAGK.2|DKPLKDVIIADC[CAM]GK.3|DKPLKDVIIADC[CAM]GK.2|SIYGERFPDENFK.3|SIYGERFPDENFK.2|DVIIADC[CAM]GKIEVEKPFAIAK.4|DVIIADC[CAM]GKIEVEKPFAIAK.3|TVDNFVALATGEKGFGYKNSK.4|TVDNFVALATGEKGFGYKNSK.3|IGDEDVGRVIFGLFGK.3|VLEGMEVVRK.2|DVIIADC[CAM]GKIEVEKPFAIAKE.4|DVIIADC[CAM]GKIEVEKPFAIAKE.3|DFMIQGGDFTRGDGTGGK.3|DFM[Oxi]IQGGDFTRGDGTGGK.3|DFM[Oxi]IQGGDFTRGDGTGGK.2|DFMIQGGDFTRGDGTGGK.2|TVDNFVALATGEKGFGYK.3|TVDNFVALATGEKGFGYK.2|DFMIQGGDFTR.2|DFM[Oxi]IQGGDFTR.2|HYGPGWVSM[Oxi]ANAGKDTNGSQFFITTVK.4|HYGPGWVSMANAGKDTNGSQFFITTVK.4|HYGPGWVSMANAGKDTNGSQFFITTVK.3|DVIIADC[CAM]GKIEVEK.2|TAWLDGKHVVFGKVLEGMEVVR.3|TVPKTVDNFVALATGEK.2
SEN / CTL,P52823,Stanniocalcin-1,STC1,2.49,0.27,3.86E-03,1.18E-03,2.93E+00,"ossification,endothelial cell morphogenesis,growth plate cartilage axis specification,cellular calcium ion homeostasis,embryo implantation,negative regulation of endothelial cell migration,negative regulation of cell migration,response to vitamin D,chondrocyte proliferation,regulation of anion transport,decidualization,negative regulation of calcium ion transport,bone development,cellular response to cAMP,cellular response to glucocorticoid stimulus,cellular response to hypoxia,regulation of cardiac muscle cell contraction,positive regulation of calcium ion import,negative regulation of renal phosphate excretion",hormone activity,"extracellular space,nucleus,cytoplasm,apical plasma membrane",3,2,3,RNPEAITEVVQLPNHFSNR.3|IGPNMASLFHILQTDHC[CAM]AQTHPR.5|IGPNMASLFHILQTDHC[CAM]AQTHPR.4
SEN / CTL,P07858,Cathepsin B,CTSB,2.47,1.67,5.55E-13,8.79E-13,1.21E+01,"toll-like receptor signaling pathway,proteolysis,collagen catabolic process,epithelial cell differentiation,regulation of apoptotic process,decidualization,viral entry into host cell,regulation of catalytic activity,proteolysis involved in cellular protein catabolic process,cellular response to thyroid hormone stimulus","cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,peptidase activity,cysteine-type peptidase activity,proteoglycan binding","extracellular region,extracellular space,intracellular,nucleolus,mitochondrion,lysosome,endolysosome lumen,melanosome,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",51,22,46,VMFTEDLKLPASFDAR.3|EQWPQC[CAM]PTIK.2|GQDHC[CAM]GIESEVVAGIPR.3|GQDHC[CAM]GIESEVVAGIPR.2|GQDHC[CAM]GIESEVVAGIPR.4|ILRGQDHC[CAM]GIESEVVAGIPR.4|ILRGQDHC[CAM]GIESEVVAGIPR.3|ILRGQDHC[CAM]GIESEVVAGIPR.5|LC[CAM]GTFLGGPKPPQR.3|HYGYNSYSVSNSEKDIMAEIYK.4|HYGYNSYSVSNSEKDIMAEIYK.3|HYGYNSYSVSNSEKDIM[Oxi]AEIYK.4|SGVYQHVTGEMMGGHAIR.4|SGVYQHVTGEMMGGHAIR.3|SGVYQHVTGEMMGGHAIR.2|SGVYQHVTGEM[Oxi]MGGHAIR.4|SGVYQHVTGEMM[Oxi]GGHAIR.4|SGVYQHVTGEM[Oxi]M[Oxi]GGHAIR.4|SGVYQHVTGEM[Oxi]MGGHAIR.3|SGVYQHVTGEMM[Oxi]GGHAIR.3|SGVYQHVTGEM[Oxi]M[Oxi]GGHAIR.3|SGVYQHVTGEMM[Oxi]GGHAIR.2|IC[CAM]EPGYSPTYK.2|IC[CAM]EPGYSPTYKQDK.3|IC[CAM]EPGYSPTYKQDK.2|NGPVEGAFSVYSDFLLYK.2|NGPVEGAFSVYSDFLLYK.3|LPASFDAR.2|DIMAEIYK.2|DIM[Oxi]AEIYK.2|QDKHYGYNSYSVSNSEK.4|QDKHYGYNSYSVSNSEK.3|PSFHPLSDELVNYVNKR.4|PSFHPLSDELVNYVNKR.3|GLVSGGLYESHVGC[CAM]R.3|GLVSGGLYESHVGC[CAM]R.2|HYGYNSYSVSNSEK.3|HYGYNSYSVSNSEK.2|QDKHYGYNSYSVSNSEKDIMAEIYK.5|QDKHYGYNSYSVSNSEKDIMAEIYK.4|SRPSFHPLSDELVNYVNK.3|LPASFDAREQWPQC[CAM]PTIK.3|DQGSC[CAM]GSC[CAM]WAFGAVEAISDR.3|DQGSC[CAM]GSC[CAM]WAFGAVEAISDR.2|EIRDQGSC[CAM]GSC[CAM]WAFGAVEAISDR.3|ILGWGVENGTPYWLVANSWNTDWGDNGFFK.3
SEN / CTL,P09429,High mobility group protein B1,HMGB1,2.46,0.87,3.33E-02,8.21E-03,2.09E+00,"negative regulation of transcription from RNA polymerase II promoter,myeloid dendritic cell activation,activation of innate immune response,dendritic cell chemotaxis,inflammatory response to antigenic stimulus,regulation of tolerance induction,regulation of T cell mediated immune response to tumor cell,DNA topological change,apoptotic DNA fragmentation,DNA recombination,regulation of transcription from RNA polymerase II promoter,autophagy,inflammatory response,positive regulation of cytosolic calcium ion concentration,regulation of autophagy,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,neuron projection development,regulation of restriction endodeoxyribonuclease activity,DNA geometric change,positive regulation of mismatch repair,negative regulation of interferon-gamma production,positive regulation of interleukin-10 production,positive regulation of interleukin-12 production,V(D)J recombination,positive regulation of toll-like receptor 9 signaling pathway,T-helper 1 cell activation,positive regulation of activated T cell proliferation,positive regulation of apoptotic process,apoptotic cell clearance,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of CD4-positive, alpha-beta T cell differentiation,positive regulation of DNA binding,positive regulation of MAPK cascade,negative regulation of blood vessel endothelial cell migration,T-helper 1 cell differentiation,innate immune response,positive regulation of transcription from RNA polymerase II promoter,positive regulation of JNK cascade,positive regulation of interleukin-1 secretion,positive chemotaxis,DNA ligation involved in DNA repair,positive regulation of DNA ligation,positive regulation of ERK1 and ERK2 cascade,positive regulation of monocyte chemotaxis,neutrophil clearance,tumor necrosis factor secretion,positive regulation of interleukin-6 secretion,positive regulation of dendritic cell differentiation","four-way junction DNA binding,bubble DNA binding,lipopolysaccharide binding,phosphatidylserine binding,damaged DNA binding,double-stranded DNA binding,single-stranded DNA binding,transcription factor activity, sequence-specific DNA binding,cytokine activity,protein binding,transcription factor binding,DNA binding, bending,lyase activity,C-X-C chemokine binding,chemoattractant activity,poly(A) RNA binding,RAGE receptor binding,DNA polymerase binding,repressing transcription factor binding,supercoiled DNA binding","condensed chromosome,extracellular region,extracellular space,nucleus,nucleoplasm,endosome,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,cell surface,transcriptional repressor complex",3,26,57,RPPSAFFLFC[CAM]SEYRPK.3|RPPSAFFLFC[CAM]SEYRPK.4|RPPSAFFLFC[CAM]SEYRPK.2|IKGEHPGLSIGDVAKK.4|IKGEHPGLSIGDVAKK.3|GEHPGLSIGDVAK.3|GEHPGLSIGDVAK.2|KHPDASVNFSEFSKK.4|KHPDASVNFSEFSKK.3|KKHPDASVNFSEFSK.4|KKHPDASVNFSEFSK.3|FKDPNAPK.2|GKFEDMAK.2|GKFEDM[Oxi]AK.2|GEHPGLSIGDVAKK.3|HPDASVNFSEFSK.3|HPDASVNFSEFSK.2|MSSYAFFVQTC[CAM]R.3|M[Oxi]SSYAFFVQTC[CAM]R.2|MSSYAFFVQTC[CAM]R.2|IKGEHPGLSIGDVAK.3|IKGEHPGLSIGDVAK.2|M[Oxi]SSYAFFVQTC[CAM]REEHK.4|MSSYAFFVQTC[CAM]REEHK.4|MSSYAFFVQTC[CAM]REEHK.3|M[Oxi]SSYAFFVQTC[CAM]REEHK.3|MSSYAFFVQTC[CAM]REEHK.2|KFKDPNAPK.2|HPDASVNFSEFSKK.3|HPDASVNFSEFSKK.2|KHPDASVNFSEFSK.3|KHPDASVNFSEFSK.2|KLGEMWNNTAADDK.3|KLGEM[Oxi]WNNTAADDK.3|KLGEM[Oxi]WNNTAADDK.2|KLGEMWNNTAADDK.2|MSSYAFFVQTC[CAM]REEHKK.4|MSSYAFFVQTC[CAM]REEHKK.3|KLGEMWNNTAADDKQPYEK.4|KLGEM[Oxi]WNNTAADDKQPYEK.4|KLGEM[Oxi]WNNTAADDKQPYEK.3|KLGEMWNNTAADDKQPYEK.3|KLGEMWNNTAADDKQPYEK.2|LGEMWNNTAADDKQPYEKK.4|LGEM[Oxi]WNNTAADDKQPYEKK.4|LGEMWNNTAADDKQPYEKK.3|LGEMWNNTAADDKQPYEKK.2|TYIPPKGETK.2|YEKDIAAYR.2|FKDPNAPKRPPSAFFLFC[CAM]SEYRPK.5|EKYEKDIAAYR.2|LGEMWNNTAADDKQPYEK.3|LGEM[Oxi]WNNTAADDKQPYEK.3|LGEMWNNTAADDKQPYEK.2|LGEMWNNTAADDK.2|LGEM[Oxi]WNNTAADDK.2|GKMSSYAFFVQTC[CAM]R.2
SEN / CTL,P24821,Tenascin,TNC,2.46,1.40,1.50E-22,7.62E-22,2.11E+01,"osteoblast differentiation,cell adhesion,negative regulation of cell adhesion,neuromuscular junction development,positive regulation of cell proliferation,response to wounding,response to mechanical stimulus,positive regulation of gene expression,peripheral nervous system axon regeneration,extracellular matrix organization,wound healing,odontogenesis of dentin-containing tooth,response to ethanol,bud outgrowth involved in lung branching,mesenchymal-epithelial cell signaling involved in prostate gland development,prostate gland epithelium morphogenesis,cellular response to retinoic acid,cellular response to vitamin D,response to fibroblast growth factor,cellular response to prostaglandin D stimulus",syndecan binding,"extracellular region,basement membrane,interstitial matrix,extracellular space,focal adhesion,membrane,extracellular matrix",63,77,105,TAHISGLPPSTDFIVYLSGLAPSIR.3|TAHISGLPPSTDFIVYLSGLAPSIR.4|GLEPGQEYNVLLTAEK.2|ITAQGQYELR.2|WQPAIATVDSYVISYTGEKVPEITR.3|WQPAIATVDSYVISYTGEKVPEITR.4|AGTPYTVTLHGEVR.3|AGTPYTVTLHGEVR.2|VSIYGVIR.2|SFSTFDKDTDSAITNC[CAM]ALSYK.3|C[CAM]VNGQC[CAM]VC[CAM]DEGYTGEDC[CAM]SQLR.3|TVSGNTVEYALTDLEPATEYTLR.3|TVSGNTVEYALTDLEPATEYTLR.4|AATPYTVSIYGVIQGYR.3|AATPYTVSIYGVIQGYR.2|KQSEPLEITLLAPER.3|KQSEPLEITLLAPER.2|QSEPLEITLLAPER.2|VPGDQTSTIIQELEPGVEYFIR.3|VPGDQTSTIIQELEPGVEYFIR.4|AVDIPGLEAATPYR.2|AVDIPGLEAATPYR.3|GLEPGQEYNVLLTAEKGR.3|GLEPGQEYNVLLTAEKGR.2|GHSTRPLAVEVVTEDLPQLGDLAVSEVGWDGLR.4|AVDIPGLK.2|STDLPGLK.2|RAC[CAM]GC[CAM]AAAPDVK.3|RPETSYR.2|AYAAGFGDR.2|VDLRDHGETAFAVYDK.4|VDLRDHGETAFAVYDK.3|GHEHSIQFAEMK.3|GHEHSIQFAEMK.2|IKYAPISGGDHAEVDVPK.4|IQALNGPLR.2|YGDNNHSQGVNWFHWK.4|YGDNNHSQGVNWFHWK.3|C[CAM]VC[CAM]EQGFK.2|VATYLPAPEGLKFK.3|FTTDLDSPR.2|VFAILENKK.2|REEFWLGLDNLNK.3|APTAQVESFR.2|LDAPSQIEVK.2|VTTTRLDAPSQIEVK.3|YAPISGGDHAEVDVPK.3|YAPISGGDHAEVDVPK.2|LIPGVEYLVSIIAM[Oxi]K.3|LIPGVEYLVSIIAM[Oxi]K.2|LIPGVEYLVSIIAMK.2|RGDM[Oxi]SSNPAKETFTTGLDAPR.4|RGDM[Oxi]SSNPAKETFTTGLDAPR.3|DLTATEVQSETALLTWRPPR.4|DLTATEVQSETALLTWRPPR.3|RVSQTDNSITLEWR.3|TPVLSAEASTAK.2|C[CAM]VNGQC[CAM]VC[CAM]HEGFMGK.3|C[CAM]VNGQC[CAM]VC[CAM]HEGFM[Oxi]GK.3|ESNPATINAATELDTPK.3|ESNPATINAATELDTPK.2|ETFTTGLDAPR.2|VATYLPAPEGLK.2|AYAAGFGDRREEFWLGLDNLNK.4|TRDITGLREATEYEIELYGISK.4|VDLRDHGETAFAVYDKFSVGDAK.4|IKYAPISGGDHAEVDVPKSQQATTK.4|EVIVGPDTTSYSLADLSPSTHYTAK.4|EVIVGPDTTSYSLADLSPSTHYTAK.3|QTGLAPGQEYEISLHIVK.3|QTGLAPGQEYEISLHIVK.2|DHGETAFAVYDK.2|TTLTGLRPGTEYGIGVSAVK.3|TTLTGLRPGTEYGIGVSAVK.2|ITYVPITGGTPSM[Oxi]VTVDGTK.3|ITYVPITGGTPSMVTVDGTK.3|ITYVPITGGTPSMVTVDGTK.2|LEELENLVSSLR.2|WQPAIATVDSYVISYTGEK.3|WQPAIATVDSYVISYTGEK.2|SNM[Oxi]IQTIFTTIGLLYPFPK.3|EEFWLGLDNLNK.2|DVTDTTALITWFK.2|SQTVSAIATTAMGSPK.2|SQTVSAIATTAM[Oxi]GSPK.2|VSQTDNSITLEWR.2|DLAPPSEPSESFQEHTVDGENQIVFTHR.4|DTDSAITNC[CAM]ALSYK.2|YAPISGGDHAEVDVPKSQQATTK.3|C[CAM]VNGMC[CAM]VC[CAM]DDGYTGEDC[CAM]RDR.3|PLAEIDGIELTYGIK.2|FTTDLDSPRDLTATEVQSETALLTWRPPR.4|TTLTGLRPGTEYGIGVSAVKEDKESNPATINAATELDTPK.5|VTEYLVVYTPTHEGGLEM[Oxi]QFR.3|VTEYLVVYTPTHEGGLEMQFR.3|TTIDLTEDENQYSIGNLKPDTEYEVSLISR.4|TTIDLTEDENQYSIGNLKPDTEYEVSLISR.3|EQC[CAM]TAGAGC[CAM]C[CAM]LQPATGR.2|LPVGSQC[CAM]SVDLESASGEK.2|LSWTADEGVFDNFVLK.2|C[CAM]VDGQC[CAM]IC[CAM]HEGFTGLDC[CAM]GQHSC[CAM]PSDC[CAM]NNLGQC[CAM]VSGR.4|DVPGDRTTIDLTEDENQYSIGNLKPDTEYEVSLISR.4|DVTDTTALITWFKPLAEIDGIELTYGIK.3|TPVLSAEASTGETPNLGEVVVAEVGWDALK.3|C[CAM]IC[CAM]NEGYSGEDC[CAM]SEVSPPK.2
SEN / CTL,Q14766,Latent-transforming growth factor beta-binding protein 1,LTBP1,2.43,1.51,9.20E-07,5.55E-07,6.26E+00,"ventricular septum development,transmembrane receptor protein serine/threonine kinase signaling pathway,sequestering of TGFbeta in extracellular matrix,aorta development,coronary vasculature development","transforming growth factor beta-activated receptor activity,calcium ion binding,protein binding,transforming growth factor beta binding,microfibril binding","microfibril,extracellular region,proteinaceous extracellular matrix,extracellular matrix,protein complex",18,35,44,VQEGYTC[CAM]DC[CAM]FDGYHLDTAK.3|MTC[CAM]VDVNEC[CAM]DELNNR.2|C[CAM]VDIDEC[CAM]TQVQHLC[CAM]SQGR.3|KC[CAM]VDIDEC[CAM]TQVQHLC[CAM]SQGR.4|KC[CAM]VDIDEC[CAM]TQVQHLC[CAM]SQGR.3|ASGLGDHC[CAM]EDINEC[CAM]LEDK.3|ASGLGDHC[CAM]EDINEC[CAM]LEDK.2|ALGTHVIHSTHTLPLTVTSQQGVK.4|ALGTHVIHSTHTLPLTVTSQQGVK.3|LC[CAM]QIPVHGASVPK.3|LC[CAM]QIPVHGASVPK.2|SKVPQETQSGGGSR.3|HPPEASVQIHQVSR.3|DQC[CAM]EDIDEC[CAM]QHR.3|DQC[CAM]EDIDEC[CAM]QHR.2|QGTYYDPVK.2|EIC[CAM]PGGMGYTVSGVHR.3|LYQHSQQPGK.2|C[CAM]EYC[CAM]DSGYR.2|TSTDLDVDVDQPKEEK.3|TSTDLDVDVDQPKEEK.2|VPQETQSGGGSR.2|DSDDYAQLC[CAM]NIPVTGR.3|DSDDYAQLC[CAM]NIPVTGR.2|EEPVEALTFSR.2|TKLEPGQPQLSPGISTIHLHPQFPVVIEK.5|TQTIHSTYSHQQVIPHVYPVAAK.4|QQLQGVNVC[CAM]GGR.2|C[CAM]FQETIGSQC[CAM]GK.2|C[CAM]TC[CAM]GQGYQLSAAK.2|TSTDLDVDVDQPK.2|LEPGQPQLSPGISTIHLHPQFPVVIEK.4|C[CAM]LC[CAM]LPGYVPSDKPNYC[CAM]TPLNTALNLEK.4|C[CAM]LC[CAM]LPGYVPSDKPNYC[CAM]TPLNTALNLEK.3|GISGEQSTEGSFPLR.2|IGFGPDPTFSSC[CAM]VPDPPVISEEK.3|DALVDFSEQYTPEADPYFIQDR.3|GFVPAGESSSEAGGENYKDADEC[CAM]LLFGQEIC[CAM]K.4|GFVPAGESSSEAGGENYKDADEC[CAM]LLFGQEIC[CAM]K.3|FLNSFEELQAEEC[CAM]GILNGC[CAM]ENGR.3|GFVPAGESSSEAGGENYK.2|QEDC[CAM]C[CAM]GTVGTSWGFNK.2|EAQPGQSQVSYQGLPVQK.2|C[CAM]IRPAESNEQIEETDVYQDLC[CAM]WEHLSDEYVC[CAM]SR.4
SEN / CTL,P10619,Lysosomal protective protein,CTSA,2.41,1.89,1.09E-02,3.00E-03,2.52E+00,"proteolysis,glycosphingolipid metabolic process,intracellular protein transport,regulation of protein stability,positive regulation of catalytic activity,proteolysis involved in cellular protein catabolic process,regulation of chaperone-mediated autophagy,negative regulation of chaperone-mediated autophagy","carboxypeptidase activity,serine-type carboxypeptidase activity,exo-alpha-sialidase activity,enzyme activator activity","nucleoplasm,lysosome,endoplasmic reticulum,membrane,lysosomal lumen,intracellular membrane-bounded organelle,extracellular exosome,lumenal side of lysosomal membrane",6,15,29,C[CAM]NFYDNKDLEC[CAM]VTNLQEVAR.3|GAGHMVPTDKPLAAFTMFSR.4|GAGHM[Oxi]VPTDKPLAAFTMFSR.4|GAGHMVPTDKPLAAFTM[Oxi]FSR.4|GAGHM[Oxi]VPTDKPLAAFTM[Oxi]FSR.4|GAGHMVPTDKPLAAFTMFSR.3|GAGHM[Oxi]VPTDKPLAAFTMFSR.3|GAGHMVPTDKPLAAFTM[Oxi]FSR.3|EFSHIAFLTIK.3|EFSHIAFLTIK.2|C[CAM]NFYDNK.2|SMNSQYLK.2|SM[Oxi]NSQYLK.2|HLHYWFVESQK.3|HLHYWFVESQK.2|DLEC[CAM]VTNLQEVAR.3|DLEC[CAM]VTNLQEVAR.2|PLAAFTMFSR.2|PLAAFTM[Oxi]FSR.2|LWSSLQTHC[CAM]C[CAM]SQNK.3|LWSSLQTHC[CAM]C[CAM]SQNK.2|YGDSGEQIAGFVKEFSHIAFLTIK.4|IVGNSGLNIYNLYAPC[CAM]AGGVPSHFR.4|YGDSGEQIAGFVK.2|ALNIPEQLPQWDMC[CAM]NFLVNLQYR.4|ALNIPEQLPQWDM[Oxi]C[CAM]NFLVNLQYR.3|ALNIPEQLPQWDMC[CAM]NFLVNLQYR.3|DTVVVQDLGNIFTR.2|KALNIPEQLPQWDMC[CAM]NFLVNLQYR.3
SEN / CTL,P07339,Cathepsin D,CTSD,2.39,1.33,1.42E-09,1.34E-09,8.87E+00,"proteolysis,autophagy,antigen processing and presentation of exogenous peptide antigen via MHC class II,protein catabolic process,collagen catabolic process","aspartic-type endopeptidase activity,cysteine-type endopeptidase activity,serine-type endopeptidase activity","extracellular region,extracellular space,lysosome,melanosome,lysosomal lumen,membrane raft,extracellular exosome,extracellular matrix",24,30,62,FDGILGMAYPR.2|FDGILGM[Oxi]AYPR.2|QVFGEATKQPGITFIAAK.3|QVFGEATKQPGITFIAAK.2|AIGAVPLIQGEYMIPC[CAM]EK.2|AIGAVPLIQGEYMIPC[CAM]EK.3|AIGAVPLIQGEYM[Oxi]IPC[CAM]EK.3|AIGAVPLIQGEYM[Oxi]IPC[CAM]EK.2|ISVNNVLPVFDNLMQQK.3|ISVNNVLPVFDNLMQQK.2|ISVNNVLPVFDNLM[Oxi]QQK.3|ISVNNVLPVFDNLM[Oxi]QQK.2|LVDQNIFSFYLSRDPDAQPGGELMLGGTDSK.4|LVDQNIFSFYLSRDPDAQPGGELM[Oxi]LGGTDSK.3|LVDQNIFSFYLSRDPDAQPGGELMLGGTDSK.3|TMSEVGGSVEDLIAK.2|TMSEVGGSVEDLIAK.3|TM[Oxi]SEVGGSVEDLIAK.2|VGFAEAAR.2|VGFAEAAR.1|LGGKGYKLSPEDYTLK.4|LGGKGYKLSPEDYTLK.3|GYKLSPEDYTLK.3|GYKLSPEDYTLK.2|LLDIAC[CAM]WIHHK.3|LLDIAC[CAM]WIHHK.2|YYTVFDR.2|YYTVFDRDNNR.3|YYTVFDRDNNR.2|GYKLSPEDYTLKVSQAGK.4|GYKLSPEDYTLKVSQAGK.3|QPGITFIAAK.2|VSTLPAITLK.2|LSPEDYTLK.2|LVDQNIFSFYLSR.3|LVDQNIFSFYLSR.2|LSPEDYTLKVSQAGK.3|LSPEDYTLKVSQAGK.2|YYTVFDRDNNRVGFAEAAR.4|YYTVFDRDNNRVGFAEAAR.3|AYWQVHLDQVEVASGLTLC[CAM]K.4|AYWQVHLDQVEVASGLTLC[CAM]K.3|AYWQVHLDQVEVASGLTLC[CAM]K.2|DPDAQPGGELMLGGTDSK.3|DPDAQPGGELMLGGTDSK.2|DPDAQPGGELM[Oxi]LGGTDSK.2|KAYWQVHLDQVEVASGLTLC[CAM]K.4|KAYWQVHLDQVEVASGLTLC[CAM]K.3|YSQAVPAVTEGPIPEVLK.3|YSQAVPAVTEGPIPEVLK.2|YNSDKSSTYVK.2|QPGITFIAAKFDGILGMAYPR.3|EGC[CAM]EAIVDTGTSLMVGPVDEVR.3|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVR.3|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVR.2|EGC[CAM]EAIVDTGTSLMVGPVDEVR.2|QVFGEATKQPGITFIAAKFDGILGMAYPR.4|QVFGEATKQPGITFIAAKFDGILGMAYPR.3|QVFGEATK.1|EGC[CAM]EAIVDTGTSLM[Oxi]VGPVDEVRELQK.3|EGC[CAM]EAIVDTGTSLMVGPVDEVRELQK.3|TLC[CAM]LSGFM[Oxi]GM[Oxi]DIPPPSGPLWILGDVFIGR.3
SEN / CTL,P40261,Nicotinamide N-methyltransferase,NNMT,2.37,0.90,5.98E-04,2.29E-04,3.64E+00,"response to organonitrogen compound,animal organ regeneration,methylation,response to drug","nicotinamide N-methyltransferase activity,pyridine N-methyltransferase activity",cytosol,6,13,20,NLGSLLKPGGFLVIMDALK.3|NLGSLLKPGGFLVIM[Oxi]DALK.3|NLGSLLKPGGFLVIMDALK.2|KEPEAFDWSPVVTYVC[CAM]DLEGNR.3|KEPEAFDWSPVVTYVC[CAM]DLEGNR.4|DTYLSHFNPR.3|DTYLSHFNPR.2|IFC[CAM]LDGVK.2|HSAESQILK.2|GPEKEEKLR.2|SSYYMIGEQK.2|SSYYM[Oxi]IGEQK.2|PGGFLVIMDALK.2|EIVVTDYSDQNLQELEK.3|EIVVTDYSDQNLQELEK.2|KEPEAFDWSPVVTYVC[CAM]DLEGNRVK.4|KEPEAFDWSPVVTYVC[CAM]DLEGNRVK.3|EPEAFDWSPVVTYVC[CAM]DLEGNR.3|GDLLIDIGSGPTIYQLLSAC[CAM]ESFK.3|C[CAM]DVTQSQPLGAVPLPPADC[CAM]VLSTLC[CAM]LDAAC[CAM]PDLPTYC[CAM]R.4
SEN / CTL,Q15149,Plectin,PLEC,2.35,1.93,5.40E-22,2.41E-21,2.06E+01,"hemidesmosome assembly,cell-cell adhesion","actin binding,protein binding,structural constituent of muscle,ankyrin binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cytosol,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,sarcoplasm,hemidesmosome,extracellular matrix,sarcolemma,costamere,intermediate filament cytoskeleton,extracellular exosome",117,489,728,VLADPSDDTKGFFDPNTHENLTYR.4|IISLETYNLLR.2|SQVEEELFSVR.2|LGFHLPLEVAYQR.3|LGFHLPLEVAYQR.2|LTAEDLFEAR.2|WQAVLAQTDVR.2|YYRESADPLGAWLQDAR.3|LTVDEAVR.2|LSVAAQEAAR.2|LLDPEDVDVPQPDEK.2|LLDPEDVDVPQPDEK.3|LREQLQLLEEQHR.4|LREQLQLLEEQHR.3|LREQLQLLEEQHR.2|HISDLYEDLRDGHNLISLLEVLSGDSLPR.4|HISDLYEDLRDGHNLISLLEVLSGDSLPR.5|QTNLENLDQAFSVAERDLGVTR.3|QVQVALETAQR.2|FLEGTSC[CAM]IAGVFVDATKER.3|FLEGTSC[CAM]IAGVFVDATKER.2|LRLQAEEVAQQK.3|LRLQAEEVAQQK.2|AALAHSEEVTASQVAATK.3|AALAHSEEVTASQVAATK.4|AALAHSEEVTASQVAATK.2|AGTLSITEFADMLSGNAGGFR.3|AGTLSITEFADM[Oxi]LSGNAGGFR.3|AGTLSITEFADMLSGNAGGFR.2|SIQEELQQLR.2|LTVEEAVR.2|QAEVELASR.2|SIITYVSSLYDAMPR.3|SIITYVSSLYDAMPR.2|SIITYVSSLYDAM[Oxi]PR.3|SIITYVSSLYDAM[Oxi]PR.2|ESADPLGAWLQDAR.2|ESADPLGAWLQDAR.3|AGVVGPELHEQLLSAEK.3|AGVVGPELHEQLLSAEK.2|LQNVQIALDYLR.2|LQNVQIALDYLR.3|VLALPEPSPAAPTLR.2|VLALPEPSPAAPTLR.3|DDGTGQLLLPLSDAR.2|DDGTGQLLLPLSDAR.3|AGEVERDLDKADSMIR.3|AGEVERDLDKADSMIR.4|LLEAQIATGGIIDPVHSHRVPVDVAYQR.5|LLEAQIATGGIIDPVHSHRVPVDVAYQR.4|LLEAQIATGGIIDPVHSHRVPVDVAYQR.3|C[CAM]VEDPETGLC[CAM]LLPLTDK.3|C[CAM]VEDPETGLC[CAM]LLPLTDK.2|LISLFQAMK.2|LISLFQAM[Oxi]K.2|QYINAIKDYELQLVTYK.3|QYINAIKDYELQLVTYK.2|C[CAM]ITDPQTGLC[CAM]LLPLKEK.3|C[CAM]ITDPQTGLC[CAM]LLPLKEK.2|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.5|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.6|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.4|QVEVTVHKGDEC[CAM]QLVGPAQPSHWK.3|EGVVGPELHHK.3|EGVVGPELHHK.2|GLHQSIEEFR.3|GLHQSIEEFR.2|HKPLLIDMNK.3|HKPLLIDMNK.2|KGLVGPELHDR.3|KGLVGPELHDR.2|LREAIAELER.3|LREAIAELER.2|MGIVGPEFKDK.3|MGIVGPEFKDK.2|RLEEQAAQHK.3|RLEEQAAQHK.2|RPELEDSTLR.3|RPELEDSTLR.2|RQHEAEEGVR.3|TISLVIR.2|VKAEAEAAREK.3|ERLSVYQAMK.3|ERLSVYQAMK.2|HGERDVEVER.3|LQLEETDHQK.3|LQLEETDHQK.2|QLQLAQEAAQK.3|QLQLAQEAAQK.2|QRELAEQELEKQR.4|QRELAEQELEKQR.3|RLAEDEAFQR.3|RLAEDEAFQR.2|SKEQAELEAAR.3|SKEQAELEAAR.2|VAQLLER.2|ARAEEAEAQKR.3|ARAEEAEAQKR.2|FLQEEAEKMK.3|FLQEEAEKMK.2|HISDLYEDLR.3|HISDLYEDLR.2|LPLDKEPAREC[CAM]AQR.4|RQVEEAERLK.3|AHEEQLK.2|ANELQLR.2|EDVRHYLQGR.3|EQLNEYKGHLSGLAK.4|GAQEVGER.2|HGEKVEEC[CAM]QR.3|KQEELQQLEQQRR.4|KQEELQQLEQQRR.3|KQEELQQLEQQRR.2|LDLQYAK.2|QYINAIK.2|RKQEELQQLEQQR.4|RKQEELQQLEQQR.3|RKQEELQQLEQQR.2|SALDQYR.2|SLVPAAELLESR.3|SLVPAAELLESR.2|AQFEQLK.2|AQQLREEQQR.3|AQQLREEQQR.2|AQVEQELTTLR.3|AQVEQELTTLR.2|AVTGYKDPYSGK.3|AVTGYKDPYSGK.2|FAEQTLR.2|FISETLR.2|KASDSELERQK.3|LRLPLDKEPAR.3|QTLSIYQALKK.3|QTLSIYQALKK.2|ALAEEAKR.2|ATVSAPFGK.2|GLVGPELHDRLLSAER.4|LHRTELATQEK.3|LHRTELATQEK.2|LTVNEAVK.2|QVAEEAAR.2|RLTAEDLFEAR.3|RLTAEDLFEAR.2|RQVEEEILALK.3|RQVEEEILALK.2|TEAEIALK.2|VAGMLMPR.2|LC[CAM]FEGLR.2|QRQLAEAHAQAK.3|QRQLAEAHAQAK.2|SVRDVAEVDTVR.3|SVRDVAEVDTVR.2|VPPGYHPLDVEK.3|VPPGYHPLDVEK.2|VRAEMEVLLASK.3|VRAEMEVLLASK.2|AGLVGPEFHEKLLSAEK.4|AGLVGPEFHEKLLSAEK.3|ASDSELER.2|AVVQLKPR.2|EAEGQLQK.2|ELQNAGDR.2|GLVEDTLR.2|LAAIGEATR.2|LAEVEAALEKQR.3|LKQSAEEQAQAR.3|LKQSAEEQAQAR.2|QALHSLELHYQAFLR.4|QALHSLELHYQAFLR.3|QALHSLELHYQAFLR.2|RQHEAEEGVRR.3|SNAEDTLR.2|SSIAGLLLK.2|AALEEVER.2|AQAEVEGLGKGVAR.3|AQAEVEGLGKGVAR.2|AREEAERELER.3|ARSDEGQLSPATR.3|ARSDEGQLSPATR.2|EAIAELER.2|ELAEQELEKQR.3|GLLSAEVAR.2|LKTEAEIALKEK.3|LLLWSQR.2|LSIYNALK.2|QLQLAQEAAQKR.3|QRELAEQELEK.3|QRELAEQELEK.2|QRGGAEGELQALR.3|QRGGAEGELQALR.2|QRQLAEGTAQQR.3|REEAAVDAQQQK.3|REEAAVDAQQQK.2|SHRVPLDVAC[CAM]AR.3|SHRVPLDVAC[CAM]AR.2|TELATQEK.2|VPPGYHPLDVEKEWGK.4|VPVDVAYR.2|ELAQEQAR.2|EQLRQEQALLEEIERHGEK.5|GRLPLLAVC[CAM]DYK.3|GRLPLLAVC[CAM]DYK.2|LAQGHTTVDELAR.3|LAQGHTTVDELAR.2|LEDLLQDAQDEK.3|LEDLLQDAQDEK.2|LKAEAELLQQQK.3|LKAEAELLQQQK.2|LSVYQAMK.2|PLLIDMNK.2|RSIQEELQQLR.3|RSIQEELQQLR.2|TTVKDLSELGSVR.3|TTVKDLSELGSVR.2|VKAEAEAAR.2|AAAGKAELELELGR.3|AAAGKAELELELGR.2|EQLQLLEEQHR.3|EQLQLLEEQHR.2|GAYRDC[CAM]LGRLDLQYAK.4|GAYRDC[CAM]LGRLDLQYAK.3|IIITVVEEQEQK.3|IIITVVEEQEQK.2|KGLVGPELHDRLLSAER.4|LHVAILER.2|LQAEEAER.2|QLAAEEER.2|SLAQAEAEK.2|AQAEQAALR.2|ARIEAENR.2|ESYSALMR.2|LEAQHQALVTLWHQLHVDMK.5|LEAQHQALVTLWHQLHVDMK.4|LEAQHQALVTLWHQLHVDM[Oxi]K.4|LEAQHQALVTLWHQLHVDM[Oxi]K.3|LQLEATER.2|LRAETEQGEQQR.3|LRAETEQGEQQR.2|LYVHEAVK.2|QRQLEMSAEAER.3|RLEEQAAQHKADIEER.4|RLEEQAAQHKADIEER.3|SAEAELQSK.2|SGRQYDIDDAIAK.3|SWSLATFR.2|VLAEKLAAIGEATR.3|VQMEELSK.2|VQM[Oxi]EELSK.2|VSIYEAMR.2|VSIYEAM[Oxi]R.2|AAEEAEEAR.2|ARQVQVALETAQR.3|ARQVQVALETAQR.2|DLSELGSVR.2|LREAIAELEREK.3|MGIVGPEFK.2|QQGLASYDYVRR.3|SLESLHSFVAAATK.3|SLESLHSFVAAATK.2|SQVMDEATALQLR.3|SQVMDEATALQLR.2|SQVM[Oxi]DEATALQLR.2|TLARPGPEPAPATDERDR.4|TLARPGPEPAPATDERDR.3|DGRHPQGEQMYR.3|DGRHPQGEQM[Oxi]YR.3|FPVTDAVNK.2|LFNAIIHR.2|QAADAEMEK.2|QAADAEM[Oxi]EK.2|QQEELLAEENQR.3|QQEELLAEENQR.2|QVQDESQR.2|SELELTLGK.2|SLQEEHVAVAQLR.3|SLQEEHVAVAQLR.2|VPDVQDGVR.2|AHAFAVQQK.2|AQAEVEGLGK.2|DVAEVDTVR.2|FLQEEAEK.2|LSYTQLLR.2|LVASMEEAR.2|LVASM[Oxi]EEAR.2|QLAEEDAAR.2|SVRDVAEVDTVRR.3|TLKPEEQR.2|VPLDVAC[CAM]AR.2|AIYEVLFR.2|AKLEQLFQDEVAK.3|AKLEQLFQDEVAK.2|DTHDQLSEPSEVR.3|DTHDQLSEPSEVR.2|EQAELEAAR.2|ILITIVEEVETLR.3|ILITIVEEVETLR.2|LLEAQIATGGIIDPVHSHR.4|LLEAQIATGGIIDPVHSHR.3|LLEAQIATGGIIDPVHSHR.2|LLEAQIATGGVIDPVHSHR.4|LLEAQIATGGVIDPVHSHR.3|LLEAQIATGGVIDPVHSHR.2|REEAAVDAQQQKR.3|RQVEEAER.2|AELELELGR.2|AQQQAEAER.2|FKEMELPAKEADK.3|LLDAQLATGGIVDPR.3|LLDAQLATGGIVDPR.2|LLEAAAQSTK.2|LLEAQIATGGVIDPVHSHRVPVDVAYRR.6|LLEAQIATGGVIDPVHSHRVPVDVAYRR.5|LLEAQIATGGVIDPVHSHRVPVDVAYRR.4|LSVYAALQR.2|LTVDEAVRK.2|LTVNEAVKEGVVGPELHHK.4|LTVNEAVKEGVVGPELHHK.3|MQAVQEATR.2|M[Oxi]QAVQEATR.2|QRLEAEAGR.2|RLTVNEAVK.2|SLSAIYLEK.2|AAEEAEEARVQAER.3|ALQALEELR.2|APVPASELLASGVLSR.3|APVPASELLASGVLSR.2|AQAEREAKELQQR.3|ATNEKLSVYAALQR.3|ATNEKLSVYAALQR.2|GYLNKDTHDQLSEPSEVR.4|GYLNKDTHDQLSEPSEVR.3|IAEQQKAQAEVEGLGKGVAR.4|IAEQQKAQAEVEGLGKGVAR.3|KAALEEVER.2|KASDSELER.2|KGLLSAEVAR.2|KQEELQQLEQQR.3|KQEELQQLEQQR.2|LAAEQELIR.2|LAQGHTTVDELARR.3|LLEAQIATGGIIDPEESHRLPVEVAYKR.6|LLEAQIATGGIIDPEESHRLPVEVAYKR.5|LLEAQIATGGIIDPEESHRLPVEVAYKR.4|LLEAQIATGGIIDPEESHRLPVEVAYKR.3|LQEAGILSAEELQR.3|LQEAGILSAEELQR.2|LRQLAEEDLAQQR.3|LRQLAEEDLAQQR.2|SLAAEEEAAR.2|SLQEEHVAVAQLREEAER.4|SLQEEHVAVAQLREEAER.3|VAQLLERWQAVLAQTDVR.4|VAQLLERWQAVLAQTDVR.3|VIDRELYQQLQR.3|VIDRELYQQLQR.2|VPLDEALQR.2|VPVDVAYQR.2|VSITEAMHR.2|ARQEELYSELQAR.3|ARQEELYSELQAR.2|GTQGAEEVLR.2|LKAEATEAAR.2|LRIEEEIR.2|MVEGYQGLR.2|M[Oxi]VEGYQGLR.2|NDDIADGNPK.2|QHEAEEGVR.2|RRQEQIQAMPLADSQAVR.4|RRQEQIQAMPLADSQAVR.3|RRQEQIQAMPLADSQAVR.2|VLADPSDDTK.2|VVIVDPETGK.2|ELYQQLQR.2|GC[CAM]LDEETSR.2|LAEDEAFQR.2|LAEVEAALEK.2|LLDAQLSTGGIVDPSK.3|LLDAQLSTGGIVDPSK.2|QLAEAHAQAK.2|QRSQVEEELFSVR.3|QRSQVEEELFSVR.2|SELELTLGKLEQVR.3|SELELTLGKLEQVR.2|SLLAWQSLR.2|SMVEEGTGLR.2|SM[Oxi]VEEGTGLR.2|TPHVQAVQGPLGSPPK.3|AEMEVLLASK.2|ELAEQELEK.2|ISYKDALDR.2|KESYSALMR.2|QSSEAEIQAK.2|YYRESADPLGAWLQDARR.4|AFC[CAM]GFEDPR.2|DPYTGQSVSLFQALK.3|DPYTGQSVSLFQALK.2|GGAEGELQALR.2|GLVGPELHDR.2|HHTAAFEER.2|IIITVVEEQEQKGR.3|LVNIRNDDIADGNPK.3|LVNIRNDDIADGNPK.2|QLAAEEERR.2|QLAEGTAQQR.2|QLLEEELAR.2|RLTVNEAVKEGVVGPELHHK.4|RQQEELLAEENQR.3|RQQEELLAEENQR.2|AQLEPVASPAK.2|EAQAVPATLPELEATK.3|EAQAVPATLPELEATK.2|GIYQSLEGAVQAGQLK.3|GIYQSLEGAVQAGQLK.2|LQLEAC[CAM]ETR.2|QITMEELVR.2|QSAEEQAQAR.2|RAQAEQAALR.2|TLARPGPEPAPATDER.3|AGEVERDLDK.2|C[CAM]ISELKDIR.2|DALDGPAAEAEPEHSFDGLRR.4|DALDGPAAEAEPEHSFDGLRR.3|DDGTGQLLLPLSDARK.3|ESADPLGAWLQDARR.3|GYFSEEMNR.2|LSAEAEKVLALPEPSPAAPTLR.4|LSAEAEKVLALPEPSPAAPTLR.3|LSAEAEKVLALPEPSPAAPTLR.2|NLLDEELQR.2|NLVDNITGQR.2|QRELEQLGR.2|RAAEEAEEAR.2|RKELEEVSPETPVVPATTQR.4|SLQEEHVAVAQLREEAERR.4|SLQEEHVAVAQLREEAERR.3|TPVEVPVGGFK.2|EMSVYEAYR.2|GFFDPNTHENLTYR.3|GFFDPNTHENLTYR.2|HPQGEQMYR.2|IKELQNAGDR.2|KGIIRPGTAFELLEAQAATGYVIDPIK.5|KGIIRPGTAFELLEAQAATGYVIDPIK.4|KGIIRPGTAFELLEAQAATGYVIDPIK.3|LQAEEVAQQK.2|RAAEEAEEARVQAER.3|AEAELLQQQK.2|AVTGYRDPYTGQSVSLFQALK.4|AVTGYRDPYTGQSVSLFQALK.3|AVTGYRDPYTGQSVSLFQALK.2|C[CAM]ITDPQTGLC[CAM]LLPLK.3|C[CAM]ITDPQTGLC[CAM]LLPLK.2|DVAEVDTVRR.2|GFFDPNTHENLTYLQLLER.4|GFFDPNTHENLTYLQLLER.3|GFFDPNTHENLTYLQLLER.2|GYFDEEMNR.2|GYFDEEM[Oxi]NR.2|LRSLESLHSFVAAATK.3|LVASMEEARR.2|QYDIDDAIAK.2|RDDGTGQLLLPLSDAR.3|RDDGTGQLLLPLSDAR.2|RQAEVELASR.2|SDEGQLSPATR.2|SYVDPSTDERLSYTQLLRR.4|TLPNGRDALDGPAAEAEPEHSFDGLRR.5|TLPNGRDALDGPAAEAEPEHSFDGLRR.4|VVIVDPETGKEMSVYEAYRK.4|VVIVDPETGKEMSVYEAYRK.3|AETEQGEQQR.2|AQFEQLKDGK.2|C[CAM]DNFTSSWR.2|C[CAM]VEDPETGLR.2|ELIPTEEALR.2|IRSNAEDTLR.2|LKAEAELLQQQKELAQEQAR.4|LKAEAELLQQQKELAQEQAR.3|LLEAQIATGGVIDPVHSHRVPVDVAYR.5|LLEAQIATGGVIDPVHSHRVPVDVAYR.4|LLEAQIATGGVIDPVHSHRVPVDVAYR.3|LRAQAEAQQPTFDALRDELR.4|LRAQAEAQQPTFDALRDELR.3|LRAQAEAQQPTFDALRDELR.2|QLEMSAEAER.2|QLEM[Oxi]SAEAER.2|QTLSIYQALK.2|QVEEEILALK.2|SSSVGSSSSYPISPAVSR.3|SSSVGSSSSYPISPAVSR.2|SYVDPSTDER.2|AGLVGPEFHEK.2|DPYSGSTISLFQAMQK.3|DPYSGSTISLFQAMQK.2|DPYTGQSVSLFQALKK.3|DPYTGQSVSLFQALKK.2|EAIAELEREK.2|ETFEKTPVEVPVGGFK.3|ETFEKTPVEVPVGGFK.2|LLEAQIATGGIIDPEESHRLPVEVAYK.5|LLEAQIATGGIIDPEESHRLPVEVAYK.4|LLEAQIATGGIIDPEESHRLPVEVAYK.3|RAQQQAEAER.2|RGPLPTEEQR.2|RQELEAELAK.2|FRELAEEAAR.2|LLFNDVQTLK.2|LLLEAQAATGFLLDPVK.3|LLLEAQAATGFLLDPVK.2|LPLLAVC[CAM]DYK.2|QEQIQAMPLADSQAVR.3|QEQIQAMPLADSQAVR.2|THYSELTTLTSQYIK.3|THYSELTTLTSQYIK.2|VAQLLERWQAVLAQTDVRQR.4|AQLMADFQAGR.2|AQLM[Oxi]ADFQAGR.2|AVTGYRDPYSGSTISLFQAMQK.4|AVTGYRDPYSGSTISLFQAM[Oxi]QK.3|AVTGYRDPYSGSTISLFQAMQK.3|AVTGYRDPYTEQTISLFQAMK.4|AVTGYRDPYTEQTISLFQAM[Oxi]K.3|AVTGYRDPYTEQTISLFQAMK.3|AVTGYRDPYTGQSVSLFQALKK.4|AVTGYRDPYTGQSVSLFQALKK.3|EGLTSIEEVTK.2|FLEGTSC[CAM]IAGVFVDATK.3|FLEGTSC[CAM]IAGVFVDATK.2|GDEC[CAM]QLVGPAQPSHWK.3|GDEC[CAM]QLVGPAQPSHWK.2|QQQQMEQER.2|SLAQAEAEKQKEEAER.3|VQSGSESVIQEYVDLR.3|VQSGSESVIQEYVDLR.2|EEAAVDAQQQK.2|GIIRPGTAFELLEAQAATGYVIDPIKGLK.5|GIIRPGTAFELLEAQAATGYVIDPIKGLK.4|GIIRPGTAFELLEAQAATGYVIDPIKGLK.3|QTNLENLDQAFSVAER.3|QTNLENLDQAFSVAER.2|DPYTGQQISLFQAMQK.3|DPYTGQQISLFQAM[Oxi]QK.2|DPYTGQQISLFQAMQK.2|GWLYYEAGQR.2|KQITMEELVR.2|LEDLLQDAQDEKEQLNEYKGHLSGLAK.5|LEDLLQDAQDEKEQLNEYKGHLSGLAK.4|LEDLLQDAQDEKEQLNEYKGHLSGLAK.3|QYLHLPPEIVPASLQR.3|QYLHLPPEIVPASLQR.2|RDDGTGQLLLPLSDARK.3|VQAEREAAQSR.2|AHEEQLKEAQAVPATLPELEATK.4|AHEEQLKEAQAVPATLPELEATK.3|EQELQQTLQQEQSVLDQLRGEAEAARR.5|EQELQQTLQQEQSVLDQLRGEAEAARR.4|EQLRQEQALLEEIER.3|EQLRQEQALLEEIER.2|SKGIYQSLEGAVQAGQLK.3|SKGIYQSLEGAVQAGQLK.2|AVTGYRDPYTEQTISLFQAMKK.4|DYELQLVTYK.2|EMSVYEAYRK.2|EQM[Oxi]AQQLAEETQGFQR.3|EQMAQQLAEETQGFQR.3|EQM[Oxi]AQQLAEETQGFQR.2|EQMAQQLAEETQGFQR.2|GGELVYTDSEARDVFEK.3|GGELVYTDSEARDVFEK.2|GTQGAEEVLRAHEEQLK.3|KGIIRPGTAFELLEAQAATGYVIDPIKGLK.5|KGIIRPGTAFELLEAQAATGYVIDPIKGLK.4|LRAETEQGEQQRQLLEEELAR.4|YLQDLLAWVEENQHR.3|YLQDLLAWVEENQHR.2|C[CAM]RPDQLTGLSLLPLSEK.3|C[CAM]RPDQLTGLSLLPLSEK.2|QRQLAEEDAAR.2|TLLQGSGC[CAM]LAGIYLEDTK.3|TLLQGSGC[CAM]LAGIYLEDTK.2|GGELVYTDSEAR.2|ILITIVEEVETLRQER.3|QLAEEDLAQQR.2|QQGLASYDYVR.2|RQEQIQAMPLADSQAVR.3|RQEQIQAMPLADSQAVR.2|VTLVQTLEIQR.2|ALQALEELRLQAEEAER.3|ATTAALLLEAQAATGFLVDPVRNQR.4|ATTAALLLEAQAATGFLVDPVRNQR.3|LEQLFQDEVAK.2|QAEEIGEKLHR.2|RGYFDEEMNR.2|AEQESARQLQLAQEAAQK.3|AGVAAPATQVAQVTLQSVQR.3|AGVAAPATQVAQVTLQSVQR.2|GANVIAGVWLEEAGQKLSIYNALKK.4|LLEAQAC[CAM]TGGIIDPSTGER.3|LLEAQAC[CAM]TGGIIDPSTGER.2|RLQEDKEQMAQQLAEETQGFQR.4|RLQEDKEQM[Oxi]AQQLAEETQGFQR.4|RLQEDKEQMAQQLAEETQGFQR.3|DSQDAGGFGPEDR.2|SATVTRLEDLLQDAQDEK.3|SATVTRLEDLLQDAQDEK.2|AEVVETTQVYTEEETRR.3|AEVVETTQVYTEEETRR.2|AQAEAQQPTFDALRDELR.3|AQAEAQQPTFDALRDELR.2|ASDSELERQKGLVEDTLR.3|DGHNLISLLEVLSGDSLPR.3|DGHNLISLLEVLSGDSLPR.2|EEAAVDAQQQKR.2|ERLAEVEAALEK.2|GIIRPGTAFELLEAQAATGYVIDPIK.4|GIIRPGTAFELLEAQAATGYVIDPIK.3|KGWLYYEAGQR.2|LLEAQIATGGIIDPEESHR.3|LLEAQIATGGIIDPEESHR.2|QEELYSELQAR.2|QEQALLEEIER.2|TLPNGRDALDGPAAEAEPEHSFDGLR.4|TLPNGRDALDGPAAEAEPEHSFDGLR.3|AYSDPSTGEPATYGELQQR.3|AYSDPSTGEPATYGELQQR.2|DALDGPAAEAEPEHSFDGLR.3|DALDGPAAEAEPEHSFDGLR.2|FLEVQYLTGGLIEPDTPGR.3|FLEVQYLTGGLIEPDTPGR.2|ELVLLLLQWMR.2|LLLEAQAATGFLLDPVKGER.3|LLLEAQAATGFLLDPVKGER.2|LMAEREYGSC[CAM]SHHYQQLLQSLEQGAQEESR.5|LMAEREYGSC[CAM]SHHYQQLLQSLEQGAQEESR.4|QEELQQLEQQR.2|SYVDPSTDERLSYTQLLR.3|AEQESARQLQLAQEAAQKR.3|AQAEAQQPTFDALRDELRGAQEVGER.4|GLFDEEMNEILTDPSDDTK.3|GLFDEEMNEILTDPSDDTK.2|TVTVWELISSEYFTAEQR.3|TVTVWELISSEYFTAEQR.2|AAEEAEEARVQAEREAAQSR.3|DLLPSDMAVALLEAQAGTGHIIDPATSAR.4|DLLPSDM[Oxi]AVALLEAQAGTGHIIDPATSAR.4|DLLPSDM[Oxi]AVALLEAQAGTGHIIDPATSAR.3|DLLPSDMAVALLEAQAGTGHIIDPATSAR.3|GYFDEEMNRVLADPSDDTK.3|QVEEAERLKQSAEEQAQAR.3|SATVTRLEDLLQDAQDEKEQLNEYK.4|TLLQGSGC[CAM]LAGIYLEDTKEK.3|TVTIWEIINSEYFTAEQR.3|TVTIWEIINSEYFTAEQR.2|VVIVDPETGKEMSVYEAYR.3|ATTAALLLEAQAATGFLVDPVR.3|ATTAALLLEAQAATGFLVDPVR.2|C[CAM]VEDPETGLC[CAM]LLPLTDKAAK.3|EYGSC[CAM]SHHYQQLLQSLEQGAQEESR.4|EYGSC[CAM]SHHYQQLLQSLEQGAQEESR.3|LKAGVAAPATQVAQVTLQSVQR.3|LLEAQAC[CAM]TGGIIDPSTGERFPVTDAVNK.4|LLEAQAC[CAM]TGGIIDPSTGERFPVTDAVNK.3|VDGAEWGVDLPSVEAQLGSHR.3|VDGAEWGVDLPSVEAQLGSHR.2|EEEEVGFDWSDR.2|EEEEVGFDWSDRNTNMTAK.3|EQELQQTLQQEQSVLDQLRGEAEAAR.4|EQELQQTLQQEQSVLDQLRGEAEAAR.3|GRTVTVWELISSEYFTAEQRQELLR.4|MQEEVVRREEAAVDAQQQK.3|RFPSSFEEIEILWSQFLK.3|VYRQTNLENLDQAFSVAER.3|YASGSSASLGGPESAVA.2|FIEQEKAKLEQLFQDEVAK.3|KDLLPSDMAVALLEAQAGTGHIIDPATSAR.4|AQAEAQQPTFDALR.2|EQELQQTLQQEQSVLDQLR.3|EQELQQTLQQEQSVLDQLR.2|GFFDPNTEENLTYLQLM[Oxi]ER.3|GFFDPNTEENLTYLQLMER.3|GFFDPNTEENLTYLQLMER.2|LEDLLQDAQDEKEQLNEYK.3|LSFSGLRAPVPASELLASGVLSR.3|QKAQVEQELTTLR.2|RGLFDEEMNEILTDPSDDTK.3|RGLFDEEM[Oxi]NEILTDPSDDTK.3|RGLFDEEMNEILTDPSDDTK.2|SIQEELQQLRQSSEAEIQAK.3|FLEVQYLTGGLIEPDTPGRVPLDEALQR.4|FLEVQYLTGGLIEPDTPGRVPLDEALQR.3|GRTVTVWELISSEYFTAEQR.3|LQLEETDHQKNLLDEELQR.3|QALHSLELHYQAFLRDSQDAGGFGPEDR.4|VLALPEPSPAAPTLRSELELTLGKLEQVR.4|AHAFAVQQKEQELQQTLQQEQSVLDQLRGEAEAAR.5|ENAAYFQFFSDVR.2|QYINAIKDYELQLVTYKAQLEPVASPAK.4|SEEMQTVQQEQLLQETQALQQSFLSEK.4|SEEM[Oxi]QTVQQEQLLQETQALQQSFLSEK.3|SEEMQTVQQEQLLQETQALQQSFLSEK.3|VLSSSGSEAAVPSVC[CAM]FLVPPPNQEAQEAVTR.4|VLSSSGSEAAVPSVC[CAM]FLVPPPNQEAQEAVTR.3|AVTGYKDPYTGQQISLFQAM[Oxi]QK.3|AVTGYKDPYTGQQISLFQAMQK.3|ENAAYFQFFSDVREAEGQLQK.3|GANVIAGVWLEEAGQK.2|YLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHR.5|YLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHR.4|LQEDKEQMAQQLAEETQGFQR.3|RYASGSSASLGGPESAVA.2|VLADPSDDTKGFFDPNTHENLTYLQLLER.4|VLALPEPSPAAPTLRSELELTLGK.3|IAEQQKAQAEVEGLGK.2|SQVMDEATALQLREGLTSIEEVTK.3|ELIPTEEALRLLDAQLATGGIVDPR.3|GYYSPYSVSGSGSTAGSR.2|LQM[Oxi]EAGLC[CAM]EEQLNQADALLQSDVR.3|LQMEAGLC[CAM]EEQLNQADALLQSDVR.3|RGSFDATGSGFSMTFSSSSYSSSGYGR.3|TVTVWELISSEYFTAEQRQELLR.3|AEVVETTQVYTEEETR.2|EALEAESAWC[CAM]YLYGTGSVAGVYLPGSR.3|TQLASWSDPTEETGPVAGILDTETLEK.3|AFEETQIDIPGGGSHGGSTMSLWEVMQSDLIPEEQR.4|ELEEVSPETPVVPATTQR.2|SEEM[Oxi]QTVQQEQLLQETQALQQSFLSEKDSLLQR.4|SEEMQTVQQEQLLQETQALQQSFLSEKDSLLQR.4|SLREALEAESAWC[CAM]YLYGTGSVAGVYLPGSR.3
SEN / CTL,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,2.33,1.23,6.03E-02,1.38E-02,1.86E+00,"activation of MAPKK activity,membrane protein ectodomain proteolysis,cell adhesion,cell-matrix adhesion,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,response to manganese ion,cell migration,keratinocyte differentiation,cell adhesion mediated by integrin,positive regulation of cell adhesion mediated by integrin,cell-cell adhesion mediated by integrin,positive regulation of macrophage fusion,response to tumor necrosis factor,response to laminar fluid shear stress,monocyte activation,response to hydrogen peroxide,positive regulation of protein secretion,positive regulation of membrane protein ectodomain proteolysis,PMA-inducible membrane protein ectodomain proteolysis,response to glucocorticoid,positive regulation of keratinocyte migration,response to calcium ion,cellular response to lipopolysaccharide","metalloendopeptidase activity,protein kinase C binding,integrin binding,protein binding,collagen binding,metallopeptidase activity,SH3 domain binding,laminin binding,metal ion binding","extracellular space,focal adhesion,cell surface,integral component of membrane,basolateral plasma membrane,intrinsic component of external side of plasma membrane,extracellular exosome",3,22,24,QVSYVIQAEGK.2|EGTLITDHPNIQNHC[CAM]HYR.5|EGTLITDHPNIQNHC[CAM]HYR.4|FAVPTYAAK.2|HDSAQLVLK.2|FLPGGTLC[CAM]R.2|C[CAM]ATGNALC[CAM]GK.2|QPQQFPSRPPPPQPK.3|SQTYESDGKNQANPSR.3|SC[CAM]IMNSGASGSR.2|NC[CAM]HC[CAM]ENGWAPPNC[CAM]ETK.3|FGNC[CAM]GFSGNEYK.2|SFAEC[CAM]AYGDC[CAM]C[CAM]K.2|FGNC[CAM]GFSGNEYKK.2|PGFQQTSHLSSYEIITPWR.3|LVDAGEEC[CAM]DC[CAM]GTPK.2|NFQC[CAM]VDASVLNYDC[CAM]DVQKK.3|VSSQGNLIPARPAPAPPLYSSLT.3|VSSQGNLIPARPAPAPPLYSSLT.2|GGNC[CAM]LLNIPKPDEAYSAPSC[CAM]GNK.3|GFGGTAGMAFVGTVC[CAM]SR.2|EC[CAM]ELDPC[CAM]C[CAM]EGSTC[CAM]K.2|LQC[CAM]ENVQEIPVFGIVPAIIQTPSR.3|LVDAGEEC[CAM]DC[CAM]GTPKEC[CAM]ELDPC[CAM]C[CAM]EGSTC[CAM]K.3
SEN / CTL,Q7Z304,MAM domain-containing protein 2,MAMDC2,2.33,0.37,7.76E-03,2.19E-03,2.66E+00,,,"proteinaceous extracellular matrix,endoplasmic reticulum,membrane",3,1,1,AGDHTTGLGYYLLANTK.3
SEN / CTL,O60814;P06899;P23527;P33778;P57053;P58876;P62807;Q16778;Q5QNW6;Q8N257;Q93079;Q99877;Q99879;Q99880,Histone H2B type 1-K;Histone H2B type 1-J;Histone H2B type 1-O;Histone H2B type 1-B;Histone H2B type F-S;Histone H2B type 1-D;Histone H2B type 1-C/E/F/G/I;Histone H2B type 2-E;Histone H2B type 2-F;Histone H2B type 3-B;Histone H2B type 1-H;Histone H2B type 1-N;Histone H2B type 1-M;Histone H2B type 1-L,HIST1H2BK;HIST1H2BJ;HIST1H2BO;HIST1H2BB;H2BFS;HIST1H2BD;HIST1H2BC;HIST2H2BE;HIST2H2BF;HIST3H2BB;HIST1H2BH;HIST1H2BN;HIST1H2BM;HIST1H2BL,2.30,0.56,1.53E-02,4.05E-03,2.39E+00,"innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium;nucleosome assembly;nucleosome assembly;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,substantia nigra development,defense response to Gram-positive bacterium;nucleosome assembly;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium;innate immune response in mucosa,nucleosome assembly,antibacterial humoral response,defense response to Gram-positive bacterium;nucleosome assembly;nucleosome assembly;nucleosome assembly;nucleosome assembly;nucleosome assembly;nucleosome assembly","molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;molecular_function,DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity;DNA binding,protein heterodimerization activity","nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm;nucleosome,nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm;nuclear chromosome, telomeric region,nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm;nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm;nuclear nucleosome,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nucleosome,nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nucleosome,nuclear nucleosome,extracellular space,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nuclear nucleosome,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nuclear nucleosome,nucleus,nucleoplasm,cytoplasm;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm,extracellular exosome;nucleosome,nuclear nucleosome,nucleus,nucleoplasm,cytoplasm,extracellular exosome",3,1,8,AMGIMNSFVNDIFER.2|AM[Oxi]GIMNSFVNDIFER.3|AMGIM[Oxi]NSFVNDIFER.3|AMGIMNSFVNDIFER.3|AM[Oxi]GIM[Oxi]NSFVNDIFER.3|AM[Oxi]GIMNSFVNDIFER.2|AMGIM[Oxi]NSFVNDIFER.2|AM[Oxi]GIM[Oxi]NSFVNDIFER.2
SEN / CTL,P53621,Coatomer subunit alpha,COPA,2.30,0.67,1.13E-06,6.78E-07,6.17E+00,"intracellular protein transport,ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,intra-Golgi vesicle-mediated transport,pancreatic juice secretion","hormone activity,structural molecule activity","Golgi membrane,extracellular space,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,COPI vesicle coat,transport vesicle,extracellular exosome",9,92,167,VTTVTEIGKDVIGLR.3|VTTVTEIGKDVIGLR.2|TLDLPIYVTR.2|LLHDQVGVIQFGPYK.3|LLHDQVGVIQFGPYK.4|LLHDQVGVIQFGPYK.2|KLDALC[CAM]NIHENIR.4|KLDALC[CAM]NIHENIR.3|KLDALC[CAM]NIHENIR.2|TGVQTFR.2|GHYNNVSC[CAM]AVFHPR.4|GHYNNVSC[CAM]AVFHPR.3|GHYNNVSC[CAM]AVFHPR.2|GYPEVALHFVK.3|GYPEVALHFVK.2|MHSLLIK.2|ALDDKNC[CAM]WEK.3|ALDDKNC[CAM]WEK.2|FEEAVEK.2|ISPLQFR.2|KYDEVLHMVR.3|KYDEVLHMVR.2|KYDEVLHM[Oxi]VR.2|LNDLIQR.2|RSSGLTAVWVAR.3|YAVTTGDHGIIR.3|YAVTTGDHGIIR.2|KGYPEVALHFVKDEK.4|KGYPEVALHFVKDEK.3|KGYPEVALHFVKDEK.2|LVGQSIIAYLQK.3|LVGQSIIAYLQK.2|KGYPEVALHFVK.3|KGYPEVALHFVK.2|RLLELGPKPEVAQQTR.4|RLLELGPKPEVAQQTR.3|RLLELGPKPEVAQQTR.2|DVAVMQLR.2|DVAVM[Oxi]QLR.2|ERPAYAVHGNMLHYVK.4|ERPAYAVHGNMLHYVK.3|TALNLFFK.2|VTTVTEIGK.2|VWDISGLR.2|HVLEGHDR.2|MC[CAM]TLIDKFDEHDGPVR.4|M[Oxi]C[CAM]TLIDKFDEHDGPVR.4|MC[CAM]TLIDKFDEHDGPVR.3|M[Oxi]C[CAM]TLIDKFDEHDGPVR.3|MC[CAM]TLIDKFDEHDGPVR.2|VLTIDPTEFKFK.3|LDALC[CAM]NIHENIR.3|VWNWQSR.2|HAIVIC[CAM]NR.2|DADSQNPDAPEGKR.3|DADSQNPDAPEGKR.2|C[CAM]PLSGAC[CAM]YSPEFK.3|C[CAM]PLSGAC[CAM]YSPEFK.2|LSFLYLITGNLEK.3|LSFLYLITGNLEK.2|SILLSVPLLVVDNK.3|SILLSVPLLVVDNK.2|AWEVDTC[CAM]R.2|GFFEGTIASK.2|SLAYLTAATHGLDEEAESLK.4|SLAYLTAATHGLDEEAESLK.3|SLAYLTAATHGLDEEAESLK.2|FDEHDGPVR.2|C[CAM]LFTLLGHLDYIR.3|C[CAM]LFTLLGHLDYIR.2|DADSITLFDVQQKR.3|DADSITLFDVQQKR.2|DHDRFWVLAAHPNLNLFAAGHDGGMIVFK.6|DHDRFWVLAAHPNLNLFAAGHDGGM[Oxi]IVFK.5|DHDRFWVLAAHPNLNLFAAGHDGGMIVFK.5|KDMSGHYQNALYLGDVSER.4|KDMSGHYQNALYLGDVSER.3|GNNVYC[CAM]LDR.2|LLELGPKPEVAQQTR.3|LLELGPKPEVAQQTR.2|QEIAEAQQLITIC[CAM]R.3|QEIAEAQQLITIC[CAM]R.2|TKNFDKLSFLYLITGNLEK.4|TKNFDKLSFLYLITGNLEK.3|QLFLQTYAR.2|SSGLTAVWVAR.2|YDEVLHMVR.2|VKSGAWDESGVFIYTTSNHIK.4|VKSGAWDESGVFIYTTSNHIK.3|VLTIDPTEFK.2|LGEVALLQGNHQIVEMC[CAM]YQR.4|LGEVALLQGNHQIVEMC[CAM]YQR.3|LGEVALLQGNHQIVEMC[CAM]YQR.2|RPWILTSLHNGVIQLWDYR.4|RPWILTSLHNGVIQLWDYR.3|ETIPDIDPNAK.2|KVQVPNC[CAM]DEIFYAGTGNLLLR.4|KVQVPNC[CAM]DEIFYAGTGNLLLR.3|YVIWSADM[Oxi]SHVALLAK.3|YVIWSADMSHVALLAK.3|YVIWSADMSHVALLAK.2|ASNLENSTYDLYTIPK.3|ASNLENSTYDLYTIPK.2|LLQPPAPIMPLDTNWPLLTVSK.4|LLQPPAPIMPLDTNWPLLTVSK.3|LLQPPAPIM[Oxi]PLDTNWPLLTVSK.3|NLSPGAVESDVR.2|QLDFNSSKDVAVMQLR.3|QELILSNSEDK.2|TTFFHHEYPWILSASDDQTIR.4|TTFFHHEYPWILSASDDQTIR.3|DADSQNPDAPEGK.2|NFDKLSFLYLITGNLEK.3|SGSKFPVFNMSYNPAENAVLLC[CAM]TR.4|SGSKFPVFNM[Oxi]SYNPAENAVLLC[CAM]TR.3|SGSKFPVFNMSYNPAENAVLLC[CAM]TR.3|DMSGHYQNALYLGDVSER.3|DM[Oxi]SGHYQNALYLGDVSER.3|DMSGHYQNALYLGDVSER.2|ETFDPEKETIPDIDPNAK.3|FWVLAAHPNLNLFAAGHDGGMIVFK.4|FWVLAAHPNLNLFAAGHDGGM[Oxi]IVFK.3|FWVLAAHPNLNLFAAGHDGGMIVFK.3|IC[CAM]EMAAYFTHSNLQPVHMILVLR.4|IC[CAM]EM[Oxi]AAYFTHSNLQPVHMILVLR.4|IC[CAM]EMAAYFTHSNLQPVHMILVLR.3|KNLSPGAVESDVR.2|EYIVGLSVETER.2|SGAWDESGVFIYTTSNHIK.3|SGAWDESGVFIYTTSNHIK.2|LLHDQVGVIQFGPYKQLFLQTYAR.4|LQLC[CAM]YQLTTVGK.2|TTYQALPC[CAM]LPSMYGYPNR.3|TTYQALPC[CAM]LPSM[Oxi]YGYPNR.3|TTYQALPC[CAM]LPSM[Oxi]YGYPNR.2|TTYQALPC[CAM]LPSMYGYPNR.2|KILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.6|KILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.5|QQPLFVSGGDDYK.2|DADSITLFDVQQK.2|SLAYLTAATHGLDEEAESLKETFDPEK.4|SLAYLTAATHGLDEEAESLKETFDPEK.3|GVNWAAFHPTMPLIVSGADDR.3|GVNWAAFHPTM[Oxi]PLIVSGADDR.3|GVNWAAFHPTMPLIVSGADDR.2|LQLC[CAM]YQLTTVGKFEEAVEK.3|LQLC[CAM]YQLTTVGKFEEAVEK.2|EYIVGLSVETERK.2|VQVPNC[CAM]DEIFYAGTGNLLLR.3|VQVPNC[CAM]DEIFYAGTGNLLLR.2|FPVFNM[Oxi]SYNPAENAVLLC[CAM]TR.3|FPVFNMSYNPAENAVLLC[CAM]TR.3|FPVFNMSYNPAENAVLLC[CAM]TR.2|GRTTYQALPC[CAM]LPSM[Oxi]YGYPNR.3|GRTTYQALPC[CAM]LPSMYGYPNR.3|SILLSVPLLVVDNKQEIAEAQQLITIC[CAM]R.4|SILLSVPLLVVDNKQEIAEAQQLITIC[CAM]R.3|GITGVDLFGTTDAVVK.2|GTSPTQIWC[CAM]NNSQLPVDHILAGSFETAMR.4|GTSPTQIWC[CAM]NNSQLPVDHILAGSFETAMR.3|SLAYLTAATHGLDEEAESLKETFDPEKETIPDIDPNAK.5|SLAYLTAATHGLDEEAESLKETFDPEKETIPDIDPNAK.4|ILSAC[CAM]EKNPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.5|NPTDAYQLNYDM[Oxi]HNPFDIC[CAM]AASYRPIYR.4|NPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.4|NPTDAYQLNYDMHNPFDIC[CAM]AASYRPIYR.3|FSLALEC[CAM]GNIEIALEAAK.2
SEN / CTL,P22392,Nucleoside diphosphate kinase B,NME2,2.28,0.67,1.79E-04,7.92E-05,4.10E+00,"negative regulation of myeloid leukocyte differentiation,purine nucleotide metabolic process,nucleoside diphosphate phosphorylation,GTP biosynthetic process,pyrimidine nucleotide metabolic process,UTP biosynthetic process,CTP biosynthetic process,transcription, DNA-templated,regulation of transcription, DNA-templated,cell adhesion,integrin-mediated signaling pathway,nucleoside triphosphate biosynthetic process,positive regulation of neuron projection development,nucleobase-containing small molecule interconversion,peptidyl-histidine phosphorylation,positive regulation of cAMP biosynthetic process,cellular response to oxidative stress,negative regulation of apoptotic process,positive regulation of keratinocyte differentiation,regulation of epidermis development,positive regulation of transcription from RNA polymerase II promoter,protein autophosphorylation,positive regulation of epithelial cell proliferation,protein oligomerization,response to growth hormone,cellular response to glucose stimulus,cellular response to fatty acid","DNA binding,transcription factor activity, sequence-specific DNA binding,nucleoside diphosphate kinase activity,protein histidine kinase activity,protein serine/threonine kinase activity,fatty acid binding,protein binding,ATP binding,drug binding,intermediate filament binding,enzyme binding,metal ion binding","ruffle,nucleus,cytoplasm,cytosol,intermediate filament,lamellipodium,mitochondrial membrane,myelin sheath,perinuclear region of cytoplasm,extracellular exosome,cell periphery,focal adhesion",6,19,36,SAEKEISLWFKPEELVDYK.4|SAEKEISLWFKPEELVDYK.3|SAEKEISLWFKPEELVDYK.2|GDFC[CAM]IQVGR.2|ASEEHLK.2|GLVGEIIK.2|GLVGEIIK.1|TFIAIKPDGVQR.3|TFIAIKPDGVQR.2|VMLGETNPADSKPGTIR.4|VMLGETNPADSKPGTIR.3|VM[Oxi]LGETNPADSKPGTIR.3|VMLGETNPADSKPGTIR.2|VM[Oxi]LGETNPADSKPGTIR.2|QHYIDLK.2|GLVGEIIKR.2|QHYIDLKDRPFFPGLVK.4|NIIHGSDSVK.2|ASEEHLKQHYIDLK.3|ASEEHLKQHYIDLKDRPFFPGLVK.5|SC[CAM]AHDWVYE.2|DRPFFPGLVK.2|TGRVM[Oxi]LGETNPADSKPGTIRGDFC[CAM]IQVGR.5|VMLGETNPADSK.2|VM[Oxi]LGETNPADSK.2|EISLWFKPEELVDYK.3|EISLWFKPEELVDYK.2|YM[Oxi]NSGPVVAMVWEGLNVVK.3|YMNSGPVVAM[Oxi]VWEGLNVVK.3|YMNSGPVVAMVWEGLNVVK.3|YM[Oxi]NSGPVVAM[Oxi]VWEGLNVVK.3|YMNSGPVVAMVWEGLNVVK.2|YM[Oxi]NSGPVVAM[Oxi]VWEGLNVVK.2|YM[Oxi]NSGPVVAMVWEGLNVVK.2|YMNSGPVVAM[Oxi]VWEGLNVVK.2|SAEKEISLWFKPEELVDYKSC[CAM]AHDWVYE.4
SEN / CTL,Q96AY3,Peptidyl-prolyl cis-trans isomerase FKBP10,FKBP10,2.28,1.06,8.36E-06,4.54E-06,5.34E+00,"protein peptidyl-prolyl isomerization,chaperone-mediated protein folding","peptidyl-prolyl cis-trans isomerase activity,calcium ion binding,FK506 binding","endoplasmic reticulum lumen,endoplasmic reticulum membrane",12,34,53,IIIPPFLAYGEK.2|GMDQGLLGMC[CAM]PGER.2|GM[Oxi]DQGLLGMC[CAM]PGER.2|GGTYDTYVGSGWLIK.2|GLMGMC[CAM]VNER.2|GLM[Oxi]GMC[CAM]VNER.2|GLMGM[Oxi]C[CAM]VNER.2|AGAGDFMR.2|AGAGDFM[Oxi]R.2|QLIVPPHLAHGESGAR.4|QLIVPPHLAHGESGAR.3|RQLIVPPHLAHGESGAR.4|KIIIPPFLAYGEK.3|KIIIPPFLAYGEK.2|EDTVQVSTLLRPPHC[CAM]PR.4|EDTVQVSTLLRPPHC[CAM]PR.3|LMPGQDPEK.2|MVQDGDFVR.2|M[Oxi]VQDGDFVR.2|DPPANLFEDMDLNK.3|DPPANLFEDMDLNK.2|EVQMGDFVR.2|EVQM[Oxi]GDFVR.2|KFDSSYDRNTLVAIVVGVGR.4|KFDSSYDRNTLVAIVVGVGR.3|RKIIIPPFLAYGEK.3|EDGLPTGYLFVWHK.3|EDGLPTGYLFVWHK.2|LKSDEDEERVHEEL.3|LKSDEDEERVHEEL.2|DAVQLETLELPPGC[CAM]VR.3|DAVQLETLELPPGC[CAM]VR.2|NTLVAIVVGVGR.2|GRLMPGQDPEK.2|VIEGLDTGLQGMC[CAM]VGER.3|VIEGLDTGLQGM[Oxi]C[CAM]VGER.3|VIEGLDTGLQGMC[CAM]VGER.2|VIEGLDTGLQGM[Oxi]C[CAM]VGER.2|TIGDMFQNQDRNQDGK.3|TIGDMFQNQDR.2|TIGDM[Oxi]FQNQDR.2|TIGDMFQNQDRNQDGKITVDELK.4|GYGTVIPPQASLVFHVLLIDVHNPK.4|GYGTVIPPQASLVFHVLLIDVHNPK.3|NQDGKITVDELK.2|FDSSYDRNTLVAIVVGVGR.3|IPGSAVLIFNVHVIDFHNPADVVEIR.4|SDEDEERVHEEL.2|ASPAGGPLEDVVIER.2|ITIPPHLAYGENGTGDKIPGSAVLIFNVHVIDFHNPADVVEIR.6|DGEVPPEEFSTFIK.2|GVPGSAVLLFEVELVSR.2|GYGTVIPPQASLVFHVLLIDVHNPKDAVQLETLELPPGC[CAM]VR.5
SEN / CTL,Q15113,Procollagen C-endopeptidase enhancer 1,PCOLCE,2.26,1.64,3.96E-04,1.58E-04,3.80E+00,"proteolysis,multicellular organism development,positive regulation of peptidase activity","protein binding,collagen binding,heparin binding,peptidase activator activity","extracellular space,extracellular exosome,extracellular matrix",9,9,10,YDALEVFAGSGTSGQR.2|TGGLDLPSPPTGASLK.2|FDLEPDTYC[CAM]R.2|ATSGTEHQFC[CAM]GGR.3|ATSGTEHQFC[CAM]GGR.2|MTTDEGTGGR.2|PAPLVAPGNQVTLR.2|GVSYLLMGQVEENR.2|TEESPSAPDAPTC[CAM]PK.2|GESGYVASEGFPNLYPPNK.2
SEN / CTL,Q7Z7M9,Polypeptide N-acetylgalactosaminyltransferase 5,GALNT5,2.24,1.52,5.85E-02,1.35E-02,1.87E+00,"glycosaminoglycan biosynthetic process,O-glycan processing","polypeptide N-acetylgalactosaminyltransferase activity,carbohydrate binding,metal ion binding","Golgi membrane,cellular_component,integral component of membrane",3,4,4,C[CAM]PVMAGGLFSIDK.2|VEVDLDQTQR.2|EILLVDDFSTK.2|EGNFNVYLSDLIPVDR.2
SEN / CTL,O60506,Heterogeneous nuclear ribonucleoprotein Q,SYNCRIP,2.24,0.51,1.36E-02,3.67E-03,2.44E+00,"mRNA splicing, via spliceosome,osteoblast differentiation,RNA processing,RNA splicing,viral process,negative regulation of translation,CRD-mediated mRNA stabilization,cellular response to interferon-gamma","nucleotide binding,RNA binding,poly(A) binding,poly(A) RNA binding","nucleus,nucleoplasm,endoplasmic reticulum,membrane,intracellular ribonucleoprotein complex,CRD-mediated mRNA stability complex,catalytic step 2 spliceosome,histone pre-mRNA 3'end processing complex,GAIT complex",3,48,77,LMMDPLTGLNR.2|LM[Oxi]MDPLTGLNR.2|LMM[Oxi]DPLTGLNR.2|VADSSKGPDEAK.3|VADSSKGPDEAK.2|KADGYNQPDSK.3|KADGYNQPDSK.2|EAAQEAVK.2|LFVGSIPK.2|NRGFC[CAM]FLEYEDHK.4|NRGFC[CAM]FLEYEDHK.3|NRGFC[CAM]FLEYEDHK.2|DYAFIHFDER.3|DYAFIHFDER.2|TGYTLDVTTGQR.3|TGYTLDVTTGQR.2|DYAFIHFDERDGAVK.4|DYAFIHFDERDGAVK.3|HIGVC[CAM]ISVANNR.3|HIGVC[CAM]ISVANNR.2|AMEEMNGK.2|TKEQILEEFSK.3|TKEQILEEFSK.2|AGPIWDLR.2|RKADGYNQPDSK.3|RKADGYNQPDSK.2|GFC[CAM]FLEYEDHK.3|GFC[CAM]FLEYEDHK.2|TGYTLDVTTGQRK.3|TGYTLDVTTGQRK.2|NLANTVTEEILEK.3|NLANTVTEEILEK.2|LKDYAFIHFDERDGAVK.4|SAFLC[CAM]GVMK.2|SAFLC[CAM]GVM[Oxi]K.2|LKDYAFIHFDER.3|VTEGLTDVILYHQPDDKK.4|DLFEDELVPLFEK.3|DLFEDELVPLFEK.2|LYNNHEIR.2|ADGYNQPDSK.2|VTEGLTDVILYHQPDDKKK.4|VTEGLTDVILYHQPDDKKK.3|KLKDYAFIHFDER.3|EQILEEFSK.2|DSDLSHVQNK.2|EFNEDGALAVLQQFK.3|EFNEDGALAVLQQFK.2|GYAFVTFC[CAM]TK.2|VAEKLDEIYVAGLVAHSDLDER.4|VAEKLDEIYVAGLVAHSDLDER.3|IPRDLFEDELVPLFEK.3|VTEGLTDVILYHQPDDK.3|VTEGLTDVILYHQPDDK.2|NLANTVTEEILEKAFSQFGKLER.4|LDEIYVAGLVAHSDLDER.3|LDEIYVAGLVAHSDLDER.2|DLEGENIEIVFAKPPDQK.3|DLEGENIEIVFAKPPDQK.2|SENQEFYQDTFGQQWK.3|SENQEFYQDTFGQQWK.2|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.5|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.4|AIEALKEFNEDGALAVLQQFKDSDLSHVQNK.3|EFNEDGALAVLQQFKDSDLSHVQNK.4|AMEEMNGKDLEGENIEIVFAKPPDQK.4|KYGGPPPDSVYSGQQPSVGTEIFVGKIPR.4|AIEALKEFNEDGALAVLQQFK.3|AIEALKEFNEDGALAVLQQFK.2|QTNNQNWGSQPIAQQPLQGGDHSGNYGYK.4|QTNNQNWGSQPIAQQPLQGGDHSGNYGYK.3|YGGPPPDSVYSGQQPSVGTEIFVGK.3|KYGGPPPDSVYSGQQPSVGTEIFVGK.3|VWGNVGTVEWADPIEDPDPEVM[Oxi]AK.3|VWGNVGTVEWADPIEDPDPEVMAK.3|VKVWGNVGTVEWADPIEDPDPEVMAK.3|YGGPPPDSVYSGQQPSVGTEIFVGKIPR.3
SEN / CTL,P62310,U6 snRNA-associated Sm-like protein LSm3,LSM3,2.23,1.76,1.05E-01,2.29E-02,1.64E+00,"mRNA splicing, via spliceosome,mRNA processing,cytoplasmic mRNA processing body assembly,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay","RNA binding,protein binding,poly(A) RNA binding","cytoplasmic mRNA processing body,nucleus,nucleoplasm,U6 snRNP,cytosol,U4/U6 x U5 tri-snRNP complex,precatalytic spliceosome,catalytic step 2 spliceosome,Lsm1-7-Pat1 complex",3,4,4,GDGVVLVAPPLRVG.2|NIPMLFVR.2|RNIPMLFVR.2|GDGVVLVAPPLR.2
SEN / CTL,O00391,Sulfhydryl oxidase 1,QSOX1,2.23,1.07,4.34E-24,2.75E-23,2.26E+01,"platelet degranulation,negative regulation of macroautophagy,cell redox homeostasis,oxidation-reduction process","protein disulfide isomerase activity,flavin-linked sulfhydryl oxidase activity","extracellular region,extracellular space,Golgi apparatus,integral component of Golgi membrane,platelet alpha granule lumen,intracellular membrane-bounded organelle,intercellular bridge,extracellular exosome",60,23,29,KFGVTDFPSC[CAM]YLLFR.3|SFYTAYLQR.2|SALYSPSDPLTLLQADTVR.2|SALYSPSDPLTLLQADTVR.3|VGSPNAAVLWLWSSHNR.3|NNEEYLALIFEK.2|DFNIPGFPTVR.2|FGVTDFPSC[CAM]YLLFR.2|NGSGAVFPVAGADVQTLR.2|LAGAPSEDPQFPK.2|AHFSPSNIILDFPAAGSAAR.3|AHFSPSNIILDFPAAGSAAR.2|AHFSPSNIILDFPAAGSAAR.4|DC[CAM]ASHFEQMAAASMHR.4|DC[CAM]ASHFEQMAAASMHR.3|DC[CAM]ASHFEQMAAASM[Oxi]HR.3|LDVPVWDVEATLNFLK.2|KVNWIGC[CAM]QGSEPHFR.4|VLNTEANVVR.2|DTGAALLAESR.2|AWRPALYLAALDC[CAM]AEETNSAVC[CAM]R.4|AWRPALYLAALDC[CAM]AEETNSAVC[CAM]R.3|ELC[CAM]SAC[CAM]HNER.3|GYVHYFFGC[CAM]R.3|VPVLMESR.2|LEEIDGFFAR.2|RVLNTEANVVR.2|DVQNVAAAPELAMGALELESR.3|AAPGQEPPEHMAELQR.2
SEN / CTL,P49721,Proteasome subunit beta type-2,PSMB2,2.22,0.49,1.11E-02,3.05E-03,2.52E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,response to organonitrogen compound,response to organic cyclic compound,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway",threonine-type endopeptidase activity,"proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,membrane,extracellular exosome",3,21,33,FILNLPTFSVR.2|AVELLRK.2|VAASNIVQMKDDHDK.4|VAASNIVQM[Oxi]KDDHDK.4|VAASNIVQMKDDHDK.3|VAASNIVQMKDDHDKMFK.5|NLADC[CAM]LR.2|C[CAM]LEELQK.2|IIDKNGIHDLDNISFPK.4|NGIHDLDNISFPK.3|NGIHDLDNISFPK.2|RFILNLPTFSVR.3|YYTPTISR.2|RNLADC[CAM]LR.2|KC[CAM]LEELQK.2|VAASNIVQMK.2|VAASNIVQM[Oxi]K.2|NGYELSPTAAANFTR.3|NGYELSPTAAANFTR.2|IIDKNGIHDLDNISFPKQGS.4|M[Oxi]RNGYELSPTAAANFTR.3|MRNGYELSPTAAANFTR.3|MRNGYELSPTAAANFTR.2|APFAAHGYGAFLTLSILDR.3|APFAAHGYGAFLTLSILDR.2|APFAAHGYGAFLTLSILDRYYTPTISR.4|SRTPYHVNLLLAGYDEHEGPALYYM[Oxi]DYLAALAK.5|SRTPYHVNLLLAGYDEHEGPALYYMDYLAALAK.5|SRTPYHVNLLLAGYDEHEGPALYYMDYLAALAK.4|ILLLC[CAM]VGEAGDTVQFAEYIQK.3|ILLLC[CAM]VGEAGDTVQFAEYIQK.2|TPYHVNLLLAGYDEHEGPALYYM[Oxi]DYLAALAK.4|TPYHVNLLLAGYDEHEGPALYYMDYLAALAK.4
SEN / CTL,P17405,Sphingomyelin phosphodiesterase,SMPD1,2.22,0.74,2.25E-02,5.72E-03,2.24E+00,"sphingomyelin metabolic process,sphingomyelin catabolic process,glycosphingolipid metabolic process,signal transduction,nervous system development,termination of signal transduction,positive regulation of protein dephosphorylation,response to cocaine,response to drug,positive regulation of apoptotic process,negative regulation of MAP kinase activity,ceramide biosynthetic process","sphingomyelin phosphodiesterase activity,zinc ion binding,hydrolase activity, acting on glycosyl bonds,acid sphingomyelin phosphodiesterase activity","extracellular space,lysosome,endosome,plasma membrane,lamellar body,lysosomal lumen,extracellular exosome",3,8,10,IGGFYALSPYPGLR.2|GHPPSEPC[CAM]GTPC[CAM]R.3|GHPPSEPC[CAM]GTPC[CAM]R.2|ALTTVTALVR.2|GLFTAINLGLK.2|LATLC[CAM]AQLSAR.2|ARETYGLPNTLPTAWHNLVYR.4|AWEPWLPAEALR.2|ETYGLPNTLPTAWHNLVYR.3|ETYGLPNTLPTAWHNLVYR.2
SEN / CTL,P17931,Galectin-3,LGALS3,2.20,0.84,2.84E-03,8.97E-04,3.05E+00,"monocyte chemotaxis,mRNA processing,RNA splicing,neutrophil chemotaxis,epithelial cell differentiation,regulation of T cell proliferation,innate immune response,negative regulation of endocytosis,eosinophil chemotaxis,macrophage chemotaxis,negative regulation of T cell receptor signaling pathway,positive chemotaxis,regulation of T cell apoptotic process,mononuclear cell migration,positive regulation of mononuclear cell migration,positive regulation of calcium ion import,regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of immunological synapse formation,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,negative regulation of extrinsic apoptotic signaling pathway,positive regulation of dendritic cell differentiation","protein binding,IgE binding,carbohydrate binding,chemoattractant activity,laminin binding,poly(A) RNA binding","immunological synapse,extracellular space,nucleus,spliceosomal complex,cytoplasm,mitochondrial inner membrane,plasma membrane,membrane,extracellular exosome,extracellular matrix",6,12,19,MLITILGTVKPNANR.3|M[Oxi]LITILGTVKPNANR.3|GNDVAFHFNPR.3|GNDVAFHFNPR.2|VAVNDAHLLQYNHR.4|VAVNDAHLLQYNHR.3|VAVNDAHLLQYNHR.2|KLNEISK.2|VIVC[CAM]NTK.2|IALDFQR.2|IQVLVEPDHFK.3|IQVLVEPDHFK.2|LDNNWGR.2|RVIVC[CAM]NTK.2|QSVFPFESGKPFK.3|QSVFPFESGKPFK.2|MLITILGTVK.2|M[Oxi]LITILGTVK.2|QSVFPFESGK.2
SEN / CTL,Q16363,Laminin subunit alpha-4,LAMA4,2.19,1.46,8.71E-21,3.48E-20,1.95E+01,"cell adhesion,regulation of cell adhesion,extracellular matrix organization,regulation of cell migration,regulation of embryonic development","receptor binding,extracellular matrix structural constituent","extracellular region,basement membrane,basal lamina,extracellular exosome,extracellular matrix",63,42,51,SLLSDVEELVEKENQASR.3|C[CAM]LDGYIGDSIR.2|ELVDEEADEAYELLSQAESWQR.3|LAALSIEEGK.2|RPELTETADQFILYLGSK.3|TLFPVVLEQLDDYNAK.2|TLFPVVLEQLDDYNAK.3|IPFTDIYIGGAPPEILQSR.3|IPFTDIYIGGAPPEILQSR.2|KC[CAM]DC[CAM]SGNSDPNLIFEDC[CAM]DEVTGQC[CAM]R.3|SGVLSVSSGAAAHR.3|DVEIPLDSKPVSSWPAYFSIVK.3|VHTSLYEC[CAM]PIESSPLFLLHK.4|VHTSLYEC[CAM]PIESSPLFLLHK.3|C[CAM]APGYYGNPLLIGSTC[CAM]K.2|VDRDVEVEDFQR.3|HIYNMDPSTSVPC[CAM]AR.3|HIYNMDPSTSVPC[CAM]AR.2|LSDLQEALDQALNYVR.3|LSDLQEALDQALNYVR.2|GAPQFC[CAM]QPC[CAM]PC[CAM]PLPHLANFAESC[CAM]YR.3|GAPQFC[CAM]QPC[CAM]PC[CAM]PLPHLANFAESC[CAM]YR.4|AHLPLDINFR.2|HFVIDGHPVSFSK.3|LHSSDMNGLVQK.3|LHSSDMNGLVQK.2|YHEISIIYHNDK.3|AESSSDEAVADTSRR.3|MLYYGEEHELSPK.3|MLYYGEEHELSPK.2|VFLTVPSLSSTAEEK.3|VFLTVPSLSSTAEEK.2|AIEHAYQYGGTANSR.3|C[CAM]APGYYGDAR.2|QDPPETSEPR.2|GKIEQTQASEK.2|IYDAVSGIDTQIIYHK.3|LTLSELDDIIK.2|IQINNAENTMK.2|DESENLLNQAR.2|QYNDGLSHFVISSVSPTR.3|VFLTVPSLSSTAEEKFIK.3|SLLSDVEELVEK.2|AESSSDEAVADTSR.2|QYNDGLSHFVISSVSPTRYELIVDK.4|NDNLVYVYNLGTK.2|AYFNGQSFIASIQK.2|AASYFFDGSGYAVVR.2|ISFFDGFEGGFNFR.2|C[CAM]IC[CAM]NENYAGPNC[CAM]ER.2|KGEFSGDDSLLDLDPEDTVFYVGGVPSNFK.3
SEN / CTL,O43399,Tumor protein D54,TPD52L2,2.18,0.53,1.47E-02,3.91E-03,2.41E+00,,poly(A) RNA binding,,3,18,28,TPAVEGLTEAEEEELRAELTKVEEEIVTLR.4|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.5|TPAVEGLTEAEEEELRAELTKVEEEIVTLR.3|KTQETLSQAGQK.3|KTQETLSQAGQK.2|LGEWNEK.2|TSAALSTVGSAISR.3|TSAALSTVGSAISR.2|TSEKLGEWNEK.3|VTQSDLYK.2|TSAALSTVGSAISRK.3|SWHDVQVSSAYVK.3|SWHDVQVSSAYVK.2|LGLSTLGELK.2|LGLSTLGELKQNLSR.3|VEEEIVTLR.2|VTQSDLYKK.2|TPAVEGLTEAEEEELR.3|TPAVEGLTEAEEEELR.2|TQETLSQAGQK.2|GLLSDSMTDVPVDTGVAAR.3|GLLSDSM[Oxi]TDVPVDTGVAAR.2|GLLSDSMTDVPVDTGVAAR.2|VVGDRENGSDNLPSSAGSGDK.3|VVGDRENGSDNLPSSAGSGDKPLSDPAPF.4|VVGDRENGSDNLPSSAGSGDKPLSDPAPF.3|TPAVEGLTEAEEEELRAELTK.3|TPAVEGLTEAEEEELRAELTK.2
SEN / CTL,Q13822,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,ENPP2,2.17,0.96,7.84E-05,3.68E-05,4.43E+00,"phosphate-containing compound metabolic process,receptor-mediated endocytosis,movement of cell or subcellular component,chemotaxis,immune response,G-protein coupled receptor signaling pathway,phospholipid catabolic process,positive regulation of epithelial cell migration,regulation of cell migration,phosphatidylcholine catabolic process,regulation of angiogenesis,positive regulation of peptidyl-tyrosine phosphorylation,nucleic acid phosphodiester bond hydrolysis,positive regulation of lamellipodium morphogenesis","nucleic acid binding,phosphodiesterase I activity,nucleotide diphosphatase activity,lysophospholipase activity,scavenger receptor activity,calcium ion binding,transcription factor binding,zinc ion binding,hydrolase activity,polysaccharide binding,alkylglycerophosphoethanolamine phosphodiesterase activity","extracellular space,plasma membrane,integral component of plasma membrane",9,5,5,WWGGQPLWITATK.2|AGTFFWSVVIPHER.3|TYLHTYESEI.2|YGPFGPEMTNPLR.2|AAEC[CAM]PAGFVRPPLIIFSVDGFR.3
SEN / CTL,Q15582,Transforming growth factor-beta-induced protein ig-h3,TGFBI,2.13,1.99,3.05E-27,2.58E-26,2.56E+01,"angiogenesis,chondrocyte differentiation,cell adhesion,negative regulation of cell adhesion,visual perception,cell proliferation,extracellular matrix organization,cellular protein metabolic process,response to stimulus","integrin binding,protein binding,collagen binding,extracellular matrix binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,trans-Golgi network,plasma membrane,extracellular matrix,extracellular exosome",105,38,60,EGVYTVFAPTNEAFR.2|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDRTEK.3|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDRTEK.4|STVISYEC[CAM]C[CAM]PGYEKVPGEK.3|LLGDAKELANILK.3|YHIGDEILVSGGIGALVR.3|YGTLFTMDR.2|VISTITNNIQQIIEIEDTFETLR.3|VISTITNNIQQIIEIEDTFETLR.4|LTLLAPLNSVFKDGTPPIDAHTR.4|LTLLAPLNSVFKDGTPPIDAHTR.3|ILGDPEALRDLLNNHILK.4|ILGDPEALRDLLNNHILK.3|SLQGDKLEVSLK.2|SLQGDKLEVSLK.3|GC[CAM]PAALPLSNLYETLGVVGSTTTQLYTDR.3|STVISYEC[CAM]C[CAM]PGYEK.2|YLYHGQTLETLGGK.3|YLYHGQTLETLGGK.2|AIISNKDILATNGVIHYIDELLIPDSAK.4|AIISNKDILATNGVIHYIDELLIPDSAK.3|LTLLAPLNSVFK.2|LTLLAPLNSVFK.3|GDELADSALEIFK.2|NSLC[CAM]IENSC[CAM]IAAHDKR.4|NSLC[CAM]IENSC[CAM]IAAHDKR.3|SPYQLVLQHSR.3|SPYQLVLQHSR.2|HGMTLTSMYQNSNIQIHHYPNGIVTVNC[CAM]AR.4|VLTPPMGTVMDVLK.2|VLTPPM[Oxi]GTVMDVLK.2|VLTPPMGTVM[Oxi]DVLK.2|DILATNGVIHYIDELLIPDSAK.3|DILATNGVIHYIDELLIPDSAK.4|GDNRFSMLVAAIQSAGLTETLNR.3|GDNRFSM[Oxi]LVAAIQSAGLTETLNR.3|YLYHGQTLETLGGKK.4|YLYHGQTLETLGGKK.3|FSMLVAAIQSAGLTETLNR.3|FSM[Oxi]LVAAIQSAGLTETLNR.3|FSMLVAAIQSAGLTETLNR.2|AAVAASGLNTMLEGNGQYTLLAPTNEAFEK.3|AAVAASGLNTMLEGNGQYTLLAPTNEAFEK.4|ADHHATNGVVHLIDK.4|ADHHATNGVVHLIDK.3|ADHHATNGVVHLIDK.2|QHGPNVC[CAM]AVQK.3|QHGPNVC[CAM]AVQK.2|NNVVSVNK.2|QAGLGNHLSGSER.3|QAGLGNHLSGSER.2|IPSETLNR.2|GRQHGPNVC[CAM]AVQK.3|ILGDPEALR.2|NSLC[CAM]IENSC[CAM]IAAHDK.3|DGTPPIDAHTR.2|NHIIKDQLASK.2|TLFELAAESDVSTAIDLFR.3|EPVAEPDIMATNGVVHVITNVLQPPANRPQER.4|NNVVSVNKEPVAEPDIMATNGVVHVITNVLQPPANRPQER.5
SEN / CTL,P61769,Beta-2-microglobulin,B2M,2.12,1.07,7.14E-05,3.40E-05,4.47E+00,"retina homeostasis,positive regulation of T cell mediated cytotoxicity,antigen processing and presentation of peptide antigen via MHC class I,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,positive regulation of T cell cytokine production,regulation of membrane depolarization,negative regulation of neuron projection development,antibacterial humoral response,antigen processing and presentation of endogenous peptide antigen via MHC class I,positive regulation of protein binding,T cell differentiation in thymus,protein refolding,response to drug,cellular protein metabolic process,innate immune response,response to cadmium ion,positive regulation of receptor-mediated endocytosis,regulation of defense response to virus by virus,regulation of immune response,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,iron ion homeostasis,interferon-gamma-mediated signaling pathway,cellular response to lipopolysaccharide,cellular response to iron ion,negative regulation of receptor binding,positive regulation of receptor binding,positive regulation of ferrous iron import into cell,positive regulation of ferrous iron binding,positive regulation of transferrin receptor binding","glycoprotein binding,protein binding,identical protein binding","Golgi membrane,extracellular region,extracellular space,cytoplasm,endoplasmic reticulum lumen,Golgi apparatus,plasma membrane,focal adhesion,external side of plasma membrane,ER to Golgi transport vesicle membrane,membrane,phagocytic vesicle membrane,early endosome membrane,early endosome lumen,MHC class I protein complex,extracellular exosome,HFE-transferrin receptor complex",12,7,9,SNFLNC[CAM]YVSGFHPSDIEVDLLK.3|SNFLNC[CAM]YVSGFHPSDIEVDLLK.4|SNFLNC[CAM]YVSGFHPSDIEVDLLKNGER.4|SNFLNC[CAM]YVSGFHPSDIEVDLLKNGER.3|IQVYSRHPAENGK.3|IEKVEHSDLSFSK.3|VNHVTLSQPK.2|VEHSDLSFSK.2|DEYAC[CAM]RVNHVTLSQPK.3
SEN / CTL,P15121,Aldose reductase,AKR1B1,2.11,0.83,1.42E-03,4.91E-04,3.31E+00,"tissue homeostasis,carbohydrate metabolic process,sorbitol biosynthetic process,C21-steroid hormone biosynthetic process,response to stress,response to water deprivation,naphthalene metabolic process,stress-activated protein kinase signaling cascade,norepinephrine metabolic process,daunorubicin metabolic process,doxorubicin metabolic process,fructose biosynthetic process,positive regulation of JAK-STAT cascade,positive regulation of smooth muscle cell proliferation,oxidation-reduction process,maternal process involved in female pregnancy,cellular response to hydrogen peroxide,inner medullary collecting duct development,response to thyroid hormone,cellular response to methylglyoxal,cellular response to peptide","alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,electron carrier activity,glyceraldehyde oxidoreductase activity","extracellular space,nucleoplasm,cytoplasm,cytosol,cell projection cytoplasm,paranodal junction,mast cell granule,Schmidt-Lanterman incisure,perinuclear region of cytoplasm,extracellular exosome,Schwann cell microvillus",6,26,42,VAIDVGYR.2|MPILGLGTWK.2|M[Oxi]PILGLGTWK.2|LLLNNGAK.2|VC[CAM]ALLSC[CAM]TSHK.3|VC[CAM]ALLSC[CAM]TSHK.2|TTAQVLIR.2|EELFIVSK.2|LIQYC[CAM]QSK.2|DYPFHEEF.2|REELFIVSK.2|SPPGQVTEAVK.2|YKPAVNQIEC[CAM]HPYLTQEK.4|YKPAVNQIEC[CAM]HPYLTQEK.3|YKPAVNQIEC[CAM]HPYLTQEK.2|LDYLDLYLIHWPTGFKPGK.4|LDYLDLYLIHWPTGFKPGK.3|LDYLDLYLIHWPTGFKPGK.2|LWC[CAM]TYHEK.2|GIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIK.6|PWAKPEDPSLLEDPR.3|TLSDLKLDYLDLYLIHWPTGFKPGK.5|TLSDLKLDYLDLYLIHWPTGFKPGK.4|TLSDLKLDYLDLYLIHWPTGFKPGK.3|VC[CAM]ALLSC[CAM]TSHKDYPFHEEF.4|VC[CAM]ALLSC[CAM]TSHKDYPFHEEF.3|AIGISNFNHLQVEM[Oxi]ILNKPGLK.4|AIGISNFNHLQVEMILNKPGLK.4|AIGISNFNHLQVEM[Oxi]ILNKPGLK.3|AIGISNFNHLQVEMILNKPGLK.3|HIDC[CAM]AHVYQNENEVGVAIQEK.4|HIDC[CAM]AHVYQNENEVGVAIQEK.3|PEDPSLLEDPR.2|PAVNQIEC[CAM]HPYLTQEK.3|YKPAVNQIEC[CAM]HPYLTQEKLIQYC[CAM]QSK.5|LDYLDLYLIHWPTGFK.3|GIVVTAYSPLGSPDRPWAK.3|VFDFELSSQDMTTLLSYNR.3|VFDFELSSQDM[Oxi]TTLLSYNR.2|VFDFELSSQDMTTLLSYNR.2|GIVVTAYSPLGSPDRPWAKPEDPSLLEDPR.4|GIVVTAYSPLGSPDRPWAKPEDPSLLEDPR.3
SEN / CTL,P00736,Complement C1r subcomponent,C1R,2.10,1.41,5.10E-13,8.24E-13,1.21E+01,"proteolysis,immune response,complement activation,complement activation, classical pathway,innate immune response","serine-type endopeptidase activity,calcium ion binding,serine-type peptidase activity","extracellular region,extracellular exosome,blood microparticle",48,25,35,TLDEFTIIQNLQPQYQFR.3|LVFQQFDLEPSEGC[CAM]FYDYVK.3|QGYQLIEGNQVLHSFTAVC[CAM]QDDGTWHR.4|LPVANPQAC[CAM]ENWLR.2|WVATGIVSWGIGC[CAM]SR.2|MGNFPWQVFTNIHGR.3|M[Oxi]GNFPWQVFTNIHGR.3|DYFIATC[CAM]K.2|YTTTMGVNTYK.2|YTTTM[Oxi]GVNTYK.2|LFGEVTSPLFPKPYPNNFETTTVITVPTGYR.3|GFLAYYQAVDLDEC[CAM]ASR.2|WILTAAHTLYPK.3|VLNYVDWIK.2|QRPPDLDTSSNAVDLLFFTDESGDSR.3|C[CAM]LPVC[CAM]GKPVNPVEQR.3|C[CAM]LPVC[CAM]GKPVNPVEQR.2|FC[CAM]GQLGSPLGNPPGKK.3|MDVFSQNMFC[CAM]AGHPSLK.3|MDVFSQNMFC[CAM]AGHPSLK.4|M[Oxi]DVFSQNMFC[CAM]AGHPSLK.3|MDVFSQNM[Oxi]FC[CAM]AGHPSLK.3|MDVFSQNMFC[CAM]AGHPSLK.2|GGGALLGDR.2|NIGEFC[CAM]GK.2|VSVHPDYR.2|IQYYC[CAM]HEPYYK.3|IQYYC[CAM]HEPYYK.2|ESEQGVYTC[CAM]TAQGIWK.3|ESEQGVYTC[CAM]TAQGIWK.2|LFGEVTSPLFPK.2|PYPNNFETTTVITVPTGYR.3|PYPNNFETTTVITVPTGYR.2|FC[CAM]GQLGSPLGNPPGK.2|QDAC[CAM]QGDSGGVFAVR.2
SEN / CTL,P80723,Brain acid soluble protein 1,BASP1,2.10,0.58,2.02E-02,5.16E-03,2.29E+00,"thorax and anterior abdomen determination,gonad development,substantia nigra development,negative regulation of transcription, DNA-templated,mesenchymal to epithelial transition,positive regulation of heart growth,diaphragm development,metanephric mesenchyme development,glomerular visceral epithelial cell differentiation,positive regulation of metanephric ureteric bud development","transcription corepressor activity,protein binding,protein domain specific binding,transcription regulatory region DNA binding","nucleus,cytoplasm,cytoskeleton,plasma membrane,nuclear speck,cell junction,growth cone,vesicle,extracellular exosome,COP9 signalosome",3,28,41,AQGPAASAEEPKPVEAPAANSDQTVTVKE.3|AQGPAASAEEPKPVEAPAANSDQTVTVKE.4|DAAAAKEEAPKAEPEK.4|DAAAAKEEAPKAEPEK.3|AEPEKTEGAAEAK.3|ETPAATEAPSSTPK.3|ETPAATEAPSSTPK.2|EEAPKAEPEKTEGAAEAK.4|EEAPKAEPEKTEGAAEAK.3|GYNVNDEK.2|KTEAPAAPAAQETK.3|KTEAPAAPAAQETK.2|ESEPQAAAEPAEAK.3|ESEPQAAAEPAEAK.2|KAEGAATEEEGTPK.3|KAEGAATEEEGTPK.2|EKPDQDAEGKAEEKEGEK.4|EKPDQDAEGKAEEK.3|KGYNVNDEK.2|DAAAAKEEAPK.2|DKKAEGAATEEEGTPK.3|DKKAEGAATEEEGTPK.2|EEAPKAEPEK.2|AEPPKAPEQEQAAPGPAAGGEAPK.4|AEPPKAPEQEQAAPGPAAGGEAPK.3|ESEPQAAAEPAEAKEGK.3|APEQEQAAPGPAAGGEAPK.3|APEQEQAAPGPAAGGEAPK.2|AEGAATEEEGTPK.2|SDGAPASDSKPGSSEAAPSSK.3|TEAPAAPAAQETK.2|AAEAAAAPAESAAPAAGEEPSK.3|AAEAAAAPAESAAPAAGEEPSK.2|AAEAAAAPAESAAPAAGEEPSKEEGEPK.4|AAEAAAAPAESAAPAAGEEPSKEEGEPK.3|KTEAPAAPAAQETKSDGAPASDSKPGSSEAAPSSK.5|AAEAAAAPAESAAPAAGEEPSKEEGEPKK.4|AQGPAASAEEPKPVEAPAANSDQTVTVK.4|AQGPAASAEEPKPVEAPAANSDQTVTVK.3|KAEGAATEEEGTPKESEPQAAAEPAEAK.4|AEGAATEEEGTPKESEPQAAAEPAEAK.3
SEN / CTL,P22692,Insulin-like growth factor-binding protein 4,IGFBP4,2.10,0.92,1.55E-07,1.04E-07,6.98E+00,"skeletal system development,regulation of cell growth,DNA metabolic process,inflammatory response,signal transduction,cell proliferation,regulation of glucose metabolic process,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space",15,3,5,THEDLYIIPIPNC[CAM]DR.3|THEDLYIIPIPNC[CAM]DR.2|GELDC[CAM]HQLADSFRE.3|GELDC[CAM]HQLADSFRE.2|EDARPVPQGSC[CAM]QSELHR.4
SEN / CTL,P05155,Plasma protease C1 inhibitor,SERPING1,2.09,1.29,5.86E-11,6.95E-11,1.02E+01,"negative regulation of complement activation, lectin pathway,platelet degranulation,complement activation, classical pathway,aging,blood coagulation, intrinsic pathway,blood circulation,negative regulation of endopeptidase activity,fibrinolysis,innate immune response","serine-type endopeptidase inhibitor activity,protein binding","extracellular region,extracellular space,platelet alpha granule lumen,extracellular exosome,blood microparticle",33,19,34,FQPTLLTLPR.2|LVLLNAIYLSAK.2|IKVTTSQDMLSIMEK.3|LLDSLPSDTR.2|TNLESILSYPKDFTC[CAM]VHQALK.4|HRLEDMEQALSPSVFK.3|HRLEDMEQALSPSVFK.4|HRLEDMEQALSPSVFK.2|HRLEDM[Oxi]EQALSPSVFK.3|TLLVFEVQQPFLFVLWDQQHK.3|TLLVFEVQQPFLFVLWDQQHK.4|LEDMEQALSPSVFK.2|LEDMEQALSPSVFK.3|LEDM[Oxi]EQALSPSVFK.2|GVTSVSQIFHSPDLAIR.3|GVTSVSQIFHSPDLAIR.4|GVTSVSQIFHSPDLAIR.2|DFTC[CAM]VHQALK.3|DFTC[CAM]VHQALK.2|FPVFMGR.2|NSVIKVPMMNSK.3|TLYSSSPR.2|YPVAHFIDQTLK.3|YPVAHFIDQTLK.2|VTTSQDMLSIMEK.3|VTTSQDMLSIMEK.2|VTTSQDM[Oxi]LSIMEK.2|VTTSQDMLSIM[Oxi]EK.2|VTTSQDM[Oxi]LSIM[Oxi]EK.2|KYPVAHFIDQTLK.3|KYPVAHFIDQTLK.2|LYHAFSAMK.2|TNLESILSYPK.2|LLDSLPSDTRLVLLNAIYLSAK.3
SEN / CTL,P07093,Glia-derived nexin,SERPINE2,2.09,1.60,2.12E-10,2.27E-10,9.64E+00,"blood coagulation,negative regulation of cell proliferation,negative regulation of plasminogen activation,negative regulation of sodium ion transport,negative regulation of endopeptidase activity,negative regulation of protein processing,negative regulation of phosphatidylinositol 3-kinase signaling,cerebellar granular layer morphogenesis,negative regulation of blood coagulation,negative regulation of cell growth,regulation of cell migration,secretion by cell,secretory granule organization,negative regulation of protein catabolic process,mating plug formation,negative regulation of proteolysis,negative regulation of smoothened signaling pathway,regulation of timing of cell differentiation,positive regulation of astrocyte differentiation,detection of mechanical stimulus involved in sensory perception,regulation of synaptic transmission, glutamatergic,long-term synaptic potentiation,innervation,seminal vesicle epithelium development,negative regulation of platelet aggregation","serine-type endopeptidase inhibitor activity,receptor binding,protein binding,glycosaminoglycan binding,heparin binding","extracellular region,extracellular space,cytosol,extracellular matrix,platelet alpha granule,extrinsic component of external side of plasma membrane,neuromuscular junction,extracellular vesicle",27,11,14,ASAATTAILIAR.2|SYQVPMLAQLSVFR.2|DMIDNLLSPDLIDGVLTR.2|DMIDNLLSPDLIDGVLTR.3|SRPHDNIVISPHGIASVLGMLQLGADGR.4|SRPHDNIVISPHGIASVLGMLQLGADGR.5|LVLVNAVYFK.2|TIDSWMSIMVPK.2|VLGITDMFDSSK.2|NKDIVTVANAVFVK.3|NKDIVTVANAVFVK.2|AKIEVSEDGTK.2|ITTGSENLHVSHILQK.3|DIVTVANAVFVK.2
SEN / CTL,P07237,Protein disulfide-isomerase,P4HB,2.09,1.13,2.47E-17,5.88E-17,1.62E+01,"response to reactive oxygen species,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,response to endoplasmic reticulum stress,lipoprotein biosynthetic process,cell redox homeostasis,positive regulation of viral entry into host cell,cellular response to hypoxia,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","protein disulfide isomerase activity,integrin binding,protein binding,enzyme binding,poly(A) RNA binding,protein heterodimerization activity,procollagen-proline 4-dioxygenase activity","extracellular region,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,focal adhesion,external side of plasma membrane,procollagen-proline 4-dioxygenase complex,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome",54,62,113,EADDIVNWLK.2|ILEFFGLK.2|LITLEEEMTK.2|LITLEEEM[Oxi]TK.2|ILFIFIDSDHTDNQR.3|ILFIFIDSDHTDNQR.2|VDATEESDLAQQYGVR.2|VDATEESDLAQQYGVR.3|THILLFLPK.2|LAKVDATEESDLAQQYGVR.3|LAKVDATEESDLAQQYGVR.2|YQLDKDGVVLFK.3|YQLDKDGVVLFK.2|HNQLPLVIEFTEQTAPK.3|HNQLPLVIEFTEQTAPK.4|HNQLPLVIEFTEQTAPK.2|QFLQAAEAIDDIPFGITSNSDVFSK.3|QFLQAAEAIDDIPFGITSNSDVFSK.4|FDEGRNNFEGEVTKENLLDFIK.4|FDEGRNNFEGEVTKENLLDFIK.3|LITLEEEMTKYKPESEELTAER.4|LITLEEEMTKYKPESEELTAER.3|IKPHLMSQELPEDWDKQPVK.5|IKPHLMSQELPEDWDKQPVK.4|IKPHLM[Oxi]SQELPEDWDKQPVK.5|IKPHLM[Oxi]SQELPEDWDKQPVK.4|IKPHLM[Oxi]SQELPEDWDKQPVK.3|IKPHLMSQELPEDWDKQPVK.3|TGPAATTLPDGAAAESLVESSEVAVIGFFK.3|TGPAATTLPDGAAAESLVESSEVAVIGFFK.4|MDSTANEVEAVKVHSFPTLK.4|M[Oxi]DSTANEVEAVKVHSFPTLK.4|MDSTANEVEAVKVHSFPTLK.3|M[Oxi]DSTANEVEAVKVHSFPTLK.3|TLDGFKK.2|ALAPEYAK.2|KSNFAEALAAHK.3|KSNFAEALAAHK.2|LGETYKDHENIVIAK.4|LGETYKDHENIVIAK.3|LGETYKDHENIVIAK.2|MDSTANEVEAVK.3|MDSTANEVEAVK.2|M[Oxi]DSTANEVEAVK.2|EADDIVNWLKK.3|EADDIVNWLKK.2|KFDEGRNNFEGEVTK.4|KFDEGRNNFEGEVTK.3|KFDEGRNNFEGEVTK.2|NFEDVAFDEKK.3|NFEDVAFDEKK.2|FFPASADR.2|IFGGEIKTHILLFLPK.4|IFGGEIKTHILLFLPK.3|VHSFPTLK.2|TAAESFKGK.2|ILEFFGLKKEEC[CAM]PAVR.4|ILEFFGLKKEEC[CAM]PAVR.3|ITEFC[CAM]HR.2|YKPESEELTAER.3|YKPESEELTAER.2|YKPESEELTAERITEFC[CAM]HR.5|YKPESEELTAERITEFC[CAM]HR.4|NGDTASPKEYTAGR.3|NGDTASPKEYTAGR.2|QLAPIWDK.2|SVSDYDGKLSNFK.3|SVSDYDGKLSNFK.2|ENLLDFIK.2|IKPHLM[Oxi]SQELPEDWDK.4|IKPHLMSQELPEDWDK.4|IKPHLMSQELPEDWDK.3|IKPHLM[Oxi]SQELPEDWDK.3|IKPHLMSQELPEDWDK.2|KEEC[CAM]PAVR.2|LKAEGSEIR.2|KNVFVEFYAPWC[CAM]GHC[CAM]K.4|KNVFVEFYAPWC[CAM]GHC[CAM]K.3|KNVFVEFYAPWC[CAM]GHC[CAM]K.2|DHENIVIAK.2|NNFEGEVTK.2|YQLDKDGVVLFKK.3|YQLDKDGVVLFKK.2|QLAPIWDKLGETYKDHENIVIAK.5|QLAPIWDKLGETYKDHENIVIAK.4|QLAPIWDKLGETYKDHENIVIAK.3|TVIDYNGER.2|FDEGRNNFEGEVTK.3|FDEGRNNFEGEVTK.2|ILEFFGLKK.2|SNFAEALAAHK.2|NFEDVAFDEK.2|EYTAGREADDIVNWLK.3|EYTAGREADDIVNWLK.2|NVFVEFYAPWC[CAM]GHC[CAM]K.3|NVFVEFYAPWC[CAM]GHC[CAM]K.2|FFPASADRTVIDYNGER.3|YLLVEFYAPWC[CAM]GHC[CAM]K.3|YLLVEFYAPWC[CAM]GHC[CAM]K.2|AAGKLKAEGSEIR.2|NNFEGEVTKENLLDFIK.3|NNFEGEVTKENLLDFIK.2|LAKVDATEESDLAQQYGVRGYPTIK.4|ENLLDFIKHNQLPLVIEFTEQTAPK.4|PHLMSQELPEDWDKQPVK.3|RTGPAATTLPDGAAAESLVESSEVAVIGFFK.4|RTGPAATTLPDGAAAESLVESSEVAVIGFFK.3|NNFEGEVTKENLLDFIKHNQLPLVIEFTEQTAPK.5|RTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK.5|RTGPAATTLPDGAAAESLVESSEVAVIGFFKDVESDSAK.4|KRTGPAATTLPDGAAAESLVESSEVAVIGFFK.4|KRTGPAATTLPDGAAAESLVESSEVAVIGFFK.3|VDATEESDLAQQYGVRGYPTIK.3
SEN / CTL,Q12907,Vesicular integral-membrane protein VIP36,LMAN2,2.09,2.22,1.47E-01,3.11E-02,1.51E+00,"ER to Golgi vesicle-mediated transport,retrograde vesicle-mediated transport, Golgi to ER,endoplasmic reticulum organization,Golgi organization,protein transport,positive regulation of phagocytosis","glycoprotein binding,mannose binding,carbohydrate binding,heat shock protein binding,metal ion binding","Golgi membrane,extracellular space,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,integral component of plasma membrane,cell surface,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",3,21,31,NLHGDGIALWYTR.3|NLHGDGIALWYTR.2|DRLVPGPVFGSK.3|DRLVPGPVFGSK.2|NRDHDTFLAVR.3|NRDHDTFLAVR.2|GRLTVMTDLEDKNEWK.4|GRLTVMTDLEDKNEWK.3|LVPGPVFGSK.2|IEPSVNFLK.2|NC[CAM]IDITGVR.2|SPKDNVDDPTGNFR.3|SPKDNVDDPTGNFR.2|DHDTFLAVR.2|EGSIWNHQPC[CAM]FLK.3|EGSIWNHQPC[CAM]FLK.2|LTVMTDLEDKNEWK.3|LTVMTDLEDKNEWK.2|LTVMTDLEDK.2|DWEMHVHFK.2|DNVDDPTGNFR.2|WTELAGC[CAM]TADFR.2|LFQLMVEHTPDEESIDWTK.3|LFQLMVEHTPDEESIDWTK.2|DNFHGLAIFLDTYPNDETTER.3|LFQLMVEHTPDEESIDWTKIEPSVNFLK.4|LPTGYYFGASAGTGDLSDNHDIISMK.3|EHSLIKPYQGVGSSSM[Oxi]PLWDFQGSTMLTSQYVR.4|EHSLIKPYQGVGSSSMPLWDFQGSTM[Oxi]LTSQYVR.4|EHSLIKPYQGVGSSSMPLWDFQGSTMLTSQYVR.4|PYQGVGSSSMPLWDFQGSTMLTSQYVR.3
SEN / CTL,O75828;P16152,Carbonyl reductase [NADPH] 3;Carbonyl reductase [NADPH] 1,CBR3;CBR1,2.08,0.12,1.23E-03,4.32E-04,3.37E+00,"phylloquinone catabolic process,cognition,oxidation-reduction process;drug metabolic process,cyclooxygenase pathway,epithelial cell differentiation,vitamin K metabolic process,oxidation-reduction process","3-keto sterol reductase activity,carbonyl reductase (NADPH) activity,NADPH binding;carbonyl reductase (NADPH) activity,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,prostaglandin-E2 9-reductase activity","extracellular space,nucleoplasm,cytoplasm,cytosol;cytosol,extracellular exosome,extracellular vesicle",3,1,2,FHQLDIDDLQSIR.3|FHQLDIDDLQSIR.2
SEN / CTL,P80303,Nucleobindin-2,NUCB2,2.08,1.30,7.85E-08,5.63E-08,7.25E+00,,"DNA binding,calcium ion binding","extracellular space,nuclear envelope,endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,cytosol,plasma membrane,extracellular exosome",21,26,37,LVTLEEFLK.2|LHDVNSDGFLDEQELEALFTK.3|VYDPKNEEDDMVEMEEERLR.4|AKLDSLQDIGMDHQALLK.4|AKLDSLQDIGMDHQALLK.3|QFDHLNHLNPDKFESTDLDMLIK.5|QFDHLNHLNPDKFESTDLDMLIK.4|ELDLVSHHVR.3|ELDLVSHHVR.2|ADIEEIK.2|VQNIHPVESAK.3|VQNIHPVESAK.2|AATSDLEHYDK.3|AATSDLEHYDK.2|DRLVTLEEFLK.3|DRLVTLEEFLK.2|QFDHLNHLNPDK.3|QFDHLNHLNPDK.2|QVIDVLETDKHFR.3|QHDQLEAQK.2|LEYHQVIQQMEQK.3|LEYHQVIQQM[Oxi]EQK.3|LEYHQVIQQMEQK.2|KLQQGIPPSGPAGELKFEPHI.4|QVIDVLETDK.2|LDSLQDIGMDHQALLK.3|LDSLQDIGM[Oxi]DHQALLK.3|LDSLQDIGMDHQALLK.2|EYENIIALQENELKK.3|QHDQLEAQKLEYHQVIQQMEQK.4|VYDPKNEEDDMVEMEEER.3|DQLKEVWEETDGLDPNDFDPK.3|NEEDDMVEMEEER.2|EYENIIALQENELK.2|IEPPDTGLYYDEYLK.2|EVWEETDGLDPNDFDPK.2|KEFLEPDSWETLDQQQFFTEEELK.3
SEN / CTL,P61604,"10 kDa heat shock protein, mitochondrial",HSPE1,2.07,1.21,2.18E-03,7.06E-04,3.15E+00,"osteoblast differentiation,protein folding,activation of cysteine-type endopeptidase activity involved in apoptotic process,response to unfolded protein,chaperone mediated protein folding requiring cofactor","protein binding,ATP binding,poly(A) RNA binding,metal ion binding,unfolded protein binding,chaperone binding","mitochondrion,mitochondrial matrix,membrane,extracellular exosome",6,19,27,FLPLFDR.2|VLQATVVAVGSGSK.2|VLQATVVAVGSGSK.3|GKGGEIQPVSVK.3|GKGGEIQPVSVK.2|SAAETVTK.2|GGIMLPEK.2|GGIM[Oxi]LPEK.2|VGDKVLLPEYGGTK.3|VGDKVLLPEYGGTK.2|FLPLFDRVLVER.3|GGEIQPVSVK.2|VVLDDKDYFLFR.3|VVLDDKDYFLFR.2|DYFLFRDGDILGK.3|DYFLFRDGDILGK.2|KFLPLFDR.2|VLLPEYGGTK.2|KFLPLFDRVLVER.3|DGDILGKYVD.2|VVLDDKDYFLFRDGDILGK.4|VVLDDKDYFLFRDGDILGK.3|VVLDDKDYFLFRDGDILGK.2|GGIM[Oxi]LPEKSQGKVLQATVVAVGSGSK.4|VLLPEYGGTKVVLDDKDYFLFR.4|SAAETVTKGGIM[Oxi]LPEKSQGK.3|VLQATVVAVGSGSKGK.2
SEN / CTL,P12111,Collagen alpha-3(VI) chain,COL6A3,2.06,1.38,7.15E-86,5.43E-84,8.33E+01,"cell adhesion,muscle organ development,negative regulation of endopeptidase activity,extracellular matrix organization,collagen catabolic process",serine-type endopeptidase inhibitor activity,"extracellular region,proteinaceous extracellular matrix,collagen type VI trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,sarcolemma,extracellular exosome,extracellular vesicle",342,165,233,ALILVGLER.2|LSDAGITPLFLTR.2|LLPSFVSSENAFYLSPDIR.3|LLVLITGGK.2|LVDYLDVGFDTTR.2|ALGSAIEYTIENVFESAPNPR.3|EVQVFEITENSAK.2|AELQHIATDDNLVFTVPEFR.3|QSGVVPFIFQAK.2|VPQIAFVITGGK.2|VVIHFTDGADGDLADLHR.3|VVIHFTDGADGDLADLHR.4|IAVAQYSDDVKVESR.3|IAVAQYSDDVKVESR.2|VGVVQFSNDVFPEFYLK.3|VGVVQFSNDVFPEFYLK.2|VGLVQFSDTPVTEFSLNTYQTK.3|IVVLMLTGEVPEQQLEEAQR.3|LLPYIVGVAQR.2|LLPSFVSSENAFYLSPDIRK.3|AC[CAM]NLDVILGFDGSRDQNVFVAQK.3|VVESLDVGQDRVR.3|QINVGNALEYVSR.2|QINVGNALEYVSR.3|LLTPITTLTSEQIQK.2|LLTPITTLTSEQIQK.3|IGDLHPQIVNLLK.3|IGDLHPQIVNLLK.2|NADPAELEQIVLSPAFILAAESLPK.3|NADPAELEQIVLSPAFILAAESLPK.4|QFGVAPFTIAR.2|IEDGVPQHLVLVLGGK.3|IEDGVPQHLVLVLGGK.2|AC[CAM]NLDVILGFDGSR.2|LDQRVPQIAFVITGGK.3|QASVFSFGLGAQAASR.2|ISLSPEYVFSVSTFR.2|ISLSPEYVFSVSTFR.3|RGGAVPIGIGIGNADITEMQTISFIPDFAVAIPTFR.4|RGGAVPIGIGIGNADITEM[Oxi]QTISFIPDFAVAIPTFR.4|VSVVANTPSGPVEAFDFDEYQPEMLEK.3|LNLLDLDYELAEQLDNIAEK.3|LNLLDLDYELAEQLDNIAEK.2|IREHVPQLLLLLTAGQSEDSYLQAANALTR.4|LVDKSTELNEEPLMR.3|VVESLDVGQDR.2|SLDEISQPAQELKR.3|SLDEISQPAQELKR.2|DVVFLIDGSQSAGPEFQYVR.3|DVVFLIDGSQSAGPEFQYVR.2|GADQAELEEIAFDSSLVFIPAEFR.3|EVYTFASEPNDVFFK.2|EVYTFASEPNDVFFK.3|SAGSRIEDGVPQHLVLVLGGK.4|SAGSRIEDGVPQHLVLVLGGK.3|NIDSEEVGKIASNSATAFR.3|NLQVALTSK.2|SSIMAFAIGNK.2|SSIM[Oxi]AFAIGNK.2|ITEGVPQLLIVLTADR.2|ITEGVPQLLIVLTADR.3|IEEGVPQFLVLISSGKSDDEVDDPAVELKQFGVAPFTIAR.4|IEEGVPQFLVLISSGKSDDEVDDPAVELKQFGVAPFTIAR.5|SVEDAQDVSLALTQR.2|SVEDAQDVSLALTQR.3|AAPLQGMLPGLLAPLR.2|AAPLQGMLPGLLAPLR.3|AAPLQGM[Oxi]LPGLLAPLR.3|AAPLQGM[Oxi]LPGLLAPLR.2|MKPLDGSALYTGSALDFVR.3|M[Oxi]KPLDGSALYTGSALDFVR.3|QLTLLGGPTPNTGAALEFVLR.3|QLTLLGGPTPNTGAALEFVLR.2|NIDRTELQTITNDPR.3|NIDRTELQTITNDPR.2|IIDELNVKPEGTR.3|IIDELNVKPEGTR.2|VGNVQELSELSEQVLETLHDAMHETLC[CAM]PGVTDAAK.4|VGNVQELSELSEQVLETLHDAM[Oxi]HETLC[CAM]PGVTDAAK.4|QLGTVQQVISER.2|QLGTVQQVISER.3|LQPVLQPLPSPGVGGK.2|LQPVLQPLPSPGVGGK.3|IEEGVPQFLVLISSGK.2|IEEGVPQFLVLISSGK.3|VAVIQFSDDPKVEFLLNAHSSKDEVQNAVQR.5|VAVIQFSDDPKVEFLLNAHSSKDEVQNAVQR.4|VAVIQFSDDPKVEFLLNAHSSKDEVQNAVQR.3|SSGIVSLGVGDR.2|VC[CAM]APVLAKPGVISVMGT.2|NNLFTSSAGYR.2|YPPPAVESDAADIVFLIDSSEGVRPDGFAHIRDFVSR.5|SDDEVDDPAVELK.2|VAVVQYSDR.2|VGVVQFSDEPR.2|GLEYIMQSHLTK.3|ALNLGYALDYAQR.2|ALNLGYALDYAQR.3|MRDVVLSIVNDLTIAESNC[CAM]PR.3|MRDVVLSIVNDLTIAESNC[CAM]PR.4|M[Oxi]RDVVLSIVNDLTIAESNC[CAM]PR.3|NILVSSAGSR.2|QIIDAINKVVYK.3|VAVVTYNNEVTTEIR.2|VAVVTYNNEVTTEIR.3|SQHPYVLTEDTLK.3|SQHPYVLTEDTLK.2|FDEHQSKPEILNLVK.4|FDEHQSKPEILNLVK.3|FDEHQSKPEILNLVK.2|QQSLETAMSFVAR.2|QQSLETAMSFVAR.3|QQSLETAM[Oxi]SFVAR.2|IEEGVPQFLVLISSGKSDDEVDDPAVELK.3|IEEGVPQFLVLISSGKSDDEVDDPAVELK.4|GAQGPAGPAGPPGLIGEQGISGPR.2|GAQGPAGPAGPPGLIGEQGISGPR.3|GFESKVDAILNR.2|GFESKVDAILNR.3|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIRDFVSR.6|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIRDFVSR.5|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTKR.5|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTKR.6|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTKR.4|SDDEVDDPAVELKQFGVAPFTIAR.3|ALGFAGGELANIGLALDFVVENHFTR.3|VAVFFSNTPTR.2|KVAVFFSNTPTR.3|TRPEFYLNSYMNK.3|TRPEFYLNSYM[Oxi]NK.3|TRPEFYLNSYMNK.2|VEEGVPQVLVLISAGPSSDEIR.3|VEEGVPQVLVLISAGPSSDEIR.2|YPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.4|YPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.5|QLQLQGGSGLNTGSALSYVYANHFTEAGGSR.4|QLQLQGGSGLNTGSALSYVYANHFTEAGGSR.3|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.5|LLASTRYPPPAVESDAADIVFLIDSSEGVRPDGFAHIR.6|VDAILNR.2|VNHFVPEAGSR.3|VNHFVPEAGSR.2|SQAPVLDAIRR.3|VGLEHLR.2|ASENLRQEGVR.3|QIIDAINKVVYKGGR.4|QIIDAINKVVYKGGR.3|GETGDDGRDGVGSEGRR.4|GETGDDGRDGVGSEGRR.3|LQPVLQPLPSPGVGGKR.4|LQPVLQPLPSPGVGGKR.2|RSSIMAFAIGNK.3|RLNIGPSK.2|SSDRVDGPASNLK.3|SSDRVDGPASNLK.2|SVHNGAPAPVSGEK.3|SVHNGAPAPVSGEK.2|VTQLTREELSR.3|YIAYLVR.2|SDILGHLR.2|SGDDVRNPSVVVK.3|SGDDVRNPSVVVK.2|SGFPLLKEFVQR.3|EFRELPNIEER.3|GIPGEDGYR.2|SLDEISQPAQELK.3|SLDEISQPAQELK.2|GMTQLQGTR.2|SQHPYVLTEDTLKVYLNKFR.5|SQHPYVLTEDTLKVYLNKFR.4|SQHPYVLTEDTLKVYLNKFR.3|DSFQEVLR.2|ELPNIEER.2|SGDDVRNPSVVVKR.3|LPIGTQQIR.2|DQNVFVAQK.2|GETGDDGRDGVGSEGR.3|IASNSATAFR.2|NADQEELVK.2|DEVQNAVQR.2|DGVPGGPGETGK.2|RQIIDAINK.2|SQAPVLDAIR.2|SQHPYVLTEDTLKVYLNK.4|LRGGSPLNTGK.2|VEFLLNAHSSKDEVQNAVQR.4|VEFLLNAHSSKDEVQNAVQR.3|GDRGPIGSIGPK.2|RDSFQEVLR.2|IAVAQYSDDVK.2|VAVIQFSDDPK.2|VAVIQFSDDPKVEFLLNAHSSK.4|KADIVFLLDGSINFRR.3|SVLLDKIKNLQVALTSK.3|GNRGDSIDQC[CAM]ALIQSIK.3|GNRGDSIDQC[CAM]ALIQSIK.2|GPRGETGDDGRDGVGSEGR.3|VVIHFTDGADGDLADLHRASENLRQEGVR.5|TELQTITNDPR.2|TRPEFYLNSYM[Oxi]NKQDVVNAVR.4|ASPQLREAVLKLSDAGITPLFLTR.4|ASPQLREAVLKLSDAGITPLFLTR.3|EAVLKLSDAGITPLFLTR.3|STELNEEPLMR.2|GDPGNPGQDSQER.2|SVHNGAPAPVSGEKDVVFLLDGSEGVR.4|SVHNGAPAPVSGEKDVVFLLDGSEGVR.3|DVVFLLDGSEGVR.2|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTK.5|LEIGQDLIQVAVAQYADTVRPEFYFNTHPTK.4|SFGDLQEKLLPYIVGVAQR.3|LVFTVREFRELPNIEER.3|VAVVQYSDRTRPEFYLNSYM[Oxi]NKQDVVNAVR.5|DIIFLLDGSANVGK.2|DIVFLVDGSSALGLANFNAIR.3|SAGSRIEDGVPQHLVLVLGGKSQDDVSR.4|VIGGLLAGQTYHVAVVC[CAM]YLR.3|GGPGQPGFEGEQGTR.2|QC[CAM]DWFQGDQPTK.2|VRVGVVQFSNDVFPEFYLK.3|AGILTFC[CAM]VGASQANK.2|GDSIDQC[CAM]ALIQSIK.2|ITEGVPQLLIVLTADRSGDDVRNPSVVVK.4|RDILFLFDGSANLVGQFPVVR.3|RDIVFLVDGSSALGLANFNAIR.3|RDVVFLIDGSQSAGPEFQYVR.3|ELPSLEQKLLTPITTLTSEQIQK.3|SSDRVDGPASNLKQSGVVPFIFQAK.3|ISLSPEYVFSVSTFRELPSLEQK.3|PLDGSALYTGSALDFVR.2|C[CAM]PC[CAM]C[CAM]YGPLEC[CAM]PVFPTELAFALDTSEGVNQDTFGR.4|EHVPQLLLLLTAGQSEDSYLQAANALTR.3|ISLSPEYVFSVSTFRELPSLEQKLLTPITTLTSEQIQK.4
SEN / CTL,P15586,N-acetylglucosamine-6-sulfatase,GNS,2.06,0.12,1.09E-03,3.87E-04,3.41E+00,"glycosaminoglycan catabolic process,keratan sulfate catabolic process","N-acetylglucosamine-6-sulfatase activity,sulfuric ester hydrolase activity,metal ion binding","lysosomal lumen,extracellular exosome",3,18,33,IQEPNTFPAILR.2|RQLYEFDIK.3|RQLYEFDIK.2|TIDPELLGK.2|TQMDGMSLLPILR.3|TQM[Oxi]DGMSLLPILR.2|TQMDGM[Oxi]SLLPILR.2|TQMDGMSLLPILR.2|TQM[Oxi]DGM[Oxi]SLLPILR.2|NFNIHGTNK.2|AFQNVFAPR.2|QLYEFDIK.2|RWQTLLSVDDLVEK.3|RWQTLLSVDDLVEK.2|QLYEFDIKVPLLVR.3|WQTLLSVDDLVEKLVK.3|RPNVVLLLTDDQDEVLGGMTPLKK.4|RPNVVLLLTDDQDEVLGGMTPLKK.3|SDVLVEYQGEGR.2|SMC[CAM]GYQTFFAGK.2|SM[Oxi]C[CAM]GYQTFFAGK.2|LM[Oxi]MLQSC[CAM]SGPTC[CAM]R.2|LMM[Oxi]LQSC[CAM]SGPTC[CAM]R.2|LMMLQSC[CAM]SGPTC[CAM]R.2|LM[Oxi]M[Oxi]LQSC[CAM]SGPTC[CAM]R.2|SNFEPFFM[Oxi]MIATPAPHSPWTAAPQYQK.4|SNFEPFFMMIATPAPHSPWTAAPQYQK.4|SNFEPFFM[Oxi]MIATPAPHSPWTAAPQYQK.3|SNFEPFFMM[Oxi]IATPAPHSPWTAAPQYQK.3|SNFEPFFMMIATPAPHSPWTAAPQYQK.3|WQTLLSVDDLVEK.2|RPNVVLLLTDDQDEVLGGMTPLK.3|YLNEYGAPDAGGLEHVPLGWSYWYALEK.3
SEN / CTL,P09871,Complement C1s subcomponent,C1S,2.06,1.32,7.03E-14,1.24E-13,1.29E+01,"proteolysis,complement activation,complement activation, classical pathway,innate immune response","serine-type endopeptidase activity,calcium ion binding","extracellular region,extracellular exosome,blood microparticle",48,26,38,TNFDNDIALVR.2|MGPTVSPIC[CAM]LPGTSSDYNLMDGDLGLISGWGR.3|YHGDPMPC[CAM]PKEDTPNSVWEPAK.4|VEKPTADAEAYVFTPNMIC[CAM]AGGEK.3|VEKPTADAEAYVFTPNMIC[CAM]AGGEK.4|VEKPTADAEAYVFTPNM[Oxi]IC[CAM]AGGEK.3|SSNNPHSPIVEEFQVPYNK.3|SSNNPHSPIVEEFQVPYNK.4|SNALDIIFQTDLTGQK.3|SNALDIIFQTDLTGQK.2|MLTPEHVFIHPGWK.4|M[Oxi]LTPEHVFIHPGWK.4|MLTPEHVFIHPGWK.2|GFQVVVTLR.2|NYVDWIMK.2|LLEVPEGR.2|GMDSC[CAM]KGDSGGAFAVQDPNDKTK.4|QFGPYC[CAM]GHGFPGPLNIETK.3|QFGPYC[CAM]GHGFPGPLNIETK.2|VGATSFYSTC[CAM]QSNGK.2|VEDPESTLFGSVIR.3|VEDPESTLFGSVIR.2|TMQENSTPR.2|GDSGGAFAVQDPNDKTK.3|GDSGGAFAVQDPNDKTK.2|YHGDPMPC[CAM]PK.2|DVVQITC[CAM]LDGFEVVEGR.3|DVVQITC[CAM]LDGFEVVEGR.2|TMQENSTPRED.2|TM[Oxi]QENSTPRED.2|EDTPNSVWEPAK.2|GMDSC[CAM]KGDSGGAFAVQDPNDK.3|GDSGGAFAVQDPNDK.2|FYAAGLVSWGPQC[CAM]GTYGLYTR.3|FYAAGLVSWGPQC[CAM]GTYGLYTR.2|EPTMYVGSTSVQTSR.2|REDFDVEAADSAGNC[CAM]LDSLVFVAGDR.3|C[CAM]QPVDC[CAM]GIPESIENGKVEDPESTLFGSVIR.3
SEN / CTL,Q15084,Protein disulfide-isomerase A6,PDIA6,2.06,1.35,5.06E-11,6.31E-11,1.02E+01,"protein folding,response to endoplasmic reticulum stress,IRE1-mediated unfolded protein response,apoptotic cell clearance,cell redox homeostasis","protein disulfide isomerase activity,protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,endoplasmic reticulum chaperone complex,melanosome,extracellular exosome",27,32,56,TGEAIVDAALSALR.2|TGEAIVDAALSALR.3|ALDLFSDNAPPPELLEIINEDIAKR.3|ALDLFSDNAPPPELLEIINEDIAKR.4|LAAVDATVNQVLASR.2|LAAVDATVNQVLASR.3|NLEPEWAAAASEVKEQTK.3|NLEPEWAAAASEVKEQTK.2|GSFSEQGINEFLR.2|GSFSEQGINEFLR.3|VGAVDADKHHSLGGQYGVQGFPTIK.4|VGAVDADKHHSLGGQYGVQGFPTIK.6|VGAVDADKHHSLGGQYGVQGFPTIK.5|VGAVDADKHHSLGGQYGVQGFPTIK.3|NSYLEVLLK.2|VKLAAVDATVNQVLASR.3|VKLAAVDATVNQVLASR.2|NSYLEVLLKLADKYK.4|NSYLEVLLKLADKYK.3|HHSLGGQYGVQGFPTIK.4|HHSLGGQYGVQGFPTIK.3|HHSLGGQYGVQGFPTIK.2|AATALKDVVK.2|KDVIELTDDSFDK.3|KDVIELTDDSFDK.2|NLEPEWAAAASEVK.3|NLEPEWAAAASEVK.2|TGEAIVDAALSALRQLVKDR.4|GSTAPVGGGAFPTIVER.3|GSTAPVGGGAFPTIVER.2|IFQKGESPVDYDGGR.3|IFQKGESPVDYDGGR.2|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.5|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.4|RTC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.3|GESPVDYDGGR.2|GSTAPVGGGAFPTIVEREPWDGR.4|GSTAPVGGGAFPTIVEREPWDGR.3|NRPEDYQGGR.2|TGEAIVDAALSALRQLVK.3|NRPEDYQGGRTGEAIVDAALSALR.4|ALDLFSDNAPPPELLEIINEDIAK.4|ALDLFSDNAPPPELLEIINEDIAK.3|TC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.4|TC[CAM]EEHQLC[CAM]VVAVLPHILDTGAAGR.3|DVIELTDDSFDK.2|SDSSSKKDVIELTDDSFDK.3|EVIQSDSLWLVEFYAPWC[CAM]GHC[CAM]QR.4|EVIQSDSLWLVEFYAPWC[CAM]GHC[CAM]QR.3|GSFSEQGINEFLRELSFGR.3|DGELPVEDDIDLSDVELDDLGK.3|EPWDGRDGELPVEDDIDLSDVELDDLGKDEL.4|EPWDGRDGELPVEDDIDLSDVELDDLGKDEL.3|NVLDSEDVWMVEFYAPWC[CAM]GHC[CAM]K.3|NVLDSEDVWM[Oxi]VEFYAPWC[CAM]GHC[CAM]K.3|DGELPVEDDIDLSDVELDDLGKDEL.3
SEN / CTL,Q9Y2E5,Epididymis-specific alpha-mannosidase,MAN2B2,2.06,1.36,9.16E-04,3.36E-04,3.47E+00,"mannose metabolic process,protein deglycosylation,oligosaccharide catabolic process","alpha-mannosidase activity,zinc ion binding,mannan endo-1,6-alpha-mannosidase activity,carbohydrate binding","lysosomal lumen,extracellular exosome",9,15,22,FIAVEQEFFR.2|GHLDPTWALQQLQQLR.3|GHLDPTWALQQLQQLR.2|SLTGTWDLSMLHR.3|SLTGTWDLSMLHR.2|LTHVPQGHDGELLC[CAM]HR.4|AHGISSQGNGQVEVMLHR.4|AHGISSQGNGQVEVMLHR.3|TPHVLWPWGC[CAM]DK.3|TPHVLWPWGC[CAM]DK.2|WAVSEVQHHDAITGTESPK.4|SALALQHRPVVLFGDLAGTAPK.4|AYAANVYTSVVEELAR.3|AYAANVYTSVVEELAR.2|VTQEFLEYHVNGDVK.3|LPGPQQQEAVTLPPNLHLQILSIPGWR.4|LPGPQQQEAVTLPPNLHLQILSIPGWR.3|VRDHHDFLPYSTEPFQAWTGFYTSR.4|VRDHHDFLPYSTEPFQAWTGFYTSR.3|QGPISDNYLFTPGK.2|AAVPAWEAVEMEIVAGQLVTEIR.3|IEQEYQAGPLELNR.2
SEN / CTL,P00558,Phosphoglycerate kinase 1,PGK1,2.05,1.11,4.83E-23,2.62E-22,2.16E+01,"gluconeogenesis,phosphorylation,epithelial cell differentiation,canonical glycolysis","phosphoglycerate kinase activity,ATP binding","cytosol,membrane,membrane raft,extracellular exosome",66,59,126,AC[CAM]ANPAAGSVILLENLR.2|AC[CAM]ANPAAGSVILLENLR.3|GC[CAM]ITIIGGGDTATC[CAM]C[CAM]AK.2|GC[CAM]ITIIGGGDTATC[CAM]C[CAM]AK.3|VLPGVDALSNI.2|WNTEDKVSHVSTGGGASLELLEGK.4|WNTEDKVSHVSTGGGASLELLEGK.3|ALESPERPFLAILGGAK.3|ALESPERPFLAILGGAK.4|ALESPERPFLAILGGAK.2|ITLPVDFVTADKFDENAK.3|ITLPVDFVTADKFDENAK.4|ITLPVDFVTADKFDENAK.2|SLLGKDVLFLKDC[CAM]VGPEVEK.4|SLLGKDVLFLKDC[CAM]VGPEVEK.3|SLLGKDVLFLKDC[CAM]VGPEVEK.2|QIVWNGPVGVFEWEAFAR.3|QIVWNGPVGVFEWEAFAR.2|VLNNMEIGTSLFDEEGAK.3|VLNNMEIGTSLFDEEGAK.2|VLNNM[Oxi]EIGTSLFDEEGAK.3|VLNNM[Oxi]EIGTSLFDEEGAK.2|TGQATVASGIPAGWMGLDC[CAM]GPESSKK.3|TGQATVASGIPAGWMGLDC[CAM]GPESSKK.4|TGQATVASGIPAGWM[Oxi]GLDC[CAM]GPESSKK.3|LGDVYVNDAFGTAHR.3|LGDVYVNDAFGTAHR.2|LGDVYVNDAFGTAHR.4|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.6|SVVLM[Oxi]SHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.5|SVVLM[Oxi]SHLGRPDGVPMPDKYSLEPVAVELK.5|SVVLMSHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.5|SVVLM[Oxi]SHLGRPDGVPMPDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPM[Oxi]PDKYSLEPVAVELK.4|SVVLMSHLGRPDGVPMPDKYSLEPVAVELK.3|AKQIVWNGPVGVFEWEAFAR.3|AKQIVWNGPVGVFEWEAFAR.4|AKQIVWNGPVGVFEWEAFAR.2|VDFNVPMKNNQITNNQR.3|VDFNVPM[Oxi]KNNQITNNQR.3|VDFNVPM[Oxi]KNNQITNNQR.2|VDFNVPMKNNQITNNQR.2|AHSSMVGVNLPQK.3|AHSSM[Oxi]VGVNLPQK.3|AHSSMVGVNLPQK.2|AHSSM[Oxi]VGVNLPQK.2|YAEAVTR.2|SLLGKDVLFLK.3|SLLGKDVLFLK.2|AGGFLMKK.2|AGGFLMKKELNYFAK.4|AGGFLM[Oxi]KKELNYFAK.3|AGGFLMKKELNYFAK.2|FHVEEEGKGKDASGNK.4|FHVEEEGKGKDASGNK.3|VSHVSTGGGASLELLEGK.4|VSHVSTGGGASLELLEGK.3|VSHVSTGGGASLELLEGK.2|ALMDEVVKATSR.3|ALM[Oxi]DEVVKATSR.3|ALM[Oxi]DEVVKATSR.2|ELNYFAK.2|ALMDEVVK.2|ALM[Oxi]DEVVK.2|VKAEPAKIEAFR.3|VKAEPAKIEAFR.2|FC[CAM]LDNGAK.2|IKAAVPSIK.2|IKAAVPSIKFC[CAM]LDNGAK.4|IKAAVPSIKFC[CAM]LDNGAK.3|KYAEAVTR.2|VDFNVPMK.2|VDFNVPM[Oxi]K.2|VDFNVPMK.1|PDGVPMPDK.2|FHVEEEGK.2|PFLAILGGAK.2|KELNYFAK.2|SVVLMSHLGRPDGVPMPDK.4|SVVLM[Oxi]SHLGRPDGVPM[Oxi]PDK.4|SVVLM[Oxi]SHLGRPDGVPMPDK.4|SVVLMSHLGRPDGVPM[Oxi]PDK.4|SVVLM[Oxi]SHLGRPDGVPMPDK.3|SVVLMSHLGRPDGVPM[Oxi]PDK.3|SVVLMSHLGRPDGVPMPDK.3|SVVLMSHLGRPDGVPMPDK.2|DC[CAM]VGPEVEK.2|LTLDKLDVK.2|AAVPSIKFC[CAM]LDNGAK.3|AAVPSIKFC[CAM]LDNGAK.2|ASLSKLGDVYVNDAFGTAHR.4|VADKIQLINNMLDK.3|VADKIQLINNMLDK.2|AEPAKIEAFRASLSK.3|NNQITNNQR.2|AEPAKIEAFR.2|FHVEEEGKGK.2|VNEMIIGGGMAFTFLK.3|VNEM[Oxi]IIGGGMAFTFLK.3|VNEMIIGGGM[Oxi]AFTFLK.3|VNEMIIGGGMAFTFLK.2|VNEM[Oxi]IIGGGM[Oxi]AFTFLK.2|VNEM[Oxi]IIGGGMAFTFLK.2|VNEMIIGGGM[Oxi]AFTFLK.2|AC[CAM]ANPAAGSVILLENLRFHVEEEGKGK.5|DVLFLKDC[CAM]VGPEVEK.3|DVLFLKDC[CAM]VGPEVEK.2|LGDVYVNDAFGTAHRAHSSM[Oxi]VGVNLPQK.5|IQLINNMLDK.2|IQLINNM[Oxi]LDK.2|NGVKITLPVDFVTADKFDENAK.4|TGQATVASGIPAGWMGLDC[CAM]GPESSK.4|TGQATVASGIPAGWM[Oxi]GLDC[CAM]GPESSK.3|TGQATVASGIPAGWMGLDC[CAM]GPESSK.3|YSLEPVAVELK.2|VVM[Oxi]RVDFNVPM[Oxi]KNNQITNNQR.4|AKQIVWNGPVGVFEWEAFARGTK.4|ITLPVDFVTADK.2|VLNNMEIGTSLFDEEGAKIVKDLMSK.4|QIVWNGPVGVFEWEAFARGTK.3|VADKIQLINNMLDKVNEM[Oxi]IIGGGM[Oxi]AFTFLK.4|VADKIQLINNMLDKVNEM[Oxi]IIGGGMAFTFLK.4|VADKIQLINNMLDKVNEMIIGGGM[Oxi]AFTFLK.4|WNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI.4
SEN / CTL,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,2.05,0.90,1.93E-03,6.33E-04,3.20E+00,"glucose metabolic process,cellular aldehyde metabolic process,glucuronate catabolic process to xylulose 5-phosphate,L-ascorbic acid biosynthetic process,D-glucuronate catabolic process,aldehyde catabolic process,oxidation-reduction process,glutathione derivative biosynthetic process","alditol:NADP+ 1-oxidoreductase activity,aldo-keto reductase (NADP) activity,electron carrier activity,L-glucuronate reductase activity","extracellular space,cytosol,apical plasma membrane,extracellular exosome",6,26,45,MPLIGLGTWK.2|M[Oxi]PLIGLGTWK.2|GLEVTAYSPLGSSDR.2|GLEVTAYSPLGSSDR.3|ALEALVAK.2|AAVKYALSVGYR.3|HHPEDVEPALR.3|SPAQILLR.2|AVPREELFVTSK.3|AVPREELFVTSK.2|YALSVGYR.2|YIVPMLTVDGKR.3|YIVPM[Oxi]LTVDGKR.3|HHPEDVEPALRK.3|GLVQALGLSNFNSR.3|GLVQALGLSNFNSR.2|AVPREELFVTSKLWNTK.4|NADGTIC[CAM]YDSTHYK.3|NADGTIC[CAM]YDSTHYK.2|NADGTIC[CAM]YDSTHYKETWK.4|NADGTIC[CAM]YDSTHYKETWK.3|PAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.5|PAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.4|AWRDPDEPVLLEEPVVLALAEK.4|AWRDPDEPVLLEEPVVLALAEK.3|YIVPMLTVDGK.2|YIVPM[Oxi]LTVDGK.2|QIDDILSVASVR.2|QIDDILSVASVRPAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.6|QIDDILSVASVRPAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.5|QIDDILSVASVRPAVLQVEC[CAM]HPYLAQNELIAHC[CAM]QAR.4|DPDEPVLLEEPVVLALAEK.3|DPDEPVLLEEPVVLALAEK.2|HIDC[CAM]AAIYGNEPEIGEALKEDVGPGK.4|HIDC[CAM]AAIYGNEPEIGEALKEDVGPGK.3|HIDC[CAM]AAIYGNEPEIGEALK.3|HIDC[CAM]AAIYGNEPEIGEALK.2|AWRDPDEPVLLEEPVVLALAEKYGR.4|AWRDPDEPVLLEEPVVLALAEKYGR.3|TLADLQLEYLDLYLM[Oxi]HWPYAFER.4|TLADLQLEYLDLYLMHWPYAFER.4|TLADLQLEYLDLYLMHWPYAFER.3|VFDFTFSPEEMK.2|VFDFTFSPEEM[Oxi]K.2|DAGHPLYPFNDPY.2
SEN / CTL,Q16610,Extracellular matrix protein 1,ECM1,2.04,0.99,1.04E-16,2.32E-16,1.56E+01,"ossification,angiogenesis,positive regulation of endothelial cell proliferation,negative regulation of cytokine-mediated signaling pathway,platelet degranulation,regulation of type 2 immune response,regulation of transcription from RNA polymerase II promoter,inflammatory response,signal transduction,negative regulation of peptidase activity,negative regulation of bone mineralization,biomineral tissue development,positive regulation of I-kappaB kinase/NF-kappaB signaling,positive regulation of angiogenesis,regulation of T cell migration","protease binding,signal transducer activity,interleukin-2 receptor binding,protein binding,protein C-terminus binding,enzyme binding,laminin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,platelet dense granule lumen,extracellular exosome",42,22,28,ELLALIQLER.2|RAPYPNYDRDILTIDIGR.4|LVWEEAMSR.2|AC[CAM]PSHQPDISSGLELPFPPGVPTLDNIK.3|FC[CAM]EAEFSVK.2|QHVVYGPWNLPQSSYSHLTR.4|QHVVYGPWNLPQSSYSHLTR.3|LLPAQLPAEKEVGPPLPQEAVPLQK.3|VTPNLMGHLC[CAM]GNQR.3|QGETLNFLEIGYSR.2|QGETLNFLEIGYSR.3|FSC[CAM]FQEEAPQPHYQLR.3|FSC[CAM]FQEEAPQPHYQLR.4|QLRPEHFQEVGYAAPPSPPLSR.4|QLRPEHFQEVGYAAPPSPPLSR.3|SLPMDHPDSSQHGPPFEGQSQVQPPPSQEATPLQQEK.4|DILTIDIGR.2|AWEDTLDKYC[CAM]DR.3|AWEDTLDKYC[CAM]DR.2|EVGPPLPQEAVPLQK.3|EVGPPLPQEAVPLQK.2|LTFINDLC[CAM]GPR.2|NVALVSGDTENAK.2|PSPDNLNQIC[CAM]LPNR.2|LDGFPPGRPSPDNLNQIC[CAM]LPNR.3|DPALC[CAM]C[CAM]YLSPGDEQVNC[CAM]FNINYLR.3|C[CAM]C[CAM]DLPFPEQAC[CAM]C[CAM]AEEEK.2|NIWRDPALC[CAM]C[CAM]YLSPGDEQVNC[CAM]FNINYLR.3
SEN / CTL,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,2.04,0.72,6.85E-04,2.59E-04,3.59E+00,"response to reactive oxygen species,apoptotic process,inflammatory response,response to oxidative stress,negative regulation of transcription from RNA polymerase III promoter,cellular response to reactive oxygen species,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","RNA polymerase III regulatory region DNA binding,peroxidase activity,receptor binding,thioredoxin peroxidase activity,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,protein dimerization activity","extracellular space,nucleus,cytoplasm,mitochondrion,mitochondrial matrix,peroxisome,cytosol,cytoplasmic vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome",6,19,35,FSMVVQDGIVK.2|FSM[Oxi]VVQDGIVK.2|THLPGFVEQAEALK.3|THLPGFVEQAEALK.2|THLPGFVEQAEALKAK.4|THLPGFVEQAEALKAK.3|VRLLADPTGAFGK.3|RFSM[Oxi]VVQDGIVK.3|RFSMVVQDGIVK.3|RFSMVVQDGIVK.2|RFSM[Oxi]VVQDGIVK.2|VNLAELFK.2|GVLFGVPGAFTPGC[CAM]SK.3|GVLFGVPGAFTPGC[CAM]SK.2|LLADPTGAFGK.2|LLADPTGAFGK.1|KGVLFGVPGAFTPGC[CAM]SK.3|KGVLFGVPGAFTPGC[CAM]SK.2|VGDAIPAVEVFEGEPGNK.3|VGDAIPAVEVFEGEPGNK.2|LLADPTGAFGKETDLLLDDSLVSIFGNRR.5|LLADPTGAFGKETDLLLDDSLVSIFGNRR.4|LLADPTGAFGKETDLLLDDSLVSIFGNRR.3|ETDLLLDDSLVSIFGNR.3|ETDLLLDDSLVSIFGNR.2|VGDAIPAVEVFEGEPGNKVNLAELFK.4|VGDAIPAVEVFEGEPGNKVNLAELFK.3|ETDLLLDDSLVSIFGNRR.3|VGDAIPAVEVFEGEPGNKVNLAELFKGK.4|LLADPTGAFGKETDLLLDDSLVSIFGNR.4|LLADPTGAFGKETDLLLDDSLVSIFGNR.3|GVQVVAC[CAM]LSVNDAFVTGEWGR.3|ALNVEPDGTGLTC[CAM]SLAPNIISQL.3|ALNVEPDGTGLTC[CAM]SLAPNIISQL.2|VRLLADPTGAFGKETDLLLDDSLVSIFGNR.4
SEN / CTL,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,2.03,1.30,9.19E-08,6.52E-08,7.19E+00,"angiogenesis,osteoblast differentiation,generation of precursor metabolites and energy,lipid metabolic process,ATP biosynthetic process,negative regulation of cell adhesion involved in substrate-bound cell migration,mitochondrion organization,proton transport,mitochondrial ATP synthesis coupled proton transport,regulation of intracellular pH","transporter activity,protein binding,ATP binding,transmembrane transporter activity,MHC class I protein binding,proton-transporting ATP synthase activity, rotational mechanism,proton-transporting ATPase activity, rotational mechanism,ATPase activity","nucleus,mitochondrion,mitochondrial proton-transporting ATP synthase complex,mitochondrial proton-transporting ATP synthase, catalytic core,mitochondrial matrix,plasma membrane,cell surface,membrane,extracellular matrix,mitochondrial membrane,mitochondrial nucleoid,myelin sheath,extracellular exosome",21,47,115,AHGGYSVFAGVGER.3|AHGGYSVFAGVGER.2|IGLFGGAGVGK.2|FTQAGSEVSALLGR.2|FTQAGSEVSALLGR.3|FLSQPFQVAEVFTGHMGK.3|FLSQPFQVAEVFTGHM[Oxi]GK.4|FLSQPFQVAEVFTGHMGK.4|FLSQPFQVAEVFTGHM[Oxi]GK.3|FLSQPFQVAEVFTGHM[Oxi]GK.2|FLSQPFQVAEVFTGHMGK.2|IMDPNIVGSEHYDVAR.3|IMDPNIVGSEHYDVAR.4|IM[Oxi]DPNIVGSEHYDVAR.3|IM[Oxi]DPNIVGSEHYDVAR.2|IMDPNIVGSEHYDVAR.2|VLDSGAPIKIPVGPETLGR.3|VLDSGAPIKIPVGPETLGR.2|VLDSGAPIKIPVGPETLGR.4|GGKIGLFGGAGVGK.3|VLDSGAPIK.2|IMNVIGEPIDER.3|IMNVIGEPIDER.2|IM[Oxi]NVIGEPIDER.2|VALTGLTVAEYFR.3|VALTGLTVAEYFR.2|TVLIMELINNVAK.3|TVLIMELINNVAK.2|TVLIM[Oxi]ELINNVAK.2|IMNVIGEPIDERGPIKTK.4|IM[Oxi]NVIGEPIDERGPIKTK.4|ETRLVLEVAQHLGESTVR.4|ETRLVLEVAQHLGESTVR.3|ETRLVLEVAQHLGESTVR.2|IPVGPETLGR.2|TIAM[Oxi]DGTEGLVRGQK.3|TIAM[Oxi]DGTEGLVRGQK.2|VALVYGQMNEPPGAR.3|VALVYGQM[Oxi]NEPPGAR.3|VALVYGQMNEPPGAR.2|VALVYGQM[Oxi]NEPPGAR.2|ADKLAEEHSS.2|VVDLLAPYAK.2|LVLEVAQHLGESTVR.3|LVLEVAQHLGESTVR.2|GQKVLDSGAPIKIPVGPETLGR.4|TREGNDLYHEMIESGVINLKDATSK.5|TREGNDLYHEM[Oxi]IESGVINLKDATSK.5|TREGNDLYHEMIESGVINLKDATSK.4|TREGNDLYHEM[Oxi]IESGVINLKDATSK.4|TREGNDLYHEM[Oxi]IESGVINLKDATSK.3|TREGNDLYHEMIESGVINLK.4|TREGNDLYHEM[Oxi]IESGVINLK.4|TREGNDLYHEMIESGVINLK.3|TREGNDLYHEMIESGVINLK.2|IMNVIGEPIDERGPIK.3|IM[Oxi]NVIGEPIDERGPIK.3|IM[Oxi]NVIGEPIDERGPIK.2|IMNVIGEPIDERGPIK.2|TIAM[Oxi]DGTEGLVR.2|TIAMDGTEGLVR.2|DQEGQDVLLFIDNIFR.3|DQEGQDVLLFIDNIFR.2|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.6|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.5|KGSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.4|AIAELGIYPAVDPLDSTSR.3|AIAELGIYPAVDPLDSTSR.2|GGKIGLFGGAGVGKTVLIMELINNVAK.4|SLQDIIAILGMDELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDKLTVSR.3|SLQDIIAILGMDELSEEDKLTVSR.3|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.4|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.4|GFQQILAGEYDHLPEQAFYM[Oxi]VGPIEEAVAK.3|GFQQILAGEYDHLPEQAFYMVGPIEEAVAK.3|EGNDLYHEM[Oxi]IESGVINLK.3|EGNDLYHEMIESGVINLK.3|EGNDLYHEMIESGVINLK.2|ILQDYKSLQDIIAILGMDELSEEDKLTVSR.5|ILQDYKSLQDIIAILGM[Oxi]DELSEEDKLTVSR.4|ILQDYKSLQDIIAILGMDELSEEDKLTVSR.4|SLQDIIAILGM[Oxi]DELSEEDK.3|SLQDIIAILGMDELSEEDK.3|SLQDIIAILGMDELSEEDK.2|IPSAVGYQPTLATDMGTMQER.3|IPSAVGYQPTLATDM[Oxi]GTM[Oxi]QER.3|IPSAVGYQPTLATDM[Oxi]GTMQER.3|IPSAVGYQPTLATDMGTM[Oxi]QER.3|IPSAVGYQPTLATDM[Oxi]GTM[Oxi]QER.2|IPSAVGYQPTLATDM[Oxi]GTMQER.2|IPSAVGYQPTLATDMGTM[Oxi]QER.2|IPSAVGYQPTLATDMGTMQER.2|IGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGER.5|IGLFGGAGVGKTVLIMELINNVAKAHGGYSVFAGVGER.4|IVAVIGAVVDVQFDEGLPPILNALEVQGR.4|IVAVIGAVVDVQFDEGLPPILNALEVQGR.3|QFAPIHAEAPEFMEMSVEQEILVTGIK.4|QFAPIHAEAPEFM[Oxi]EM[Oxi]SVEQEILVTGIK.3|QFAPIHAEAPEFM[Oxi]EMSVEQEILVTGIK.3|QFAPIHAEAPEFMEM[Oxi]SVEQEILVTGIK.3|QFAPIHAEAPEFMEMSVEQEILVTGIK.3|LTPSASLPPAQLLLR.2|IGLFGGAGVGKTVLIMELINNVAK.3|TKQFAPIHAEAPEFMEMSVEQEILVTGIK.4|EGNDLYHEM[Oxi]IESGVINLKDATSK.3|LVPLKETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAK.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAKADKLAEEHSS.5|GFQQILAGEYDHLPEQAFYMVGPIEEAVAKADK.4|FTQAGSEVSALLGRIPSAVGYQPTLATDMGTMQER.4|GSITSVQAIYVPADDLTDPAPATTFAHLDATTVLSR.4|ETIKGFQQILAGEYDHLPEQAFYMVGPIEEAVAK.4
SEN / CTL,P12109,Collagen alpha-1(VI) chain,COL6A1,2.01,1.35,1.27E-16,2.77E-16,1.56E+01,"osteoblast differentiation,cell adhesion,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,protein heterotrimerization,cellular response to amino acid stimulus",platelet-derived growth factor binding,"extracellular region,collagen type VI trimer,lysosomal membrane,endoplasmic reticulum lumen,membrane,extracellular matrix,sarcolemma,protein complex,extracellular exosome",63,49,69,LLLFSDGNSQGATPAAIEK.2|LLLFSDGNSQGATPAAIEK.3|IALVITDGR.2|VFSVAITPDHLEPR.3|VFSVAITPDHLEPR.2|GLEQLLVGGSHLKENK.4|TAEYDVAYGESHLFR.3|TAEYDVAYGESHLFR.2|TAEYDVAYGESHLFR.4|VPSYQALLR.2|YLIVVTDGHPLEGYKEPC[CAM]GGLEDAVNEAK.4|YLIVVTDGHPLEGYKEPC[CAM]GGLEDAVNEAK.3|NLVWNAGALHYSDEVEIIQGLTR.3|LSIIATDHTYRR.3|GLEQLLVGGSHLK.3|GLEQLLVGGSHLK.2|LSIIATDHTYR.3|LSIIATDHTYR.2|NNVEQVC[CAM]C[CAM]SFEC[CAM]QPAR.3|NNVEQVC[CAM]C[CAM]SFEC[CAM]QPAR.2|RLLLFSDGNSQGATPAAIEK.3|AVAFQDC[CAM]PVDLFFVLDTSESVALR.3|VAVVQYSGTGQQRPER.3|VAVVQYSGTGQQRPER.4|VAVVQYSGTGQQRPER.2|PYGALVDK.2|LKPYGALVDKVK.3|LKPYGALVDKVK.2|TDPAHDVR.2|RFIDNLR.2|GDPGFEGER.2|KGLEQLLVGGSHLK.3|QVNEPHIR.2|LAERFLTAGRTDPAHDVR.4|GTYTDC[CAM]AIK.2|GVFHQTVSR.2|ENYAELLEDAFLK.3|ENYAELLEDAFLK.2|LKPYGALVDK.2|DALKSSVDAVK.2|GDEGPPGSEGAR.2|MC[CAM]SC[CAM]C[CAM]EC[CAM]K.2|YLIVVTDGHPLEGYK.3|YLIVVTDGHPLEGYK.2|AGIEIFVVVVGR.2|DQLLPPSPNNR.2|GDEGEAGDPGDDNNDIAPR.3|GDEGEAGDPGDDNNDIAPR.2|TDPAHDVRVAVVQYSGTGQQRPER.4|DAEEAISQTIDTIVDM[Oxi]IK.3|GDPGEAGPQGDQGR.2|FEPGQSYAGVVQYSHSQMQEHVSLRSPSIR.5|SLQWMAGGTFTGEALQYTR.3|TAEYDVAYGESHLFRVPSYQALLR.4|FEPGQSYAGVVQYSHSQM[Oxi]QEHVSLR.4|FEPGQSYAGVVQYSHSQMQEHVSLR.4|FEPGQSYAGVVQYSHSQM[Oxi]QEHVSLR.3|FEPGQSYAGVVQYSHSQMQEHVSLR.3|DTTPLNVLC[CAM]SPGIQVVSVGIK.3|DTTPLNVLC[CAM]SPGIQVVSVGIK.2|EPC[CAM]GGLEDAVNEAK.2|C[CAM]DRNLVWNAGALHYSDEVEIIQGLTR.4|C[CAM]DRNLVWNAGALHYSDEVEIIQGLTR.3|DALKSSVDAVKYFGK.2|DVFDFIPGSDQLNVISC[CAM]QGLAPSQGRPGLSLVK.4|DVFDFIPGSDQLNVISC[CAM]QGLAPSQGRPGLSLVK.3|SDTQRDTTPLNVLC[CAM]SPGIQVVSVGIK.3|C[CAM]PDYTC[CAM]PITFSSPADITILLDGSASVGSHNFDTTKR.4|KC[CAM]PDYTC[CAM]PITFSSPADITILLDGSASVGSHNFDTTK.4
SEN / CTL,P68104,Elongation factor 1-alpha 1,EEF1A1,2.00,1.49,9.16E-11,1.02E-10,9.99E+00,"transcription, DNA-templated,regulation of transcription, DNA-templated,translational elongation,cellular response to epidermal growth factor stimulus,regulation of chaperone-mediated autophagy","tRNA binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,protein kinase binding,poly(A) RNA binding","extracellular space,nucleus,nucleolus,cytoplasm,cytosol,eukaryotic translation elongation factor 1 complex,membrane,cortical actin cytoskeleton,ruffle membrane,extracellular exosome,cytoplasmic side of lysosomal membrane",42,52,144,EHALLAYTLGVK.3|EHALLAYTLGVK.2|IGGIGTVPVGR.2|YYVTIIDAPGHRDFIK.4|YYVTIIDAPGHRDFIK.3|YYVTIIDAPGHRDFIK.2|THINIVVIGHVDSGK.3|THINIVVIGHVDSGK.2|VETGVLKPGMVVTFAPVNVTTEVK.3|VETGVLKPGM[Oxi]VVTFAPVNVTTEVK.3|VETGVLKPGMVVTFAPVNVTTEVK.4|VETGVLKPGMVVTFAPVNVTTEVK.5|VETGVLKPGM[Oxi]VVTFAPVNVTTEVK.4|YEEIVKEVSTYIK.3|YEEIVKEVSTYIK.2|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.6|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.7|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.4|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.5|SGDAAIVDM[Oxi]VPGKPMC[CAM]VESFSDYPPLGR.4|SGDAAIVDMVPGKPM[Oxi]C[CAM]VESFSDYPPLGR.4|SGDAAIVDMVPGKPMC[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPM[Oxi]C[CAM]VESFSDYPPLGR.4|SGDAAIVDM[Oxi]VPGKPMC[CAM]VESFSDYPPLGR.3|SGDAAIVDMVPGKPM[Oxi]C[CAM]VESFSDYPPLGR.3|SGDAAIVDM[Oxi]VPGKPM[Oxi]C[CAM]VESFSDYPPLGR.3|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|RGNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|RGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|TIEKFEKEAAEMGK.4|TIEKFEKEAAEMGK.3|TIEKFEKEAAEM[Oxi]GK.3|TIEKFEKEAAEMGK.2|TIEKFEKEAAEM[Oxi]GK.2|SGDAAIVDMVPGK.3|SGDAAIVDM[Oxi]VPGK.3|SGDAAIVDMVPGK.2|SGDAAIVDM[Oxi]VPGK.2|QLIVGVNK.2|YEEIVKEVSTYIKK.4|YEEIVKEVSTYIKK.3|YEEIVKEVSTYIKK.2|DMRQTVAVGVIK.3|DM[Oxi]RQTVAVGVIK.3|DMRQTVAVGVIK.2|FAVRDMRQTVAVGVIK.4|PLRLPLQDVYK.3|PLRLPLQDVYK.2|TIEKFEK.2|YAWVLDK.2|QTVAVGVIK.2|EKTHINIVVIGHVDSGK.4|NGQTREHALLAYTLGVK.4|NGQTREHALLAYTLGVK.3|NGQTREHALLAYTLGVK.2|RYEEIVK.2|YYVTIIDAPGHR.3|YYVTIIDAPGHR.2|EVSTYIKK.2|LPLQDVYK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDK.3|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.6|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.3|THINIVVIGHVDSGKSTTTGHLIYK.5|THINIVVIGHVDSGKSTTTGHLIYK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.5|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.4|KDGNASGTTLLEALDC[CAM]ILPPTRPTDK.3|STTTGHLIYK.2|FEKEAAEMGK.2|GITIDISLWK.2|PMC[CAM]VESFSDYPPLGR.3|PMC[CAM]VESFSDYPPLGR.2|PM[Oxi]C[CAM]VESFSDYPPLGR.2|RYEEIVKEVSTYIK.3|RYEEIVKEVSTYIK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.4|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLR.3|PGM[Oxi]VVTFAPVNVTTEVK.3|PGMVVTFAPVNVTTEVK.2|PGM[Oxi]VVTFAPVNVTTEVK.2|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.6|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.6|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.5|KIGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.5|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.5|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANM[Oxi]PWFK.4|KIGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.4|KIGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.4|KIGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.4|SVEMHHEALSEALPGDNVGFNVK.4|SVEM[Oxi]HHEALSEALPGDNVGFNVK.4|SVEMHHEALSEALPGDNVGFNVK.3|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.4|NDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.4|MDSTEPPYSQK.2|M[Oxi]DSTEPPYSQK.2|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.6|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.5|DGNASGTTLLEALDC[CAM]ILPPTRPTDKPLRLPLQDVYK.4|FETSKYYVTIIDAPGHR.3|LPLQDVYKIGGIGTVPVGR.3|IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK.5|IGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVK.4|IGGIGTVPVGRVETGVLKPGM[Oxi]VVTFAPVNVTTEVK.4|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.5|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.4|IGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.4|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANM[Oxi]PWFK.4|IGYNPDTVAFVPISGWNGDNM[Oxi]LEPSANMPWFK.3|IGYNPDTVAFVPISGWNGDNMLEPSANM[Oxi]PWFK.3|IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK.3|QLIVGVNKMDSTEPPYSQK.3|MDSTEPPYSQKR.2|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.7|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.6|GNVAGDSKNDPPM[Oxi]EAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|GNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDC[CAM]HTAHIAC[CAM]K.5|NM[Oxi]ITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.4|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.4|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.3|NM[Oxi]ITGTSQADC[CAM]AVLIVAAGVGEFEAGISK.3|DGNASGTTLLEALDC[CAM]ILPPTR.3|DGNASGTTLLEALDC[CAM]ILPPTR.2|KDGNASGTTLLEALDC[CAM]ILPPTR.3|NMITGTSQADC[CAM]AVLIVAAGVGEFEAGISKNGQTR.4
SEN / CTL,P55058,Phospholipid transfer protein,PLTP,2.00,2.42,2.51E-03,8.00E-04,3.10E+00,"lipid metabolic process,lipid transport,vitamin E biosynthetic process,positive regulation of cholesterol efflux,flagellated sperm motility,high-density lipoprotein particle remodeling",lipid binding,"extracellular region,extracellular space",12,6,7,FLEQELETITIPDLR.2|FLEQELETITIPDLR.3|GVQIPLPEGINFVHEVVTNHAGFLTIGADLHFAK.5|ATYFGSIVLLSPAVIDSPLKLELR.3|AGALQLLLVGDK.2|AVEPQLQEEER.2|DPVASTSNLDMDFR.2
SEN / CTL,P51884,Lumican,LUM,1.99,1.42,1.40E-23,8.21E-23,2.21E+01,"visual perception,response to organic cyclic compound,keratan sulfate biosynthetic process,extracellular matrix organization,collagen fibril organization,positive regulation of transforming growth factor beta1 production,keratan sulfate catabolic process,positive regulation of transcription from RNA polymerase II promoter,cartilage development,response to growth factor,axonogenesis","extracellular matrix structural constituent,collagen binding","extracellular region,proteinaceous extracellular matrix,fibrillar collagen trimer,extracellular space,Golgi lumen,lysosomal lumen,extracellular exosome,extracellular matrix",69,21,29,SLEYLDLSFNQIAR.2|SLEYLDLSFNQIAR.3|FNALQYLR.2|LPSGLPVSLLTLYLDNNKISNIPDEYFKR.4|LPSGLPVSLLTLYLDNNKISNIPDEYFKR.5|LPSGLPVSLLTLYLDNNKISNIPDEYFK.3|LPSGLPVSLLTLYLDNNKISNIPDEYFK.4|NIPTVNENLENYYLEVNQLEK.3|NIPTVNENLENYYLEVNQLEKFDIK.3|SLEDLQLTHNKITK.4|SLEDLQLTHNKITK.3|LPSGLPVSLLTLYLDNNK.2|LPSGLPVSLLTLYLDNNK.3|ISNIPDEYFK.2|VANEVTLN.2|RFNALQYLR.2|SVPMVPPGIK.2|ILGPLSYSK.2|LKEDAVSAAFK.2|SLEDLQLTHNK.3|SLEDLQLTHNK.2|ISETSLPPDMYEC[CAM]LR.2|ISETSLPPDM[Oxi]YEC[CAM]LR.2|ISNIPDEYFKR.3|NNQIDHIDEK.3|NNQIDHIDEK.2|EDAVSAAFK.2|LKEDAVSAAFKGLK.3|AFENVTDLQWLILDHNLLENSK.3
SEN / CTL,P11047,Laminin subunit gamma-1,LAMC1,1.99,0.90,1.51E-35,1.86E-34,3.37E+01,"protein complex assembly,cell adhesion,endoderm development,cell migration,extracellular matrix disassembly,extracellular matrix organization,hemidesmosome assembly,substrate adhesion-dependent cell spreading,positive regulation of epithelial cell proliferation",extracellular matrix structural constituent,"extracellular region,basement membrane,laminin-1 complex,extracellular space,extracellular matrix,laminin-10 complex,laminin-11 complex,extracellular exosome",81,77,97,SQEC[CAM]YFDPELYR.2|TREDGPWIPYQYYSGSC[CAM]ENTYSK.3|LGNNEAC[CAM]SSC[CAM]HC[CAM]SPVGSLSTQC[CAM]DSYGR.3|C[CAM]IYNTAGFYC[CAM]DR.2|LSAEDLVLEGAGLR.2|LSAEDLVLEGAGLR.3|NTIEETGNLAEQAR.2|NTIEETGNLAEQAR.3|RC[CAM]ELC[CAM]DDGYFGDPLGR.3|LNTFGDEVFNDPK.2|EAQDVKDVDQNLMDR.3|LHEATDYPWRPALTPFEFQK.3|LHEATDYPWRPALTPFEFQK.4|QDIAVISDSYFPR.2|C[CAM]ELC[CAM]DDGYFGDPLGR.2|DTRLSAEDLVLEGAGLR.3|TFAEVTDLDNEVNNMLK.2|TFAEVTDLDNEVNNMLK.3|EAQQALGSAAADATEAK.2|EAQQALGSAAADATEAK.3|TLPSGC[CAM]FNTPSIEKP.2|DGSEASLEWSSER.2|SYYYAISDFAVGGR.2|SYYYAISDFAVGGR.3|VSVPLIAQGNSYPSETTVK.2|VSVPLIAQGNSYPSETTVK.3|SAGYLDDVTLASAR.2|SAGYLDDVTLASAR.3|LQNIRNTIEETGNLAEQAR.3|LQNIRNTIEETGNLAEQAR.4|ALAEEAAK.2|HKQEADDIVR.3|HKQEADDIVR.2|YFIAPAKFLGK.3|AHVENTERLIEIASR.4|LIEIASRELEK.3|TAAEEALR.2|TKEVVC[CAM]TNC[CAM]PTGTTGKR.4|AFDITYVR.2|RDTRLSAEDLVLEGAGLR.4|STGHGGHC[CAM]TNC[CAM]QDNTDGAHC[CAM]ER.5|STGHGGHC[CAM]TNC[CAM]QDNTDGAHC[CAM]ER.4|VSDLENEAK.2|EAQQALGSAAADATEAKNKAHEAER.5|GKTEQQTADQLLAR.3|GKTEQQTADQLLAR.2|FHTSRPESFAIYK.3|C[CAM]KDGFFGNPLAPNPADKC[CAM]K.4|DTLQEANDILNNLK.3|DTLQEANDILNNLK.2|C[CAM]KPGFFNLESSNPR.3|C[CAM]KPGFFNLESSNPR.2|DVDQNLMDR.2|DVDQNLM[Oxi]DR.2|AHVENTERLIEIASRELEK.4|C[CAM]SC[CAM]KPGVMGDKC[CAM]DR.3|KVSDLENEAK.2|LNEIEGTLNK.2|GRDTLQEANDILNNLKDFDR.4|TKEVVC[CAM]TNC[CAM]PTGTTGK.3|LVKDKVADHR.2|C[CAM]VC[CAM]KDNVEGFNC[CAM]ER.3|GRDTLQEANDILNNLK.3|GRDTLQEANDILNNLK.2|HNTYGVDC[CAM]EK.2|LNTFGDEVFNDPKVLK.3|C[CAM]DC[CAM]HALGSTNGQC[CAM]DIR.3|C[CAM]SC[CAM]KPGVMGDK.2|DGFFGNPLAPNPADKC[CAM]K.3|DGFFGNPLAPNPADKC[CAM]K.2|DNVEGFNC[CAM]ER.2|EAQQALGSAAADATEAKNK.3|TREAQQALGSAAADATEAK.3|VSVPLIAQGNSYPSETTVKYVFR.4|VSVPLIAQGNSYPSETTVKYVFR.3|LKFHTSRPESFAIYKR.3|TGQC[CAM]EC[CAM]QPGITGQHC[CAM]ER.3|RATAESASEC[CAM]LPC[CAM]DC[CAM]NGR.3|TEQQTADQLLAR.2|VTLNRLNTFGDEVFNDPK.3|DTLQEANDILNNLKDFDR.3|KQEAAIMDYNRDIEEIMK.3|KQEAAIM[Oxi]DYNRDIEEIMK.3|EVVC[CAM]TNC[CAM]PTGTTGK.2|DGFFGNPLAPNPADK.2|M[Oxi]EAENLEQLIDQK.2|MEAENLEQLIDQK.2|TFAEVTDLDNEVNNMLKQLQEAEKELK.4|EVVC[CAM]TNC[CAM]PTGTTGKR.2|PSAYNFDNSPVLQEWVTATDIR.3|SWPGC[CAM]QEC[CAM]PAC[CAM]YR.2|C[CAM]EVNHFGFGPEGC[CAM]KPC[CAM]DC[CAM]HPEGSLSLQC[CAM]K.4|ATAESASEC[CAM]LPC[CAM]DC[CAM]NGR.2|LC[CAM]QC[CAM]SDNIDPNAVGNC[CAM]NRLTGEC[CAM]LK.3|LQELESLIANLGTGDEMVTDQAFEDR.3|AVEIYASVAQLSPLDSETLENEANNIK.3|LC[CAM]QC[CAM]SDNIDPNAVGNC[CAM]NR.2
SEN / CTL,P01034,Cystatin-C,CST3,1.99,0.60,1.13E-10,1.24E-10,9.91E+00,"eye development,response to hypoxia,cell activation,apoptotic process,defense response,brain development,salivary gland development,embryo implantation,positive regulation of cell proliferation,response to toxic substance,response to carbohydrate,negative regulation of peptidase activity,negative regulation of collagen catabolic process,negative regulation of extracellular matrix disassembly,response to nutrient levels,response to estradiol,regulation of tissue remodeling,response to drug,circadian sleep/wake cycle, REM sleep,regulation of programmed cell death,extracellular fibril organization,cellular protein metabolic process,positive regulation of DNA replication,negative regulation of proteolysis,response to axon injury,Sertoli cell development,negative regulation of elastin catabolic process,negative regulation of blood vessel remodeling,negative regulation of cell death,cellular response to hydrogen peroxide,negative regulation of cysteine-type endopeptidase activity","beta-amyloid binding,protease binding,endopeptidase inhibitor activity,cysteine-type endopeptidase inhibitor activity,protein binding,identical protein binding","extracellular region,basement membrane,extracellular space,lysosome,multivesicular body,endoplasmic reticulum,axon,nuclear membrane,neuronal cell body,contractile fiber,perinuclear region of cytoplasm,extracellular exosome",18,7,11,ALDFAVGEYNK.2|KQIVAGVNYFLDVELGR.3|AFC[CAM]SFQIYAVPWQGTMTLSK.2|AFC[CAM]SFQIYAVPWQGTMTLSK.3|AFC[CAM]SFQIYAVPWQGTM[Oxi]TLSK.3|LVGGPMDASVEEEGVRR.3|LVGGPM[Oxi]DASVEEEGVRR.3|LVGGPMDASVEEEGVR.2|TQPNLDNC[CAM]PFHDQPHLK.4|TQPNLDNC[CAM]PFHDQPHLK.3|ASNDMYHSR.2
SEN / CTL,Q9NR99,Matrix-remodeling-associated protein 5,MXRA5,1.99,1.00,4.68E-02,1.11E-02,1.96E+00,biological_process,molecular_function,extracellular exosome,3,3,3,C[CAM]VASNAAGADSLAIR.2|HSEKEPETNVAEGR.3|VLVQSPSTQPAEK.2
SEN / CTL,O00151,PDZ and LIM domain protein 1,PDLIM1,1.97,1.39,1.55E-05,7.89E-06,5.10E+00,"response to hypoxia,regulation of transcription, DNA-templated,response to oxidative stress,cell-cell adhesion","transcription coactivator activity,zinc ion binding,cadherin binding involved in cell-cell adhesion","transcription factor complex,cytoplasm,cytoskeleton,cell-cell adherens junction,focal adhesion",15,27,50,GHFFVEDQIYC[CAM]EK.3|GHFFVEDQIYC[CAM]EK.2|IKGC[CAM]TDNLTLTVAR.3|IKGC[CAM]TDNLTLTVAR.2|LVGGKDFEQPLAISR.3|LVGGKDFEQPLAISR.2|C[CAM]GTGIVGVFVK.2|GC[CAM]TDNLTLTVAR.3|GC[CAM]TDNLTLTVAR.2|VWSPLVTEEGKR.3|VWSPLVTEEGKR.2|QELNEPPK.2|VAASIGNAQK.2|M[Oxi]NLASEPQEVLHIGSAHNR.4|MNLASEPQEVLHIGSAHNR.4|MNLASEPQEVLHIGSAHNR.3|MNLASEPQEVLHIGSAHNR.2|HRHPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.4|HRHPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.3|PLDHAQPPSSLVIDK.3|VTPPEGYEVVTVFPK.3|VTPPEGYEVVTVFPK.2|DFEQPLAISR.2|QSTSFLVLQEILESEEKGDPNKPSGFR.5|QSTSFLVLQEILESEEKGDPNKPSGFR.4|QSTSFLVLQEILESEEKGDPNKPSGFR.3|HPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.3|HPEC[CAM]YVC[CAM]TDC[CAM]GTNLK.2|VWSPLVTEEGK.2|SEHKVWSPLVTEEGKR.3|QKGHFFVEDQIYC[CAM]EK.3|ERVTPPEGYEVVTVFPK.3|QSTSFLVLQEILESEEK.3|QSTSFLVLQEILESEEK.2|TAASGVEANSRPLDHAQPPSSLVIDK.4|TAASGVEANSRPLDHAQPPSSLVIDK.3|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.5|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.4|TAASGVEANSRPLDHAQPPSSLVIDKESEVYK.3|VITNQYNNPAGLYSSENISNFNNALESK.4|VITNQYNNPAGLYSSENISNFNNALESK.3|SAMPFTASPASSTTAR.2|SAM[Oxi]PFTASPASSTTAR.2|QELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFR.5|QELNEPPKQSTSFLVLQEILESEEKGDPNKPSGFR.4|AALANLC[CAM]IGDVITAIDGENTSNM[Oxi]THLEAQNR.4|AALANLC[CAM]IGDVITAIDGENTSNMTHLEAQNR.4|AALANLC[CAM]IGDVITAIDGENTSNMTHLEAQNR.3|AALANLC[CAM]IGDVITAIDGENTSNM[Oxi]THLEAQNR.3|QELNEPPKQSTSFLVLQEILESEEK.3
SEN / CTL,P51888,Prolargin,PRELP,1.97,1.49,3.13E-04,1.28E-04,3.89E+00,"skeletal system development,cell aging,keratan sulfate biosynthetic process,keratan sulfate catabolic process,axonogenesis","extracellular matrix structural constituent,heparin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi lumen,lysosomal lumen,extracellular exosome,extracellular vesicle,extracellular matrix",9,19,26,VLEKLPGLVFLYMEK.3|LDGNYLKPPIPLDLMMC[CAM]FR.3|LENLLLLDLQHNR.3|LENLLLLDLQHNR.2|LSDGVFKPDTFHGLK.4|LSDGVFKPDTFHGLK.3|LSQNHISR.2|NLMQLNLAHNILR.3|NLM[Oxi]QLNLAHNILR.3|NLMQLNLAHNILR.2|WINLDNNR.2|LEHLYLNNNSIEK.3|LEHLYLNNNSIEK.2|SFPNLAFIR.2|ISSVPAINNR.2|VPTAIHQLYLDSNK.3|IETIPNGYFK.2|IPPGVFSKLENLLLLDLQHNR.4|MPPRVPTAIHQLYLDSNKIETIPNGYFK.5|MPPRVPTAIHQLYLDSNKIETIPNGYFK.4|LPGLVFLYMEK.2|LPGLVFLYM[Oxi]EK.2|NQLEEVPSALPR.2|VLEKLPGLVFLYMEKNQLEEVPSALPR.4|VPTAIHQLYLDSNKIETIPNGYFK.3|EC[CAM]YC[CAM]PPDFPSALYC[CAM]DSR.2
SEN / CTL,P49588,"Alanine--tRNA ligase, cytoplasmic",AARS,1.97,0.52,2.05E-02,5.22E-03,2.28E+00,"hair follicle development,tRNA modification,tRNA aminoacylation for protein translation,alanyl-tRNA aminoacylation,regulation of translational fidelity,protein folding,tRNA processing,cerebellar Purkinje cell layer development,endoplasmic reticulum unfolded protein response,response to amino acid,negative regulation of neuron apoptotic process,neuromuscular process controlling balance","tRNA binding,aminoacyl-tRNA editing activity,alanine-tRNA ligase activity,ATP binding,zinc ion binding,amino acid binding","cytoplasm,cytosol,membrane,extracellular exosome,mitochondrion",3,62,112,NVGC[CAM]LQEALQLATSFAQLR.3|NVGC[CAM]LQEALQLATSFAQLR.4|NVGC[CAM]LQEALQLATSFAQLR.2|GSLVAPDR.2|RIVAVTGAEAQK.3|RIVAVTGAEAQK.2|PIFLNTIDPSHPMAK.4|PIFLNTIDPSHPMAK.3|PIFLNTIDPSHPM[Oxi]AK.3|PIFLNTIDPSHPMAK.2|DVSAQATGK.2|LVSVLQNK.2|AVYTQDC[CAM]PLAAAK.3|AVYTQDC[CAM]PLAAAK.2|C[CAM]LSVMEAK.2|SVLGEADQK.2|GAMSTQQIK.2|GAM[Oxi]STQQIK.2|KIQSLGDSK.2|VGAEDADGIDMAYR.3|VGAEDADGIDMAYR.2|VGAEDADGIDM[Oxi]AYR.2|GTGARPYTGK.2|HNDLDDVGK.2|KAEEIANEMIEAAK.3|KAEEIANEM[Oxi]IEAAK.3|KAEEIANEMIEAAK.2|RPIMSNHTATHILNFALR.4|RPIMSNHTATHILNFALR.3|GLEVTDDSPK.2|VGDQVWLFIDEPR.3|VGDQVWLFIDEPR.2|GGYVLHIGTIYGDLK.3|GGYVLHIGTIYGDLK.2|SIDTGMGLER.2|SIDTGM[Oxi]GLER.2|VDDSSEDKTEFTVK.3|VDDSSEDKTEFTVK.2|ASEWVQQVSGLMDGK.3|ASEWVQQVSGLMDGK.2|ASEWVQQVSGLM[Oxi]DGK.2|GLVVDMDGFEEERK.3|GLVVDM[Oxi]DGFEEERK.3|GLVVDMDGFEEERK.2|IVAVTGAEAQK.2|ITC[CAM]LC[CAM]QVPQNAANR.3|ITC[CAM]LC[CAM]QVPQNAANR.2|KDPDMVKDIINEEEVQFLK.4|KDPDMVKDIINEEEVQFLK.3|TITVALADGGRPDNTGR.3|TITVALADGGRPDNTGR.2|SVLGEADQKGSLVAPDR.3|VGDQVWLFIDEPRR.3|YNYHLDSSGSYVFENTVATVMALRR.5|YNYHLDSSGSYVFENTVATVMALRR.4|YNYHLDSSGSYVFENTVATVM[Oxi]ALRR.4|EADGILKPLPK.2|GGGKDVSAQATGK.2|KSIDTGMGLER.2|NSSHAGAFVIVTEEAIAK.3|NSSHAGAFVIVTEEAIAK.2|MALELLTQEFGIPIER.3|M[Oxi]ALELLTQEFGIPIER.3|M[Oxi]ALELLTQEFGIPIER.2|MALELLTQEFGIPIER.2|EIADLGEALATAVIPQWQKDELR.4|EIADLGEALATAVIPQWQKDELR.3|MFVEEVSTGQEC[CAM]GVVLDK.3|M[Oxi]FVEEVSTGQEC[CAM]GVVLDK.2|MFVEEVSTGQEC[CAM]GVVLDK.2|SVLGEADQKGSLVAPDRLR.3|EIADLGEALATAVIPQWQK.3|EIADLGEALATAVIPQWQK.2|YNYHLDSSGSYVFENTVATVMALR.4|YNYHLDSSGSYVFENTVATVM[Oxi]ALR.3|YNYHLDSSGSYVFENTVATVMALR.3|GAGGEDLIMLDIYAIEELR.3|M[Oxi]HSPQTSAMLFTVDNEAGK.3|MHSPQTSAM[Oxi]LFTVDNEAGK.3|MHSPQTSAMLFTVDNEAGK.3|MHSPQTSAMLFTVDNEAGK.2|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.5|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.4|VVSIGVPVSELLDDPSGPAGSLTSVEFC[CAM]GGTHLR.3|AVFDETYPDPVR.2|AEEIANEMIEAAK.2|QIWQNLGLDDTK.2|M[Oxi]SNYDTDLFVPYFEAIQK.3|MSNYDTDLFVPYFEAIQK.3|M[Oxi]SNYDTDLFVPYFEAIQK.2|MSNYDTDLFVPYFEAIQK.2|DIINEEEVQFLK.2|MHSPQTSAMLFTVDNEAGKITC[CAM]LC[CAM]QVPQNAANR.5|MHSPQTSAMLFTVDNEAGKITC[CAM]LC[CAM]QVPQNAANR.4|GLVVDM[Oxi]DGFEEER.2|GLVVDMDGFEEER.2|TC[CAM]FYAEQGGQIYDEGYLVK.3|TC[CAM]FYAEQGGQIYDEGYLVK.2|EIADLGEALATAVIPQWQKDELRETLK.4|EKMFVEEVSTGQEC[CAM]GVVLDK.3|LYVTYFGGDEAAGLEADLEC[CAM]K.3|LYVTYFGGDEAAGLEADLEC[CAM]K.2|NEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.6|NEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.5|QFIDSNPNQPLVILEMESGASAK.3|RNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.6|RNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAK.5|DNFWEMGDTGPC[CAM]GPC[CAM]SEIHYDR.3|TKQFIDSNPNQPLVILEMESGASAK.3|GLEVTDDSPKYNYHLDSSGSYVFENTVATVMALR.4|DAAHLVNQDDPNVLEIWNLVFIQYNR.3|TIPGDTAWLLYDTYGFPVDLTGLIAEEK.3
SEN / CTL,Q9NWM8,Peptidyl-prolyl cis-trans isomerase FKBP14,FKBP14,1.97,0.92,4.38E-02,1.04E-02,1.98E+00,"protein peptidyl-prolyl isomerization,IRE1-mediated unfolded protein response,chaperone-mediated protein folding","peptidyl-prolyl cis-trans isomerase activity,calcium ion binding,FK506 binding","endoplasmic reticulum lumen,endoplasmic reticulum membrane",3,8,10,GKIPPESTLIFNIDLLEIR.3|HNNGQPIWFTLGILEALK.4|HNNGQPIWFTLGILEALK.3|HNNGQPIWFTLGILEALK.2|IEVLQKPFIC[CAM]HR.3|DGSLFHSTHK.2|LIIPPALGYGK.2|GGDLMLVHYEGYLEK.3|SHESFQEMDLNDDWK.3|IPPESTLIFNIDLLEIR.3
SEN / CTL,Q01995,Transgelin,TAGLN,1.96,1.46,2.07E-08,1.71E-08,7.77E+00,"muscle organ development,epithelial cell differentiation",actin binding,cytoplasm,33,24,41,LGFQVWLK.2|QMEQVAQFLK.2|QM[Oxi]EQVAQFLK.2|TDMFQTVDLFEGKDMAAVQR.3|TLMALGSLAVTK.2|TLMALGSLAVTK.3|TLM[Oxi]ALGSLAVTK.2|EFTESQLQEGK.2|LVNSLYPDGSKPVKVPENPPSMVFK.4|LVNSLYPDGSKPVKVPENPPSM[Oxi]VFK.4|LVNSLYPDGSKPVKVPENPPSMVFK.3|LVEWIIVQC[CAM]GPDVGRPDR.4|LVEWIIVQC[CAM]GPDVGRPDR.3|LVEWIIVQC[CAM]GPDVGRPDR.2|HVIGLQMGSNR.3|HVIGLQMGSNR.2|HVIGLQM[Oxi]GSNR.2|EFTESQLQEGKHVIGLQMGSNR.4|TDMFQTVDLFEGK.2|TDMFQTVDLFEGK.3|TDM[Oxi]FQTVDLFEGK.2|GPSYGMSR.2|NDGHYRGDPNWFMK.4|NDGHYRGDPNWFM[Oxi]K.4|NDGHYRGDPNWFMK.3|NDGHYRGDPNWFM[Oxi]K.2|GASQAGMTGYGRPR.3|AAEDYGVIK.2|REFTESQLQEGK.3|REFTESQLQEGK.2|GDPNWFMK.2|LVNSLYPDGSKPVK.3|LVNSLYPDGSKPVK.2|PVKVPENPPSMVFK.3|YDEELEER.2|GASQAGMTGYGR.2|LVNSLYPDGSK.2|KYDEELEER.2|VPENPPSMVFK.2|VPENPPSM[Oxi]VFK.2|AAEDYGVIKTDMFQTVDLFEGK.3
SEN / CTL,Q9NZN4,EH domain-containing protein 2,EHD2,1.96,0.86,5.48E-02,1.28E-02,1.89E+00,"endocytosis,blood coagulation,cortical actin cytoskeleton organization,endocytic recycling,protein localization to plasma membrane,membrane tubulation,positive regulation of myoblast fusion,positive regulation of endocytic recycling","nucleic acid binding,calcium ion binding,protein binding,ATP binding,GTP binding,hydrolase activity,protein domain specific binding","nucleus,cytosol,plasma membrane,caveola,endosome membrane,extrinsic component of membrane,perinuclear region of cytoplasm,recycling endosome membrane,extracellular exosome",3,30,46,SKYDEIFYNLAPADGK.3|SKYDEIFYNLAPADGK.2|DIQGLPR.2|VHAYIISYLK.3|VHAYIISYLK.2|LEGHGLPANLPR.3|LEGHGLPANLPR.2|GQQPEAIR.2|MQELLMAHDFTK.3|MQELLMAHDFTK.2|VVGTPEVLR.2|IQLEHHISPGDFPDC[CAM]QK.4|IQLEHHISPGDFPDC[CAM]QK.3|IQLEHHISPGDFPDC[CAM]QK.2|GYDFPAVLR.2|RLFELEEQDLFR.3|LEISDEFSEAIGALRGHEDK.4|LLEALDEMLTHDIAK.3|LLEALDEMLTHDIAK.2|RLFELEEQDLFRDIQGLPR.4|VYGALMWALGK.2|VYGALM[Oxi]WALGK.2|FGAFHSPALEDADFDGK.3|TSFIQYLLEQEVPGSR.3|TSFIQYLLEQEVPGSR.2|LNPFGNTFLNR.2|ADMVETQQLM[Oxi]R.2|ADMVETQQLMR.2|VYIGSFWSQPLLVPDNR.3|VYIGSFWSQPLLVPDNR.2|PMVLVAGQYSTGK.2|DGMLDDEEFALASHLIEAK.3|LSDVDRDGMLDDEEFALASHLIEAK.4|LSDVDRDGMLDDEEFALASHLIEAK.3|LFELEEQDLFR.2|VYIGSFWSQPLLVPDNRR.3|LFELEEQDLFRDIQGLPR.3|FGAFHSPALEDADFDGKPMVLVAGQYSTGK.4|FGAFHSPALEDADFDGKPM[Oxi]VLVAGQYSTGK.4|FGAFHSPALEDADFDGKPMVLVAGQYSTGK.3|VGPEPTTDC[CAM]FVAVMHGDTEGTVPGNALVVDPDKPFRK.5|VGPEPTTDC[CAM]FVAVMHGDTEGTVPGNALVVDPDKPFRK.4|YDEIFYNLAPADGK.2|LEISDEFSEAIGALR.2|FMC[CAM]AQLPNQVLESISIIDTPGILSGAK.3|FM[Oxi]C[CAM]AQLPNQVLESISIIDTPGILSGAK.3
SEN / CTL,Q9Y6C2,EMILIN-1,EMILIN1,1.96,1.22,8.10E-11,9.47E-11,1.00E+01,cell adhesion,"protein binding,extracellular matrix constituent conferring elasticity","extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular matrix,extracellular exosome",27,36,48,VLLNDGGYYDPETGVFTAPLAGR.3|FRGLEEGQAQAGQC[CAM]PSLEGR.3|QATLEGLQEVVGR.2|QATLEGLQEVVGR.3|LVGSGLHTVEAAGEAR.3|LVGSGLHTVEAAGEAR.2|LLASVEER.2|RLDVVAGSVTVLSGR.3|RLDVVAGSVTVLSGR.2|RGTELGGAAGQGGHPPGYTSLASR.4|RGTELGGAAGQGGHPPGYTSLASR.3|YLLSAVLTGHRHEK.4|YLLSAVLTGHRHEK.3|YLLSAVLTGHR.3|LAEDVQR.2|RPPQEC[CAM]C[CAM]SPELGRR.4|RPPQEC[CAM]C[CAM]SPELGRR.3|GVLQGLSGR.2|HLAGLAVGR.2|LVGGQAGLGR.2|AVETAFNGR.2|VLDSEGQLR.2|RPPQEC[CAM]C[CAM]SPELGR.3|GPGAGPGVGGPSR.2|HVAGLWAGLR.2|APAPASAPPGPSEELLR.3|APAPASAPPGPSEELLR.2|C[CAM]SC[CAM]PLLPPR.2|SEPGTVPFDR.2|DRIISEINR.2|LQQEATEHATESEER.3|LQQEATEHATESEER.2|PGVHETLNEIQHQLQLLDTR.4|PGVHETLNEIQHQLQLLDTR.3|RVLDSEGQLR.2|LGRLEGVC[CAM]ER.2|LDTVAGGLQGLR.2|LQESC[CAM]SVC[CAM]LAGLDGFR.3|LQESC[CAM]SVC[CAM]LAGLDGFR.2|GLEEGQAQAGQC[CAM]PSLEGR.3|GLEEGQAQAGQC[CAM]PSLEGR.2|VSTHDQELGHLNNHHGGSSSSGGSR.4|VSTHDQELGHLNNHHGGSSSSGGSR.3|GTELGGAAGQGGHPPGYTSLASR.3|VQQLEEQVQSLTK.2|GFSLYTGSSGALSPGGPQAQIAPR.3|LQQEATEHATESEERFRGLEEGQAQAGQC[CAM]PSLEGR.5|LGQLEGLLQAHGDEGC[CAM]GAC[CAM]GGVQEELGR.3
SEN / CTL,P55268,Laminin subunit beta-2,LAMB2,1.96,1.08,3.63E-10,3.72E-10,9.43E+00,"cell adhesion,axon guidance,neuromuscular junction development,visual perception,astrocyte development,Schwann cell development,extracellular matrix organization,axon extension involved in regeneration,retina development in camera-type eye,metanephric glomerular visceral epithelial cell development,metanephric glomerular basement membrane development","integrin binding,structural molecule activity","extracellular region,basement membrane,basal lamina,laminin-3 complex,laminin-11 complex,synapse,extracellular exosome,extracellular matrix",24,53,60,SLADVDAILAR.2|GAVADTRDTEQTLYQVQER.3|TGGSAQPETPYSGPGLLIDSLVLLPR.3|YSEIEPSTEGEVIYR.2|QLDALLEALK.2|SWAEDEKQKAETVQAALEEAQR.4|VLDPAIPIPDPYSSR.2|VLDPAIPIPDPYSSR.3|VLELSIPASAEQIQHLAGAIAER.3|VLELSIPASAEQIQHLAGAIAER.4|ARHTQAELQR.3|VVQDLAAR.2|AETVQAALEEAQR.3|AETVQAALEEAQR.2|DLLQAAQDKLQR.3|C[CAM]EAC[CAM]APGHFGDPSRPGGR.4|AQGIAQGAIR.2|AQGVLAAQAR.2|HTQAELQR.2|TSGQC[CAM]LC[CAM]R.2|DLLQAAQDK.2|GQVLDVVER.2|HRTEALMDAQKEDFNSK.4|HFATSC[CAM]HQDEYSQQIVC[CAM]HC[CAM]R.5|HFATSC[CAM]HQDEYSQQIVC[CAM]HC[CAM]R.4|AAQLDGLEAR.2|AEQLLQDAR.2|ALAEGGSILSR.2|LGIVQGIVGAR.2|KAQGVLAAQAR.2|GPTC[CAM]NEFTGQC[CAM]HC[CAM]R.3|LQEGQTLEFLVASVPK.3|LQEGQTLEFLVASVPK.2|RAEQLLQDAR.2|DGFFGLSISDR.2|GPLGDQYQTVK.2|AGNSLAASTAEETAGSAQGR.3|AGNSLAASTAEETAGSAQGR.2|YLIFPNPVC[CAM]LEPGISYKLHLK.4|DLPWRPAEDGHSHAC[CAM]R.3|RAGNSLAASTAEETAGSAQGR.3|VLELSIPASAEQIQHLAGAIAERVR.4|GQVEQANQELQELIQSVK.3|GQVEQANQELQELIQSVK.2|IQNVVTSFAPQR.2|HSNFLGAYDSIR.2|GNC[CAM]FC[CAM]YGHASEC[CAM]APAPGAPAHAEGMVHGAC[CAM]IC[CAM]K.5|GQWGFPSC[CAM]RPC[CAM]VC[CAM]NGHADEC[CAM]NTHTGAC[CAM]LGC[CAM]R.5|GSC[CAM]YPATGDLLVGR.2|YYYALYELVVR.2|DTEQTLYQVQER.2|GLNC[CAM]EQC[CAM]QDFYR.2|LQELEGTYEENER.2|GFSGIFPAC[CAM]HPC[CAM]HAC[CAM]FGDWDR.3|AQELQQTGVLGAFESSFWHMQEK.3|LVTPGETPSWTGSGFVR.2|VLVLEMFSGGDAAALER.2|EIGEATEHLTQLEADLTDVQDENFNANHALSGLER.4|YLIFPNPVC[CAM]LEPGISYK.2|AQEAEQLLRGPLGDQYQTVK.2
SEN / CTL,Q02818,Nucleobindin-1,NUCB1,1.95,1.24,8.51E-22,3.59E-21,2.04E+01,"response to cisplatin,regulation of protein targeting","G-protein alpha-subunit binding,DNA binding,calcium ion binding","extracellular space,nucleus,early endosome,rough endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,Golgi apparatus,Golgi-associated vesicle,cis-Golgi network,trans-Golgi network,microtubule cytoskeleton,membrane,Golgi cisterna membrane,extracellular exosome,extrinsic component of Golgi membrane,lumenal side of Golgi membrane",66,33,46,DLELLIQTATR.2|ELQQAVLHMEQR.3|ELQQAVLHMEQR.2|LLERLPEVEVPQHL.3|YLQEVIDVLETDGHFR.3|EVWEELDGLDPNRFNPK.3|YLQEVIDVLETDGHFREK.4|YLQEVIDVLETDGHFREK.3|VNVPGSQAQLKEVWEELDGLDPNRFNPK.4|FHPDTDDVPVPAPAGDQKEVDTSEK.4|LSQETEALGR.2|AKMDAEQDPNVQVDHLNLLK.4|AKMDAEQDPNVQVDHLNLLK.3|LVTLEEFLASTQR.2|LVTLEEFLASTQR.3|LVTLEEFLASTQRK.3|LVTLEEFLASTQRK.2|TFFILHDINSDGVLDEQELEALFTK.3|LPEVEVPQHL.2|MDAEQDPNVQVDHLNLLK.3|MDAEQDPNVQVDHLNLLK.2|QFEHLDPQNQHTFEAR.4|QFEHLDPQNQHTFEAR.3|LQAANAEDIK.2|ELDFVSHHVR.3|ELDFVSHHVR.2|RELQQAVLHMEQR.4|RELQQAVLHMEQR.3|RELQQAVLHMEQR.2|DLAQYDAAHHEEFK.4|DLAQYDAAHHEEFK.3|DLAQYDAAHHEEFK.2|LQAANAEDIKSGK.3|YLESLGEEQRK.3|YLESLGEEQRK.2|DLAQYDAAHHEEFKR.4|QQQQQQQGHKAPAAHPEGQLK.5|FEEELAAR.2|APAAHPEGQLK.2|RFEEELAAR.2|NEEDDMREMEEER.3|VNVPGSQAQLK.2|YLESLGEEQR.2|FHPDTDDVPVPAPAGDQK.3|EFGDTGEGWETVEMHPAYTEEELRR.4|EVWEELDGLDPNR.2
SEN / CTL,P37837,Transaldolase,TALDO1,1.94,0.43,1.35E-02,3.67E-03,2.44E+00,"carbohydrate metabolic process,xylulose biosynthetic process,fructose 6-phosphate metabolic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch","sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,protein binding,monosaccharide binding","nucleus,cytoplasm,cytosol,extracellular exosome",3,31,43,ALAGC[CAM]DFLTISPK.2|ALAGC[CAM]DFLTISPK.3|KLGGSQEDQIK.3|KLGGSQEDQIK.2|LLGELLQDNAK.3|LLGELLQDNAK.2|LIELYKEAGISKDR.4|AAQASDLEKIHLDEK.4|KFAADAVKLER.3|LSFDKDAMVAR.3|LSFDKDAMVAR.2|KFAADAVK.2|ILDWHVANTDK.3|ILDWHVANTDK.2|VSTEVDAR.2|LIELYKEAGISK.3|MFNAENGK.2|LFVLFGAEILKK.3|AAQASDLEK.2|RLIELYK.2|ILDWHVANTDKK.3|ILDWHVANTDKK.2|NAIDKLFVLFGAEILKK.4|NAIDKLFVLFGAEILKK.3|TIVMGASFR.2|TIVM[Oxi]GASFR.2|WLHNEDQMAVEK.3|WLHNEDQM[Oxi]AVEK.3|WLHNEDQMAVEK.2|RLIELYKEAGISK.3|MESALDQLK.2|M[Oxi]ESALDQLK.2|LGGSQEDQIK.2|LGGSQEDQIKNAIDK.3|KLGGSQEDQIKNAIDK.3|NAIDKLFVLFGAEILK.3|SYEPLEDPGVK.2|LFVLFGAEILK.2|LSSTWEGIQAGK.2|QRMESALDQLK.2|LLGELLQDNAKLVPVLSAK.3|LLGELLQDNAKLVPVLSAK.2|QFTTVVADTGDFHAIDEYKPQDATTNPSLILAAAQMPAYQELVEEAIAYGR.5
SEN / CTL,O75882,Attractin,ATRN,1.94,0.90,5.00E-02,1.18E-02,1.93E+00,"inflammatory response,response to oxidative stress,cerebellum development,regulation of multicellular organism growth,myelination,pigmentation","receptor activity,carbohydrate binding","extracellular space,cytoplasm,plasma membrane,integral component of plasma membrane,extracellular exosome",3,29,41,LTLTPWVGLR.2|EQYAVVGHSAHIVTLK.4|EQYAVVGHSAHIVTLK.3|C[CAM]ENLTTGK.2|WSVLPRPDLHHDVNR.4|WSVLPRPDLHHDVNR.3|NHNALLASLTTQK.3|NHNALLASLTTQK.2|AKEQYAVVGHSAHIVTLK.4|ALYVHGGYK.2|YGHSLALYK.2|GEAC[CAM]DIPHC[CAM]TDNC[CAM]GFPHR.4|SC[CAM]ALDQNC[CAM]QWEPR.3|SC[CAM]ALDQNC[CAM]QWEPR.2|IMQSSQSMSK.2|C[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.6|C[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.5|C[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.3|DLDMFINASK.2|DLDM[Oxi]FINASK.2|NTWSILHTQGALVQGGYGHSSVYDHR.5|NTWSILHTQGALVQGGYGHSSVYDHR.4|GVKGDEC[CAM]QLC[CAM]EVENR.3|DNPMYYC[CAM]NK.2|DNPM[Oxi]YYC[CAM]NK.2|SEAAC[CAM]LAAGPGIR.2|YYTAINFVATPDEQNR.3|YYTAINFVATPDEQNR.2|HC[CAM]ETC[CAM]ISGFYGDPTNGGK.3|HC[CAM]ETC[CAM]ISGFYGDPTNGGK.2|C[CAM]TWLIEGQPNR.2|TLDHDRC[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.6|TLDHDRC[CAM]DQHTDC[CAM]YSC[CAM]TANTNDC[CAM]HWC[CAM]NDHC[CAM]VPR.5|GDEC[CAM]QLC[CAM]EVENR.2|YDVDTQMWTILK.2|C[CAM]NGHASLC[CAM]NTNTGK.2|TAC[CAM]GDC[CAM]TSGSSEC[CAM]MWC[CAM]SNMK.3|LTGSSGFVTDGPGNYK.2|C[CAM]FSSDFMAYDIAC[CAM]DR.2|C[CAM]NPGTGQC[CAM]VC[CAM]PAGWVGEQC[CAM]QHC[CAM]GGR.3|NQEC[CAM]IALPENIC[CAM]GIGWHLVGNSC[CAM]LK.3
SEN / CTL,P98095,Fibulin-2,FBLN2,1.94,0.60,8.08E-10,7.87E-10,9.10E+00,positive regulation of cell-substrate adhesion,"extracellular matrix structural constituent,calcium ion binding,extracellular matrix binding","extracellular region,proteinaceous extracellular matrix,extracellular matrix,extracellular exosome,extracellular vesicle",15,7,8,ITHYQLNFQTGLLVPAHIFR.4|RLNAYTGVVYLQR.3|IGPAPAFTGDTIALNIIK.2|IGPAPAFTGDTIALNIIK.3|MHIFFTTFAL.2|C[CAM]VDVNEC[CAM]ETGVHR.3|HC[CAM]C[CAM]VSYLQEK.2|LNAYTGVVYLQR.2
SEN / CTL,P08253,72 kDa type IV collagenase,MMP2,1.93,0.50,1.94E-02,4.97E-03,2.30E+00,"angiogenesis,response to hypoxia,blood vessel maturation,intramembranous ossification,proteolysis,embryo implantation,extracellular matrix disassembly,collagen catabolic process,endodermal cell differentiation,cellular protein metabolic process,positive regulation of innate immune response,ephrin receptor signaling pathway,face morphogenesis,bone trabecula formation,cellular response to amino acid stimulus,positive regulation of vascular smooth muscle cell proliferation","metalloendopeptidase activity,serine-type endopeptidase activity,metallopeptidase activity,zinc ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,nucleus,mitochondrion,plasma membrane,sarcomere,extracellular matrix",3,2,2,IIGYTPDLDPETVDDAFAR.2|IDAVYEAPQEEK.2
SEN / CTL,P17900,Ganglioside GM2 activator,GM2A,1.93,1.85,1.92E-03,6.32E-04,3.20E+00,"glycosphingolipid metabolic process,ganglioside catabolic process,lipid transport,learning or memory,oligosaccharide catabolic process,lipid storage,neuromuscular process controlling balance,positive regulation of hydrolase activity","lipid transporter activity,phospholipase activator activity,sphingolipid activator protein activity,beta-N-acetylgalactosaminidase activity","mitochondrion,hydrogen:potassium-exchanging ATPase complex,cytoplasmic side of plasma membrane,lysosomal lumen,apical cortex,extracellular exosome",9,10,12,SEFVVPDLELPSWLTTGNYR.3|SEFVVPDLELPSWLTTGNYR.2|IPC[CAM]TDYIGSC[CAM]TFEHFC[CAM]DVLDMLIPTGEPC[CAM]PEPLR.4|EGTYSLPK.2|EVAGLWIK.2|TYGLPC[CAM]HC[CAM]PFK.3|TYGLPC[CAM]HC[CAM]PFK.2|IESVLSSSGK.2|KPSQLSSFSWDNC[CAM]DEGKDPAVIR.4|TYGLPC[CAM]HC[CAM]PFKEGTYSLPK.3|SEFVVPDLELPSWLTTGNYRIESVLSSSGKR.4|SEFVVPDLELPSWLTTGNYRIESVLSSSGK.3
SEN / CTL,P16070,CD44 antigen,CD44,1.92,0.48,2.62E-06,1.51E-06,5.82E+00,"cell-matrix adhesion,single organismal cell-cell adhesion,extracellular matrix disassembly,extracellular matrix organization,hyaluronan catabolic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of heterotypic cell-cell adhesion,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,negative regulation of DNA damage response, signal transduction by p53 class mediator,cellular response to fibroblast growth factor stimulus,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,cartilage development,interferon-gamma-mediated signaling pathway,positive regulation of ERK1 and ERK2 cascade,monocyte aggregation,positive regulation of monocyte aggregation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator","collagen binding,hyaluronic acid binding,cytokine receptor activity","cytoplasm,Golgi apparatus,plasma membrane,integral component of plasma membrane,focal adhesion,cell surface,macrophage migration inhibitory factor receptor complex,extracellular exosome",9,12,18,YGFIEGHVVIPR.3|YGFIEGHVVIPR.2|ALSIGFETC[CAM]R.2|SQEM[Oxi]VHLVNK.3|SQEMVHLVNK.2|SQEM[Oxi]VHLVNK.2|TEAADLC[CAM]K.2|NLQNVDMK.2|NLQNVDM[Oxi]K.2|KLVINSGNGAVEDR.3|KLVINSGNGAVEDR.2|FAGVFHVEK.2|KPSGLNGEASK.2|LVINSGNGAVEDRKPSGLNGEASK.4|LVINSGNGAVEDR.2|SQEMVHLVNKESSETPDQFMTADETR.4|ESSETPDQFM[Oxi]TADETR.2|ESSETPDQFMTADETR.2
SEN / CTL,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,1.91,1.18,6.91E-20,2.50E-19,1.86E+01,"microtubule cytoskeleton organization,gluconeogenesis,regulation of macroautophagy,negative regulation of translation,peptidyl-cysteine S-trans-nitrosylation,protein stabilization,neuron apoptotic process,canonical glycolysis,cellular response to interferon-gamma","glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,protein binding,microtubule binding,peptidyl-cysteine S-nitrosylase activity,NADP binding,NAD binding","nucleus,cytoplasm,lipid particle,cytosol,plasma membrane,microtubule cytoskeleton,membrane,intracellular ribonucleoprotein complex,extracellular matrix,nuclear membrane,vesicle,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,GAIT complex",72,51,166,VPTANVSVVDLTC[CAM]R.2|VPTANVSVVDLTC[CAM]R.3|IISNASC[CAM]TTNC[CAM]LAPLAK.2|IISNASC[CAM]TTNC[CAM]LAPLAK.3|IISNASC[CAM]TTNC[CAM]LAPLAK.4|LISWYDNEFGYSNR.3|LISWYDNEFGYSNR.2|GALQNIIPASTGAAK.2|GALQNIIPASTGAAK.3|VIHDNFGIVEGLMTTVHAITATQK.4|VIHDNFGIVEGLMTTVHAITATQK.3|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.5|VIHDNFGIVEGLMTTVHAITATQK.5|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.4|VIHDNFGIVEGLM[Oxi]TTVHAITATQK.3|VVDLMAHMASKE.3|VVDLMAHMASKE.2|VVDLM[Oxi]AHMASKE.3|VVDLMAHM[Oxi]ASKE.3|VVDLM[Oxi]AHM[Oxi]ASKE.3|VVDLM[Oxi]AHMASKE.2|VVDLMAHM[Oxi]ASKE.2|VVDLM[Oxi]AHM[Oxi]ASKE.2|LTGMAFRVPTANVSVVDLTC[CAM]R.3|LTGMAFRVPTANVSVVDLTC[CAM]R.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]R.3|LTGMAFRVPTANVSVVDLTC[CAM]R.2|LVINGNPITIFQERDPSK.3|LVINGNPITIFQERDPSK.4|LVINGNPITIFQERDPSK.2|IKWGDAGAEYVVESTGVFTTMEK.3|IKWGDAGAEYVVESTGVFTTMEK.4|IKWGDAGAEYVVESTGVFTTM[Oxi]EK.3|VPTANVSVVDLTC[CAM]RLEKPAK.4|VPTANVSVVDLTC[CAM]RLEKPAK.3|VPTANVSVVDLTC[CAM]RLEKPAKYDDIK.5|VPTANVSVVDLTC[CAM]RLEKPAKYDDIK.4|VIISAPSADAPMFVMGVNHEKYDNSLK.4|VIISAPSADAPMFVMGVNHEKYDNSLK.5|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.4|VIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.4|VIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.4|VIISAPSADAPMFVMGVNHEKYDNSLK.3|RVIISAPSADAPMFVMGVNHEKYDNSLK.5|RVIISAPSADAPMFVMGVNHEKYDNSLK.4|RVIISAPSADAPMFVMGVNHEKYDNSLK.6|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.6|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.6|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.5|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.5|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.4|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.4|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEKYDNSLK.4|RVIISAPSADAPM[Oxi]FVMGVNHEKYDNSLK.3|RVIISAPSADAPMFVM[Oxi]GVNHEKYDNSLK.3|RVIISAPSADAPMFVMGVNHEKYDNSLK.3|QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.6|QASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.5|VIISAPSADAPMFVMGVNHEK.3|VIISAPSADAPM[Oxi]FVMGVNHEK.4|VIISAPSADAPMFVM[Oxi]GVNHEK.4|VIISAPSADAPMFVMGVNHEK.4|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.4|VIISAPSADAPM[Oxi]FVMGVNHEK.3|VIISAPSADAPMFVM[Oxi]GVNHEK.3|VIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.3|VIISAPSADAPMFVMGVNHEK.2|VIISAPSADAPM[Oxi]FVMGVNHEK.2|VIISAPSADAPMFVM[Oxi]GVNHEK.2|WGDAGAEYVVESTGVFTTMEK.3|WGDAGAEYVVESTGVFTTM[Oxi]EK.3|WGDAGAEYVVESTGVFTTM[Oxi]EK.2|WGDAGAEYVVESTGVFTTMEK.2|RVIISAPSADAPMFVMGVNHEK.4|RVIISAPSADAPMFVMGVNHEK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.5|RVIISAPSADAPM[Oxi]FVMGVNHEK.5|RVIISAPSADAPMFVM[Oxi]GVNHEK.5|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.4|RVIISAPSADAPM[Oxi]FVMGVNHEK.4|RVIISAPSADAPMFVM[Oxi]GVNHEK.4|RVIISAPSADAPMFVMGVNHEK.3|RVIISAPSADAPM[Oxi]FVM[Oxi]GVNHEK.3|RVIISAPSADAPM[Oxi]FVMGVNHEK.3|RVIISAPSADAPMFVM[Oxi]GVNHEK.3|RVIISAPSADAPM[Oxi]FVMGVNHEK.2|RVIISAPSADAPMFVMGVNHEK.2|VDIVAINDPFIDLNYMVYMFQYDSTHGK.3|VDIVAINDPFIDLNYM[Oxi]VYMFQYDSTHGK.4|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.4|VDIVAINDPFIDLNYMVYMFQYDSTHGK.4|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.3|VDIVAINDPFIDLNYM[Oxi]VYM[Oxi]FQYDSTHGK.3|GKVKVGVNGFGR.3|LTGM[Oxi]AFR.2|TVDGPSGKLWR.3|TVDGPSGKLWR.2|VGVNGFGR.2|VVDLM[Oxi]AHMASK.3|VVDLMAHM[Oxi]ASK.3|VVDLMAHMASK.3|VVDLM[Oxi]AHM[Oxi]ASK.3|VVDLMAHMASK.2|VVDLM[Oxi]AHMASK.2|VVDLMAHM[Oxi]ASK.2|VVDLM[Oxi]AHM[Oxi]ASK.2|AVGKVIPELNGK.3|AVGKVIPELNGK.2|QASEGPLK.2|DGRGALQNIIPASTGAAK.4|DGRGALQNIIPASTGAAK.3|DGRGALQNIIPASTGAAK.2|LEKPAKYDDIK.3|LEKPAKYDDIK.2|AGAHLQGGAK.2|PAKYDDIK.2|LEKPAKYDDIKK.3|LEKPAKYDDIKK.2|AGAHLQGGAKR.2|LVINGNPITIFQER.3|LVINGNPITIFQER.2|PAKYDDIKK.2|LWRDGRGALQNIIPASTGAAK.4|LWRDGRGALQNIIPASTGAAK.3|VIPELNGKLTGMAFR.3|VIPELNGKLTGM[Oxi]AFR.3|LVINGNPITIFQERDPSKIK.4|LVINGNPITIFQERDPSKIK.3|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.7|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.6|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.5|GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.4|GALQNIIPASTGAAKAVGK.3|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEKPAK.5|LTGMAFRVPTANVSVVDLTC[CAM]RLEKPAK.5|AENGKLVINGNPITIFQERDPSK.4|AENGKLVINGNPITIFQERDPSK.3|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWR.6|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWR.5|VPTANVSVVDLTC[CAM]RLEK.3|VPTANVSVVDLTC[CAM]RLEK.2|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.7|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.6|AAFNSGKVDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGKFHGTVK.6|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.6|VDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.5|VDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVK.4|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGK.5|VIHDNFGIVEGLM[Oxi]TTVHAITATQKTVDGPSGK.5|VIHDNFGIVEGLMTTVHAITATQKTVDGPSGK.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEK.4|LTGMAFRVPTANVSVVDLTC[CAM]RLEK.4|LTGM[Oxi]AFRVPTANVSVVDLTC[CAM]RLEK.3|LTGMAFRVPTANVSVVDLTC[CAM]RLEK.3|AENGKLVINGNPITIFQER.3|AENGKLVINGNPITIFQER.2|LISWYDNEFGYSNRVVDLMAHMASKE.4|VIPELNGKLTGMAFRVPTANVSVVDLTC[CAM]R.4|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK.5|AAFNSGKVDIVAINDPFIDLNYM[Oxi]VYMFQYDSTHGK.4|AAFNSGKVDIVAINDPFIDLNYMVYM[Oxi]FQYDSTHGK.4|AAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGK.4|YDNSLKIISNASC[CAM]TTNC[CAM]LAPLAK.3
SEN / CTL,P09382,Galectin-1,LGALS1,1.91,1.51,3.75E-13,6.33E-13,1.22E+01,"plasma cell differentiation,apoptotic process,signal transduction,negative regulation of cell-substrate adhesion,negative regulation of neuron projection development,T cell costimulation,multicellular organismal response to stress,positive regulation of erythrocyte aggregation,response to drug,regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,myoblast differentiation,positive regulation of viral entry into host cell,response to axon injury,cellular response to glucose stimulus,cellular response to organic cyclic compound,positive regulation of dendritic cell differentiation","glycoprotein binding,signal transducer activity,protein binding,lactose binding,protein homodimerization activity,laminin binding,poly(A) RNA binding","proteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,cell surface,extracellular matrix,extracellular exosome",48,17,33,SFVLNLGKDSNNLC[CAM]LHFNPR.4|SFVLNLGKDSNNLC[CAM]LHFNPR.3|FNAHGDANTIVC[CAM]NSKDGGAWGTEQR.4|LPDGYEFKFPNR.3|LPDGYEFKFPNR.2|DSNNLC[CAM]LHFNPR.3|DSNNLC[CAM]LHFNPR.2|SFVLNLGK.2|FNAHGDANTIVC[CAM]NSK.3|FNAHGDANTIVC[CAM]NSK.2|FNAHGDANTIVC[CAM]NSK.4|LNLEAINYMAADGDFK.2|LNLEAINYMAADGDFK.3|LNLEAINYM[Oxi]AADGDFK.3|LNLEAINYM[Oxi]AADGDFK.2|FPNRLNLEAINYMAADGDFK.3|FPNRLNLEAINYM[Oxi]AADGDFK.3|FPNRLNLEAINYMAADGDFK.2|EAVFPFQPGSVAEVC[CAM]ITFDQANLTVK.3|EAVFPFQPGSVAEVC[CAM]ITFDQANLTVK.4|FPNRLNLEAINYMAADGDFKIK.4|FPNRLNLEAINYMAADGDFKIK.3|LNLEAINYMAADGDFKIK.3|LNLEAINYM[Oxi]AADGDFKIK.3|LNLEAINYMAADGDFKIK.2|VRGEVAPDAKSFVLNLGK.4|VRGEVAPDAKSFVLNLGK.3|LPDGYEFK.2|VRGEVAPDAK.2|DGGAWGTEQR.2|AC[CAM]GLVASNLNLKPGEC[CAM]LR.3|LPDGYEFKFPNRLNLEAINYM[Oxi]AADGDFK.4|LPDGYEFKFPNRLNLEAINYMAADGDFK.4
SEN / CTL,P31946,14-3-3 protein beta/alpha,YWHAB,1.90,1.22,9.98E-06,5.30E-06,5.28E+00,"MAPK cascade,protein targeting,viral process,negative regulation of protein dephosphorylation,hippo signaling,positive regulation of catalytic activity,regulation of mRNA stability,negative regulation of G-protein coupled receptor protein signaling pathway,negative regulation of transcription, DNA-templated,cytoplasmic sequestering of protein,protein heterooligomerization,membrane organization,cell-cell adhesion,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","transcription corepressor activity,protein binding,protein C-terminus binding,enzyme binding,protein domain specific binding,protein complex binding,histone deacetylase binding,phosphoserine binding,phosphoprotein binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,focal adhesion,membrane,transcriptional repressor complex,cytoplasmic vesicle membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome",15,37,87,NLLSVAYK.2|NLLSVAYK.1|LAEQAERYDDMAAAMK.3|LAEQAERYDDM[Oxi]AAAM[Oxi]K.3|LAEQAERYDDM[Oxi]AAAMK.3|LAEQAERYDDMAAAM[Oxi]K.3|LAEQAERYDDM[Oxi]AAAMK.2|LAEQAERYDDMAAAM[Oxi]K.2|LAEQAERYDDMAAAMK.2|LAEQAERYDDM[Oxi]AAAM[Oxi]K.2|DSTLIMQLLR.2|DSTLIM[Oxi]QLLR.2|DSTLIMQLLR.1|QTTVSNSQQAYQEAFEISKK.3|QTTVSNSQQAYQEAFEISKK.4|QTTVSNSQQAYQEAFEISKK.2|TAFDEAIAELDTLNEESYKDSTLIMQLLR.4|TAFDEAIAELDTLNEESYKDSTLIM[Oxi]QLLR.4|TAFDEAIAELDTLNEESYKDSTLIM[Oxi]QLLR.3|TAFDEAIAELDTLNEESYKDSTLIMQLLR.3|KEMQPTHPIR.3|KEM[Oxi]QPTHPIR.3|KEMQPTHPIR.2|KEM[Oxi]QPTHPIR.2|LAEQAER.2|VISSIEQKTERNEK.4|VISSIEQKTERNEK.3|VISSIEQKTERNEK.2|VISSIEQK.2|YLIPNATQPESK.3|YLIPNATQPESK.2|MKGDYFR.2|M[Oxi]KGDYFR.2|AKLAEQAERYDDMAAAMK.4|AKLAEQAERYDDMAAAM[Oxi]K.3|AKLAEQAERYDDMAAAMK.3|AKLAEQAERYDDM[Oxi]AAAM[Oxi]K.3|AKLAEQAERYDDM[Oxi]AAAM[Oxi]K.2|AKLAEQAERYDDM[Oxi]AAAMK.2|AKLAEQAERYDDMAAAM[Oxi]K.2|AKLAEQAERYDDMAAAMK.2|NLLSVAYKNVVGAR.3|NLLSVAYKNVVGAR.2|AKLAEQAER.2|YDDMAAAMK.2|YDDM[Oxi]AAAMK.2|YDDMAAAM[Oxi]K.2|YDDM[Oxi]AAAM[Oxi]K.2|VFYLKMKGDYFR.3|AVTEQGHELSNEER.3|AVTEQGHELSNEER.2|NLLSVAYKNVVGARR.3|EMQPTHPIR.2|EM[Oxi]QPTHPIR.2|TMDKSELVQK.2|YLSEVASGDNK.2|YLSEVASGDNK.1|EKIEAELQDIC[CAM]NDVLELLDK.4|EKIEAELQDIC[CAM]NDVLELLDK.3|EKIEAELQDIC[CAM]NDVLELLDK.2|AVTEQGHELSNEERNLLSVAYK.4|AVTEQGHELSNEERNLLSVAYK.3|AVTEQGHELSNEERNLLSVAYKNVVGAR.5|AVTEQGHELSNEERNLLSVAYKNVVGAR.4|AVTEQGHELSNEERNLLSVAYKNVVGAR.3|VISSIEQKTER.2|YDDM[Oxi]AAAM[Oxi]KAVTEQGHELSNEER.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.5|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISKK.3|EYREKIEAELQDIC[CAM]NDVLELLDK.4|EYREKIEAELQDIC[CAM]NDVLELLDK.3|IEAELQDIC[CAM]NDVLELLDK.3|IEAELQDIC[CAM]NDVLELLDK.2|QTTVSNSQQAYQEAFEISK.3|QTTVSNSQQAYQEAFEISK.2|TAFDEAIAELDTLNEESYK.3|TAFDEAIAELDTLNEESYK.2|LGLALNFSVFYYEILNSPEK.3|LGLALNFSVFYYEILNSPEK.2|DNLTLWTSENQGDEGDAGEGEN.3|YLSEVASGDNKQTTVSNSQQAYQEAFEISK.4|YLSEVASGDNKQTTVSNSQQAYQEAFEISK.3|IEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.4|IEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.3|EKIEAELQDIC[CAM]NDVLELLDKYLIPNATQPESK.4|LGLALNFSVFYYEILNSPEKAC[CAM]SLAK.3
SEN / CTL,O75347,Tubulin-specific chaperone A,TBCA,1.90,1.33,4.82E-05,2.38E-05,4.62E+00,"protein folding,tubulin complex assembly,post-chaperonin tubulin folding pathway","poly(A) RNA binding,beta-tubulin binding,chaperone binding","nucleolus,cytoplasm,microtubule,microtubule cytoskeleton,extracellular exosome",12,14,23,ILENEKDLEEAEEYKEAR.4|ILENEKDLEEAEEYKEAR.3|RLEAAYLDLQR.3|RLEAAYLDLQR.2|LVLDSVKLEA.2|LEAAYLDLQR.2|AEDGENYDIKK.3|AEDGENYDIKK.2|MRAEDGENYDIK.3|M[Oxi]RAEDGENYDIK.3|DLEEAEEYKEAR.3|DLEEAEEYKEAR.2|MRAEDGENYDIKK.3|M[Oxi]RAEDGENYDIKK.3|MMIPDC[CAM]QR.2|MM[Oxi]IPDC[CAM]QR.2|M[Oxi]M[Oxi]IPDC[CAM]QR.2|QAEILQESR.2|DLEEAEEYK.2|AEDGENYDIK.2|KQAEILQESR.2|ILENEKDLEEAEEYK.3|ILENEKDLEEAEEYK.2
SEN / CTL,P23142,Fibulin-1,FBLN1,1.90,1.48,1.65E-17,4.18E-17,1.64E+01,"negative regulation of protein phosphorylation,negative regulation of cell adhesion,embryo implantation,positive regulation of peptidase activity,viral process,extracellular matrix organization,negative regulation of ERK1 and ERK2 cascade,blood coagulation, fibrin clot formation,negative regulation of substrate adhesion-dependent cell spreading,negative regulation of cell motility,negative regulation of stem cell proliferation,integrin-mediated signaling pathway","fibronectin binding,extracellular matrix structural constituent,calcium ion binding,protein C-terminus binding,peptidase activator activity,protein complex binding,identical protein binding,fibrinogen binding","extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular exosome,elastic fiber,fibrinogen complex,extracellular matrix",66,25,36,EFTRPEEIIFLR.3|EFTRPEEIIFLR.2|RGYQLSDVDGVTC[CAM]EDIDEC[CAM]ALPTGGHIC[CAM]SYR.4|YMDGMTVGVVR.2|GYQLSDVDGVTC[CAM]EDIDEC[CAM]ALPTGGHIC[CAM]SYR.3|AITPPHPASQANIIFDITEGNLR.3|AITPPHPASQANIIFDITEGNLRDSFDIIKR.5|MC[CAM]VDVNEC[CAM]QR.2|C[CAM]VDVDEC[CAM]APPAEPC[CAM]GK.3|C[CAM]VDVDEC[CAM]APPAEPC[CAM]GK.2|DC[CAM]SLPYATESK.2|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.5|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.4|SC[CAM]RPNDVTC[CAM]VFDPVHTISHTVISLPTFR.3|SQETGDLDVGGLQETDKIIEVEEEQEDPYLNDR.4|MVQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.4|MVQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.3|M[Oxi]VQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.3|M[Oxi]VQEQC[CAM]C[CAM]HSQLEELHC[CAM]ATGISLANEQDR.4|DIDEC[CAM]ESGIHNC[CAM]LPDFIC[CAM]QNTLGSFR.3|TGYYFDGISR.2|LEMNYVVGGVVSHR.3|LEMNYVVGGVVSHR.2|C[CAM]C[CAM]HC[CAM]C[CAM]LLGR.3|SAATLQQEK.2|C[CAM]VNSPGSFR.2|SAATLQQEKTDTVR.3|SAATLQQEKTDTVR.2|GYHLNEEGTR.2|DSSC[CAM]GTGYELTEDNSC[CAM]K.3|DSSC[CAM]GTGYELTEDNSC[CAM]K.2|IIEVEEEQEDPYLNDR.3|IIEVEEEQEDPYLNDR.2|C[CAM]LAFEC[CAM]PENYR.2|AITPPHPASQANIIFDITEGNLRDSFDIIK.4|SQETGDLDVGGLQETDK.2
SEN / CTL,P14314,Glucosidase 2 subunit beta,PRKCSH,1.89,0.54,7.82E-07,4.79E-07,6.32E+00,"protein folding,N-glycan processing,intracellular signal transduction","protein kinase C binding,calcium ion binding,ion channel binding,phosphoprotein binding","intracellular,endoplasmic reticulum,endoplasmic reticulum lumen",9,34,64,SLEDQVEMLR.2|SLEDQVEM[Oxi]LR.2|ESLQQMAEVTR.2|ESLQQM[Oxi]AEVTR.2|LGGSPTSLGTWGSWIGPDHDKFSAMK.4|LGGSPTSLGTWGSWIGPDHDKFSAM[Oxi]K.4|LGGSPTSLGTWGSWIGPDHDKFSAM[Oxi]K.3|LGGSPTSLGTWGSWIGPDHDKFSAMK.3|SLKDMEESIR.3|SLKDMEESIR.2|SLKDM[Oxi]EESIR.2|GVSLTNHHFYDESK.4|GVSLTNHHFYDESK.3|GVSLTNHHFYDESK.2|TVKEEAEKPEREAK.4|TVKEEAEKPEREAK.3|LIELQAGK.2|DMEESIR.2|DM[Oxi]EESIR.2|TVKEEAEKPER.3|TVKEEAEKPER.2|AQQEQELAADAFK.3|AQQEQELAADAFK.2|KLIELQAGK.2|LIELQAGKK.2|NKFEEAER.2|ILIEDWKK.2|KILIEDWK.2|YEQGTGC[CAM]WQGPNR.3|YEQGTGC[CAM]WQGPNR.2|ERESLQQM[Oxi]AEVTR.3|ERESLQQMAEVTR.3|ERESLQQMAEVTR.2|ERESLQQM[Oxi]AEVTR.2|KLIELQAGKK.2|LWEEQLAAAK.2|KILIEDWKK.2|ETM[Oxi]VTSTTEPSR.2|ETMVTSTTEPSR.2|SEALPTDLPAPSAPDLTEPK.3|SEALPTDLPAPSAPDLTEPK.2|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYKPLYIPSNR.5|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYKPLYIPSNR.4|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYKPLYIPSNR.3|PFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.4|PFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.3|LGGSPTSLGTWGSWIGPDHDK.3|LGGSPTSLGTWGSWIGPDHDK.2|M[Oxi]PPYDEQTQAFIDAAQEAR.3|MPPYDEQTQAFIDAAQEAR.3|MPPYDEQTQAFIDAAQEAR.2|VNDGVC[CAM]DC[CAM]C[CAM]DGTDEYNSGVIC[CAM]ENTC[CAM]K.4|VNDGVC[CAM]DC[CAM]C[CAM]DGTDEYNSGVIC[CAM]ENTC[CAM]K.3|YRSEALPTDLPAPSAPDLTEPK.3|YRSEALPTDLPAPSAPDLTEPK.2|DGSDEPGTAAC[CAM]PNGSFHC[CAM]TNTGYK.3|LGGSPTSLGTWGSWIGPDHDKFSAM[Oxi]KYEQGTGC[CAM]WQGPNR.5|LGGSPTSLGTWGSWIGPDHDKFSAMKYEQGTGC[CAM]WQGPNR.5|LGGSPTSLGTWGSWIGPDHDKFSAMKYEQGTGC[CAM]WQGPNR.4|GVSLTNHHFYDESKPFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.5|GVSLTNHHFYDESKPFTC[CAM]LDGSATIPFDQVNDDYC[CAM]DC[CAM]K.4|ILIEDWK.1|VNDGVC[CAM]DC[CAM]C[CAM]DGTDEYNSGVIC[CAM]ENTC[CAM]KEK.3|C[CAM]EYLMELMTPAAC[CAM]PEPPPEAPTEDDHDEL.3
SEN / CTL,P14174,Macrophage migration inhibitory factor,MIF,1.89,0.60,1.56E-11,2.08E-11,1.07E+01,"prostaglandin biosynthetic process,negative regulation of mature B cell apoptotic process,inflammatory response,cell surface receptor signaling pathway,cell aging,cell proliferation,negative regulation of gene expression,positive regulation of protein kinase A signaling,carboxylic acid metabolic process,DNA damage response, signal transduction by p53 class mediator,positive regulation of B cell proliferation,positive regulation of lipopolysaccharide-mediated signaling pathway,negative regulation of cellular protein metabolic process,negative regulation of myeloid cell apoptotic process,positive regulation of peptidyl-serine phosphorylation,positive regulation of phosphorylation,regulation of macrophage activation,negative regulation of apoptotic process,positive regulation of MAP kinase activity,negative regulation of DNA damage response, signal transduction by p53 class mediator,innate immune response,positive regulation of fibroblast proliferation,positive regulation of cytokine secretion,positive regulation of peptidyl-tyrosine phosphorylation,leukocyte migration,positive chemotaxis,positive regulation of prostaglandin secretion involved in immune response,positive regulation of myeloid leukocyte cytokine production involved in immune response,protein homotrimerization,positive regulation of ERK1 and ERK2 cascade,negative regulation of cell cycle arrest,positive regulation of arachidonic acid secretion,negative regulation of cell aging,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,positive regulation of chemokine (C-X-C motif) ligand 2 production","dopachrome isomerase activity,receptor binding,cytokine activity,cytokine receptor binding,protein binding,chemoattractant activity,phenylpyruvate tautomerase activity","extracellular region,extracellular space,nucleoplasm,cytoplasm,cell surface,vesicle,myelin sheath,extracellular exosome",21,10,22,LLC[CAM]GLLAER.2|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.5|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.6|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPC[CAM]ALC[CAM]SLHSIGK.7|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM[Oxi]AFGGSSEPC[CAM]ALC[CAM]SLHSIGK.7|ASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLM[Oxi]AFGGSSEPC[CAM]ALC[CAM]SLHSIGK.6|PMFIVNTNVPR.2|PMFIVNTNVPR.3|PM[Oxi]FIVNTNVPR.3|PM[Oxi]FIVNTNVPR.2|LLC[CAM]GLLAERLR.3|SYSKLLC[CAM]GLLAERLR.4|SYSKLLC[CAM]GLLAERLR.3|SYSKLLC[CAM]GLLAER.3|SYSKLLC[CAM]GLLAER.2|MPMFIVNTNVPR.2|MPM[Oxi]FIVNTNVPR.2|ASVPDGFLSELTQQLAQATGK.3|ASVPDGFLSELTQQLAQATGK.2|VYINYYDM[Oxi]NAANVGWNNSTFA.3|VYINYYDMNAANVGWNNSTFA.3|ISPDRVYINYYDMNAANVGWNNSTFA.3
SEN / CTL,P31949,Protein S100-A11,S100A11,1.88,1.18,3.01E-04,1.24E-04,3.91E+00,"signal transduction,negative regulation of DNA replication,negative regulation of cell proliferation,cell-cell adhesion","calcium ion binding,protein homodimerization activity,S100 protein binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion","ruffle,extracellular space,nucleus,cytoplasm,cell-cell adherens junction,extracellular exosome",12,8,13,TEFLSFMNTELAAFTK.2|TEFLSFMNTELAAFTK.3|TEFLSFM[Oxi]NTELAAFTK.2|C[CAM]IESLIAVFQK.2|C[CAM]IESLIAVFQK.3|ISSPTETERC[CAM]IESLIAVFQK.3|YAGKDGYNYTLSK.3|YAGKDGYNYTLSK.2|ISSPTETER.2|DGYNYTLSK.2|NQKDPGVLDR.2|KLDTNSDGQLDFSEFLNLIGGLAM[Oxi]AC[CAM]HDSFLK.4|KLDTNSDGQLDFSEFLNLIGGLAM[Oxi]AC[CAM]HDSFLK.3
SEN / CTL,P24592,Insulin-like growth factor-binding protein 6,IGFBP6,1.88,0.34,1.05E-07,7.37E-08,7.13E+00,"regulation of cell growth,signal transduction,negative regulation of cell proliferation,regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space,Golgi apparatus,extracellular exosome",9,4,4,HLDSVLQQLQTEVYR.3|EGQEC[CAM]GVYTPNC[CAM]APGLQC[CAM]HPPKDDEAPLR.4|GAQTLYVPNC[CAM]DHR.2|APAVAEENPK.2
SEN / CTL,Q969H8,Myeloid-derived growth factor,MYDGF,1.88,2.30,1.79E-01,3.75E-02,1.43E+00,"angiogenesis,positive regulation of protein phosphorylation,positive regulation of endothelial cell proliferation,apoptotic process,positive regulation of phosphatidylinositol 3-kinase signaling,IRE1-mediated unfolded protein response,negative regulation of apoptotic process,positive regulation of MAPK cascade,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of protein kinase B signaling",protein binding,"extracellular space,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,extracellular exosome",3,8,13,SYLYFTQFK.2|PGGVVHSFSHNVGPGDK.4|PGGVVHSFSHNVGPGDK.3|PGGVVHSFSHNVGPGDK.2|TEEFEVTK.2|TAVAHRPGAFK.2|AAFERESDVPLKTEEFEVTK.4|AAFERESDVPLKTEEFEVTK.3|ESDVPLKTEEFEVTK.3|ESDVPLKTEEFEVTK.2|GAEIEYAMAYSK.2|GAEIEYAM[Oxi]AYSK.2|YTC[CAM]MFTYASQGGTNEQWQMSLGTSEDHQHFTC[CAM]TIWRPQGK.5
SEN / CTL,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",PLOD1,1.88,1.03,3.06E-32,2.91E-31,3.05E+01,"response to hypoxia,cellular protein modification process,epidermis development,hydroxylysine biosynthetic process,oxidation-reduction process","iron ion binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding,protein homodimerization activity","endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",99,37,56,SEDYVDIVQGR.2|FWTFETGC[CAM]TVC[CAM]DEGLR.2|FLLEYIAPMTEK.2|RVGVWNVPYISNIYLIK.3|QQDVFMFLTNR.2|AQFDLAFVVR.2|IFQNLDGALDEVVLKFEMGHVR.4|VGVDYEGGGC[CAM]R.2|FLGSGGFIGYAPNLSK.2|FLGSGGFIGYAPNLSK.3|LDPDMAFC[CAM]ANIR.2|LQLNYLGNYIPR.2|LQLNYLGNYIPR.3|TTHLHNDLWEVFSNPEDWKEK.4|TTHLHNDLWEVFSNPEDWKEK.3|HTLGHLLSLDSYR.3|HTLGHLLSLDSYR.2|IFQNLDGALDEVVLK.2|IFQNLDGALDEVVLK.3|HADKEDLVILFADSYDVLFASGPR.4|IQALGLGEDWNVEK.2|VGVWNVPYISNIYLIK.2|VGVWNVPYISNIYLIK.3|AQVEEFLAQHGSEYQSVK.3|AQVEEFLAQHGSEYQSVK.2|AQVEEFLAQHGSEYQSVK.4|IQGGYENVPTIDIHMNQIGFER.3|GSALRGELQSSDLFHHSK.4|GSALRGELQSSDLFHHSK.3|NLAYDTLPVLIHGNGPTK.3|NLAYDTLPVLIHGNGPTK.4|NLAYDTLPVLIHGNGPTK.2|YKPDEQPSLMPHHDASTFTINIALNR.4|YKPDEQPSLMPHHDASTFTINIALNR.5|YKPDEQPSLM[Oxi]PHHDASTFTINIALNR.5|SQVVFSAEELIYPDRR.3|LWSNFWGALSADGYYAR.2|YPVVSDGK.2|NMGADLC[CAM]R.2|LTHYHEGLPTTR.3|LTHYHEGLPTTR.2|LFIHNHEQHHK.3|LFIHNHEQHHK.2|GELQSSDLFHHSK.3|GELQSSDLFHHSK.2|SAQFFNYK.2|IFLDPEKR.2|NVIAPLMTR.2|LYPGYYTR.2|TTHLHNDLWEVFSNPEDWK.4|TTHLHNDLWEVFSNPEDWK.3|TTHLHNDLWEVFSNPEDWK.2|RFLGSGGFIGYAPNLSK.3|LVAEWEGQDSDSDQLFYTK.3|LVAEWEGQDSDSDQLFYTK.2|SQVVFSAEELIYPDR.2
SEN / CTL,Q9UBX5,Fibulin-5,FBLN5,1.87,0.92,2.25E-07,1.48E-07,6.83E+00,"regulation of cell growth,cell-matrix adhesion,extracellular matrix organization,protein localization to cell surface,secretion,elastic fiber assembly,regulation of removal of superoxide radicals","integrin binding,calcium ion binding,protein binding,protein C-terminus binding,protein homodimerization activity","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular matrix,extracellular exosome,elastic fiber",15,9,10,YPGAYYIFQIK.2|SVPADIFQMQATTR.2|DQPFTILYR.2|IYVSQYPF.2|QSGQC[CAM]LDIDEC[CAM]R.2|DMDVVSGR.2|SC[CAM]QDINEC[CAM]EHR.3|C[CAM]MC[CAM]PAENPGC[CAM]R.2|GPYSNPYSTPYSGPYPAAAPPLSAPNYPTISRPLIC[CAM]R.5|GPYSNPYSTPYSGPYPAAAPPLSAPNYPTISRPLIC[CAM]R.4
SEN / CTL,P26447,Protein S100-A4,S100A4,1.87,1.06,6.38E-03,1.85E-03,2.73E+00,"epithelial to mesenchymal transition,positive regulation of I-kappaB kinase/NF-kappaB signaling","actin binding,calcium ion binding,protein binding,identical protein binding,poly(A) RNA binding,calcium-dependent protein binding,RAGE receptor binding","extracellular space,nucleus,neuron projection,perinuclear region of cytoplasm,extracellular exosome",6,6,10,ALDVMVSTFHK.3|ALDVMVSTFHK.2|ALDVM[Oxi]VSTFHK.3|ALDVM[Oxi]VSTFHK.2|ELPSFLGK.2|TDEAAFQK.2|LMSNLDSNR.2|LM[Oxi]SNLDSNR.2|RTDEAAFQK.2|YSGKEGDKFK.2
SEN / CTL,P34096,Ribonuclease 4,RNASE4,1.86,0.24,5.34E-03,1.59E-03,2.80E+00,"mRNA cleavage,RNA phosphodiester bond hydrolysis, endonucleolytic","nucleic acid binding,endonuclease activity,ribonuclease A activity,ribonuclease activity","extracellular region,extracellular exosome",3,5,6,RVVIAC[CAM]EGNPQVPVHFDG.3|RFNTFIHEDIWNIR.4|RFNTFIHEDIWNIR.3|MNC[CAM]HEGVVK.2|SIC[CAM]STTNIQC[CAM]K.2|VVIAC[CAM]EGNPQVPVHFDG.2
SEN / CTL,Q08431,Lactadherin,MFGE8,1.86,1.30,1.53E-08,1.29E-08,7.89E+00,"angiogenesis,phagocytosis, recognition,phagocytosis, engulfment,cell adhesion,single fertilization,viral process,cellular protein metabolic process,positive regulation of apoptotic cell clearance","phosphatidylserine binding,integrin binding,phosphatidylethanolamine binding","extracellular region,extracellular space,external side of plasma membrane,membrane,extrinsic component of plasma membrane,extracellular exosome,extracellular vesicle,extracellular matrix",27,15,19,VTFLGLQHWVPELAR.3|VTFLGLQHWVPELAR.2|TWGLHLFSWNPSYAR.3|NFGSVQFVASYK.2|NAVHVNLFETPVEAQYVR.3|NAVHVNLFETPVEAQYVR.2|NLFETPILAR.2|MWVTGVVTQGASR.2|AGM[Oxi]VNAWTPSSNDDNPWIQVNLLR.3|EVTGIITQGAR.2|LASHEYLK.2|LYPTSC[CAM]HTAC[CAM]TLR.3|VAYSLNGHEFDFIHDVNKK.4|VAYSLNGHEFDFIHDVNKK.3|NPC[CAM]HNGGLC[CAM]EEISQEVR.3|NPC[CAM]HNGGLC[CAM]EEISQEVR.2|GDVFPSYTC[CAM]TC[CAM]LK.2|C[CAM]VEPLGMENGNIANSQIAASSVR.3|FELLGC[CAM]ELNGC[CAM]ANPLGLK.2
SEN / CTL,P35579,Myosin-9,MYH9,1.85,1.20,1.89E-50,2.87E-49,4.85E+01,"meiotic spindle organization,cytokinesis,angiogenesis,in utero embryonic development,establishment of T cell polarity,membrane protein ectodomain proteolysis,phagocytosis, engulfment,integrin-mediated signaling pathway,myoblast fusion,regulation of cell shape,protein transport,actin filament-based movement,platelet formation,monocyte differentiation,actomyosin structure organization,actin cytoskeleton reorganization,uropod organization,blood vessel endothelial cell migration,leukocyte migration,establishment of meiotic spindle localization,platelet aggregation,negative regulation of actin filament severing,positive regulation of protein processing in phagocytic vesicle","microfilament motor activity,motor activity,actin binding,protein binding,calmodulin binding,ATP binding,ATPase activity,protein domain specific binding,actin-dependent ATPase activity,protein homodimerization activity,protein anchor,ADP binding,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","stress fiber,ruffle,uropod,nucleus,cytoplasm,spindle,actomyosin contractile ring,cytosol,plasma membrane,brush border,cell-cell adherens junction,actin cytoskeleton,membrane,myosin II complex,extracellular matrix,cell leading edge,neuromuscular junction,cleavage furrow,actomyosin,protein complex,extracellular exosome,myosin II filament,immunological synapse,focal adhesion,COP9 signalosome,integrin complex",186,243,483,ALELDSNLYR.2|TRLQQELDDLLVDLDHQR.4|TRLQQELDDLLVDLDHQR.3|IAQLEEQLDNETKER.3|IAQLEEQLDNETKER.2|LQQELDDLLVDLDHQR.3|LQQELDDLLVDLDHQR.2|KLEGDSTDLSDQIAELQAQIAELK.3|KLEGDSTDLSDQIAELQAQIAELK.4|VSHLLGINVTDFTR.3|VSHLLGINVTDFTR.2|ALEEAMEQKAELER.3|ALEEAMEQKAELER.2|ALEEAM[Oxi]EQKAELER.3|ALEEAM[Oxi]EQKAELER.2|VISGVLQLGNIVFKK.3|VISGVLQLGNIVFKK.2|QLLQANPILEAFGNAK.2|QLLQANPILEAFGNAK.3|ANLQIDQINTDLNLER.2|ANLQIDQINTDLNLER.3|KLEEEQIILEDQNC[CAM]K.3|KLEEEQIILEDQNC[CAM]K.2|VIQYLAYVASSHK.3|VIQYLAYVASSHK.2|ALEQQVEEMKTQLEELEDELQATEDAKLR.4|VEDMAELTC[CAM]LNEASVLHNLKER.4|IIGLDQVAGMSETALPGAFK.3|IIGLDQVAGMSETALPGAFK.2|IIGLDQVAGM[Oxi]SETALPGAFK.3|IIGLDQVAGM[Oxi]SETALPGAFK.2|IRELESQISELQEDLESER.3|IRELESQISELQEDLESER.4|IRELESQISELQEDLESER.2|KANLQIDQINTDLNLER.3|KANLQIDQINTDLNLER.4|KANLQIDQINTDLNLER.2|AGKLDPHLVLDQLR.3|AGKLDPHLVLDQLR.2|ELESQISELQEDLESER.3|ELESQISELQEDLESER.2|IAQLEEELEEEQGNTELINDRLK.3|IAQLEEELEEEQGNTELINDRLK.4|LQVELDNVTGLLSQSDSK.3|LQVELDNVTGLLSQSDSK.2|RKLEGDSTDLSDQIAELQAQIAELK.4|RKLEGDSTDLSDQIAELQAQIAELK.3|DLGEELEALKTELEDTLDSTAAQQELR.4|DLGEELEALKTELEDTLDSTAAQQELR.3|MEDSVGC[CAM]LETAEEVKR.3|M[Oxi]EDSVGC[CAM]LETAEEVKR.3|SMEAEMIQLQEELAAAER.3|SMEAEMIQLQEELAAAER.2|SM[Oxi]EAEMIQLQEELAAAER.3|SMEAEM[Oxi]IQLQEELAAAER.3|SM[Oxi]EAEMIQLQEELAAAER.2|SMEAEM[Oxi]IQLQEELAAAER.2|MQQNIQELEEQLEEEESAR.3|MQQNIQELEEQLEEEESAR.2|M[Oxi]QQNIQELEEQLEEEESAR.3|M[Oxi]QQNIQELEEQLEEEESAR.2|EMEAELEDER.2|EM[Oxi]EAELEDER.2|VISGVLQLGNIVFK.2|VISGVLQLGNIVFK.3|IMGIPEEEQMGLLR.2|IMGIPEEEQMGLLR.3|IM[Oxi]GIPEEEQMGLLR.2|IMGIPEEEQM[Oxi]GLLR.2|IM[Oxi]GIPEEEQM[Oxi]GLLR.2|ALEQQVEEMKTQLEELEDELQATEDAK.4|ALEQQVEEMKTQLEELEDELQATEDAK.3|ALEQQVEEM[Oxi]KTQLEELEDELQATEDAK.3|LKKLEEEQIILEDQNC[CAM]K.4|LKKLEEEQIILEDQNC[CAM]K.3|LKKLEEEQIILEDQNC[CAM]K.2|ELEDATETADAMNR.2|ELEDATETADAMNR.3|ELEDATETADAM[Oxi]NR.2|NMDPLNDNIATLLHQSSDKFVSELWKDVDR.5|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWKDVDR.5|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWKDVDR.4|NMDPLNDNIATLLHQSSDKFVSELWKDVDR.4|KTLEEEAKTHEAQIQEMR.4|KTLEEEAKTHEAQIQEM[Oxi]R.4|KTLEEEAKTHEAQIQEMR.3|ELEDATETADAMNREVSSLK.3|ELEDATETADAM[Oxi]NREVSSLK.3|QIATLHAQVADMK.3|QIATLHAQVADMK.2|QIATLHAQVADM[Oxi]K.3|QIATLHAQVADM[Oxi]K.2|KEEELQAALAR.3|KEEELQAALAR.2|NLPIYSEEIVEMYK.2|NLPIYSEEIVEMYK.3|NLPIYSEEIVEM[Oxi]YK.2|HSQAVEELAEQLEQTKR.4|HSQAVEELAEQLEQTKR.3|HSQAVEELAEQLEQTKR.2|KMEDSVGC[CAM]LETAEEVKR.4|KM[Oxi]EDSVGC[CAM]LETAEEVKR.4|KMEDSVGC[CAM]LETAEEVKR.3|KM[Oxi]EDSVGC[CAM]LETAEEVKR.3|KMEDSVGC[CAM]LETAEEVKR.2|QAQQERDELADEIANSSGK.3|QAQQERDELADEIANSSGK.4|QAQQERDELADEIANSSGK.2|TLEEEAKTHEAQIQEMR.4|TLEEEAKTHEAQIQEM[Oxi]R.4|TLEEEAKTHEAQIQEMR.3|TLEEEAKTHEAQIQEM[Oxi]R.2|FLSNGHVTIPGQQDKDMFQETMEAMR.4|FLSNGHVTIPGQQDKDM[Oxi]FQETMEAM[Oxi]R.4|FLSNGHVTIPGQQDKDM[Oxi]FQETMEAMR.4|FLSNGHVTIPGQQDKDMFQETM[Oxi]EAMR.4|FLSNGHVTIPGQQDKDMFQETMEAM[Oxi]R.4|FLSNGHVTIPGQQDKDMFQETMEAMR.3|DFSALESQLQDTQELLQEENR.3|DFSALESQLQDTQELLQEENR.4|DFSALESQLQDTQELLQEENRQK.3|DFSALESQLQDTQELLQEENRQK.4|IAEFTTNLTEEEEKSK.3|IAEFTTNLTEEEEKSK.2|KAGKLDPHLVLDQLR.4|KAGKLDPHLVLDQLR.3|KAGKLDPHLVLDQLR.2|ASREEILAQAK.3|ASREEILAQAK.2|DLEAHIDSANK.3|DLEAHIDSANK.2|KVIQYLAYVASSHK.4|KVIQYLAYVASSHK.3|LKDVLLQVDDERR.4|LKDVLLQVDDERR.3|LKDVLLQVDDERR.2|NKHEAM[Oxi]ITDLEER.4|NKHEAMITDLEER.3|NKHEAM[Oxi]ITDLEER.3|NKHEAM[Oxi]ITDLEER.2|NKHEAMITDLEER.2|QLAAENR.2|TDLLLEPYNK.3|TDLLLEPYNK.2|RHEMPPHIYAITDTAYR.5|RHEM[Oxi]PPHIYAITDTAYR.4|RHEMPPHIYAITDTAYR.4|RHEM[Oxi]PPHIYAITDTAYR.3|RHEMPPHIYAITDTAYR.3|RHEMPPHIYAITDTAYR.2|THEAQIQEMR.3|THEAQIQEM[Oxi]R.3|THEAQIQEMR.2|THEAQIQEM[Oxi]R.2|TLEEEAK.2|GALALEEK.2|QVEDEKNSFR.3|QVEDEKNSFR.2|REQEVNILKK.3|SVHELEK.2|VKLQEMEGTVK.3|VKLQEM[Oxi]EGTVK.3|VKLQEMEGTVK.2|VKLQEM[Oxi]EGTVK.2|VRTELADKVTK.3|DQGELER.2|VEAQLQELQVK.3|VEAQLQELQVK.2|ASREEILAQAKENEK.4|ASREEILAQAKENEK.3|GELANEVK.2|KFDQLLAEEKTISAK.4|KFDQLLAEEKTISAK.3|KFDQLLAEEKTISAK.2|NAEQYKDQADKASTR.4|NAEQYKDQADKASTR.3|DC[CAM]MRELDDTR.3|KLEMDLK.2|KQELEEIC[CAM]HDLEAR.4|KQELEEIC[CAM]HDLEAR.3|KQELEEIC[CAM]HDLEAR.2|LRLEVNLQAM[Oxi]K.3|LRLEVNLQAMK.3|LRLEVNLQAMK.2|LRLEVNLQAM[Oxi]K.2|NAEQYKDQADK.3|NAEQYKDQADK.2|DELADEIANSSGK.3|DELADEIANSSGK.2|HEAMITDLEER.3|HEAM[Oxi]ITDLEER.3|HEAMITDLEER.2|HEAM[Oxi]ITDLEER.2|QLEEAEEEAQR.3|QLEEAEEEAQR.2|SKREQEVNILK.3|ASITALEAK.2|DVLLQVDDERR.3|DVLLQVDDERR.2|FVSELWK.2|KGAGDGSDEEVDGK.3|LKNKHEAMITDLEER.4|LKNKHEAM[Oxi]ITDLEER.4|LKNKHEAM[Oxi]ITDLEER.3|LKNKHEAMITDLEER.3|LKNKHEAMITDLEER.2|QKHSQAVEELAEQLEQTKR.5|QKHSQAVEELAEQLEQTKR.4|QKHSQAVEELAEQLEQTKR.3|RALEQQVEEMK.3|RALEQQVEEM[Oxi]K.3|RALEQQVEEMK.2|RALEQQVEEM[Oxi]K.2|VEEEAAQK.2|DLEGLSQR.2|EM[Oxi]EAELEDERK.3|EMEAELEDERK.3|EMEAELEDERK.2|EM[Oxi]EAELEDERK.2|EQLEEEEEAKHNLEK.4|EQLEEEEEAKHNLEK.3|EQLEEEEEAKHNLEK.2|TVGQLYKEQLAK.3|TVGQLYKEQLAK.2|VVFQEFR.2|KVEAQLQELQVK.3|KVEAQLQELQVK.2|LVWVPSDK.2|SGFEPASLK.2|SKYKASITALEAK.3|KTLEEEAK.2|LRRGDLPFVVPR.3|QSAC[CAM]NLEK.2|ADGAEAKPAE.2|AKQTLENERGELANEVK.4|AKQTLENERGELANEVK.3|DLQGRDEQSEEK.3|DLQGRDEQSEEK.2|HEM[Oxi]PPHIYAITDTAYR.4|HEMPPHIYAITDTAYR.4|HEMPPHIYAITDTAYR.3|HEM[Oxi]PPHIYAITDTAYR.3|HEMPPHIYAITDTAYR.2|LKDVLLQVDDER.3|LKDVLLQVDDER.2|QAC[CAM]VLMIK.2|QAC[CAM]VLM[Oxi]IK.2|VNKDDIQK.2|EQEVNILK.2|KDQGELER.2|RNAEQYKDQADK.3|VLLQGKGDSEHKR.3|VLLQGKGDSEHKR.2|DLEAHIDSANKNR.3|GALALEEKR.2|LKQVEDEK.2|LQRELEDATETADAMNR.4|LQRELEDATETADAMNR.3|RQLEEAEEEAQR.3|RQLEEAEEEAQR.2|YRFLSNGHVTIPGQQDK.4|YRFLSNGHVTIPGQQDK.3|GDLPFVVPR.2|KKLEMDLK.2|LKQVEDEKNSFR.3|LKQVEDEKNSFR.2|QLEEAEEEAQRANASRR.4|RQLEEAEEEAQRANASR.4|RQLEEAEEEAQRANASR.3|TELADKVTK.2|TFHIFYYLLSGAGEHLK.4|TFHIFYYLLSGAGEHLK.3|TFHIFYYLLSGAGEHLK.2|C[CAM]QHLQAEK.2|TDLLLEPYNKYR.3|TDLLLEPYNKYR.2|IAQLEEQLDNETK.3|IAQLEEQLDNETK.2|KKVEAQLQELQVK.3|KKVEAQLQELQVK.2|ALEEAMEQK.2|ALEEAM[Oxi]EQK.2|KLEMDLKDLEAHIDSANK.4|KLKDVLLQVDDER.3|LEVNLQAMK.2|LEVNLQAM[Oxi]K.2|LQEMEGTVK.2|LQEM[Oxi]EGTVK.2|QIATLHAQVADM[Oxi]KK.3|QIATLHAQVADMKK.3|QIATLHAQVADMKK.2|QKHSQAVEELAEQLEQTK.4|QKHSQAVEELAEQLEQTK.3|QKHSQAVEELAEQLEQTK.2|QRYEILTPNSIPK.3|QRYEILTPNSIPK.2|VAAYDKLEK.2|VKPLLQVSR.2|FDQLLAEEKTISAK.3|QFRTEMEDLMSSKDDVGK.4|QFRTEMEDLMSSKDDVGK.3|KLVWVPSDK.2|KVEAQLQELQVKFNEGER.4|QFRTEMEDLMSSK.3|QGFPNRVVFQEFR.3|TENTKKVIQYLAYVASSHK.4|EQEVNILKK.2|FLSNGHVTIPGQQDK.3|FLSNGHVTIPGQQDK.2|IAEFTTNLTEEEEK.3|IAEFTTNLTEEEEK.2|KRHEMPPHIYAITDTAYR.4|KRHEM[Oxi]PPHIYAITDTAYR.4|KRHEMPPHIYAITDTAYR.3|QELEEIC[CAM]HDLEAR.3|QELEEIC[CAM]HDLEAR.2|NFINNPLAQADWAAK.3|NFINNPLAQADWAAK.2|REQEVNILK.2|RQAQQERDELADEIANSSGK.4|RQAQQERDELADEIANSSGK.3|TEM[Oxi]EDLMSSKDDVGK.3|TEMEDLM[Oxi]SSKDDVGK.3|TEMEDLMSSKDDVGK.3|TEM[Oxi]EDLM[Oxi]SSKDDVGK.3|TEMEDLMSSKDDVGK.2|C[CAM]IIPNHEKK.2|QEEEMMAKEEELVK.3|QEEEM[Oxi]MAKEEELVK.3|QEEEMM[Oxi]AKEEELVK.3|QEEEMMAKEEELVK.2|AQTKEQADFAIEALAK.3|KGAGDGSDEEVDGKADGAEAKPAE.4|KGAGDGSDEEVDGKADGAEAKPAE.3|NSFREQLEEEEEAK.3|NSFREQLEEEEEAK.2|QTLENERGELANEVK.3|QTLENERGELANEVK.2|RGDLPFVVPR.2|VMQEQGTHPK.2|VM[Oxi]QEQGTHPK.2|EEVGEEAIVELVENGK.3|EEVGEEAIVELVENGK.2|FSKVEDMAELTC[CAM]LNEASVLHNLKER.5|FSKVEDMAELTC[CAM]LNEASVLHNLKER.4|LEEEQIILEDQNC[CAM]K.3|LEEEQIILEDQNC[CAM]K.2|LTEMETLQSQLMAEK.3|LTEM[Oxi]ETLQSQLMAEK.3|LTEMETLQSQLMAEK.2|LTEM[Oxi]ETLQSQLMAEK.2|LTEMETLQSQLM[Oxi]AEK.2|TEMEDLMSSK.2|TEM[Oxi]EDLMSSK.2|TEMEDLM[Oxi]SSK.2|TEM[Oxi]EDLM[Oxi]SSK.2|TFHIFYYLLSGAGEHLKTDLLLEPYNKYR.6|TFHIFYYLLSGAGEHLKTDLLLEPYNKYR.5|NSFREQLEEEEEAKHNLEK.4|VKVNKDDIQK.2|NFINNPLAQADWAAKK.3|YKASITALEAK.2|ALEQQVEEMK.2|ALEQQVEEM[Oxi]K.2|DVLLQVDDER.2|HSQAVEELAEQLEQTK.3|HSQAVEELAEQLEQTK.2|KIRELESQISELQEDLESER.4|KIRELESQISELQEDLESER.3|KM[Oxi]EDSVGC[CAM]LETAEEVK.3|KMEDSVGC[CAM]LETAEEVK.3|KMEDSVGC[CAM]LETAEEVK.2|KM[Oxi]EDSVGC[CAM]LETAEEVK.2|KMQQNIQELEEQLEEEESAR.4|KM[Oxi]QQNIQELEEQLEEEESAR.3|KMQQNIQELEEQLEEEESAR.3|QLEEAEEEAQRANASR.3|TKTRLQQELDDLLVDLDHQR.4|EQLEEEEEAK.2|GAGDGSDEEVDGK.2|IAQLEEELEEEQGNTELINDR.4|IAQLEEELEEEQGNTELINDR.3|LEGDSTDLSDQIAELQAQIAELK.4|LEGDSTDLSDQIAELQAQIAELK.3|DVDRIIGLDQVAGMSETALPGAFK.4|DVDRIIGLDQVAGM[Oxi]SETALPGAFK.3|DVDRIIGLDQVAGMSETALPGAFK.3|EEVGEEAIVELVENGKK.3|EEVGEEAIVELVENGKK.2|GAGDGSDEEVDGKADGAEAK.3|LLEDRIAEFTTNLTEEEEKSK.4|LLEDRIAEFTTNLTEEEEKSK.3|TRLQQELDDLLVDLDHQRQSAC[CAM]NLEK.5|TRLQQELDDLLVDLDHQRQSAC[CAM]NLEK.4|DLKITDVIIGFQAC[CAM]C[CAM]R.3|NLPIYSEEIVEMYKGK.3|VEEEEERC[CAM]QHLQAEK.3|YEILTPNSIPK.2|LQKDLEGLSQR.2|TELEDTLDSTAAQQELR.3|TELEDTLDSTAAQQELR.2|ELDDTRASREEILAQAK.3|EQADFAIEALAK.2|KKMEDSVGC[CAM]LETAEEVK.3|KKM[Oxi]EDSVGC[CAM]LETAEEVK.3|KKM[Oxi]QQNIQELEEQLEEEESAR.4|KKM[Oxi]QQNIQELEEQLEEEESAR.3|LQRELEDATETADAMNREVSSLK.4|LQRELEDATETADAMNREVSSLK.3|MQQNIQELEEQLEEEESARQK.4|MQQNIQELEEQLEEEESARQK.3|M[Oxi]QQNIQELEEQLEEEESARQK.3|IRELESQISELQEDLESERASR.4|VLLQGKGDSEHK.2|KQELEEIC[CAM]HDLEARVEEEEER.4|ASITALEAKIAQLEEQLDNETKER.4|KDQGELERQLLQANPILEAFGNAK.4|DLEAHIDSANKNRDEAIK.3|KMQQNIQELEEQLEEEESARQK.4|KMQQNIQELEEQLEEEESARQK.3|AQFERDLQGRDEQSEEK.3|DMFQETMEAMR.2|DMFQETM[Oxi]EAMR.2|DMFQETMEAM[Oxi]R.2|LEEEQIILEDQNC[CAM]KLAK.3|TVGQLYKEQLAKLMATLR.3|DVLLQVDDERRNAEQYK.3|PAGPPGILALLDEEC[CAM]WFPK.3|PAGPPGILALLDEEC[CAM]WFPK.2|SGFEPASLKEEVGEEAIVELVENGKK.4|SGFEPASLKEEVGEEAIVELVENGKK.3|IAQLEEELEEEQGNTELINDRLKK.4|IAQLEEELEEEQGNTELINDRLKK.3|KEEELQAALARVEEEAAQK.3|LTKDFSALESQLQDTQELLQEENR.4|LTKDFSALESQLQDTQELLQEENR.3|NM[Oxi]DPLNDNIATLLHQSSDK.3|NMDPLNDNIATLLHQSSDK.3|NM[Oxi]DPLNDNIATLLHQSSDK.2|NMDPLNDNIATLLHQSSDK.2|DLEGLSQRHEEK.2|GAGDGSDEEVDGKADGAEAKPAE.3|GAGDGSDEEVDGKADGAEAKPAE.2|LQQELDDLLVDLDHQRQSAC[CAM]NLEK.4|LQQELDDLLVDLDHQRQSAC[CAM]NLEK.3|SMM[Oxi]QDREDQSILC[CAM]TGESGAGKTENTK.4|SMMQDREDQSILC[CAM]TGESGAGKTENTK.4|SMMQDREDQSILC[CAM]TGESGAGKTENTK.3|KLEEEQIILEDQNC[CAM]KLAK.3|QAQQERDELADEIANSSGKGALALEEK.4|QAQQERDELADEIANSSGKGALALEEK.3|TELADKVTKLQVELDNVTGLLSQSDSK.4|TELADKVTKLQVELDNVTGLLSQSDSK.3|NMDPLNDNIATLLHQSSDKFVSELWK.4|NM[Oxi]DPLNDNIATLLHQSSDKFVSELWK.4|NMDPLNDNIATLLHQSSDKFVSELWK.3|LKSMEAEMIQLQEELAAAER.3|SMMQDREDQSILC[CAM]TGESGAGK.3|SM[Oxi]MQDREDQSILC[CAM]TGESGAGK.3|SMM[Oxi]QDREDQSILC[CAM]TGESGAGK.3|SMMQDREDQSILC[CAM]TGESGAGK.2|ITDVIIGFQAC[CAM]C[CAM]R.2|LTKDFSALESQLQDTQELLQEENRQK.4|LTKDFSALESQLQDTQELLQEENRQK.3|AGVLAHLEEERDLKITDVIIGFQAC[CAM]C[CAM]R.4|ELESQISELQEDLESERASR.3|NTDQASM[Oxi]PDNTAAQKVSHLLGINVTDFTR.4|NTDQASM[Oxi]PDNTAAQKVSHLLGINVTDFTR.3|INFDVNGYIVGANIETYLLEK.3|INFDVNGYIVGANIETYLLEK.2|RDLGEELEALKTELEDTLDSTAAQQELR.4|RDLGEELEALKTELEDTLDSTAAQQELR.3|YLYVDKNFINNPLAQADWAAK.3|RALEQQVEEMKTQLEELEDELQATEDAK.4|DFSALESQLQDTQELLQEENRQKLSLSTK.4|DFSALESQLQDTQELLQEENRQKLSLSTK.3|LQLQEQLQAETELC[CAM]AEAEELR.3|MEDSVGC[CAM]LETAEEVK.2|M[Oxi]EDSVGC[CAM]LETAEEVK.2|QLAAENRLTEMETLQSQLMAEK.3|DQGELERQLLQANPILEAFGNAK.3|SGFEPASLKEEVGEEAIVELVENGK.3|LQLQEQLQAETELC[CAM]AEAEELRAR.3
SEN / CTL,P16949,Stathmin,STMN1,1.84,1.45,1.12E-01,2.42E-02,1.62E+00,"mitotic cytokinesis,microtubule depolymerization,mitotic spindle organization,signal transduction,axonogenesis,brain development,response to virus,negative regulation of microtubule polymerization,neuron projection development,intracellular signal transduction,positive regulation of cellular component movement,regulation of cytoskeleton organization","signal transducer activity,tubulin binding","intracellular,cytoplasm,cytosol,microtubule,membrane,neuron projection,extracellular exosome",3,18,24,ASGQAFELILSPR.2|ASGQAFELILSPR.3|DLSLEEIQKK.3|DLSLEEIQKK.2|LEAAEER.2|REHEKEVLQK.3|KKDLSLEEIQK.3|KKDLSLEEIQK.2|HIEEVRK.2|SHEAEVLK.2|KLEAAEER.2|NKESKDPADETEAD.3|NKESKDPADETEAD.2|RASGQAFELILSPR.3|RASGQAFELILSPR.2|SKESVPEFPLSPPK.3|SKESVPEFPLSPPK.2|KSHEAEVLK.2|DLSLEEIQK.2|EHEKEVLQK.2|ENREAQMAAK.2|AIEENNNFSK.2|ESKDPADETEAD.2|ESVPEFPLSPPK.2
SEN / CTL,P07910,Heterogeneous nuclear ribonucleoproteins C1/C2,HNRNPC,1.84,1.24,3.19E-03,9.93E-04,3.00E+00,"mRNA splicing, via spliceosome,osteoblast differentiation,RNA splicing,gene expression,protein sumoylation,negative regulation of telomere maintenance via telomerase,ATP-dependent chromatin remodeling,3'-UTR-mediated mRNA stabilization","nucleotide binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,RNA binding,mRNA 3'-UTR binding,protein binding,poly(U) RNA binding,nucleosomal DNA binding,identical protein binding,poly(A) RNA binding,telomerase RNA binding,N6-methyladenosine-containing RNA binding","nuclear chromatin,nucleus,nucleoplasm,spliceosomal complex,cytosol,membrane,protein complex,extracellular exosome,catalytic step 2 spliceosome,telomerase holoenzyme complex",6,30,47,GFAFVQYVNER.2|GFAFVQYVNER.3|VFIGNLNTLVVK.2|VFIGNLNTLVVK.3|LKGDDLQAIKK.3|LKGDDLQAIKK.2|NDKSEEEQSSSSVKK.4|NDKSEEEQSSSSVKK.3|NDKSEEEQSSSSVKK.2|AAVAGEDGR.2|GDDLQAIK.2|MYSYPAR.2|SEEEQSSSSVKK.3|SEEEQSSSSVKK.2|IVGC[CAM]SVHK.2|QKVDSLLENLEKIEK.4|QKVDSLLENLEKIEK.3|QKVDSLLENLEK.3|QKVDSLLENLEK.2|VPPPPPIAR.2|VFIGNLNTLVVKK.3|GDDLQAIKK.2|SDVEAIFSK.2|SEEEQSSSSVKKDETNVK.4|SEEEQSSSSVKKDETNVK.3|GDDQLELIK.2|NDKSEEEQSSSSVK.3|NDKSEEEQSSSSVK.2|EAEEGEDDR.2|LKGDDLQAIK.2|QAVEMKNDKSEEEQSSSSVK.4|QAVEM[Oxi]KNDKSEEEQSSSSVK.4|QAVEMKNDKSEEEQSSSSVK.3|QAVEMKNDKSEEEQSSSSVK.2|KSDVEAIFSK.2|M[Oxi]IAGQVLDINLAAEPK.3|MIAGQVLDINLAAEPK.3|MIAGQVLDINLAAEPK.2|M[Oxi]IAGQVLDINLAAEPK.2|VDSLLENLEK.2|SEEEQSSSSVK.2|GDDQLELIKDDEK.2|AAVAGEDGRM[Oxi]IAGQVLDINLAAEPK.3|RSAAEMYGSVTEHPSPSPLLSSSFDLDYDFQRDYYDR.5|RSAAEMYGSVTEHPSPSPLLSSSFDLDYDFQR.4|RSAAEMYGSVTEHPSPSPLLSSSFDLDYDFQR.3|EAEEGEDDRDSANGEDDS.2
SEN / CTL,Q99439,Calponin-2,CNN2,1.83,0.52,1.03E-09,9.91E-10,9.00E+00,"cytoskeleton organization,actomyosin structure organization,regulation of actin filament-based process,cellular response to mechanical stimulus,cell-cell adhesion","actin binding,calmodulin binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoskeleton,cell-cell junction,cell-cell adherens junction,focal adhesion,membrane,extracellular exosome",15,17,33,TWIEGLTGLSIGPDFQK.2|TWIEGLTGLSIGPDFQK.3|GLKDGTILC[CAM]TLMNK.3|GLKDGTILC[CAM]TLMNK.2|SMQNWHQLENLSNFIK.3|SM[Oxi]QNWHQLENLSNFIK.3|SM[Oxi]QNWHQLENLSNFIK.2|SMQNWHQLENLSNFIK.2|LLSKYDPQKEAELR.4|TKGLQSGVDIGVK.3|TKGLQSGVDIGVK.2|C[CAM]ASQVGMTAPGTR.3|C[CAM]ASQVGMTAPGTR.2|C[CAM]ASQVGM[Oxi]TAPGTR.2|C[CAM]ASQSGMTAYGTR.3|C[CAM]ASQSGMTAYGTR.2|C[CAM]ASQSGM[Oxi]TAYGTR.2|NFDDATMK.2|C[CAM]ASQVGMTAPGTRR.3|GLQSGVDIGVK.2|GPSYGLSAEVK.2|NHILPPMDHSTISLQMGTNK.4|NHILPPM[Oxi]DHSTISLQMGTNK.4|NHILPPMDHSTISLQM[Oxi]GTNK.4|NHILPPMDHSTISLQMGTNK.3|NHILPPMDHSTISLQMGTNK.2|DGTILC[CAM]TLMNK.2|DGTILC[CAM]TLM[Oxi]NK.2|AGQC[CAM]VIGLQMGTNK.2|AGQC[CAM]VIGLQM[Oxi]GTNK.2|C[CAM]DNSSMSLQMGYTQGANQSGQVFGLGR.3|YC[CAM]PQGTVADGAPSGTGDC[CAM]PDPGEVPEYPPYYQEEAGY.4|LGTDKC[CAM]DNSSMSLQMGYTQGANQSGQVFGLGR.3
SEN / CTL,Q9Y2B0,Protein canopy homolog 2,CNPY2,1.82,0.62,1.30E-04,5.90E-05,4.23E+00,"enzyme linked receptor protein signaling pathway,tissue development,negative regulation of gene expression,regulation of low-density lipoprotein particle clearance,positive regulation of low-density lipoprotein particle receptor biosynthetic process",protein binding,"endoplasmic reticulum,integral component of plasma membrane",6,15,27,SEAHLTELLEEIC[CAM]DR.3|SEAHLTELLEEIC[CAM]DR.2|INPDGSQSVVEVPYAR.2|INPDGSQSVVEVPYAR.3|SQDLHC[CAM]GAC[CAM]R.3|SQDLHC[CAM]GAC[CAM]R.2|MKEYGEQIDPSTHR.4|MKEYGEQIDPSTHR.3|MKEYGEQIDPSTHRK.4|MKEYGEQIDPSTHRK.3|TIQMGSFR.2|NGESSELDLQGIR.3|NGESSELDLQGIR.2|EYGEQIDPSTHR.3|EYGEQIDPSTHR.2|RTDLC[CAM]DHALHISHDEL.4|RTDLC[CAM]DHALHISHDEL.3|RTDLC[CAM]DHALHISHDEL.2|EYGEQIDPSTHRK.3|EYGEQIDPSTHRK.2|IDSDISGTLK.2|TDLC[CAM]DHALHISHDEL.3|TDLC[CAM]DHALHISHDEL.2|ALVDELEWEIAQVDPK.3|ALVDELEWEIAQVDPK.2|ALVDELEWEIAQVDPKK.3|NGESSELDLQGIRIDSDISGTLK.3
SEN / CTL,P28066,Proteasome subunit alpha type-5,PSMA5,1.82,0.42,1.78E-02,4.65E-03,2.33E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",3,17,34,LFQVEYAIEAIK.2|LFQVEYAIEAIK.3|PFGVALLFGGVDEK.3|PFGVALLFGGVDEK.2|AIGSASEGAQSSLQEVYHK.4|AIGSASEGAQSSLQEVYHK.3|AIGSASEGAQSSLQEVYHK.2|EELEEVIK.2|GVNTFSPEGR.2|RITSPLMEPSSIEK.3|RITSPLM[Oxi]EPSSIEK.3|RITSPLM[Oxi]EPSSIEK.2|RITSPLMEPSSIEK.2|GPQLFHMDPSGTFVQC[CAM]DAR.4|GPQLFHMDPSGTFVQC[CAM]DAR.3|GPQLFHM[Oxi]DPSGTFVQC[CAM]DAR.3|SEYDRGVNTFSPEGR.3|EELEEVIKDI.2|LNATNIELATVQPGQNFHM[Oxi]FTK.4|LNATNIELATVQPGQNFHMFTK.4|LNATNIELATVQPGQNFHM[Oxi]FTK.3|LNATNIELATVQPGQNFHMFTK.3|LGSTAIGIQTSEGVC[CAM]LAVEK.3|LGSTAIGIQTSEGVC[CAM]LAVEK.2|IVEIDAHIGC[CAM]AMSGLIADAK.3|IVEIDAHIGC[CAM]AM[Oxi]SGLIADAK.3|IVEIDAHIGC[CAM]AMSGLIADAK.2|ITSPLM[Oxi]EPSSIEK.2|ITSPLMEPSSIEK.2|LGSTAIGIQTSEGVC[CAM]LAVEKR.3|LNATNIELATVQPGQNFHMFTKEELEEVIK.4|LNATNIELATVQPGQNFHMFTKEELEEVIK.3|PFGVALLFGGVDEKGPQLFHMDPSGTFVQC[CAM]DAR.4|LNATNIELATVQPGQNFHMFTKEELEEVIKDI.4
SEN / CTL,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,1.82,1.06,2.60E-04,1.10E-04,3.96E+00,"epithelial cell development,acute inflammatory response,lactose biosynthetic process,galactose metabolic process,protein N-linked glycosylation,cell adhesion,binding of sperm to zona pellucida,penetration of zona pellucida,negative regulation of cell proliferation,oligosaccharide biosynthetic process,keratan sulfate biosynthetic process,extracellular matrix organization,mammary gland development,development of secondary sexual characteristics,branching morphogenesis of an epithelial tube,leukocyte migration,regulation of cellular component movement,regulation of acrosome reaction,positive regulation of epithelial cell proliferation involved in wound healing,angiogenesis involved in wound healing,positive regulation of apoptotic process involved in mammary gland involution","beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,N-acetyllactosamine synthase activity,lactose synthase activity,cytoskeletal protein binding,galactosyltransferase activity,manganese ion binding,UDP-galactosyltransferase activity","Golgi trans cisterna,Golgi membrane,extracellular space,Golgi apparatus,plasma membrane,external side of plasma membrane,membrane,integral component of membrane,basolateral plasma membrane,desmosome,glycocalyx,filopodium,brush border membrane,Golgi cisterna membrane,extracellular exosome",9,7,9,QQLDYGIYVINQAGDTIFNR.3|VAIIIPFR.2|ETMLSDGLNSLTYQVLDVQR.3|ETMLSDGLNSLTYQVLDVQR.2|HISVAMDK.2|YWLYYLHPVLQR.3|LLNVGFQEALK.2|FGFSLPYVQYFGGVSALSK.3|FGFSLPYVQYFGGVSALSK.2
SEN / CTL,Q8IUX7,Adipocyte enhancer-binding protein 1,AEBP1,1.80,1.03,1.34E-08,1.15E-08,7.94E+00,"negative regulation of transcription from RNA polymerase II promoter,skeletal system development,transcription, DNA-templated,peptide metabolic process,muscle organ development,protein processing","RNA polymerase II regulatory region sequence-specific DNA binding,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,transcription factor activity, sequence-specific DNA binding,transcription corepressor activity,carboxypeptidase activity,metallocarboxypeptidase activity,serine-type carboxypeptidase activity,calmodulin binding,zinc ion binding","extracellular space,nucleus,cytoplasm,extracellular exosome,extracellular matrix",18,9,11,YLSPDATVSTEVR.2|YTAGIHGNEVLGR.3|YTAGIHGNEVLGR.2|NPFVLGANLNGGER.2|FTGVITQGR.2|VVNEEC[CAM]PTITR.2|VTAHAEGYTPSAK.3|VTAHAEGYTPSAK.2|APAPAPEER.2|EALLTFMEQVHR.3|KGEELEEEWTPTEK.2
SEN / CTL,Q08380,Galectin-3-binding protein,LGALS3BP,1.79,0.85,2.39E-17,5.86E-17,1.62E+01,"platelet degranulation,receptor-mediated endocytosis,cellular defense response,cell adhesion,signal transduction",scavenger receptor activity,"extracellular region,proteinaceous extracellular matrix,extracellular space,membrane,platelet dense granule lumen,extracellular exosome,blood microparticle,extracellular matrix",42,23,30,SDLAVPSELALLK.2|IYTSPTWSAFVTDSSWSAR.3|IYTSPTWSAFVTDSSWSAR.2|GQWGTVC[CAM]DNLWDLTDASVVC[CAM]R.3|YSSDYFQAPSDYR.2|ELSEALGQIFDSQR.2|ELSEALGQIFDSQR.3|TLQALEFHTVPFQLLAR.3|TLQALEFHTVPFQLLAR.2|YYPYQSFQTPQHPSFLFQDKR.4|AVDTWSWGER.2|LADGGATNQGRVEIFYR.3|AAFGQGSGPIMLDEVQC[CAM]TGTEASLADC[CAM]K.3|AAFGQGSGPIMLDEVQC[CAM]TGTEASLADC[CAM]K.4|ASHEEVEGLVEK.3|ASHEEVEGLVEK.2|TIAYENK.2|IDITLSSVK.2|SQLVYQSR.2|STHTLDLSR.2|KTLQALEFHTVPFQLLAR.4|KTLQALEFHTVPFQLLAR.3|LADGGATNQGR.2|KSQLVYQSR.2|RIDITLSSVK.2|STSSFPC[CAM]PAGHFNGFR.3|STSSFPC[CAM]PAGHFNGFR.2|STHTLDLSRELSEALGQIFDSQR.4|IYTSPTWSAFVTDSSWSARK.3|YYPYQSFQTPQHPSFLFQDK.3
SEN / CTL,P30101,Protein disulfide-isomerase A3,PDIA3,1.79,1.19,6.10E-12,8.75E-12,1.11E+01,"antigen processing and presentation of peptide antigen via MHC class I,protein folding,proteolysis,protein import into nucleus,protein retention in ER lumen,signal transduction,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,cell redox homeostasis,oxidation-reduction process,positive regulation of extrinsic apoptotic signaling pathway","protein disulfide isomerase activity,cysteine-type endopeptidase activity,phospholipase C activity,protein binding,disulfide oxidoreductase activity,poly(A) RNA binding","nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,focal adhesion,cell surface,melanosome,myelin sheath,extracellular exosome",33,62,120,ELSDFISYLQR.2|ELSDFISYLQR.3|FISDKDASIVGFFDDSFSEAHSEFLK.4|FISDKDASIVGFFDDSFSEAHSEFLK.3|FLQDYFDGNLKR.2|FLQDYFDGNLKR.3|KTFSHELSDFGLESTAGEIPVVAIR.4|KTFSHELSDFGLESTAGEIPVVAIR.3|KTFSHELSDFGLESTAGEIPVVAIR.5|FVMQEEFSR.2|FVM[Oxi]QEEFSR.2|GFPTIYFSPANK.2|GFPTIYFSPANK.3|MDATANDVPSPYEVR.2|MDATANDVPSPYEVR.3|M[Oxi]DATANDVPSPYEVR.2|TFSHELSDFGLESTAGEIPVVAIR.3|TFSHELSDFGLESTAGEIPVVAIR.5|TFSHELSDFGLESTAGEIPVVAIR.4|LSKDPNIVIAK.3|LSKDPNIVIAK.2|DGEEAGAYDGPR.3|DGEEAGAYDGPR.2|FLDAGHKLNFAVASR.4|FLDAGHKLNFAVASR.3|EATNPPVIQEEKPKK.4|EATNPPVIQEEKPKK.3|DPNIVIAK.2|KFLDAGHKLNFAVASR.4|KFLDAGHKLNFAVASR.3|LNFAVASR.2|PSHLTNKFEDK.3|PSHLTNKFEDK.2|RLAPEYEAAATR.3|RLAPEYEAAATR.2|SEPIPESNDGPVK.3|SEPIPESNDGPVK.2|TEEEFKK.2|KFLDAGHK.2|KQAGPASVPLRTEEEFK.4|KQAGPASVPLRTEEEFK.3|LKGIVPLAK.2|TVAYTEQK.2|VDC[CAM]TANTNTC[CAM]NK.3|VDC[CAM]TANTNTC[CAM]NK.2|RYLKSEPIPESNDGPVK.4|RYLKSEPIPESNDGPVK.3|FEDKTVAYTEQK.3|FEDKTVAYTEQK.2|GFPTIYFSPANKK.3|GFPTIYFSPANKK.2|FVMQEEFSRDGK.3|QAGPASVPLR.2|KYEGGRELSDFISYLQR.4|KYEGGRELSDFISYLQR.3|TADGIVSHLK.2|EATNPPVIQEEKPK.3|EATNPPVIQEEKPK.2|YGVSGYPTLK.2|FIQENIFGIC[CAM]PHMTEDNK.4|FIQENIFGIC[CAM]PHMTEDNK.3|FIQENIFGIC[CAM]PHM[Oxi]TEDNK.3|FIQENIFGIC[CAM]PHM[Oxi]TEDNK.2|FIQENIFGIC[CAM]PHMTEDNK.2|IFRDGEEAGAYDGPR.3|IFRDGEEAGAYDGPR.2|PSHLTNKFEDKTVAYTEQK.4|KQAGPASVPLR.2|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.7|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.5|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDK.4|KFIQENIFGIC[CAM]PHMTEDNK.4|KFIQENIFGIC[CAM]PHM[Oxi]TEDNK.4|KFIQENIFGIC[CAM]PHMTEDNK.3|KFIQENIFGIC[CAM]PHM[Oxi]TEDNK.3|KFIQENIFGIC[CAM]PHMTEDNK.2|DASIVGFFDDSFSEAHSEFLK.4|DASIVGFFDDSFSEAHSEFLK.3|DASIVGFFDDSFSEAHSEFLK.2|QAGPASVPLRTEEEFK.3|QAGPASVPLRTEEEFK.2|TADGIVSHLKK.2|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.6|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.5|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.4|FAHTNVESLVNEYDDNGEGIILFRPSHLTNK.3|YLKSEPIPESNDGPVK.3|YLKSEPIPESNDGPVK.2|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.5|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.4|KFIQENIFGIC[CAM]PHMTEDNKDLIQGK.3|LAPEYEAAATR.2|KFISDKDASIVGFFDDSFSEAHSEFLK.5|KFISDKDASIVGFFDDSFSEAHSEFLK.4|VVVAENFDEIVNNENK.3|VVVAENFDEIVNNENK.2|QAGPASVPLRTEEEFKK.3|QAGPASVPLRTEEEFKK.2|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]K.4|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]K.4|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]K.3|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]K.3|YEGGRELSDFISYLQR.3|EATNPPVIQEEK.2|FLQDYFDGNLK.2|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]KR.4|ISDTGSAGLM[Oxi]LVEFFAPWC[CAM]GHC[CAM]KR.4|ISDTGSAGLMLVEFFAPWC[CAM]GHC[CAM]KR.3|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQK.7|FAHTNVESLVNEYDDNGEGIILFRPSHLTNKFEDKTVAYTEQK.6|FIQENIFGIC[CAM]PHMTEDNKDLIQGK.4|FIQENIFGIC[CAM]PHM[Oxi]TEDNKDLIQGK.4|FIQENIFGIC[CAM]PHMTEDNKDLIQGK.3|GEKFVMQEEFSR.2|DLLIAYYDVDYEK.2|VDC[CAM]TANTNTC[CAM]NKYGVSGYPTLK.3|FAHTNVESLVNEYDDNGEGIILFR.3|VVVAENFDEIVNNENKDVLIEFYAPWC[CAM]GHC[CAM]K.4|SEPIPESNDGPVKVVVAENFDEIVNNENK.3
SEN / CTL,O15145,Actin-related protein 2/3 complex subunit 3,ARPC3,1.79,0.14,1.92E-03,6.32E-04,3.20E+00,"movement of cell or subcellular component,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,cellular response to nerve growth factor stimulus","structural constituent of cytoskeleton,protein binding,actin filament binding","cytosol,Arp2/3 protein complex,focal adhesion,actin cytoskeleton,membrane,lamellipodium,growth cone,extracellular exosome",3,16,27,LIGNMALLPIR.2|LIGNMALLPIR.3|LIGNM[Oxi]ALLPIR.2|NYEIKNEADR.3|NYEIKNEADR.2|VFDPQNDKPSK.3|VFDPQNDKPSK.2|PANKQEDEVMR.3|PANKQEDEVM[Oxi]R.3|PANKQEDEVMR.2|AYLQQLR.2|PAYHSSLMDPDTK.3|PAYHSSLM[Oxi]DPDTK.3|PAYHSSLMDPDTK.2|WWTC[CAM]FVK.2|AYLQQLRQETGLR.3|DTDIVDEAIYYFK.3|DTDIVDEAIYYFK.2|VFDPQNDKPSKWWTC[CAM]FVK.4|ETKDTDIVDEAIYYFK.3|ETKDTDIVDEAIYYFK.2|PAYHSSLMDPDTKLIGNMALLPIR.4|EM[Oxi]YTLGITNFPIPGEPGFPLNAIYAK.3|EMYTLGITNFPIPGEPGFPLNAIYAK.3|EMYTLGITNFPIPGEPGFPLNAIYAKPANKQEDEVMR.4|EMYTLGITNFPIPGEPGFPLNAIYAKPANK.3|SQGEKEMYTLGITNFPIPGEPGFPLNAIYAK.3
SEN / CTL,P11021,78 kDa glucose-regulated protein,HSPA5,1.78,1.21,2.13E-18,5.79E-18,1.72E+01,"ER overload response,activation of signaling protein activity involved in unfolded protein response,cerebellum structural organization,cerebellar Purkinje cell layer development,substantia nigra development,positive regulation of cell migration,ER-associated ubiquitin-dependent protein catabolic process,negative regulation of transforming growth factor beta receptor signaling pathway,endoplasmic reticulum unfolded protein response,positive regulation of protein ubiquitination,protein folding in endoplasmic reticulum,maintenance of protein localization in endoplasmic reticulum,IRE1-mediated unfolded protein response,PERK-mediated unfolded protein response,ATF6-mediated unfolded protein response,cellular response to glucose starvation,negative regulation of apoptotic process,regulation of protein folding in endoplasmic reticulum,cellular response to antibiotic,cellular response to manganese ion,cellular response to interleukin-4,negative regulation of protein homodimerization activity,cell-cell adhesion,toxin transport,regulation of ATF6-mediated unfolded protein response,regulation of IRE1-mediated unfolded protein response,regulation of PERK-mediated unfolded protein response,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress","glycoprotein binding,calcium ion binding,protein binding,ATP binding,ATPase activity,enzyme binding,protein domain specific binding,ubiquitin protein ligase binding,ribosome binding,unfolded protein binding,chaperone binding,misfolded protein binding,cadherin binding involved in cell-cell adhesion","nucleus,mitochondrion,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,smooth endoplasmic reticulum,endoplasmic reticulum-Golgi intermediate compartment,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,membrane,integral component of endoplasmic reticulum membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,myelin sheath,extracellular exosome,COP9 signalosome",54,68,133,IINEPTAAAIAYGLDKR.3|IINEPTAAAIAYGLDKR.2|TKPYIQVDIGGGQTK.3|TKPYIQVDIGGGQTK.2|TKPYIQVDIGGGQTK.4|VLEDSDLKKSDIDEIVLVGGSTR.4|VLEDSDLKKSDIDEIVLVGGSTR.3|TFAPEEISAMVLTK.2|TFAPEEISAMVLTK.3|TFAPEEISAM[Oxi]VLTK.3|TFAPEEISAM[Oxi]VLTK.2|SQIFSTASDNQPTVTIK.2|SQIFSTASDNQPTVTIK.3|SQIFSTASDNQPTVTIK.4|AKFEELNMDLFR.3|AKFEELNMDLFR.2|AKFEELNM[Oxi]DLFR.3|AKFEELNM[Oxi]DLFR.2|IDTRNELESYAYSLK.3|IDTRNELESYAYSLK.2|NGRVEIIANDQGNR.3|NGRVEIIANDQGNR.2|DAGTIAGLNVMR.2|DAGTIAGLNVMR.3|DAGTIAGLNVM[Oxi]R.2|ITPSYVAFTPEGER.2|ITPSYVAFTPEGER.3|DNHLLGTFDLTGIPPAPR.3|DNHLLGTFDLTGIPPAPR.4|DNHLLGTFDLTGIPPAPR.2|ELEEIVQPIISK.2|ELEEIVQPIISK.3|EFFNGKEPSR.3|EFFNGKEPSR.2|KVTHAVVTVPAYFNDAQR.5|KVTHAVVTVPAYFNDAQR.4|KVTHAVVTVPAYFNDAQR.3|KVTHAVVTVPAYFNDAQR.2|KKELEEIVQPIISK.4|KKELEEIVQPIISK.3|KKELEEIVQPIISK.2|MKETAEAYLGK.3|MKETAEAYLGK.2|M[Oxi]KETAEAYLGK.2|MVNDAEKFAEEDKK.4|M[Oxi]VNDAEKFAEEDKK.4|MVNDAEKFAEEDKK.3|M[Oxi]VNDAEKFAEEDKK.3|MVNDAEKFAEEDKK.2|FAEEDKK.2|KTKPYIQVDIGGGQTK.4|KTKPYIQVDIGGGQTK.3|KTKPYIQVDIGGGQTK.2|LSSEDKETMEK.3|LSSEDKETMEK.2|LSSEDKETM[Oxi]EK.2|NELESYAYSLK.3|NELESYAYSLK.2|NKITITNDQNR.3|NKITITNDQNR.2|NTVVPTKK.2|MKETAEAYLGKK.3|M[Oxi]KETAEAYLGKK.3|MKETAEAYLGKK.2|M[Oxi]KETAEAYLGKK.2|VMEHFIK.2|VM[Oxi]EHFIK.2|STMKPVQK.2|VLEDSDLK.2|VTHAVVTVPAYFNDAQR.4|VTHAVVTVPAYFNDAQR.3|VTHAVVTVPAYFNDAQR.2|TWNDPSVQQDIK.3|TWNDPSVQQDIK.2|IQQLVKEFFNGKEPSR.4|SDIDEIVLVGGSTR.3|SDIDEIVLVGGSTR.2|ETAEAYLGK.2|KSQIFSTASDNQPTVTIK.4|KSQIFSTASDNQPTVTIK.3|KSQIFSTASDNQPTVTIK.2|LTPEEIER.2|ALSSQHQAR.2|KELEEIVQPIISK.3|MVNDAEKFAEEDK.3|MVNDAEKFAEEDK.2|TWNDPSVQQDIKFLPFK.4|TWNDPSVQQDIKFLPFK.3|TWNDPSVQQDIKFLPFK.2|ERIDTRNELESYAYSLK.4|ERIDTRNELESYAYSLK.3|VLEDSDLKK.2|KSDIDEIVLVGGSTR.3|KSDIDEIVLVGGSTR.2|ITITNDQNR.2|IEWLESHQDADIEDFKAK.4|IEWLESHQDADIEDFKAK.3|IEWLESHQDADIEDFKAK.2|AVEEKIEWLESHQDADIEDFKAK.5|AVEEKIEWLESHQDADIEDFKAK.4|LGGKLSSEDKETMEK.3|QATKDAGTIAGLNVMR.3|ETAEAYLGKK.2|NQLTSNPENTVFDAK.3|NQLTSNPENTVFDAK.2|IINEPTAAAIAYGLDKREGEK.4|VYEGERPLTK.2|LYGSAGPPPTGEEDTAEK.3|LYGSAGPPPTGEEDTAEK.2|NQLTSNPENTVFDAKR.3|NQLTSNPENTVFDAKR.2|VYEGERPLTKDNHLLGTFDLTGIPPAPR.5|VYEGERPLTKDNHLLGTFDLTGIPPAPR.4|LIGDAAKNQLTSNPENTVFDAKR.4|AVEEKIEWLESHQDADIEDFK.4|AVEEKIEWLESHQDADIEDFK.3|FEELNMDLFR.2|FEELNM[Oxi]DLFR.2|IEWLESHQDADIEDFK.3|IEWLESHQDADIEDFK.2|GVPQIEVTFEIDVNGILR.3|ITITNDQNRLTPEEIER.3|PYIQVDIGGGQTK.2|IEIESFYEGEDFSETLTR.3|IEIESFYEGEDFSETLTR.2|LYGSAGPPPTGEEDTAEKDEL.3|LYGSAGPPPTGEEDTAEKDEL.2|ITPSYVAFTPEGERLIGDAAK.3|NELESYAYSLKNQIGDKEK.3|NKITITNDQNRLTPEEIER.3|LIGDAAKNQLTSNPENTVFDAK.3|MVNDAEK.1|KEDVGTVVGIDLGTTYSC[CAM]VGVFK.3
SEN / CTL,P06748,Nucleophosmin,NPM1,1.77,0.78,1.12E-07,7.79E-08,7.11E+00,"DNA repair,nucleosome assembly,intracellular protein transport,nucleocytoplasmic transport,response to stress,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,centrosome cycle,signal transduction,cell aging,protein localization,positive regulation of cell proliferation,negative regulation of cell proliferation,negative regulation of centrosome duplication,viral process,regulation of endodeoxyribonuclease activity,CENP-A containing nucleosome assembly,ribosome assembly,negative regulation of apoptotic process,positive regulation of catalytic activity,regulation of neuron apoptotic process,negative regulation of protein kinase activity by regulation of protein phosphorylation,positive regulation of translation,positive regulation of DNA replication,positive regulation of transcription, DNA-templated,regulation of centriole replication,positive regulation of NF-kappaB transcription factor activity,protein oligomerization,protein homooligomerization,regulation of endoribonuclease activity,regulation of eIF2 alpha phosphorylation by dsRNA,positive regulation of cell cycle G2/M phase transition","DNA binding,transcription coactivator activity,RNA binding,protein kinase inhibitor activity,protein binding,phosphatidylinositol-3,4,5-trisphosphate binding,protein kinase binding,Tat protein binding,histone binding,protein homodimerization activity,ribosomal large subunit binding,ribosomal small subunit binding,poly(A) RNA binding,protein heterodimerization activity,NF-kappaB binding,unfolded protein binding","nucleus,nucleoplasm,nucleolus,cytoplasm,centrosome,cytosol,focal adhesion,membrane,intracellular ribonucleoprotein complex,spindle pole centrosome",15,26,61,MSVQPTVSLGGFEITPPVVLR.3|MSVQPTVSLGGFEITPPVVLR.2|M[Oxi]SVQPTVSLGGFEITPPVVLR.2|MSVQPTVSLGGFEITPPVVLR.4|M[Oxi]SVQPTVSLGGFEITPPVVLR.4|M[Oxi]SVQPTVSLGGFEITPPVVLR.3|MTDQEAIQDLWQWR.2|MTDQEAIQDLWQWR.3|M[Oxi]TDQEAIQDLWQWR.3|M[Oxi]TDQEAIQDLWQWR.2|MQASIEK.2|M[Oxi]QASIEK.2|SNQNGKDSKPSSTPR.4|SNQNGKDSKPSSTPR.2|SAPGGGSKVPQKK.3|SAPGGGSKVPQKK.2|TPKGPSSVEDIK.3|RSAPGGGSKVPQK.3|ADKDYHFKVDNDENEHQLSLR.6|ADKDYHFKVDNDENEHQLSLR.5|ADKDYHFKVDNDENEHQLSLR.4|ADKDYHFKVDNDENEHQLSLR.3|SIRDTPAK.2|MQASIEKGGSLPK.3|DYHFKVDNDENEHQLSLR.5|DYHFKVDNDENEHQLSLR.4|DYHFKVDNDENEHQLSLR.3|DYHFKVDNDENEHQLSLR.2|FINYVKNC[CAM]FR.3|GPSSVEDIK.2|DSKPSSTPR.2|TPKGPSSVEDIKAK.3|TPKGPSSVEDIKAK.2|ADKDYHFK.2|VDNDENEHQLSLR.3|VDNDENEHQLSLR.2|DELHIVEAEAMNYEGSPIK.4|DELHIVEAEAM[Oxi]NYEGSPIK.3|DELHIVEAEAMNYEGSPIK.3|DELHIVEAEAM[Oxi]NYEGSPIK.2|DELHIVEAEAMNYEGSPIK.2|SAPGGGSKVPQK.2|GPSSVEDIKAK.2|TVSLGAGAKDELHIVEAEAMNYEGSPIK.5|TVSLGAGAKDELHIVEAEAMNYEGSPIK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIK.3|TVSLGAGAKDELHIVEAEAMNYEGSPIK.3|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.6|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.6|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.5|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.5|TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK.4|TVSLGAGAKDELHIVEAEAM[Oxi]NYEGSPIKVTLATLK.4|MTDQEAIQDLWQWRK.3|M[Oxi]TDQEAIQDLWQWRK.3|MTDQEAIQDLWQWRK.2|NAQKSNQNGKDSKPSSTPR.3|PQNYLFGC[CAM]ELK.2|DELHIVEAEAMNYEGSPIKVTLATLK.4|DELHIVEAEAMNYEGSPIKVTLATLK.3
SEN / CTL,P61916,Epididymal secretory protein E1,NPC2,1.75,1.04,5.54E-04,2.14E-04,3.67E+00,"cholesterol metabolic process,response to virus,phospholipid transport,regulation of isoprenoid metabolic process,cholesterol transport,intracellular sterol transport,intracellular cholesterol transport,cholesterol efflux,cholesterol homeostasis,glycolipid transport","protein binding,cholesterol binding,enzyme binding","lysosome,endoplasmic reticulum,extracellular exosome",9,12,19,DC[CAM]GSVDGVIKEVNVSPC[CAM]PTQPC[CAM]QLSK.3|AVVHGILMGVPVPFPIPEPDGC[CAM]K.3|AVVHGILMGVPVPFPIPEPDGC[CAM]K.4|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]K.4|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]K.3|AVVHGILMGVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.4|AVVHGILMGVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.5|AVVHGILM[Oxi]GVPVPFPIPEPDGC[CAM]KSGINC[CAM]PIQK.4|LPVKSEYPSIK.3|TYSYLNK.2|SGINC[CAM]PIQK.2|DKTYSYLNKLPVK.3|DC[CAM]GSVDGVIK.2|DKTYSYLNK.2|EVNVSPC[CAM]PTQPC[CAM]QLSK.3|EVNVSPC[CAM]PTQPC[CAM]QLSK.2|LVVEWQLQDDK.2|NQSLFC[CAM]WEIPVQIVSHL.3|NQSLFC[CAM]WEIPVQIVSHL.2
SEN / CTL,P46940,Ras GTPase-activating-like protein IQGAP1,IQGAP1,1.75,0.96,1.61E-04,7.17E-05,4.14E+00,"regulation of cytokine production,signal transduction,epidermal growth factor receptor signaling pathway,fibroblast growth factor receptor signaling pathway,negative regulation of GTPase activity,negative regulation of dephosphorylation,cellular response to platelet-derived growth factor stimulus,positive regulation of MAP kinase activity,positive regulation of GTPase activity,positive regulation of protein kinase activity,platelet-derived growth factor receptor signaling pathway,positive regulation of focal adhesion assembly,cellular response to calcium ion,cellular response to epidermal growth factor stimulus,glomerular visceral epithelial cell development,cell-cell adhesion,positive regulation of dendrite development,positive regulation of peptidyl-tyrosine autophosphorylation,positive regulation of cellular protein localization,positive regulation of vascular associated smooth muscle cell migration,neuron projection extension,response to angiotensin","GTPase inhibitor activity,GTPase activator activity,calcium ion binding,protein binding,calmodulin binding,phosphatidylinositol-3,4,5-trisphosphate binding,protein kinase binding,protein phosphatase binding,protein domain specific binding,protein complex binding,protein serine/threonine kinase activator activity,S100 protein binding,Rac GTPase binding,mitogen-activated protein kinase binding,cadherin binding involved in cell-cell adhesion","ruffle,nucleus,cytoplasm,cytosol,microtubule,actin filament,plasma membrane,cell-cell adherens junction,focal adhesion,lateral plasma membrane,axon,growth cone,midbody,extrinsic component of cytoplasmic side of plasma membrane,slit diaphragm,cytoplasmic ribonucleoprotein granule,neuron projection,protein complex,membrane raft,extracellular exosome,actin cytoskeleton,microtubule cytoskeleton",9,128,200,EQLWLANEGLITR.2|EQLWLANEGLITR.3|NKYQELINDIAR.3|NKYQELINDIAR.2|LEGVLAEVAQHYQDTLIR.3|LEGVLAEVAQHYQDTLIR.4|LEGVLAEVAQHYQDTLIR.2|ATGLHFR.2|KLTELGTVDPK.3|KLTELGTVDPK.2|RIPADTFAALK.3|RIPADTFAALK.2|TILLNTK.2|ITLQDVVSHSK.3|ITLQDVVSHSK.2|LIVDVIR.2|ELATLQR.2|MREEVITLIR.3|MREEVITLIR.2|RQSGQTDPLQK.3|RQSGQTDPLQK.2|MVVSFNR.2|LAAVALINAAIQK.3|LAAVALINAAIQK.2|LGNFFSPK.2|YLDELMK.2|LAVGDNNSK.2|TALQEEIK.2|TDPVDIYK.2|DHINDIIK.2|RLAAVALINAAIQK.3|RLAAVALINAAIQK.2|DSLHEKFPDAGEDELLK.4|DSLHEKFPDAGEDELLK.3|NKITLQDVVSHSK.3|ATFYGEQVDYYK.3|ATFYGEQVDYYK.2|GLQQQNSDWYLK.3|GLQQQNSDWYLK.2|RLIVDVIR.2|SKVDQIQEIVTGNPTVIK.4|SKVDQIQEIVTGNPTVIK.3|SKVDQIQEIVTGNPTVIK.2|MLQHAASNK.2|SLNIKTDPVDIYK.3|SLNIKTDPVDIYK.2|SVKEDSNLTLQEK.3|SVKEDSNLTLQEK.2|QNVAYEYLC[CAM]HLEEAKR.4|VNVNLLIFLLNKK.3|ALQSPALGLR.2|TC[CAM]LDNLASK.2|IPADTFAALK.2|KLAVGDNNSK.2|TLINAEDPPMVVVR.3|TLINAEDPPMVVVR.2|TLINAEDPPM[Oxi]VVVR.2|NKEQLSDMMMINK.3|NKEQLSDMMMINK.2|AKVNVNLLIFLLNK.3|LTELGTVDPK.2|QIPAITC[CAM]IQSQWR.3|QIPAITC[CAM]IQSQWR.2|RQNVAYEYLC[CAM]HLEEAKR.4|SVKEDSNLTLQEKK.3|LTAEEMDER.2|LTAEEM[Oxi]DER.2|QSGQTDPLQK.2|TEVSLTLTNK.2|AVTDKFLSAIVSSVDK.3|IFYPETTDIYDRK.3|IFYPETTDIYDRK.2|LIFQMPQNK.2|LIFQM[Oxi]PQNK.2|LQYFRDHINDIIK.3|FFQTAC[CAM]DVPELQDK.3|FFQTAC[CAM]DVPELQDK.2|IIGNLLYYR.2|TLINAEDPPMVVVRK.3|VLKDSLHEKFPDAGEDELLK.4|YGIQMPAFSK.2|YGIQM[Oxi]PAFSK.2|EEIQSSISGVTAAYNR.3|EEIQSSISGVTAAYNR.2|TLQALQIPAAK.2|FLSAIVSSVDK.2|GVLLEIEDLQVNQFK.3|GVLLEIEDLQVNQFK.2|VDQIQEIVTGNPTVIK.3|VDQIQEIVTGNPTVIK.2|EDSNLTLQEK.2|LAAVALINAAIQKGVAEK.3|QSPEHNLTHPELSVAVEMLSSVALINR.5|QSPEHNLTHPELSVAVEMLSSVALINR.4|QSPEHNLTHPELSVAVEM[Oxi]LSSVALINR.4|QSPEHNLTHPELSVAVEMLSSVALINR.3|SNQQLENDLNLMDIK.3|SNQQLENDLNLM[Oxi]DIK.2|SNQQLENDLNLMDIK.2|AVTDKFLSAIVSSVDKIPYGMR.4|AVTDKFLSAIVSSVDKIPYGM[Oxi]R.4|AVTDKFLSAIVSSVDKIPYGM[Oxi]R.3|AVTDKFLSAIVSSVDKIPYGMR.3|C[CAM]IYC[CAM]IHALSLYLFK.3|C[CAM]IYC[CAM]IHALSLYLFK.2|LEAYQHLFYLLQTNPTYLAK.4|LEAYQHLFYLLQTNPTYLAK.3|FVHLLDQSDQDFQEELDLMK.4|FVHLLDQSDQDFQEELDLMK.3|FVHLLDQSDQDFQEELDLM[Oxi]K.3|FPDAGEDELLK.2|LQQTYAALNSK.2|QNVAYEYLC[CAM]HLEEAK.3|QNVAYEYLC[CAM]HLEEAK.2|YQELINDIAR.2|FLSAIVSSVDKIPYGMR.3|FLSAIVSSVDKIPYGM[Oxi]R.3|ILAIGLINEALDEGDAQK.3|ILAIGLINEALDEGDAQK.2|FALGIFAINEAVESGDVGK.3|FALGIFAINEAVESGDVGK.2|KFVHLLDQSDQDFQEELDLMK.4|KFVHLLDQSDQDFQEELDLMK.3|LPYDVTPEQALAHEEVK.3|LPYDVTPEQALAHEEVK.2|MFLGDNAHLSIINEYLSQSYQK.4|M[Oxi]FLGDNAHLSIINEYLSQSYQK.3|MFLGDNAHLSIINEYLSQSYQK.3|PHYGSVLDNER.2|ALESGDVNTVWK.2|EKLEAYQHLFYLLQTNPTYLAK.4|EKLEAYQHLFYLLQTNPTYLAK.3|EQLSDMMMINK.2|EQLSDMMM[Oxi]INK.2|RQNVAYEYLC[CAM]HLEEAK.3|NVIFEISPTEEVGDFEVK.3|NVIFEISPTEEVGDFEVK.2|DVYEELLTQAEIQGNINK.3|DVYEELLTQAEIQGNINK.2|EELQSGVDAANSAAQQYQR.3|EELQSGVDAANSAAQQYQR.2|FM[Oxi]DSVIFTLYNYASNQR.3|FMDSVIFTLYNYASNQR.3|FMDSVIFTLYNYASNQR.2|LKAQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.6|LKAQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.5|VDFTEEEINNMKTELEK.3|VNVNLLIFLLNK.2|FQPGETLTEILETPATSEQEAEHQR.4|FQPGETLTEILETPATSEQEAEHQR.3|LGLAPQIQDLYGK.2|SPDVGLYGVIPEC[CAM]GETYHSDLAEAKK.4|QLSSSVTGLTNIEEENC[CAM]QR.3|QLSSSVTGLTNIEEENC[CAM]QR.2|TALQEEIKSKVDQIQEIVTGNPTVIK.4|TVLELMNPEAQLPQVYPFAADLYQK.4|TVLELM[Oxi]NPEAQLPQVYPFAADLYQK.3|TVLELMNPEAQLPQVYPFAADLYQK.3|HTDNVIQWLNAMDEIGLPK.3|HTDNVIQWLNAM[Oxi]DEIGLPK.3|HTDNVIQWLNAMDEIGLPK.2|VDFTEEEINNMK.2|VDFTEEEINNM[Oxi]K.2|ILAIGLINEALDEGDAQKTLQALQIPAAK.4|ILAIGLINEALDEGDAQKTLQALQIPAAK.3|DSLHEKFPDAGEDELLKIIGNLLYYR.4|IFYPETTDIYDR.2|AQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.5|AQAHAENNEFITWNDIQAC[CAM]VDHVNLVVQEEHER.4|ERDVYEELLTQAEIQGNINK.3|ERDVYEELLTQAEIQGNINK.2|FDVPGDENAEM[Oxi]DAR.2|FDVPGDENAEMDAR.2|QSGQTDPLQKEELQSGVDAANSAAQQYQR.4|QSGQTDPLQKEELQSGVDAANSAAQQYQR.3|YMNPAIVAPDAFDIIDLSAGGQLTTDQRR.4|YMNPAIVAPDAFDIIDLSAGGQLTTDQRR.3|TLQALQIPAAKLEGVLAEVAQHYQDTLIR.4|FNVDEYSDLVTLTK.2|RQSGQTDPLQKEELQSGVDAANSAAQQYQR.4|RWMEAC[CAM]LGEDLPPTTELEEGLRNGVYLAK.4|SWVNQMESQTGEASK.2|TLSALRSPDVGLYGVIPEC[CAM]GETYHSDLAEAK.4|FALGIFAINEAVESGDVGKTLSALR.3|VNTFSALANIDLALEQGDALALFR.3|LGLAPQIQDLYGKVDFTEEEINNMKTELEK.4|RWMEAC[CAM]LGEDLPPTTELEEGLR.3|TEVSLTLTNKFDVPGDENAEMDAR.3|SPDVGLYGVIPEC[CAM]GETYHSDLAEAK.3|SWVNQMESQTGEASKLPYDVTPEQALAHEEVK.4|GGYYYYHNLETQEGGWDEPPNFVQNSMQLSR.4|AQEIQDESAVLWLDEIQGGIWQSNK.3|IPADTFAALKNPNAMLVNLEEPLASTYQDILYQAK.4|LGLAPQIQDLYGKVDFTEEEINNMK.3|NPNAMLVNLEEPLASTYQDILYQAK.3|EKAQEIQDESAVLWLDEIQGGIWQSNKDTQEAQK.4|YM[Oxi]NPAIVAPDAFDIIDLSAGGQLTTDQR.3|YMNPAIVAPDAFDIIDLSAGGQLTTDQR.3|RIPADTFAALKNPNAMLVNLEEPLASTYQDILYQAK.4|IPADTFAALKNPNAMLVNLEEPLASTYQDILYQAKQDK.4
SEN / CTL,Q14393,Growth arrest-specific protein 6,GAS6,1.75,0.76,1.86E-08,1.56E-08,7.81E+00,"neuron migration,positive regulation of protein phosphorylation,positive regulation of cytokine-mediated signaling pathway,platelet degranulation,positive regulation of glomerular filtration,signal peptide processing,protein phosphorylation,ER to Golgi vesicle-mediated transport,phagocytosis,apoptotic process,cell cycle arrest,cell adhesion,signal transduction,enzyme linked receptor protein signaling pathway,cell proliferation,cellular response to starvation,positive regulation of gene expression,negative regulation of tumor necrosis factor-mediated signaling pathway,macrophage cytokine production,cell migration,peptidyl-serine phosphorylation,fusion of virus membrane with host plasma membrane,viral genome replication,platelet activation,animal organ regeneration,cell-substrate adhesion,positive regulation of TOR signaling,activation of protein kinase B activity,negative regulation of interferon-gamma production,negative regulation of interleukin-6 production,negative regulation of tumor necrosis factor production,positive regulation of natural killer cell differentiation,positive regulation of peptidyl-serine phosphorylation,negative regulation of protein import into nucleus, translocation,cellular response to interferon-alpha,cellular response to drug,B cell chemotaxis,regulation of growth,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,apoptotic cell clearance,negative regulation of sequence-specific DNA binding transcription factor activity,protein kinase B signaling,positive regulation of protein kinase activity,negative regulation of transcription, DNA-templated,viral entry into host cell,receptor-mediated virion attachment to host cell,positive regulation of protein export from nucleus,positive regulation of fibroblast proliferation,negative regulation of interleukin-1 secretion,positive regulation of phagocytosis,leukocyte migration,positive regulation of protein kinase B signaling,positive regulation of protein tyrosine kinase activity,negative regulation of biomineral tissue development,positive regulation of ERK1 and ERK2 cascade,platelet aggregation,calcium ion transmembrane transport,cellular response to vitamin K,cellular response to glucose stimulus,cellular response to growth factor stimulus,protein targeting to plasma membrane,extracellular matrix assembly,dendritic cell differentiation,hematopoietic stem cell migration to bone marrow,negative regulation of oligodendrocyte apoptotic process,negative regulation of interleukin-6 secretion,negative regulation of fibroblast apoptotic process,negative regulation of endothelial cell apoptotic process,positive regulation of dendritic cell chemotaxis,negative regulation of renal albumin absorption,negative regulation of dendritic cell apoptotic process","phosphatidylserine binding,receptor binding,voltage-gated calcium channel activity,calcium ion binding,protein binding,protein tyrosine kinase activator activity,receptor tyrosine kinase binding,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,receptor agonist activity,binding, bridging","extracellular region,extracellular space,cytoplasm,endoplasmic reticulum lumen,Golgi lumen,platelet alpha granule lumen,extracellular exosome",15,11,13,SPVLTFAGGLPDVPVTSAPVTAFYR.3|TC[CAM]QDIDEC[CAM]ADSEAC[CAM]GEAR.3|TC[CAM]QDIDEC[CAM]ADSEAC[CAM]GEAR.2|AVPLSVALVDYHSTK.3|AVPLSVALVDYHSTK.2|GQSEVSAAQLQER.2|AFQVFEEAK.2|DVDEC[CAM]LQGR.2|HSDITAHSC[CAM]PPVEPAAA.3|DGEATLEVDGTR.2|QLVVLAVEHTALALMEIK.3|NSGFATC[CAM]VQNLPDQC[CAM]TPNPC[CAM]DRK.3|GTQAC[CAM]QDLMGNFFC[CAM]LC[CAM]K.2
SEN / CTL,P60842,Eukaryotic initiation factor 4A-I,EIF4A1,1.73,1.26,1.08E-05,5.62E-06,5.25E+00,"nuclear-transcribed mRNA poly(A) tail shortening,translational initiation,regulation of translational initiation,regulation of gene expression,RNA secondary structure unwinding,viral process","RNA cap binding,double-stranded RNA binding,mRNA binding,translation initiation factor activity,ATP-dependent RNA helicase activity,helicase activity,protein binding,ATP binding,translation factor activity, RNA binding,poly(A) RNA binding","cytoplasm,cytosol,membrane,eukaryotic translation initiation factor 4F complex,extracellular matrix,extracellular exosome,nucleus",15,39,86,VLITTDLLAR.2|AEVQKLQMEAPHIIVGTPGR.4|LQMEAPHIIVGTPGR.3|LQM[Oxi]EAPHIIVGTPGR.3|LQM[Oxi]EAPHIIVGTPGR.2|LQMEAPHIIVGTPGR.2|MFVLDEADEMLSR.2|MFVLDEADEMLSR.3|M[Oxi]FVLDEADEMLSR.3|MFVLDEADEM[Oxi]LSR.3|M[Oxi]FVLDEADEMLSR.2|MFVLDEADEM[Oxi]LSR.2|M[Oxi]FVLDEADEM[Oxi]LSR.2|KGVAINM[Oxi]VTEEDKR.4|KGVAINMVTEEDKR.3|KGVAINM[Oxi]VTEEDKR.3|KGVAINMVTEEDKR.2|PSAIQQR.2|AILPC[CAM]IK.2|ILVKKEELTLEGIR.4|ILVKKEELTLEGIR.3|ILVKKEELTLEGIR.2|VDWLTEK.2|VFDMLNR.2|VFDM[Oxi]LNR.2|GYDVIAQAQSGTGK.3|GYDVIAQAQSGTGK.2|DFTVSAMHGDMDQKER.4|DFTVSAMHGDMDQKER.3|ELAQQIQK.2|GVAINMVTEEDKR.3|GVAINM[Oxi]VTEEDKR.3|GVAINMVTEEDKR.2|GVAINM[Oxi]VTEEDKR.2|GFKDQIYDIFQK.3|GFKDQIYDIFQK.2|KVDWLTEK.2|GIYAYGFEK.2|DFTVSAMHGDMDQK.3|DFTVSAM[Oxi]HGDM[Oxi]DQK.3|DFTVSAM[Oxi]HGDMDQK.3|DFTVSAMHGDM[Oxi]DQK.3|DFTVSAMHGDMDQK.2|DFTVSAM[Oxi]HGDMDQK.2|DFTVSAMHGDM[Oxi]DQK.2|EELTLEGIR.2|QFYINVER.2|QFYINVEREEWK.3|QFYINVEREEWK.2|ATQALVLAPTR.2|DQIYDIFQK.2|RKVDWLTEK.2|KEELTLEGIR.2|GIYAYGFEKPSAIQQR.3|GIYAYGFEKPSAIQQR.2|VVM[Oxi]ALGDYMGASC[CAM]HAC[CAM]IGGTNVR.4|VVMALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.4|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVR.4|VVM[Oxi]ALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.4|VVM[Oxi]ALGDYMGASC[CAM]HAC[CAM]IGGTNVR.3|VVMALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.3|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVR.3|VVM[Oxi]ALGDYM[Oxi]GASC[CAM]HAC[CAM]IGGTNVR.3|TATFAISILQQIELDLK.3|TATFAISILQQIELDLK.2|GVAINMVTEEDK.2|GVAINM[Oxi]VTEEDK.2|LNSNTQVVLLSATMPSDVLEVTKK.4|LNSNTQVVLLSATMPSDVLEVTKK.3|LNSNTQVVLLSATM[Oxi]PSDVLEVTKK.3|ATQALVLAPTRELAQQIQK.3|GIDVQQVSLVINYDLPTNR.3|GIDVQQVSLVINYDLPTNR.2|KGVAINMVTEEDK.2|GIDVQQVSLVINYDLPTNRENYIHR.4|GIDVQQVSLVINYDLPTNRENYIHR.3|VVMALGDYMGASC[CAM]HAC[CAM]IGGTNVRAEVQK.4|DIETFYNTSIEEM[Oxi]PLNVADLI.3|DIETFYNTSIEEMPLNVADLI.3|LNSNTQVVLLSATM[Oxi]PSDVLEVTK.3|LNSNTQVVLLSATMPSDVLEVTK.3|SRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.5|SRDNGPDGM[Oxi]EPEGVIESNWNEIVDSFDDMNLSESLLR.4|SRDNGPDGMEPEGVIESNWNEIVDSFDDM[Oxi]NLSESLLR.4|SRDNGPDGMEPEGVIESNWNEIVDSFDDMNLSESLLR.4|TLRDIETFYNTSIEEMPLNVADLI.3
SEN / CTL,P07602,Prosaposin,PSAP,1.73,2.11,1.24E-05,6.39E-06,5.19E+00,"platelet degranulation,glycosphingolipid metabolic process,lipid transport,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,regulation of autophagy,regulation of lipid metabolic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,prostate gland growth,epithelial cell differentiation involved in prostate gland development,cellular response to organic substance,negative regulation of hydrogen peroxide-induced cell death","G-protein coupled receptor binding,protein binding,enzyme activator activity,lipid binding","extracellular region,extracellular space,cytoplasm,mitochondrion,lysosome,lysosomal membrane,integral component of membrane,lysosomal lumen,extracellular exosome",21,30,59,EIVDSYLPVILDIIK.2|EIVDSYLPVILDIIK.3|GEMSRPGEVC[CAM]SALNLC[CAM]ESLQK.3|C[CAM]IWGPSYWC[CAM]QNTETAAQC[CAM]NAVEHC[CAM]KR.4|SDVYC[CAM]EVC[CAM]EFLVK.2|SDVYC[CAM]EVC[CAM]EFLVK.3|NVIPALELVEPIKK.3|NVIPALELVEPIKK.2|NYISQYSEIAIQMMMHMQPK.3|NYISQYSEIAIQM[Oxi]MMHMQPK.4|NYISQYSEIAIQMM[Oxi]MHMQPK.4|NYISQYSEIAIQMMM[Oxi]HMQPK.4|NYISQYSEIAIQMMMHM[Oxi]QPK.4|NYISQYSEIAIQMMMHMQPK.4|NYISQYSEIAIQM[Oxi]MM[Oxi]HMQPK.4|NYISQYSEIAIQMM[Oxi]MHM[Oxi]QPK.4|NYISQYSEIAIQM[Oxi]M[Oxi]MHM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]M[Oxi]MHMQPK.3|NYISQYSEIAIQM[Oxi]MM[Oxi]HM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]MM[Oxi]HMQPK.3|NYISQYSEIAIQM[Oxi]MMHM[Oxi]QPK.3|NYISQYSEIAIQM[Oxi]MMHMQPK.3|NYISQYSEIAIQMM[Oxi]MHM[Oxi]QPK.3|NYISQYSEIAIQMM[Oxi]MHMQPK.3|NYISQYSEIAIQMMM[Oxi]HM[Oxi]QPK.3|NYISQYSEIAIQMMM[Oxi]HMQPK.3|NYISQYSEIAIQMMMHM[Oxi]QPK.3|DGGFC[CAM]EVC[CAM]KK.3|DGGFC[CAM]EVC[CAM]KK.2|IGAC[CAM]PSAHKPLLGTEK.4|IGAC[CAM]PSAHKPLLGTEK.3|IGAC[CAM]PSAHKPLLGTEK.2|LVGYLDR.2|LPALTVHVTQPK.3|LPALTVHVTQPK.2|GC[CAM]SFLPDPYQK.3|GC[CAM]SFLPDPYQK.2|LVGYLDRNLEK.3|LVGYLDRNLEK.2|EILDAFDK.2|KLVGYLDR.2|KLVGYLDRNLEK.3|EILDAFDKMC[CAM]SK.3|SLPC[CAM]DIC[CAM]K.2|QEILAALEK.2|LGPGMADIC[CAM]K.2|LGPGM[Oxi]ADIC[CAM]K.2|DGGFC[CAM]EVC[CAM]K.2|HLAELNHQK.2|DVVTAAGDMLK.2|DVVTAAGDM[Oxi]LK.2|GSAVWC[CAM]QNVK.2|HEVPAKSDVYC[CAM]EVC[CAM]EFLVK.4|EEC[CAM]DRLGPGMADIC[CAM]K.3|EMPMQTLVPAK.2|SLPC[CAM]DIC[CAM]KDVVTAAGDMLK.3|NVIPALELVEPIK.2|EIC[CAM]ALVGFC[CAM]DEVK.2|C[CAM]IWGPSYWC[CAM]QNTETAAQC[CAM]NAVEHC[CAM]K.3
SEN / CTL,Q15262,Receptor-type tyrosine-protein phosphatase kappa,PTPRK,1.73,0.07,2.84E-08,2.26E-08,7.65E+00,"protein dephosphorylation,cell adhesion,signal transduction,transforming growth factor beta receptor signaling pathway,negative regulation of cell proliferation,negative regulation of keratinocyte proliferation,cell migration,negative regulation of cell migration,neuron projection development,protein localization to cell surface,cellular response to reactive oxygen species,cellular response to UV,peptidyl-tyrosine dephosphorylation,negative regulation of cell cycle,negative regulation of transcription, DNA-templated,focal adhesion assembly","protein tyrosine phosphatase activity,transmembrane receptor protein tyrosine phosphatase activity,protein binding,beta-catenin binding,protein kinase binding,gamma-catenin binding","photoreceptor outer segment,integral component of plasma membrane,cell-cell junction,adherens junction,cell surface,integral component of membrane,axon,dendrite,leading edge membrane,neuronal cell body",6,12,13,VLLTRPGEGGTGLPGPPLITR.3|GLNPGTLNILVR.2|YENHSATAESSR.3|VADLLQHINLMK.3|VADLLQHINLMK.2|GAPISAYQIVVEELHPHR.4|ADC[CAM]LDMDPK.2|NGEDIPVAQTK.2|MTSGSWTETHAVNAPTYK.3|GSGVSNFAQLIVR.2|TYQGFWNPPLAPR.2|YLC[CAM]EGTESPYQTGQLHPAIR.3|IFLNWKEPLDPNGIITQYEISYSSIR.3
SEN / CTL,P55083,Microfibril-associated glycoprotein 4,MFAP4,1.72,0.86,2.60E-04,1.10E-04,3.96E+00,"cell adhesion,UV protection,regulation of collagen metabolic process,extracellular fibril organization,elastic fiber assembly,cellular response to UV-B","molecular_function,protein binding","microfibril,extracellular region,extracellular matrix,extracellular exosome,elastic fiber",9,4,9,ADGEYWLGLQNMHLLTLK.3|ADGEYWLGLQNMHLLTLK.2|ADGEYWLGLQNMHLLTLK.4|ADGEYWLGLQNM[Oxi]HLLTLK.3|FSTFDRDQDLFVQNC[CAM]AALSSGAFWFR.3|FSTFDRDQDLFVQNC[CAM]AALSSGAFWFR.4|GFYYSLK.2|SC[CAM]HFANLNGFYLGGSHLSYANGINWAQWK.4|SC[CAM]HFANLNGFYLGGSHLSYANGINWAQWK.3
SEN / CTL,P21333,Filamin-A,FLNA,1.70,1.02,8.42E-77,2.13E-75,7.47E+01,"platelet degranulation,adenylate cyclase-inhibiting dopamine receptor signaling pathway,negative regulation of transcription from RNA polymerase I promoter,platelet activation,regulation of cell migration,actin cytoskeleton reorganization,cell junction assembly,protein localization to cell surface,negative regulation of protein catabolic process,cilium assembly,mRNA transcription from RNA polymerase II promoter,positive regulation of transcription factor import into nucleus,negative regulation of apoptotic process,receptor clustering,positive regulation of I-kappaB kinase/NF-kappaB signaling,negative regulation of sequence-specific DNA binding transcription factor activity,wound healing, spreading of cells,establishment of protein localization,protein stabilization,cytoplasmic sequestering of protein,actin crosslink formation,platelet aggregation,semaphorin-plexin signaling pathway,mitotic spindle assembly,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of integrin-mediated signaling pathway","G-protein coupled receptor binding,glycoprotein binding,signal transducer activity,protein binding,transcription factor binding,Rho GTPase binding,Ral GTPase binding,kinase binding,small GTPase binding,mu-type opioid receptor binding,Fc-gamma receptor I complex binding,protein homodimerization activity,poly(A) RNA binding,SMAD binding,Rac GTPase binding,actin filament binding,GTPase binding,cadherin binding involved in cell-cell adhesion","extracellular region,nucleus,nucleolus,cytoplasm,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,cortical cytoskeleton,extracellular matrix,Myb complex,neuronal cell body,dendritic shaft,perinuclear region of cytoplasm,extracellular exosome,apical dendrite,filamentous actin",234,207,388,LYSVSYLLK.2|YGGDEIPFSPYR.2|AEAGVPAEFSIWTR.2|AEAGVPAEFSIWTR.3|IVGPSGAAVPC[CAM]KVEPGLGADNSVVR.3|IVGPSGAAVPC[CAM]KVEPGLGADNSVVR.4|TGVAVNKPAEFTVDAK.3|TGVAVNKPAEFTVDAK.2|VTVLFAGQHIAK.3|VTVLFAGQHIAK.2|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.3|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASKPVTNAR.5|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.4|EATTEFSVDAR.2|KTHIQDNHDGTYTVAYVPDVTGR.5|KTHIQDNHDGTYTVAYVPDVTGR.4|KTHIQDNHDGTYTVAYVPDVTGR.3|GAGTGGLGLAVEGPSEAK.2|GAGTGGLGLAVEGPSEAK.3|SPFSVAVSPSLDLSK.2|SPFSVAVSPSLDLSK.3|YTPVQQGPVGVNVTYGGDPIPK.3|YTPVQQGPVGVNVTYGGDPIPK.2|LSPFMADIRDAPQDFHPDRVK.5|GKLDVQFSGLTK.3|GKLDVQFSGLTK.2|IANLQTDLSDGLR.2|IANLQTDLSDGLR.3|EGPYSISVLYGDEEVPRSPFK.3|EGPYSISVLYGDEEVPRSPFK.2|HTAMVSWGGVSIPNSPFR.3|HTAMVSWGGVSIPNSPFR.2|HTAM[Oxi]VSWGGVSIPNSPFR.2|HTAM[Oxi]VSWGGVSIPNSPFR.3|VHGPGIQSGTTNKPNKFTVETR.5|VHGPGIQSGTTNKPNKFTVETR.4|FGGEHVPNSPFQVTALAGDQPSVQPPLR.3|FGGEHVPNSPFQVTALAGDQPSVQPPLR.4|FGGEHVPNSPFQVTALAGDQPSVQPPLR.5|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.4|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.5|FLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.6|VANPSGNLTETYVQDR.2|VANPSGNLTETYVQDR.3|AWGPGLEGGVVGK.2|DAGEGLLAVQITDPEGKPK.2|DAGEGLLAVQITDPEGKPK.3|DAGEGLLAVQITDPEGKPK.4|VQVQDNEGC[CAM]PVEALVK.2|VQVQDNEGC[CAM]PVEALVK.3|TGVELGKPTHFTVNAK.4|TGVELGKPTHFTVNAK.3|TGVELGKPTHFTVNAK.2|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.4|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.5|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLKR.6|GLVEPVDVVDNADGTQTVNYVPSR.3|GLVEPVDVVDNADGTQTVNYVPSR.4|LVSNHSLHETSSVFVDSLTK.4|LVSNHSLHETSSVFVDSLTK.3|LVSNHSLHETSSVFVDSLTK.2|EAGAGGLAIAVEGPSKAEISFEDRK.4|EAGAGGLAIAVEGPSKAEISFEDRK.3|YGGQPVPNFPSKLQVEPAVDTSGVQC[CAM]YGPGIEGQGVFR.4|MDC[CAM]QEC[CAM]PEGYRVTYTPMAPGSYLISIK.3|EGPYSISVLYGDEEVPR.2|EGPYSISVLYGDEEVPR.3|FNEEHIPDSPFVVPVASPSGDAR.3|FNEEHIPDSPFVVPVASPSGDAR.4|C[CAM]SYQPTM[Oxi]EGVHTVHVTFAGVPIPR.4|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.4|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.5|C[CAM]SYQPTMEGVHTVHVTFAGVPIPR.3|C[CAM]SYQPTM[Oxi]EGVHTVHVTFAGVPIPR.3|LPQLPITNFSR.2|LPQLPITNFSR.3|ASGPGLNTTGVPASLPVEFTIDAK.3|ASGPGLNTTGVPASLPVEFTIDAK.2|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.4|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.5|VHSPSGALEEC[CAM]YVTEIDQDKYAVR.3|GAGSYTIMVLFADQATPTSPIR.3|GAGSYTIM[Oxi]VLFADQATPTSPIR.3|GAGSYTIM[Oxi]VLFADQATPTSPIR.2|GAGSYTIMVLFADQATPTSPIR.2|VRVHGPGIQSGTTNKPNKFTVETR.5|VRVHGPGIQSGTTNKPNKFTVETR.6|VRVHGPGIQSGTTNKPNKFTVETR.4|VRVHGPGIQSGTTNKPNKFTVETR.3|VSGQGLHEGHTFEPAEFIIDTR.4|VSGQGLHEGHTFEPAEFIIDTR.3|VKMDC[CAM]QEC[CAM]PEGYRVTYTPMAPGSYLISIK.4|VAQPTITDNKDGTVTVR.3|VAQPTITDNKDGTVTVR.2|LSPFMADIRDAPQDFHPDR.4|LSPFM[Oxi]ADIRDAPQDFHPDR.4|LSPFMADIRDAPQDFHPDR.3|VTYTPMAPGSYLISIK.2|VTYTPMAPGSYLISIK.3|VTYTPM[Oxi]APGSYLISIK.3|VTYTPM[Oxi]APGSYLISIK.2|YWPQEAGEYAVHVLC[CAM]NSEDIR.3|YWPQEAGEYAVHVLC[CAM]NSEDIR.4|VGSAADIPINISETDLSLLTATVVPPSGR.3|VGSAADIPINISETDLSLLTATVVPPSGR.4|SAGQGEVLVYVEDPAGHQEEAK.3|SAGQGEVLVYVEDPAGHQEEAK.4|SAGQGEVLVYVEDPAGHQEEAK.2|LSPFMADIR.2|LSPFM[Oxi]ADIR.2|RLTVSSLQESGLK.3|RLTVSSLQESGLK.2|LIALLEVLSQKK.3|LIALLEVLSQKK.2|VSGLGEKVDVGKDQEFTVK.4|VSGLGEKVDVGKDQEFTVK.3|AGNNMLLVGVHGPR.3|AGNNM[Oxi]LLVGVHGPR.3|AGNNMLLVGVHGPR.2|AGNNM[Oxi]LLVGVHGPR.2|GDAVRDVDIIDHHDNTYTVK.4|GDAVRDVDIIDHHDNTYTVK.5|GDAVRDVDIIDHHDNTYTVK.3|GDAVRDVDIIDHHDNTYTVK.2|DAPQDFHPDR.3|DAPQDFHPDR.2|VKVEPSHDASK.3|VKVEPSHDASK.2|AHVVPC[CAM]FDASK.3|AHVVPC[CAM]FDASK.2|KRAEFTVETR.3|VHGPGIQSGTTNKPNK.4|VHGPGIQSGTTNKPNK.3|VHGPGIQSGTTNKPNK.2|ETGEHLVHVKK.3|ETGEHLVHVKK.2|FNGTHIPGSPFK.3|FNGTHIPGSPFK.2|VNVGAGSHPNKVK.3|VNVGAGSHPNKVK.2|AGVAPLQVK.2|C[CAM]SGPGLER.2|MSC[CAM]MDNK.2|VEPGLGADNSVVR.3|VEPGLGADNSVVR.2|VTGDDSMR.2|ATC[CAM]APQHGAPGPGPADASK.4|ATC[CAM]APQHGAPGPGPADASK.3|ATC[CAM]APQHGAPGPGPADASK.2|DVDIIDHHDNTYTVK.4|DVDIIDHHDNTYTVK.3|DVDIIDHHDNTYTVK.2|GKLDVQFSGLTKGDAVR.4|GKLDVQFSGLTKGDAVR.3|RAPSVANVGSHC[CAM]DLSLK.4|RAPSVANVGSHC[CAM]DLSLK.3|RAPSVANVGSHC[CAM]DLSLK.2|VDVGKDQEFTVK.3|VDVGKDQEFTVK.2|AGVAPLQVKVQGPK.3|YGGPYHIGGSPFK.3|YGGPYHIGGSPFK.2|VKETADFK.2|WGDEHIPGSPYR.3|WGDEHIPGSPYR.2|AEFTVETR.2|AFGPGLQGGSAGSPAR.3|AFGPGLQGGSAGSPAR.2|EAGAGGLAIAVEGPSK.3|EAGAGGLAIAVEGPSK.2|LRNGHVGISFVPK.3|VKETADFKVYTK.3|VRVHGPGIQSGTTNKPNK.4|VRVHGPGIQSGTTNKPNK.3|YKGQHVPGSPFQFTVGPLGEGGAHKVR.6|YKGQHVPGSPFQFTVGPLGEGGAHKVR.5|YKGQHVPGSPFQFTVGPLGEGGAHKVR.4|AEISFEDR.2|AGQSAAGAAPGGGVDTR.3|AGQSAAGAAPGGGVDTR.2|ANLPQSFQVDTSK.3|ANLPQSFQVDTSK.2|AYGPGIEPTGNMVK.3|AYGPGIEPTGNM[Oxi]VK.2|AYGPGIEPTGNMVK.2|MDC[CAM]QEC[CAM]PEGYR.3|MDC[CAM]QEC[CAM]PEGYR.2|M[Oxi]DC[CAM]QEC[CAM]PEGYR.2|VLPTHDASK.2|PAEFTVDAK.2|PATFTVNTK.2|DAEMPATEK.2|DAEM[Oxi]PATEK.2|KGEITGEVR.2|RRAPSVANVGSHC[CAM]DLSLK.4|VGTEC[CAM]GNQK.2|VRAWGPGLEGGVVGK.3|VRAWGPGLEGGVVGK.2|DAGEGGLSLAIEGPSK.3|DAGEGGLSLAIEGPSK.2|FVPAEMGTHTVSVK.3|FVPAEM[Oxi]GTHTVSVK.3|FVPAEMGTHTVSVK.2|FVPAEM[Oxi]GTHTVSVK.2|VNQPASFAVSLNGAK.3|VNQPASFAVSLNGAK.2|FADQHVPGSPFSVK.3|FADQHVPGSPFSVK.2|NRTFSVWYVPEVTGTHK.4|VKAEGPGLSR.2|DAGEGLLAVQITDPEGKPKK.4|DAGEGLLAVQITDPEGKPKK.3|DAGEGLLAVQITDPEGKPKK.2|DNGNGTYSC[CAM]SYVPRKPVK.4|SSFTVDC[CAM]SK.2|THEAEIVEGENHTYC[CAM]IR.4|THEAEIVEGENHTYC[CAM]IR.3|THEAEIVEGENHTYC[CAM]IR.2|RIANLQTDLSDGLR.3|RIANLQTDLSDGLR.2|YKGQHVPGSPFQFTVGPLGEGGAHK.5|YKGQHVPGSPFQFTVGPLGEGGAHK.4|YKGQHVPGSPFQFTVGPLGEGGAHK.3|NDNDTFTVK.2|YAPSEAGLHEMDIR.3|YAPSEAGLHEM[Oxi]DIR.3|YAPSEAGLHEMDIR.2|DAEMPATEKDLAEDAPWKK.4|DAEMPATEKDLAEDAPWKK.3|LKPGAPLRPK.2|YNEQHVPGSPFTAR.3|YNEQHVPGSPFTAR.2|IEC[CAM]DDKGDGSC[CAM]DVR.3|IEC[CAM]DDKGDGSC[CAM]DVR.2|SPFEVYVDK.2|TPC[CAM]EEILVK.2|VAQPTITDNK.2|VDINTEDLEDGTC[CAM]R.3|VDINTEDLEDGTC[CAM]R.2|VNVGAGSHPNK.2|VRVSGQGLHEGHTFEPAEFIIDTR.5|VRVSGQGLHEGHTFEPAEFIIDTR.4|AEISFEDRK.2|APSVANVGSHC[CAM]DLSLK.3|APSVANVGSHC[CAM]DLSLK.2|GTVEPQLEAR.2|KTHIQDNHDGTYTVAYVPDVTGRYTILIK.6|KTHIQDNHDGTYTVAYVPDVTGRYTILIK.4|VKAFGPGLQGGSAGSPAR.3|VTAQGPGLEPSGNIANK.3|VTAQGPGLEPSGNIANK.2|YGGDEIPFSPYRVR.3|ALTQTGGPHVK.2|FIPRENGVYLIDVK.3|LDVQFSGLTK.2|LLGWIQNKLPQLPITNFSR.4|LLGWIQNKLPQLPITNFSR.3|LLGWIQNKLPQLPITNFSR.2|RAEFTVETR.2|SPFEVKVGTEC[CAM]GNQK.3|SPFEVKVGTEC[CAM]GNQK.2|VKMDC[CAM]QEC[CAM]PEGYR.3|VKMDC[CAM]QEC[CAM]PEGYR.2|ETGEHLVHVK.2|GAGSGELKVTVK.2|VHSPSGALEEC[CAM]YVTEIDQDK.4|VHSPSGALEEC[CAM]YVTEIDQDK.3|VHSPSGALEEC[CAM]YVTEIDQDK.2|DKGEYTLVVK.2|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.6|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.5|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.4|EEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSK.3|ENGVYLIDVK.2|GQHVPGSPFQFTVGPLGEGGAHK.4|GQHVPGSPFQFTVGPLGEGGAHK.3|GQHVPGSPFQFTVGPLGEGGAHK.2|IVGPSGAAVPC[CAM]K.2|NGHVGISFVPK.2|SPFEVYVDKSQGDASK.3|SPFEVYVDKSQGDASK.2|TFSVWYVPEVTGTHK.3|TFSVWYVPEVTGTHK.2|VPVHDVTDASK.2|SPFSVAVSPSLDLSKIK.3|SPFSVAVSPSLDLSKIK.2|C[CAM]SGPGLSPGMVR.2|C[CAM]SGPGLSPGM[Oxi]VR.2|NGQHVASSPIPVVISQSEIGDASR.4|NGQHVASSPIPVVISQSEIGDASR.3|THIQDNHDGTYTVAYVPDVTGR.4|THIQDNHDGTYTVAYVPDVTGR.3|SPYTVTVGQAC[CAM]NPSAC[CAM]R.3|SPYTVTVGQAC[CAM]NPSAC[CAM]R.2|LTVSSLQESGLK.2|QRLLGWIQNKLPQLPITNFSR.4|VGTEC[CAM]GNQKVR.2|VTYC[CAM]PTEPGNYIINIK.3|VTYC[CAM]PTEPGNYIINIK.2|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.6|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.5|RAPSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.4|KNGQHVASSPIPVVISQSEIGDASR.4|KNGQHVASSPIPVVISQSEIGDASR.3|VKASGPGLNTTGVPASLPVEFTIDAK.4|VKASGPGLNTTGVPASLPVEFTIDAK.3|YGGQPVPNFPSK.2|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASK.4|ALGALVDSC[CAM]APGLC[CAM]PDWDSWDASK.3|FNEEHIPDSPFVVPVASPSGDARR.4|ARVANPSGNLTETYVQDR.3|GAIDAKVHSPSGALEEC[CAM]YVTEIDQDKYAVR.5|IPEISIQDMTAQVTSPSGK.3|IPEISIQDMTAQVTSPSGK.2|IPEISIQDM[Oxi]TAQVTSPSGK.2|SAGQGEVLVYVEDPAGHQEEAKVTANNDKNR.5|SAGQGEVLVYVEDPAGHQEEAKVTANNDKNR.4|C[CAM]APGVVGPAEADIDFDIIR.3|C[CAM]APGVVGPAEADIDFDIIR.2|DAEMPATEKDLAEDAPWK.3|DAEMPATEKDLAEDAPWK.2|IANLQTDLSDGLRLIALLEVLSQKK.4|DAPQDFHPDRVK.2|VASKIVGPSGAAVPC[CAM]KVEPGLGADNSVVR.4|VEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGC[CAM]DPSR.6|VEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGC[CAM]DPSR.4|AHVVPC[CAM]FDASKVK.2|RLTVSSLQESGLKVNQPASFAVSLNGAK.4|RLTVSSLQESGLKVNQPASFAVSLNGAK.3|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.7|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.7|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.6|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.6|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNKPATFTVNTK.5|APLRVQVQDNEGC[CAM]PVEALVK.3|LLGWIQNKLPQLPITNFSRDWQSGR.4|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.7|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.6|SQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIK.5|DGSC[CAM]GVAYVVQEPGDYEVSVK.3|DGSC[CAM]GVAYVVQEPGDYEVSVK.2|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLK.5|VGSAADIPINISETDLSLLTATVVPPSGREEPC[CAM]LLK.4|AGGPGLERAEAGVPAEFSIWTR.3|ANLPQSFQVDTSKAGVAPLQVK.3|ANLPQSFQVDTSKAGVAPLQVK.2|C[CAM]APGVVGPAEADIDFDIIRNDNDTFTVK.4|C[CAM]APGVVGPAEADIDFDIIRNDNDTFTVK.3|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.6|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.5|EAM[Oxi]QQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.4|EAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPK.4|DAGYGGLSLSIEGPSK.2|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.6|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.5|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.4|EAGAGGLAIAVEGPSKAEISFEDR.3|EAGAGGLAIAVEGPSKAEISFEDR.2|AGQSAAGAAPGGGVDTRDAEMPATEK.3|DNGNGTYSC[CAM]SYVPR.2|KDGSC[CAM]GVAYVVQEPGDYEVSVK.3|KDGSC[CAM]GVAYVVQEPGDYEVSVK.2|VANPSGNLTETYVQDRGDGMYK.3|VGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSK.6|AEISC[CAM]TDNQDGTC[CAM]SVSYLPVLPGDYSILVK.4|AEISC[CAM]TDNQDGTC[CAM]SVSYLPVLPGDYSILVK.3|IEC[CAM]DDKGDGSC[CAM]DVRYWPQEAGEYAVHVLC[CAM]NSEDIR.5|IEC[CAM]DDKGDGSC[CAM]DVRYWPQEAGEYAVHVLC[CAM]NSEDIR.4|YDNM[Oxi]HIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.5|YDNMHIPGSPLQFYVDYVNC[CAM]GHVTAYGPGLTHGVVNK.4|SPFEVYVDKSQGDASKVTAQGPGLEPSGNIANK.4|AHEPTYFTVDC[CAM]AEAGQGDVSIGIK.3|DAGEGLLAVQITDPEGK.2|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.4|DGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.3|SADFVVEAIGDDVGTLGFSVEGPSQAK.3|APSVANVGSHC[CAM]DLSLKIPEISIQDMTAQVTSPSGK.4|LTVSSLQESGLKVNQPASFAVSLNGAK.3|LQVEPAVDTSGVQC[CAM]YGPGIEGQGVFREATTEFSVDAR.4|ASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPK.4|DAGYGGLSLSIEGPSKVDINTEDLEDGTC[CAM]R.3|MSC[CAM]MDNKDGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFK.4|MSC[CAM]MDNKDGSC[CAM]SVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASK.5|VQVQDNEGC[CAM]PVEALVKDNGNGTYSC[CAM]SYVPR.3
SEN / CTL,Q9BTY2,Plasma alpha-L-fucosidase,FUCA2,1.69,1.79,6.53E-03,1.89E-03,2.72E+00,"fucose metabolic process,response to bacterium,glycoside catabolic process,regulation of entry of bacterium into host cell",alpha-L-fucosidase activity,"extracellular space,extracellular exosome",9,12,14,FDPTWESLDAR.2|LVYAIFLK.2|FFNANQWADIFQASGAK.3|FFNANQWADIFQASGAK.2|AILGATEVK.2|WPTSGQLFLGHPK.3|WPTSGQLFLGHPK.2|VNGEAIYETHTWR.3|GTVVTNDRWGAGSIC[CAM]K.3|HGGFYTC[CAM]SDR.2|WENC[CAM]MTIDK.2|YEDFGPLFTAK.2|EAGISDYLTIEELVK.2|LLGHGQPLNWISLEQNGIMVELPQLTIHQMPC[CAM]K.4
SEN / CTL,P22626,Heterogeneous nuclear ribonucleoproteins A2/B1,HNRNPA2B1,1.69,0.94,2.87E-03,9.02E-04,3.04E+00,"negative regulation of transcription from RNA polymerase II promoter,mRNA splicing, via spliceosome,mRNA processing,mRNA export from nucleus,gene expression,primary miRNA processing,negative regulation of mRNA splicing, via spliceosome,RNA transport,miRNA transport","nucleotide binding,RNA binding,mRNA 3'-UTR binding,protein binding,miRNA binding,single-stranded telomeric DNA binding,poly(A) RNA binding,pre-mRNA intronic binding,N6-methyladenosine-containing RNA binding","nucleus,nucleoplasm,spliceosomal complex,cytoplasm,membrane,intracellular ribonucleoprotein complex,extracellular exosome,catalytic step 2 spliceosome",6,47,96,GFGFVTFDDHDPVDKIVLQK.4|GFGFVTFDDHDPVDKIVLQK.3|GFGFVTFDDHDPVDKIVLQK.2|KLFVGGIKEDTEEHHLR.5|KLFVGGIKEDTEEHHLR.4|KLFVGGIKEDTEEHHLR.3|KLFVGGIKEDTEEHHLR.2|PGAHVTVK.2|LTDC[CAM]VVMRDPASKR.4|LTDC[CAM]VVM[Oxi]RDPASKR.4|LTDC[CAM]VVMRDPASKR.3|QEMQEVQSSR.3|QEMQEVQSSR.2|QEM[Oxi]QEVQSSR.2|AVAREESGKPGAHVTVK.4|AVAREESGKPGAHVTVK.3|KLFVGGIK.2|SGRGGNFGFGDSR.3|EESGKPGAHVTVK.3|EESGKPGAHVTVK.2|GGSDGYGSGR.2|GGGGNFGPGPGSNFR.3|GGGGNFGPGPGSNFR.2|RGFGFVTFDDHDPVDK.4|RGFGFVTFDDHDPVDK.3|RGFGFVTFDDHDPVDK.2|LFVGGIKEDTEEHHLR.4|LFVGGIKEDTEEHHLR.3|PGAHVTVKK.2|YHTINGHNAEVR.3|YHTINGHNAEVR.2|RAVAREESGKPGAHVTVK.4|EESGKPGAHVTVKK.3|EESGKPGAHVTVKK.2|KRGFGFVTFDDHDPVDK.4|LTDC[CAM]VVMR.2|LTDC[CAM]VVM[Oxi]R.2|LTDC[CAM]VVM[Oxi]RDPASK.3|LTDC[CAM]VVMRDPASK.3|LTDC[CAM]VVM[Oxi]RDPASK.2|LTDC[CAM]VVMRDPASK.2|GGNFGFGDSR.2|YHTINGHNAEVRK.3|YHTINGHNAEVRK.2|DYFEEYGK.2|IDTIEIITDRQSGK.3|TLETVPLER.2|NYYEQWGK.2|ALSRQEMQEVQSSR.3|ALSRQEM[Oxi]QEVQSSR.3|ALSRQEMQEVQSSR.2|EDTEEHHLRDYFEEYGK.4|EDTEEHHLRDYFEEYGK.3|EDTEEHHLRDYFEEYGK.2|NMGGPYGGGNYGPGGSGGSGGYGGR.4|NM[Oxi]GGPYGGGNYGPGGSGGSGGYGGR.3|NMGGPYGGGNYGPGGSGGSGGYGGR.3|NM[Oxi]GGPYGGGNYGPGGSGGSGGYGGR.2|NMGGPYGGGNYGPGGSGGSGGYGGR.2|GFGFVTFDDHDPVDK.3|GFGFVTFDDHDPVDK.2|GFGFVTFSSMAEVDAAMAARPHSIDGR.5|GFGFVTFSSM[Oxi]AEVDAAMAARPHSIDGR.4|GFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.4|GFGFVTFSSMAEVDAAMAARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAM[Oxi]AARPHSIDGR.4|GFGFVTFSSM[Oxi]AEVDAAMAARPHSIDGR.3|GFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.3|GFGFVTFSSMAEVDAAMAARPHSIDGR.3|LFVGGIKEDTEEHHLRDYFEEYGK.5|LFVGGIKEDTEEHHLRDYFEEYGK.4|LFVGGIKEDTEEHHLRDYFEEYGK.3|IDTIEIITDR.2|TLETVPLERK.2|LFIGGLSFETTEESLR.3|LFIGGLSFETTEESLR.2|RGFGFVTFDDHDPVDKIVLQK.4|RGFGFVTFDDHDPVDKIVLQK.3|SRGFGFVTFSSMAEVDAAMAARPHSIDGR.5|SRGFGFVTFSSMAEVDAAM[Oxi]AARPHSIDGR.5|KLFIGGLSFETTEESLR.3|KLFIGGLSFETTEESLR.2|EDTEEHHLRDYFEEYGKIDTIEIITDR.5|EDTEEHHLRDYFEEYGKIDTIEIITDR.4|GFGFVTFSSMAEVDAAMAAR.3|GFGFVTFSSMAEVDAAMAAR.2|LFIGGLSFETTEESLRNYYEQWGK.4|LFIGGLSFETTEESLRNYYEQWGK.3|DYFEEYGKIDTIEIITDR.3|DYFEEYGKIDTIEIITDR.2|KLFIGGLSFETTEESLRNYYEQWGK.4|KLFIGGLSFETTEESLRNYYEQWGK.3|GGGGNFGPGPGSNFRGGSDGYGSGR.3|GGNFGFGDSRGGGGNFGPGPGSNFR.3|GFGDGYNGYGGGPGGGNFGGSPGYGGGR.3|SGNFGGSRNMGGPYGGGNYGPGGSGGSGGYGGR.3
SEN / CTL,P40926,"Malate dehydrogenase, mitochondrial",MDH2,1.69,1.83,3.18E-08,2.47E-08,7.61E+00,"gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,internal protein amino acid acetylation,NADH metabolic process","L-malate dehydrogenase activity,protein self-association,poly(A) RNA binding,malate dehydrogenase (NADP+) activity","nucleus,nucleoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial matrix,plasma membrane,myelin sheath,extracellular exosome",27,31,62,ANTFVAELK.2|IFGVTTLDIVR.2|IFGVTTLDIVR.3|GYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.3|GYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.4|HGVYNPNKIFGVTTLDIVR.4|HGVYNPNKIFGVTTLDIVR.3|HGVYNPNKIFGVTTLDIVR.2|AGAGSATLSMAYAGAR.2|AGAGSATLSMAYAGAR.3|AGAGSATLSM[Oxi]AYAGAR.3|AGAGSATLSM[Oxi]AYAGAR.2|VAVLGASGGIGQPLSLLLK.2|VAVLGASGGIGQPLSLLLK.4|VAVLGASGGIGQPLSLLLK.3|MISDAIPELK.2|M[Oxi]ISDAIPELK.2|SQETEC[CAM]TYFSTPLLLGK.3|SQETEC[CAM]TYFSTPLLLGK.2|LTLYDIAHTPGVAADLSHIETK.4|LTLYDIAHTPGVAADLSHIETK.3|LTLYDIAHTPGVAADLSHIETK.2|KGEDFVK.2|IQEAGTEVVKAK.3|FVFSLVDAMNGK.3|FVFSLVDAM[Oxi]NGK.3|FVFSLVDAMNGK.2|FVFSLVDAM[Oxi]NGK.2|GLDPARVNVPVIGGHAGK.4|GLDPARVNVPVIGGHAGK.3|GC[CAM]DVVVIPAGVPR.3|GC[CAM]DVVVIPAGVPR.2|TIIPLISQC[CAM]TPK.3|TIIPLISQC[CAM]TPK.2|HGVYNPNK.2|GYLGPEQLPDC[CAM]LK.3|GYLGPEQLPDC[CAM]LK.2|VDFPQDQLTALTGR.3|VDFPQDQLTALTGR.2|SQETEC[CAM]TYFSTPLLLGKK.4|SQETEC[CAM]TYFSTPLLLGKK.3|SQETEC[CAM]TYFSTPLLLGKK.2|ANTFVAELKGLDPAR.3|ANTFVAELKGLDPAR.2|IQEAGTEVVK.2|AKAGAGSATLSMAYAGAR.3|AKAGAGSATLSM[Oxi]AYAGAR.3|ANTFVAELKGLDPARVNVPVIGGHAGK.5|ANTFVAELKGLDPARVNVPVIGGHAGK.4|VNVPVIGGHAGK.2|EGVVEC[CAM]SFVK.2|FVFSLVDAMNGKEGVVEC[CAM]SFVK.4|FVFSLVDAM[Oxi]NGKEGVVEC[CAM]SFVK.4|FVFSLVDAM[Oxi]NGKEGVVEC[CAM]SFVK.3|FVFSLVDAMNGKEGVVEC[CAM]SFVK.3|VSSFEEKM[Oxi]ISDAIPELK.3|VSSFEEKMISDAIPELK.3|TIIPLISQC[CAM]TPKVDFPQDQLTALTGR.4|TIIPLISQC[CAM]TPKVDFPQDQLTALTGR.3|AAVKGYLGPEQLPDC[CAM]LKGC[CAM]DVVVIPAGVPR.4|VDFPQDQLTALTGRIQEAGTEVVK.3|DDLFNTNATIVATLTAAC[CAM]AQHC[CAM]PEAMIC[CAM]VIANPVNSTIPITAEVFKK.5
SEN / CTL,Q12931,"Heat shock protein 75 kDa, mitochondrial",TRAP1,1.69,0.10,1.21E-03,4.24E-04,3.37E+00,"response to stress,translational attenuation,chaperone-mediated protein folding,negative regulation of cellular respiration,negative regulation of reactive oxygen species biosynthetic process,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide","tumor necrosis factor receptor binding,protein binding,ATP binding,protein kinase binding,poly(A) RNA binding,unfolded protein binding","nucleoplasm,mitochondrion,mitochondrial inner membrane,mitochondrial intermembrane space,mitochondrial matrix,lipid particle,membrane,extracellular exosome",3,53,85,GVVDSEDIPLNLSR.2|GVVDSEDIPLNLSR.3|LNELLVK.2|HLAEHSPYYEAMKK.4|NIYYLC[CAM]APNR.3|NIYYLC[CAM]APNR.2|YTLHYKTDAPLNIR.4|YTLHYKTDAPLNIR.3|ELLQESALIRK.3|ELLQESALIRK.2|EWQHEEFYR.3|EWQHEEFYR.2|FFIDQSK.2|SDC[CAM]KEFSSEAR.3|SLYSEKEVFIR.3|KLLDIVAR.2|HEFQAETK.2|AQLLQPTLEINPR.3|AQLLQPTLEINPR.2|FFIDQSKK.2|LISVETDIVVDHYKEEK.4|LISVETDIVVDHYKEEK.3|LISVETDIVVDHYKEEK.2|LRDVLQQR.2|ELISNASDALEKLR.3|AFLDALQNQAEASSK.3|AFLDALQNQAEASSK.2|HLAEHSPYYEAM[Oxi]K.3|HLAEHSPYYEAMK.3|HLAEHSPYYEAMK.2|KLISVETDIVVDHYKEEK.4|KLISVETDIVVDHYKEEK.3|LISVETDIVVDHYK.3|SPAAEC[CAM]LSEK.2|FEDRSPAAEC[CAM]LSEK.3|FEDRSPAAEC[CAM]LSEK.2|SIFYVPDMK.2|HEFQAETKK.2|YSNFVSFPLYLNGR.3|YSNFVSFPLYLNGR.2|VTLRLDTHPAMVTVLEMGAAR.4|VTLRLDTHPAMVTVLEMGAAR.3|RMNTLQAIWMMDPK.3|RMNTLQAIWMMDPK.2|ELLQESALIR.2|ELGSSVALYSR.2|SPAAEC[CAM]LSEKETEELMAWMR.4|SPAAEC[CAM]LSEKETEELMAWMR.3|SPAAEC[CAM]LSEKETEELMAWMR.2|YVAQAHDKPR.2|LDTHPAMVTVLEMGAAR.3|LDTHPAM[Oxi]VTVLEM[Oxi]GAAR.3|LDTHPAM[Oxi]VTVLEMGAAR.3|LDTHPAMVTVLEM[Oxi]GAAR.3|LDTHPAMVTVLEMGAAR.2|YSNFVSFPLYLNGRR.3|EGIVTATEQEVKEDIAK.3|EGIVTATEQEVKEDIAK.2|ELISNASDALEK.2|FIRGVVDSEDIPLNLSR.3|EGIVTATEQEVK.2|ETEELMAWMR.2|HKLVSDGQALPEMEIHLQTNAEK.4|HKLVSDGQALPEMEIHLQTNAEK.3|FFEDYGLFMR.2|FFEDYGLFM[Oxi]R.2|SIFYVPDMKPSMFDVSR.3|SIFYVPDM[Oxi]KPSM[Oxi]FDVSR.3|SIFYVPDMKPSM[Oxi]FDVSR.3|SIFYVPDMKPSMFDVSR.2|KKDTEVLFC[CAM]FEQFDELTLLHLR.4|EEPLHSIISSTESVQGSTSK.3|YESSALPSGQLTSLSEYASR.3|YESSALPSGQLTSLSEYASR.2|FEDRSPAAEC[CAM]LSEKETEELMAWMR.4|FFIDQSKKDAEK.2|LVSDGQALPEMEIHLQTNAEK.3|LVSDGQALPEM[Oxi]EIHLQTNAEK.3|LVSDGQALPEMEIHLQTNAEK.2|MNTLQAIWMMDPK.2|DVREWQHEEFYR.2|LLRYESSALPSGQLTSLSEYASR.3|GTITIQDTGIGM[Oxi]TQEELVSNLGTIAR.3|GTITIQDTGIGMTQEELVSNLGTIAR.3|SAAPGSLGYQWLSDGSGVFEIAEASGVR.3
SEN / CTL,P49747,Cartilage oligomeric matrix protein,COMP,1.69,0.17,3.37E-03,1.05E-03,2.98E+00,"skeletal system development,growth plate cartilage development,apoptotic process,cell adhesion,animal organ morphogenesis,extracellular matrix organization,negative regulation of apoptotic process,limb development","protease binding,extracellular matrix structural constituent,calcium ion binding,protein binding,collagen binding,heparin binding,heparan sulfate proteoglycan binding","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome,extracellular matrix",3,10,11,C[CAM]EAC[CAM]PPGYSGPTHQGVGLAFAK.3|AVAEPGIQLK.2|FC[CAM]PDGSPSEC[CAM]HEHADC[CAM]VLER.4|DSDGDGIGDAC[CAM]DNC[CAM]PQK.3|DSDGDGIGDAC[CAM]DNC[CAM]PQK.2|NTDEDKWGDAC[CAM]DNC[CAM]R.3|DTDLDGFPDEK.2|NDDQKDTDQDGRGDAC[CAM]DDDIDGDR.4|VPNSDQKDSDGDGIGDAC[CAM]DNC[CAM]PQK.3|IDVC[CAM]PENAEVTLTDFR.2|GSFQC[CAM]GPC[CAM]QPGFVGDQASGC[CAM]QR.2
SEN / CTL,P53634,Dipeptidyl peptidase 1,CTSC,1.68,0.49,2.15E-04,9.29E-05,4.03E+00,"T cell mediated cytotoxicity,proteolysis,ER to Golgi vesicle-mediated transport,apoptotic process,immune response,aging,response to organic substance,COPII vesicle coating,proteolysis involved in cellular protein catabolic process,positive regulation of proteolysis involved in cellular protein catabolic process,positive regulation of apoptotic signaling pathway","cysteine-type endopeptidase activity,serine-type endopeptidase activity,cysteine-type peptidase activity,peptidase activator activity involved in apoptotic process,phosphatase binding,chloride ion binding,identical protein binding,protein self-association,chaperone binding","Golgi membrane,extracellular space,lysosome,endoplasmic reticulum lumen,membrane,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular exosome",6,16,31,ILHLPTSWDWR.3|ILHLPTSWDWR.2|NSWGTGWGENGYFR.2|VVVYLQK.2|NVHGINFVSPVR.3|NVHGINFVSPVR.2|LELVHHGPMAVAFEVYDDFLHYKK.6|LELVHHGPMAVAFEVYDDFLHYKK.5|LELVHHGPM[Oxi]AVAFEVYDDFLHYKK.5|LELVHHGPMAVAFEVYDDFLHYKK.4|LELVHHGPM[Oxi]AVAFEVYDDFLHYKK.4|LELVHHGPMAVAFEVYDDFLHYKK.3|KVVVYLQK.2|RGTDEC[CAM]AIESIAVAATPIPK.4|RGTDEC[CAM]AIESIAVAATPIPK.3|RGTDEC[CAM]AIESIAVAATPIPK.2|PAPLTAEIQQK.2|GTDEC[CAM]AIESIAVAATPIPK.3|GTDEC[CAM]AIESIAVAATPIPK.2|YAQDFGLVEEAC[CAM]FPYTGTDSPC[CAM]K.4|YAQDFGLVEEAC[CAM]FPYTGTDSPC[CAM]K.3|LELVHHGPMAVAFEVYDDFLHYK.4|LELVHHGPMAVAFEVYDDFLHYK.3|NQASC[CAM]GSC[CAM]YSFASMGMLEAR.3|NQASC[CAM]GSC[CAM]YSFASMGMLEAR.2|RGTDEC[CAM]AIESIAVAATPIPKL.3|YYSSEYHYVGGFYGGC[CAM]NEALM[Oxi]K.3|YYSSEYHYVGGFYGGC[CAM]NEALMK.3|DPFNPFELTNHAVLLVGYGTDSASGMDYWIVK.4|DPFNPFELTNHAVLLVGYGTDSASGMDYWIVK.3|GTDEC[CAM]AIESIAVAATPIPKL.2
SEN / CTL,P21810,Biglycan,BGN,1.68,1.59,1.26E-15,2.52E-15,1.46E+01,"blood vessel remodeling,negative regulation of protein kinase activity,biological_process,cytokine-mediated signaling pathway,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,negative regulation of JAK-STAT cascade","protein kinase inhibitor activity,extracellular matrix structural constituent,glycosaminoglycan binding,extracellular matrix binding","extracellular region,proteinaceous extracellular matrix,cytoplasm,Golgi lumen,cell surface,transport vesicle,sarcolemma,lysosomal lumen,extracellular exosome,extracellular matrix",69,23,37,IQAIELEDLLR.2|DLPETLNELHLDHNKIQAIELEDLLR.5|DLPETLNELHLDHNKIQAIELEDLLR.4|DLPETLNELHLDHNKIQAIELEDLLR.3|LTGIPKDLPETLNELHLDHNKIQAIELEDLLR.6|LTGIPKDLPETLNELHLDHNKIQAIELEDLLR.5|LTGIPKDLPETLNELHLDHNKIQAIELEDLLR.4|GLQHLYALVLVNNK.3|GLQHLYALVLVNNK.2|VVQC[CAM]SDLGLK.2|SVPKEISPDTTLLDLQNNDISELRK.4|VPSGLPDLK.2|NHLVEIPPNLPSSLVELR.3|NHLVEIPPNLPSSLVELR.2|LAIQFGNYK.2|NMNC[CAM]IEMGGNPLENSGFEPGAFDGLK.3|EISPDTTLLDLQNNDISELRK.4|EISPDTTLLDLQNNDISELRK.3|VGVNDFC[CAM]PMGFGVK.2|VGVNDFC[CAM]PM[Oxi]GFGVK.2|AYYNGISLFNNPVPYWEVQPATFR.3|AYYNGISLFNNPVPYWEVQPATFR.4|EISPDTTLLDLQNNDISELR.3|EISPDTTLLDLQNNDISELR.2|DDFKGLQHLYALVLVNNK.3|DDFKGLQHLYALVLVNNK.4|ELHLDNNKLAR.3|DLPETLNELHLDHNK.4|DLPETLNELHLDHNK.3|DLPETLNELHLDHNK.2|LGLGHNQIR.2|VGVNDFC[CAM]PM[Oxi]GFGVKR.3|DDFKGLQHLYALVLVNNKISK.4|LYISKNHLVEIPPNLPSSLVELR.4|RAYYNGISLFNNPVPYWEVQPATFR.4|RAYYNGISLFNNPVPYWEVQPATFR.3|C[CAM]VTDRLAIQFGNYK.2
SEN / CTL,P06865,Beta-hexosaminidase subunit alpha,HEXA,1.68,1.26,4.71E-11,5.97E-11,1.02E+01,"carbohydrate metabolic process,glycosaminoglycan biosynthetic process,glycosphingolipid metabolic process,chondroitin sulfate catabolic process,hyaluronan catabolic process,keratan sulfate catabolic process","beta-N-acetylhexosaminidase activity,acetylglucosaminyltransferase activity,protein heterodimerization activity","membrane,azurophil granule,lysosomal lumen,extracellular exosome",30,21,32,ALLSAPWYLNR.2|GLETFSQLVWK.2|YRDLLFGSGSWPRPYLTGK.4|LNVFHWHLVDDPSFPYESFTFPELMR.4|LNVFHWHLVDDPSFPYESFTFPELMR.3|GYVVWQEVFDNKVK.3|GYVVWQEVFDNKVK.2|IQPDTIIQVWR.2|IQPDTIIQVWR.3|SNPEIQDFMR.2|LTSDLTFAYER.2|HYLPLSSILDTLDVMAYNK.3|HYLPLSSILDTLDVMAYNK.4|HYLPLSSILDTLDVM[Oxi]AYNK.3|HYLPLSSILDTLDVM[Oxi]AYNK.2|HYLPLSSILDTLDVMAYNK.2|RGVQAQPLNVGFC[CAM]EQEFEQT.3|RGVQAQPLNVGFC[CAM]EQEFEQT.2|GLLLDTSR.2|ISYGPDWK.2|GYVVWQEVFDNK.3|GYVVWQEVFDNK.2|TEIEDFPR.2|EDIPVNYMK.2|GSYNPVTHIYTAQDVK.3|GSYNPVTHIYTAQDVK.2|IQPDTIIQVWREDIPVNYMK.4|IQPDTIIQVWREDIPVNYMK.3|DLLFGSGSWPRPYLTGK.3|KGSYNPVTHIYTAQDVK.3|YVLYPNNFQFQYDVSSAAQPGC[CAM]SVLDEAFQR.4|GVQAQPLNVGFC[CAM]EQEFEQT.2
SEN / CTL,Q9NZP8,Complement C1r subcomponent-like protein,C1RL,1.68,2.79,2.33E-01,4.74E-02,1.32E+00,"proteolysis,complement activation, classical pathway,innate immune response",serine-type endopeptidase activity,"extracellular space,extracellular exosome",3,9,11,WILTAAHTIYPK.3|WILTAAHTIYPK.2|VVVHPDYR.2|EAC[CAM]NAWLQK.2|VLSYVDWIK.2|LGNFPWQAFTSIHGR.3|GSEAINAPGDNPAK.2|DRQDGEEVLQC[CAM]MPVC[CAM]GR.3|QRPEVFSDNM[Oxi]FC[CAM]VGDETQR.3|QRPEVFSDNMFC[CAM]VGDETQR.3|VQNHC[CAM]QEPYYQAAAAGALTC[CAM]ATPGTWK.3
SEN / CTL,P35556,Fibrillin-2,FBN2,1.66,1.12,6.55E-03,1.89E-03,2.72E+00,"extracellular matrix disassembly,extracellular matrix organization,embryonic limb morphogenesis,positive regulation of bone mineralization,sequestering of TGFbeta in extracellular matrix,camera-type eye development,positive regulation of osteoblast differentiation,embryonic eye morphogenesis,bone trabecula formation,regulation of cellular response to growth factor stimulus","extracellular matrix structural constituent,calcium ion binding,protein binding,extracellular matrix constituent conferring elasticity","microfibril,extracellular region,extracellular matrix",6,5,5,C[CAM]WGIGTIPEAC[CAM]PVR.2|LSSTGLIC[CAM]IDSLK.2|RPDGEGC[CAM]VDENEC[CAM]R.3|GWGHQC[CAM]ELC[CAM]PLPGTAQYK.3|SATAGSEGGFLAPEYR.2
SEN / CTL,P08865,40S ribosomal protein SA,RPSA,1.65,0.17,4.09E-03,1.25E-03,2.90E+00,"ribosomal small subunit assembly,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),rRNA processing,rRNA export from nucleus,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,cell adhesion,viral transcription,viral entry into host cell","virus receptor activity,structural constituent of ribosome,laminin receptor activity,protein binding,ribosome binding,laminin binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,cytosolic small ribosomal subunit,90S preribosome,extracellular exosome",3,21,46,AIVAIENPADVSVISSR.2|AIVAIENPADVSVISSR.3|FAAATGATPIAGR.3|FAAATGATPIAGR.2|KSDGIYIINLK.3|KSDGIYIINLK.2|DPEEIEK.2|SDGIYIINLKR.3|LLVVTDPR.2|RKSDGIYIINLK.3|FTPGTFTNQIQAAFREPR.4|FTPGTFTNQIQAAFREPR.3|FTPGTFTNQIQAAFREPR.2|AVLKFAAATGATPIAGR.3|GAHSVGLMWWMLAR.3|GAHSVGLM[Oxi]WWMLAR.3|GAHSVGLMWWM[Oxi]LAR.3|GAHSVGLM[Oxi]WWM[Oxi]LAR.3|GAHSVGLM[Oxi]WWMLAR.2|GAHSVGLMWWMLAR.2|GAHSVGLM[Oxi]WWM[Oxi]LAR.2|FTPGTFTNQIQAAFR.3|FTPGTFTNQIQAAFR.2|DPEEIEKEEQAAAEK.3|DPEEIEKEEQAAAEK.2|SDGIYIINLK.2|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.5|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.4|ADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.3|EHPWEVMPDLYFYR.3|EHPWEVMPDLYFYR.2|YVDIAIPC[CAM]NNK.2|FLAAGTHLGGTNLDFQMEQYIYK.4|FLAAGTHLGGTNLDFQM[Oxi]EQYIYK.3|FLAAGTHLGGTNLDFQMEQYIYK.3|EHPWEVM[Oxi]PDLYFYRDPEEIEK.4|EHPWEVMPDLYFYRDPEEIEK.4|EHPWEVMPDLYFYRDPEEIEK.3|FLAAGTHLGGTNLDFQMEQYIYKR.4|FLAAGTHLGGTNLDFQM[Oxi]EQYIYKR.4|FLAAGTHLGGTNLDFQMEQYIYKR.3|EHPWEVM[Oxi]PDLYFYRDPEEIEKEEQAAAEK.5|EHPWEVMPDLYFYRDPEEIEKEEQAAAEK.5|EHPWEVMPDLYFYRDPEEIEKEEQAAAEK.4|EHPWEVM[Oxi]PDLYFYRDPEEIEKEEQAAAEK.4|LLVVTDPRADHQPLTEASYVNLPTIALC[CAM]NTDSPLR.4
SEN / CTL,Q99536,Synaptic vesicle membrane protein VAT-1 homolog,VAT1,1.65,0.89,4.26E-03,1.30E-03,2.89E+00,"negative regulation of mitochondrial fusion,oxidation-reduction process","zinc ion binding,oxidoreductase activity","mitochondrial outer membrane,integral component of membrane,extracellular exosome",6,28,53,AC[CAM]GLNFADLMAR.2|AC[CAM]GLNFADLM[Oxi]AR.2|GVDIVMDPLGGSDTAK.2|GVDIVM[Oxi]DPLGGSDTAK.3|GVDIVMDPLGGSDTAK.3|GVDIVM[Oxi]DPLGGSDTAK.2|VLLVPGPEK.2|LQSRPAAPPAPGPGQLTLR.4|LQSRPAAPPAPGPGQLTLR.3|PAAPPAPGPGQLTLR.3|PAAPPAPGPGQLTLR.2|VVTYGMANLLTGPK.3|VVTYGMANLLTGPK.2|VVTYGM[Oxi]ANLLTGPK.2|ENGVTHPIDYHTTDYVDEIKK.5|ENGVTHPIDYHTTDYVDEIKK.4|ENGVTHPIDYHTTDYVDEIKK.3|HEALKENGVTHPIDYHTTDYVDEIKK.6|HEALKENGVTHPIDYHTTDYVDEIKK.5|HEALKENGVTHPIDYHTTDYVDEIKK.4|C[CAM]LVLTGFGGYDKVK.3|LLALYNQGHIKPHIDSVWPFEK.5|LLALYNQGHIKPHIDSVWPFEK.4|LLALYNQGHIKPHIDSVWPFEK.3|TVENVTVFGTASASKHEALK.4|TVENVTVFGTASASKHEALK.3|VKLQSRPAAPPAPGPGQLTLR.4|EVAEAATGEDASSPPPK.3|EVAEAATGEDASSPPPK.2|ENGVTHPIDYHTTDYVDEIK.4|ENGVTHPIDYHTTDYVDEIK.3|HEALKENGVTHPIDYHTTDYVDEIK.5|HEALKENGVTHPIDYHTTDYVDEIK.4|VLLVPGPEKEN.2|AVC[CAM]GFHLGYLDGEVELVSGVVAR.4|AVC[CAM]GFHLGYLDGEVELVSGVVAR.3|LLALYNQGHIK.2|TEAASDPQHPAASEGAAAAAASPPLLR.4|TEAASDPQHPAASEGAAAAAASPPLLR.3|C[CAM]LVLTGFGGYDK.2|LPPLPVTPGMEGAGVVIAVGEGVSDRK.4|LPPLPVTPGMEGAGVVIAVGEGVSDRK.3|PHIDSVWPFEK.2|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRK.5|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDRK.4|QGLYDRLPPLPVTPGM[Oxi]EGAGVVIAVGEGVSDRK.4|TWWNQFSVTALQLLQANR.3|TVENVTVFGTASASK.2|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDR.4|QGLYDRLPPLPVTPGMEGAGVVIAVGEGVSDR.3|LPPLPVTPGM[Oxi]EGAGVVIAVGEGVSDR.3|LPPLPVTPGMEGAGVVIAVGEGVSDR.3|EVAEAATGEDASSPPPKTEAASDPQHPAASEGAAAAAASPPLLR.4
SEN / CTL,P08238,Heat shock protein HSP 90-beta,HSP90AB1,1.65,1.13,1.05E-09,9.97E-10,9.00E+00,"placenta development,protein folding,response to unfolded protein,response to salt stress,virion attachment to host cell,regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of phosphoprotein phosphatase activity,positive regulation of protein import into nucleus, translocation,cellular response to drug,Fc-gamma receptor signaling pathway involved in phagocytosis,response to cocaine,negative regulation of neuron apoptotic process,positive regulation of nitric oxide biosynthetic process,positive regulation of cell size,protein stabilization,regulation of interferon-gamma-mediated signaling pathway,regulation of type I interferon-mediated signaling pathway,cellular response to interleukin-4,cellular response to organic cyclic compound,positive regulation of protein serine/threonine kinase activity,fibril organization,cell-cell adhesion,regulation of cellular response to heat,negative regulation of complement-dependent cytotoxicity","glycoprotein binding,UTP binding,CTP binding,double-stranded RNA binding,protein binding,ATP binding,GTP binding,drug binding,sulfonylurea receptor binding,protein kinase regulator activity,kinase binding,protein kinase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,dATP binding,histone deacetylase binding,ion channel binding,poly(A) RNA binding,unfolded protein binding,cadherin binding involved in cell-cell adhesion","nucleoplasm,cytoplasm,mitochondrion,lysosomal membrane,cytosol,cell-cell adherens junction,cell surface,membrane,inclusion body,basolateral plasma membrane,apical plasma membrane,brush border membrane,melanosome,extracellular exosome,sperm head plasma membrane,ooplasm,COP9 signalosome",33,84,175,ELISNASDALDKIR.3|ELISNASDALDKIR.2|GVVDSEDLPLNISR.2|GVVDSEDLPLNISR.3|ADLINNLGTIAK.2|ADLINNLGTIAK.3|LVSSPC[CAM]C[CAM]IVTSTYGWTANMER.3|LVSSPC[CAM]C[CAM]IVTSTYGWTANMER.4|LVSSPC[CAM]C[CAM]IVTSTYGWTANM[Oxi]ER.3|TLTLVDTGIGMTK.2|TLTLVDTGIGMTK.3|TLTLVDTGIGM[Oxi]TK.3|TLTLVDTGIGM[Oxi]TK.2|RVFIMDSC[CAM]DELIPEYLNFIR.3|RVFIMDSC[CAM]DELIPEYLNFIR.4|RVFIM[Oxi]DSC[CAM]DELIPEYLNFIR.3|HLEINPDHPIVETLR.4|HLEINPDHPIVETLR.3|HLEINPDHPIVETLR.2|SLTNDWEDHLAVK.3|SLTNDWEDHLAVK.2|EQVANSAFVER.2|EQVANSAFVER.3|YHTSQSGDEMTSLSEYVSR.3|YHTSQSGDEMTSLSEYVSR.4|YHTSQSGDEM[Oxi]TSLSEYVSR.3|YHTSQSGDEM[Oxi]TSLSEYVSR.2|YHTSQSGDEMTSLSEYVSR.2|APFDLFENKK.3|APFDLFENKK.2|ALLFIPR.2|RAPFDLFENK.3|RAPFDLFENK.2|EGLELPEDEEEKKK.4|EGLELPEDEEEKKK.3|EGLELPEDEEEKKK.2|ELISNASDALDK.3|ELISNASDALDK.2|EMLQQSK.2|LGIHEDSTNRR.3|VILHLKEDQTEYLEERR.5|VILHLKEDQTEYLEERR.4|VILHLKEDQTEYLEERR.3|EDQTEYLEER.3|EDQTEYLEER.2|IRYESLTDPSK.3|IRYESLTDPSK.2|RLSELLR.2|FYEAFSK.2|FYEAFSK.1|HFSVEGQLEFR.3|HFSVEGQLEFR.2|GEKEEEDKDDEEKPK.4|GEKEEEDKDDEEKPK.3|HSQFIGYPITLYLEK.4|HSQFIGYPITLYLEK.3|HSQFIGYPITLYLEK.2|IRYESLTDPSKLDSGK.4|IRYESLTDPSKLDSGK.3|IRYESLTDPSKLDSGK.2|RAPFDLFENKK.3|RAPFDLFENKK.2|EGLELPEDEEEK.3|EGLELPEDEEEK.2|EKYIDQEELNK.3|EKYIDQEELNK.2|IEDVGSDEEDDSGKDKK.4|IEDVGSDEEDDSGKDKK.3|ADHGEPIGR.2|KHLEINPDHPIVETLR.4|KHLEINPDHPIVETLR.3|KHLEINPDHPIVETLR.2|YESLTDPSKLDSGKELK.4|YESLTDPSKLDSGKELK.3|YESLTDPSKLDSGKELK.2|EDQTEYLEERR.3|EDQTEYLEERR.2|KHSQFIGYPITLYLEK.4|KHSQFIGYPITLYLEK.3|KHSQFIGYPITLYLEK.2|LMKEILDK.2|NLKLGIHEDSTNR.3|AKFENLC[CAM]K.2|KFYEAFSK.2|VILHLKEDQTEYLEER.4|VILHLKEDQTEYLEER.3|VILHLKEDQTEYLEER.2|YIDQEELNKTKPIWTR.4|YIDQEELNKTKPIWTR.3|EGLELPEDEEEKK.3|EGLELPEDEEEKK.2|YESLTDPSKLDSGK.3|YESLTDPSKLDSGK.2|ELKIDIIPNPQER.3|ELKIDIIPNPQER.2|HSQFIGYPITLYLEKER.4|HSQFIGYPITLYLEKER.3|YESLTDPSK.2|C[CAM]LELFSELAEDKENYKK.4|C[CAM]LELFSELAEDKENYKK.3|C[CAM]LELFSELAEDKENYKK.2|KC[CAM]LELFSELAEDKENYK.4|KC[CAM]LELFSELAEDKENYK.3|APFDLFENK.2|IKEKYIDQEELNK.3|KHSQFIGYPITLYLEKER.4|KHSQFIGYPITLYLEKER.3|HNDDEQYAWESSAGGSFTVR.4|HNDDEQYAWESSAGGSFTVR.3|HNDDEQYAWESSAGGSFTVR.2|SLVSVTKEGLELPEDEEEKK.4|LGIHEDSTNR.2|IEDVGSDEEDDSGKDK.3|SIYYITGESK.2|YIDQEELNK.2|VFIMDSC[CAM]DELIPEYLNFIR.4|VFIMDSC[CAM]DELIPEYLNFIR.3|VFIM[Oxi]DSC[CAM]DELIPEYLNFIR.3|VFIM[Oxi]DSC[CAM]DELIPEYLNFIR.2|VFIMDSC[CAM]DELIPEYLNFIR.2|AQALRDNSTMGYMMAK.3|AQALRDNSTM[Oxi]GYMMAK.3|AQALRDNSTMGYM[Oxi]MAK.3|AQALRDNSTMGYMM[Oxi]AK.3|AQALRDNSTMGYMMAK.2|IDIIPNPQER.2|SIYYITGESKEQVANSAFVER.4|SIYYITGESKEQVANSAFVER.3|SIYYITGESKEQVANSAFVER.2|GFEVVYMTEPIDEYC[CAM]VQQLK.4|GFEVVYMTEPIDEYC[CAM]VQQLK.3|GFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.3|NPDDITQEEYGEFYK.3|NPDDITQEEYGEFYK.2|DNSTMGYMMAK.2|DNSTM[Oxi]GYMMAK.2|DNSTMGYM[Oxi]MAK.2|DNSTMGYMM[Oxi]AK.2|DNSTM[Oxi]GYM[Oxi]MAK.2|DNSTM[Oxi]GYMM[Oxi]AK.2|DNSTMGYM[Oxi]M[Oxi]AK.2|DNSTM[Oxi]GYM[Oxi]M[Oxi]AK.2|EIFLRELISNASDALDK.3|EISDDEAEEEK.2|TLTLVDTGIGMTKADLINNLGTIAK.4|TLTLVDTGIGMTKADLINNLGTIAK.3|RGFEVVYMTEPIDEYC[CAM]VQQLK.4|RGFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.3|RGFEVVYMTEPIDEYC[CAM]VQQLK.3|C[CAM]LELFSELAEDKENYK.3|KRGFEVVYMTEPIDEYC[CAM]VQQLK.4|KRGFEVVYM[Oxi]TEPIDEYC[CAM]VQQLK.4|KRGFEVVYMTEPIDEYC[CAM]VQQLK.3|TKPIWTRNPDDITQEEYGEFYK.4|TKPIWTRNPDDITQEEYGEFYK.3|LDSGKELKIDIIPNPQER.3|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.5|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.4|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASR.3|SLTNDWEDHLAVKHFSVEGQLEFR.4|SLTNDWEDHLAVKHFSVEGQLEFR.3|SLVSVTKEGLELPEDEEEK.3|VVVITKHNDDEQYAWESSAGGSFTVR.4|VVVITKHNDDEQYAWESSAGGSFTVR.3|C[CAM]LELFSELAEDK.2|DLVVLLFETALLSSGFSLEDPQTHSNR.4|DLVVLLFETALLSSGFSLEDPQTHSNR.3|GFEVVYMTEPIDEYC[CAM]VQQLKEFDGK.4|GFEVVYMTEPIDEYC[CAM]VQQLKEFDGK.3|IEDVGSDEEDDSGK.2|YIDQEELNKTKPIWTRNPDDITQEEYGEFYK.5|KC[CAM]LELFSELAEDK.2|PIWTRNPDDITQEEYGEFYK.3|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRM[Oxi]EEVD.4|LGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD.4
SEN / CTL,P48740,Mannan-binding lectin serine protease 1,MASP1,1.64,1.17,4.36E-05,2.17E-05,4.66E+00,"complement activation, lectin pathway,proteolysis,receptor-mediated endocytosis,complement activation","serine-type endopeptidase activity,calcium ion binding,protein binding,peptidase activity,protein homodimerization activity,calcium-dependent protein binding","extracellular region,extracellular space",15,18,21,TGVITSPDFPNPYPK.2|APGELEHGLITFSTR.3|APGELEHGLITFSTR.2|VLKDNVEMDTFQIEC[CAM]LK.3|DQVLVSC[CAM]DTGYK.2|APEPISTQSHSVLILFHSDNSGENR.4|APEPISTQSHSVLILFHSDNSGENR.3|SDFSNEER.2|VLGPFC[CAM]GEK.2|LRSDENEQHLGVK.3|VETEDQVLATFC[CAM]GR.3|VETEDQVLATFC[CAM]GR.2|AAGNEC[CAM]PELQPPVHGK.3|DSDLLSPSDFK.2|YSC[CAM]QEPYYK.2|VEC[CAM]SDNLFTQR.2|YGVYSYIHHNK.2|SLPTC[CAM]LPVC[CAM]GLPK.2|FPETLMEIEIPIVDHSTC[CAM]QK.3|DAC[CAM]AGDSGGPMVTLNR.2|DNVEMDTFQIEC[CAM]LK.2
SEN / CTL,P13693,Translationally-controlled tumor protein,TPT1,1.64,0.55,4.54E-04,1.79E-04,3.75E+00,"calcium ion transport,cellular calcium ion homeostasis,response to virus,cell differentiation,regulation of apoptotic process,negative regulation of apoptotic process,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage","calcium ion binding,protein binding,microtubule binding,poly(A) RNA binding","extracellular space,nucleus,cytoplasm,multivesicular body,extracellular exosome,tubulin complex",6,14,26,DLISHDEMFSDIYK.3|DLISHDEM[Oxi]FSDIYK.3|DLISHDEM[Oxi]FSDIYK.2|DLISHDEMFSDIYK.2|IREIADGLC[CAM]LEVEGK.3|IREIADGLC[CAM]LEVEGK.2|DGLEMEK.2|DGLEM[Oxi]EK.2|HILANFK.2|VKPFMTGAAEQIK.3|VKPFM[Oxi]TGAAEQIK.3|VKPFMTGAAEQIK.2|VKPFM[Oxi]TGAAEQIK.2|EIADGLC[CAM]LEVEGK.3|EIADGLC[CAM]LEVEGK.2|VKPFMTGAAEQIKHILANFK.4|MIIYRDLISHDEMFSDIYK.4|MIIYRDLISHDEMFSDIYK.3|PFMTGAAEQIK.2|PFM[Oxi]TGAAEQIK.2|GKLEEQRPER.2|EDGVTPYMIFFK.2|EDGVTPYMIFFKDGLEMEK.3|TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK.6|TEGNIDDSLIGGNASAEGPEGEGTESTVITGVDIVMNHHLQETSFTK.5|NYQFFIGENMNPDGMVALLDYR.3
SEN / CTL,Q92743,Serine protease HTRA1,HTRA1,1.63,0.62,1.04E-03,3.71E-04,3.43E+00,"regulation of cell growth,placenta development,proteolysis,extracellular matrix disassembly,negative regulation of transforming growth factor beta receptor signaling pathway,negative regulation of BMP signaling pathway,positive regulation of epithelial cell proliferation,negative regulation of defense response to virus,chorionic trophoblast cell differentiation,dentinogenesis","serine-type endopeptidase activity,insulin-like growth factor binding,serine-type peptidase activity","extracellular region,extracellular space,cytosol,plasma membrane,extracellular matrix,extracellular exosome",6,2,2,IAPAVVHIELFR.3|SSELRPGEFVVAIGSPFSLQNTVTTGIVSTTQR.3
SEN / CTL,O14950;P19105,Myosin regulatory light chain 12B;Myosin regulatory light chain 12A,MYL12B;MYL12A,1.63,0.44,1.93E-04,8.36E-05,4.08E+00,"muscle contraction,regulation of cell shape;muscle contraction,ephrin receptor signaling pathway,platelet aggregation","calcium ion binding,myosin heavy chain binding;calcium ion binding","stress fiber,cytosol,brush border,myosin II complex,Z disc,apical part of cell,extracellular exosome;cytosol,myosin complex,extracellular exosome",6,18,38,GNFNYIEFTR.2|ELLTTMGDRFTDEEVDELYR.3|ELLTTM[Oxi]GDRFTDEEVDELYR.3|EDLHDMLASLGK.3|EDLHDMLASLGK.2|KGNFNYIEFTR.3|KGNFNYIEFTR.2|FTDEEVDELYR.3|FTDEEVDELYR.2|DGFIDKEDLHDMLASLGK.4|DGFIDKEDLHDM[Oxi]LASLGK.4|DGFIDKEDLHDMLASLGK.3|DGFIDKEDLHDMLASLGK.2|ELLTTMGDR.2|ELLTTM[Oxi]GDR.2|LNGTDPEDVIR.2|EAFNMIDQNR.2|EAFNM[Oxi]IDQNR.2|EAFNMIDQNRDGFIDK.3|EAFNMIDQNRDGFIDK.2|EAFNMIDQNRDGFIDKEDLHDMLASLGK.5|EAFNMIDQNRDGFIDKEDLHDMLASLGK.4|EAFNM[Oxi]IDQNRDGFIDKEDLHDMLASLGK.4|EAPIDKKGNFNYIEFTR.3|FTDEEVDELYREAPIDK.3|FTDEEVDELYREAPIDK.2|ATSNVFAM[Oxi]FDQSQIQEFK.3|ATSNVFAMFDQSQIQEFK.3|ATSNVFAMFDQSQIQEFK.2|ATSNVFAM[Oxi]FDQSQIQEFK.2|ELLTTM[Oxi]GDRFTDEEVDELYREAPIDK.4|ELLTTMGDRFTDEEVDELYREAPIDK.4|ELLTTMGDRFTDEEVDELYREAPIDK.3|NAFAC[CAM]FDEEATGTIQEDYLR.3|NAFAC[CAM]FDEEATGTIQEDYLR.2|LNGTDPEDVIRNAFAC[CAM]FDEEATGTIQEDYLR.4|LNGTDPEDVIRNAFAC[CAM]FDEEATGTIQEDYLR.3|ATSNVFAMFDQSQIQEFKEAFNMIDQNR.3
SEN / CTL,Q9BS26,Endoplasmic reticulum resident protein 44,ERP44,1.63,1.82,4.64E-03,1.40E-03,2.85E+00,"protein folding,response to unfolded protein,glycoprotein metabolic process,response to endoplasmic reticulum stress,cell redox homeostasis",protein disulfide isomerase activity,"endoplasmic reticulum lumen,endoplasmic reticulum membrane,endoplasmic reticulum-Golgi intermediate compartment,cell surface,extracellular exosome",9,22,40,TPADC[CAM]PVIAIDSFR.2|TPADC[CAM]PVIAIDSFR.3|VANILHDDC[CAM]AFLSAFGDVSKPER.4|VANILHDDC[CAM]AFLSAFGDVSKPER.3|ALADYIR.2|GTINFLHADC[CAM]DKFR.4|GTINFLHADC[CAM]DKFR.3|RNIIGYFEQK.3|RNIIGYFEQK.2|GTINFLHADC[CAM]DK.3|GTINFLHADC[CAM]DK.2|HMYVFGDFKDVLIPGK.4|HMYVFGDFKDVLIPGK.3|HM[Oxi]YVFGDFKDVLIPGK.3|HMYVFGDFKDVLIPGK.2|SDPIQEIR.2|VDC[CAM]DQHSDIAQR.3|VDC[CAM]DQHSDIAQR.2|HPLLHIQK.2|NIIGYFEQK.2|DLAEITTLDR.2|HMYVFGDFK.2|HM[Oxi]YVFGDFK.2|EDTESLEIFQNEVAR.3|EDTESLEIFQNEVAR.2|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.6|FSQM[Oxi]LHPIFEEASDVIKEEFPNENQVVFAR.5|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.5|FSQM[Oxi]LHPIFEEASDVIKEEFPNENQVVFAR.4|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.4|FSQM[Oxi]LHPIFEEASDVIKEEFPNENQVVFAR.3|FSQMLHPIFEEASDVIKEEFPNENQVVFAR.3|QFVFDLHSGK.2|FSQMLHPIFEEASDVIK.3|SDPIQEIRDLAEITTLDR.3|LHREFHHGPDPTDTAPGEQAQDVASSPPESSFQK.5|LHREFHHGPDPTDTAPGEQAQDVASSPPESSFQK.4|EEFPNENQVVFAR.2|EFHHGPDPTDTAPGEQAQDVASSPPESSFQK.4|EITFENGEELTEEGLPFLILFHMK.3
SEN / CTL,O75369,Filamin-B,FLNB,1.62,1.07,8.26E-11,9.51E-11,1.00E+01,"keratinocyte development,epithelial cell morphogenesis,cytoskeletal anchoring at plasma membrane,signal transduction,skeletal muscle tissue development,actin cytoskeleton organization,cell-cell adhesion","actin binding,protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,cytosol,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,cell cortex,actin cytoskeleton,integral component of membrane,Z disc,extracellular matrix,extracellular exosome",27,208,346,VLFASQEIPASPFR.2|VLFASQEIPASPFR.3|SPFTVGVAAPLDLSK.2|SPFTVGVAAPLDLSK.3|GLHVVEVTYDDVPIPNSPFK.3|GLHVVEVTYDDVPIPNSPFK.4|GLHVVEVTYDDVPIPNSPFK.2|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.5|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.6|VHSPSGAVEEC[CAM]HVSELEPDKYAVR.4|TFEMSDFIVDTR.2|TFEMSDFIVDTR.3|TFEM[Oxi]SDFIVDTR.2|YMIGVTYGGDDIPLSPYR.2|YM[Oxi]IGVTYGGDDIPLSPYR.2|AHGPGLEGGLVGKPAEFTIDTK.4|AHGPGLEGGLVGKPAEFTIDTK.3|AGGPGLERGEAGVPAEFSIWTR.3|AGGPGLERGEAGVPAEFSIWTR.2|EATTDFTVDSRPLTQVGGDHIK.4|EATTDFTVDSRPLTQVGGDHIK.3|FIPHENGVHTIDVK.4|FIPHENGVHTIDVK.3|VAVTEGC[CAM]QPSR.3|VAVTEGC[CAM]QPSR.2|VKVEPAVDTSR.3|VKVEPAVDTSR.2|YAPTEVGLHEMHIK.4|YAPTEVGLHEM[Oxi]HIK.4|YAPTEVGLHEMHIK.3|YAPTEVGLHEM[Oxi]HIK.3|YAPTEVGLHEM[Oxi]HIK.2|AIVDGNLK.2|EVGEHLVSIKK.3|EVGEHLVSIKK.2|LDVTILSPSRK.3|LDVTILSPSRK.2|LNGLENR.2|RLPNNHIGISFIPR.4|RLPNNHIGISFIPR.3|AYGPGLEK.2|IKVFGPGIEGKDVFR.4|AWGPGLHGGIVGR.3|AWGPGLHGGIVGR.2|FNGSHVVGSPFK.3|FNGSHVVGSPFK.2|GDYVLAVK.2|PVTEKDLAEDAPWKK.4|PVTEKDLAEDAPWKK.3|VFGPGVER.2|VTVLFAGQHISK.3|VTVLFAGQHISK.2|VVPC[CAM]LVTPVTGR.3|VVPC[CAM]LVTPVTGR.2|AGVENGKPTHFTVYTK.4|AGVENGKPTHFTVYTK.3|APSGRDEPC[CAM]LLK.3|APSGRDEPC[CAM]LLK.2|GAGGQGKLDVTILSPSRK.4|GEITGEVHMPSGK.3|GEITGEVHMPSGK.2|VQAQGPGLK.2|YGGELVPHFPAR.3|YGGELVPHFPAR.2|VFGPGIEGK.2|AGLAPLEVR.2|GQHVTGSPFQFTVGPLGEGGAHK.5|GQHVTGSPFQFTVGPLGEGGAHK.4|GQHVTGSPFQFTVGPLGEGGAHK.3|YGGPNHIVGSPFK.3|YGGPNHIVGSPFK.2|AGPGTLSVTIEGPSK.3|AGPGTLSVTIEGPSK.2|KVVPC[CAM]LVTPVTGR.3|VFGPGIEGKDVFR.3|VDPSHDASK.2|YADEEIPRSPFK.3|YADEEIPRSPFK.2|YRGQHVTGSPFQFTVGPLGEGGAHKVR.6|YRGQHVTGSPFQFTVGPLGEGGAHKVR.5|AIVHDNKDGTYAVTYIPDKTGR.5|AIVHDNKDGTYAVTYIPDKTGR.4|IRETTDFKVDTK.3|KGEITGEVHMPSGK.3|KGEITGEVHM[Oxi]PSGK.3|LLGWIQNK.2|RLTVMSLQESGLK.3|RLTVMSLQESGLK.2|RLTVM[Oxi]SLQESGLK.2|VEPAVDTSR.2|IAGPGLGSGVR.2|IPEINSSDMSAHVTSPSGR.4|IPEINSSDM[Oxi]SAHVTSPSGR.3|IPEINSSDMSAHVTSPSGR.3|LPNNHIGISFIPR.3|WC[CAM]NEHLK.2|YADEEIPR.2|AEVSIQNNK.2|HTIAVVWGGVNIPHSPYR.4|HTIAVVWGGVNIPHSPYR.3|HTIAVVWGGVNIPHSPYR.2|VLPTYDASK.2|IQQNTFTR.2|SPFEVSVDK.2|FADEHVPGSPFTVK.3|FADEHVPGSPFTVK.2|KVVPC[CAM]LVTPVTGRENSTAK.4|NGNHVANSPVSIMVVQSEIGDARR.5|NGNHVANSPVSIMVVQSEIGDARR.4|NGNHVANSPVSIM[Oxi]VVQSEIGDARR.4|PAEFTIDTK.2|DLAEDAPWK.2|FVPQEMGVHTVSVK.3|FVPQEM[Oxi]GVHTVSVK.3|FVPQEM[Oxi]GVHTVSVK.2|FVPQEMGVHTVSVK.2|GIEPTGNMVK.2|GIEPTGNM[Oxi]VK.2|RIGNLQTDLSDGLR.3|RIGNLQTDLSDGLR.2|SSFLVDC[CAM]SK.2|AEISC[CAM]IDNK.2|AIVHDNKDGTYAVTYIPDK.4|AIVHDNKDGTYAVTYIPDK.3|DAGEGLLAVQITDQEGKPKR.4|DAGEGLLAVQITDQEGKPKR.3|VKMDC[CAM]QETPEGYK.3|VKMDC[CAM]QETPEGYK.2|YRGQHVTGSPFQFTVGPLGEGGAHK.5|YRGQHVTGSPFQFTVGPLGEGGAHK.4|YSIAITWGGHHIPK.3|YSIAITWGGHHIPK.2|AEITFDDHK.2|PGTYVIYVR.2|PVTEKDLAEDAPWK.3|SPFEVQVGPEAGMQK.3|SPFEVQVGPEAGMQK.2|SPFEVQVGPEAGM[Oxi]QK.2|ASSDASKVTSK.2|GAGIGGLGITVEGPSESK.3|GAGIGGLGITVEGPSESK.2|TATPEIVDNK.2|VDIQTEDLEDGTC[CAM]K.3|VDIQTEDLEDGTC[CAM]K.2|VEVGKDQEFTVDTR.3|VEVGKDQEFTVDTR.2|APSVATVGSIC[CAM]DLNLK.3|APSVATVGSIC[CAM]DLNLK.2|GAGGQGKLDVTILSPSR.3|GAGGQGKLDVTILSPSR.2|HVGNQQYNVTYVVK.3|HVGNQQYNVTYVVK.2|IEYNDQNDGSC[CAM]DVK.3|IEYNDQNDGSC[CAM]DVK.2|LDVTILSPSR.2|TYSVEYLPK.2|VHSPSGAVEEC[CAM]HVSELEPDK.4|VHSPSGAVEEC[CAM]HVSELEPDK.3|VNQPASFAIR.2|AAGSGELGVTMK.2|AAGSGELGVTM[Oxi]K.2|DQEFTVDTR.2|EVGEHLVSIK.2|GAGTGGLGLTVEGPC[CAM]EAK.3|GAGTGGLGLTVEGPC[CAM]EAK.2|IFAQDGEGQR.2|IFFAGDTIPK.2|SPFEVSVDKAQGDASK.3|SPFEVSVDKAQGDASK.2|EAFTNKPNVFTVVTR.3|EAFTNKPNVFTVVTR.2|IKVFGPGIEGK.2|IRATQTGDASK.2|KIQQNTFTR.2|RAIVHDNKDGTYAVTYIPDK.4|AIKHTIAVVWGGVNIPHSPYR.4|DGTC[CAM]TVTYLPTLPGDYSILVK.4|DGTC[CAM]TVTYLPTLPGDYSILVK.3|DGTC[CAM]TVTYLPTLPGDYSILVK.2|DSPYMAFIHPATGGYNPDLVR.4|DSPYMAFIHPATGGYNPDLVR.3|DSPYM[Oxi]AFIHPATGGYNPDLVR.3|DSPYMAFIHPATGGYNPDLVR.2|DVFREATTDFTVDSRPLTQVGGDHIK.5|DVFREATTDFTVDSRPLTQVGGDHIK.4|ERGDYVLAVK.2|NTVELLVEDK.2|VVASGPGLEHGK.2|DLAEDAPWKK.2|DVFREATTDFTVDSR.3|NRMDGTYAC[CAM]SYTPVK.3|NRM[Oxi]DGTYAC[CAM]SYTPVK.3|NRMDGTYAC[CAM]SYTPVK.2|VNIGQGSHPQK.2|VSYFPTVPGVYIVSTK.3|VSYFPTVPGVYIVSTK.2|VTEAEIVPMGK.2|VTEAEIVPM[Oxi]GK.2|APLNVQFNSPLPGDAVK.3|APLNVQFNSPLPGDAVK.2|SGC[CAM]IVNNLAEFTVDPK.3|SGC[CAM]IVNNLAEFTVDPK.2|VKVDPSHDASK.2|VPVKDVVDPSK.2|ADIEMPFDPSKVVASGPGLEHGK.4|AHGPGLEGGLVGK.2|VMYTPM[Oxi]APGNYLISVK.3|VMYTPMAPGNYLISVK.3|VMYTPMAPGNYLISVK.2|VM[Oxi]YTPM[Oxi]APGNYLISVK.2|VM[Oxi]YTPMAPGNYLISVK.2|VMYTPM[Oxi]APGNYLISVK.2|WGEEHIPGSPFHVTVP.3|WGEEHIPGSPFHVTVP.2|DLDIIDNYDYSHTVK.3|DLDIIDNYDYSHTVK.2|TATPEIVDNKDGTVTVR.3|TATPEIVDNKDGTVTVR.2|VKAHGPGLEGGLVGKPAEFTIDTK.4|VKAHGPGLEGGLVGKPAEFTIDTK.3|VLQSFTVDSSK.2|EATTDFTVDSR.2|IFAQDGEGQRIDIQMK.3|ADIEMPFDPSK.2|ADIEM[Oxi]PFDPSK.2|EAGAGGLSIAVEGPSKAEITFDDHK.4|EAGAGGLSIAVEGPSKAEITFDDHK.3|KNGNHVANSPVSIMVVQSEIGDAR.4|NTVELLVEDKGNQVYR.3|NTVELLVEDKGNQVYR.2|QMQLENVSVALEFLDR.3|QM[Oxi]QLENVSVALEFLDR.3|QM[Oxi]QLENVSVALEFLDR.2|QMQLENVSVALEFLDR.2|TGEEVGFVVDAK.2|VRAGGPGLERGEAGVPAEFSIWTR.4|C[CAM]LATGPGIASTVK.2|PFDLVIPFAVR.2|RLTVMSLQESGLKVNQPASFAIR.4|RLTVM[Oxi]SLQESGLKVNQPASFAIR.4|SPFVVQVGEAC[CAM]NPNAC[CAM]R.3|SPFVVQVGEAC[CAM]NPNAC[CAM]R.2|VFGPGIEGKDVFREATTDFTVDSRPLTQVGGDHIK.6|VTASGPGLSSYGVPASLPVDFAIDAR.4|VTASGPGLSSYGVPASLPVDFAIDAR.3|FNDEHIPESPYLVPVIAPSDDAR.4|FNDEHIPESPYLVPVIAPSDDAR.3|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.6|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.5|GAGKAPLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.4|VVPC[CAM]LVTPVTGRENSTAK.3|LTVMSLQESGLK.2|LTVM[Oxi]SLQESGLK.2|VQAQGPGLKEAFTNKPNVFTVVTR.4|DAGEGLLAVQITDQEGKPK.3|DAGEGLLAVQITDQEGKPK.2|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.6|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.4|TSRAPSVATVGSIC[CAM]DLNLK.3|DGTYAVTYIPDK.2|EPGEYAVHIMC[CAM]DDEDIK.3|SSTETC[CAM]YSAIPK.2|FNDEHIPESPYLVPVIAPSDDARR.4|FNDEHIPESPYLVPVIAPSDDARR.3|IPYLPITNFNQNWQDGK.3|IPYLPITNFNQNWQDGK.2|LVSPGSANETSSILVESVTR.3|LVSPGSANETSSILVESVTR.2|M[Oxi]DC[CAM]QETPEGYK.2|MDC[CAM]QETPEGYK.2|GAGKAPLNVQFNSPLPGDAVK.3|IGNLQTDLSDGLRLIALLEVLSQKR.4|YTIKVLFASQEIPASPFR.3|DFLDGVYAFEYYPSTPGR.3|DFLDGVYAFEYYPSTPGR.2|IGNLQTDLSDGLR.2|VLQSFTVDSSKAGLAPLEVR.3|VLQSFTVDSSKAGLAPLEVR.2|AAGSGELGVTM[Oxi]KGPK.2|VGEAGLLSVDC[CAM]SEAGPGALGLEAVSDSGTK.4|VGEAGLLSVDC[CAM]SEAGPGALGLEAVSDSGTK.3|APSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.5|APSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.4|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.6|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.5|DNKDGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFRVPVK.4|EAGAGGLSIAVEGPSK.2|LLGWIQNKIPYLPITNFNQNWQDGK.4|LLGWIQNKIPYLPITNFNQNWQDGK.3|M[Oxi]DGTYAC[CAM]SYTPVK.2|MDGTYAC[CAM]SYTPVK.2|DAGYGGISLAVEGPSK.2|DGTYAVTYVPLTAGMYTLTMK.3|DGTYAVTYVPLTAGMYTLTM[Oxi]K.3|DGTYAVTYVPLTAGM[Oxi]YTLTMK.2|DGTYAVTYVPLTAGMYTLTMK.2|GEAGVPAEFSIWTR.2|NGSC[CAM]GVSYIAQEPGNYEVSIK.3|NGSC[CAM]GVSYIAQEPGNYEVSIK.2|GLEELVKQKDFLDGVYAFEYYPSTPGR.4|QKDFLDGVYAFEYYPSTPGR.3|QKDFLDGVYAFEYYPSTPGR.2|QM[Oxi]QLENVSVALEFLDRESIK.3|QMQLENVSVALEFLDRESIK.3|QMQLENVSVALEFLDRESIK.2|TSRAPSVATVGSIC[CAM]DLNLKIPEINSSDMSAHVTSPSGR.5|YNDKHIPGSPFTAK.2|LTVMSLQESGLKVNQPASFAIR.3|NGNHVANSPVSIMVVQSEIGDAR.3|NGNHVANSPVSIMVVQSEIGDAR.2|YTPTQQGNMQVLVTYGGDPIPK.3|YTPTQQGNM[Oxi]QVLVTYGGDPIPK.3|AGSNM[Oxi]LLIGVHGPTTPC[CAM]EEVSMK.3|AGSNMLLIGVHGPTTPC[CAM]EEVSM[Oxi]K.3|AGSNMLLIGVHGPTTPC[CAM]EEVSMK.3|LNGLENRVEVGKDQEFTVDTR.3|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQKPVDNAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQKPVDNAR.3|LGSAADFLLDISETDLSSLTASIK.3|TATFTIVTEDAGEGGLDLAIEGPSK.3|ANEPTHFTVDC[CAM]TEAGEGDVSVGIK.3|EPGEYAVHIMC[CAM]DDEDIKDSPYMAFIHPATGGYNPDLVR.5|AHIANPSGASTEC[CAM]FVTDNADGTYQVEYTPFEK.4|AHIANPSGASTEC[CAM]FVTDNADGTYQVEYTPFEK.3|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFR.4|DGSC[CAM]SAEYIPFAPGDYDVNITYGGAHIPGSPFR.3|GLVEPVNVVDNGDGTHTVTYTPSQEGPYMVSVK.4|GLVEPVNVVDNGDGTHTVTYTPSQEGPYMVSVK.3|VLPTYDASKVTASGPGLSSYGVPASLPVDFAIDAR.4|ALGALVDSC[CAM]APGLC[CAM]PDWESWDPQK.3|APLNVQFNSPLPGDAVKDLDIIDNYDYSHTVK.4|SADFVVESIGSEVGSLGFAIEGPSQAK.3|IEC[CAM]SDNGDGTC[CAM]SVSYLPTKPGEYFVNILFEEVHIPGSPFK.5|IEC[CAM]SDNGDGTC[CAM]SVSYLPTKPGEYFVNILFEEVHIPGSPFK.4|EAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPK.5|EAMQQADDWLGVPQVITPEEIIHPDVDEHSVMTYLSQFPK.4|VGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTR.4|VLSEDEEDVDFDIIHNANDTFTVK.3|LGSAADFLLDISETDLSSLTASIKAPSGRDEPC[CAM]LLK.4|FTVDTISAGQGDVMVFVEDPEGNKEEAQVTPDSDKNK.4|VRVGEPGQAGNPALVSAYGTGLEGGTTGIQSEFFINTTR.4|YM[Oxi]GSHIPESPLQFYVNYPNSGSVSAYGPGLVYGVANK.4|YMGSHIPESPLQFYVNYPNSGSVSAYGPGLVYGVANK.4|DAGYGGISLAVEGPSKVDIQTEDLEDGTC[CAM]K.3|AEISC[CAM]IDNKDGTC[CAM]TVTYLPTLPGDYSILVK.3|EEGLYAVDVTYDGHPVPGSPYTVEASLPPDPSK.3
SEN / CTL,P06744,Glucose-6-phosphate isomerase,GPI,1.62,2.00,1.70E-03,5.65E-04,3.25E+00,"angiogenesis,in utero embryonic development,mesoderm formation,carbohydrate metabolic process,gluconeogenesis,humoral immune response,hemostasis,learning or memory,methylglyoxal biosynthetic process,response to estradiol,response to progesterone,response to testosterone,erythrocyte homeostasis,response to immobilization stress,response to muscle stretch,glucose homeostasis,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to morphine,negative regulation of neuron apoptotic process,aldehyde catabolic process,response to cadmium ion,glucose 6-phosphate metabolic process,canonical glycolysis","glucose-6-phosphate isomerase activity,cytokine activity,growth factor activity,intramolecular transferase activity,ubiquitin protein ligase binding,monosaccharide binding","extracellular space,nucleoplasm,cytoplasm,cytosol,plasma membrane,membrane,neuron projection,myelin sheath,ciliary membrane,extracellular exosome",12,49,107,ILLANFLAQTEALMR.2|ILLANFLAQTEALMR.3|ILLANFLAQTEALM[Oxi]R.3|ILLANFLAQTEALM[Oxi]R.2|MIPC[CAM]DFLIPVQTQHPIRK.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIRK.4|MIPC[CAM]DFLIPVQTQHPIRK.3|TLAQLNPESSLFIIASK.3|TLAQLNPESSLFIIASK.2|HFVALSTNTTK.3|HFVALSTNTTK.2|M[Oxi]LVDLAK.2|VWYVSNIDGTHIAK.4|VWYVSNIDGTHIAK.3|VWYVSNIDGTHIAK.2|KELQAAGKSPEDLER.4|KELQAAGKSPEDLER.3|INYTEGR.2|KELQAAGK.2|SPEDLER.2|RLFDANK.2|AVLHVALR.2|NRSNTPILVDGK.3|NRSNTPILVDGK.2|DRFNHFSLTLNTNHGHILVDYSK.6|DRFNHFSLTLNTNHGHILVDYSK.5|DRFNHFSLTLNTNHGHILVDYSK.4|DRFNHFSLTLNTNHGHILVDYSK.3|LTPFMLGALVAMYEHK.4|LTPFMLGALVAMYEHK.3|LTPFM[Oxi]LGALVAMYEHK.3|LTPFMLGALVAM[Oxi]YEHK.3|LTPFM[Oxi]LGALVAM[Oxi]YEHK.3|LTPFMLGALVAMYEHK.2|LTPFM[Oxi]LGALVAMYEHK.2|LTPFMLGALVAM[Oxi]YEHK.2|VRSGDWKGYTGK.3|DVM[Oxi]PEVNK.2|SPEDLERLLPHK.3|EWFLQAAK.2|FNHFSLTLNTNHGHILVDYSK.5|FNHFSLTLNTNHGHILVDYSK.4|FNHFSLTLNTNHGHILVDYSK.3|STEEARKELQAAGK.3|STEEARKELQAAGK.2|ELQAAGKSPEDLER.3|ELQAAGKSPEDLER.2|MIPC[CAM]DFLIPVQTQHPIR.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIR.4|M[Oxi]IPC[CAM]DFLIPVQTQHPIR.3|MIPC[CAM]DFLIPVQTQHPIR.3|MIPC[CAM]DFLIPVQTQHPIR.2|SNTPILVDGK.2|NLVTEDVMR.2|NLVTEDVM[Oxi]R.2|SGDWKGYTGK.2|TFTTQETITNAETAK.3|TFTTQETITNAETAK.2|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.6|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.5|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.4|VDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.3|EWFLQAAKDPSAVAK.3|EWFLQAAKDPSAVAK.2|FAAYFQQGDMESNGK.3|FAAYFQQGDM[Oxi]ESNGK.3|FAAYFQQGDMESNGK.2|FAAYFQQGDM[Oxi]ESNGK.2|GLHHKILLANFLAQTEALM[Oxi]R.4|GLHHKILLANFLAQTEALMR.4|LFDANKDRFNHFSLTLNTNHGHILVDYSK.6|LFDANKDRFNHFSLTLNTNHGHILVDYSK.5|LFDANKDRFNHFSLTLNTNHGHILVDYSK.4|RLFDANKDR.2|VFEGNRPTNSIVFTK.3|VFEGNRPTNSIVFTK.2|SNTPILVDGKDVMPEVNKVLDK.4|SNTPILVDGKDVMPEVNKVLDK.3|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.6|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.5|SGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTK.4|SNTPILVDGKDVMPEVNK.3|SNTPILVDGKDVM[Oxi]PEVNK.3|SNTPILVDGKDVM[Oxi]PEVNK.2|SNTPILVDGKDVMPEVNK.2|TFTTQETITNAETAKEWFLQAAK.4|TFTTQETITNAETAKEWFLQAAK.3|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.5|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.4|TITDVINIGIGGSDLGPLM[Oxi]VTEALKPYSSGGPR.4|TITDVINIGIGGSDLGPLM[Oxi]VTEALKPYSSGGPR.3|TITDVINIGIGGSDLGPLMVTEALKPYSSGGPR.3|IEPELDGSAQVTSHDASTNGLINFIK.4|IEPELDGSAQVTSHDASTNGLINFIK.3|KIEPELDGSAQVTSHDASTNGLINFIK.4|KIEPELDGSAQVTSHDASTNGLINFIK.3|FAAYFQQGDMESNGKYITK.3|FAAYFQQGDM[Oxi]ESNGKYITK.3|NRSNTPILVDGKDVMPEVNK.3|KIEPELDGSAQVTSHDASTNGLINFIKQQR.4|TFTTQETITNAETAKEWFLQAAKDPSAVAK.4|TFTTQETITNAETAKEWFLQAAKDPSAVAK.3|TITDVINIGIGGSDLGPLM[Oxi]VTEALK.3|TITDVINIGIGGSDLGPLMVTEALK.3|IFVQGIIWDINSFDQWGVELGK.3|VKEFGIDPQNMFEFWDWVGGR.3|EFGIDPQNMFEFWDWVGGR.2
SEN / CTL,P06733,Alpha-enolase,ENO1,1.61,1.13,2.03E-18,5.73E-18,1.72E+01,"gluconeogenesis,transcription, DNA-templated,response to virus,negative regulation of cell growth,negative regulation of transcription, DNA-templated,canonical glycolysis,cell-cell adhesion","magnesium ion binding,DNA binding,phosphopyruvate hydratase activity,protein binding,poly(A) RNA binding,GTPase binding,cadherin binding involved in cell-cell adhesion","phosphopyruvate hydratase complex,extracellular space,nucleus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,membrane,M band,extracellular exosome",66,54,117,SFIKDYPVVSIEDPFDQDDWGAWQK.3|SFIKDYPVVSIEDPFDQDDWGAWQK.4|VNQIGSVTESLQAC[CAM]K.2|VNQIGSVTESLQAC[CAM]K.3|YISPDQLADLYK.2|YISPDQLADLYK.3|AAVPSGASTGIYEALELR.3|AAVPSGASTGIYEALELR.2|GNPTVEVDLFTSK.2|GNPTVEVDLFTSK.3|YGKDATNVGDEGGFAPNILENKEGLELLK.4|YGKDATNVGDEGGFAPNILENKEGLELLK.3|YGKDATNVGDEGGFAPNILENKEGLELLK.5|AAVPSGASTGIYEALELRDNDKTR.4|AAVPSGASTGIYEALELRDNDKTR.3|LAMQEFMILPVGAANFR.2|LAMQEFMILPVGAANFR.3|LAMQEFMILPVGAANFR.4|LAM[Oxi]QEFM[Oxi]ILPVGAANFR.3|LAM[Oxi]QEFMILPVGAANFR.3|LAMQEFM[Oxi]ILPVGAANFR.3|LAM[Oxi]QEFM[Oxi]ILPVGAANFR.2|LAM[Oxi]QEFMILPVGAANFR.2|LAMQEFM[Oxi]ILPVGAANFR.2|SGKYDLDFKSPDDPSR.4|SGKYDLDFKSPDDPSR.3|SGKYDLDFKSPDDPSR.2|EIFDSRGNPTVEVDLFTSK.3|EIFDSRGNPTVEVDLFTSK.4|EIFDSRGNPTVEVDLFTSK.2|YNQLLRIEEELGSK.3|YNQLLRIEEELGSK.2|SGETEDTFIADLVVGLC[CAM]TGQIK.3|SGETEDTFIADLVVGLC[CAM]TGQIK.4|SGETEDTFIADLVVGLC[CAM]TGQIK.2|DATNVGDEGGFAPNILENKEGLELLK.3|DATNVGDEGGFAPNILENKEGLELLK.4|LMIEMDGTENK.2|LM[Oxi]IEMDGTENK.2|LMIEM[Oxi]DGTENK.2|LM[Oxi]IEM[Oxi]DGTENK.2|AVEHINK.2|EGLELLK.2|EGLELLK.1|IGAEVYHNLKNVIK.4|IGAEVYHNLKNVIK.3|AGAVEKGVPLYR.3|AVEHINKTIAPALVSK.4|AVEHINKTIAPALVSK.3|AVEHINKTIAPALVSK.2|LNVTEQEKIDK.3|LNVTEQEKIDK.2|TIAPALVSK.2|IEEELGSK.2|IGAEVYHNLKNVIKEK.4|IGAEVYHNLKNVIKEK.3|YNQLLRIEEELGSKAK.4|YNQLLRIEEELGSKAK.3|YNQLLRIEEELGSKAK.2|KLNVTEQEKIDK.3|KLNVTEQEKIDK.2|LNVTEQEK.2|NFRNPLAK.2|LAKYNQLLRIEEELGSK.4|LAKYNQLLRIEEELGSK.3|LMIEMDGTENKSK.3|LAQANGWGVMVSHR.3|LAQANGWGVM[Oxi]VSHR.3|LAQANGWGVMVSHR.2|LAQANGWGVM[Oxi]VSHR.2|SC[CAM]NC[CAM]LLLK.2|AVNEKSC[CAM]NC[CAM]LLLK.3|VVIGMDVAASEFFR.3|VVIGM[Oxi]DVAASEFFR.3|VVIGM[Oxi]DVAASEFFR.2|VVIGMDVAASEFFR.2|YDLDFKSPDDPSR.3|YDLDFKSPDDPSR.2|SGKYDLDFK.2|AGYTDKVVIGMDVAASEFFR.4|AGYTDKVVIGM[Oxi]DVAASEFFR.3|AGYTDKVVIGMDVAASEFFR.3|AGYTDKVVIGM[Oxi]DVAASEFFR.2|AGYTDKVVIGMDVAASEFFR.2|IDKLMIEMDGTENK.3|IDKLM[Oxi]IEMDGTENK.3|IDKLMIEM[Oxi]DGTENK.3|IDKLM[Oxi]IEM[Oxi]DGTENK.3|IDKLMIEMDGTENK.2|KLNVTEQEK.2|FTASAGIQVVGDDLTVTNPKR.4|FTASAGIQVVGDDLTVTNPKR.3|FTASAGIQVVGDDLTVTNPKR.2|AAVPSGASTGIYEALELRDNDK.4|AAVPSGASTGIYEALELRDNDK.3|AAVPSGASTGIYEALELRDNDK.2|IGAEVYHNLK.2|HIADLAGNSEVILPVPAFNVINGGSHAGNK.5|HIADLAGNSEVILPVPAFNVINGGSHAGNK.4|HIADLAGNSEVILPVPAFNVINGGSHAGNK.3|YISPDQLADLYKSFIK.3|EKYGKDATNVGDEGGFAPNILENK.4|LNVTEQEKIDKLMIEMDGTENK.4|DATNVGDEGGFAPNILENK.3|DATNVGDEGGFAPNILENK.2|FTASAGIQVVGDDLTVTNPK.3|FTASAGIQVVGDDLTVTNPK.2|SPDDPSRYISPDQLADLYK.3|SPDDPSRYISPDQLADLYK.2|YDLDFKSPDDPSRYISPDQLADLYK.4|YGKDATNVGDEGGFAPNILENK.3|DATNVGDEGGFAPNILENKEGLELLKTAIGK.4|DYPVVSIEDPFDQDDWGAWQK.3|IHAREIFDSRGNPTVEVDLFTSK.3|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM[Oxi]QEFM[Oxi]ILPVGAANFR.5|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAM[Oxi]QEFMILPVGAANFR.5|HIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFR.5
SEN / CTL,O75368,SH3 domain-binding glutamic acid-rich-like protein,SH3BGRL,1.60,1.28,7.58E-04,2.84E-04,3.55E+00,positive regulation of signal transduction,"SH3/SH2 adaptor activity,SH3 domain binding","extracellular space,nucleus,cytoplasm,extracellular exosome",9,12,17,VYIASSSGSTAIK.2|ENNAVYAFLGLTAPPGSK.3|ENNAVYAFLGLTAPPGSK.2|IGFEEKDIAANEENRK.4|IGFEEKDIAANEENRK.3|VYIASSSGSTAIKK.3|VYIASSSGSTAIKK.2|KQQDVLGFLEANK.3|KQQDVLGFLEANK.2|DIAANEENR.2|DIAANEENRK.2|GDYDAFFEAR.2|QQDVLGFLEANK.2|ENVPENSRPATGYPLPPQIFNESQYR.4|ENVPENSRPATGYPLPPQIFNESQYR.3|ENVPENSRPATGYPLPPQIFNESQYRGDYDAFFEAR.4|PATGYPLPPQIFNESQYR.2
SEN / CTL,Q9UBG0,C-type mannose receptor 2,MRC2,1.60,0.87,3.35E-04,1.36E-04,3.87E+00,"osteoblast differentiation,endocytosis,signal transduction,collagen catabolic process","transmembrane signaling receptor activity,protein binding,collagen binding,carbohydrate binding","integral component of plasma membrane,focal adhesion,membrane",9,30,39,TLGDQLSLLLGAR.2|DC[CAM]SIALPYVC[CAM]K.2|WSDGVGFSYHNFDR.3|WSDGVGFSYHNFDR.2|FFEHHSTWAQAQR.4|FFEHHSTWAQAQR.3|FFEHHSTWAQAQR.2|AGQLSQGAAEEDHGC[CAM]RK.4|C[CAM]VYMTASR.2|GTDVREPDDSPQGR.3|GTDVREPDDSPQGR.2|SC[CAM]TEETHGFIC[CAM]QK.3|SC[CAM]TEETHGFIC[CAM]QK.2|TPLWIGLAGEEGSRR.3|TESSGGWQNR.2|AGQLSQGAAEEDHGC[CAM]R.3|LC[CAM]TDHGSQLVTITNR.3|YDNQWFHGC[CAM]TSTGR.3|YDNQWFHGC[CAM]TSTGR.2|KAGQLSQGAAEEDHGC[CAM]R.3|RISYHGSC[CAM]PQGLADSAWIPFR.4|C[CAM]LTALPYIC[CAM]K.2|GAWLGMNFNPK.2|KAGQLSQGAAEEDHGC[CAM]RK.3|IFGESEPEIHEQHWFWIGLNR.4|IFGESEPEIHEQHWFWIGLNR.3|VEC[CAM]EPSWQPFQGHC[CAM]YR.3|C[CAM]FQVQGQEPQSR.2|TPLWIGLAGEEGSR.2|ISYHGSC[CAM]PQGLADSAWIPFR.3|ISYHGSC[CAM]PQGLADSAWIPFR.2|IYGSEEDLC[CAM]ALPYHEVYTIQGNSHGKPC[CAM]TIPFK.5|LQGAVC[CAM]GVSSGPPPPR.2|IC[CAM]TWFQAELTSVHSQAELDFLSHNLQK.4|IC[CAM]TWFQAELTSVHSQAELDFLSHNLQK.3|YLNWESDQPDNPSEENC[CAM]GVIR.3|DSLEDC[CAM]VTIWGPEGR.2|ETQPPDLPTTALGGC[CAM]PSDWIQFLNK.3|GWTWHSPSC[CAM]YWLGEDQVTYSEAR.3
SEN / CTL,P24593,Insulin-like growth factor-binding protein 5,IGFBP5,1.60,1.46,3.04E-02,7.55E-03,2.12E+00,"regulation of cell growth,osteoblast differentiation,glucose metabolic process,signal transduction,female pregnancy,aging,regulation of glucose metabolic process,negative regulation of smooth muscle cell migration,negative regulation of translation,negative regulation of cell migration,hair follicle morphogenesis,intracellular signal transduction,glucose homeostasis,positive regulation of insulin-like growth factor receptor signaling pathway,negative regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,negative regulation of osteoblast differentiation,negative regulation of growth,lung alveolus development,negative regulation of smooth muscle cell proliferation,striated muscle cell differentiation,positive regulation of protein kinase B signaling,mammary gland involution,response to growth hormone,cellular response to cAMP,cellular response to organic cyclic compound,negative regulation of muscle tissue development,negative regulation of skeletal muscle hypertrophy","fibronectin binding,protein binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,intracellular,insulin-like growth factor binding protein complex,insulin-like growth factor ternary complex",6,3,3,ALSMC[CAM]PPSPLGC[CAM]ELVK.2|HMEASLQELK.2|FVGGAENTAHPR.3
SEN / CTL,P04216,Thy-1 membrane glycoprotein,THY1,1.59,1.96,1.89E-01,3.93E-02,1.41E+00,"angiogenesis,negative regulation of protein kinase activity,cytoskeleton organization,single organismal cell-cell adhesion,negative regulation of cell migration,positive regulation of GTPase activity,retinal cone cell development,protein autophosphorylation,focal adhesion assembly,negative regulation of axonogenesis,T cell receptor signaling pathway,negative regulation of T cell receptor signaling pathway,positive regulation of T cell activation,positive regulation of release of sequestered calcium ion into cytosol","GTPase activator activity,integrin binding,protein binding,protein kinase binding,GPI anchor binding","endoplasmic reticulum,cytosol,plasma membrane,integral component of plasma membrane,focal adhesion,external side of plasma membrane,apical plasma membrane,dendrite,growth cone,anchored component of external side of plasma membrane,myelin sheath,membrane raft,extracellular exosome",3,4,7,KHVLFGTVGVPEHTYR.4|HVLFGTVGVPEHTYR.4|HVLFGTVGVPEHTYR.3|HVLFGTVGVPEHTYR.2|VTSLTAC[CAM]LVDQSLR.3|VTSLTAC[CAM]LVDQSLR.2|VLYLSAFTSK.2
SEN / CTL,Q9UJJ9,N-acetylglucosamine-1-phosphotransferase subunit gamma,GNPTG,1.59,0.59,5.36E-04,2.08E-04,3.68E+00,"N-glycan processing to lysosome,carbohydrate phosphorylation","UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,protein homodimerization activity","Golgi membrane,Golgi apparatus,extracellular exosome",6,6,9,LAHVSEPSTC[CAM]VYALTFETPLVC[CAM]HPHALLVYPTLPEALQR.5|LAHVSEPSTC[CAM]VYALTFETPLVC[CAM]HPHALLVYPTLPEALQR.4|QWDQVEQDLADELITPQGHEK.3|RDPSPVSGPVHLFR.3|GLLTQHGIPYTRPTETSNLEHLGHETPR.6|GLLTQHGIPYTRPTETSNLEHLGHETPR.4|TLFEDAGYLK.2|VVEEPNAFGVNNPFLPQASR.3|VVEEPNAFGVNNPFLPQASR.2
SEN / CTL,Q15121,Astrocytic phosphoprotein PEA-15,PEA15,1.59,0.81,7.76E-02,1.73E-02,1.76E+00,"DNA damage checkpoint,MAPK cascade,activation of MAPK activity,transport,apoptotic process,carbohydrate transport,response to morphine,negative regulation of glucose import,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors",protein binding,"cytosol,microtubule associated complex",3,11,16,RPDLLTMVVDYR.3|RPDLLTMVVDYR.2|SAC[CAM]KEDIPSEK.3|SAC[CAM]KEDIPSEK.2|VLKISEEDELDTK.3|QPSEEEIIK.2|DNLSYIEHIFEISR.3|DNLSYIEHIFEISR.2|ISEEDELDTK.2|SEEITTGSAWFSFLESHNKLDK.4|LDKDNLSYIEHIFEISR.3|SEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISR.6|SEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISR.5|SEEITTGSAWFSFLESHNK.3|SEEITTGSAWFSFLESHNK.2|DIIRQPSEEEIIK.2
SEN / CTL,P50990,T-complex protein 1 subunit theta,CCT8,1.58,1.11,7.79E-04,2.90E-04,3.54E+00,"protein folding,binding of sperm to zona pellucida,positive regulation of telomere maintenance via telomerase,pore complex assembly,protein stabilization,cell-cell adhesion,toxin transport,positive regulation of establishment of protein localization to telomere,positive regulation of protein localization to Cajal body,positive regulation of telomerase RNA localization to Cajal body","protein binding,ATP binding,ATPase activity, coupled,unfolded protein binding,cadherin binding involved in cell-cell adhesion","zona pellucida receptor complex,nucleoplasm,cytoplasm,centrosome,cytosol,chaperonin-containing T-complex,microtubule,cell-cell adherens junction,cilium,cell body,intermediate filament cytoskeleton,extracellular exosome",9,59,110,LFVTNDAATILR.2|LFVTNDAATILR.3|NLRDIDEVSSLLR.3|NLRDIDEVSSLLR.2|AIADTGANVVVTGGK.2|AIADTGANVVVTGGK.3|VADMALHYANK.3|VADM[Oxi]ALHYANK.3|VADMALHYANK.2|VADM[Oxi]ALHYANK.2|KFAEAFEAIPR.3|KFAEAFEAIPR.2|HFSGLEEAVYR.3|HFSGLEEAVYR.2|KAHEILPNLVC[CAM]C[CAM]SAK.4|KAHEILPNLVC[CAM]C[CAM]SAK.3|KAHEILPNLVC[CAM]C[CAM]SAK.2|TVGATALPR.2|ALAENSGVK.2|ILGSGISSSSVLHGMVFK.4|ILGSGISSSSVLHGMVFK.3|ILGSGISSSSVLHGM[Oxi]VFK.3|ILGSGISSSSVLHGM[Oxi]VFK.2|ILGSGISSSSVLHGMVFK.2|LVPGGGATEIELAK.3|LVPGGGATEIELAK.2|YNIMLVR.2|YNIM[Oxi]LVR.2|ETEGDVTSVKDAK.3|ETEGDVTSVKDAK.2|VDQIIMAK.2|VDQIIM[Oxi]AK.2|VDQIIMAKPAGGPKPPSGK.4|VDQIIMAKPAGGPKPPSGK.3|APGFAQMLK.2|APGFAQM[Oxi]LK.2|ILGSGISSSSVLHGMVFKK.4|ILGSGISSSSVLHGM[Oxi]VFKK.4|ILGSGISSSSVLHGMVFKK.3|NVGLDIEAEVPAVK.3|NVGLDIEAEVPAVK.2|MVINHLEK.2|M[Oxi]VINHLEK.2|PAGGPKPPSGK.2|RLVPGGGATEIELAK.3|RLVPGGGATEIELAK.2|DMLEAGILDTYLGK.3|DM[Oxi]LEAGILDTYLGK.3|DM[Oxi]LEAGILDTYLGK.2|DMLEAGILDTYLGK.2|NIQAC[CAM]KELAQTTR.3|NIQAC[CAM]KELAQTTR.2|HEKEDGAISTIVLR.3|HEKEDGAISTIVLR.2|ETEGDVTSVK.2|TAYGPNGMNK.2|TAYGPNGM[Oxi]NK.2|VADMALHYANKYNIMLVR.4|AHEILPNLVC[CAM]C[CAM]SAK.3|AHEILPNLVC[CAM]C[CAM]SAK.2|AVDDGVNTFK.2|ALAENSGVKANEVISK.3|ALAENSGVKANEVISK.2|QITSYGETC[CAM]PGLEQYAIKK.4|QITSYGETC[CAM]PGLEQYAIKK.3|QITSYGETC[CAM]PGLEQYAIKK.2|ELEVQHPAAK.2|LATNAAVTVLR.2|DIDEVSSLLR.2|FAEAFEAIPR.2|KDWDDDQND.2|LYAVHQEGNK.2|EDGAISTIVLR.2|QYGNEVFLAK.2|TAEELMNFSK.2|TAEELM[Oxi]NFSK.2|KETEGDVTSVK.2|IAVYSC[CAM]PFDGMITETK.3|IAVYSC[CAM]PFDGMITETK.2|IAVYSC[CAM]PFDGM[Oxi]ITETK.2|LFVTNDAATILRELEVQHPAAK.4|GEENLMDAQVK.2|GEENLM[Oxi]DAQVK.2|LIAQAC[CAM]VSIFPDSGHFNVDNIR.4|LIAQAC[CAM]VSIFPDSGHFNVDNIR.3|IGLSVSEVIEGYEIAC[CAM]R.3|IGLSVSEVIEGYEIAC[CAM]R.2|LYAVHQEGNKNVGLDIEAEVPAVK.4|LYAVHQEGNKNVGLDIEAEVPAVK.3|IGLSVSEVIEGYEIAC[CAM]RK.3|IGLSVSEVIEGYEIAC[CAM]RK.2|LATNAAVTVLRVDQIIMAK.3|LATNAAVTVLRVDQIIM[Oxi]AK.3|GSTDNLMDDIER.2|GSTDNLM[Oxi]DDIER.2|QITSYGETC[CAM]PGLEQYAIK.3|QITSYGETC[CAM]PGLEQYAIK.2|DMLEAGILDTYLGKYWAIK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEK.5|GSTDNLMDDIERAVDDGVNTFK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEKEDGAISTIVLR.6|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFKHEKEDGAISTIVLR.5|TAEELM[Oxi]NFSKGEENLMDAQVK.3|TAEELMNFSKGEENLM[Oxi]DAQVK.3|TAEELMNFSKGEENLMDAQVK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFK.4|LTPPVLEEM[Oxi]GHC[CAM]DSVYLSEVGDTQVVVFK.3|LTPPVLEEMGHC[CAM]DSVYLSEVGDTQVVVFK.3|LYAVHQEGNKNVGLDIEAEVPAVKDMLEAGILDTYLGK.5|NVGLDIEAEVPAVKDMLEAGILDTYLGK.3
SEN / CTL,Q13308,Inactive tyrosine-protein kinase 7,PTK7,1.58,1.30,1.35E-07,9.27E-08,7.03E+00,"establishment of planar polarity,ventricular septum development,axis elongation,protein phosphorylation,cell adhesion,signal transduction,positive regulation of neuron projection development,cell migration,actin cytoskeleton reorganization,wound healing,establishment of epithelial cell apical/basal polarity,convergent extension,canonical Wnt signaling pathway,lung-associated mesenchyme development,coronary vasculature development,cellular response to retinoic acid,cochlea morphogenesis,planar cell polarity pathway involved in neural tube closure","protein kinase activity,protein binding,ATP binding,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway","integral component of plasma membrane,cell-cell junction,focal adhesion",21,30,35,ADGSSLPEWVTDNAGTLHFAR.3|VVLAPQDVVVAR.2|WIEAGPVVLKHPASEAEIQPQTQVTLR.4|GLPEPSVWWEHAGVR.3|GLPEPSVWWEHAGVR.2|LKFTPPPQPQQC[CAM]MEFDKEATVPC[CAM]SATGR.4|GHELVLANIAESDAGVYTC[CAM]HAANLAGQR.4|HPASEAEIQPQTQVTLR.3|HPASEAEIQPQTQVTLR.4|DVYNSEYYHFR.3|DVYNSEYYHFR.2|VFTAGSEER.2|AQGLEEGVAETLVLVK.3|AQGLEEGVAETLVLVK.2|LPQPEGC[CAM]PSK.2|WIEAGPVVLK.2|SEFGEVFLAK.2|SSLQPITTLGK.2|DEQQQLDFR.2|QPSSQDALQGR.2|NQMLISEDSR.2|KPQDSQLEEGKPGYLDC[CAM]LTQATPK.4|VALC[CAM]TQVALGMEHLSNNR.3|LQDSGTFQC[CAM]VAR.2|YTC[CAM]IAGNSC[CAM]NIK.2|EAEPHYMVLEYVDLGDLK.3|KPQDSQLEEGKPGYLDC[CAM]LTQATPKPTVVWYR.5|DRPSFSEIASALGDSTVDSKP.3|FAQGSSLSFAAVDR.2|HTEAPLYVVDKPVPEESEGPGSPPPYK.4|TTVYQGHTALLQC[CAM]EAQGDPKPLIQWK.4|TTVYQGHTALLQC[CAM]EAQGDPKPLIQWK.3|C[CAM]MSSTPAGSIEAQAR.2|INSVEVYDGTWYR.2|GPPIILEATLHLAEIEDMPLFEPR.3
SEN / CTL,P60660,Myosin light polypeptide 6,MYL6,1.58,0.72,1.63E-07,1.09E-07,6.96E+00,"muscle contraction,skeletal muscle tissue development,muscle filament sliding","motor activity,calcium ion binding,structural constituent of muscle,actin-dependent ATPase activity","cytosol,brush border,membrane,myosin complex,unconventional myosin complex,extracellular matrix,vesicle,extracellular exosome",15,13,27,NKDQGTYEDYVEGLR.3|NKDQGTYEDYVEGLR.2|NKDQGTYEDYVEGLR.4|HVLVTLGEK.2|VLDFEHFLPMLQTVAK.3|VLDFEHFLPMLQTVAK.4|VLDFEHFLPM[Oxi]LQTVAK.3|VLDFEHFLPM[Oxi]LQTVAK.2|VLDFEHFLPMLQTVAK.2|ILYSQC[CAM]GDVMR.2|ILYSQC[CAM]GDVMR.3|ILYSQC[CAM]GDVM[Oxi]R.2|SDEMNVK.2|EAFQLFDRTGDGK.3|EAFQLFDRTGDGK.2|DQGTYEDYVEGLR.3|DQGTYEDYVEGLR.2|EAFQLFDR.2|VFDKEGNGTVMGAEIR.3|VFDKEGNGTVM[Oxi]GAEIR.3|VFDKEGNGTVMGAEIR.2|EGNGTVMGAEIR.2|EGNGTVM[Oxi]GAEIR.2|DQGTYEDYVEGLRVFDK.3|VLGNPKSDEM[Oxi]NVK.2|MTEEEVEM[Oxi]LVAGHEDSNGC[CAM]INYEAFVR.3|MTEEEVEMLVAGHEDSNGC[CAM]INYEAFVR.3
SEN / CTL,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,1.58,0.65,7.25E-19,2.40E-18,1.76E+01,"protein peptidyl-prolyl isomerization,RNA-dependent DNA biosynthetic process,protein folding,viral life cycle,uncoating of virus,fusion of virus membrane with host plasma membrane,virion assembly,viral release from host cell,entry into host cell,lipid particle organization,regulation of viral genome replication,positive regulation of viral genome replication,positive regulation of protein secretion,leukocyte migration,establishment of integrated proviral latency","peptidyl-prolyl cis-trans isomerase activity,protein binding,peptide binding,poly(A) RNA binding,virion binding,unfolded protein binding","extracellular region,extracellular space,nucleus,cytosol,focal adhesion,membrane,extracellular exosome",42,24,52,VSFELFADKVPK.3|VSFELFADKVPK.2|VNPTVFFDIAVDGEPLGR.3|VNPTVFFDIAVDGEPLGR.2|SIYGEKFEDENFILK.3|SIYGEKFEDENFILK.2|SIYGEKFEDENFILK.4|IIPGFMC[CAM]QGGDFTR.2|IIPGFMC[CAM]QGGDFTR.3|IIPGFM[Oxi]C[CAM]QGGDFTR.3|IIPGFM[Oxi]C[CAM]QGGDFTR.2|KITIADC[CAM]GQLE.2|KITIADC[CAM]GQLE.3|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAK.3|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAK.4|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAK.5|HTGPGILSM[Oxi]ANAGPNTNGSQFFIC[CAM]TAK.4|HTGPGILSM[Oxi]ANAGPNTNGSQFFIC[CAM]TAK.3|VSFELFADK.2|EGMNIVEAMER.2|EGMNIVEAMER.3|EGM[Oxi]NIVEAMER.2|EGMNIVEAM[Oxi]ER.2|EGM[Oxi]NIVEAM[Oxi]ER.2|VKEGMNIVEAMER.3|VKEGM[Oxi]NIVEAMER.3|VKEGMNIVEAM[Oxi]ER.3|VKEGM[Oxi]NIVEAM[Oxi]ER.3|VKEGMNIVEAMER.2|VKEGM[Oxi]NIVEAMER.2|VKEGMNIVEAM[Oxi]ER.2|VKEGM[Oxi]NIVEAM[Oxi]ER.2|ALSTGEKGFGYKGSC[CAM]FHR.5|ALSTGEKGFGYKGSC[CAM]FHR.4|ALSTGEKGFGYK.3|TEWLDGK.2|TEWLDGKHVVFGKVK.4|TAENFRALSTGEK.3|TAENFRALSTGEKGFGYK.4|TEWLDGKHVVFGK.3|TEWLDGKHVVFGK.2|VSFELFADKVPKTAENFR.4|ITIADC[CAM]GQLE.2|IIPGFM[Oxi]C[CAM]QGGDFTRHNGTGGK.4|IIPGFMC[CAM]QGGDFTRHNGTGGK.3|FEDENFILK.2|GFGYKGSC[CAM]FHR.2|MVNPTVFFDIAVDGEPLGR.3|M[Oxi]VNPTVFFDIAVDGEPLGR.3|MVNPTVFFDIAVDGEPLGR.2|HTGPGILSMANAGPNTNGSQFFIC[CAM]TAKTEWLDGK.4|SIYGEKFEDENFILKHTGPGILSM[Oxi]ANAGPNTNGSQFFIC[CAM]TAK.5
SEN / CTL,P60174,Triosephosphate isomerase,TPI1,1.58,1.46,1.10E-18,3.35E-18,1.75E+01,"gluconeogenesis,glycolytic process,pentose-phosphate shunt,multicellular organism development,glycerol catabolic process,glyceraldehyde-3-phosphate biosynthetic process,canonical glycolysis","triose-phosphate isomerase activity,ubiquitin protein ligase binding","extracellular space,nucleus,cytosol,extracellular exosome",78,37,70,VVLAYEPVWAIGTGK.2|VVLAYEPVWAIGTGK.3|KQSLGELIGTLNAAK.3|KQSLGELIGTLNAAK.2|IAVAAQNC[CAM]YK.2|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.5|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.4|VAHALAEGLGVIAC[CAM]IGEKLDEREAGITEK.3|QSLGELIGTLNAAK.2|QSLGELIGTLNAAK.3|VPADTEVVC[CAM]APPTAYIDFAR.3|VPADTEVVC[CAM]APPTAYIDFAR.2|VPADTEVVC[CAM]APPTAYIDFAR.4|HVFGESDELIGQK.3|HVFGESDELIGQK.2|IIYGGSVTGATC[CAM]K.2|IIYGGSVTGATC[CAM]K.3|KQSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.4|KQSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.5|VAHALAEGLGVIAC[CAM]IGEK.3|VAHALAEGLGVIAC[CAM]IGEK.2|VAHALAEGLGVIAC[CAM]IGEK.4|VAHALAEGLGVIAC[CAM]IGEKLDER.4|VAHALAEGLGVIAC[CAM]IGEKLDER.3|VTNGAFTGEISPGMIK.2|VTNGAFTGEISPGMIK.3|VTNGAFTGEISPGM[Oxi]IK.3|VTNGAFTGEISPGM[Oxi]IK.2|ELASQPDVDGFLVGGASLKPEFVDIINAK.3|ELASQPDVDGFLVGGASLKPEFVDIINAK.4|ELASQPDVDGFLVGGASLKPEFVDIINAKQ.4|ELASQPDVDGFLVGGASLKPEFVDIINAKQ.3|DC[CAM]GATWVVLGHSER.3|DC[CAM]GATWVVLGHSER.2|SNVSDAVAQSTR.2|SNVSDAVAQSTR.3|RHVFGESDELIGQK.4|RHVFGESDELIGQK.3|RHVFGESDELIGQK.2|LDEREAGITEK.3|LDEREAGITEK.2|VIADNVKDWSK.3|VIADNVKDWSK.2|VVFEQTK.2|DC[CAM]GATWVVLGHSERR.4|DC[CAM]GATWVVLGHSERR.3|DC[CAM]GATWVVLGHSERR.2|TATPQQAQEVHEKLR.4|TATPQQAQEVHEKLR.3|TATPQQAQEVHEKLRGWLK.5|TATPQQAQEVHEKLRGWLK.4|FFVGGNWK.2|TATPQQAQEVHEK.3|TATPQQAQEVHEK.2|LDEREAGITEKVVFEQTK.4|KFFVGGNWK.2|GWLKSNVSDAVAQSTR.3|PEFVDIINAK.2|HVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.5|HVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.4|VTNGAFTGEISPGM[Oxi]IKDC[CAM]GATWVVLGHSERR.5|VTNGAFTGEISPGMIKDC[CAM]GATWVVLGHSERR.5|RHVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.5|RHVFGESDELIGQKVAHALAEGLGVIAC[CAM]IGEK.4|VIADNVKDWSKVVLAYEPVWAIGTGK.4|IIYGGSVTGATC[CAM]KELASQPDVDGFLVGGASLKPEFVDIINAKQ.6|VTNGAFTGEISPGMIKDC[CAM]GATWVVLGHSER.4|SNVSDAVAQSTRIIYGGSVTGATC[CAM]K.3|QSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.4|QSLGELIGTLNAAKVPADTEVVC[CAM]APPTAYIDFAR.3
SEN / CTL,P05067,Amyloid beta A4 protein,APP,1.57,0.96,1.72E-07,1.14E-07,6.94E+00,"response to yeast,suckling behavior,platelet degranulation,mRNA polyadenylation,regulation of translation,protein phosphorylation,cellular copper ion homeostasis,endocytosis,response to oxidative stress,cell adhesion,regulation of epidermal growth factor-activated receptor activity,Notch signaling pathway,axonogenesis,mating behavior,locomotory behavior,axo-dendritic transport,cholesterol metabolic process,adult locomotory behavior,visual learning,cellular process,response to lead ion,negative regulation of endopeptidase activity,positive regulation of peptidase activity,positive regulation of G2/M transition of mitotic cell cycle,axon midline choice point recognition,neuron remodeling,dendrite development,antibacterial humoral response,antifungal humoral response,extracellular matrix organization,forebrain development,neuron projection development,ionotropic glutamate receptor signaling pathway,regulation of multicellular organism growth,regulation of protein binding,cellular protein metabolic process,innate immune response,negative regulation of neuron differentiation,positive regulation of mitotic cell cycle,positive regulation of transcription from RNA polymerase II promoter,collateral sprouting in absence of injury,regulation of synapse structure or activity,defense response to Gram-negative bacterium,defense response to Gram-positive bacterium,neuromuscular process controlling balance,synaptic growth at neuromuscular junction,neuron apoptotic process,smooth endoplasmic reticulum calcium ion homeostasis,cellular response to cAMP,cellular response to norepinephrine stimulus,amyloid fibril formation,cellular response to nerve growth factor stimulus","DNA binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding,heparin binding,peptidase activator activity,enzyme binding,identical protein binding,transition metal ion binding,PTB domain binding,growth factor receptor binding","extracellular region,extracellular space,nuclear envelope lumen,cytoplasm,endosome,smooth endoplasmic reticulum,rough endoplasmic reticulum,Golgi apparatus,cytosol,plasma membrane,integral component of plasma membrane,clathrin-coated pit,cell-cell junction,cell surface,integral component of membrane,ER to Golgi transport vesicle,axon,platelet alpha granule lumen,neuromuscular junction,endosome lumen,trans-Golgi network membrane,ciliary rootlet,terminal bouton,dendritic spine,dendritic shaft,intracellular membrane-bounded organelle,receptor complex,main axon,membrane raft,apical part of cell,synapse,perinuclear region of cytoplasm,spindle midzone,extracellular exosome,astrocyte projection,growth cone lamellipodium,growth cone filopodium",18,21,26,WYFDVTEGK.2|ISYGNDALMPSLTETK.2|AVIQHFQEKVESLEQEAANER.3|LALENYITALQAVPPRPR.3|STNLHDYGMLLPC[CAM]GIDK.3|STNLHDYGMLLPC[CAM]GIDK.2|LNMHMNVQNGKWDSDPSGTK.4|LNMHMNVQNGKWDSDPSGTK.3|QQLVETHMAR.3|THPHFVIPYR.3|HDSGYEVHHQK.3|YLETPGDENEHAHFQK.4|YLETPGDENEHAHFQK.3|WDSDPSGTK.2|AVIQHFQEK.2|C[CAM]LVGEFVSDALLVPDK.3|C[CAM]LVGEFVSDALLVPDK.2|QYTSIHHGVVEVDAAVTPEER.4|QYTSIHHGVVEVDAAVTPEER.3|LVFFAEDVGSNK.2|VESLEQEAANER.2|C[CAM]APFFYGGC[CAM]GGNR.2|MQQNGYENPTYK.2|EVC[CAM]SEQAETGPC[CAM]R.2|EGILQYC[CAM]QEVYPELQITNVVEANQPVTIQNWC[CAM]K.4|EQNYSDDVLANMISEPR.2
SEN / CTL,P18669,Phosphoglycerate mutase 1,PGAM1,1.55,0.68,1.33E-13,2.30E-13,1.26E+01,"gluconeogenesis,glycolytic process,regulation of glycolytic process,regulation of pentose-phosphate shunt,respiratory burst,canonical glycolysis","bisphosphoglycerate mutase activity,phosphoglycerate mutase activity,hydrolase activity,protein kinase binding,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity","cytoplasm,cytosol,membrane,extracellular exosome",30,38,83,ALPFWNEEIVPQIK.2|ALPFWNEEIVPQIK.3|YADLTEDQLPSC[CAM]ESLKDTIAR.3|YADLTEDQLPSC[CAM]ESLKDTIAR.4|FSGWYDADLSPAGHEEAKR.4|FSGWYDADLSPAGHEEAKR.3|FSGWYDADLSPAGHEEAKR.2|FSGWYDADLSPAGHEEAK.3|FSGWYDADLSPAGHEEAK.2|SYDVPPPPMEPDHPFYSNISK.3|SYDVPPPPMEPDHPFYSNISK.4|SYDVPPPPM[Oxi]EPDHPFYSNISK.4|SYDVPPPPM[Oxi]EPDHPFYSNISK.3|NLKPIKPMQFLGDEETVR.4|NLKPIKPM[Oxi]QFLGDEETVR.4|NLKPIKPMQFLGDEETVR.3|NLKPIKPM[Oxi]QFLGDEETVR.3|NLKPIKPMQFLGDEETVR.2|RYADLTEDQLPSC[CAM]ESLKDTIAR.4|RYADLTEDQLPSC[CAM]ESLKDTIAR.3|HGEAQVKIWR.3|HYGGLTGLNKAETAAK.4|HYGGLTGLNKAETAAK.3|LNERHYGGLTGLNKAETAAK.5|LNERHYGGLTGLNKAETAAK.4|LNERHYGGLTGLNKAETAAK.3|RVLIAAHGNSLR.3|RVLIAAHGNSLR.2|HGESAWNLENR.3|HGESAWNLENR.2|NLKPIKPMQFLGDEETVRK.5|NLKPIKPM[Oxi]QFLGDEETVRK.5|NLKPIKPM[Oxi]QFLGDEETVRK.4|NLKPIKPMQFLGDEETVRK.4|NLKPIKPMQFLGDEETVRK.3|NLKPIKPMQFLGDEETVRK.2|PIKPMQFLGDEETVRK.4|PIKPM[Oxi]QFLGDEETVRK.4|PIKPMQFLGDEETVRK.3|PIKPM[Oxi]QFLGDEETVRK.3|LVLIRHGESAWNLENR.4|LVLIRHGESAWNLENR.3|LVLIRHGESAWNLENR.2|AMEAVAAQGK.2|AM[Oxi]EAVAAQGK.2|PMQFLGDEETVRK.3|PM[Oxi]QFLGDEETVRK.3|PMQFLGDEETVRK.2|LNERHYGGLTGLNK.3|HYGGLTGLNK.2|ALPFWNEEIVPQIKEGKR.4|ALPFWNEEIVPQIKEGKR.2|KAMEAVAAQGK.2|KAM[Oxi]EAVAAQGK.2|HGESAWNLENRFSGWYDADLSPAGHEEAKR.6|HGESAWNLENRFSGWYDADLSPAGHEEAKR.5|VLIAAHGNSLR.2|PIKPMQFLGDEETVR.3|DAGYEFDIC[CAM]FTSVQK.3|DAGYEFDIC[CAM]FTSVQK.2|YADLTEDQLPSC[CAM]ESLK.3|YADLTEDQLPSC[CAM]ESLK.2|GGQALRDAGYEFDIC[CAM]FTSVQKR.4|GGQALRDAGYEFDIC[CAM]FTSVQKR.3|RGGQALRDAGYEFDIC[CAM]FTSVQK.4|DAGYEFDIC[CAM]FTSVQKR.3|DAGYEFDIC[CAM]FTSVQKR.2|RSYDVPPPPMEPDHPFYSNISK.4|RSYDVPPPPM[Oxi]EPDHPFYSNISK.4|RSYDVPPPPMEPDHPFYSNISK.3|HGESAWNLENRFSGWYDADLSPAGHEEAK.5|HGESAWNLENRFSGWYDADLSPAGHEEAK.4|ALPFWNEEIVPQIKEGK.3|RYADLTEDQLPSC[CAM]ESLK.3|SYDVPPPPMEPDHPFYSNISKDR.4|PMQFLGDEETVR.2|PM[Oxi]QFLGDEETVR.2|TLWTVLDAIDQM[Oxi]WLPVVR.3|HLEGLSEEAIMELNLPTGIPIVYELDK.4|HLEGLSEEAIM[Oxi]ELNLPTGIPIVYELDK.4|HLEGLSEEAIM[Oxi]ELNLPTGIPIVYELDK.3|HLEGLSEEAIMELNLPTGIPIVYELDK.3|HLEGLSEEAIMELNLPTGIPIVYELDKNLKPIKPMQFLGDEETVR.5
SEN / CTL,P07942,Laminin subunit beta-1,LAMB1,1.55,1.35,3.47E-22,1.65E-21,2.08E+01,"cell adhesion,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,extracellular matrix organization,positive regulation of cell migration,neuron projection development,substrate adhesion-dependent cell spreading,endodermal cell differentiation,odontogenesis,positive regulation of epithelial cell proliferation","structural molecule activity,extracellular matrix structural constituent","extracellular region,basement membrane,laminin-1 complex,laminin-2 complex,extracellular space,extracellular matrix,laminin-8 complex,laminin-10 complex,perinuclear region of cytoplasm,extracellular exosome",93,76,100,ISGVIGPYRETVDSVER.3|IPSWTGAGFVR.2|SC[CAM]YQDPVTLQLAC[CAM]VC[CAM]DPGYIGSR.3|C[CAM]GNTIPDDDNQVVSLSPGSR.3|C[CAM]GNTIPDDDNQVVSLSPGSR.2|GIETPQC[CAM]DQSTGQC[CAM]VC[CAM]VEGVEGPR.3|EGFYDLSSEDPFGC[CAM]K.2|YSDIEPSTEGEVIFR.2|YSDIEPSTEGEVIFR.3|NFLTQDSADLDSIEAVANEVLK.3|NFLTQDSADLDSIEAVANEVLK.2|VESLSQVEVILQHSAADIAR.3|VESLSQVEVILQHSAADIAR.2|GLNC[CAM]ELC[CAM]MDFYHDLPWRPAEGR.4|AMDLDQDVLSALAEVEQLSK.3|AM[Oxi]DLDQDVLSALAEVEQLSK.3|AMDLDQDVLSALAEVEQLSK.2|AM[Oxi]DLDQDVLSALAEVEQLSK.2|ALDPAFKIEDPYSPR.3|ALDPAFKIEDPYSPR.2|TC[CAM]SEC[CAM]QELFWGDPDVEC[CAM]R.2|C[CAM]FIC[CAM]NSQDPYHETLNPDSHLIENVVTTFAPNR.4|QYIQDRIPSWTGAGFVR.3|C[CAM]LAGYYGDPIIGSGDHC[CAM]RPC[CAM]PC[CAM]PDGPDSGR.4|EALEEAEKAQVAAEK.3|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.4|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.5|LSVTSTC[CAM]GLHKPEPYC[CAM]IVSHLQEDKK.6|LELPQYTSSDSDVESPYTLIDSLVLMPYC[CAM]K.3|YVVLPRPVC[CAM]FEK.3|ELAEQLEFIK.2|GNC[CAM]FC[CAM]YGHASEC[CAM]APVDGFNEEVEGMVHGHC[CAM]MC[CAM]R.5|GNC[CAM]FC[CAM]YGHASEC[CAM]APVDGFNEEVEGMVHGHC[CAM]MC[CAM]R.4|TFRPAAMLIER.3|YFAYDC[CAM]EASFPGISTGPMKK.3|LLDELAGK.2|GALDSITK.2|ISELERNVEELKR.4|PFYYQHPER.3|PFYYQHPER.2|DIRDPNFC[CAM]ER.3|RKAEM[Oxi]LQNEAK.3|YLEDKAQELAR.3|YLEDKAQELAR.2|KVENLIAK.2|LHTLGDNLLDSR.3|LHTLGDNLLDSR.2|VAVYSTC[CAM]L.2|EALEEAEK.2|ETVDSVER.2|SSDFGKTWGVYR.3|C[CAM]LYHTEGEHC[CAM]QFC[CAM]R.4|C[CAM]LYHTEGEHC[CAM]QFC[CAM]R.3|TLLAQANSK.2|ISGVIGPYR.2|IEDPYSPR.2|LNVEGEHC[CAM]DVC[CAM]K.3|LNVEGEHC[CAM]DVC[CAM]K.2|TPMTDVC[CAM]R.2|KVSEIKDILAQSPAAEPLK.4|KVSEIKDILAQSPAAEPLK.3|QSAEDILLK.2|TLDGELDEK.2|AEMLLEEAK.2|AEM[Oxi]LLEEAK.2|AEMLQNEAK.2|AEM[Oxi]LQNEAK.2|KAAQNSGEAEYIEK.3|KAAQNSGEAEYIEK.2|NC[CAM]EQC[CAM]KPFYYQHPER.4|TLLAQANSKLQLLKDLER.4|TLLAQANSKLQLLKDLER.3|ESQFKEKQEEQAR.3|ESQFKEKQEEQAR.2|VDDIIC[CAM]DSR.2|KAAQNSGEAEYIEKVVYTVK.4|KAAQNSGEAEYIEKVVYTVK.3|FGYYGDALQQDC[CAM]RK.3|KAEMLQNEAK.2|LIKDVTEMMAQVEVK.3|KVDDIIC[CAM]DSR.2|ELDSLQTEAESLDNTVK.3|ELDSLQTEAESLDNTVK.2|DRVEDVMMER.2|NIGNLFEEAEK.2|VSEIKDILAQSPAAEPLK.3|C[CAM]GGPGC[CAM]GGLVTVAHNAWQK.3|TLDGELDEKYK.2|DILAQSPAAEPLK.2|DVTEMMAQVEVK.2|AAQNSGEAEYIEK.2|AAQNSGEAEYIEKVVYTVK.3|YFQMSLEAEER.2|YYYAVYDMVVR.2|ERVESLSQVEVILQHSAADIAR.3|SLDIFTVGGSGDGVVTNSAWETFQR.3|PC[CAM]EC[CAM]HLQGSVNAFC[CAM]NPVTGQC[CAM]HC[CAM]FQGVYAR.4|C[CAM]APGTFGFGPSGC[CAM]KPC[CAM]EC[CAM]HLQGSVNAFC[CAM]NPVTGQC[CAM]HC[CAM]FQGVYAR.5|SC[CAM]AC[CAM]NPLGTIPGGNPC[CAM]DSETGHC[CAM]YC[CAM]K.3|ATGQC[CAM]LC[CAM]LPNVIGQNC[CAM]DR.2
SEN / CTL,P07355,Annexin A2,ANXA2,1.55,1.06,2.43E-18,6.38E-18,1.72E+01,"angiogenesis,membrane raft assembly,positive regulation of protein phosphorylation,negative regulation of receptor internalization,membrane budding,body fluid secretion,collagen fibril organization,positive regulation of vesicle fusion,negative regulation of low-density lipoprotein particle receptor catabolic process,osteoclast development,fibrinolysis,negative regulation of catalytic activity,positive regulation of fibroblast proliferation,positive regulation of binding,protein heterotetramerization,protein targeting to plasma membrane,response to thyroid hormone,cell-cell adhesion,negative regulation of receptor binding,positive regulation of receptor activity","protease binding,calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylinositol-4,5-bisphosphate binding,cytoskeletal protein binding,Rab GTPase binding,phospholipase A2 inhibitor activity,S100 protein binding,poly(A) RNA binding,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion,receptor activator activity","ruffle,basement membrane,extracellular space,nucleus,lysosomal membrane,endosome,early endosome,lipid particle,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,cell cortex,cell surface,membrane,basolateral plasma membrane,extrinsic component of plasma membrane,midbody,late endosome membrane,vesicle,myelin sheath adaxonal region,sarcolemma,melanosome,Schmidt-Lanterman incisure,macropinosome,perinuclear region of cytoplasm,extracellular exosome,PCSK9-AnxA2 complex,extracellular matrix,membrane raft",66,49,99,GLGTDEDSLIEIIC[CAM]SR.2|GLGTDEDSLIEIIC[CAM]SR.3|GVDEVTIVNILTNR.2|GVDEVTIVNILTNR.3|QDIAFAYQR.2|TDLEKDIISDTSGDFRK.4|TDLEKDIISDTSGDFRK.3|TDLEKDIISDTSGDFRK.2|RAEDGSVIDYELIDQDAR.3|RAEDGSVIDYELIDQDAR.2|RAEDGSVIDYELIDQDAR.4|TKGVDEVTIVNILTNR.3|TKGVDEVTIVNILTNR.4|TKGVDEVTIVNILTNR.2|SALSGHLETVILGLLK.3|SALSGHLETVILGLLK.4|SALSGHLETVILGLLK.2|TDLEKDIISDTSGDFR.3|TDLEKDIISDTSGDFR.4|TDLEKDIISDTSGDFR.2|AEDGSVIDYELIDQDAR.2|AEDGSVIDYELIDQDAR.3|ALLYLC[CAM]GGDD.2|GDLENAFLNLVQC[CAM]IQNKPLYFADR.3|GDLENAFLNLVQC[CAM]IQNKPLYFADR.4|SLYYYIQQDTKGDYQK.3|SLYYYIQQDTKGDYQK.2|RAEDGSVIDYELIDQDARDLYDAGVK.4|RAEDGSVIDYELIDQDARDLYDAGVK.3|SYSPYDMLESIR.2|SYSPYDMLESIR.3|SYSPYDM[Oxi]LESIR.3|SYSPYDM[Oxi]LESIR.2|SNAQRQDIAFAYQR.3|SNAQRQDIAFAYQR.2|SYSPYDMLESIRK.3|SYSPYDM[Oxi]LESIRK.3|SYSPYDM[Oxi]LESIRK.2|SYSPYDMLESIRK.2|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.4|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.5|EVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.3|SEVDMLK.2|TPAQYDASELK.3|TPAQYDASELK.2|TNQELQEINR.3|TNQELQEINR.2|KELASALK.2|DLYDAGVK.2|KLMVALAK.2|PLYFADR.2|KGTDVPKWISIM[Oxi]TER.4|KGTDVPKWISIMTER.3|KGTDVPKWISIM[Oxi]TER.3|DIISDTSGDFRK.3|DIISDTSGDFRK.2|YKSYSPYDMLESIRK.4|YKSYSPYDMLESIRK.3|SLYYYIQQDTK.3|SLYYYIQQDTK.2|DLYDAGVKR.2|WISIMTER.2|WISIM[Oxi]TER.2|AYTNFDAERDALNIETAIK.4|AYTNFDAERDALNIETAIK.3|AYTNFDAERDALNIETAIK.2|AYTNFDAER.2|DALNIETAIK.2|GTDVPKWISIMTER.3|GTDVPKWISIMTER.2|TNQELQEINRVYK.3|TNQELQEINRVYK.2|TPAQYDASELKASM[Oxi]K.3|TPAQYDASELKASMK.3|TPAQYDASELKASM[Oxi]K.2|TPAQYDASELKASMK.2|GRRAEDGSVIDYELIDQDAR.4|GRRAEDGSVIDYELIDQDAR.3|GRRAEDGSVIDYELIDQDAR.2|EMYKTDLEK.2|EVKGDLENAFLNLVQC[CAM]IQNK.4|EVKGDLENAFLNLVQC[CAM]IQNK.3|ELASALKSALSGHLETVILGLLK.4|ELASALKSALSGHLETVILGLLK.3|AYTNFDAERDALNIETAIKTK.4|DIISDTSGDFR.2|LSLEGDHSTPPSAYGSVK.3|LSLEGDHSTPPSAYGSVK.2|GDLENAFLNLVQC[CAM]IQNK.3|GDLENAFLNLVQC[CAM]IQNK.2|SALSGHLETVILGLLKTPAQYDASELKASM[Oxi]K.5|SALSGHLETVILGLLKTPAQYDASELKASMK.5|SALSGHLETVILGLLKTPAQYDASELKASMK.4|KEVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.5|KEVKGDLENAFLNLVQC[CAM]IQNKPLYFADR.4|AEDGSVIDYELIDQDARDLYDAGVK.4|AEDGSVIDYELIDQDARDLYDAGVK.3|SALSGHLETVILGLLKTPAQYDASELK.4|AEDGSVIDYELIDQDARDLYDAGVKR.4
SEN / CTL,P0CG47;P0CG48;P62979;P62987,Polyubiquitin-B;Polyubiquitin-C;Ubiquitin-40S ribosomal protein S27a;Ubiquitin-60S ribosomal protein L40,UBB;UBC;RPS27A;UBA52,1.55,1.04,3.04E-03,9.51E-04,3.02E+00,"G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,regulation of necrotic cell death,Wnt signaling pathway,endosomal transport,macroautophagy,viral life cycle,virion assembly,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,positive regulation of protein ubiquitination,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,mitochondrion transport along microtubule,neuron projection morphogenesis,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of mitochondrial membrane potential,Wnt signaling pathway, planar cell polarity pathway,regulation of proteasomal protein catabolic process,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of neuron death,regulation of signal transduction by p53 class mediator,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,positive regulation of protein monoubiquitination;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,regulation of necrotic cell death,Wnt signaling pathway,endosomal transport,macroautophagy,viral life cycle,virion assembly,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translation,translational initiation,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,regulation of necrotic cell death,Wnt signaling pathway,endosomal transport,macroautophagy,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator;G2/M transition of mitotic cell cycle,negative regulation of transcription from RNA polymerase II promoter,MAPK cascade,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,activation of MAPK activity,protein polyubiquitination,nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,stimulatory C-type lectin receptor signaling pathway,MyD88-dependent toll-like receptor signaling pathway,MyD88-independent toll-like receptor signaling pathway,glycogen biosynthetic process,transcription-coupled nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,nucleotide-excision repair, DNA incision, 5'-to lesion,nucleotide-excision repair, DNA gap filling,rRNA processing,translational initiation,cellular protein modification process,SRP-dependent cotranslational protein targeting to membrane,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,transforming growth factor beta receptor signaling pathway,Notch signaling pathway,I-kappaB kinase/NF-kappaB signaling,JNK cascade,fibroblast growth factor receptor signaling pathway,regulation of tumor necrosis factor-mediated signaling pathway,regulation of necrotic cell death,Wnt signaling pathway,endosomal transport,macroautophagy,viral life cycle,virion assembly,viral transcription,translesion synthesis,negative regulation of transforming growth factor beta receptor signaling pathway,anaphase-promoting complex-dependent catabolic process,regulation of type I interferon production,negative regulation of type I interferon production,tumor necrosis factor-mediated signaling pathway,nucleotide-excision repair, DNA incision,ion transmembrane transport,TRIF-dependent toll-like receptor signaling pathway,interstrand cross-link repair,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,ERBB2 signaling pathway,negative regulation of epidermal growth factor receptor signaling pathway,error-prone translesion synthesis,DNA damage response, detection of DNA damage,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,positive regulation of apoptotic process,negative regulation of apoptotic process,positive regulation of I-kappaB kinase/NF-kappaB signaling,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,cellular protein metabolic process,innate immune response,positive regulation of epidermal growth factor receptor signaling pathway,positive regulation of transcription from RNA polymerase II promoter,T cell receptor signaling pathway,positive regulation of NF-kappaB transcription factor activity,stress-activated MAPK cascade,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,regulation of transcription from RNA polymerase II promoter in response to hypoxia,nucleotide-binding oligomerization domain containing signaling pathway,global genome nucleotide-excision repair,error-free translesion synthesis,intracellular transport of virus,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,regulation of signal transduction by p53 class mediator","protein binding;protease binding,protein binding,poly(A) RNA binding;structural constituent of ribosome,protein binding,poly(A) RNA binding,metal ion binding;structural constituent of ribosome,protein binding","extracellular space,nucleus,nucleoplasm,mitochondrion,cytosol,plasma membrane,endosome membrane,endocytic vesicle membrane,neuron projection,neuronal cell body,extracellular exosome;extracellular space,nucleus,nucleoplasm,cytosol,plasma membrane,endosome membrane,endocytic vesicle membrane,extracellular exosome;extracellular space,nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,endosome membrane,small ribosomal subunit,membrane,cytosolic small ribosomal subunit,endocytic vesicle membrane,myelin sheath,extracellular exosome;extracellular space,nucleus,nucleoplasm,lysosomal membrane,cytosol,ribosome,plasma membrane,endosome membrane,endocytic vesicle membrane,extracellular exosome",6,1,2,TITLEVEPSDTIENVK.2|TITLEVEPSDTIENVK.3
SEN / CTL,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,1.54,0.59,9.80E-04,3.56E-04,3.45E+00,"protein peptidyl-prolyl isomerization,heart morphogenesis,protein folding,'de novo' protein folding,transforming growth factor beta receptor signaling pathway,SMAD protein complex assembly,protein maturation by protein folding,positive regulation of protein ubiquitination,positive regulation of protein binding,negative regulation of protein phosphatase type 2B activity,regulation of protein localization,regulation of activin receptor signaling pathway,protein refolding,T cell activation,positive regulation of I-kappaB kinase/NF-kappaB signaling,extracellular fibril organization,regulation of immune response,ventricular cardiac muscle tissue morphogenesis,regulation of ryanodine-sensitive calcium-release channel activity,heart trabecula formation,chaperone-mediated protein folding,calcium ion transmembrane transport,regulation of amyloid precursor protein catabolic process,amyloid fibril formation,negative regulation of release of sequestered calcium ion into cytosol,negative regulation of ryanodine-sensitive calcium-release channel activity","peptidyl-prolyl cis-trans isomerase activity,signal transducer activity,transforming growth factor beta receptor binding,protein binding,macrolide binding,FK506 binding,type I transforming growth factor beta receptor binding,ion channel binding,SMAD binding,activin binding,calcium channel inhibitor activity","cytoplasm,endoplasmic reticulum membrane,cytosol,terminal cisterna,membrane,Z disc,extracellular matrix,extracellular exosome",6,8,23,GWEEGVAQMSVGQR.2|GWEEGVAQMSVGQR.3|GWEEGVAQM[Oxi]SVGQR.2|RGQTC[CAM]VVHYTGMLEDGKK.5|RGQTC[CAM]VVHYTGM[Oxi]LEDGKK.4|RGQTC[CAM]VVHYTGMLEDGKK.4|RGQTC[CAM]VVHYTGMLEDGKK.3|RGQTC[CAM]VVHYTGM[Oxi]LEDGKK.3|GVQVETISPGDGR.3|GVQVETISPGDGR.2|RGQTC[CAM]VVHYTGMLEDGK.4|RGQTC[CAM]VVHYTGM[Oxi]LEDGK.4|RGQTC[CAM]VVHYTGMLEDGK.3|RGQTC[CAM]VVHYTGM[Oxi]LEDGK.3|RGQTC[CAM]VVHYTGM[Oxi]LEDGK.2|RGQTC[CAM]VVHYTGMLEDGK.2|GQTC[CAM]VVHYTGMLEDGK.3|GVQVETISPGDGRTFPK.3|LTISPDYAYGATGHPGIIPPHATLVFDVELLK.5|LTISPDYAYGATGHPGIIPPHATLVFDVELLK.4|LTISPDYAYGATGHPGIIPPHATLVFDVELLK.3|QEVIRGWEEGVAQMSVGQR.3|QEVIRGWEEGVAQMSVGQR.2
SEN / CTL,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,1.54,0.48,4.18E-04,1.65E-04,3.78E+00,"gluconeogenesis,tricarboxylic acid cycle,oxaloacetate metabolic process,malate metabolic process,NADH metabolic process","malic enzyme activity,L-malate dehydrogenase activity,diiodophenylpyruvate reductase activity,NAD binding","extracellular space,cytoplasm,mitochondrion,centrosome,cytosol,myelin sheath,extracellular exosome",6,23,39,FVEGLPINDFSR.2|NVIIWGNHSSTQYPDVNHAK.4|NVIIWGNHSSTQYPDVNHAK.5|NVIIWGNHSSTQYPDVNHAK.3|NVIIWGNHSSTQYPDVNHAK.2|AIC[CAM]DHVR.2|LSSAMSAAK.2|LGVTANDVK.2|DVIATDKEDVAFK.3|DVIATDKEDVAFK.2|KLSSAMSAAK.2|KLSSAM[Oxi]SAAK.2|EVGVYEALK.2|ENFSC[CAM]LTR.2|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.6|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.5|LGVTANDVKNVIIWGNHSSTQYPDVNHAK.4|ESAFEFLSSA.2|FVEGLPINDFSREK.3|SAPSIPKENFSC[CAM]LTR.3|SAPSIPKENFSC[CAM]LTR.2|SQGAALDKYAK.2|EVGVYEALKDDSWLK.3|EVGVYEALKDDSWLK.2|GEFVTTVQQR.2|VIVVGNPANTNC[CAM]LTASK.3|VIVVGNPANTNC[CAM]LTASK.2|ELTEEKESAFEFLSSA.3|ELTEEKESAFEFLSSA.2|VLVTGAAGQIAYSLLYSIGNGSVFGK.4|VLVTGAAGQIAYSLLYSIGNGSVFGK.3|DLDVAILVGSMPR.2|DLDVAILVGSM[Oxi]PR.2|SVKVIVVGNPANTNC[CAM]LTASK.3|DVIATDKEDVAFKDLDVAILVGSMPR.4|DVIATDKEDVAFKDLDVAILVGSM[Oxi]PR.4|DVIATDKEDVAFKDLDVAILVGSMPR.3|EVGVYEALKDDSWLKGEFVTTVQQR.4|EVGVYEALKDDSWLKGEFVTTVQQR.3
SEN / CTL,P54802,Alpha-N-acetylglucosaminidase,NAGLU,1.54,1.24,8.48E-06,4.57E-06,5.34E+00,"glycosaminoglycan catabolic process,lysosome organization,nervous system development,cerebellar Purkinje cell layer development,middle ear morphogenesis,locomotor rhythm,retinal rod cell development,inner ear receptor cell development",alpha-N-acetylglucosaminidase activity,"lysosome,lysosomal lumen,extracellular exosome",15,21,31,FLLGSWLEQAR.2|YDLLDLTR.2|AGGVLAYELLPALDEVLASDSR.3|AGGVLAYELLPALDEVLASDSR.2|KDPVPDLAAWVTSFAAR.3|LLGPGPAADFSVSVER.2|YGVSHPDAGAAWR.3|QLAGLVANYYTPR.3|QLAGLVANYYTPR.2|LLLTSAPSLATSPAFR.3|LLLTSAPSLATSPAFR.2|GSTGVAAAAGLHR.2|DFC[CAM]GC[CAM]HVAWSGSQLR.3|DFC[CAM]GC[CAM]HVAWSGSQLR.2|ALAAKPGLDTYSLGGGGAAR.3|AAAVSEAEADFYEQNSR.3|AAAVSEAEADFYEQNSR.2|LLVLDLFAESQPVYTR.3|LLVLDLFAESQPVYTR.2|LFLEALVDSVAQGIPFQQHQFDK.4|LFLEALVDSVAQGIPFQQHQFDK.3|LPRPLPAVPGELTEATPNR.3|GRLLVLDLFAESQPVYTR.3|PGLDTYSLGGGGAAR.2|YQLTLWGPEGNILDYANK.3|YQLTLWGPEGNILDYANK.2|SFGM[Oxi]TPVLPAFAGHVPEAVTR.3|SFGMTPVLPAFAGHVPEAVTR.3|SFGMTPVLPAFAGHVPEAVTR.2|NVFQLEQAFVLSK.2|DPVPDLAAWVTSFAAR.2
SEN / CTL,P26641,Elongation factor 1-gamma,EEF1G,1.53,0.41,2.36E-02,5.95E-03,2.23E+00,"translational elongation,glutathione metabolic process,response to virus,cell-cell adhesion","translation elongation factor activity,glutathione transferase activity,protein binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cell-cell adherens junction,membrane,extracellular exosome,endoplasmic reticulum",3,36,59,ALIAAQYSGAQVR.2|ALIAAQYSGAQVR.3|FAETQPK.2|STFVLDEFKR.3|STFVLDEFKR.2|TFLVGER.2|EYFSWEGAFQHVGK.4|EYFSWEGAFQHVGK.3|EYFSWEGAFQHVGK.2|QATENAKEEVR.3|QATENAKEEVR.2|RILGLLDAYLK.3|RILGLLDAYLK.2|VLSAPPHFHFGQTNR.4|VLSAPPHFHFGQTNR.3|VLSAPPHFHFGQTNR.2|TPEFLRK.2|DPFAHLPK.2|KFAETQPK.2|QAFPNTNR.2|QATENAKEEVRR.3|LDPGSEETQTLVR.3|LDPGSEETQTLVR.2|QVLEPSFR.2|VLSAPPHFHFGQTNRTPEFLR.5|KLDPGSEETQTLVR.3|KLDPGSEETQTLVR.2|WFLTC[CAM]INQPQFR.3|WFLTC[CAM]INQPQFR.2|STFVLDEFK.2|ILGLLDAYLK.2|AKDPFAHLPK.2|YSNEDTLSVALPYFWEHFDK.4|YSNEDTLSVALPYFWEHFDK.3|FPEELTQTFMSC[CAM]NLITGMFQR.4|FPEELTQTFM[Oxi]SC[CAM]NLITGMFQR.3|FPEELTQTFMSC[CAM]NLITGMFQR.3|KYSNEDTLSVALPYFWEHFDK.4|KYSNEDTLSVALPYFWEHFDK.3|RKYSNEDTLSVALPYFWEHFDK.4|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIM[Oxi]HHNK.6|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.6|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.5|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIM[Oxi]HHNK.4|GSTPEAAAQVVQWVSFADSDIVPPASTWVFPTLGIMHHNK.4|DGWSLWYSEYR.2|AAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.3|AAAPAPEEEMDEC[CAM]EQALAAEPK.3|AAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.2|AAAPAPEEEMDEC[CAM]EQALAAEPK.2|KLDPGSEETQTLVREYFSWEGAFQHVGK.4|KAAAPAPEEEMDEC[CAM]EQALAAEPK.3|KAAAPAPEEEM[Oxi]DEC[CAM]EQALAAEPK.3|QAFPNTNRWFLTC[CAM]INQPQFR.3|NAFASVILFGTNNSSSISGVWVFR.3|GQELAFPLSPDWQVDYESYTWR.3|GQELAFPLSPDWQVDYESYTWRK.3|KFPAGKVPAFEGDDGFC[CAM]VFESNAIAYYVSNEELR.4|VPAFEGDDGFC[CAM]VFESNAIAYYVSNEELR.3
SEN / CTL,P05387,60S acidic ribosomal protein P2,RPLP2,1.52,1.47,8.38E-05,3.88E-05,4.41E+00,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,cytoplasmic translation,rRNA processing,translation,translational initiation,translational elongation,SRP-dependent cotranslational protein targeting to membrane,viral transcription","structural constituent of ribosome,large ribosomal subunit rRNA binding","cytosol,focal adhesion,membrane,cytosolic large ribosomal subunit,preribosome, large subunit precursor,extracellular exosome",15,13,30,NIEDVIAQGIGK.2|NIEDVIAQGIGK.3|YVASYLLAALGGNSSPSAK.2|YVASYLLAALGGNSSPSAK.3|YVASYLLAALGGNSSPSAK.4|ILDSVGIEADDDRLNK.3|ILDSVGIEADDDRLNK.2|ILDSVGIEADDDR.3|ILDSVGIEADDDR.2|KILDSVGIEADDDRLNK.4|KILDSVGIEADDDRLNK.3|KILDSVGIEADDDRLNK.2|KILDSVGIEADDDR.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.6|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.5|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKKDEK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.5|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEK.3|ILDSVGIEADDDRLNKVISELNGK.4|ILDSVGIEADDDRLNKVISELNGK.3|RYVASYLLAALGGNSSPSAK.3|RYVASYLLAALGGNSSPSAK.2|VISELNGKNIEDVIAQGIGK.3|VISELNGKNIEDVIAQGIGK.2|M[Oxi]RYVASYLLAALGGNSSPSAK.3|MRYVASYLLAALGGNSSPSAK.3|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKK.4|LASVPAGGAVAVSAAPGSAAPAAGSAPAAAEEKK.3
SEN / CTL,P30041,Peroxiredoxin-6,PRDX6,1.52,1.30,1.74E-12,2.59E-12,1.16E+01,"response to reactive oxygen species,lipid catabolic process,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction process,cell-cell adhesion,cellular oxidant detoxification","glutathione peroxidase activity,protein binding,hydrolase activity,ubiquitin protein ligase binding,peroxiredoxin activity,cadherin binding involved in cell-cell adhesion","extracellular space,cytoplasm,lysosome,cytosol,cell-cell adherens junction,membrane,cytoplasmic, membrane-bounded vesicle,extracellular exosome",45,31,62,FHDFLGDSWGILFSHPR.4|FHDFLGDSWGILFSHPR.3|FHDFLGDSWGILFSHPR.2|PGGLLLGDVAPNFEANTTVGR.3|PGGLLLGDVAPNFEANTTVGR.2|PGGLLLGDVAPNFEANTTVGR.4|IRFHDFLGDSWGILFSHPR.4|IRFHDFLGDSWGILFSHPR.3|DFTPVC[CAM]TTELGR.2|DFTPVC[CAM]TTELGR.3|LIALSIDSVEDHLAWSK.3|LIALSIDSVEDHLAWSK.2|ELAILLGMLDPAEKDEK.3|ELAILLGMLDPAEKDEK.2|ELAILLGM[Oxi]LDPAEKDEK.3|ELAILLGM[Oxi]LDPAEKDEK.2|VATPVDWKDGDSVMVLPTIPEEEAK.3|VATPVDWKDGDSVMVLPTIPEEEAK.4|LKLSILYPATTGR.3|LKLSILYPATTGR.2|DINAYNC[CAM]EEPTEKLPFPIIDDRNR.4|LPFPIIDDRNR.3|NFDEILR.2|VVISLQLTAEKR.3|VVISLQLTAEKR.2|VATPVDWK.2|ELAILLGMLDPAEK.3|ELAILLGMLDPAEK.2|ELAILLGM[Oxi]LDPAEK.2|VVFVFGPDK.2|DINAYNC[CAM]EEPTEK.3|DINAYNC[CAM]EEPTEK.2|NRELAILLGMLDPAEKDEK.4|NRELAILLGM[Oxi]LDPAEKDEK.3|NRELAILLGMLDPAEKDEK.3|RVATPVDWK.2|LPFPIIDDR.2|NFDEILRVVISLQLTAEKR.4|NFDEILRVVISLQLTAEKR.3|VVFVFGPDKK.2|NRELAILLGMLDPAEK.3|NRELAILLGM[Oxi]LDPAEK.3|NRELAILLGMLDPAEK.2|LSILYPATTGR.2|VVISLQLTAEK.2|DGDSVM[Oxi]VLPTIPEEEAK.3|DGDSVMVLPTIPEEEAK.3|DGDSVMVLPTIPEEEAK.2|DGDSVM[Oxi]VLPTIPEEEAK.2|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.6|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.5|IRFHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.4|DGDSVMVLPTIPEEEAKK.3|DGDSVM[Oxi]VLPTIPEEEAKK.3|DGDSVMVLPTIPEEEAKK.2|DINAYNC[CAM]EEPTEKLPFPIIDDR.4|DINAYNC[CAM]EEPTEKLPFPIIDDR.3|FHDFLGDSWGILFSHPRDFTPVC[CAM]TTELGR.5|VATPVDWKDGDSVMVLPTIPEEEAKK.4|RVATPVDWKDGDSVM[Oxi]VLPTIPEEEAK.4|RVATPVDWKDGDSVMVLPTIPEEEAK.4|RVATPVDWKDGDSVMVLPTIPEEEAK.3
SEN / CTL,O14786,Neuropilin-1,NRP1,1.52,0.80,6.85E-08,5.00E-08,7.30E+00,"angiogenesis,patterning of blood vessels,neuron migration,positive regulation of endothelial cell proliferation,sprouting angiogenesis,cell migration involved in sprouting angiogenesis,signal transduction,cell-cell signaling,axon guidance,axonal fasciculation,response to wounding,animal organ morphogenesis,positive regulation of endothelial cell migration,positive regulation of smooth muscle cell migration,dendrite development,facial nerve structural organization,trigeminal nerve structural organization,vestibulocochlear nerve structural organization,nerve development,branchiomotor neuron axon guidance,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,retinal ganglion cell axon guidance,cellular response to hepatocyte growth factor stimulus,endothelial cell chemotaxis,cellular response to vascular endothelial growth factor stimulus,ventral trunk neural crest cell migration,VEGF-activated neuropilin signaling pathway,negative regulation of neuron apoptotic process,platelet-derived growth factor receptor signaling pathway,vascular endothelial growth factor receptor signaling pathway,hepatocyte growth factor receptor signaling pathway,positive regulation of axon extension involved in axon guidance,negative regulation of axon extension involved in axon guidance,artery morphogenesis,axon extension involved in axon guidance,positive regulation of peptidyl-tyrosine phosphorylation,positive chemotaxis,positive regulation of cytokine activity,axonogenesis involved in innervation,regulation of vesicle-mediated transport,dichotomous subdivision of terminal units involved in salivary gland branching,angiogenesis involved in coronary vascular morphogenesis,coronary artery morphogenesis,retina vasculature morphogenesis in camera-type eye,renal artery morphogenesis,sympathetic ganglion development,trigeminal ganglion development,positive regulation of ERK1 and ERK2 cascade,semaphorin-plexin signaling pathway,commissural neuron axon guidance,regulation of retinal ganglion cell axon guidance,endothelial tip cell fate specification,sensory neuron axon guidance,sympathetic neuron projection extension,sympathetic neuron projection guidance,neural crest cell migration involved in autonomic nervous system development,toxin transport,semaphorin-plexin signaling pathway involved in neuron projection guidance,semaphorin-plexin signaling pathway involved in axon guidance,positive regulation of retinal ganglion cell axon guidance,VEGF-activated neuropilin signaling pathway involved in axon guidance,protein localization to early endosome,facioacoustic ganglion development,dorsal root ganglion morphogenesis,otic placode development,negative regulation of extrinsic apoptotic signaling pathway","vascular endothelial growth factor-activated receptor activity,heparin binding,coreceptor activity,semaphorin receptor activity,growth factor binding,cytokine binding,vascular endothelial growth factor binding,metal ion binding","semaphorin receptor complex,extracellular space,early endosome,cytosol,neurofilament,plasma membrane,focal adhesion,cell surface,integral component of membrane,axon,growth cone,cytoplasmic vesicle,neuronal cell body,receptor complex,sorting endosome",18,12,14,EGNKPVLFQGNTNPTDVVVAVFPKPLITR.4|FVTAVGTQGAISK.2|YDRLEIWDGFPDVGPHIGR.4|IAPPPVVSSGPFLFIK.2|IAPPPVVSSGPFLFIK.3|FVSDYETHGAGFSIR.3|IESPGYLTSPGYPHSYHPSEK.4|IESPGYLTSPGYPHSYHPSEK.3|C[CAM]GDTIKIESPGYLTSPGYPHSYHPSEK.5|SSSGILSMVFYTDSAIAK.3|DKLNTQSTYSEA.2|LYQVIFEGEIGK.2|SFEGNNNYDTPELR.2|EGNKPVLFQGNTNPTDVVVAVFPK.3
SEN / CTL,P09211,Glutathione S-transferase P,GSTP1,1.51,0.57,2.29E-11,3.00E-11,1.05E+01,"response to reactive oxygen species,negative regulation of acute inflammatory response,negative regulation of protein kinase activity,glutathione metabolic process,xenobiotic metabolic process,central nervous system development,negative regulation of biosynthetic process,negative regulation of tumor necrosis factor-mediated signaling pathway,oligodendrocyte development,animal organ regeneration,response to estradiol,negative regulation of interleukin-1 beta production,negative regulation of tumor necrosis factor production,cellular response to insulin stimulus,regulation of stress-activated MAPK cascade,negative regulation of stress-activated MAPK cascade,positive regulation of superoxide anion generation,response to L-ascorbic acid,common myeloid progenitor cell proliferation,nitric oxide storage,negative regulation of apoptotic process,negative regulation of I-kappaB kinase/NF-kappaB signaling,response to amino acid,negative regulation of MAP kinase activity,negative regulation of MAPK cascade,negative regulation of JUN kinase activity,linoleic acid metabolic process,response to ethanol,negative regulation of fibroblast proliferation,negative regulation of nitric-oxide synthase biosynthetic process,regulation of ERK1 and ERK2 cascade,negative regulation of ERK1 and ERK2 cascade,negative regulation of leukocyte proliferation,cellular response to lipopolysaccharide,cellular response to epidermal growth factor stimulus,cellular response to glucocorticoid stimulus,cellular response to cell-matrix adhesion,negative regulation of monocyte chemotactic protein-1 production,negative regulation of smooth muscle cell chemotaxis,cellular oxidant detoxification,glutathione derivative biosynthetic process,negative regulation of vascular smooth muscle cell proliferation,negative regulation of extrinsic apoptotic signaling pathway","glutathione transferase activity,glutathione peroxidase activity,protein binding,drug binding,JUN kinase binding,kinase regulator activity,S-nitrosoglutathione binding,dinitrosyl-iron complex binding,glutathione binding,nitric oxide binding","extracellular space,intracellular,nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,vesicle,extracellular exosome,TRAF2-GSTP1 complex",21,20,44,PPYTVVYFPVR.2|PPYTVVYFPVR.3|FQDGDLTLYQSNTILR.2|FQDGDLTLYQSNTILR.3|ALPGQLKPFETLLSQNQGGK.3|ALPGQLKPFETLLSQNQGGK.4|ALPGQLKPFETLLSQNQGGK.2|TLGLYGKDQQEAALVDMVNDGVEDLR.3|TLGLYGKDQQEAALVDMVNDGVEDLR.4|TLGLYGKDQQEAALVDM[Oxi]VNDGVEDLR.3|MLLADQGQSWKEEVVTVETWQEGSLK.4|M[Oxi]LLADQGQSWKEEVVTVETWQEGSLK.3|MLLADQGQSWKEEVVTVETWQEGSLK.3|MLLADQGQSWK.3|MLLADQGQSWK.2|M[Oxi]LLADQGQSWK.2|MPPYTVVYFPVR.3|M[Oxi]PPYTVVYFPVR.3|MPPYTVVYFPVR.2|M[Oxi]PPYTVVYFPVR.2|DQQEAALVDMVNDGVEDLR.4|DQQEAALVDMVNDGVEDLR.3|DQQEAALVDM[Oxi]VNDGVEDLR.3|DQQEAALVDM[Oxi]VNDGVEDLR.2|DQQEAALVDMVNDGVEDLR.2|YISLIYTNYEAGKDDYVK.4|YISLIYTNYEAGKDDYVK.3|YISLIYTNYEAGKDDYVK.2|ASC[CAM]LYGQLPK.2|EEVVTVETWQEGSLK.3|EEVVTVETWQEGSLK.2|AFLASPEYVNLPINGNGK.3|AFLASPEYVNLPINGNGK.2|AFLASPEYVNLPINGNGKQ.3|AFLASPEYVNLPINGNGKQ.2|PFETLLSQNQGGK.2|LKAFLASPEYVNLPINGNGK.3|ASC[CAM]LYGQLPKFQDGDLTLYQSNTILR.4|ASC[CAM]LYGQLPKFQDGDLTLYQSNTILR.3|LKAFLASPEYVNLPINGNGKQ.3|LKAFLASPEYVNLPINGNGKQ.2|YISLIYTNYEAGK.2|TLGLYGKDQQEAALVDMVNDGVEDLRC[CAM]K.4|DQQEAALVDMVNDGVEDLRC[CAM]K.3
SEN / CTL,P14618,Pyruvate kinase PKM,PKM,1.50,1.17,7.05E-25,5.36E-24,2.33E+01,"programmed cell death,canonical glycolysis,cell-cell adhesion","magnesium ion binding,pyruvate kinase activity,protein binding,ATP binding,kinase activity,MHC class II protein complex binding,potassium ion binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,mitochondrion,cytosol,plasma membrane,cell-cell adherens junction,cilium,extracellular matrix,vesicle,myelin sheath,extracellular exosome,extracellular vesicle",102,71,161,GDLGIEIPAEK.2|IYVDDGLISLQVK.2|IYVDDGLISLQVK.3|KGVNLPGAAVDLPAVSEKDIQDLK.4|KGVNLPGAAVDLPAVSEKDIQDLK.3|EAEAAIYHLQLFEELRR.3|EAEAAIYHLQLFEELRR.4|EAEAAIYHLQLFEELRR.2|TATESFASDPILYRPVAVALDTKGPEIR.4|TATESFASDPILYRPVAVALDTKGPEIR.5|TATESFASDPILYRPVAVALDTKGPEIR.3|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.5|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.6|KPRPTRAEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.5|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.3|AEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.5|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAKGDYPLEAVR.3|GVNLPGAAVDLPAVSEKDIQDLK.3|GVNLPGAAVDLPAVSEKDIQDLK.4|GVNLPGAAVDLPAVSEKDIQDLK.2|LAPITSDPTEATAVGAVEASFK.3|LAPITSDPTEATAVGAVEASFK.2|LAPITSDPTEATAVGAVEASFK.4|KGDVVIVLTGWRPGSGFTNTMR.4|KGDVVIVLTGWRPGSGFTNTMR.3|KGDVVIVLTGWRPGSGFTNTM[Oxi]R.4|KGDVVIVLTGWRPGSGFTNTM[Oxi]R.3|KGDVVIVLTGWRPGSGFTNTMR.2|C[CAM]C[CAM]SGAIIVLTK.2|C[CAM]C[CAM]SGAIIVLTK.3|RFDEILEASDGIMVAR.3|RFDEILEASDGIM[Oxi]VAR.3|RFDEILEASDGIMVAR.4|RFDEILEASDGIM[Oxi]VAR.4|RFDEILEASDGIMVAR.2|RFDEILEASDGIM[Oxi]VAR.2|LDIDSPPITAR.2|LDIDSPPITAR.3|C[CAM]DENILWLDYK.2|C[CAM]DENILWLDYK.3|TATESFASDPILYRPVAVALDTK.3|TATESFASDPILYRPVAVALDTK.4|AGKPVIC[CAM]ATQMLESMIK.3|AGKPVIC[CAM]ATQMLESMIK.4|AGKPVIC[CAM]ATQM[Oxi]LESMIK.3|AGKPVIC[CAM]ATQMLESM[Oxi]IK.3|AGKPVIC[CAM]ATQM[Oxi]LESM[Oxi]IK.3|AGKPVIC[CAM]ATQMLESMIK.2|AGKPVIC[CAM]ATQM[Oxi]LESMIK.2|AGKPVIC[CAM]ATQMLESM[Oxi]IK.2|GSGTAEVELK.2|KGVNLPGAAVDLPAVSEK.3|KGVNLPGAAVDLPAVSEK.4|KGVNLPGAAVDLPAVSEK.2|FGVEQDVDMVFASFIR.3|FGVEQDVDM[Oxi]VFASFIR.3|FGVEQDVDM[Oxi]VFASFIR.2|FGVEQDVDMVFASFIR.2|GDLGIEIPAEKVFLAQK.3|GDLGIEIPAEKVFLAQK.2|NTGIIC[CAM]TIGPASR.2|NTGIIC[CAM]TIGPASR.3|QKGADFLVTEVENGGSLGSK.3|QKGADFLVTEVENGGSLGSK.2|VNFAMNVGK.2|VNFAM[Oxi]NVGK.2|TGLIKGSGTAEVELKK.4|TGLIKGSGTAEVELKK.3|APIIAVTR.2|AGKPVIC[CAM]ATQMLESMIKKPRPTR.6|AGKPVIC[CAM]ATQM[Oxi]LESM[Oxi]IKKPRPTR.6|AGKPVIC[CAM]ATQMLESMIKKPRPTR.5|MQHLIAR.2|M[Oxi]QHLIAR.2|ASDVHEVR.2|LNFSHGTHEYHAETIKNVR.5|LNFSHGTHEYHAETIKNVR.4|PVAVALDTK.2|IISKIENHEGVR.3|IISKIENHEGVR.2|GIFPVLC[CAM]K.2|GIFPVLC[CAM]K.1|LNFSHGTHEYHAETIK.4|LNFSHGTHEYHAETIK.3|LNFSHGTHEYHAETIK.2|YRPRAPIIAVTR.3|GADFLVTEVENGGSLGSKK.4|GADFLVTEVENGGSLGSKK.3|GADFLVTEVENGGSLGSKK.2|IENHEGVR.2|PVAVALDTKGPEIR.3|APIIAVTRNPQTAR.3|TGLIKGSGTAEVELK.3|GDYPLEAVR.2|ASDVHEVRK.2|KASDVHEVR.2|TATESFASDPILYR.3|TATESFASDPILYR.2|PGSGFTNTMR.2|PVIC[CAM]ATQMLESMIK.3|PVIC[CAM]ATQMLESMIK.2|QKGADFLVTEVENGGSLGSKK.4|QKGADFLVTEVENGGSLGSKK.3|DPVQEAWAEDVDLR.3|DPVQEAWAEDVDLR.2|GVNLPGAAVDLPAVSEK.3|GVNLPGAAVDLPAVSEK.2|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.6|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.5|PHSEAGTAFIQTQQLHAAM[Oxi]ADTFLEHMC[CAM]R.5|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.4|PHSEAGTAFIQTQQLHAAMADTFLEHMC[CAM]R.3|FDEILEASDGIMVAR.3|FDEILEASDGIMVAR.2|FDEILEASDGIM[Oxi]VAR.2|GSGTAEVELKK.2|GDVVIVLTGWRPGSGFTNTMR.4|GDVVIVLTGWRPGSGFTNTM[Oxi]R.4|GDVVIVLTGWRPGSGFTNTMR.3|GDVVIVLTGWRPGSGFTNTM[Oxi]R.3|GDVVIVLTGWRPGSGFTNTMR.2|GFFKKGDVVIVLTGWRPGSGFTNTMR.5|GFFKKGDVVIVLTGWRPGSGFTNTMR.4|KASDVHEVRK.2|RLAPITSDPTEATAVGAVEASFK.4|RLAPITSDPTEATAVGAVEASFK.3|RLAPITSDPTEATAVGAVEASFK.2|GADFLVTEVENGGSLGSK.3|GADFLVTEVENGGSLGSK.2|SVETLKEMIK.2|ITLDNAYMEK.2|ITLDNAYM[Oxi]EK.2|GDVVIVLTGWR.2|AEGSDVANAVLDGADC[CAM]IMLSGETAK.4|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.4|AEGSDVANAVLDGADC[CAM]IMLSGETAK.3|AEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.3|GIFPVLC[CAM]KDPVQEAWAEDVDLR.4|GIFPVLC[CAM]KDPVQEAWAEDVDLR.3|EAEAAIYHLQLFEELR.3|EAEAAIYHLQLFEELR.2|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.5|KPRPTRAEGSDVANAVLDGADC[CAM]IM[Oxi]LSGETAK.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.4|KPRPTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.3|C[CAM]DENILWLDYKNIC[CAM]K.3|FGVEQDVDM[Oxi]VFASFIRK.3|FGVEQDVDMVFASFIRK.3|FGVEQDVDM[Oxi]VFASFIRK.2|FGVEQDVDMVFASFIRK.2|KGDVVIVLTGWR.2|IYVDDGLISLQVKQK.2|GIFPVLC[CAM]KDPVQEAWAEDVDLRVNFAMNVGK.4|GIFPVLC[CAM]KDPVQEAWAEDVDLRVNFAM[Oxi]NVGK.4|ITLDNAYMEKC[CAM]DENILWLDYK.3|ITLDNAYM[Oxi]EKC[CAM]DENILWLDYK.3|PTRAEGSDVANAVLDGADC[CAM]IMLSGETAK.3|PTRAEGSDVANAVLDGADC[CAM]IMLSGETAKGDYPLEAVR.4
SEN / CTL,Q9UBR2,Cathepsin Z,CTSZ,1.50,1.25,3.67E-04,1.48E-04,3.83E+00,"angiotensin maturation,proteolysis,ER to Golgi vesicle-mediated transport,COPII vesicle coating,proteolysis involved in cellular protein catabolic process,epithelial tube branching involved in lung morphogenesis","cysteine-type endopeptidase activity,protein binding,cysteine-type peptidase activity","Golgi membrane,extracellular space,lysosome,endoplasmic reticulum,endoplasmic reticulum lumen,plasma membrane,ER to Golgi transport vesicle,endoplasmic reticulum-Golgi intermediate compartment membrane,intracellular membrane-bounded organelle,extracellular exosome",12,16,25,STYPRPHEYLSPADLPK.4|STYPRPHEYLSPADLPK.3|VGDYGSLSGR.2|MMAEIYANGPISC[CAM]GIMATER.3|M[Oxi]MAEIYANGPISC[CAM]GIMATER.3|MM[Oxi]AEIYANGPISC[CAM]GIMATER.3|MMAEIYANGPISC[CAM]GIMATER.2|VGDYGSLSGREK.3|NVDGVNYASITR.3|NVDGVNYASITR.2|FNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.4|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.5|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFKEC[CAM]HAIR.4|NSWGEPWGER.2|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADRINIK.5|NQHIPQYC[CAM]GSC[CAM]WAHASTSAM[Oxi]ADR.4|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADR.4|NQHIPQYC[CAM]GSC[CAM]WAHASTSAMADR.3|NQHIPQYC[CAM]GSC[CAM]WAHASTSAM[Oxi]ADR.3|SWDWRNVDGVNYASITR.3|FNQC[CAM]GTC[CAM]NEFK.2|IVTSTYKDGKGAR.2|DQEC[CAM]DKFNQC[CAM]GTC[CAM]NEFK.3|YNLAIEEHC[CAM]TFGDPIV.2|KGAWPSTLLSVQNVIDC[CAM]GNAGSC[CAM]EGGNDLSVWDYAHQHGIPDETC[CAM]NNYQAK.5
SEN / CTL,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,1.50,1.03,9.04E-04,3.34E-04,3.48E+00,"response to reactive oxygen species,mesoderm formation,selenium compound metabolic process,signal transduction,cell proliferation,nucleobase-containing small molecule interconversion,cell redox homeostasis,oxidation-reduction process,cellular oxidant detoxification","thioredoxin-disulfide reductase activity,electron carrier activity,protein disulfide oxidoreductase activity,flavin adenine dinucleotide binding,methylselenol reductase activity,methylseleninic acid reductase activity","nucleus,mitochondrion,cytosol,extracellular exosome",9,36,59,QFVPIKVEQIEAGTPGR.3|VVGFHVLGPNAGEVTQGFAAALK.3|VVGFHVLGPNAGEVTQGFAAALK.4|VVGFHVLGPNAGEVTQGFAAALK.2|VMVLDFVTPTPLGTR.2|VMVLDFVTPTPLGTR.3|VM[Oxi]VLDFVTPTPLGTR.2|IIC[CAM]NTKDNER.3|LYAGSTVK.2|IGEHMEEHGIK.3|IGEHMEEHGIK.2|IGGHGPTLK.2|IGLETVGVK.2|KLMHQAALLGQALQDSR.4|KLMHQAALLGQALQDSR.3|KLM[Oxi]HQAALLGQALQDSR.3|KLMHQAALLGQALQDSR.2|KVVYENAYGQFIGPHR.4|KVVYENAYGQFIGPHR.3|VEETVKHDWDR.3|MNGPEDLPK.2|GFDQDMANK.2|GFDQDM[Oxi]ANK.2|KIGLETVGVK.2|GFDQDMANKIGEHMEEHGIK.4|FLIATGERPR.2|VEQIEAGTPGR.2|LMHQAALLGQALQDSR.3|LM[Oxi]HQAALLGQALQDSR.3|LMHQAALLGQALQDSR.2|LM[Oxi]HQAALLGQALQDSR.2|VVYENAYGQFIGPHR.3|VVYENAYGQFIGPHR.2|KVMVLDFVTPTPLGTR.3|KVMVLDFVTPTPLGTR.2|QLDSTIGIHPVC[CAM]AEVFTTLSVTK.4|QLDSTIGIHPVC[CAM]AEVFTTLSVTK.3|VELTPVAIQAGR.2|SYDYDLIIIGGGSGGLAAAK.3|SYDYDLIIIGGGSGGLAAAK.2|KQLDSTIGIHPVC[CAM]AEVFTTLSVTK.4|M[Oxi]IEAVQNHIGSLNWGYR.3|MIEAVQNHIGSLNWGYR.3|M[Oxi]IEAVQNHIGSLNWGYR.2|MIEAVQNHIGSLNWGYR.2|QLDSTIGIHPVC[CAM]AEVFTTLSVTKR.4|NYGWKVEETVK.2|EYC[CAM]ISSDDLFSLPYC[CAM]PGK.3|EYC[CAM]ISSDDLFSLPYC[CAM]PGK.2|FGEENIEVYHSYFWPLEWTIPSR.4|FGEENIEVYHSYFWPLEWTIPSR.3|ALEGTLSELAAETDLPVVFVK.3|ALEGTLSELAAETDLPVVFVK.2|IPVTDEEQTNVPYIYAIGDILEDK.3|VVAQSTNSEEIIEGEYNTVMLAIGR.3|C[CAM]DYENVPTTVFTPLEYGAC[CAM]GLSEEK.3|IPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGR.4|YLGIPGDKEYC[CAM]ISSDDLFSLPYC[CAM]PGK.3|TGKIPVTDEEQTNVPYIYAIGDILEDKVELTPVAIQAGR.4
SEN / CTL,P39060,Collagen alpha-1(XVIII) chain,COL18A1,1.49,0.69,4.03E-06,2.27E-06,5.64E+00,"angiogenesis,endothelial cell morphogenesis,cell adhesion,visual perception,positive regulation of cell proliferation,negative regulation of cell proliferation,animal organ morphogenesis,extracellular matrix organization,positive regulation of cell migration,collagen catabolic process,response to drug,response to hydrostatic pressure,positive regulation of endothelial cell apoptotic process","structural molecule activity,metal ion binding","extracellular region,collagen trimer,basement membrane,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome",12,31,46,IFSFDGKDVLR.3|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.4|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.6|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.5|AAVPIVNLKDELLFPSWEALFSGSEGPLKPGAR.3|AVGLAGTFR.2|LQDLYSIVR.2|SVWHGSDPNGR.3|SVWHGSDPNGR.2|YHFPSLFFR.3|GADFQC[CAM]FQQAR.3|GADFQC[CAM]FQQAR.2|HPTWPQK.2|AAVPIVNLK.2|FQGVIAELK.2|ADDILASPPR.2|ELLREETGAALKPR.3|EETGAALKPR.2|TEAPSATGQASSLLGGR.3|TEAPSATGQASSLLGGR.2|GIRGADFQC[CAM]FQQAR.3|AFLSSRLQDLYSIVR.3|LSGVQDGHQDISLLYTEPGAGQTHTAASFR.5|LSGVQDGHQDISLLYTEPGAGQTHTAASFR.4|LSGVQDGHQDISLLYTEPGAGQTHTAASFR.3|GTDNEVAALQPPVVQLHDSNPYPR.4|GTDNEVAALQPPVVQLHDSNPYPR.3|LTESYC[CAM]ETWR.2|GTDNEVAALQPPVVQLHDSNPYPRR.4|GLELEPGAGLFVAQAGGADPDK.3|GLELEPGAGLFVAQAGGADPDK.2|DFQPVLHLVALNSPLSGGM[Oxi]R.3|DFQPVLHLVALNSPLSGGMR.3|DFQPVLHLVALNSPLSGGMR.2|LTESYC[CAM]ETWRTEAPSATGQASSLLGGR.4|LTESYC[CAM]ETWRTEAPSATGQASSLLGGR.3|RLTESYC[CAM]ETWR.2|GLELEPGAGLFVAQAGGADPDKFQGVIAELK.4|GLELEPGAGLFVAQAGGADPDKFQGVIAELK.3|RLTESYC[CAM]ETWRTEAPSATGQASSLLGGR.4|GPPGPQGPPGPPGPSFR.2|GLELEPGAGLFVAQAGGADPDKFQGVIAELKVR.4|GLELEPGAGLFVAQAGGADPDKFQGVIAELKVR.3|DELLFPSWEALFSGSEGPLKPGAR.3|QAMLGQVHEVPEGWLIFVAEQEELYVR.3|ISEEVGLLQLLGDPPPQQVTQTDDPDVGLAYVFGPDANSGQVAR.4
SEN / CTL,Q16555,Dihydropyrimidinase-related protein 2,DPYSL2,1.48,1.70,6.21E-04,2.37E-04,3.62E+00,"response to amphetamine,nucleobase-containing compound metabolic process,endocytosis,cytoskeleton organization,signal transduction,nervous system development,axon guidance,positive regulation of glutamate secretion,spinal cord development,olfactory bulb development,regulation of axon extension,response to cocaine,response to drug,synaptic vesicle transport","dihydropyrimidinase activity,protein binding,microtubule binding,protein kinase binding","mitochondrion,cytosol,dendrite,growth cone,neuronal cell body,terminal bouton,myelin sheath,protein complex,extracellular exosome,microtubule,membrane",12,35,74,AITIANQTNC[CAM]PLYITK.2|AITIANQTNC[CAM]PLYITK.3|GSPLVVISQGK.2|IVLEDGTLHVTEGSGR.3|IVLEDGTLHVTEGSGR.2|FQLTDC[CAM]QIYEVLSVIR.3|FQLTDC[CAM]QIYEVLSVIR.2|KPFPDFVYKR.3|MVIPGGIDVHTR.3|M[Oxi]VIPGGIDVHTR.3|MVIPGGIDVHTR.2|VFNLYPR.2|DHGVNSFLVYMAFKDR.4|DHGVNSFLVYMAFKDR.3|SC[CAM]C[CAM]DYSLHVDISEWHK.4|SC[CAM]C[CAM]DYSLHVDISEWHK.3|SC[CAM]C[CAM]DYSLHVDISEWHK.2|SSAEVIAQAR.2|KKGTVVYGEPITASLGTDGSHYWSK.5|KKGTVVYGEPITASLGTDGSHYWSK.4|DHGVNSFLVYMAFK.3|DHGVNSFLVYM[Oxi]AFK.3|DHGVNSFLVYMAFK.2|DHGVNSFLVYM[Oxi]AFK.2|GLYDGPVC[CAM]EVSVTPK.3|GLYDGPVC[CAM]EVSVTPK.2|NLHQSGFSLSGAQIDDNIPR.4|NLHQSGFSLSGAQIDDNIPR.3|NLHQSGFSLSGAQIDDNIPR.2|KPFPDFVYK.2|MDENQFVAVTSTNAAK.3|MDENQFVAVTSTNAAK.2|M[Oxi]DENQFVAVTSTNAAK.2|NLHQSGFSLSGAQIDDNIPRR.4|DIGAIAQVHAENGDIIAEEQQR.4|DIGAIAQVHAENGDIIAEEQQR.3|DIGAIAQVHAENGDIIAEEQQR.2|DNFTLIPEGTNGTEER.3|DNFTLIPEGTNGTEER.2|GTVVYGEPITASLGTDGSHYWSK.4|GTVVYGEPITASLGTDGSHYWSK.3|GIQEEMEALVK.2|IAVGSDADLVIWDPDSVK.3|IAVGSDADLVIWDPDSVK.2|KGTVVYGEPITASLGTDGSHYWSK.4|KGTVVYGEPITASLGTDGSHYWSK.3|QIGENLIVPGGVK.2|THNSSLEYNIFEGMEC[CAM]R.3|THNSSLEYNIFEGM[Oxi]EC[CAM]R.3|THNSSLEYNIFEGM[Oxi]EC[CAM]R.2|THNSSLEYNIFEGMEC[CAM]R.2|GRIAVGSDADLVIWDPDSVK.3|AVGKDNFTLIPEGTNGTEER.3|AVGKDNFTLIPEGTNGTEER.2|FQM[Oxi]PDQGMTSADDFFQGTK.3|FQMPDQGM[Oxi]TSADDFFQGTK.3|FQMPDQGMTSADDFFQGTK.3|FQMPDQGM[Oxi]TSADDFFQGTK.2|FQMPDQGMTSADDFFQGTK.2|ILDLGITGPEGHVLSRPEEVEAEAVNR.4|ILDLGITGPEGHVLSRPEEVEAEAVNR.3|DRFQLTDC[CAM]QIYEVLSVIR.3|DRFQLTDC[CAM]QIYEVLSVIR.2|AVVTGKM[Oxi]DENQFVAVTSTNAAK.3|AAAFVTSPPLSPDPTTPDFLNSLLSC[CAM]GDLQVTGSAHC[CAM]TFNTAQK.6|AAAFVTSPPLSPDPTTPDFLNSLLSC[CAM]GDLQVTGSAHC[CAM]TFNTAQK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSK.5|AALAGGTTM[Oxi]IIDHVVPEPGTSLLAAFDQWREWADSK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWREWADSK.4|AALAGGTTMIIDHVVPEPGTSLLAAFDQWR.4|AALAGGTTM[Oxi]IIDHVVPEPGTSLLAAFDQWR.3|AALAGGTTMIIDHVVPEPGTSLLAAFDQWR.3|IVNDDQSFYADIYMEDGLIK.3|IVNDDQSFYADIYMEDGLIK.2
SEN / CTL,P07737,Profilin-1,PFN1,1.48,1.25,1.05E-11,1.48E-11,1.08E+01,"neural tube closure,positive regulation of epithelial cell migration,actin cytoskeleton organization,negative regulation of actin filament polymerization,positive regulation of actin filament polymerization,negative regulation of actin filament bundle assembly,positive regulation of actin filament bundle assembly,positive regulation of ATPase activity,positive regulation of transcription from RNA polymerase II promoter,positive regulation of viral transcription,protein stabilization,positive regulation of DNA metabolic process,positive regulation of stress fiber assembly,negative regulation of stress fiber assembly,Wnt signaling pathway, planar cell polarity pathway,cellular response to growth factor stimulus,cell-cell adhesion,positive regulation of ruffle assembly","adenyl-nucleotide exchange factor activity,actin binding,actin monomer binding,receptor binding,protein binding,phosphatidylinositol-4,5-bisphosphate binding,Rho GTPase binding,poly(A) RNA binding,proline-rich region binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,cytoskeleton,cell-cell adherens junction,focal adhesion,cell cortex,membrane,neuron projection,synapse,extracellular exosome,blood microparticle",36,19,37,TFVNITPAEVGVLVGKDR.3|TFVNITPAEVGVLVGKDR.2|STGGAPTFNVTVTK.2|STGGAPTFNVTVTK.3|STGGAPTFNVTVTKTDK.3|STGGAPTFNVTVTKTDK.2|SSFYVNGLTLGGQK.2|SSFYVNGLTLGGQK.3|TFVNITPAEVGVLVGK.2|TFVNITPAEVGVLVGK.3|TKSTGGAPTFNVTVTK.3|TKSTGGAPTFNVTVTK.2|C[CAM]SVIRDSLLQDGEFSMDLR.3|C[CAM]SVIRDSLLQDGEFSMDLR.4|C[CAM]SVIRDSLLQDGEFSM[Oxi]DLR.3|C[CAM]SVIRDSLLQDGEFSMDLR.2|DSLLQDGEFSMDLR.2|DSLLQDGEFSMDLR.3|DSLLQDGEFSM[Oxi]DLR.3|DSLLQDGEFSM[Oxi]DLR.2|DSPSVWAAVPGK.3|DSPSVWAAVPGK.2|TDKTLVLLMGK.3|TDKTLVLLMGK.2|DRSSFYVNGLTLGGQK.4|DRSSFYVNGLTLGGQK.3|DRSSFYVNGLTLGGQK.2|KC[CAM]YEMASHLR.3|C[CAM]YEMASHLRR.3|TLVLLMGK.2|TLVLLM[Oxi]GK.2|EGVHGGLINK.2|EGVHGGLINKK.2|C[CAM]YEMASHLR.2|C[CAM]YEM[Oxi]ASHLR.2|C[CAM]SVIRDSLLQDGEFSM[Oxi]DLRTK.3|TFVNITPAEVGVLVGKDRSSFYVNGLTLGGQK.4
SEN / CTL,P58546,Myotrophin,MTPN,1.47,1.04,3.54E-05,1.77E-05,4.75E+00,"regulation of translation,catecholamine metabolic process,positive regulation of macromolecule biosynthetic process,positive regulation of cardiac muscle hypertrophy,cell growth,regulation of striated muscle tissue development,cerebellar granule cell differentiation,neuron differentiation,positive regulation of cell growth,skeletal muscle tissue regeneration,positive regulation of NF-kappaB transcription factor activity,striated muscle cell differentiation,positive regulation of protein metabolic process,cellular response to mechanical stimulus,regulation of barbed-end actin filament capping",sequence-specific DNA binding,"nucleus,cytosol,F-actin capping protein complex,axon,perinuclear region of cytoplasm,extracellular exosome",12,13,27,TLEGGRKPLHYAADC[CAM]GQLEILEFLLLK.5|TLEGGRKPLHYAADC[CAM]GQLEILEFLLLK.4|TLEGGRKPLHYAADC[CAM]GQLEILEFLLLK.3|NGDLDEVKDYVAKGEDVNR.4|NGDLDEVKDYVAKGEDVNR.3|GPDGLTAFEATDNQAIK.2|GPDGLTAFEATDNQAIK.3|DYVAKGEDVNR.3|DYVAKGEDVNR.2|HHITPLLSAVYEGHVSC[CAM]VK.5|HHITPLLSAVYEGHVSC[CAM]VK.4|HHITPLLSAVYEGHVSC[CAM]VK.3|HHITPLLSAVYEGHVSC[CAM]VK.2|GADINAPDK.2|NGDLDEVK.2|NGDLDEVKDYVAK.3|NGDLDEVKDYVAK.2|KPLHYAADC[CAM]GQLEILEFLLLK.5|KPLHYAADC[CAM]GQLEILEFLLLK.4|KPLHYAADC[CAM]GQLEILEFLLLK.3|GADINAPDKHHITPLLSAVYEGHVSC[CAM]VK.6|GADINAPDKHHITPLLSAVYEGHVSC[CAM]VK.5|GADINAPDKHHITPLLSAVYEGHVSC[CAM]VK.4|PLHYAADC[CAM]GQLEILEFLLLK.4|PLHYAADC[CAM]GQLEILEFLLLK.3|GADKTVKGPDGLTAFEATDNQAIK.4|TVKGPDGLTAFEATDNQAIK.3
SEN / CTL,P07686,Beta-hexosaminidase subunit beta,HEXB,1.46,1.87,1.09E-04,5.00E-05,4.30E+00,"skeletal system development,glycosphingolipid metabolic process,ganglioside catabolic process,cellular calcium ion homeostasis,lysosome organization,penetration of zona pellucida,sensory perception of sound,locomotory behavior,male courtship behavior,regulation of cell shape,phospholipid biosynthetic process,oligosaccharide catabolic process,lipid storage,chondroitin sulfate catabolic process,hyaluronan catabolic process,keratan sulfate catabolic process,myelination,astrocyte cell migration,cellular protein metabolic process,positive regulation of transcription from RNA polymerase II promoter,oogenesis,neuromuscular process controlling balance","beta-N-acetylhexosaminidase activity,acetylglucosaminyltransferase activity,protein homodimerization activity,protein heterodimerization activity","acrosomal vesicle,extracellular space,membrane,azurophil granule,lysosomal lumen,extracellular exosome",21,27,38,VLDIIATINK.2|EISEVFPDQFIHLGGDEVEFK.3|LAPGTIVEVWKDSAYPEELSR.3|LAPGTIVEVWKDSAYPEELSR.4|LAPGTIVEVWKDSAYPEELSR.2|PGPALWPLPLSVK.2|VLPEFDTPGHTLSWGK.3|VLPEFDTPGHTLSWGK.2|GSIVWQEVFDDKAK.3|GSIVWQEVFDDKAK.2|YHGYIFGFYK.3|YHGYIFGFYK.2|LAPGTIVEVWK.3|LAPGTIVEVWK.2|GILIDTSR.2|DVRDMDDAYDR.3|C[CAM]WESNPK.2|WHHEPAEFQAK.3|WHHEPAEFQAK.2|RYHGYIFGFYK.3|TLDAMAFNK.2|LESFYIQK.2|YYKVEPLDFGGTQK.3|YYKVEPLDFGGTQK.2|DLLTPC[CAM]YSR.2|GSYSLSHVYTPNDVR.3|GSYSLSHVYTPNDVR.2|DVRDMDDAYDRLTR.3|KLESFYIQK.2|DSAYPEELSR.2|KYYKVEPLDFGGTQK.3|VEPLDFGGTQK.2|GSIVWQEVFDDK.2|VTASGFPVILSAPWYLDLISYGQDWRK.4|VTASGFPVILSAPWYLDLISYGQDWRK.3|FNVLHWHIVDDQSFPYQSITFPELSNK.4|FNVLHWHIVDDQSFPYQSITFPELSNK.3|GIAAQPLYAGYC[CAM]NHENM.2
SEN / CTL,Q96CN7,Isochorismatase domain-containing protein 1,ISOC1,1.46,1.10,1.10E-01,2.39E-02,1.62E+00,"biological_process,metabolic process","molecular_function,catalytic activity","cytoplasm,peroxisome,extracellular exosome",3,16,25,FSM[Oxi]VLPEVEAALAEIPGVR.3|FSMVLPEVEAALAEIPGVR.3|FSM[Oxi]VLPEVEAALAEIPGVR.2|FSMVLPEVEAALAEIPGVR.2|FLSLYGDQIDMHRK.4|FLSLYGDQIDMHRK.3|FLSLYGDQIDMHRK.2|GVEVHIVADATSSR.3|GVEVHIVADATSSR.2|GLGSTVQEIDLTGVK.3|GLGSTVQEIDLTGVK.2|ILGIPVIVTEQYPK.3|ILGIPVIVTEQYPK.2|ASAPESGLLSK.2|FLSLYGDQIDMHR.3|PSSVPHGAGYELLIQK.3|TKFSMVLPEVEAALAEIPGVR.4|TKFSMVLPEVEAALAEIPGVR.3|ASAPESGLLSKV.2|TGIIVTTSEAVLLQLVADKDHPK.4|YFGDIISVGQR.2|TGIIVTTSEAVLLQLVADK.3|FVVQLFAEEWGQYVDLPK.3|SVVLFGVETHVC[CAM]IQQTALELVGR.3|LVPLQIQLTTLGNLTPSSTVFFC[CAM]C[CAM]DMQER.3
SEN / CTL,Q96TA1,Niban-like protein 1,FAM129B,1.46,0.53,7.02E-04,2.64E-04,3.58E+00,"negative regulation of apoptotic process,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"nucleus,nucleoplasm,nucleolus,cytoplasm,cytosol,plasma membrane,adherens junction,cell-cell adherens junction,actin cytoskeleton,extracellular exosome",6,38,58,FQELIFEDFAR.2|ILTSVDQYLELIGNSLPGTTAK.3|ILTSVDQYLELIGNSLPGTTAK.2|FEEVLSK.2|KVPLDER.2|WQAVLQDC[CAM]IR.3|WQAVLQDC[CAM]IR.2|KYDYDSSSVRK.3|KYDYDSSSVRK.2|AVINSAGYK.2|IVFSGNLFQHQEDSKK.4|IVFSGNLFQHQEDSKK.3|AAPEASSPPASPLQHLLPGK.4|AAPEASSPPASPLQHLLPGK.3|GPTKEELC[CAM]K.2|ARFEEVLSK.2|EALLQISIPFLLKK.3|NRFSLVPHNYGLVLYENK.4|NRFSLVPHNYGLVLYENK.3|YDYDSSSVR.2|FDVSSTSVFK.2|TDMDQIITSK.2|TDM[Oxi]DQIITSK.2|IVFSGNLFQHQEDSK.3|IVFSGNLFQHQEDSK.2|VEGPAFTDAIR.2|HC[CAM]NNGIPEDSKVEGPAFTDAIR.4|HC[CAM]NNGIPEDSKVEGPAFTDAIR.3|KYDYDSSSVR.2|HEIEGTGLPQAQLLWR.3|HEIEGTGLPQAQLLWR.2|HYYFC[CAM]MMTEAEQDK.3|QRQWIQISDAVYHMVYEQAK.4|QRQWIQISDAVYHMVYEQAK.3|FSLVPHNYGLVLYENK.3|FSLVPHNYGLVLYENK.2|C[CAM]PTQFPLILWHPYAR.3|C[CAM]PTQFPLILWHPYAR.2|HC[CAM]NNGIPEDSK.2|EQMDNAVYTFETLLHQELGKGPTKEELC[CAM]K.5|EQMDNAVYTFETLLHQELGKGPTKEELC[CAM]K.4|EQMDNAVYTFETLLHQELGKGPTK.4|FILVENTYEEVVLQTVMK.3|NHVQPYIPSILEALM[Oxi]VPTSQGFTEVR.4|NHVQPYIPSILEALMVPTSQGFTEVR.4|NHVQPYIPSILEALM[Oxi]VPTSQGFTEVR.3|NHVQPYIPSILEALMVPTSQGFTEVR.3|VQQVQPAMQAVIR.2|VQQVQPAM[Oxi]QAVIR.2|EALLQISIPFLLK.2|QWIQISDAVYHMVYEQAK.3|QWIQISDAVYHMVYEQAK.2|EQMDNAVYTFETLLHQELGK.3|EQMDNAVYTFETLLHQELGK.2|EVTDMNLNVINEGGIDKLGEYMEK.3|EVTDMNLNVINEGGIDK.2|GLLAQGLRPESPPPAGPLLNGAPAGESPQPK.3|QVVSVVQDEEVGLPFEASPESPPPASPDGVTEIR.3
SEN / CTL,P11142,Heat shock cognate 71 kDa protein,HSPA8,1.46,1.17,3.38E-08,2.59E-08,7.59E+00,"mRNA splicing, via spliceosome,transcription, DNA-templated,protein folding,response to unfolded protein,neurotransmitter secretion,cellular response to starvation,viral process,regulation of protein stability,protein refolding,regulation of protein complex assembly,regulation of mRNA stability,negative regulation of transcription, DNA-templated,ATP metabolic process,positive regulation of mRNA splicing, via spliceosome,chaperone mediated protein folding requiring cofactor,regulation of cell cycle,regulation of protein complex stability,chaperone-mediated autophagy,late endosomal microautophagy,protein targeting to lysosome involved in chaperone-mediated autophagy,chaperone-mediated protein transport involved in chaperone-mediated autophagy,clathrin coat disassembly,cell-cell adhesion,regulation of cellular response to heat,negative regulation of fibril organization,regulation of protein import,chaperone-mediated autophagy translocation complex disassembly","G-protein coupled receptor binding,phosphatidylserine binding,protein binding,ATP binding,ATPase activity,enzyme binding,MHC class II protein complex binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,poly(A) RNA binding,unfolded protein binding,C3HC4-type RING finger domain binding,cadherin binding involved in cell-cell adhesion","Prp19 complex,extracellular space,intracellular,nucleus,nucleoplasm,spliceosomal complex,nucleolus,lysosomal membrane,late endosome,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,membrane,intracellular ribonucleoprotein complex,extracellular matrix,melanosome,lysosomal lumen,myelin sheath,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,extracellular exosome,blood microparticle,lumenal side of lysosomal membrane,presynapse,ubiquitin ligase complex",45,50,118,ARFEELNADLFR.3|ARFEELNADLFR.2|DAGTIAGLNVLR.2|DAGTIAGLNVLR.3|TVTNAVVTVPAYFNDSQR.3|TVTNAVVTVPAYFNDSQR.2|TVTNAVVTVPAYFNDSQR.4|FEELNADLFR.2|FEELNADLFR.3|SFYPEEVSSMVLTK.2|SFYPEEVSSMVLTK.3|SFYPEEVSSM[Oxi]VLTK.3|SFYPEEVSSM[Oxi]VLTK.2|IINEPTAAAIAYGLDKK.3|IINEPTAAAIAYGLDKK.2|SQIHDIVLVGGSTR.3|SQIHDIVLVGGSTR.2|RFDDAVVQSDMKHWPFMVVNDAGRPK.5|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.5|RFDDAVVQSDMKHWPFMVVNDAGRPK.6|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.6|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.6|RFDDAVVQSDM[Oxi]KHWPFM[Oxi]VVNDAGRPK.5|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.5|RFDDAVVQSDM[Oxi]KHWPFMVVNDAGRPK.4|RFDDAVVQSDMKHWPFM[Oxi]VVNDAGRPK.4|RFDDAVVQSDMKHWPFMVVNDAGRPK.4|RFDDAVVQSDMKHWPFMVVNDAGRPK.3|LDKSQIHDIVLVGGSTR.4|LDKSQIHDIVLVGGSTR.3|LDKSQIHDIVLVGGSTR.2|NSLESYAFNMK.2|NSLESYAFNMK.3|NSLESYAFNM[Oxi]K.2|MKEIAEAYLGK.2|MKEIAEAYLGK.3|M[Oxi]KEIAEAYLGK.3|M[Oxi]KEIAEAYLGK.2|GRLSKEDIER.3|GRLSKEDIER.2|HWPFMVVNDAGRPK.4|HWPFM[Oxi]VVNDAGRPK.4|HWPFMVVNDAGRPK.3|HWPFM[Oxi]VVNDAGRPK.3|HWPFMVVNDAGRPK.2|MVNHFIAEFK.3|M[Oxi]VNHFIAEFK.3|MVNHFIAEFK.2|M[Oxi]VNHFIAEFK.2|FDDAVVQSDMK.3|FDDAVVQSDMK.2|FDDAVVQSDM[Oxi]K.2|GTLDPVEK.2|GTLDPVEK.1|NQTAEKEEFEHQQK.4|NQTAEKEEFEHQQK.3|NQTAEKEEFEHQQK.2|MVNHFIAEFKR.3|MVNHFIAEFKR.2|RFDDAVVQSDMK.3|RFDDAVVQSDM[Oxi]K.3|RFDDAVVQSDMK.2|RFDDAVVQSDM[Oxi]K.2|VC[CAM]NPIITK.2|HWPFMVVNDAGR.3|LSKEDIER.2|EIAEAYLGK.2|DAKLDKSQIHDIVLVGGSTR.4|DAKLDKSQIHDIVLVGGSTR.3|DAKLDKSQIHDIVLVGGSTR.2|EEFEHQQK.2|QATKDAGTIAGLNVLR.3|NQVAMNPTNTVFDAK.3|NQVAM[Oxi]NPTNTVFDAK.3|NQVAM[Oxi]NPTNTVFDAK.2|NQVAMNPTNTVFDAK.2|GPAVGIDLGTTYSC[CAM]VGVFQHGK.4|GPAVGIDLGTTYSC[CAM]VGVFQHGK.3|GPAVGIDLGTTYSC[CAM]VGVFQHGK.2|MVQEAEKYKAEDEK.3|MVQEAEKYKAEDEK.2|NQTAEKEEFEHQQKELEK.4|NQTAEKEEFEHQQKELEK.3|SINPDEAVAYGAAVQAAILSGDK.4|SINPDEAVAYGAAVQAAILSGDK.3|SINPDEAVAYGAAVQAAILSGDK.2|ARFEELNADLFRGTLDPVEK.4|ARFEELNADLFRGTLDPVEK.3|FDDAVVQSDMKHWPFMVVNDAGRPK.5|FDDAVVQSDMKHWPFMVVNDAGRPK.4|FDDAVVQSDMKHWPFMVVNDAGRPK.3|IINEPTAAAIAYGLDKKVGAER.4|YKAEDEKQR.2|ILDKC[CAM]NEIINWLDK.3|ILDKC[CAM]NEIINWLDK.2|FELTGIPPAPR.2|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.5|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.4|C[CAM]NEIINWLDKNQTAEKEEFEHQQK.3|NQVAM[Oxi]NPTNTVFDAKR.3|NQVAMNPTNTVFDAKR.3|NQVAMNPTNTVFDAKR.2|ILDKC[CAM]NEIINWLDKNQTAEK.4|C[CAM]NEIINWLDK.2|DNNLLGKFELTGIPPAPR.3|C[CAM]NEIINWLDKNQTAEK.3|C[CAM]NEIINWLDKNQTAEK.2|QTQTFTTYSDNQPGVLIQVYEGER.4|QTQTFTTYSDNQPGVLIQVYEGER.3|ELEKVC[CAM]NPIITK.2|RTLSSSTQASIEIDSLYEGIDFYTSITR.4|RTLSSSTQASIEIDSLYEGIDFYTSITR.3|GVPQIEVTFDIDANGILNVSAVDK.3|LYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD.4|LYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD.3|NTTIPTKQTQTFTTYSDNQPGVLIQVYEGER.4|NTTIPTKQTQTFTTYSDNQPGVLIQVYEGER.3|TLSSSTQASIEIDSLYEGIDFYTSITR.3
SEN / CTL,O60888,Protein CutA,CUTA,1.46,0.88,4.12E-08,3.13E-08,7.50E+00,"protein localization,response to metal ion","copper ion binding,enzyme binding","membrane,extracellular exosome",18,7,14,TQSSLVPALTDFVR.2|TQSSLVPALTDFVR.3|SVHPYEVAEVIALPVEQGNFPYLQWVR.3|SVHPYEVAEVIALPVEQGNFPYLQWVR.4|SVHPYEVAEVIALPVEQGNFPYLQWVR.5|LAAC[CAM]VNLIPQITSIYEWK.3|LAAC[CAM]VNLIPQITSIYEWK.2|RLAAC[CAM]VNLIPQITSIYEWK.3|RLAAC[CAM]VNLIPQITSIYEWK.4|RLAAC[CAM]VNLIPQITSIYEWK.2|GKIEEDSEVLMMIK.3|GKIEEDSEVLMMIK.2|IEEDSEVLMMIK.2|QVTESVSDSITVLP.2
SEN / CTL,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,1.46,0.16,4.96E-03,1.49E-03,2.83E+00,"glucose metabolic process,pentose-phosphate shunt,lipid metabolic process,cholesterol biosynthetic process,NADP metabolic process,NADPH regeneration,glutathione metabolic process,pentose-phosphate shunt, oxidative branch,response to iron(III) ion,negative regulation of protein glutathionylation,response to organic cyclic compound,pentose biosynthetic process,substantia nigra development,response to food,cellular response to oxidative stress,erythrocyte maturation,regulation of neuron apoptotic process,response to ethanol,ribose phosphate biosynthetic process,glucose 6-phosphate metabolic process,oxidation-reduction process,negative regulation of cell growth involved in cardiac muscle cell development,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,negative regulation of reactive oxygen species metabolic process","glucose-6-phosphate dehydrogenase activity,glucose binding,identical protein binding,protein homodimerization activity,NADP binding","nucleus,cytoplasm,centrosome,microtubule organizing center,cytosol,cytoplasmic side of plasma membrane,membrane,intracellular membrane-bounded organelle,extracellular exosome",3,50,86,LFYLALPPTVYEAVTK.2|LFYLALPPTVYEAVTK.3|NVKLPDAYER.3|IDHYLGK.2|LPDAYER.2|PKPIPYIYGSR.3|LNSHMNALHLGSQANR.4|LNSHM[Oxi]NALHLGSQANR.4|LNSHMNALHLGSQANR.3|LNSHM[Oxi]NALHLGSQANR.3|LNSHMNALHLGSQANR.2|LEDFFAR.2|RNELVIR.2|RVGFQYEGTYK.3|RVGFQYEGTYK.2|WVNPHKL.2|LILDVFC[CAM]GSQMHFVR.4|LILDVFC[CAM]GSQMHFVR.3|LILDVFC[CAM]GSQM[Oxi]HFVR.3|LILDVFC[CAM]GSQMHFVR.2|LILDVFC[CAM]GSQM[Oxi]HFVR.2|TQVC[CAM]GILR.2|PASTNSDDVRDEK.3|PASTNSDDVRDEK.2|LQFHDVAGDIFHQQC[CAM]K.4|LQFHDVAGDIFHQQC[CAM]K.3|LQFHDVAGDIFHQQC[CAM]K.2|LSNHISSLFREDQIYR.4|LSNHISSLFREDQIYR.3|IFGPIWNR.2|KQSEPFFK.2|IFTPLLHQIELEK.3|IFTPLLHQIELEK.2|IIVEKPFGR.2|DNIAC[CAM]VILTFKEPFGTEGR.4|DNIAC[CAM]VILTFKEPFGTEGR.3|DNIAC[CAM]VILTFKEPFGTEGR.2|GPTEADELMK.2|GPTEADELM[Oxi]K.2|KKIYPTIWWLFR.3|WDGVPFILR.2|DGLLPENTFIVGYAR.3|DGLLPENTFIVGYAR.2|GYLDDPTVPR.2|IFTPLLHQIELEKPKPIPYIYGSR.5|IFTPLLHQIELEKPKPIPYIYGSR.4|IFTPLLHQIELEKPKPIPYIYGSR.3|LKLEDFFAR.2|VQPNEAVYTK.2|NIHESC[CAM]MSQIGWNR.3|NIHESC[CAM]M[Oxi]SQIGWNR.3|NIHESC[CAM]M[Oxi]SQIGWNR.2|NIHESC[CAM]MSQIGWNR.2|LSNHISSLFR.2|VGFQYEGTYK.2|NSYVAGQYDDAASYQR.3|NSYVAGQYDDAASYQR.2|EMVQNLMVLR.2|EM[Oxi]VQNLMVLR.2|GPTEADELMKR.2|GGYFDEFGIIR.2|DNIAC[CAM]VILTFK.2|GSTTATFAAVVLYVENER.3|GSTTATFAAVVLYVENER.2|DLQSSDRLSNHISSLFR.3|KPGMFFNPEESELDLTYGNRYK.4|IDHYLGKEMVQNLMVLR.3|IYPTIWWLFR.2|LQFHDVAGDIFHQQC[CAM]KR.3|DVMQNHLLQMLC[CAM]LVAMEK.3|DVM[Oxi]QNHLLQMLC[CAM]LVAMEK.3|DVMQNHLLQM[Oxi]LC[CAM]LVAMEK.3|DVMQNHLLQMLC[CAM]LVAM[Oxi]EK.3|DVMQNHLLQMLC[CAM]LVAMEK.2|DVMQNHLLQMLC[CAM]LVAMEKPASTNSDDVRDEK.5|DVMQNHLLQMLC[CAM]LVAMEKPASTNSDDVRDEK.4|GSTTATFAAVVLYVENERWDGVPFILR.4|GSTTATFAAVVLYVENERWDGVPFILR.3|IFGPIWNRDNIAC[CAM]VILTFKEPFGTEGR.4|KPGM[Oxi]FFNPEESELDLTYGNR.3|KPGMFFNPEESELDLTYGNR.3|KPGM[Oxi]FFNPEESELDLTYGNR.2|KPGMFFNPEESELDLTYGNR.2|DVMQNHLLQMLC[CAM]LVAMEKPASTNSDDVR.4|C[CAM]ISEVQANNVVLGQYVGNPDGEGEATK.3|C[CAM]ISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPR.4
SEN / CTL,O14818;Q8TAA3,Proteasome subunit alpha type-7;Proteasome subunit alpha type-7-like,PSMA7;PSMA8,1.46,1.34,1.56E-01,3.29E-02,1.48E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway;MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding;threonine-type endopeptidase activity","proteasome complex,nucleus,nucleoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome;nucleus,cytosol,proteasome core complex, alpha-subunit complex,extracellular exosome,spermatoproteasome complex",3,1,2,LTVEDPVTVEYITR.2|LTVEDPVTVEYITR.3
SEN / CTL,P0DMV8;P0DMV9,Heat shock 70 kDa protein 1A;Heat shock 70 kDa protein 1B,HSPA1A;HSPA1B,1.45,1.55,3.09E-04,1.27E-04,3.90E+00,"positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,regulation of mRNA stability,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,negative regulation of inclusion body assembly,cell-cell adhesion,regulation of cellular response to heat,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,positive regulation of endoribonuclease activity,positive regulation of tumor necrosis factor-mediated signaling pathway,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death;positive regulation of gene expression,regulation of protein ubiquitination,negative regulation of protein ubiquitination,positive regulation of interleukin-8 production,cellular response to oxidative stress,cellular response to heat,protein refolding,ATP metabolic process,viral entry into host cell,protein stabilization,positive regulation of NF-kappaB transcription factor activity,negative regulation of cell death,cellular heat acclimation,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,negative regulation of inclusion body assembly,regulation of cellular response to heat,positive regulation of tumor necrosis factor-mediated signaling pathway,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,regulation of cell death","virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding,cadherin binding involved in cell-cell adhesion;virus receptor activity,G-protein coupled receptor binding,receptor binding,protein binding,ATP binding,ATPase activity,enzyme binding,heat shock protein binding,ubiquitin protein ligase binding,ATPase activity, coupled,histone deacetylase binding,protein binding involved in protein folding,unfolded protein binding,C3HC4-type RING finger domain binding","nucleoplasm,cytoplasm,mitochondrion,centriole,cytosol,cell-cell adherens junction,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ubiquitin ligase complex;nucleoplasm,cytoplasm,centriole,cytosol,focal adhesion,inclusion body,perinuclear region of cytoplasm,blood microparticle,ubiquitin ligase complex",21,60,132,ARFEELC[CAM]SDLFR.3|ARFEELC[CAM]SDLFR.2|TTPSYVAFTDTER.2|TTPSYVAFTDTER.3|AQIHDLVLVGGSTR.3|AQIHDLVLVGGSTR.2|DAGVIAGLNVLR.2|DAGVIAGLNVLR.3|DAGVIAGLNVLR.1|VEIIANDQGNR.2|VEIIANDQGNR.3|AFYPEEISSMVLTK.2|AFYPEEISSMVLTK.3|AFYPEEISSM[Oxi]VLTK.3|AFYPEEISSM[Oxi]VLTK.2|GRLSKEEIER.3|GRLSKEEIER.2|HWPFQVINDGDKPK.4|HWPFQVINDGDKPK.3|HWPFQVINDGDKPK.2|LVNHFVEEFK.3|LVNHFVEEFK.2|MVQEAEK.2|M[Oxi]VQEAEK.2|AEDEVQR.2|NALESYAFNM[Oxi]K.3|NALESYAFNMK.3|NALESYAFNMK.2|NALESYAFNM[Oxi]K.2|ANKITITNDKGR.3|ANKITITNDKGR.2|KFGDPVVQSDMK.3|KFGDPVVQSDM[Oxi]K.3|KFGDPVVQSDMK.2|KFGDPVVQSDM[Oxi]K.2|LDKAQIHDLVLVGGSTR.4|LDKAQIHDLVLVGGSTR.3|LDKAQIHDLVLVGGSTR.2|STLEPVEK.2|LVNHFVEEFKR.3|LVNHFVEEFKR.2|SAVEDEGLK.2|YKAEDEVQRER.3|YKAEDEVQRER.2|MVQEAEKYKAEDEVQR.4|M[Oxi]VQEAEKYKAEDEVQR.4|MVQEAEKYKAEDEVQR.3|M[Oxi]VQEAEKYKAEDEVQR.3|MVQEAEKYKAEDEVQR.2|KFGDPVVQSDMKHWPFQVINDGDKPK.6|KFGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.5|KFGDPVVQSDMKHWPFQVINDGDKPK.5|KFGDPVVQSDMKHWPFQVINDGDKPK.4|KFGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.4|KFGDPVVQSDMKHWPFQVINDGDKPK.3|LSKEEIER.2|ITITNDKGR.2|ATAGDTHLGGEDFDNRLVNHFVEEFKR.6|ATAGDTHLGGEDFDNRLVNHFVEEFKR.5|ATAGDTHLGGEDFDNRLVNHFVEEFKR.4|LLQDFFNGRDLNK.3|LLQDFFNGRDLNK.2|DAKLDKAQIHDLVLVGGSTR.4|DAKLDKAQIHDLVLVGGSTR.3|QATKDAGVIAGLNVLR.3|QATKDAGVIAGLNVLR.2|NQVALNPQNTVFDAK.3|NQVALNPQNTVFDAK.2|ATAGDTHLGGEDFDNR.3|ATAGDTHLGGEDFDNR.2|LLQDFFNGR.2|AAAIGIDLGTTYSC[CAM]VGVFQHGK.4|AAAIGIDLGTTYSC[CAM]VGVFQHGK.3|AAAIGIDLGTTYSC[CAM]VGVFQHGK.2|C[CAM]QEVISWLDANTLAEKDEFEHKR.5|C[CAM]QEVISWLDANTLAEKDEFEHKR.4|C[CAM]QEVISWLDANTLAEKDEFEHKR.3|IINEPTAAAIAYGLDR.3|IINEPTAAAIAYGLDR.2|MVQEAEKYK.2|SAVEDEGLKGK.2|VQVSYKGETK.2|YKAEDEVQR.2|FGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.5|FGDPVVQSDMKHWPFQVINDGDKPK.5|FGDPVVQSDMKHWPFQVINDGDKPK.4|FGDPVVQSDM[Oxi]KHWPFQVINDGDKPK.4|FGDPVVQSDMKHWPFQVINDGDKPK.3|ATAGDTHLGGEDFDNRLVNHFVEEFK.5|ATAGDTHLGGEDFDNRLVNHFVEEFK.4|ATAGDTHLGGEDFDNRLVNHFVEEFK.3|FELSGIPPAPR.2|GGSGSGPTIEEVD.2|NQVALNPQNTVFDAKR.3|NQVALNPQNTVFDAKR.2|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.5|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|ELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|FGDPVVQSDMK.2|FGDPVVQSDM[Oxi]K.2|AMTKDNNLLGR.2|C[CAM]QEVISWLDANTLAEK.3|C[CAM]QEVISWLDANTLAEK.2|VLDKC[CAM]QEVISWLDANTLAEKDEFEHK.5|VLDKC[CAM]QEVISWLDANTLAEKDEFEHK.4|FEELC[CAM]SDLFR.2|C[CAM]QEVISWLDANTLAEKDEFEHK.4|C[CAM]QEVISWLDANTLAEKDEFEHK.3|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.5|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|RKELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|QTQIFTTYSDNQPGVLIQVYEGER.4|QTQIFTTYSDNQPGVLIQVYEGER.3|TTPSYVAFTDTERLIGDAAK.3|TTPSYVAFTDTERLIGDAAK.2|EIAEAYLGYPVTNAVITVPAYFNDSQR.4|EIAEAYLGYPVTNAVITVPAYFNDSQR.3|SINPDEAVAYGAAVQAAILM[Oxi]GDK.3|SINPDEAVAYGAAVQAAILMGDK.3|SINPDEAVAYGAAVQAAILM[Oxi]GDK.2|SINPDEAVAYGAAVQAAILMGDK.2|RTLSSSTQASLEIDSLFEGIDFYTSITR.4|RTLSSSTQASLEIDSLFEGIDFYTSITR.3|KELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.4|KELEQVC[CAM]NPIISGLYQGAGGPGPGGFGAQGPK.3|MKEIAEAYLGYPVTNAVITVPAYFNDSQR.4|M[Oxi]KEIAEAYLGYPVTNAVITVPAYFNDSQR.4|M[Oxi]KEIAEAYLGYPVTNAVITVPAYFNDSQR.3|MKEIAEAYLGYPVTNAVITVPAYFNDSQR.3|VEIIANDQGNRTTPSYVAFTDTER.3|DAGVIAGLNVLRIINEPTAAAIAYGLDR.3|TLSSSTQASLEIDSLFEGIDFYTSITR.3
SEN / CTL,P47756,F-actin-capping protein subunit beta,CAPZB,1.45,0.52,1.33E-03,4.62E-04,3.34E+00,"movement of cell or subcellular component,cytoskeleton organization,blood coagulation,regulation of lamellipodium assembly,regulation of cell morphogenesis,actin cytoskeleton organization,barbed-end actin filament capping,negative regulation of filopodium assembly,cell-cell adhesion","actin binding,actin filament binding,cadherin binding involved in cell-cell adhesion","cytosol,cytoskeleton,actin filament,cell-cell adherens junction,F-actin capping protein complex,actin cytoskeleton,sarcomere,extracellular exosome,WASH complex",6,22,40,SGSGTMNLGGSLTR.2|SGSGTM[Oxi]NLGGSLTR.2|SPWSNKYDPPLEDGAMPSAR.3|SPWSNKYDPPLEDGAMPSAR.4|SPWSNKYDPPLEDGAM[Oxi]PSAR.3|LVEDMENKIR.3|DKVVGKDYLLC[CAM]DYNR.4|DKVVGKDYLLC[CAM]DYNR.3|QMEKDETVSDC[CAM]SPHIANIGR.5|QMEKDETVSDC[CAM]SPHIANIGR.4|QM[Oxi]EKDETVSDC[CAM]SPHIANIGR.4|QMEKDETVSDC[CAM]SPHIANIGR.3|LPPQQIEK.2|IKGC[CAM]WDSIHVVEVQEK.4|IKGC[CAM]WDSIHVVEVQEK.3|IRSTLNEIYFGK.3|IRSTLNEIYFGK.2|LVEDMENK.2|LVEDM[Oxi]ENK.2|YDPPLEDGAMPSAR.3|YDPPLEDGAMPSAR.2|YDPPLEDGAM[Oxi]PSAR.2|VVGKDYLLC[CAM]DYNR.3|VVGKDYLLC[CAM]DYNR.2|RLPPQQIEK.2|GC[CAM]WDSIHVVEVQEK.3|GC[CAM]WDSIHVVEVQEK.2|KLEVEANNAFDQYR.3|KLEVEANNAFDQYR.2|STLNEIYFGK.2|DETVSDC[CAM]SPHIANIGR.3|DETVSDC[CAM]SPHIANIGR.2|DYLLC[CAM]DYNR.2|DYLLC[CAM]DYNRDGDSYR.3|DYLLC[CAM]DYNRDGDSYR.2|LTSTVM[Oxi]LWLQTNK.2|LTSTVMLWLQTNK.2|VVGKDYLLC[CAM]DYNRDGDSYR.3|LEVEANNAFDQYR.2|RLPPQQIEKNLSDLIDLVPSLC[CAM]EDLLSSVDQPLK.4
SEN / CTL,Q12805,EGF-containing fibulin-like extracellular matrix protein 1,EFEMP1,1.45,1.25,1.48E-11,2.01E-11,1.07E+01,"regulation of transcription, DNA-templated,epidermal growth factor receptor signaling pathway,visual perception,peptidyl-tyrosine phosphorylation,negative regulation of chondrocyte differentiation,camera-type eye development,embryonic eye morphogenesis,post-embryonic eye morphogenesis","epidermal growth factor-activated receptor activity,epidermal growth factor receptor binding,calcium ion binding,protein binding,growth factor activity","extracellular region,proteinaceous extracellular matrix,extracellular space,extracellular exosome,extracellular matrix",33,16,18,SVPSDIFQIQATTIYANTINTFR.3|RGEQC[CAM]VDIDEC[CAM]TIPPYC[CAM]HQR.4|ADQVC[CAM]INLR.2|IQC[CAM]AAGYEQSEHNVC[CAM]QDIDEC[CAM]TAGTHNC[CAM]R.4|QTSPVSAMLVLVK.2|EHIVDLEMLTVSSIGTFR.3|NPC[CAM]QDPYILTPENR.2|SGNENGEFYLR.2|FSC[CAM]MC[CAM]PQGYQVVR.2|C[CAM]VC[CAM]PVSNAMC[CAM]R.2|C[CAM]VC[CAM]PVSNAM[Oxi]C[CAM]R.2|DIDEC[CAM]DIVPDAC[CAM]K.2|DIDEC[CAM]DIVPDAC[CAM]K.3|C[CAM]VNHYGGYLC[CAM]LPK.3|LTIIVGPFSF.2|LNC[CAM]EDIDEC[CAM]R.2|GSFAC[CAM]QC[CAM]PPGYQK.2|GEQC[CAM]VDIDEC[CAM]TIPPYC[CAM]HQR.3
SEN / CTL,O43707,Alpha-actinin-4,ACTN4,1.44,1.48,2.77E-14,5.02E-14,1.33E+01,"response to hypoxia,platelet degranulation,protein transport,vesicle transport along actin filament,positive regulation of cell migration,positive regulation of sodium:proton antiporter activity,peroxisome proliferator activated receptor signaling pathway,regulation of apoptotic process,retinoic acid receptor signaling pathway,positive regulation of pinocytosis,actin filament bundle assembly,negative regulation of cellular component movement,positive regulation of cellular component movement,bicellular tight junction assembly,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,protein localization to bicellular tight junction,regulation of nucleic acid-templated transcription","RNA polymerase II regulatory region sequence-specific DNA binding,nucleoside binding,actin binding,integrin binding,calcium ion binding,protein binding,ligand-dependent nuclear receptor transcription coactivator activity,chromatin DNA binding,nuclear hormone receptor binding,protein homodimerization activity,retinoic acid receptor binding,ion channel binding,poly(A) RNA binding,protein N-terminus binding,actin filament binding","stress fiber,extracellular region,extracellular space,intracellular,nucleus,cytoplasm,brush border,cell-cell junction,focal adhesion,Z disc,intracellular ribonucleoprotein complex,cortical cytoskeleton,platelet alpha granule lumen,pseudopodium,neuron projection,protein complex,perinuclear region of cytoplasm,extracellular exosome,actin cytoskeleton",108,85,169,VGWEQLLTTIAR.2|VGWEQLLTTIAR.3|ETTDTDTADQVIASFK.2|ETTDTDTADQVIASFK.3|C[CAM]QLEINFNTLQTK.2|C[CAM]QLEINFNTLQTK.3|FAIQDISVEETSAK.2|FAIQDISVEETSAK.3|VLAVNQENEHLMEDYEKLASDLLEWIR.4|EGLLLWC[CAM]QR.2|TINEVENQILTR.2|TINEVENQILTR.3|LSGSNPYTTVTPQIINSK.2|LSGSNPYTTVTPQIINSK.3|GYEEWLLNEIR.2|GYEEWLLNEIR.3|MLDAEDIVNTARPDEK.3|MLDAEDIVNTARPDEK.2|M[Oxi]LDAEDIVNTARPDEK.3|M[Oxi]LDAEDIVNTARPDEK.2|IC[CAM]DQWDALGSLTHSR.3|IC[CAM]DQWDALGSLTHSR.2|LSGSNPYTTVTPQIINSKWEK.3|MAPYQGPDAVPGALDYK.2|MAPYQGPDAVPGALDYK.3|M[Oxi]APYQGPDAVPGALDYK.3|M[Oxi]APYQGPDAVPGALDYK.2|LASDLLEWIR.2|LASDLLEWIR.3|KAGTQIENIDEDFRDGLK.4|KAGTQIENIDEDFRDGLK.3|IMSLVDPNHSGLVTFQAFIDFMSR.3|IM[Oxi]SLVDPNHSGLVTFQAFIDFMSR.3|IMSLVDPNHSGLVTFQAFIDFMSR.4|VLAGDKNFITAEELRR.4|VLAGDKNFITAEELRR.3|LMLLLEVISGER.2|LM[Oxi]LLLEVISGER.2|DGLAFNALIHR.2|DGLAFNALIHR.3|AIMTYVSSFYHAFSGAQK.3|AIMTYVSSFYHAFSGAQK.4|AIM[Oxi]TYVSSFYHAFSGAQK.3|AIMTYVSSFYHAFSGAQK.2|AIM[Oxi]TYVSSFYHAFSGAQK.2|QFASQANVVGPWIQTK.2|QFASQANVVGPWIQTK.3|AGTQIENIDEDFRDGLK.3|AGTQIENIDEDFRDGLK.2|AC[CAM]LISLGYDVENDRQGEAEFNR.3|AC[CAM]LISLGYDVENDRQGEAEFNR.4|ASIHEAWTDGKEAMLK.4|ASIHEAWTDGKEAMLK.3|ELPPDQAEYC[CAM]IAR.2|ELPPDQAEYC[CAM]IAR.3|KDDPVTNLNNAFEVAEK.3|KDDPVTNLNNAFEVAEK.2|VQQLVPK.2|DHGGALGPEEFK.3|DHGGALGPEEFK.2|NFITAEELRR.3|HRPELIEYDK.3|HRPELIEYDK.2|ASFNHFDKDHGGALGPEEFK.5|ASFNHFDKDHGGALGPEEFK.4|ASFNHFDKDHGGALGPEEFK.3|RDHALLEEQSK.3|RDHALLEEQSK.2|TEKQLEAIDQLHLEYAKR.5|TEKQLEAIDQLHLEYAKR.4|EAILAIHK.2|GISQEQMQEFR.3|GISQEQMQEFR.2|GISQEQM[Oxi]QEFR.2|IAESNHIK.2|QLEAIDQLHLEYAKR.4|QLEAIDQLHLEYAKR.3|QLEAIDQLHLEYAKR.2|DHALLEEQSKQQSNEHLRR.5|DHALLEEQSKQQSNEHLRR.4|RDHALLEEQSKQQSNEHLR.5|RDHALLEEQSKQQSNEHLR.4|ASFNHFDK.2|IC[CAM]DQWDALGSLTHSRR.4|IC[CAM]DQWDALGSLTHSRR.3|LSNRPAFM[Oxi]PSEGK.3|LSNRPAFMPSEGK.3|LSNRPAFM[Oxi]PSEGK.2|LSNRPAFMPSEGK.2|NVNVQNFHISWK.3|NVNVQNFHISWK.2|TIPWLEDRVPQK.3|TIPWLEDRVPQK.2|TIQEMQQK.2|TIQEM[Oxi]QQK.2|LVSIGAEEIVDGNAK.3|LVSIGAEEIVDGNAK.2|QQSNEHLR.2|TEKQLEAIDQLHLEYAK.4|TEKQLEAIDQLHLEYAK.3|HRDYETATLSDIK.3|HRDYETATLSDIK.2|HRPELIEYDKLR.3|HRPELIEYDKLR.2|LMLLLEVISGERLPKPER.4|LM[Oxi]LLLEVISGERLPKPER.4|LMLLLEVISGERLPKPER.3|NVNVQNFHISWKDGLAFNALIHR.5|NVNVQNFHISWKDGLAFNALIHR.4|NVNVQNFHISWKDGLAFNALIHR.3|AC[CAM]LISLGYDVENDR.3|AC[CAM]LISLGYDVENDR.2|DHALLEEQSKQQSNEHLR.4|KAGTQIENIDEDFR.3|LRKDDPVTNLNNAFEVAEK.4|LRKDDPVTNLNNAFEVAEK.3|LRKDDPVTNLNNAFEVAEK.2|TAPYKNVNVQNFHISWKDGLAFNALIHR.6|NFITAEELR.2|RTIPWLEDRVPQK.3|QLEAIDQLHLEYAK.3|QLEAIDQLHLEYAK.2|VLAGDKNFITAEELR.3|VLAGDKNFITAEELR.2|DHALLEEQSK.2|DDPVTNLNNAFEVAEK.3|DDPVTNLNNAFEVAEK.2|DYETATLSDIK.2|ISIEMNGTLEDQLSHLKQYER.4|ISIEMNGTLEDQLSHLKQYER.3|ISIEMNGTLEDQLSHLK.3|ISIEM[Oxi]NGTLEDQLSHLK.3|ISIEMNGTLEDQLSHLK.2|RQFASQANVVGPWIQTK.3|SFSTALYGESDL.2|IAESNHIKLSGSNPYTTVTPQIINSKWEK.5|KDDPVTNLNNAFEVAEKYLDIPK.4|KDDPVTNLNNAFEVAEKYLDIPK.3|PNLDLLEQQHQLIQEALIFDNK.4|PNLDLLEQQHQLIQEALIFDNK.3|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.7|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.6|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.5|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.4|MVSDINNGWQHLEQAEK.3|M[Oxi]VSDINNGWQHLEQAEK.3|MVSDINNGWQHLEQAEK.2|M[Oxi]VSDINNGWQHLEQAEK.2|SIVDYKPNLDLLEQQHQLIQEALIFDNK.5|SIVDYKPNLDLLEQQHQLIQEALIFDNK.4|SIVDYKPNLDLLEQQHQLIQEALIFDNK.3|MLDAEDIVNTAR.2|QKASIHEAWTDGKEAMLK.3|VLAVNQENEHLM[Oxi]EDYEKLASDLLEWIRR.5|VLAVNQENEHLMEDYEKLASDLLEWIRR.5|VLAVNQENEHLMEDYEKLASDLLEWIRR.4|VLAVNQENEHLM[Oxi]EDYEK.3|VLAVNQENEHLMEDYEK.3|VLAVNQENEHLMEDYEK.2|IAESNHIKLSGSNPYTTVTPQIINSK.4|VEQIAAIAQELNELDYYDSHNVNTR.4|VEQIAAIAQELNELDYYDSHNVNTR.3|AGTQIENIDEDFR.2|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.6|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.5|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSHNVNTR.4|SIVDYKPNLDLLEQQHQLIQEALIFDNKHTNYTMEHIR.6|DDPVTNLNNAFEVAEKYLDIPK.3|M[Oxi]VSDINNGWQHLEQAEKGYEEWLLNEIR.4
SEN / CTL,P27348,14-3-3 protein theta,YWHAQ,1.43,1.72,8.86E-03,2.49E-03,2.60E+00,"protein targeting,small GTPase mediated signal transduction,substantia nigra development,negative regulation of ion transmembrane transport,negative regulation of transcription, DNA-templated,membrane organization,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","protein binding,protein C-terminus binding,protein domain specific binding,ion channel binding,protein N-terminus binding,14-3-3 protein binding","cytoplasm,mitochondrion,cytosol,focal adhesion,membrane,cytoplasmic vesicle membrane,protein complex,extracellular exosome",9,23,46,SIC[CAM]TTVLELLDKYLIANATNPESK.3|SIC[CAM]TTVLELLDKYLIANATNPESK.4|LAEQAERYDDMATC[CAM]MK.3|LAEQAERYDDM[Oxi]ATC[CAM]MK.3|LAEQAERYDDMATC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]ATC[CAM]M[Oxi]K.3|LAEQAERYDDMATC[CAM]MK.2|LAEQAERYDDM[Oxi]ATC[CAM]MK.2|LAEQAERYDDMATC[CAM]M[Oxi]K.2|YLIANATNPESK.3|YLIANATNPESK.2|SIC[CAM]TTVLELLDK.3|SIC[CAM]TTVLELLDK.2|YLAEVAC[CAM]GDDRK.3|YLAEVAC[CAM]GDDRK.2|AVTEQGAELSNEER.3|AVTEQGAELSNEER.2|AKLAEQAERYDDMATC[CAM]MK.4|AKLAEQAERYDDMATC[CAM]MK.3|QTIDNSQGAYQEAFDISKK.4|QTIDNSQGAYQEAFDISKK.3|QTIDNSQGAYQEAFDISKK.2|VISSIEQKTDTSDKK.3|YDDMATC[CAM]MK.2|YDDM[Oxi]ATC[CAM]MK.2|YDDMATC[CAM]M[Oxi]K.2|YDDM[Oxi]ATC[CAM]M[Oxi]K.2|KQTIDNSQGAYQEAFDISKK.4|KQTIDNSQGAYQEAFDISKK.3|KQTIDNSQGAYQEAFDISKK.2|KLQLIKDYR.2|YLAEVAC[CAM]GDDR.2|QTIDNSQGAYQEAFDISK.3|QTIDNSQGAYQEAFDISK.2|DYREKVESELR.2|KQTIDNSQGAYQEAFDISK.3|KQTIDNSQGAYQEAFDISK.2|TAFDEAIAELDTLNEDSYK.3|TAFDEAIAELDTLNEDSYK.2|NLLSVAYKNVVGGR.2|AVTEQGAELSNEERNLLSVAYKNVVGGR.4|AVTEQGAELSNEERNLLSVAYK.3|DNLTLWTSDSAGEEC[CAM]DAAEGAEN.3|TAFDEAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.4|TAFDEAIAELDTLNEDSYKDSTLIM[Oxi]QLLR.3|YLAEVAC[CAM]GDDRKQTIDNSQGAYQEAFDISK.4
SEN / CTL,P10253,Lysosomal alpha-glucosidase,GAA,1.43,1.56,1.48E-03,5.01E-04,3.30E+00,"maltose metabolic process,regulation of the force of heart contraction,diaphragm contraction,heart morphogenesis,glycogen catabolic process,sucrose metabolic process,glucose metabolic process,lysosome organization,locomotory behavior,tissue development,vacuolar sequestering,muscle cell cellular homeostasis,neuromuscular process controlling posture,neuromuscular process controlling balance,cardiac muscle contraction","alpha-1,4-glucosidase activity,oligo-1,6-glucosidase activity,carbohydrate binding,maltose alpha-glucosidase activity","lysosome,lysosomal membrane,membrane,lysosomal lumen,extracellular exosome",12,34,49,GAYTQVIFLAR.2|WTQLGAFYPFMR.2|WTQLGAFYPFM[Oxi]R.2|AHFPLDVQWNDLDYMDSR.3|AGYIIPLQGPGLTTTESR.2|AGYIIPLQGPGLTTTESR.3|VTSEGAGLQLQK.3|VTSEGAGLQLQK.2|RYEVPLETPHVHSR.4|RYEVPLETPHVHSR.3|LHFTIKDPANR.3|TTPTFFPK.2|PLFLEFPK.2|DGFRDFPAMVQELHQGGR.4|DGFRDFPAMVQELHQGGR.3|YALLPHLYTLFHQAHVAGETVAR.5|YALLPHLYTLFHQAHVAGETVAR.4|YALLPHLYTLFHQAHVAGETVAR.3|YEVPLETPHVHSR.3|DFPAMVQELHQGGR.3|TTPTFFPKDILTLR.3|DGFRDFPAMVQELHQGGRR.4|WGYSSTAITR.2|AHFPLDVQWNDLDYMDSRR.4|YALLPHLYTLFHQAHVAGETVARPLFLEFPK.6|YALLPHLYTLFHQAHVAGETVARPLFLEFPK.5|AITQEQC[CAM]EAR.2|LDVMMETENR.2|LDVM[Oxi]METENR.2|RYMMIVDPAISSSGPAGSYRPYDEGLRR.5|QQPMALAVALTK.2|NHNSLLSLPQEPYSFSEPAQQAMR.4|NHNSLLSLPQEPYSFSEPAQQAMR.3|NHNSLLSLPQEPYSFSEPAQQAM[Oxi]R.3|EPAIHSEGQWVTLPAPLDTINVHLR.4|EPAIHSEGQWVTLPAPLDTINVHLR.3|NHNSLLSLPQEPYSFSEPAQQAMRK.4|APSPLYSVEFSEEPFGVIVR.3|APSPLYSVEFSEEPFGVIVR.2|DSSTWTVDHQLLWGEALLITPVLQAGK.4|DSSTWTVDHQLLWGEALLITPVLQAGK.3|YMMIVDPAISSSGPAGSYRPYDEGLRR.4|VTVLGVATAPQQVLSNGVPVSNFTYSPDTK.4|VTVLGVATAPQQVLSNGVPVSNFTYSPDTK.3|APSPLYSVEFSEEPFGVIVRR.3|STGGILDVYIFLGPEPK.2|GELFWDDGESLEVLER.2|YMMIVDPAISSSGPAGSYRPYDEGLR.3|GSEDGC[CAM]PNNELENPPYVPGVVGGTLQAATIC[CAM]ASSHQFLSTHYNLHNLYGLTEAIASHR.6
SEN / CTL,P28072,Proteasome subunit beta type-6,PSMB6,1.43,1.25,2.06E-01,4.26E-02,1.37E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway,cell-cell adhesion","endopeptidase activity,threonine-type endopeptidase activity,cadherin binding involved in cell-cell adhesion","proteasome complex,nucleus,nucleoplasm,cytoplasm,Golgi apparatus,cytosol,proteasome core complex,cell-cell adherens junction,extracellular exosome",3,11,17,LAAIAESGVER.2|DGSSGGVIR.2|VTDKLTPIHDR.3|VTDKLTPIHDR.2|FAVATLPPA.2|TTTGSYIANR.2|QVLLGDQIPK.2|EEC[CAM]LQFTANALALAMER.3|EEC[CAM]LQFTANALALAMER.2|SGSAADTQAVADAVTYQLGFHSIELNEPPLVHTAASLFK.6|SGSAADTQAVADAVTYQLGFHSIELNEPPLVHTAASLFK.5|SGSAADTQAVADAVTYQLGFHSIELNEPPLVHTAASLFK.4|LAAIAESGVERQVLLGDQIPK.3|QSFAIGGSGSSYIYGYVDATYR.3|QSFAIGGSGSSYIYGYVDATYR.2|EGM[Oxi]TKEEC[CAM]LQFTANALALAMER.3|EGMTKEEC[CAM]LQFTANALALAMER.3
SEN / CTL,Q06481,Amyloid-like protein 2,APLP2,1.43,0.76,6.39E-02,1.45E-02,1.84E+00,"platelet degranulation,G-protein coupled receptor signaling pathway,negative regulation of endopeptidase activity","DNA binding,serine-type endopeptidase inhibitor activity,protein binding,heparin binding,transition metal ion binding","nucleus,plasma membrane,membrane,integral component of membrane,platelet alpha granule membrane,extracellular exosome",3,16,20,VPYVAQEIQEEIDELLQEQR.3|HYQHVLAVDPEK.3|HYQHVLAVDPEK.2|HYQHVLAVDPEKAAQMK.4|MQNHGYENPTYK.3|MQNHGYENPTYK.2|SQVMTHLHVIEER.3|MALENYLAALQSDPPRPHR.4|FIYGGC[CAM]GGNR.2|ERMEVC[CAM]ENHQHWHTVVK.4|ERMEVC[CAM]ENHQHWHTVVK.3|LNMHVNIQTGKWEPDPTGTK.4|QQLVETHLAR.2|C[CAM]LVGEFVSDVLLVPEK.3|C[CAM]LVGEFVSDVLLVPEK.2|EWEEAELQAK.2|LNMHVNIQTGK.2|ADMDQFTASISETPVDVR.3|AVC[CAM]SQEAMTGPC[CAM]R.2|VKKEWEEAELQAK.2
SEN / CTL,P16035,Metalloproteinase inhibitor 2,TIMP2,1.43,0.92,2.26E-08,1.85E-08,7.73E+00,"central nervous system development,aging,negative regulation of cell proliferation,response to hormone,negative regulation of endopeptidase activity,extracellular matrix disassembly,regulation of Rap protein signal transduction,response to cytokine,response to drug,positive regulation of MAPK cascade,positive regulation of neuron differentiation,positive regulation of adenylate cyclase activity,negative regulation of mitotic cell cycle,negative regulation of Ras protein signal transduction,negative regulation of membrane protein ectodomain proteolysis","protease binding,integrin binding,metalloendopeptidase inhibitor activity,metal ion binding","extracellular region,proteinaceous extracellular matrix,extracellular space,cell surface,growth cone,extracellular matrix,neuronal cell body,extracellular exosome",27,8,11,MHITLC[CAM]DFIVPWDTLSTTQKK.4|MHITLC[CAM]DFIVPWDTLSTTQKK.3|GAAPPKQEFLDIEDP.2|AVSEKEVDSGNDIYGNPIKR.4|AVSEKEVDSGNDIYGNPIKR.3|C[CAM]PMIPC[CAM]YISSPDEC[CAM]LWMDWVTEK.3|MHITLC[CAM]DFIVPWDTLSTTQK.3|M[Oxi]HITLC[CAM]DFIVPWDTLSTTQK.3|DIEFIYTAPSSAVC[CAM]GVSLDVGGKK.3|EVDSGNDIYGNPIKR.3|EVDSGNDIYGNPIK.2
SEN / CTL,P13929,Beta-enolase,ENO3,1.43,0.36,2.44E-06,1.43E-06,5.84E+00,"gluconeogenesis,aging,response to drug,skeletal muscle tissue regeneration,canonical glycolysis","magnesium ion binding,phosphopyruvate hydratase activity,protein homodimerization activity,protein heterodimerization activity","phosphopyruvate hydratase complex,extracellular space,cytoplasm,cytosol,plasma membrane,extracellular exosome",9,16,23,YGKDATNVGDEGGFAPNILENNEALELLK.4|VNQIGSVTESIQAC[CAM]K.2|VNQIGSVTESIQAC[CAM]K.3|NGKYDLDFKSPDDPAR.4|AC[CAM]NC[CAM]LLLK.2|FGANAILGVSLAVC[CAM]K.3|FGANAILGVSLAVC[CAM]K.2|LAQSNGWGVMVSHR.3|LAQSNGWGVM[Oxi]VSHR.3|LAQSNGWGVM[Oxi]VSHR.2|KLSVVDQEK.2|TAIQAAGYPDK.2|SKFGANAILGVSLAVC[CAM]K.3|SKFGANAILGVSLAVC[CAM]K.2|IGAEVYHHLK.2|LAMQEFMILPVGASSFK.3|LAMQEFMILPVGASSFK.2|GNPTVEVDLHTAK.2|AAVPSGASTGIYEALELRDGDK.3|HIADLAGNPDLILPVPAFNVINGGSHAGNK.4|HIADLAGNPDLILPVPAFNVINGGSHAGNK.3|AVENINNTLGPALLQK.2|DATNVGDEGGFAPNILENNEALELLK.3
SEN / CTL,Q6EMK4,Vasorin,VASN,1.41,1.32,1.88E-05,9.54E-06,5.02E+00,"negative regulation of epithelial to mesenchymal transition,negative regulation of transforming growth factor beta receptor signaling pathway,cellular response to hypoxia,cellular response to redox state,cell-cell adhesion","transforming growth factor beta binding,cadherin binding involved in cell-cell adhesion","extracellular space,mitochondrion,lysosomal membrane,plasma membrane,cell-cell adherens junction,cell surface,integral component of membrane,extracellular exosome",15,8,8,SLTLGIEPVSPTSLR.2|LAGLGLQQLDEGLFSR.2|LLLLDLSHNSLLALEPGILDTANVEALR.3|NPFNC[CAM]VC[CAM]PLSWFGPWVR.3|NLHDLDVSDNQLER.3|ESHVTLASPEETR.3|YLQGSSVQLR.2|HIQPGAFDTLDR.2
SEN / CTL,Q09666,Neuroblast differentiation-associated protein AHNAK,AHNAK,1.41,1.42,7.35E-15,1.36E-14,1.39E+01,"regulation of RNA splicing,protein oligomerization,cell-cell adhesion,regulation of voltage-gated calcium channel activity","protein binding,S100 protein binding,poly(A) RNA binding,structural molecule activity conferring elasticity,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,lysosomal membrane,cytosol,plasma membrane,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,T-tubule,vesicle,sarcolemma,costamere,cell-cell contact zone,extracellular exosome,membrane raft",78,433,666,ISMPEVDLNLKGPK.3|ISIPDVDLDLKGPK.3|ISMPDLDLNLKGPK.3|ISMPDLDLNLKGPK.2|VNVEAPDVNLEGLGGK.2|VNVEAPDVNLEGLGGK.3|MDVNVGDIDIEGPEGK.2|M[Oxi]DVNVGDIDIEGPEGK.2|MSLPDVDLDLKGPK.3|M[Oxi]SLPDVDLDLKGPK.3|VDINAPDVEVQGK.2|IKGDVPSVGLEGPDVDLQGPEAK.3|ISMPDIDLNLKGPK.3|ISMPDIDLNLKGPK.2|ISM[Oxi]PDIDLNLKGPK.3|ISMPDIDLNLTGPK.2|ISMPDIDLNLTGPK.3|VDVSAPDVEAHGPEWNLK.3|VDVSAPDVEAHGPEWNLK.2|ADIDVSGPKVDVEVPDVSLEGPEGK.3|VDIKAPEVNLNAPDVDVHGPDWNLK.4|VDIKAPDVEGQGLDWSLK.3|VDIKAPDVEGQGLDWSLKIPK.4|VTAYTVDVTGR.2|VDINAPDVDVQGPDWHLK.3|VDINAPDVDVQGPDWHLK.4|VDINAPDVDVQGPDWHLK.2|VKGDLDIAGPNLEGDFKGPK.4|VKGDLDIAGPNLEGDFKGPK.3|VKGDLDIAGPNLEGDFKGPK.2|VDIEGPDVNIEGPEGK.2|VDIEGPDVNIEGPEGK.3|GSRVDIETPNLEGTLTGPR.3|GSRVDIETPNLEGTLTGPR.2|ISAPNVDFNLEGPK.2|ISAPNVDFNLEGPK.3|VDISAPDVDVHGPDWHLK.4|VDISAPDVDVHGPDWHLK.3|VDISAPDVDVHGPDWHLK.2|HELTEISNVDVETQSGK.3|HELTEISNVDVETQSGK.2|RVTAYTVDVTGR.3|RVTAYTVDVTGR.2|AVEVQGPSLESGDHGK.4|AVEVQGPSLESGDHGK.3|AVEVQGPSLESGDHGK.2|FSMPGFK.2|FSM[Oxi]PGFK.2|FSMPGFKGEGR.3|FSMPGFKGEGR.2|IKGDMDISVPK.3|IKGDMDISVPK.2|IPMPDFDLHLKGPK.4|IPMPDFDLHLKGPK.3|ISM[Oxi]PDFDLHLKGPK.4|ISMPDFDLHLKGPK.4|ISM[Oxi]PDFDLHLKGPK.3|ISMPDFDLHLKGPK.3|LKTDVDVSLPK.3|LKTDVDVSLPK.2|MPDMHVNMPK.3|MPDMHVNMPK.2|VKGDMDISLPK.3|VKGDMDISLPK.2|VPDVDIR.2|VPDVEIK.2|VPDVELK.2|VTAPDVDLHLK.3|VTAPDVDLHLK.2|AGAISASGPELQGAGHSK.4|AGAISASGPELQGAGHSK.3|AGAISASGPELQGAGHSK.2|LEGGEVDLKGPK.3|VEGDLKGPEADIKGPK.4|VEGDLKGPEADIKGPK.3|VKGEYDVTVPK.3|VKGEYDVTVPK.2|ISMPDIDLNLK.3|ISMPDIDLNLK.2|ISM[Oxi]PDIDLNLK.2|ISMPDVDLHVK.3|ISMPDVDLHVK.2|MKGDYDVTVPK.3|MKGDYDVTVPK.2|VEGDLKGPEVDIKGPK.4|VEGDLKGPEVDIKGPK.3|VEGDLKGPEVDLKGPK.4|VEGDLKGPEVDLKGPK.3|ADLGVSGPK.2|AEGPEVDVNLPK.3|AEGPEVDVNLPK.2|GEGPDVHMTLPK.3|GEGPDVHMTLPK.2|GKKPDIDITGPK.3|GPDWHLK.2|ISMPDLDLHLK.3|ISM[Oxi]PDLDLHLK.3|ISMPDLDLHLK.2|ISM[Oxi]PDVDLHLK.3|ISMPDVDLHLK.3|ISMPDVDLHLK.2|ISM[Oxi]PDVDLHLK.2|MEGDLKGPEVDIKGPK.4|MEGDLKGPEVDIKGPK.3|VEGDLKGPEIDVKAPK.4|VEGEIKAPDVDIKGPK.4|VEGTLKGPEVDLKGPR.4|VEGTLKGPEVDLKGPR.3|VKGEYDMTVPK.3|VKGEYDMTVPK.2|ADVVVSGPK.2|GPRLDFEGPDAK.3|ISMPDVDLHMK.3|ISMPDVDLHMK.2|MPEMNIK.2|M[Oxi]PEMNIK.2|MPEM[Oxi]NIK.2|VEGDMKVPDVDIKGPK.4|VEGEMKVPDVDIKGPK.4|VHAPGLNLSGVGGK.3|VHAPGLNLSGVGGK.2|ADVDVSGPK.2|GDISISGPK.2|GDVDVSAPK.2|GDVDVSGPK.2|IKGDVDVTGPKVEGDLK.4|IPMPDFDLHLK.3|IPM[Oxi]PDFDLHLK.3|IPMPDFDLHLK.2|ISMPDFDLHLK.3|ISM[Oxi]PDFDLHLK.3|ISMPDFDLHLK.2|ISM[Oxi]PDFDLHLK.2|ISMPDVDLHLKGPNVK.4|ISMPDVDLHLKGPNVK.3|LKGDVDVSGPKLEGDIK.4|LKGDVDVSGPKLEGDIK.3|VEGEMKVPDVEIKGPK.4|VEGEMKVPDVEIKGPK.3|VKMPDVDISVPK.3|VKVPEVDVRGPK.3|GNVDISAPK.2|GPGVDVNLK.2|IKGDVDVSAPKLEGELK.4|IKGDVDVSAPKLEGELK.3|MQVGGDGVK.2|ADIDVSGPK.2|ADLDVSGPK.2|ADVDISGPK.2|AEAPLPSPK.2|AKGEVDVDVPKLEGDLK.4|AKGEVDVDVPKLEGDLK.3|ANVDISAPK.2|EVDVNLPK.2|GDVVVSLPK.2|GGVDVTLPR.2|GPQVSGELK.2|LEVPDMNIRGPK.3|VEGDLKGPEADIK.3|VEGDLKGPEADIK.2|VPGIDATTK.2|ADIEISGPK.2|FKMPFLSISSPK.3|GDVDVSLPK.2|GDVDVSVPK.2|GEGPEVDVK.2|GPKVDIDAPDVDVHGPDWHLK.5|GPKVDIDAPDVDVHGPDWHLK.4|GPKVDIDAPDVDVHGPDWHLK.3|GPKVDIDAPDVDVHGPDWHLK.2|MPEMHFK.2|VEGTLKGPEVDLK.3|VKGDMDVSVPKVEGEMK.4|GDVDISLPK.2|GDVDVTLPK.2|GSLGATGEIK.2|LEGDLKGPEVDIK.3|LPQFGISTPGSDLHVNAK.4|LPQFGISTPGSDLHVNAK.3|LPQFGISTPGSDLHVNAK.2|VEGDLKGPEIDIK.3|VEGDLKGPEIDVK.3|VEGDLKGPEIDVK.2|VEGDLKGPEVDIK.3|VEGDLKGPEVDIK.2|VEGDLKGPEVDLK.3|VEGDLKGPEVDLK.2|GDMDVSVPK.2|GPKVDIDAPDVEVHDPDWHLK.5|LEGELKGPELDVK.3|MEGDLKGPEVDIK.3|VEGDLKGPEVDIR.3|VKGEYDVTVPKLEGELK.4|GDFDVSVPK.2|GDMDISVPK.2|GDMDVSLPK.2|GEVDVDVPK.2|GGLKGSEVGFHGAAPDISVK.4|GKGGVTGSPEASISGSKGDLK.4|GPHVDVSGPDIDIEGPEGK.4|GPHVDVSGPDIDIEGPEGK.3|GPHVDVSGPDIDIEGPEGK.2|IGFSGPKLEGGEVDLKGPK.4|IGFSGPKLEGGEVDLKGPK.3|LEGGEVDLK.2|LEGPDVSLK.2|MEGDLKAPEVDIK.3|M[Oxi]EGDLKAPEVDIK.3|TPEMIIQK.2|VEGDMKVPDVDIK.3|FGTFGGLGSK.2|GDMDISLPK.2|TDVDVSLPK.2|VEGEMKVPDVDIK.3|GDRSPEPGQTWTR.3|GDRSPEPGQTWTR.2|GPEVDVSGPK.2|ISIPDVGLHLKGPK.3|ISMPDVGLNLKAPK.3|LDFEGPDAK.2|LQVTMPGIK.2|LQVTM[Oxi]PGIK.2|VEGEMKVPDVDIR.3|VESEIKVPDVELK.3|VESEIKVPDVELK.2|FSMPGFKGEGPDGDVKLPK.4|GDYDVTVPK.2|GHYEVTGSDDETGK.3|GHYEVTGSDDETGK.2|ISMPGFKGEGPDVDVNLPK.4|ISMPGFKGEGPDVDVNLPK.3|ISM[Oxi]PGFKGEGPDVDVNLPK.3|ISMPGFKGEGPDVDVNLPK.2|ISMQDVDLSLGSPK.3|ISMQDVDLSLGSPK.2|ISM[Oxi]QDVDLSLGSPK.2|VGGSGVNVNAK.2|VTAPDVDLHLKAPK.3|VTAPDVDLHLKAPK.2|APDVEGQGLDWSLK.3|APDVEGQGLDWSLK.2|FSMPGFKGEGPEVDVTLPK.4|FSM[Oxi]PGFKGEGPEVDVTLPK.3|FSMPGFKGEGPEVDVTLPK.3|GEYDVTVPK.2|GKGGVTGSPEASISGSK.3|GKGGVTGSPEASISGSK.2|ISMPDVDLNLKGPK.3|ISM[Oxi]PDVDLNLKGPK.3|ISMPDVDLNLKGPK.2|ISMPDVNLNLKGPK.3|ISMPGFKGEGPEVDVNLPK.4|ISM[Oxi]PGFKGEGPEVDVNLPK.3|ISMPGFKGEGPEVDVNLPK.3|ISMPGFKGEGPEVDVNLPK.2|LKGPDVKLPDMSVK.3|VDIDAPDVDVHGPDWHLK.4|VDIDAPDVDVHGPDWHLK.3|VDIDAPDVDVHGPDWHLK.2|VDINAPDVDVHGPDWHLK.4|VDINAPDVDVHGPDWHLK.3|VQTPEVDVK.2|VSMPDVDLNLKGPK.3|VSMPDVDLNLKGPK.2|EGAKDIDISSPEFK.3|FSMPGFKAEGPEVDVNLPK.4|FSM[Oxi]PGFKAEGPEVDVNLPK.3|FSMPGFKAEGPEVDVNLPK.3|FSMPGFKAEGPEVDVNLPK.2|FSMPGFKGEGPEVDVKLPK.4|GPNVKGEYDVTMPK.3|ISMPDVDLHLKGPK.3|ISM[Oxi]PDVDLHLKGPK.3|ISMPDVDLHLKGPK.2|ISMPEIDLNLKGSK.3|MDIDAPDVDVHGPDWHLK.4|MDIDAPDVDVHGPDWHLK.3|MDIDAPDVDVHGPDWHLK.2|MDIDAPDVEVQGPDWHLK.4|M[Oxi]DIDAPDVEVQGPDWHLK.3|MDIDAPDVEVQGPDWHLK.3|MDIDAPDVEVQGPDWHLK.2|VDIDVPDVDVQGPDWHLK.4|VDIDVPDVDVQGPDWHLK.3|VDIDVPDVDVQGPDWHLK.2|VDINAPDVDVRGPDWHLK.4|VDINAPDVDVRGPDWHLK.3|VDINAPDVEVHGPDWHLK.4|VDINAPDVEVHGPDWHLK.3|VDINAPDVEVHGPDWHLK.2|VDINTPDVDVHGPDWHLK.4|VDINTPDVDVHGPDWHLK.3|APDVDIKGPK.2|GEYDMTVPK.2|GEYDVTMPK.2|GEYDVTM[Oxi]PK.2|GPEVDIKGPK.2|GSEVGFHGAAPDISVK.3|GSEVGFHGAAPDISVK.2|IKGDVDVSVPEVEGK.3|IKGDVDVSVPEVEGK.2|ISMPDVDFNLKGPK.3|ISM[Oxi]PDVDFNLKGPK.3|ISMPDVDLHMKGPK.3|ISMPDVDLHMKGPK.2|LQGSGVSLASK.2|MPTFSTPGAK.2|SPQISMSDIDLNLK.3|SPQISM[Oxi]SDIDLNLK.2|SPQISMSDIDLNLK.2|VSMPDVELNLKSPK.3|GPQVSGELKGPGVDVNLKGPR.4|ISMPDFDLNLKGPK.3|ISMPDIDFNLKGPK.3|ISMPDIDFNLKGPK.2|VDIDAPDVEVHDPDWHLK.4|VDIDAPDVEVHDPDWHLK.3|VSAPGVQGDVK.2|VSVGAPDLSLEASEGSIKLPK.4|VSVGAPDLSLEASEGSIKLPK.3|VSVGAPDLSLEASEGSIKLPK.2|GEVDVDVPKLEGDLK.3|GGVQVPAVDISSSLGGR.3|GGVQVPAVDISSSLGGR.2|GPSLKGDLDASVPSMK.3|GPSLKGDLDASVPSMK.2|M[Oxi]KLPQFGISTPGSDLHVNAK.4|MKLPQFGISTPGSDLHVNAK.4|MKLPQFGISTPGSDLHVNAK.3|M[Oxi]KLPQFGISTPGSDLHVNAK.3|MPSLEISAPK.2|VPDVDIKGPK.2|ELLLPNWQGSGSHGLTIAQR.4|ELLLPNWQGSGSHGLTIAQR.3|ELLLPNWQGSGSHGLTIAQR.2|KPDIDITGPK.2|LEVPDMNIR.2|VDTNAPDLSLEGPEGKLKGPK.4|VGVEVPDVNIEGPEGKLKGPK.4|IGFSGPKLEGGEVDLK.3|LPSGSGAASPTGSAVDIR.3|LPSGSGAASPTGSAVDIR.2|MPDVDISVPK.2|MPFLSISSPK.2|M[Oxi]PFLSISSPK.2|SKGHYEVTGSDDETGKLQGSGVSLASK.5|VDIEAPDVSLEGPEGK.3|VDIEAPDVSLEGPEGK.2|VDTNAPDLSLEGPEGK.3|VDTNAPDLSLEGPEGK.2|VDVEGPDVNIEGPEGK.3|VDVEGPDVNIEGPEGK.2|VDVEVPDVSLEGPEGKLKGPK.4|VGVEVPDVNIEGPEGK.3|VGVEVPDVNIEGPEGK.2|FAGGLHFSGPK.2|FSMPGFKGEGPDGDVK.3|FSMPGFKGEGPDGDVK.2|GDLDASVPSMK.2|IDVTAPDVSIEEPEGKLKGPK.4|ISMPDVDLHLKGPNVKGEYDVTMPK.5|LKGDVDVSGPK.2|VDVDVPDVNIEGPDAK.3|VDVDVPDVNIEGPDAK.2|VDVEVPDVSLEGPEGK.3|VDVEVPDVSLEGPEGK.2|VGIDTPDIDIHGPEGK.3|VGIDTPDIDIHGPEGK.2|VKGDADVSVPK.2|VSAPEVSVGHK.2|GPKVDVSAPDVEAHGPEWNLK.4|GPKVDVSAPDVEAHGPEWNLK.3|IDVDAPDIDIHGPDAK.3|IDVDAPDIDIHGPDAK.2|IDVTAPDVSIEEPEGK.3|IDVTAPDVSIEEPEGK.2|IKGDVDVSAPK.2|IKGDVDVTGPK.2|IPRHELTEISNVDVETQSGK.4|IPRHELTEISNVDVETQSGK.3|MDAEVPDVNIEGPDAK.3|M[Oxi]DAEVPDVNIEGPDAK.2|MDAEVPDVNIEGPDAK.2|VDIDTPDINIEGSEGKFKGPK.4|VDIDVPDVNIEGPDAK.3|VDIDVPDVNIEGPDAK.2|VDIDVPDVNIEGPEGK.3|VDIDVPDVNIEGPEGK.2|APSLDIKGPEVDVSGPK.3|APSLDIKGPEVDVSGPK.2|GPKVDISAPDVDVHGPDWHLK.4|GPQVDIDVPDVGVQGPDWHLK.4|GPQVDIDVPDVGVQGPDWHLK.3|LEGELKGPELDVKGPK.3|SKGHYEVTGSDDETGK.3|VDIDTPDIDIHGPEGK.3|VDIDTPDINIEGSEGK.3|VDIDTPDINIEGSEGK.2|VDIDVPDVNLEAPEGK.3|VDIDVPDVNLEAPEGK.2|VDIETPNLEGTLTGPR.3|VDIETPNLEGTLTGPR.2|VKGDVDVSVPK.2|VKGGVDVTLPR.2|AKGEVDVDVPK.2|ASLGSLEGEAEAEASSPK.3|ASLGSLEGEAEAEASSPK.2|DIDISSPEFK.2|EMGVDVHFPK.2|FSM[Oxi]PGFKGEGPEVDVK.3|FSMPGFKGEGPEVDVK.3|GPKVDINAPDVDVQGPDWHLK.4|GPKVDINAPDVEVHGPDWHLK.4|LNVGAPDVTLR.2|MEGDLKAPEVDIKGPK.3|MKGNVDISAPK.2|M[Oxi]KGNVDISAPK.2|MPTFSTPGAKGEGPDVHMTLPK.4|SPEPGQTWTR.2|VEGDMQVPDLDIKGPK.3|VEGDMQVPDLDIKGPK.2|VKGDVDVSLPK.2|GPKVDIDVPDVDVQGPDWHLK.4|GPKVDIDVPDVNVQGPDWHLK.4|GPKVDIDVPDVNVQGPDWHLK.3|MKGDVVVSLPK.2|M[Oxi]KGDVVVSLPK.2|QGFDLNVPGGEIDASLK.3|QGFDLNVPGGEIDASLK.2|VDVEC[CAM]PDVNIEGPEGK.3|VDVEC[CAM]PDVNIEGPEGK.2|VKGDMDVSVPK.2|VKGDM[Oxi]DVSVPK.2|VKGDVDISLPK.2|VKGDVDVTLPK.2|VSAPGVQGDVKGPQVALK.3|VSGPDLDLNLK.2|FKAEAPLPSPK.2|IEGEMQVPDVDIRGPK.3|ISMPDVGLNLK.2|LEGDIKAPSLDIKGPEVDVSGPK.4|MKGDVDVSLPK.2|MPEMSIKPQK.2|MPSMNIQTHK.2|MQVGGDGVKVPGIDATTK.3|M[Oxi]QVGGDGVKVPGIDATTK.3|TPEMIIQKPK.2|VKGDMDVSLPK.2|EVDVNLPKADIDVSGPK.3|GPQVSGELKGPGVDVNLK.3|GPQVSGELKGPGVDVNLK.2|ISIPDVGLHLK.2|VKGDFDVSVPK.2|VKGDLDIAGPNLEGDFK.3|VKGDLDIAGPNLEGDFK.2|AEGPDVAVDLPK.2|APNISMPDVDLNLKGPK.3|APNISMPDVDLNLKGPK.2|GEGPDVDVSLPK.2|GGQIGLQAPGLSVSGPQGHLESGSGK.4|GGQIGLQAPGLSVSGPQGHLESGSGK.3|LKGPQITGPSLEGDLGLK.3|LKGPQITGPSLEGDLGLK.2|LKSEDGVEGDLGETQSR.3|LKSEDGVEGDLGETQSR.2|MKGEVDVSLANVEGDLK.3|VDINAPDVDVR.2|VDVNAPDVQAPDWHLK.3|VDVNAPDVQAPDWHLK.2|VKGDVDVSVPKVEGEMK.3|DDGVFVQEVTQNSPAAR.3|DDGVFVQEVTQNSPAAR.2|GDLDIAGPNLEGDFKGPK.3|GEGPDVDVTLPK.2|GPEVDIEGPEGK.2|GPTVGGGLPGIGVQGLEGNLQMPGIK.4|GPTVGGGLPGIGVQGLEGNLQMPGIK.3|GPTVGGGLPGIGVQGLEGNLQM[Oxi]PGIK.3|IKGGADVSGGVSAPDISLGEGHLSVK.4|ISIPDVDLDLK.2|SPQISMSDIDLNLKGPK.3|SPQISMSDIDLNLKGPK.2|VQANLGAPDINIEGLDAK.3|VQANLGAPDINIEGLDAK.2|VSMPDVDLNLK.2|GEGPDVDVNLPK.2|GEGPEVDVTLPK.2|ISMPDVDLNLK.2|ISMPDVNLNLK.2|LPTGQISGPEIK.2|MSLPDVDLDLK.2|TPSFGISAPQVSIPDVNVNLKGPK.4|TPSFGISAPQVSIPDVNVNLKGPK.3|VEAPSLDVHMDSPDINIEGPDVK.4|VEAPSLDVHM[Oxi]DSPDINIEGPDVK.3|VEAPSLDVHMDSPDINIEGPDVK.3|VGIQLPEVELSVSTKKE.3|VSMPDVELNLK.2|GEGPEVDVNLPK.2|GHYEVTGSDDETGKLQGSGVSLASK.4|GHYEVTGSDDETGKLQGSGVSLASK.3|ISMPDLDLNLK.2|ISM[Oxi]PDLDLNLK.2|ISMPEVDLNLK.2|KQGFDLNVPGGEIDASLK.3|KQGFDLNVPGGEIDASLK.2|M[Oxi]KGEVDVSLANVEGDLKGPALDIK.4|MKGEVDVSLANVEGDLKGPALDIK.4|MKGEVDVSLANVEGDLKGPALDIK.3|GPAFNMASPESDFGINLK.3|GPAFNM[Oxi]ASPESDFGINLK.2|GPAFNMASPESDFGINLK.2|ISMPDVDFNLK.2|ISMPEIDLNLK.2|VESDLKGPEVDIEGPEGK.3|VESDLKGPEVDIEGPEGK.2|FSVSGLKAEGPDVAVDLPK.3|GEGPEFDVNLSK.2|GEGPEVDMNLPK.2|GPKLDADMPEVAVEGPNGK.3|ISMPDFDLNLK.2|ISMPDIDFNLK.2|LKGEIDASVPELEGDLRGPQVDVK.4|M[Oxi]EGGGAEVHAQLPSLEGDLRGPDVK.4|MEGGGAEVHAQLPSLEGDLRGPDVK.4|SPSLDVTVPEAELNLETPEISVGGK.4|SPSLDVTVPEAELNLETPEISVGGK.3|ADIDVSGPKVDIDTPDIDIHGPEGK.4|ADIDVSGPKVDIDTPDIDIHGPEGK.3|GPSLDIDTPDVNIEGPEGK.3|GPSLDIDTPDVNIEGPEGK.2|LKGDVDVSLPEVEGEMKVPDVDIK.4|VDINAPDVGVQGPDWHLK.3|VDINAPDVGVQGPDWHLK.2|GKKPDIDITGPKVDINAPDVEVQGK.4|GKKPDIDITGPKVDINAPDVEVQGK.3|IKGDVDVSVPEVEGKLEVPDMNIR.4|FSMPGFKGEGPDVDVSLPK.3|FSM[Oxi]PGFKGEGPDVDVSLPK.3|GDVDVSVPEVEGK.2|GGVTGSPEASISGSK.2|GPKVDIDTPDINIEGSEGK.3|VDVSAPDVEMQGPDWNLK.3|VDVSAPDVEMQGPDWNLK.2|FSMPGFKGEGPDVDVTLPK.3|FSM[Oxi]PGFKGEGPDVDVTLPK.3|FSVPGFKAEGPEVDVNLPK.3|FSVPGFKAEGPEVDVNLPK.2|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.5|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.4|GSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.3|LEGELQAPDLELSLPAIHVEGLDIK.4|LEGELQAPDLELSLPAIHVEGLDIK.3|VKTPSFGISAPQVSIPDVNVNLKGPK.4|FSM[Oxi]PGFKGEGPDVDVNLPK.3|FSMPGFKGEGPDVDVNLPK.3|FSMPGFKGEGPDVDVNLPK.2|FSMPGFKGEGPEVDVNLPK.3|FSM[Oxi]PGFKGEGPEVDVNLPK.2|FSMPGFKGEGPEVDVNLPK.2|FSMPSLKGEGPEVDVNLPK.3|FSM[Oxi]PSLKGEGPEVDVNLPK.3|VDIDVPDVNVQGPDWHLK.3|VDIDVPDVNVQGPDWHLK.2|AEASIQAGAGDGEWEESEVK.3|AEASIQAGAGDGEWEESEVK.2|FSMPGFKGEGPEVDMNLPK.3|FSMPGFKGEGPEVDM[Oxi]NLPK.3|FSMPSLKGEGPEFDVNLSK.3|GPFVEAEVPDVDLEC[CAM]PDAK.3|GPFVEAEVPDVDLEC[CAM]PDAK.2|MEGGGAEVHAQLPSLEGDLR.3|VSGPDLDLNLKGPSLKGDLDASVPSMK.4|VSGPDLDLNLKGPSLKGDLDASVPSMK.3|EETTRELLLPNWQGSGSHGLTIAQR.4|GGKPGLTIQAPQLEVSVPSANIEGLEGK.4|GGKPGLTIQAPQLEVSVPSANIEGLEGK.3|M[Oxi]DIDVPDVEVQGPDWHLK.3|MDIDVPDVEVQGPDWHLK.3|MEGGGAEVHAQLPSLEGDLRGPDVKLEGPDVSLK.5|MYFPDVEFDIK.2|M[Oxi]YFPDVEFDIK.2|TVIRLPSGSGAASPTGSAVDIR.3|VEAPSLDVHMDSPDINIEGPDVKIPK.4|GPQVSSALNLDTSK.2|GSGGEWKGPQVSSALNLDTSK.3|GSGGEWKGPQVSSALNLDTSK.2|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.6|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.5|TGVVKEGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.4|AEGPEVDVNLPKADVDISGPK.3|AEGPEVDVNLPKADVDISGPK.2|FSMPSLKGEGPEVDVNLPKADVVVSGPK.4|FSMPSLKGEGPEVDVNLPKADVVVSGPK.3|SSGC[CAM]DVNLPGVNVK.2|FSVPGFKAEGPEVDVNLPKADVDISGPK.4|GPAFNMASPESDFGINLKGPK.3|GPSLQGDLAVSGDIK.2|TPSFGISAPQVSIPDVNVNLK.3|TPSFGISAPQVSIPDVNVNLK.2|VEGDMQVPDLDIK.2|VEGEMKVPDVEIK.2|GGADVSGGVSAPDISLGEGHLSVK.3|ISM[Oxi]SEVDLNVAAPK.2|ISMSEVDLNVAAPK.2|GLDLGGRGGVQVPAVDISSSLGGR.3|GPGVDLPSVNLSMPK.2|GPGVDLPSVNLSM[Oxi]PK.2|IEGEMQVPDVDIR.2|IEGEM[Oxi]QVPDVDIR.2|APEVNLNAPDVDVHGPDWNLK.3|APEVNLNAPDVDVHGPDWNLK.2|APNISMPDVDLNLK.2|APNISM[Oxi]PDVDLNLK.2|EGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.5|EGDQIVGATIYFDNLQSGEVTQLLNTMGHHTVGLK.4|GEIDASVPELEGDLRGPQVDVK.3|GEVDVSLANVEGDLK.2|VSAPEVSVGHKGGKPGLTIQAPQLEVSVPSANIEGLEGK.5|APDVDVNIAGPDAALK.2|GAKPQGHIGVDASAPQIGGSITGPSVEVQAPDIDVQGPGSK.5|GAKPQGHIGVDASAPQIGGSITGPSVEVQAPDIDVQGPGSK.4|GDLDIAGPNLEGDFK.2|GPQITGPSLEGDLGLK.2|SEDGVEGDLGETQSR.2|GEIDASVPELEGDLR.2|VGIQLPEVELSVSTK.2|VKTPSFGISAPQVSIPDVNVNLK.3|EVFSSC[CAM]SSEVVLSGDDEEYQR.3|LEGPDVSLKGPGVDLPSVNLSMPK.3|LDADM[Oxi]PEVAVEGPNGK.2|LDADMPEVAVEGPNGK.2|VDIDAPDVSIEGPDAK.2|ADIDVSGPSVDTDAPDLDIEGPEGK.3|ADLGVSGPKVDIDVPDVNLEAPEGK.3|ADVDVSGPKVDVEGPDVNIEGPEGK.3|ADVDVSGPKVDVEVPDVSLEGPEGK.3|ADVVVSGPKVDIEAPDVSLEGPEGK.3|ADVVVSGPKVDVEVPDVSLEGPEGK.3|ANVDISAPKVDTNAPDLSLEGPEGK.3|EFSGPSTPTGTLEFEGGEVSLEGGK.3|VDVDIPDVNIEGPDAK.2|ADIDISGPNVDVDVPDVNIEGPDAK.3|ADIDVSGPKVDIEGPDVNIEGPEGK.3|ADIDVSGPKVDVDIPDVNIEGPDAK.3|ADIDVSGPKVDVDVPDVNIEGPDAK.3|ADLDVSGPKVDIDVPDVNIEGPDAK.3|ADLDVSGPKVDIDVPDVNIEGPEGK.3|ADLDVSGPKVDVDVPDVNIEGPDAK.3|ADVDISGPKVDIEGPDVNIEGPEGK.3|LNVGAPDVTLRGPSLQGDLAVSGDIK.3|PGLTIQAPQLEVSVPSANIEGLEGK.3|ADIDVSGPKVDVEC[CAM]PDVNIEGPEGK.3|LEGDLTGPSVGVEVPDVELEC[CAM]PDAK.3|VSVGAPDLSLEASEGSIK.2|GEETGIDVTLPTGEVTVPGVSGDVSLPEIATGGLEGK.4|GEETGIDVTLPTGEVTVPGVSGDVSLPEIATGGLEGK.3|LEGDLTGPSVDVEVPDVELEC[CAM]PDAK.3|VKGSLGATGEIKGPTVGGGLPGIGVQGLEGNLQMPGIK.4|VKGDADVSVPKLEGDLTGPSVGVEVPDVELEC[CAM]PDAK.4|VKGDVDVSVPKLEGDLTGPSVGVEVPDVELEC[CAM]PDAK.4|VKGDVDVSLPKLEGDLTGPSVDVEVPDVELEC[CAM]PDAK.4|ADIKSPSLDVTVPEAELNLETPEISVGGK.3|ELLLPNWQGSGSHGLTIAQRDDGVFVQEVTQNSPAAR.4|GDVPSVGLEGPDVDLQGPEAK.2|SNSFSDEREFSGPSTPTGTLEFEGGEVSLEGGK.3
SEN / CTL,Q12841,Follistatin-related protein 1,FSTL1,1.40,0.89,4.15E-06,2.32E-06,5.63E+00,"BMP signaling pathway,response to starvation","calcium ion binding,protein binding,heparin binding","extracellular region,extracellular space,extracellular exosome",15,12,12,LSFQEFLK.2|IIQWLEAEIIPDGWFSK.3|IC[CAM]ANVFC[CAM]GAGR.2|C[CAM]VC[CAM]AC[CAM]GNWVC[CAM]TAMTC[CAM]DGK.2|GAQTQTEEEMTR.2|C[CAM]LNPSFNPPEKK.3|GEPTC[CAM]LC[CAM]IEQC[CAM]KPHK.3|IQVDYDGHC[CAM]K.2|C[CAM]LNPSFNPPEK.2|TYLNHC[CAM]ELHR.2|GEPTC[CAM]LC[CAM]IEQC[CAM]K.2|SVSPSASPVVC[CAM]YQSNR.2
SEN / CTL,P02461,Collagen alpha-1(III) chain,COL3A1,1.39,1.38,6.07E-08,4.53E-08,7.34E+00,"skeletal system development,cell-matrix adhesion,transforming growth factor beta receptor signaling pathway,integrin-mediated signaling pathway,heart development,aging,response to radiation,response to mechanical stimulus,peptide cross-linking,cerebral cortex development,platelet activation,extracellular matrix organization,collagen fibril organization,collagen catabolic process,response to cytokine,positive regulation of Rho protein signal transduction,wound healing,extracellular fibril organization,skin development,digestive tract development,regulation of immune response,negative regulation of immune response,aorta smooth muscle tissue morphogenesis,cellular response to amino acid stimulus,negative regulation of neuron migration","integrin binding,extracellular matrix structural constituent,protein binding,SMAD binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type III trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix",30,25,27,SVNGQIESLISPDGSR.2|VFC[CAM]NMETGETC[CAM]ISANPLNVPR.3|NSIAYMDQASGNVK.2|FTYTVLEDGC[CAM]TK.2|LMGSNEGEFKAEGNSK.3|LPIVDIAPYDIGGPDQEFGVDVGPVC[CAM]FL.3|NSIAYMDQASGNVKK.3|NSIAYMDQASGNVKK.2|INTDEIMTSLK.2|INTDEIM[Oxi]TSLK.2|SGEYWVDPNQGC[CAM]K.2|KHWWTDSSAEK.3|GPVGPSGPPGK.2|DGTSGHPGPIGPPGPR.3|GPPGLAGAPGLR.2|GAAGEPGRDGVPGGPGMR.3|GPAGPNGIPGEK.2|LMGSNEGEFK.2|GGPGGPGPQGPPGK.2|HWWTDSSAEK.2|GSPGGPGAAGFPGAR.2|SGDRGESGPAGPAGAPGPAGSR.3|GPPGPAGANGAPGLR.2|GENGSPGAPGAPGHPGPPGPVGPAGK.3|NGETGPQGPPGPTGPGGDK.2|AGGFAPYYGDEPMDFK.2|AGGFAPYYGDEPMDFKINTDEIMTSLK.3
SEN / CTL,Q13442,28 kDa heat- and acid-stable phosphoprotein,PDAP1,1.39,1.55,1.27E-01,2.71E-02,1.57E+00,"signal transduction,cell proliferation",poly(A) RNA binding,,3,15,23,KVTQLDLDGPK.2|KVTQLDLDGPK.3|KVTQLDLDGPKELSR.4|KVTQLDLDGPKELSR.3|MQSLSLNK.2|M[Oxi]QSLSLNK.2|EEEEQKEGGDGAAGDPKK.4|GVEGLIDIENPNR.3|GVEGLIDIENPNR.2|AREEEEQKEGGDGAAGDPK.4|AREEEEQKEGGDGAAGDPK.3|AKDDATLSGK.2|KGVEGLIDIENPNR.3|KGVEGLIDIENPNR.2|RMQSLSLNK.2|VTQLDLDGPK.2|RKGVEGLIDIENPNR.3|RKGVEGLIDIENPNR.2|EEEEQKEGGDGAAGDPK.3|QYTSPEEIDAQLQAEK.3|QYTSPEEIDAQLQAEK.2|GVEGLIDIENPNRVAQTTK.3|QYTSPEEIDAQLQAEKQK.3
SEN / CTL,P62258,14-3-3 protein epsilon,YWHAE,1.39,2.21,9.47E-03,2.66E-03,2.58E+00,"G2/M transition of mitotic cell cycle,neuron migration,regulation of heart rate by hormone,protein targeting,viral process,substantia nigra development,hippocampus development,cerebral cortex development,hippo signaling,intracellular signal transduction,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,regulation of membrane repolarization,membrane organization,membrane repolarization during cardiac muscle cell action potential,regulation of heart rate by cardiac conduction,cell-cell adhesion,regulation of cellular response to heat,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,regulation of potassium ion transmembrane transporter activity,negative regulation of peptidyl-serine dephosphorylation","protein binding,potassium channel regulator activity,enzyme binding,protein domain specific binding,MHC class II protein complex binding,ubiquitin protein ligase binding,histone deacetylase binding,ion channel binding,poly(A) RNA binding,protein heterodimerization activity,phosphoserine binding,phosphoprotein binding,cadherin binding involved in cell-cell adhesion","mitochondrion,cytosol,kinesin complex,cell-cell adherens junction,focal adhesion,membrane,axon,cytoplasmic vesicle membrane,melanosome,extracellular exosome",18,36,102,LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.3|QMVETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.5|QM[Oxi]VETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.5|QM[Oxi]VETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|QMVETELKLIC[CAM]C[CAM]DILDVLDKHLIPAANTGESK.4|LAEQAERYDEMVESMKK.4|LAEQAERYDEM[Oxi]VESM[Oxi]KK.4|LAEQAERYDEM[Oxi]VESMKK.4|LAEQAERYDEMVESM[Oxi]KK.4|LAEQAERYDEMVESMKK.3|LAEQAERYDEM[Oxi]VESMKK.3|LAEQAERYDEMVESM[Oxi]KK.3|LAEQAERYDEM[Oxi]VESM[Oxi]KK.3|LAEQAERYDEM[Oxi]VESMKK.2|LAEQAERYDEMVESM[Oxi]KK.2|LAEQAERYDEMVESMKK.2|YLAEFATGNDRKEAAENSLVAYK.4|YLAEFATGNDRKEAAENSLVAYK.3|AASDIAMTELPPTHPIR.3|AASDIAMTELPPTHPIR.4|AASDIAM[Oxi]TELPPTHPIR.4|AASDIAM[Oxi]TELPPTHPIR.3|AASDIAM[Oxi]TELPPTHPIR.2|AASDIAMTELPPTHPIR.2|HLIPAANTGESK.3|HLIPAANTGESK.2|EENKGGEDKLK.3|EENKGGEDKLK.2|YDEMVESMKK.3|YDEM[Oxi]VESMKK.3|YDEMVESM[Oxi]KK.3|YDEM[Oxi]VESM[Oxi]KK.3|YDEMVESMKK.2|YDEM[Oxi]VESMKK.2|YDEMVESM[Oxi]KK.2|YDEM[Oxi]VESM[Oxi]KK.2|KEAAENSLVAYK.3|KEAAENSLVAYK.2|IISSIEQK.2|YLAEFATGNDRK.3|YLAEFATGNDRK.2|IISSIEQKEENK.3|IISSIEQKEENK.2|IISSIEQKEENKGGEDK.4|IISSIEQKEENKGGEDK.3|IISSIEQKEENKGGEDK.2|EDLVYQAK.2|EDLVYQAK.1|QMVETELK.2|QM[Oxi]VETELK.2|QMVETELK.1|VAGM[Oxi]DVELTVEER.3|VAGMDVELTVEER.2|VAGM[Oxi]DVELTVEER.2|LIC[CAM]C[CAM]DILDVLDK.3|LIC[CAM]C[CAM]DILDVLDK.2|NLLSVAYKNVIGAR.3|NLLSVAYKNVIGAR.2|KVAGM[Oxi]DVELTVEER.3|KVAGMDVELTVEER.3|KVAGMDVELTVEER.2|KVAGM[Oxi]DVELTVEER.2|NLLSVAYKNVIGARR.3|YDEMVESMK.2|YDEM[Oxi]VESMK.2|YDEMVESM[Oxi]K.2|YDEM[Oxi]VESM[Oxi]K.2|EAAENSLVAYK.2|YLAEFATGNDR.2|EALQDVEDENQ.2|HLIPAANTGESKVFYYK.3|LAEQAERYDEMVESMK.3|LAEQAERYDEM[Oxi]VESM[Oxi]K.3|LAEQAERYDEM[Oxi]VESMK.3|LAEQAERYDEMVESM[Oxi]K.3|LAEQAERYDEMVESMK.2|LAEQAERYDEM[Oxi]VESM[Oxi]K.2|LAEQAERYDEM[Oxi]VESMK.2|LAEQAERYDEMVESM[Oxi]K.2|DDREDLVYQAK.2|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESKVFYYK.5|LIC[CAM]C[CAM]DILDVLDKHLIPAANTGESKVFYYK.4|AAFDDAIAELDTLSEESYK.3|AAFDDAIAELDTLSEESYK.2|DNLTLWTSDM[Oxi]QGDGEEQNK.3|DNLTLWTSDMQGDGEEQNK.3|DNLTLWTSDM[Oxi]QGDGEEQNK.2|DNLTLWTSDMQGDGEEQNK.2|VAGM[Oxi]DVELTVEERNLLSVAYKNVIGAR.4|VAGMDVELTVEERNLLSVAYKNVIGAR.4|VAGMDVELTVEERNLLSVAYKNVIGAR.3|LGLALNFSVFYYEILNSPDR.3|LGLALNFSVFYYEILNSPDR.2|LAKAAFDDAIAELDTLSEESYK.3|AAFDDAIAELDTLSEESYKDSTLIMQLLR.4|AAFDDAIAELDTLSEESYKDSTLIMQLLR.3|QMVETELKLIC[CAM]C[CAM]DILDVLDK.3|DNLTLWTSDMQGDGEEQNKEALQDVEDENQ.4|DNLTLWTSDM[Oxi]QGDGEEQNKEALQDVEDENQ.4|DNLTLWTSDM[Oxi]QGDGEEQNKEALQDVEDENQ.3|DNLTLWTSDMQGDGEEQNKEALQDVEDENQ.3
SEN / CTL,P00441,Superoxide dismutase [Cu-Zn],SOD1,1.39,0.62,2.48E-10,2.59E-10,9.59E+00,"activation of MAPK activity,response to reactive oxygen species,response to superoxide,ovarian follicle development,positive regulation of cytokine production,placenta development,retina homeostasis,response to amphetamine,myeloid cell homeostasis,platelet degranulation,glutathione metabolic process,superoxide metabolic process,cellular iron ion homeostasis,spermatogenesis,embryo implantation,cell aging,sensory perception of sound,locomotory behavior,anterograde axonal transport,retrograde axonal transport,regulation of blood pressure,response to heat,response to organic substance,transmission of nerve impulse,removal of superoxide radicals,response to nutrient levels,peripheral nervous system myelin maintenance,positive regulation of superoxide anion generation,regulation of T cell differentiation in thymus,response to carbon monoxide,cellular response to potassium ion,regulation of multicellular organism growth,response to drug,response to hydrogen peroxide,superoxide anion generation,positive regulation of apoptotic process,positive regulation of catalytic activity,regulation of GTPase activity,negative regulation of neuron apoptotic process,response to ethanol,negative regulation of cholesterol biosynthetic process,regulation of protein kinase activity,regulation of organ growth,response to antibiotic,response to copper ion,muscle cell cellular homeostasis,thymus development,response to axon injury,hydrogen peroxide biosynthetic process,regulation of mitochondrial membrane potential,oxidation-reduction process,heart contraction,neurofilament cytoskeleton organization,relaxation of vascular smooth muscle,auditory receptor cell stereocilium organization,cellular response to cadmium ion,cellular response to ATP,reactive oxygen species metabolic process,response to antipsychotic drug,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway","superoxide dismutase activity,copper ion binding,protein binding,zinc ion binding,protein phosphatase 2B binding,identical protein binding,protein homodimerization activity,Rac GTPase binding,chaperone binding","extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,lysosome,peroxisome,cytosol,extracellular matrix,dense core granule,cytoplasmic vesicle,dendrite cytoplasm,neuronal cell body,myelin sheath,protein complex,extracellular exosome,axon cytoplasm,plasma membrane",21,20,39,GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.5|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.6|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.4|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.7|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSR.3|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.5|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.4|HVGDLGNVTADKDGVADVSIEDSVISLSGDHC[CAM]IIGR.6|AVC[CAM]VLKGDGPVQGIINFEQK.3|AVC[CAM]VLKGDGPVQGIINFEQK.2|LAC[CAM]GVIGIAQ.2|HVGDLGNVTADK.3|HVGDLGNVTADK.2|TLVVHEK.2|DEERHVGDLGNVTADK.4|DEERHVGDLGNVTADK.3|TLVVHEKADDLGKGGNEESTK.5|TLVVHEKADDLGKGGNEESTK.4|TLVVHEKADDLGKGGNEESTK.3|ADDLGKGGNEESTK.3|ADDLGKGGNEESTK.2|TLVVHEKADDLGK.3|TLVVHEKADDLGK.2|GDGPVQGIINFEQK.3|GDGPVQGIINFEQK.2|ADDLGKGGNEESTKTGNAGSR.4|ADDLGKGGNEESTKTGNAGSR.3|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSRK.7|GLTEGLHGFHVHEFGDNTAGC[CAM]TSAGPHFNPLSRK.5|HGGPKDEERHVGDLGNVTADK.4|HGGPKDEERHVGDLGNVTADK.3|DGVADVSIEDSVISLSGDHC[CAM]IIGR.4|DGVADVSIEDSVISLSGDHC[CAM]IIGR.3|ESNGPVKVWGSIK.2|AVC[CAM]VLKGDGPVQGIINFEQKESNGPVK.4|AVC[CAM]VLKGDGPVQGIINFEQKESNGPVK.3|GDGPVQGIINFEQKESNGPVKVWGSIK.4|GGNEESTKTGNAGSRLAC[CAM]GVIGIAQ.3|TGNAGSRLAC[CAM]GVIGIAQ.2
SEN / CTL,Q9BYZ2,L-lactate dehydrogenase A-like 6B,LDHAL6B,1.38,0.41,3.85E-04,1.54E-04,3.81E+00,"carbohydrate metabolic process,pyruvate metabolic process,oxidation-reduction process",L-lactate dehydrogenase activity,"nucleus,mitochondrial matrix",6,1,2,LIIVSNPVDILTYVAWK.3|LIIVSNPVDILTYVAWK.2
SEN / CTL,P52565,Rho GDP-dissociation inhibitor 1,ARHGDIA,1.37,1.05,1.83E-04,8.04E-05,4.09E+00,"movement of cell or subcellular component,negative regulation of cell adhesion,regulation of Rho protein signal transduction,negative regulation of apoptotic process,positive regulation of GTPase activity,negative regulation of axonogenesis,positive regulation of axonogenesis,regulation of small GTPase mediated signal transduction,semaphorin-plexin signaling pathway,regulation of actin cytoskeleton reorganization","Rho GDP-dissociation inhibitor activity,GTPase activator activity,protein binding","cytosol,cytoskeleton,extracellular exosome",15,15,29,AEEYEFLTPVEEAPK.2|AEEYEFLTPVEEAPK.3|SIQEIQELDKDDESLR.3|SIQEIQELDKDDESLR.2|QSFVLKEGVEYR.3|QSFVLKEGVEYR.2|GVKIDKTDYMVGSYGPR.4|YIQHTYR.2|FTDDDKTDHLSWEWNLTIKK.5|FTDDDKTDHLSWEWNLTIKK.4|SIQEIQELDKDDESLRK.4|SIQEIQELDKDDESLRK.3|SIQEIQELDKDDESLRK.2|SRFTDDDKTDHLSWEWNLTIK.5|SRFTDDDKTDHLSWEWNLTIK.4|IDKTDYMVGSYGPR.3|IDKTDYM[Oxi]VGSYGPR.3|IDKTDYMVGSYGPR.2|FTDDDKTDHLSWEWNLTIK.4|FTDDDKTDHLSWEWNLTIK.3|FTDDDKTDHLSWEWNLTIK.2|SIQEIQELDK.2|TDYMVGSYGPR.2|TDYM[Oxi]VGSYGPR.2|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.6|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.5|VAVSADPNVPNVVVTGLTLVC[CAM]SSAPGPLELDLTGDLESFKK.4|AEEYEFLTPVEEAPKGM[Oxi]LAR.3|IDKTDYMVGSYGPRAEEYEFLTPVEEAPK.4
SEN / CTL,Q9Y240,C-type lectin domain family 11 member A,CLEC11A,1.37,1.15,3.23E-06,1.83E-06,5.74E+00,positive regulation of cell proliferation,"growth factor activity,carbohydrate binding","extracellular region,extracellular space,cytoplasm",24,12,16,DFEAQAAAQAR.2|VVELTQGLR.2|LAGLDAGLHQLHVR.3|LAGLDAGLHQLHVR.2|AALAPYNWPVWLGVHDR.3|AALAPYNWPVWLGVHDR.2|DAVQALQEAQGR.2|DAVQALQEAQGR.3|RAEGLYLFENGQR.3|HLQEALGLPAGR.3|HLQEALGLPAGR.2|GGSLAQPADR.2|GDENPAGTVEGK.2|LYYVC[CAM]EFPF.2|AEGLYLFENGQR.2|RLYYVC[CAM]EFPF.2
SEN / CTL,P12814,Alpha-actinin-1,ACTN1,1.37,1.42,6.06E-17,1.40E-16,1.59E+01,"platelet degranulation,actin filament organization,platelet formation,platelet morphogenesis,regulation of apoptotic process,focal adhesion assembly,actin filament bundle assembly,negative regulation of cellular component movement,actin filament network formation,actin crosslink formation,regulation of nucleic acid-templated transcription,platelet activation,platelet aggregation","double-stranded RNA binding,integrin binding,calcium ion binding,protein binding,vinculin binding,ligand-dependent nuclear receptor transcription coactivator activity,protein homodimerization activity,ion channel binding,actin filament binding","stress fiber,ruffle,extracellular region,extracellular space,intracellular,cytoplasm,cytosol,plasma membrane,brush border,cell-cell junction,fascia adherens,focal adhesion,Z disc,platelet alpha granule lumen,pseudopodium,cell projection,extracellular exosome,actin filament",81,84,180,DGLGFC[CAM]ALIHR.2|DGLGFC[CAM]ALIHR.3|LLETIDQLYLEYAKR.3|IC[CAM]DQWDNLGALTQK.2|IC[CAM]DQWDNLGALTQK.3|LAILGIHNEVSK.3|LAILGIHNEVSK.2|IDQLEGDHQLIQEALIFDNKHTNYTMEHIR.6|IDQLEGDHQLIQEALIFDNKHTNYTMEHIR.5|IDQLEGDHQLIQEALIFDNKHTNYTMEHIR.4|AGTQIENIEEDFRDGLK.3|AGTQIENIEEDFRDGLK.2|MLDAEDIVGTARPDEK.3|MLDAEDIVGTARPDEK.2|M[Oxi]LDAEDIVGTARPDEK.3|M[Oxi]LDAEDIVGTARPDEK.2|LVSIGAEEIVDGNVK.2|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.6|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.5|KHEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.4|LRKDDPLTNLNTAFDVAEK.4|LRKDDPLTNLNTAFDVAEK.3|LRKDDPLTNLNTAFDVAEK.2|ETADTDTADQVMASFK.2|ETADTDTADQVMASFK.3|ETADTDTADQVM[Oxi]ASFK.3|ETADTDTADQVM[Oxi]ASFK.2|KQFGAQANVIGPWIQTK.3|KQFGAQANVIGPWIQTK.2|IDQLEGDHQLIQEALIFDNK.3|IDQLEGDHQLIQEALIFDNK.4|IDQLEGDHQLIQEALIFDNK.2|KAGTQIENIEEDFRDGLK.4|KAGTQIENIEEDFRDGLK.3|KAGTQIENIEEDFRDGLK.2|KDDPLTNLNTAFDVAEK.3|KDDPLTNLNTAFDVAEK.2|ISIEMHGTLEDQLSHLR.4|ISIEM[Oxi]HGTLEDQLSHLR.4|ISIEMHGTLEDQLSHLR.3|ISIEM[Oxi]HGTLEDQLSHLR.3|ISIEMHGTLEDQLSHLR.2|ASIHEAWTDGKEAMLR.4|ASIHEAWTDGKEAM[Oxi]LR.4|ASIHEAWTDGKEAMLR.3|ASIHEAWTDGKEAM[Oxi]LR.3|ASIHEAWTDGKEAMLR.2|NVNIQNFHISWK.2|NVNIQNFHISWK.3|LGVVTFQAFIDFMSR.2|LGVVTFQAFIDFMSR.3|IVQTYHVNMAGTNPYTTITPQEINGK.3|IVQTYHVNMAGTNPYTTITPQEINGK.5|IVQTYHVNMAGTNPYTTITPQEINGK.4|IVQTYHVNM[Oxi]AGTNPYTTITPQEINGK.4|IVQTYHVNM[Oxi]AGTNPYTTITPQEINGK.3|ASIHEAWTDGK.3|ASIHEAWTDGK.2|HEAFESDLAAHQDR.4|HEAFESDLAAHQDR.3|HEAFESDLAAHQDR.2|HRPELIDYGK.3|HRPELIDYGK.2|KTFTAWC[CAM]NSHLRK.4|KTFTAWC[CAM]NSHLRK.3|KTFTAWC[CAM]NSHLRK.2|LDHLAEK.2|LERLDHLAEK.3|LERLDHLAEK.2|ATLPDADK.2|DYETATLSEIK.3|DYETATLSEIK.2|ALDFIASK.2|EGLLLWC[CAM]QRK.3|HTNYTMEHIR.3|HTNYTM[Oxi]EHIR.3|HTNYTMEHIR.2|HTNYTM[Oxi]EHIR.2|LRLSNRPAFMPSEGR.4|DHSGTLGPEEFK.3|DHSGTLGPEEFK.2|KHEAFESDLAAHQDR.4|KHEAFESDLAAHQDR.3|KHEAFESDLAAHQDR.2|NYITMDELRR.3|NYITMDELRR.2|RDQALTEEHAR.3|RDQALTEEHAR.2|LASDLLEWIRR.3|LASDLLEWIRR.2|ASFNHFDRDHSGTLGPEEFK.5|ASFNHFDRDHSGTLGPEEFK.4|ASFNHFDRDHSGTLGPEEFK.3|TFTAWC[CAM]NSHLR.3|TFTAWC[CAM]NSHLR.2|VPENTMHAMQQK.3|VPENTM[Oxi]HAMQQK.3|VPENTMHAM[Oxi]QQK.3|VPENTM[Oxi]HAM[Oxi]QQK.3|VPENTMHAMQQK.2|ILAGDKNYITMDELRR.4|SIVNYKPK.2|LSNRPAFMPSEGR.3|LSNRPAFM[Oxi]PSEGR.3|LSNRPAFMPSEGR.2|ASFNHFDR.2|AGTQIENIEEDFR.3|AGTQIENIEEDFR.2|KTFTAWC[CAM]NSHLR.3|KTFTAWC[CAM]NSHLR.2|QKDYETATLSEIK.3|QKDYETATLSEIK.2|TFTAWC[CAM]NSHLRK.3|TFTAWC[CAM]NSHLRK.2|TIPWLENR.2|IMSIVDPNR.2|IM[Oxi]SIVDPNR.2|QKASIHEAWTDGKEAMLR.4|ERLAILGIHNEVSK.3|ERLAILGIHNEVSK.2|GYEEWLLNEIRR.3|GYEEWLLNEIRR.2|RDQALTEEHARQQHNER.4|KAGTQIENIEEDFR.3|KAGTQIENIEEDFR.2|ATLPDADKER.2|TEKLLETIDQLYLEYAKR.4|TEKLLETIDQLYLEYAKR.3|LLETIDQLYLEYAK.3|LLETIDQLYLEYAK.2|RELPPDQAEYC[CAM]IAR.3|NYITMDELR.2|NYITM[Oxi]DELR.2|DDPLTNLNTAFDVAEK.3|DDPLTNLNTAFDVAEK.2|DQALTEEHAR.2|ILAGDKNYITMDELR.3|ILAGDKNYITM[Oxi]DELR.3|ILAGDKNYITMDELR.2|QFGAQANVIGPWIQTK.3|QFGAQANVIGPWIQTK.2|DLLLDPAWEK.2|IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.6|IVQTYHVNM[Oxi]AGTNPYTTITPQEINGKWDHVR.5|IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.5|IVQTYHVNMAGTNPYTTITPQEINGKWDHVR.4|IC[CAM]DQWDNLGALTQKR.3|TIPWLENRVPENTMHAMQQK.4|TIPWLENRVPENTMHAMQQK.3|KDDPLTNLNTAFDVAEKYLDIPK.4|KDDPLTNLNTAFDVAEKYLDIPK.3|MVSDINNAWGC[CAM]LEQVEK.3|M[Oxi]VSDINNAWGC[CAM]LEQVEK.3|M[Oxi]VSDINNAWGC[CAM]LEQVEK.2|MVSDINNAWGC[CAM]LEQVEK.2|GISQEQM[Oxi]NEFR.2|GISQEQMNEFR.2|VLAVNQENEQLMEDYEK.3|VLAVNQENEQLM[Oxi]EDYEK.3|VLAVNQENEQLM[Oxi]EDYEK.2|VLAVNQENEQLMEDYEK.2|TEKLLETIDQLYLEYAK.3|VEQIAAIAQELNELDYYDSPSVNAR.4|VEQIAAIAQELNELDYYDSPSVNAR.3|VQEKC[CAM]QLEINFNTLQTK.3|MTLGMIWTIILR.2|M[Oxi]TLGMIWTIILR.2|MTLGM[Oxi]IWTIILR.2|M[Oxi]TLGM[Oxi]IWTIILR.2|ASFNHFDRDHSGTLGPEEFKAC[CAM]LISLGYDIGNDPQGEAEFAR.6|AC[CAM]LISLGYDIGNDPQGEAEFAR.3|AC[CAM]LISLGYDIGNDPQGEAEFAR.2|DDPLTNLNTAFDVAEKYLDIPK.3|VLAVNQENEQLM[Oxi]EDYEKLASDLLEWIRR.4|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.5|HEAFESDLAAHQDRVEQIAAIAQELNELDYYDSPSVNAR.4|FAIQDISVEETSAKEGLLLWC[CAM]QR.3|RAAPFNNWM[Oxi]EGAM[Oxi]EDLQDTFIVHTIEEIQGLTTAHEQFK.5|RAAPFNNWM[Oxi]EGAM[Oxi]EDLQDTFIVHTIEEIQGLTTAHEQFK.4|MAPYTGPDSVPGALDYMSFSTALYGESDL.3
SEN / CTL,O00410,Importin-5,IPO5,1.36,0.92,5.87E-03,1.73E-03,2.76E+00,"protein import into nucleus, docking,protein import into nucleus, translocation,NLS-bearing protein import into nucleus,ribosomal protein import into nucleus,viral process,negative regulation of GTPase activity,positive regulation of protein import into nucleus,cellular response to amino acid stimulus","GTPase inhibitor activity,protein binding,nuclear localization sequence binding,Ran GTPase binding,protein transporter activity,poly(A) RNA binding","nucleus,nuclear pore,nucleoplasm,nucleolus,cytoplasm,Golgi apparatus,membrane,nuclear membrane,nuclear periphery,intracellular membrane-bounded organelle",6,60,117,AIGTEPDSDVLSEIMHSFAK.3|AIGTEPDSDVLSEIMHSFAK.2|ITFLLQAIR.2|LVLPMIK.2|AKLEEHFKNQELR.4|AKLEEHFKNQELR.3|KVC[CAM]DIAAELAR.3|KVC[CAM]DIAAELAR.2|LQELIQK.2|VSDILHSIFSSYKEK.4|VSDILHSIFSSYKEK.3|ATAAFILANEHNVALFK.4|ATAAFILANEHNVALFK.3|ATAAFILANEHNVALFK.2|SLLIPYLDNLVK.3|SLLIPYLDNLVK.2|HIVENAVQKELR.3|NTTAAEEAR.2|STAC[CAM]QMLVC[CAM]YAK.3|STAC[CAM]QM[Oxi]LVC[CAM]YAK.2|STAC[CAM]QMLVC[CAM]YAK.2|VQAHAAAALINFTEDC[CAM]PK.4|VQAHAAAALINFTEDC[CAM]PK.3|VQAHAAAALINFTEDC[CAM]PK.2|TIEC[CAM]ISLIGLAVGK.3|TIEC[CAM]ISLIGLAVGK.2|VSDILHSIFSSYK.3|VSDILHSIFSSYK.2|IFSIIAEGEMHEAIKHEDPC[CAM]AK.5|IFSIIAEGEMHEAIKHEDPC[CAM]AK.4|IFSIIAEGEMHEAIKHEDPC[CAM]AK.3|RMLVQC[CAM]MQDQEHPSIR.4|FLFDSVSSQNVGLR.3|FLFDSVSSQNVGLR.2|FYFHDGVR.2|HIVENAVQK.2|QAEETYENIPGQSK.3|QAEETYENIPGQSK.2|FVPYYDLFMPSLK.3|FVPYYDLFM[Oxi]PSLK.2|FVPYYDLFMPSLK.2|VAAAESMPLLLEC[CAM]AR.3|VAAAESMPLLLEC[CAM]AR.2|VAAAESM[Oxi]PLLLEC[CAM]AR.2|FM[Oxi]QDASDVMQLLLK.3|FMQDASDVMQLLLK.3|FM[Oxi]QDASDVMQLLLK.2|FMQDASDVMQLLLK.2|EHIMQMLQNPDWK.3|EHIMQM[Oxi]LQNPDWK.3|EHIM[Oxi]QMLQNPDWK.2|EHIMQM[Oxi]LQNPDWK.2|EHIMQMLQNPDWK.2|VC[CAM]DIAAELAR.2|IFSIIAEGEMHEAIK.3|KQAEETYENIPGQSK.3|KQAEETYENIPGQSK.2|SLVEIADTVPK.2|EFQQYLPVVMGPLMK.3|EFQQYLPVVM[Oxi]GPLMK.2|EFQQYLPVVMGPLM[Oxi]K.2|EFQQYLPVVMGPLMK.2|YLRPHLEATLQLSLK.3|YLRPHLEATLQLSLK.2|ELKEGFVEYTEQVVK.3|ELKEGFVEYTEQVVK.2|VIAALLQTMEDQGNQR.3|VIAALLQTMEDQGNQR.2|VIAALLQTM[Oxi]EDQGNQR.2|NLIDEDGNNQWPEGLK.3|NLIDEDGNNQWPEGLK.2|SLLIPYLDNLVKHLHSIMVLK.4|TKENVNATENC[CAM]ISAVGK.3|TKENVNATENC[CAM]ISAVGK.2|FKPDC[CAM]VNVEEVLPHWLSWLPLHEDK.5|FKPDC[CAM]VNVEEVLPHWLSWLPLHEDK.4|LVLPMIKEHIMQMLQNPDWK.4|LVLPMIKEHIMQMLQNPDWK.3|MLVQC[CAM]MQDQEHPSIR.3|MLVQC[CAM]MQDQEHPSIR.2|VRGPEYLTQM[Oxi]WHFMC[CAM]DALIK.4|VRGPEYLTQMWHFM[Oxi]C[CAM]DALIK.4|VRGPEYLTQMWHFMC[CAM]DALIK.4|VRGPEYLTQMWHFMC[CAM]DALIK.3|SELLMIIQMETQSSMR.3|YAEYFLRPMLQYVC[CAM]DNSPEVR.4|YAEYFLRPM[Oxi]LQYVC[CAM]DNSPEVR.3|YAEYFLRPMLQYVC[CAM]DNSPEVR.3|LC[CAM]GDTSLNNMQR.2|LC[CAM]GDTSLNNM[Oxi]QR.2|LVLEQVVTSIASVADTAEEK.3|LVLEQVVTSIASVADTAEEK.2|YAAC[CAM]NAVGQM[Oxi]ATDFAPGFQK.3|YAAC[CAM]NAVGQMATDFAPGFQK.3|YAAC[CAM]NAVGQMATDFAPGFQK.2|ILGKEFQQYLPVVMGPLMK.3|HFADLLPGFLQAVNDSC[CAM]YQNDDSVLK.4|HFADLLPGFLQAVNDSC[CAM]YQNDDSVLK.3|GPEYLTQMWHFMC[CAM]DALIK.3|EAALHIFWNFPGIFGNQQQHYLDVIK.4|EAALHIFWNFPGIFGNQQQHYLDVIK.3|LLSSAFDEVYPALPSDVQTAIK.3|LLSSAFDEVYPALPSDVQTAIK.2|ENVNATENC[CAM]ISAVGK.2|QWGLC[CAM]IFDDVIEHC[CAM]SPASFK.3|RQDEDYDEQVEESLQDEDDNDVYILTK.4|RQDEDYDEQVEESLQDEDDNDVYILTK.3|RLLSSAFDEVYPALPSDVQTAIK.3|PMLQYVC[CAM]DNSPEVR.2|QAAAYGLGVMAQYGGDNYRPFC[CAM]TEALPLLVR.4|QAAAYGLGVMAQYGGDNYRPFC[CAM]TEALPLLVR.3|C[CAM]IEVMGDGC[CAM]LNNEHFEELGGILK.3|C[CAM]IEVM[Oxi]GDGC[CAM]LNNEHFEELGGILK.3|EEAVQTFNYLC[CAM]DLIESNHPIVLGPNNTNLPK.4|EEAVQTFNYLC[CAM]DLIESNHPIVLGPNNTNLPK.3|TQTDFNDMEDDDPQISYMISAWAR.3|TASIKPEVALLDTQDMENMSDDDGWEFVNLGDQQSFGIK.4
SEN / CTL,Q6YHK3,CD109 antigen,CD109,1.36,1.20,3.47E-09,3.11E-09,8.51E+00,"negative regulation of protein phosphorylation,hair follicle development,negative regulation of keratinocyte proliferation,negative regulation of endopeptidase activity,negative regulation of transforming growth factor beta receptor signaling pathway,regulation of keratinocyte differentiation,negative regulation of wound healing,osteoclast fusion","serine-type endopeptidase inhibitor activity,transforming growth factor beta binding","extracellular space,plasma membrane,cell surface,anchored component of membrane",30,27,34,ISVTQPDSIVGIVAVDK.2|TLTLPSLPLNSADEIYELR.3|TLTLPSLPLNSADEIYELR.2|ALSEFAALMNTER.2|GDVTLTFLPLSFWGK.2|VIHSELQGGNKSPVTLTAYIVTSLLGYR.4|TNIQVTVTGPSSPSPVK.2|KYQPNIDVQESIHFLESEFSR.4|KYQPNIDVQESIHFLESEFSR.3|VQITAIGDVLGPSINGLASLIR.3|VQITAIGDVLGPSINGLASLIR.2|FMEENEGHIVDIHDFSLGSSPHVR.5|FM[Oxi]EENEGHIVDIHDFSLGSSPHVR.5|FM[Oxi]EENEGHIVDIHDFSLGSSPHVR.4|FMEENEGHIVDIHDFSLGSSPHVR.4|IPVQLVFK.2|IVTLFSDFKPYK.3|LSDSWQPR.2|ELSYMVVSR.2|SSMAVHSLFK.2|EALNMLTWR.2|NNVVITVTQR.2|VIHSELQGGNK.2|RISVFIQTDK.2|ADGNQLTLEER.2|TSLNILIKDPK.2|VGSPFELVVSGNK.2|SNLIQQWLSQQSDLGVISK.3|SNLIQQWLSQQSDLGVISK.2|YQPNIDVQESIHFLESEFSR.3|NSLGGFASTQDTTVALK.2|IEFPILEDSSELQLK.2|TLSFSFPPNTVTGSER.2|FEVTLQTPLYC[CAM]SMNSK.2
SEN / CTL,Q9P2E9,Ribosome-binding protein 1,RRBP1,1.36,0.71,2.47E-03,7.93E-04,3.10E+00,"osteoblast differentiation,translation,protein transport","receptor activity,poly(A) RNA binding","endoplasmic reticulum,ribosome,membrane,integral component of endoplasmic reticulum membrane",6,99,145,SIEALLEAGQAR.2|SIEALLEAGQAR.3|LREAEETQSTLQAEC[CAM]DQYR.3|LREAEETQSTLQAEC[CAM]DQYR.4|ELESQVSGLEK.3|ELESQVSGLEK.2|GDPVAILK.2|ATQKGDPVAILK.3|AKVGAAEEELQK.3|AKVGAAEEELQK.2|QQLSEMK.2|LQEQLEK.2|RLDEVSR.2|KLQEQLEKAEDGSSSK.4|KLQEQLEKAEDGSSSK.3|KLQEQLEKAEDGSSSK.2|SEAVRQDEQQR.3|AAILETAPK.2|LKGELESSDQVR.3|LKGELESSDQVR.2|AMEALATAEQAC[CAM]K.3|AM[Oxi]EALATAEQAC[CAM]K.2|AMEALATAEQAC[CAM]K.2|EVQQLQGK.2|ATQKGDPVAILKR.3|ESEEALQK.2|LIEILSEK.2|TESASVQGR.2|EHTSHLEAELEK.3|EHTSHLEAELEK.2|EHVKEVQQLQGK.3|EHVKEVQQLQGK.2|TTQEQLAR.2|VEGITNQGK.2|LKELESQVSGLEK.3|LKELESQVSGLEK.2|SKC[CAM]EELSGLHGQLQEAR.4|SKC[CAM]EELSGLHGQLQEAR.3|KGEGAPIQGK.2|SEAVRQDEQQRK.3|HLEEIVEK.2|HPPAPAEPSSDLASK.3|HPPAPAEPSSDLASK.2|NTDVAQSPEAPKQEAPAKK.4|ELC[CAM]HTQSSHASLR.3|IRSIEALLEAGQAR.3|KLQEQLEK.2|LQSSEAEVR.2|ETSYEEALANQRK.3|KADSVANQGTKVEGITNQGK.4|KADSVANQGTKVEGITNQGK.3|KKGEPGPPDADGPLYLPYK.4|KKGEPGPPDADGPLYLPYK.3|PNGKIPDHDPAPNVTVLLR.4|PNGKIPDHDPAPNVTVLLR.3|QLLLESQSQLDAAK.3|QLLLESQSQLDAAK.2|QSDELALVR.2|AENSQLTER.2|HM[Oxi]AAASAEC[CAM]QNYAK.3|HMAAASAEC[CAM]QNYAK.3|HMAAASAEC[CAM]QNYAK.2|HM[Oxi]AAASAEC[CAM]QNYAK.2|KVEGAPTQGR.2|GPTLLKHPPAPAEPSSDLASK.4|GPTLLKHPPAPAEPSSDLASK.3|SEAQKQSDELALVR.3|SEAQKQSDELALVR.2|EKLLATEQEDAAVAK.3|IPDHDPAPNVTVLLREPVR.4|VGAAEEELQK.2|ADAEKAQEQQQQMAELHSK.4|ADAEKAQEQQQQM[Oxi]AELHSK.4|ESEEALQKR.2|KVDTTPNQGK.2|AMEALATAEQAC[CAM]KEK.3|AM[Oxi]EALATAEQAC[CAM]KEK.3|AMEALATAEQAC[CAM]KEK.2|AQEQQQQMAELHSK.3|AQEQQQQM[Oxi]AELHSK.3|IPDHDPAPNVTVLLR.3|LKGELESSDQVREHTSHLEAELEK.5|LKGELESSDQVREHTSHLEAELEK.3|LQQENSILR.2|GELESSDQVR.2|GNTPATGTTQGK.2|EQEITAVQAR.2|SILAETEGMLRDLQK.3|C[CAM]EELSGLHGQLQEAR.3|C[CAM]EELSGLHGQLQEAR.2|AGIIQDTWHK.2|LRTAGPLESSETEEASQLKER.4|QVLQLQASHR.2|TAGPLESSETEEASQLK.3|TAGPLESSETEEASQLK.2|TLQEQLENGPNTQLAR.3|TLQEQLENGPNTQLAR.2|SILAETEGMLR.2|SILAETEGM[Oxi]LR.2|TAGPLESSETEEASQLKERLEK.4|LQQENSILRDALNQATSQVESK.4|LQQENSILRDALNQATSQVESK.3|QKLTAEFEEAQTSAC[CAM]R.3|QKLTAEFEEAQTSAC[CAM]R.2|VEPAVSSVVNSIQVLTSK.3|VEPAVSSVVNSIQVLTSK.2|AEDGSSSKEGTSV.2|NTDVAQSPEAPK.2|NTDVAQSPEAPKQEAPAK.3|AEGAQNQGQKGEGAQNQGK.3|KGEPGPPDADGPLYLPYK.3|KGEPGPPDADGPLYLPYK.2|SVEEEEQVWR.2|TLVSTVGSMVFNEGEAQR.3|TLVSTVGSM[Oxi]VFNEGEAQR.2|TLVSTVGSMVFNEGEAQR.2|DAQDVQASQAEADQQQTR.3|DAQDVQASQAEADQQQTR.2|EVPMVVVPPVGAK.2|EAEETQSTLQAEC[CAM]DQYR.3|EAEETQSTLQAEC[CAM]DQYR.2|ELC[CAM]HTQSSHASLRADAEK.3|LLATEQEDAAVAK.2|LRTAGPLESSETEEASQLK.3|DALNQATSQVESK.2|EPVRAPAVAVAPTPVQPPIIVAPVATVPAMPQEK.5|EPVRAPAVAVAPTPVQPPIIVAPVATVPAMPQEK.4|EPVRAPAVAVAPTPVQPPIIVAPVATVPAMPQEK.3|IRTLQEQLENGPNTQLAR.3|QLLLESQSQLDAAKSEAQK.3|TAGPLESSETEEASQLKER.3|ETSYEEALANQR.2|TQLEWTEAILEDEQTQR.3|TQLEWTEAILEDEQTQR.2|LQEQLEKAEDGSSSKEGTSV.3|LKELESQVSGLEKEAIELR.3|VAKVEPAVSSVVNSIQVLTSK.3|SHVEDGDIAGAPASSPEAPPAEQDPVQLK.4|SHVEDGDIAGAPASSPEAPPAEQDPVQLK.3|APAVAVAPTPVQPPIIVAPVATVPAMPQEK.4|APAVAVAPTPVQPPIIVAPVATVPAM[Oxi]PQEK.3|APAVAVAPTPVQPPIIVAPVATVPAMPQEK.3|QLLLESQSQLDAAKSEAQKQSDELALVR.4|LTAEFEEAQTSAC[CAM]R.2|GEPGPPDADGPLYLPYK.2
SEN / CTL,Q9UHB6,LIM domain and actin-binding protein 1,LIMA1,1.36,0.89,9.51E-02,2.09E-02,1.68E+00,"negative regulation of actin filament depolymerization,ruffle organization,actin filament bundle assembly,cell-cell adhesion","actin monomer binding,zinc ion binding,actin filament binding,cadherin binding involved in cell-cell adhesion","stress fiber,cytoplasm,plasma membrane,brush border,cell-cell adherens junction,focal adhesion,actin cytoskeleton,cleavage furrow",3,53,80,LLANQQVFHISC[CAM]FR.3|LLANQQVFHISC[CAM]FR.2|ADHPPAEVTSHAASGAK.4|ADHPPAEVTSHAASGAK.3|ADHPPAEVTSHAASGAK.2|ADQEEQIHPR.3|ADQEEQIHPR.2|LSLGTYASLHGR.3|LSLGTYASLHGR.2|LRSPPEALVQGR.3|LRSPPEALVQGR.2|SNTENLSQHFR.3|SNTENLSQHFR.2|TVYPM[Oxi]ER.2|KWENPGLGAESHTDSLR.4|KWENPGLGAESHTDSLR.3|KWENPGLGAESHTDSLR.2|SEVQQPVHPKPLSPDSR.4|SEVQQPVHPKPLSPDSR.3|HRADHPPAEVTSHAASGAK.4|HRADHPPAEVTSHAASGAK.3|SNTENLSQHFRK.3|STPAEDDSR.2|RSNTENLSQHFR.3|GNYDEGFGHRPHK.3|GNYDEGFGHRPHK.2|KKWENPGLGAESHTDSLR.4|KKWENPGLGAESHTDSLR.3|KKWENPGLGAESHTDSLR.2|SQDVELWEGEVVK.3|SQDVELWEGEVVK.2|AAEETNMEK.2|ETPHSPGVEDAPIAK.3|ETPHSPGVEDAPIAK.2|STPAEDDSRDSQVK.3|STPAEDDSRDSQVK.2|LSETSIKDR.2|ETC[CAM]VEC[CAM]QK.2|IYC[CAM]KPHFNQLFK.3|IYC[CAM]KPHFNQLFK.2|SPPEALVQGR.2|YPHIKDGEDLKDHSTESK.4|YPHIKDGEDLKDHSTESK.3|ELSVEEQIK.2|SEISENTDASGKIEK.3|SEISENTDASGKIEK.2|VGVLAASMEAK.2|VGVLAASM[Oxi]EAK.2|ASSLSESSPPK.2|SSAIVEIFSK.2|MENC[CAM]LGESR.2|ASSQQEKEDKPAETK.3|HEVEKSEISENTDASGKIEK.4|SEVQQPVHPK.2|SRPFTVAASFQSTSVK.3|SRPFTVAASFQSTSVK.2|STPAEDDSRDSQVKSEVQQPVHPKPLSPDSR.6|STPAEDDSRDSQVKSEVQQPVHPKPLSPDSR.5|ISANENSLAVR.2|KGWSMSEQSEESVGGR.3|WENPGLGAESHTDSLR.3|KMENC[CAM]LGESR.2|KM[Oxi]ENC[CAM]LGESR.2|HEVEKSEISENTDASGK.3|SEISENTDASGK.2|WPPEDEISKPEVPEDVDLDLKK.4|NENEEILERPAQLANAR.3|NENEEILERPAQLANAR.2|DLWASKNENEEILERPAQLANAR.4|DLWASKNENEEILERPAQLANAR.3|PKWPPEDEISKPEVPEDVDLDLK.4|ENVPPGPEVC[CAM]ITHQEGEK.3|QSSSTNYTNELK.2|SQDVELWEGEVVKELSVEEQIKR.4|IAWPPPTELGSSGSALEEGIK.3|IAWPPPTELGSSGSALEEGIK.2|GWSMSEQSEESVGGR.2|SLNWSSFVDNTFAEEFTTQNQK.3|KISENSYSLDDLEIGPGQLSSSTFDSEKNESR.4|ISENSYSLDDLEIGPGQLSSSTFDSEK.3
SEN / CTL,P08670,Vimentin,VIM,1.36,1.35,3.75E-24,2.59E-23,2.26E+01,"movement of cell or subcellular component,positive regulation of gene expression,negative regulation of neuron projection development,astrocyte development,viral process,muscle filament sliding,intermediate filament organization,Bergmann glial cell differentiation,SMAD protein signal transduction,lens fiber cell development","glycoprotein binding,double-stranded RNA binding,structural constituent of cytoskeleton,structural constituent of eye lens,protein binding,protein C-terminus binding,identical protein binding,scaffold protein binding,keratin filament binding","cytoplasm,peroxisome,cytosol,cytoskeleton,intermediate filament,focal adhesion,extracellular matrix,cell leading edge,neuron projection,intermediate filament cytoskeleton,extracellular exosome,plasma membrane",138,93,188,ILLAELEQLKGQGK.3|ILLAELEQLKGQGK.2|KVESLQEEIAFLK.3|KVESLQEEIAFLK.2|ILLAELEQLK.2|ISLPLPNFSSLNLR.2|ISLPLPNFSSLNLR.3|RQVQSLTC[CAM]EVDALKGTNESLER.4|RQVQSLTC[CAM]EVDALKGTNESLER.3|SRLGDLYEEEMRELR.4|SRLGDLYEEEMRELR.3|EYQDLLNVK.2|KVESLQEEIAFLKK.4|KVESLQEEIAFLKK.3|KVESLQEEIAFLKK.2|HLREYQDLLNVK.2|HLREYQDLLNVK.3|VEVERDNLAEDIMR.3|VEVERDNLAEDIMR.2|VEVERDNLAEDIM[Oxi]R.3|VEVERDNLAEDIM[Oxi]R.2|MALDIEIATYRK.3|MALDIEIATYRK.2|M[Oxi]ALDIEIATYRK.3|M[Oxi]ALDIEIATYRK.2|MALDIEIATYR.2|M[Oxi]ALDIEIATYR.2|NLQEAEEWYK.2|NLQEAEEWYK.3|QVQSLTC[CAM]EVDALKGTNESLER.3|QVQSLTC[CAM]EVDALKGTNESLER.2|QVQSLTC[CAM]EVDALKGTNESLER.4|TNEKVELQELNDR.3|TNEKVELQELNDR.2|LGDLYEEEMR.2|LGDLYEEEM[Oxi]R.2|LGDLYEEEMRELR.3|LGDLYEEEM[Oxi]RELR.3|LGDLYEEEMRELR.2|LQDEIQNMKEEMAR.3|LQDEIQNMKEEMAR.2|LQDEIQNM[Oxi]KEEMAR.3|LQDEIQNMKEEM[Oxi]AR.3|LQDEIQNM[Oxi]KEEM[Oxi]AR.3|LQDEIQNM[Oxi]KEEMAR.2|LQDEIQNMKEEM[Oxi]AR.2|FADLSEAANRNNDALR.3|FADLSEAANRNNDALR.4|FADLSEAANRNNDALR.2|LQEEMLQREEAENTLQSFRQDVDNASLAR.4|LQEEM[Oxi]LQREEAENTLQSFRQDVDNASLAR.4|LQEEMLQREEAENTLQSFRQDVDNASLAR.5|LQEEM[Oxi]LQREEAENTLQSFRQDVDNASLAR.3|LQEEMLQREEAENTLQSFRQDVDNASLAR.3|EEAENTLQSFRQDVDNASLAR.3|EEAENTLQSFRQDVDNASLAR.4|EEAENTLQSFRQDVDNASLAR.2|QMREMEENFAVEAANYQDTIGR.3|SRLGDLYEEEMR.3|SRLGDLYEEEMR.2|SRLGDLYEEEM[Oxi]R.3|SRLGDLYEEEM[Oxi]R.2|LQEEMLQREEAENTLQSFR.3|LQEEMLQREEAENTLQSFR.4|LQEEM[Oxi]LQREEAENTLQSFR.3|LQEEMLQREEAENTLQSFR.2|ARVEVERDNLAEDIMR.4|ARVEVERDNLAEDIM[Oxi]R.4|ARVEVERDNLAEDIMR.3|ARVEVERDNLAEDIM[Oxi]R.3|ARVEVERDNLAEDIMR.2|EKLQEEMLQREEAENTLQSFR.4|EKLQEEM[Oxi]LQREEAENTLQSFR.4|EKLQEEMLQREEAENTLQSFR.3|EMEENFAVEAANYQDTIGR.3|EMEENFAVEAANYQDTIGR.4|EM[Oxi]EENFAVEAANYQDTIGR.3|EM[Oxi]EENFAVEAANYQDTIGR.2|EMEENFAVEAANYQDTIGR.2|FLEQQNKILLAELEQLKGQGK.4|FLEQQNKILLAELEQLKGQGK.3|VELQELNDRFANYIDKVR.4|VELQELNDRFANYIDKVR.3|LGDLYEEEMRELRR.4|LGDLYEEEMRELRR.3|LGDLYEEEM[Oxi]RELRR.3|RQVDQLTNDK.3|RQVDQLTNDK.2|RMFGGPGTASRPSSSR.4|RMFGGPGTASRPSSSR.3|PDLTAALR.2|ARVEVER.2|FANYIDK.2|QVDQLTNDKAR.3|QVDQLTNDKAR.2|SVSSSSYR.2|EEAENTLQSFR.3|EEAENTLQSFR.2|SKFADLSEAANR.3|SKFADLSEAANR.2|ETNLDSLPLVDTHSKR.4|ETNLDSLPLVDTHSKR.3|ETNLDSLPLVDTHSKR.2|GTNESLER.2|SYVTTSTR.2|DVRQQYESVAAK.3|DVRQQYESVAAK.2|QAKQESTEYRR.3|LLEGEESR.2|VESLQEEIAFLK.3|VESLQEEIAFLK.2|SLYASSPGGVYATR.3|SLYASSPGGVYATR.2|RQVDQLTNDKAR.3|TYSLGSALR.2|MFGGPGTASR.2|M[Oxi]FGGPGTASR.2|MFGGPGTASRPSSSR.3|M[Oxi]FGGPGTASRPSSSR.3|QVQSLTC[CAM]EVDALK.3|QVQSLTC[CAM]EVDALK.2|SKFADLSEAANRNNDALR.4|SKFADLSEAANRNNDALR.3|TYSLGSALRPSTSR.3|NLQEAEEWYKSK.3|NLQEAEEWYKSK.2|QQYESVAAK.2|VESLQEEIAFLKK.3|VESLQEEIAFLKK.2|LQEEMLQR.2|LQEEM[Oxi]LQR.2|KLLEGEESR.2|QVDQLTNDK.2|DNLAEDIMR.2|DNLAEDIM[Oxi]R.2|QESTEYRR.2|QDVDNASLAR.2|FADLSEAANR.2|RQVQSLTC[CAM]EVDALK.3|RQVQSLTC[CAM]EVDALK.2|ETNLDSLPLVDTHSK.3|ETNLDSLPLVDTHSK.2|LQDEIQNMK.2|LQDEIQNM[Oxi]K.2|VELQELNDR.2|FANYIDKVR.2|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.6|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.5|ISLPLPNFSSLNLRETNLDSLPLVDTHSKR.4|RMFGGPGTASR.2|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.7|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.6|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.5|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.4|TVETRDGQVINETSQHHDDLE.4|TVETRDGQVINETSQHHDDLE.3|DGQVINETSQHHDDLE.3|DGQVINETSQHHDDLE.2|TNEKVELQELNDRFANYIDK.4|TNEKVELQELNDRFANYIDK.3|LLQDSVDFSLADAINTEFKNTR.4|LLQDSVDFSLADAINTEFKNTR.3|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.5|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.4|ISLPLPNFSSLNLRETNLDSLPLVDTHSK.3|EKLQEEMLQR.2|KLLEGEESRISLPLPNFSSLNLR.4|KLLEGEESRISLPLPNFSSLNLR.3|NTRTNEKVELQELNDR.3|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.6|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.5|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR.4|VELQELNDRFANYIDK.3|VELQELNDRFANYIDK.2|FLEQQNKILLAELEQLK.3|FADLSEAANRNNDALRQAK.3|LLQDSVDFSLADAINTEFK.3|LLQDSVDFSLADAINTEFK.2|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.6|LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.5|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.6|KLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVR.5|SSVPGVRLLQDSVDFSLADAINTEFKNTR.4|LLEGEESRISLPLPNFSSLNLR.3|LLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSK.5|TYSLGSALRPSTSRSLYASSPGGVYATR.3|EMEENFAVEAANYQDTIGRLQDEIQNMKEEMAR.4|EMEENFAVEAANYQDTIGRLQDEIQNMK.3
SEN / CTL,P29401,Transketolase,TKT,1.35,1.13,6.44E-07,4.01E-07,6.40E+00,"xylulose biosynthetic process,pentose-phosphate shunt,pentose-phosphate shunt, non-oxidative branch,regulation of growth,glyceraldehyde-3-phosphate biosynthetic process","transketolase activity,protein homodimerization activity,metal ion binding,cofactor binding","nucleus,nucleoplasm,peroxisome,cytosol,vesicle,myelin sheath,extracellular exosome",18,53,103,ILATPPQEDAPSVDIANIR.3|ILATPPQEDAPSVDIANIR.2|ILATPPQEDAPSVDIANIR.4|NMAEQIIQEIYSQIQSK.3|NM[Oxi]AEQIIQEIYSQIQSK.3|NM[Oxi]AEQIIQEIYSQIQSK.2|NMAEQIIQEIYSQIQSK.2|LDNLVAILDINR.2|LDNLVAILDINR.3|MFGIDRDAIAQAVR.3|M[Oxi]FGIDRDAIAQAVR.3|MFGIDRDAIAQAVR.2|TVPFC[CAM]STFAAFFTR.3|TVPFC[CAM]STFAAFFTR.2|NSTFSEIFKK.3|NSTFSEIFKK.2|AYGQALAK.2|GITGVEDK.2|LGHASDRIIALDGDTK.4|LGHASDRIIALDGDTK.3|DAIAQAVR.2|ISSDLDGHPVPK.3|ISSDLDGHPVPK.2|GRGITGVEDKESWHGKPLPK.5|NPHNDRFVLSK.3|AVELAANTK.2|KISSDLDGHPVPK.3|KISSDLDGHPVPK.2|KLILDSAR.2|MPSLPSYK.2|M[Oxi]PSLPSYK.2|SKDDQVTVIGAGVTLHEALAAAELLKK.6|SKDDQVTVIGAGVTLHEALAAAELLKK.5|SKDDQVTVIGAGVTLHEALAAAELLKK.4|SKDDQVTVIGAGVTLHEALAAAELLKK.3|SGKPAELLK.2|VLDPFTIK.2|VLDPFTIKPLDR.3|VLDPFTIKPLDR.2|IIALDGDTK.2|KAYGQALAK.2|HQPTAIIAK.2|GITGVEDKESWHGKPLPK.4|GITGVEDKESWHGKPLPK.3|GRGITGVEDK.2|VLDPFTIKPLDRK.3|VLDPFTIKPLDRK.2|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.5|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.4|RC[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.3|IIALDGDTKNSTFSEIFKK.4|SKDDQVTVIGAGVTLHEALAAAELLK.5|SKDDQVTVIGAGVTLHEALAAAELLK.4|SKDDQVTVIGAGVTLHEALAAAELLK.3|NSTFSEIFK.2|LGQSDPAPLQHQMDIYQKR.4|LQALKDTANR.2|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.7|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.6|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.5|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.4|ESWHGKPLPK.2|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTM[Oxi]R.6|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.6|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.5|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIM[Oxi]AVLFFHTM[Oxi]R.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIM[Oxi]AVLFFHTMR.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTM[Oxi]R.4|ISSIQATTAAGSGHPTSC[CAM]C[CAM]SAAEIMAVLFFHTMR.4|C[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.4|C[CAM]EAFGWHAIIVDGHSVEELC[CAM]K.3|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.6|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.5|ILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.4|SVPTSTVFYPSDGVATEK.3|SVPTSTVFYPSDGVATEK.2|TSRPENAIIYNNNEDFQVGQAK.4|TSRPENAIIYNNNEDFQVGQAK.3|QAFTDVATGSLGQGLGAAC[CAM]GMAYTGK.4|QAFTDVATGSLGQGLGAAC[CAM]GMAYTGK.3|QAFTDVATGSLGQGLGAAC[CAM]GM[Oxi]AYTGK.3|NRTVPFC[CAM]STFAAFFTR.3|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.6|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.5|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNR.4|LGQSDPAPLQHQM[Oxi]DIYQK.3|LGQSDPAPLQHQMDIYQK.3|LGQSDPAPLQHQM[Oxi]DIYQK.2|LGQSDPAPLQHQMDIYQK.2|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.6|GRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPR.5|KILATPPQEDAPSVDIANIR.3|KILATPPQEDAPSVDIANIR.2|EHPDRFIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.4|EHPDRFIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.3|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQMALEDLAMFR.5|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQM[Oxi]ALEDLAMFR.4|MAAISESNINLC[CAM]GSHC[CAM]GVSIGEDGPSQMALEDLAMFR.4|DDQVTVIGAGVTLHEALAAAELLK.3|FIEC[CAM]YIAEQNMVSIAVGC[CAM]ATR.3|SVPTSTVFYPSDGVATEKAVELAANTK.3|VYC[CAM]LLGDGELSEGSVWEAMAFASIYK.3|GHAAPILYAVWAEAGFLAEAELLNLRK.3
SEN / CTL,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,1.34,1.12,1.36E-04,6.12E-05,4.21E+00,"G2/M transition of mitotic cell cycle,neuron migration,skeletal muscle contraction,mitochondrial transport,receptor-mediated endocytosis,response to unfolded protein,signal transduction,response to heat,response to cold,response to salt stress,positive regulation of lamellipodium assembly,cardiac muscle cell apoptotic process,peptidyl-tyrosine phosphorylation,regulation of protein ubiquitination,positive regulation of protein import into nucleus, translocation,Fc-gamma receptor signaling pathway involved in phagocytosis,ERBB2 signaling pathway,protein refolding,response to cocaine,response to drug,regulation of protein complex assembly,protein unfolding,response to estrogen,protein import into mitochondrial outer membrane,positive regulation of nitric oxide biosynthetic process,positive regulation of cell size,response to antibiotic,vascular endothelial growth factor receptor signaling pathway,protein stabilization,regulation of nitric-oxide synthase activity,chaperone-mediated protein complex assembly,positive regulation of cardiac muscle contraction,chaperone-mediated autophagy,regulation of cellular response to heat","nucleotide binding,glycoprotein binding,UTP binding,CTP binding,mRNA binding,protein tyrosine kinase activity,protein binding,ATP binding,GTP binding,ATPase activity,sulfonylurea receptor binding,protein kinase binding,protein phosphatase binding,MHC class II protein complex binding,nitric-oxide synthase regulator activity,TPR domain binding,dATP binding,identical protein binding,protein homodimerization activity,histone deacetylase binding,ion channel binding,poly(A) RNA binding,tau protein binding,GTPase binding,Rho GDP-dissociation inhibitor binding,unfolded protein binding","extracellular region,nucleus,nucleoplasm,cytoplasm,cytosol,plasma membrane,cell surface,membrane,basolateral plasma membrane,apical plasma membrane,extracellular matrix,brush border membrane,ruffle membrane,melanosome,neuron projection,neuronal cell body,lysosomal lumen,myelin sheath,protein complex,perinuclear region of cytoplasm,extracellular exosome,endocytic vesicle lumen,sperm mitochondrial sheath,sperm plasma membrane",15,69,151,LVTSPC[CAM]C[CAM]IVTSTYGWTANMER.3|LVTSPC[CAM]C[CAM]IVTSTYGWTANMER.4|LVTSPC[CAM]C[CAM]IVTSTYGWTANM[Oxi]ER.3|KHLEINPDHSIIETLR.4|KHLEINPDHSIIETLR.3|KHLEINPDHSIIETLR.2|RVFIMDNC[CAM]EELIPEYLNFIR.3|RVFIMDNC[CAM]EELIPEYLNFIR.4|RVFIM[Oxi]DNC[CAM]EELIPEYLNFIR.4|RVFIM[Oxi]DNC[CAM]EELIPEYLNFIR.3|TLTIVDTGIGMTK.2|TLTIVDTGIGMTK.3|TLTIVDTGIGM[Oxi]TK.3|TLTIVDTGIGM[Oxi]TK.2|ELISNSSDALDKIR.3|ELISNSSDALDKIR.2|ALLFVPR.2|APFDLFENRK.3|APFDLFENRK.2|DQVANSAFVER.3|DQVANSAFVER.2|HIYYITGETK.3|HIYYITGETK.2|LDSGKELHINLIPNKQDR.5|LDSGKELHINLIPNKQDR.4|LDSGKELHINLIPNKQDR.3|LDSGKELHINLIPNKQDR.2|LDSGKELHINLIPNK.4|LDSGKELHINLIPNK.3|LDSGKELHINLIPNK.2|RAPFDLFENR.3|RAPFDLFENR.2|KLSELLR.2|LGIHEDSQNRK.3|LGIHEDSQNRK.2|HLEINPDHSIIETLR.4|HLEINPDHSIIETLR.3|HLEINPDHSIIETLR.2|HSQFIGYPITLFVEK.4|HSQFIGYPITLFVEK.3|HSQFIGYPITLFVEK.2|RAPFDLFENRK.3|RAPFDLFENRK.2|FYEQFSK.2|FYEQFSK.1|KHSQFIGYPITLFVEK.4|KHSQFIGYPITLFVEK.3|KHSQFIGYPITLFVEK.2|TDTGEPMGR.2|TDTGEPM[Oxi]GR.2|C[CAM]LELFTELAEDK.3|C[CAM]LELFTELAEDK.2|IMKDILEK.2|IM[Oxi]KDILEK.2|HSQFIGYPITLFVEKER.4|HSQFIGYPITLFVEKER.3|HSQFIGYPITLFVEKER.2|YYTSASGDEMVSLK.3|YYTSASGDEM[Oxi]VSLK.3|YYTSASGDEMVSLK.2|YYTSASGDEM[Oxi]VSLK.2|TKFENLC[CAM]K.2|ELHINLIPNKQDR.3|ELHINLIPNKQDR.2|C[CAM]LELFTELAEDKENYKK.4|C[CAM]LELFTELAEDKENYKK.3|C[CAM]LELFTELAEDKENYKK.2|KC[CAM]LELFTELAEDKENYK.4|KC[CAM]LELFTELAEDKENYK.3|KFYEQFSK.2|YESLTDPSKLDSGKELHINLIPNK.5|KHSQFIGYPITLFVEKER.4|KHSQFIGYPITLFVEKER.3|APFDLFENR.2|AQALRDNSTMGYMAAK.3|AQALRDNSTM[Oxi]GYM[Oxi]AAK.3|AQALRDNSTM[Oxi]GYMAAK.3|AQALRDNSTMGYM[Oxi]AAK.3|AQALRDNSTMGYMAAK.2|ENQKHIYYITGETK.3|ESEDKPEIEDVGSDEEEEKK.4|ESEDKPEIEDVGSDEEEEKK.3|EVSDDEAEEK.2|KTKFENLC[CAM]K.2|LGIHEDSQNR.2|QDRTLTIVDTGIGMTK.3|DNSTMGYMAAK.2|DNSTM[Oxi]GYMAAK.2|DNSTMGYM[Oxi]AAK.2|DNSTM[Oxi]GYM[Oxi]AAK.2|ELHINLIPNK.2|VFIMDNC[CAM]EELIPEYLNFIR.4|VFIM[Oxi]DNC[CAM]EELIPEYLNFIR.4|VFIMDNC[CAM]EELIPEYLNFIR.3|VFIM[Oxi]DNC[CAM]EELIPEYLNFIR.3|HIYYITGETKDQVANSAFVER.4|HIYYITGETKDQVANSAFVER.3|NPDDITNEEYGEFYK.3|NPDDITNEEYGEFYK.2|ELISNSSDALDK.2|ELISNSSDALDKIRYESLTDPSK.4|ELISNSSDALDKIRYESLTDPSK.3|HGLEVIYMIEPIDEYC[CAM]VQQLK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.3|HGLEVIYMIEPIDEYC[CAM]VQQLK.3|TLTIVDTGIGMTKADLINNLGTIAK.4|TLTIVDTGIGM[Oxi]TKADLINNLGTIAK.3|TLTIVDTGIGMTKADLINNLGTIAK.3|EIFLRELISNSSDALDK.3|EIFLRELISNSSDALDK.2|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.5|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.4|KHGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.3|C[CAM]LELFTELAEDKENYK.3|C[CAM]LELFTELAEDKENYK.2|KHGLEVIYMIEPIDEYC[CAM]VQQLK.4|KHGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.4|KHGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLK.3|KHGLEVIYMIEPIDEYC[CAM]VQQLK.3|ESEDKPEIEDVGSDEEEEKKDGDK.4|EVSDDEAEEKEDKEEEK.3|TKPIWTRNPDDITNEEYGEFYK.4|TKPIWTRNPDDITNEEYGEFYK.3|DKEVSDDEAEEK.2|LGIHEDSQNRKK.2|TLVSVTKEGLELPEDEEEK.3|VTVITKHNDDEQYAWESSAGGSFTVR.4|VTVITKHNDDEQYAWESSAGGSFTVR.3|ESEDKPEIEDVGSDEEEEK.3|DLVILLYETALLSSGFSLEDPQTHANR.4|DLVILLYETALLSSGFSLEDPQTHANR.3|SVKDLVILLYETALLSSGFSLEDPQTHANRIYR.5|SVKDLVILLYETALLSSGFSLEDPQTHANRIYR.4|YYTSASGDEM[Oxi]VSLKDYC[CAM]TR.3|YYTSASGDEMVSLKDYC[CAM]TR.3|YYTSASGDEMVSLKDYC[CAM]TR.2|NIKLGIHEDSQNR.2|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLKEFEGK.4|HGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.4|HGLEVIYM[Oxi]IEPIDEYC[CAM]VQQLKEFEGK.3|HGLEVIYMIEPIDEYC[CAM]VQQLKEFEGK.3|KC[CAM]LELFTELAEDK.2|PIWTRNPDDITNEEYGEFYK.3|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSR.4|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSR.3|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSR.3|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSRM[Oxi]EEVD.4|LGLGIDEDDPTADDTSAAVTEEM[Oxi]PPLEGDDDTSRMEEVD.4|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRM[Oxi]EEVD.4|LGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD.4
SEN / CTL,P10909,Clusterin,CLU,1.34,1.48,1.10E-05,5.69E-06,5.24E+00,"cell morphogenesis,microglial cell activation,release of cytochrome c from mitochondria,platelet degranulation,lipid metabolic process,complement activation,complement activation, classical pathway,response to virus,protein import,central nervous system myelin maintenance,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,negative regulation of protein homooligomerization,positive regulation of tumor necrosis factor production,reverse cholesterol transport,innate immune response,positive regulation of nitric oxide biosynthetic process,protein stabilization,positive regulation of NF-kappaB transcription factor activity,chaperone-mediated protein complex assembly,response to misfolded protein,chaperone-mediated protein folding,microglial cell proliferation,regulation of beta-amyloid clearance,regulation of neuron death,positive regulation of neuron death,positive regulation of beta-amyloid formation,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,negative regulation of beta-amyloid formation,regulation of neuronal signal transduction,positive regulation of tau-protein kinase activity,positive regulation of neurofibrillary tangle assembly,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process","protein binding,ubiquitin protein ligase binding,chaperone binding,misfolded protein binding,ATPase activity","extracellular region,extracellular space,nucleus,cytoplasm,mitochondrion,endoplasmic reticulum,Golgi apparatus,cytosol,cell surface,extracellular matrix,platelet alpha granule lumen,mitochondrial membrane,spherical high-density lipoprotein particle,chromaffin granule,protein complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle,neurofibrillary tangle,apical dendrite",21,25,42,LFDSDPITVTVPVEVSR.2|LFDSDPITVTVPVEVSR.3|ELDESLQVAER.2|ELDESLQVAER.3|ASSIIDELFQDR.2|ASSIIDELFQDRFFTR.3|VTTVASHTSDSDVPSGVTEVVVK.3|VTTVASHTSDSDVPSGVTEVVVK.4|VTTVASHTSDSDVPSGVTEVVVK.2|EPQDTYHYLPFSLPHR.4|KTLLSNLEEAK.3|KTLLSNLEEAK.2|TLLSNLEEAKK.3|TLLSNLEEAKK.2|KYNELLK.2|KTLLSNLEEAKK.3|KTLLSNLEEAKK.2|QQTHMLDVMQDHFSR.4|QQTHM[Oxi]LDVMQDHFSR.4|QQTHMLDVM[Oxi]QDHFSR.4|QQTHM[Oxi]LDVMQDHFSR.3|QQTHMLDVM[Oxi]QDHFSR.3|QQTHMLDVMQDHFSR.3|FMETVAEK.2|FM[Oxi]ETVAEK.2|RELDESLQVAER.3|LFDSDPITVTVPVEVSRK.4|LFDSDPITVTVPVEVSRK.3|FFTREPQDTYHYLPFSLPHR.5|FFTREPQDTYHYLPFSLPHR.4|FFTREPQDTYHYLPFSLPHR.3|EIQNAVNGVK.2|IDSLLENDR.2|RPHFFFPK.2|TLLSNLEEAK.2|EILSVDC[CAM]STNNPSQAK.3|EILSVDC[CAM]STNNPSQAK.2|C[CAM]REILSVDC[CAM]STNNPSQAK.3|IDSLLENDRQQTHMLDVMQDHFSR.4|ASSIIDELFQDRFFTREPQDTYHYLPFSLPHR.5|YVNKEIQNAVNGVK.2|LANLTQGEDQYYLR.2
SEN / CTL,P27797,Calreticulin,CALR,1.32,0.83,2.33E-06,1.37E-06,5.86E+00,"negative regulation of transcription from RNA polymerase II promoter,antigen processing and presentation of peptide antigen via MHC class I,peptide antigen assembly with MHC class I protein complex,regulation of transcription, DNA-templated,protein folding,protein export from nucleus,cellular calcium ion homeostasis,receptor-mediated endocytosis,cell cycle arrest,spermatogenesis,positive regulation of cell proliferation,positive regulation of gene expression,negative regulation of translation,protein maturation by protein folding,cortical actin cytoskeleton organization,response to estradiol,negative regulation of intracellular steroid hormone receptor signaling pathway,response to testosterone,protein localization to nucleus,protein folding in endoplasmic reticulum,ATF6-mediated unfolded protein response,regulation of meiotic nuclear division,response to drug,glucocorticoid receptor signaling pathway,regulation of apoptotic process,negative regulation of neuron differentiation,positive regulation of DNA replication,positive regulation of cell cycle,negative regulation of transcription, DNA-templated,negative regulation of retinoic acid receptor signaling pathway,positive regulation of phagocytosis,protein stabilization,sequestering of calcium ion,cardiac muscle cell differentiation,chaperone-mediated protein folding,cellular response to lithium ion,cellular senescence,positive regulation of substrate adhesion-dependent cell spreading,positive regulation of NIK/NF-kappaB signaling,positive regulation of dendritic cell chemotaxis","complement component C1q binding,glycoprotein binding,DNA binding,mRNA binding,integrin binding,iron ion binding,calcium ion binding,protein binding,zinc ion binding,carbohydrate binding,ubiquitin protein ligase binding,peptide binding,hormone binding,protein binding involved in protein folding,poly(A) RNA binding,androgen receptor binding,unfolded protein binding,chaperone binding","acrosomal vesicle,extracellular region,proteinaceous extracellular matrix,extracellular space,intracellular,nucleus,cytoplasm,endoplasmic reticulum,endoplasmic reticulum lumen,smooth endoplasmic reticulum,Golgi apparatus,cytosol,polysome,focal adhesion,external side of plasma membrane,cell surface,membrane,sarcoplasmic reticulum lumen,MHC class I peptide loading complex,perinuclear region of cytoplasm,extracellular exosome,integral component of lumenal side of endoplasmic reticulum membrane,endocytic vesicle lumen",15,52,95,EQFLDGDGWTSR.2|FYALSASFEPFSNK.2|FYALSASFEPFSNK.3|SGTIFDNFLITNDEAYAEEFGNETWGVTK.3|SGTIFDNFLITNDEAYAEEFGNETWGVTK.4|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.5|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.4|C[CAM]KDDEFTHLYTLIVRPDNTYEVK.3|FYGDEEKDKGLQTSQDAR.4|FYGDEEKDKGLQTSQDAR.3|FYGDEEKDKGLQTSQDAR.2|DKGLQTSQDAR.3|DKGLQTSQDAR.2|IKDPDASKPEDWDERAK.5|IKDPDASKPEDWDERAK.4|IKDPDASKPEDWDERAK.3|IKDPDASKPEDWDERAK.2|HKSDFGK.2|FYGDEEK.2|GKNVLINK.2|IKDPDASKPEDWDER.4|IKDPDASKPEDWDER.3|IKDPDASKPEDWDER.2|FVLSSGKFYGDEEKDK.4|FVLSSGKFYGDEEKDK.3|KIKDPDASKPEDWDER.4|KIKDPDASKPEDWDER.3|KIKDPDASKPEDWDER.2|GLQTSQDAR.2|AKIDDPTDSKPEDWDKPEHIPDPDAK.6|AKIDDPTDSKPEDWDKPEHIPDPDAK.5|AKIDDPTDSKPEDWDKPEHIPDPDAK.4|AKIDDPTDSKPEDWDKPEHIPDPDAK.3|HEQNIDC[CAM]GGGYVK.3|HEQNIDC[CAM]GGGYVK.2|QIDNPDYK.2|LKEEEEDK.2|VHVIFNYK.2|VHVIFNYK.1|HKSDFGKFVLSSGK.3|HKSDFGKFVLSSGK.2|DPDASKPEDWDER.3|DPDASKPEDWDER.2|FVLSSGKFYGDEEK.3|FVLSSGKFYGDEEK.2|NVLINKDIR.2|IDDPTDSKPEDWDKPEHIPDPDAK.5|IDDPTDSKPEDWDKPEHIPDPDAK.4|IDDPTDSKPEDWDKPEHIPDPDAK.3|KEEEEAEDK.2|FYGDEEKDK.2|EEEEAEDKEDDEDK.3|KVHVIFNYK.2|IDNSQVESGSLEDDWDFLPPK.4|IDNSQVESGSLEDDWDFLPPK.3|IDNSQVESGSLEDDWDFLPPK.2|GQTLVVQFTVK.2|KEEEEAEDKEDDEDK.3|DEDEEDEEDK.2|IDNSQVESGSLEDDWDFLPPKK.4|IDNSQVESGSLEDDWDFLPPKK.3|GKNVLINKDIR.2|SDFGKFVLSSGK.2|DDEFTHLYTLIVRPDNTYEVK.4|DDEFTHLYTLIVRPDNTYEVK.3|EDDEDKDEDEEDEEDK.3|KVHVIFNYKGK.2|GQTLVVQFTVKHEQNIDC[CAM]GGGYVK.4|GQTLVVQFTVKHEQNIDC[CAM]GGGYVK.3|EEEEAEDKEDDEDKDEDEEDEEDK.4|EEDEEEDVPGQAK.2|FVLSSGK.1|KPEDWDEEMDGEWEPPVIQNPEYK.4|KPEDWDEEM[Oxi]DGEWEPPVIQNPEYK.3|KPEDWDEEMDGEWEPPVIQNPEYK.3|KPEDWDEEMDGEWEPPVIQNPEYKGEWKPR.5|KPEDWDEEMDGEWEPPVIQNPEYKGEWKPR.4|GTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVK.5|GTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVK.4|EDDEDKDEDEEDEEDKEEDEEEDVPGQAK.4|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTK.4|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTK.3|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTKK.4|LFPNSLDQTDM[Oxi]HGDSEYNIMFGPDIC[CAM]GPGTKK.4|LFPNSLDQTDMHGDSEYNIM[Oxi]FGPDIC[CAM]GPGTKK.4|LFPNSLDQTDMHGDSEYNIMFGPDIC[CAM]GPGTKK.3|DEDEEDEEDKEEDEEEDVPGQAK.3|EEDEEEDVPGQAKDEL.2|FYALSASFEPFSNKGQTLVVQFTVK.3|DEDEEDEEDKEEDEEEDVPGQAKDEL.3
SEN / CTL,Q8NBS9,Thioredoxin domain-containing protein 5,TXNDC5,1.32,1.59,2.52E-03,8.00E-04,3.10E+00,"protein folding,response to endoplasmic reticulum stress,negative regulation of apoptotic process,apoptotic cell clearance,cell redox homeostasis",protein disulfide isomerase activity,"endoplasmic reticulum,endoplasmic reticulum lumen,lysosomal lumen,extracellular exosome",15,30,49,GYPTLLLFR.2|GYPTLLWFR.2|DLESLREYVESQLQR.3|DLESLREYVESQLQR.2|ALAPTWEQLALGLEHSETVK.3|ALAPTWEQLALGLEHSETVK.4|ALAPTWEQLALGLEHSETVK.2|IGKVDC[CAM]TQHYELC[CAM]SGNQVR.4|IGKVDC[CAM]TQHYELC[CAM]SGNQVR.3|VSEHSGGRDLDSLHR.4|VSEHSGGRDLDSLHR.3|DLDSLHR.2|FFAPWC[CAM]GHC[CAM]K.3|FYAPWC[CAM]GHC[CAM]K.3|FYAPWC[CAM]GHC[CAM]K.2|VDC[CAM]TAHSDVC[CAM]SAQGVR.4|VDC[CAM]TAHSDVC[CAM]SAQGVR.3|VDC[CAM]TAHSDVC[CAM]SAQGVR.2|KVSEHSGGRDLDSLHR.4|KVSEHSGGRDLDSLHR.3|TLAPTWEELSKK.3|TLAPTWEELSKK.2|YNSMEDAK.2|YNSM[Oxi]EDAK.2|VDC[CAM]TQHYELC[CAM]SGNQVR.4|VDC[CAM]TQHYELC[CAM]SGNQVR.3|VDC[CAM]TQHYELC[CAM]SGNQVR.2|KEFPGLAGVK.2|QGLYELSASNFELHVAQGDHFIK.5|QGLYELSASNFELHVAQGDHFIK.4|QGLYELSASNFELHVAQGDHFIK.3|LFKPGQEAVK.2|EYVESQLQR.2|FVLSQAKDEL.2|TLAPTWEELSKKEFPGLAGVK.4|IAEVDC[CAM]TAER.2|GTVLALTENNFDDTIAEGITFIK.4|GTVLALTENNFDDTIAEGITFIK.3|TLAPTWEELSK.2|LQPTWNDLGDK.2|RDLESLREYVESQLQR.3|HLYTADMFTHGIQSAAHFVMFFAPWC[CAM]GHC[CAM]QR.5|HLYTADMFTHGIQSAAHFVM[Oxi]FFAPWC[CAM]GHC[CAM]QR.5|LQPTWNDLGDKYNSMEDAK.3|LQPTWNDLGDKYNSM[Oxi]EDAK.3|LQPTWNDLGDKYNSMEDAK.2|TETGATETVTPSEAPVLAAEPEADK.3|DFQTLENWMLQTLNEEPVTPEPEVEPPSAPELK.4|TETGATETVTPSEAPVLAAEPEADKGTVLALTENNFDDTIAEGITFIK.5
SEN / CTL,P42785,Lysosomal Pro-X carboxypeptidase,PRCP,1.32,1.32,1.00E-03,3.63E-04,3.44E+00,"regulation of thyroid hormone mediated signaling pathway,plasma kallikrein-kinin cascade,negative regulation of systemic arterial blood pressure,proteolysis,blood coagulation, intrinsic pathway,glucose homeostasis,regulation of blood vessel endothelial cell migration,angiogenesis involved in wound healing,energy homeostasis,regulation of reactive oxygen species metabolic process","serine-type carboxypeptidase activity,dipeptidyl-peptidase activity","lysosome,plasma membrane,basal part of cell,extracellular exosome",12,11,19,NALDPMSVLLAR.2|NALDPMSVLLAR.3|NALDPM[Oxi]SVLLAR.2|YYGESLPFGDNSFKDSR.3|HLNFLTSEQALADFAELIK.3|HLNFLTSEQALADFAELIK.4|HLNFLTSEQALADFAELIK.2|DITDTLVAVTISEGAHHLDLR.4|DITDTLVAVTISEGAHHLDLR.3|DITDTLVAVTISEGAHHLDLR.2|SGPHC[CAM]SESIHR.3|SGPHC[CAM]SESIHR.2|AMLVFAEHR.2|VDHFGFNTVK.2|PSWITTMYGGK.2|ALGSLHLPTNPTSLPAVAK.3|YYGESLPFGDNSFK.2|LSNTGSGLQWLTGALHLC[CAM]SPLTSQDIQHLK.4|LSNTGSGLQWLTGALHLC[CAM]SPLTSQDIQHLK.3
SEN / CTL,P35052,Glypican-1,GPC1,1.31,1.21,2.86E-08,2.26E-08,7.65E+00,"retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,axon guidance,Schwann cell differentiation,heparan sulfate proteoglycan catabolic process,glycosaminoglycan metabolic process,myelin assembly,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of skeletal muscle cell differentiation","copper ion binding,fibroblast growth factor binding,laminin binding,heparan sulfate proteoglycan binding","proteinaceous extracellular matrix,extracellular space,endosome,Golgi lumen,plasma membrane,integral component of plasma membrane,anchored component of membrane,lysosomal lumen,membrane raft,extracellular exosome",24,13,13,VLQAMLATQLR.2|GFSLSDVPQAEISGEHLR.3|SFVQGLGVASDVVR.2|DVQDFWISLPGTLC[CAM]SEK.3|LVYC[CAM]AHC[CAM]LGVPGARPC[CAM]PDYC[CAM]R.4|QLHPQLLLPDDYLDC[CAM]LGK.3|SFVQGLGVASDVVRK.3|GC[CAM]LANQADLDAEWR.2|QAEALRPFGEAPR.3|SHAELETALR.2|VAQVPLGPEC[CAM]SR.2|NLLDSMVLITDK.2|TLQATFPGAFGELYTQNAR.2
SEN / CTL,P12259,Coagulation factor V,F5,1.30,2.19,3.60E-02,8.82E-03,2.05E+00,"platelet degranulation,proteolysis,ER to Golgi vesicle-mediated transport,blood coagulation,blood circulation,platelet activation,COPII vesicle coating","serine-type endopeptidase activity,copper ion binding,protein binding","Golgi membrane,extracellular region,extracellular space,endoplasmic reticulum lumen,plasma membrane,membrane,ER to Golgi transport vesicle,platelet alpha granule lumen,endoplasmic reticulum-Golgi intermediate compartment membrane,extracellular vesicle",6,40,46,AEVDDVIQVR.2|DIHSGLIGPLLIC[CAM]QK.3|FC[CAM]ENPDEVKR.3|SQHLDNFSNQIGK.3|SQHLDNFSNQIGK.2|PYSLHAHGLSYEK.3|SHEFHAINGMIYSLPGLK.4|SHEFHAINGMIYSLPGLK.3|EDGILGPIIR.2|ITAIITQGC[CAM]K.2|SGPESPGSAC[CAM]R.2|DPPSDLLLLK.2|KGTLTEGGTQK.2|GEYEEHLGILGPIIR.3|GEYEEHLGILGPIIR.2|LELFGC[CAM]DIY.2|QHQLGVWPLLPGSFK.3|KVMYTQYEDESFTK.3|LSEGASYLDHTFPAEK.3|LSEGASYLDHTFPAEK.2|SEAYNTFSER.2|KITAIITQGC[CAM]K.2|AVQPGETYTYK.2|FTVNNLAEPQK.2|AADIEQQAVFAVFDENK.3|AADIEQQAVFAVFDENK.2|DGTDYIEIIPK.2|ENQFDPPIVAR.2|SWYLEDNINK.2|EFNPLVIVGLSK.2|LAAEFASKPWIQVDMQK.3|DPDNIAAWYLR.2|ASEFLGYWEPR.2|EVIITGIQTQGAK.2|HEDTLTLFPMR.2|ASKPGWWLLNTEVGENQR.3|AWAYYSAVNPEK.2|ETDIEDSDDIPEDTTYKK.3|SYTIHYSEQGVEWKPYR.3|DIASGLIGLLLIC[CAM]K.2|HLSQDTGSPSGMRPWEDLPSQDTGSPSR.4|VM[Oxi]YTQYEDESFTK.2|VMYTQYEDESFTK.2|EKPQSTISGLLGPTLYAEVGDIIK.3|MPMGLSTGIISDSQIK.2|ETDIEDSDDIPEDTTYK.2
SEN / CTL,Q16851,UTP--glucose-1-phosphate uridylyltransferase,UGP2,1.30,1.10,1.18E-01,2.54E-02,1.59E+00,"glycogen biosynthetic process,UDP-glucose metabolic process,UDP-glucuronate biosynthetic process,glucose 1-phosphate metabolic process","UTP:glucose-1-phosphate uridylyltransferase activity,protein binding,glucose binding,pyrimidine ribonucleotide binding,identical protein binding,metal ion binding","nucleus,cytosol,extracellular exosome",3,37,59,SFENSLGINVPR.2|SFENSLGINVPR.3|ILTTASSHEFEHTK.4|ILTTASSHEFEHTK.3|ILTTASSHEFEHTK.2|INKESLLPVAK.3|INKESLLPVAK.2|AHVDEFK.2|GPSVDWGK.2|GTVIIIANHGDR.3|GTVIIIANHGDR.2|LRLVEIAQVPK.3|ILTTASSHEFEHTKK.4|ILTTASSHEFEHTKK.3|RC[CAM]EFVMEVTNK.3|RC[CAM]EFVM[Oxi]EVTNK.3|RC[CAM]EFVMEVTNK.2|ARGLPDNISSVLNK.3|FLQEKGPSVDWGK.3|LVEIAQVPK.2|LGSSFTKVQDYLR.3|EFPTVPLVK.2|IYTFNQSR.2|GGTLTQYEGK.2|AMSQDGASQFQEVIR.3|AMSQDGASQFQEVIR.2|IQRPPEDSIQPYEK.3|IQRPPEDSIQPYEK.2|IFNTNNLWISLAAVK.3|IFNTNNLWISLAAVK.2|REFPTVPLVK.2|LNGGLGTSMGC[CAM]K.2|LNGGLGTSM[Oxi]GC[CAM]K.2|IFNTNNLWISLAAVKR.3|C[CAM]EFVMEVTNK.2|GLPDNISSVLNK.2|GTVIIIANHGDRIDIPPGAVLENK.4|GTVIIIANHGDRIDIPPGAVLENK.3|IDIPPGAVLENK.2|RLQEQNAIDM[Oxi]EIIVNAK.3|RLQEQNAIDMEIIVNAK.3|RLQEQNAIDMEIIVNAK.2|TLDGGLNVIQLETAVGAAIK.3|TLDGGLNVIQLETAVGAAIK.2|RFESIPDMLELDHLTVSGDVTFGK.4|RFESIPDM[Oxi]LELDHLTVSGDVTFGK.4|RFESIPDMLELDHLTVSGDVTFGK.3|TTSDLLLVMSNLYSLNAGSLTMSEK.4|TTSDLLLVMSNLYSLNAGSLTMSEK.3|TTSDLLLVMSNLYSLNAGSLTM[Oxi]SEK.3|AMSQDGASQFQEVIRQELELSVKK.4|SLIGVRNENTFLDLTVQQIEHLNK.4|SLIGVRNENTFLDLTVQQIEHLNK.3|NENTFLDLTVQQIEHLNK.3|NENTFLDLTVQQIEHLNK.2|TYNTDVPLVLMNSFNTDEDTK.3|AMSQDGASQFQEVIRQELELSVK.3|TYNTDVPLVLMNSFNTDEDTKK.3|LQEQNAIDMEIIVNAK.2
SEN / CTL,Q14118,Dystroglycan,DAG1,1.29,0.51,4.11E-02,9.87E-03,2.01E+00,"morphogenesis of an epithelial sheet,protein O-linked glycosylation,membrane protein ectodomain proteolysis,NLS-bearing protein import into nucleus,cytoskeletal anchoring at plasma membrane,regulation of gastrulation,regulation of epithelial to mesenchymal transition,calcium-dependent cell-matrix adhesion,regulation of embryonic cell shape,modulation by virus of host morphology or physiology,nerve maturation,myelination in peripheral nervous system,extracellular matrix organization,negative regulation of cell migration,microtubule anchoring,negative regulation of MAPK cascade,response to peptide hormone,viral entry into host cell,negative regulation of protein kinase B signaling,epithelial tube branching involved in lung morphogenesis,branching involved in salivary gland morphogenesis,commissural neuron axon guidance,basement membrane organization,positive regulation of basement membrane assembly involved in embryonic body morphogenesis","virus receptor activity,dystroglycan binding,actin binding,calcium ion binding,protein binding,structural constituent of muscle,tubulin binding,vinculin binding,protein complex binding,SH2 domain binding,laminin-1 binding,alpha-actinin binding","extracellular region,basement membrane,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,focal adhesion,cell outer membrane,dystrophin-associated glycoprotein complex,dystroglycan complex,integral component of membrane,basolateral plasma membrane,lamellipodium,filopodium,node of Ranvier,sarcolemma,costamere,membrane raft,postsynaptic membrane,extracellular exosome,contractile ring",3,17,21,VTIPTDLIASSGDIIK.2|GGLSAVDAFEIHVHR.4|GGLSAVDAFEIHVHR.3|GGLSAVDAFEIHVHR.2|LREQQLVGEK.3|LREQQLVGEK.2|FVGDPALVLNDIHKK.4|FVGDPALVLNDIHKK.3|FVGDPALVLNDIHK.3|IAEDDGKPRPAFSNALEPDFK.4|RIAEDDGKPRPAFSNALEPDFK.4|IPSDTFYDHEDTTTDK.3|LTLEDQATFIK.2|ATSITVTGSGSC[CAM]R.2|PAFSNALEPDFK.2|EGAMSAQLGYPVVGWHIANK.3|VDAWVGTYFEVK.2|LGC[CAM]SLNQNSVPDIHGVEAPAR.3|SWVQFNSNSQLMYGLPDSSHVGKHEYFMHATDK.5|SWVQFNSNSQLMYGLPDSSHVGK.3|GVPIIFADELDDSKPPPSSSMPLILQEEK.3
SEN / CTL,A5A3E0,POTE ankyrin domain family member F,POTEF,1.29,1.17,1.50E-03,5.04E-04,3.30E+00,retina homeostasis,,"extracellular space,cell cortex,extracellular exosome,blood microparticle",9,3,4,VAPEEHPVLLTEATLNPK.3|LC[CAM]YVALDFEQEMATVASSSSLEK.3|FRC[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPC[CAM]FLGMESC[CAM]GIHETTFNSIMK.4
SEN / CTL,P07951,Tropomyosin beta chain,TPM2,1.29,1.10,1.87E-09,1.73E-09,8.76E+00,"muscle contraction,muscle filament sliding,regulation of ATPase activity","actin binding,structural constituent of muscle","cytosol,muscle thin filament tropomyosin",42,34,56,IQLVEEELDR.2|IQLVEEELDRAQER.3|IQLVEEELDRAQER.2|RIQLVEEELDRAQER.3|RIQLVEEELDRAQER.4|LATALQKLEEAEKAADESER.4|LATALQKLEEAEKAADESER.3|LATALQKLEEAEKAADESER.2|KLVILEGELER.3|KLVILEGELER.2|RIQLVEEELDR.3|RIQLVEEELDR.2|KATDAEADVASLNR.3|KATDAEADVASLNR.2|AMKDEEKMELQEMQLK.4|AMKDEEKMELQEMQLK.3|TIDDLEDEVYAQK.2|KATDAEADVASLNRR.4|KATDAEADVASLNRR.3|KATDAEADVASLNRR.2|SEERAEVAESK.3|ENAIDRAEQAEADKK.4|ENAIDRAEQAEADKK.3|C[CAM]KQLEEEQQALQKK.4|C[CAM]KQLEEEQQALQKK.3|QLEEEQQALQK.3|QLEEEQQALQK.2|SLEAQADKYSTK.3|SLEAQADKYSTK.2|ATDAEADVASLNR.3|ATDAEADVASLNR.2|GTEDEVEK.2|HIAEDSDRKYEEVAR.4|HIAEDSDRKYEEVAR.3|HIAEDSDR.2|EAQEKLEQAEKK.3|QLEEEQQALQKK.3|QLEEEQQALQKK.2|ATDAEADVASLNRR.3|ATDAEADVASLNRR.2|ENAIDRAEQAEADK.3|LDKENAIDR.2|C[CAM]KQLEEEQQALQK.3|C[CAM]KQLEEEQQALQK.2|C[CAM]GDLEEELK.2|AISEELDNALNDITSL.3|AISEELDNALNDITSL.2|LKGTEDEVEK.2|MELQEMQLK.2|M[Oxi]ELQEMQLK.2|MELQEM[Oxi]QLK.2|LVILEGELER.2|KLVILEGELERSEER.3|EAQEKLEQAEK.2|YSESVKEAQEK.2|GTEDEVEKYSESVK.2
SEN / CTL,P00338,L-lactate dehydrogenase A chain,LDHA,1.29,1.86,5.53E-11,6.67E-11,1.02E+01,"response to hypoxia,lactate metabolic process,pyruvate metabolic process,glycolytic process,response to nutrient,response to glucose,NAD metabolic process,response to drug,response to hydrogen peroxide,positive regulation of apoptotic process,response to estrogen,post-embryonic animal organ development,response to cAMP,oxidation-reduction process,cell-cell adhesion","L-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD binding,cadherin binding involved in cell-cell adhesion","nucleus,cytosol,cell-cell adherens junction,membrane,extracellular exosome",60,38,92,LVIITAGAR.2|VTLTSEEEAR.2|SADTLWGIQKELQF.2|LLIVSNPVDILTYVAWK.3|LLIVSNPVDILTYVAWK.2|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.5|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.4|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGMNVAGVSLK.6|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.5|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.6|LGVHPLSC[CAM]HGWVLGEHGDSSVPVWSGM[Oxi]NVAGVSLK.4|GLYGIKDDVFLSVPC[CAM]ILGQNGISDLVK.3|GLYGIKDDVFLSVPC[CAM]ILGQNGISDLVK.4|QVVESAYEVIK.2|QVVESAYEVIK.3|DQLIYNLLKEEQTPQNK.3|DQLIYNLLKEEQTPQNK.4|DQLIYNLLKEEQTPQNK.2|SADTLWGIQK.2|EVHKQVVESAYEVIK.3|EVHKQVVESAYEVIK.4|EVHKQVVESAYEVIK.2|FIIPNVVK.2|FIIPNVVK.1|VIGSGC[CAM]NLDSAR.2|VIGSGC[CAM]NLDSAR.3|DLADELALVDVIEDKLK.3|DLADELALVDVIEDKLK.2|LKGEMMDLQHGSLFLR.4|LKGEM[Oxi]M[Oxi]DLQHGSLFLR.4|LKGEM[Oxi]MDLQHGSLFLR.4|LKGEMM[Oxi]DLQHGSLFLR.4|LKGEM[Oxi]MDLQHGSLFLR.3|LKGEMM[Oxi]DLQHGSLFLR.3|LKGEMMDLQHGSLFLR.3|LKGEM[Oxi]M[Oxi]DLQHGSLFLR.3|LKGEMMDLQHGSLFLR.2|LKGEMM[Oxi]DLQHGSLFLR.2|GEMMDLQHGSLFLR.4|GEMMDLQHGSLFLR.3|GEM[Oxi]MDLQHGSLFLR.3|GEMM[Oxi]DLQHGSLFLR.3|GEM[Oxi]M[Oxi]DLQHGSLFLR.3|GEMMDLQHGSLFLR.2|GEM[Oxi]MDLQHGSLFLR.2|GEMM[Oxi]DLQHGSLFLR.2|KSADTLWGIQK.3|KSADTLWGIQK.2|TLHPDLGTDKDK.3|TLHPDLGTDKDK.2|VTLTSEEEARLK.3|TLHPDLGTDKDKEQWK.4|TLHPDLGTDKDKEQWK.3|TLHPDLGTDKDKEQWK.2|EEQTPQNK.2|IVSGKDYNVTANSK.3|IVSGKDYNVTANSK.2|DYNVTANSK.2|NRVIGSGC[CAM]NLDSAR.3|NRVIGSGC[CAM]NLDSAR.2|VHPVSTMIK.2|QQEGESRLNLVQR.3|DLADELALVDVIEDK.3|DLADELALVDVIEDK.2|NVNIFKFIIPNVVK.3|NVNIFKFIIPNVVK.2|TLHPDLGTDK.2|DQLIYNLLK.2|DDVFLSVPC[CAM]ILGQNGISDLVK.4|DDVFLSVPC[CAM]ILGQNGISDLVK.3|DDVFLSVPC[CAM]ILGQNGISDLVK.2|IVSGKDYNVTANSKLVIITAGAR.4|IVSGKDYNVTANSKLVIITAGAR.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILMK.3|ITVVGVGAVGMAC[CAM]AISILM[Oxi]K.3|ITVVGVGAVGMAC[CAM]AISILMK.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILM[Oxi]K.3|ITVVGVGAVGM[Oxi]AC[CAM]AISILMK.2|ITVVGVGAVGMAC[CAM]AISILM[Oxi]K.2|ITVVGVGAVGMAC[CAM]AISILMK.2|ITVVGVGAVGM[Oxi]AC[CAM]AISILM[Oxi]K.2|GYTSWAIGLSVADLAESIMK.3|GYTSWAIGLSVADLAESIM[Oxi]K.3|GYTSWAIGLSVADLAESIM[Oxi]K.2|GYTSWAIGLSVADLAESIMK.2|LLIVSNPVDILTYVAWKISGFPKNR.4|LKGYTSWAIGLSVADLAESIM[Oxi]K.3|LKGYTSWAIGLSVADLAESIMK.3|LKGYTSWAIGLSVADLAESIMK.2|NVNIFKFIIPNVVKYSPNC[CAM]K.3|YSPNC[CAM]KLLIVSNPVDILTYVAWKISGFPK.4|YSPNC[CAM]KLLIVSNPVDILTYVAWK.3
SEN / CTL,P62158,Calmodulin,CALM1,1.28,1.10,2.81E-06,1.60E-06,5.80E+00,"G2/M transition of mitotic cell cycle,MAPK cascade,response to amphetamine,regulation of heart rate,platelet degranulation,detection of calcium ion,glycogen catabolic process,muscle contraction,G-protein coupled receptor signaling pathway,activation of adenylate cyclase activity,Wnt signaling pathway, calcium modulating pathway,positive regulation of peptidyl-threonine phosphorylation,negative regulation of peptidyl-threonine phosphorylation,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,substantia nigra development,regulation of rhodopsin mediated signaling pathway,positive regulation of cyclic nucleotide metabolic process,positive regulation of protein autophosphorylation,regulation of cytokinesis,positive regulation of phosphoprotein phosphatase activity,ion transmembrane transport,positive regulation of protein dephosphorylation,Fc-epsilon receptor signaling pathway,positive regulation of DNA binding,positive regulation of GTPase activity,inositol phosphate metabolic process,regulation of nitric-oxide synthase activity,positive regulation of nitric-oxide synthase activity,positive regulation of cyclic-nucleotide phosphodiesterase activity,response to corticosterone,response to calcium ion,regulation of cardiac muscle contraction,negative regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of ryanodine-sensitive calcium-release channel activity,positive regulation of protein serine/threonine kinase activity,regulation of high voltage-gated calcium channel activity,regulation of cell communication by electrical coupling involved in cardiac conduction","Ras guanyl-nucleotide exchange factor activity,calcium ion binding,protein binding,adenylate cyclase binding,inositol-1,4,5-trisphosphate 3-kinase activity,ligand-gated ion channel activity,protein kinase binding,protein domain specific binding,nitric-oxide synthase regulator activity,titin binding,type 3 metabotropic glutamate receptor binding,thioesterase binding,N-terminal myristoylation domain binding,phospholipase binding,protein serine/threonine kinase activator activity,phosphatidylinositol 3-kinase binding,ion channel binding,calcium-dependent protein binding,nitric-oxide synthase binding,protein phosphatase activator activity","spindle pole,extracellular region,nucleus,nucleoplasm,cytoplasm,centrosome,cytosol,spindle microtubule,plasma membrane,voltage-gated potassium channel complex,sarcomere,growth cone,vesicle,extracellular exosome,calcium channel complex",21,13,30,VFDKDGNGYISAAELR.3|VFDKDGNGYISAAELR.2|EAFSLFDKDGDGTITTK.3|EAFSLFDKDGDGTITTK.2|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMAR.4|SLGQNPTEAELQDM[Oxi]INEVDADGNGTIDFPEFLTMMAR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM[Oxi]M[Oxi]AR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTM[Oxi]MAR.4|SLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMM[Oxi]AR.4|MKDTDSEEEIREAFR.4|MKDTDSEEEIREAFR.3|M[Oxi]KDTDSEEEIREAFR.4|M[Oxi]KDTDSEEEIREAFR.3|MKDTDSEEEIREAFR.2|DGDGTITTK.2|M[Oxi]KDTDSEEEIR.3|MKDTDSEEEIR.3|MKDTDSEEEIR.2|M[Oxi]KDTDSEEEIR.2|KMKDTDSEEEIR.3|KM[Oxi]KDTDSEEEIR.3|HVMTNLGEK.2|DTDSEEEIREAFR.3|DTDSEEEIREAFR.2|DTDSEEEIR.2|DGNGYISAAELR.2|LTDEEVDEMIR.2|EADIDGDGQVNYEEFVQMMTAK.3|EADIDGDGQVNYEEFVQM[Oxi]MTAK.3|EADIDGDGQVNYEEFVQMM[Oxi]TAK.3
SEN / CTL,Q99715,Collagen alpha-1(XII) chain,COL12A1,1.28,1.12,1.72E-35,1.86E-34,3.37E+01,"skeletal system development,cell adhesion,collagen fibril organization,collagen catabolic process,endodermal cell differentiation",extracellular matrix structural constituent conferring tensile strength,"extracellular region,collagen type XII trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome,extracellular vesicle",153,96,114,IVEVFDIGPK.2|LLPETPSDPFAIWQITDRDYKPQVGVIADPSSK.4|NVGVEVFSLGIK.2|FNQMLNQIPNDYQSSR.2|VSWDPSPSPVLGYK.2|ALALGALQNIR.2|RVQIALAQYSGDPR.3|NSDVEIFAVGVK.2|SLLQAVANLPYKGGNTLTGMALNFIR.3|MIATDPDDTHAYNVADFESLSR.3|LGELVVGPYDNTVVLEELR.3|LGELVVGPYDNTVVLEELR.2|LQPQTTYDITVLPIYK.2|LQPQTTYDITVLPIYK.3|QHALSVGPQTTTLSVR.3|QHALSVGPQTTTLSVR.2|TYQIGWDTFC[CAM]VK.2|VLVVVTDGR.2|LNWNPSPSPVTGYK.2|SLLQAVANLPYK.2|QVC[CAM]EQLISGQMNR.2|VQISLVQYSR.2|LKPDTPYTITVSSLYPDGEGGR.3|SELEAIASPPAETHVFTVEDFDAFQR.3|SELEAIASPPAETHVFTVEDFDAFQR.4|NAFVNQPTADLHPNGLPPSYTIILLFR.3|NAFVNQPTADLHPNGLPPSYTIILLFR.4|VQIALAQYSGDPR.2|VGVVQYSSDTR.2|VEDIIEAINTFPYR.2|VEDIIEAINTFPYR.3|FRVSWDPSPSPVLGYK.3|LKDEGVELFAIGIK.3|LKDEGVELFAIGIK.2|RLQPQTTYDITVLPIYK.3|RLQPQTTYDITVLPIYK.2|FTKVEDIIEAINTFPYR.3|IYIDC[CAM]YEIIEK.2|SAAFQIQSFDIVC[CAM]SPVWTSR.3|KFTKVEDIIEAINTFPYR.4|TNWSPAGENVFSYHITYK.3|TEFNLNQYYQR.2|VTWEPAPGEVK.2|VVYSPVDGTRPSESIVVPGNTR.3|VVYSPVDGTRPSESIVVPGNTR.4|AYVPPKDLSFSEVTSYGFK.3|VAIIITDGKSQDEVEIPAR.3|NSDVEIFAVGVKDAVR.3|NSDVEIFAVGVKDAVR.2|GMTSSEPISIMEK.2|LRDVTHSTMNVFWEPVPGK.4|GGNTLTGMALNFIR.2|GGNTLTGMALNFIR.3|GGNTLTGM[Oxi]ALNFIR.2|NTFTESAGAR.2|LLPETPSDPFAIWQITDR.3|LLPETPSDPFAIWQITDR.2|SQDDVEAPSKK.3|YRIIYRPVAGGESR.4|VPPTVTSTVLKR.3|VTFHPTGDDRR.3|IIYRPVAGGESR.3|VTWKPAPGK.2|IEQELAAIK.2|EVTTPPNQR.2|GTWDHGASDVSLYR.3|VTWEPAPGEVKGYK.3|EVEVDRSETSTSLK.3|SQDDVEAPSK.2|VSDPTTSTMK.2|GISGAIGPPGPR.2|TSDPTMSSFR.2|ITEVTSEGFR.2|SQDEVEIPAR.2|VPPTVTSTVLK.2|VTDETTDSFK.2|VILTPM[Oxi]TAGSR.2|IIYSPTVGDPIDEYTTVPGRR.4|IIYSPTVGDPIDEYTTVPGRR.3|SSDAFRDPAIK.2|VDEETENTMR.2|ITVDPTTDGPTK.2|SLYDDVDTGEK.2|IIDENTVHMSWAKPVDPIVGYR.4|RNNVILQPLQPDTPYK.3|VYDPSTSTLNVR.2|ITVIAVYEDGDGGHLTGNGR.3|ITYQPSTGEGNEQTTTIGGR.3|ITYQPSTGEGNEQTTTIGGR.2|LKPDTPYTITVSSLYPDGEGGRM[Oxi]TGR.4|VTDETTDSFKITWTQAPGR.3|IIYSPTVGDPIDEYTTVPGR.3|IIYSPTVGDPIDEYTTVPGR.2|DLSFSEVTSYGFK.2|EVTLPLPRPQDLK.2|TVGLLPPQNIHISDEWYTR.3|NVQVYNPTPNSLDVRWDPAPGPVLQYR.4|NVQVYNPTPNSLDVRWDPAPGPVLQYR.3|HVFIVDDFESFEK.2|NQPGPPGPPGPPGSAGAR.2|YRITYQPSTGEGNEQTTTIGGR.3|GPGDLEAPSNLVISER.2|NLQPDTSYTVTVVPVYTEGDGGR.3|DLKPETEYVVNVYSVVEDEYSEPLKGTEK.4|DLKPETEYVVNVYSVVEDEYSEPLKGTEK.3|NVQVYNPTPNSLDVR.2|NNVILQPLQPDTPYK.2|VFGETTNSLSVAWDHADGPVQQYR.3|LFYAPAAGGPEELVPIPGNTNYAILR.3|LIPDTLYSVNLVALYSDGEGNPSPAQGR.3|LGPTVNDMQLTDLVPNTEYAVTVQAVLHDLTSEPVTVR.4|DLFSQTLYTVSVSAVHDEGESPPVTAQETTRPVPAPTNLK.4|QYLVTYTPVAGGETQEVTVR.2|IEDNLITFVC[CAM]ETATSSC[CAM]PLIYLDGYTSPGFK.3
SEN / CTL,P00742,Coagulation factor X,F10,1.27,0.72,5.69E-03,1.69E-03,2.77E+00,"signal peptide processing,ER to Golgi vesicle-mediated transport,blood coagulation,blood coagulation, intrinsic pathway,blood coagulation, extrinsic pathway,peptidyl-glutamic acid carboxylation,positive regulation of cell migration,positive regulation of protein kinase B signaling","serine-type endopeptidase activity,calcium ion binding,protein binding,phospholipid binding","extracellular region,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,intrinsic component of external side of plasma membrane",6,13,15,ETYDFDIAVLR.2|MLEVPYVDR.2|TGIVSGFGR.2|NTEQEEGGEAVHEVEVVIKHNR.5|QEDAC[CAM]QGDSGGPHVTR.3|QEDAC[CAM]QGDSGGPHVTR.2|MNVAPAC[CAM]LPER.2|VGDRNTEQEEGGEAVHEVEVVIK.4|AC[CAM]IPTGPYPC[CAM]GK.2|DWAESTLMTQK.2|DWAESTLM[Oxi]TQK.2|YKDGDQC[CAM]ETSPC[CAM]QNQGK.3|NTEQEEGGEAVHEVEVVIK.3|DGDQC[CAM]ETSPC[CAM]QNQGK.2|MNVAPAC[CAM]LPERDWAESTLMTQK.3
SEN / CTL,P07195,L-lactate dehydrogenase B chain,LDHB,1.27,2.19,2.60E-04,1.10E-04,3.96E+00,"carbohydrate metabolic process,lactate metabolic process,pyruvate metabolic process,NAD metabolic process,oxidation-reduction process","L-lactate dehydrogenase activity,protein binding,kinase binding,identical protein binding,NAD binding","cytoplasm,mitochondrion,cytosol,membrane,myelin sheath,membrane raft,extracellular exosome",24,35,73,IVVVTAGVR.2|MVVESAYEVIK.2|MVVESAYEVIK.3|M[Oxi]VVESAYEVIK.2|GMYGIENEVFLSLPC[CAM]ILNAR.3|GMYGIENEVFLSLPC[CAM]ILNAR.4|GM[Oxi]YGIENEVFLSLPC[CAM]ILNAR.3|GM[Oxi]YGIENEVFLSLPC[CAM]ILNAR.2|GMYGIENEVFLSLPC[CAM]ILNAR.2|SLADELALVDVLEDKLKGEMM[Oxi]DLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEMMDLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEM[Oxi]MDLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEM[Oxi]M[Oxi]DLQHGSLFLQTPK.5|SLADELALVDVLEDKLKGEM[Oxi]MDLQHGSLFLQTPK.4|SLADELALVDVLEDKLKGEMMDLQHGSLFLQTPK.4|LIAPVAEEEATVPNNK.2|LIAPVAEEEATVPNNK.3|KSADTLWDIQK.3|KSADTLWDIQK.2|LKDDEVAQLKK.3|LKDDEVAQLKK.2|DDEVAQLK.2|FIIPQIVK.2|GEMMDLQHGSLFLQTPK.4|GEMMDLQHGSLFLQTPK.3|GEM[Oxi]MDLQHGSLFLQTPK.3|GEMM[Oxi]DLQHGSLFLQTPK.3|GEM[Oxi]M[Oxi]DLQHGSLFLQTPK.3|GEMMDLQHGSLFLQTPK.2|GEM[Oxi]MDLQHGSLFLQTPK.2|GLTSVINQK.2|DYSVTANSK.2|MVVESAYEVIKLK.3|IHPVSTMVK.2|IHPVSTM[Oxi]VK.1|IVADKDYSVTANSK.3|IVADKDYSVTANSK.2|HRVIGSGC[CAM]NLDSAR.3|HRVIGSGC[CAM]NLDSAR.2|SADTLWDIQKDLK.3|SADTLWDIQKDLK.2|LKGEMMDLQHGSLFLQTPK.4|LKGEM[Oxi]M[Oxi]DLQHGSLFLQTPK.4|LKGEM[Oxi]MDLQHGSLFLQTPK.4|LKGEMM[Oxi]DLQHGSLFLQTPK.4|LKGEMMDLQHGSLFLQTPK.3|LKGEM[Oxi]MDLQHGSLFLQTPK.3|LKGEMM[Oxi]DLQHGSLFLQTPK.3|LKGEMMDLQHGSLFLQTPK.2|SLADELALVDVLEDK.3|SLADELALVDVLEDK.2|NVNVFKFIIPQIVK.3|IVVVTAGVRQQEGESR.3|LKDDEVAQLK.2|SADTLWDIQKDLKDL.3|SADTLWDIQKDLKDL.2|SADTLWDIQK.2|IVVVTAGVRQQEGESRLNLVQR.4|SLADELALVDVLEDKLK.3|SLADELALVDVLEDKLK.2|EKLIAPVAEEEATVPNNK.3|EKLIAPVAEEEATVPNNK.2|ITVVGVGQVGMAC[CAM]AISILGK.3|ITVVGVGQVGM[Oxi]AC[CAM]AISILGK.3|ITVVGVGQVGM[Oxi]AC[CAM]AISILGK.2|ITVVGVGQVGMAC[CAM]AISILGK.2|GYTNWAIGLSVADLIESM[Oxi]LK.3|LKGYTNWAIGLSVADLIESM[Oxi]LKNLSR.4|LKGYTNWAIGLSVADLIESM[Oxi]LK.3|YSPDC[CAM]IIIVVSNPVDILTYVTWK.3|LIAPVAEEEATVPNNKITVVGVGQVGMAC[CAM]AISILGK.4|EKLIAPVAEEEATVPNNKITVVGVGQVGMAC[CAM]AISILGK.4|LGIHPSSC[CAM]HGWILGEHGDSSVAVWSGVNVAGVSLQELNPEMGTDNDSENWK.5
SEN / CTL,P55290,Cadherin-13,CDH13,1.26,0.92,4.58E-03,1.39E-03,2.86E+00,"mitotic cell cycle,positive regulation of endothelial cell proliferation,positive regulation of cell-matrix adhesion,sprouting angiogenesis,homophilic cell adhesion via plasma membrane adhesion molecules,negative regulation of cell adhesion,Rho protein signal transduction,negative regulation of cell proliferation,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,Rac protein signal transduction,lamellipodium assembly,regulation of endocytosis,positive regulation of cell migration,adherens junction organization,regulation of epidermal growth factor receptor signaling pathway,endothelial cell migration,keratinocyte proliferation,positive regulation of transcription from RNA polymerase II promoter,positive regulation of smooth muscle cell proliferation,positive regulation of calcium-mediated signaling,positive regulation of positive chemotaxis,localization within membrane,low-density lipoprotein particle mediated signaling","calcium ion binding,low-density lipoprotein particle binding,protein homodimerization activity,cadherin binding,adiponectin binding,lipoprotein particle binding","extracellular space,cytoplasm,plasma membrane,caveola,focal adhesion,external side of plasma membrane,anchored component of membrane,neuron projection,perinuclear region of cytoplasm,extracellular exosome",9,7,9,SIVVSPILIPENQR.2|DIQGSLQDIFK.2|TLEGPVPLEVIVIDQNDNRPIFR.3|TLEGPVPLEVIVIDQNDNRPIFR.4|DLHPNTDPFKFEIHK.4|TLDREVIAVYQLFVETTDVNGK.4|TLDREVIAVYQLFVETTDVNGK.3|INENTGSVSVTR.2|SIVVSPILIPENQRQPFPR.3
SEN / CTL,P08603,Complement factor H,CFH,1.26,1.09,1.60E-12,2.43E-12,1.16E+01,"complement activation,complement activation, alternative pathway,regulation of complement activation","protein binding,heparin binding,heparan sulfate proteoglycan binding","extracellular region,extracellular space,extracellular exosome,blood microparticle",42,65,114,C[CAM]FEGFGIDGPAIAK.2|EIMENYNIALR.2|EIMENYNIALR.3|EIM[Oxi]ENYNIALR.2|RPC[CAM]GHPGDTPFGTFTLTGGNVFEYGVK.4|RPC[CAM]GHPGDTPFGTFTLTGGNVFEYGVK.5|RPC[CAM]GHPGDTPFGTFTLTGGNVFEYGVK.3|AGEQVTYTC[CAM]ATYYK.2|AGEQVTYTC[CAM]ATYYK.3|SSNLIILEEHLK.3|SSNLIILEEHLK.2|LSYTC[CAM]EGGFR.2|DTSC[CAM]VNPPTVQNAYIVSR.2|DTSC[CAM]VNPPTVQNAYIVSR.3|DTSC[CAM]VNPPTVQNAYIVSR.4|SITC[CAM]IHGVWTQLPQC[CAM]VAIDK.3|SITC[CAM]IHGVWTQLPQC[CAM]VAIDK.4|SITC[CAM]IHGVWTQLPQC[CAM]VAIDK.2|FSC[CAM]KPGFTIVGPNSVQC[CAM]YHFGLSPDLPIC[CAM]K.4|FSC[CAM]KPGFTIVGPNSVQC[CAM]YHFGLSPDLPIC[CAM]K.3|TTC[CAM]WDGKLEYPTC[CAM]AK.3|TTC[CAM]WDGKLEYPTC[CAM]AK.2|TGESVEFVC[CAM]K.2|TGDEITYQC[CAM]R.2|IVSSAMEPDREYHFGQAVR.4|IVSSAM[Oxi]EPDREYHFGQAVR.4|IVSSAM[Oxi]EPDREYHFGQAVR.3|IVSSAMEPDREYHFGQAVR.3|HGGLYHENMR.3|HGGLYHENM[Oxi]R.3|WQSIPLC[CAM]VEK.3|WQSIPLC[CAM]VEK.2|KGEWVALNPLR.3|KGEWVALNPLR.2|SC[CAM]DIPVFMNAR.3|SC[CAM]DIPVFMNAR.2|SC[CAM]DIPVFM[Oxi]NAR.2|TGESVEFVC[CAM]KR.3|TGESVEFVC[CAM]KR.2|C[CAM]VEISC[CAM]K.2|EC[CAM]ELPKIDVHLVPDR.4|KGEWVALNPLRK.3|EGWIHTVC[CAM]INGR.3|NDFTWFK.2|FVC[CAM]NSGYK.2|C[CAM]TLKPC[CAM]DYPDIK.3|C[CAM]TLKPC[CAM]DYPDIK.2|EKTKEEYGHSEVVEYYC[CAM]NPR.5|EKTKEEYGHSEVVEYYC[CAM]NPR.4|EKTKEEYGHSEVVEYYC[CAM]NPR.3|SIDVAC[CAM]HPGYALPK.3|SIDVAC[CAM]HPGYALPK.2|IDVHLVPDR.2|SITC[CAM]IHGVWTQLPQC[CAM]VAIDKLKK.5|IVSSAMEPDR.2|TKEEYGHSEVVEYYC[CAM]NPR.4|TKEEYGHSEVVEYYC[CAM]NPR.3|SLGNVIMVC[CAM]R.2|SLGNVIM[Oxi]VC[CAM]R.2|GEWVALNPLR.2|SPPEISHGVVAHMSDSYQYGEEVTYK.5|SPPEISHGVVAHM[Oxi]SDSYQYGEEVTYK.4|SPPEISHGVVAHMSDSYQYGEEVTYK.4|SPPEISHGVVAHMSDSYQYGEEVTYK.3|C[CAM]LPVTAPENGK.2|TKNDFTWFK.2|SSQESYAHGTK.2|LGYVTADGETSGSITC[CAM]GK.3|LGYVTADGETSGSITC[CAM]GK.2|C[CAM]TSTGWIPAPR.2|GDAVC[CAM]TESGWR.2|SC[CAM]DNPYIPNGDYSPLR.3|SC[CAM]DNPYIPNGDYSPLR.2|KEFDHNSNIR.2|DGWSAQPTC[CAM]IK.2|AQTTVTC[CAM]MENGWSPTPR.3|AQTTVTC[CAM]MENGWSPTPR.2|AQTTVTC[CAM]M[Oxi]ENGWSPTPR.2|NTEILTGSWSDQTYPEGTQAIYK.4|NTEILTGSWSDQTYPEGTQAIYK.3|C[CAM]NMGYEYSER.2|C[CAM]NM[Oxi]GYEYSER.2|EQVQSC[CAM]GPPPELLNGNVK.3|EQVQSC[CAM]GPPPELLNGNVK.2|EEYGHSEVVEYYC[CAM]NPR.3|SPDVINGSPISQK.2|TDC[CAM]LSLPSFENAIPM[Oxi]GEK.3|TDC[CAM]LSLPSFENAIPMGEK.3|TDC[CAM]LSLPSFENAIPMGEK.2|TDC[CAM]LSLPSFENAIPM[Oxi]GEK.2|IEGDEEM[Oxi]HC[CAM]SDDGFWSK.3|IEGDEEMHC[CAM]SDDGFWSK.3|IEGDEEMHC[CAM]SDDGFWSK.2|TDC[CAM]LSLPSFENAIPMGEKK.3|AVYTC[CAM]NEGYQLLGEINYR.3|AVYTC[CAM]NEGYQLLGEINYR.2|EC[CAM]DTDGWTNDIPIC[CAM]EVVK.3|EC[CAM]DTDGWTNDIPIC[CAM]EVVK.2|GDAVC[CAM]TESGWRPLPSC[CAM]EEK.3|GDAVC[CAM]TESGWRPLPSC[CAM]EEK.2|PGFTIVGPNSVQC[CAM]YHFGLSPDLPIC[CAM]K.4|PGFTIVGPNSVQC[CAM]YHFGLSPDLPIC[CAM]K.3|FVC[CAM]NSGYKIEGDEEMHC[CAM]SDDGFWSK.4|SSIDIENGFISESQYTYALK.3|SSIDIENGFISESQYTYALK.2|YYSYYC[CAM]DEHFETPSGSYWDHIHC[CAM]TQDGWSPAVPC[CAM]LR.6|YYSYYC[CAM]DEHFETPSGSYWDHIHC[CAM]TQDGWSPAVPC[CAM]LR.5|YYSYYC[CAM]DEHFETPSGSYWDHIHC[CAM]TQDGWSPAVPC[CAM]LR.4|HRTGDEITYQC[CAM]R.2|WSSPPQC[CAM]EGLPC[CAM]K.2|ISEENETTC[CAM]YMGK.2|VSVLC[CAM]QENYLIQEGEEITC[CAM]K.3|VSVLC[CAM]QENYLIQEGEEITC[CAM]KDGR.3|RNTEILTGSWSDQTYPEGTQAIYK.3
SEN / CTL,O60568,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",PLOD3,1.25,1.51,6.64E-03,1.90E-03,2.72E+00,"in utero embryonic development,endothelial cell morphogenesis,protein localization,neural tube development,collagen fibril organization,cellular response to hormone stimulus,vasodilation,epidermis morphogenesis,oxidation-reduction process,lung morphogenesis,basement membrane assembly","iron ion binding,protein binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding,procollagen glucosyltransferase activity,procollagen galactosyltransferase activity","endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",24,41,68,VFLAVFVEQPTPFLPR.3|VFLAVFVEQPTPFLPR.2|QVGYEDQWLQLLR.2|QVGYEDQWLQLLR.3|VGVWNVPYISQAYVIR.3|VGVWNVPYISQAYVIR.2|FLNSGGFIGFATTIHQIVR.3|FLNSGGFIGFATTIHQIVR.2|LAGGYENVPTVDIHMK.3|LAGGYENVPTVDIHMK.2|SEDYVELVQR.2|GIFLHLSNQHEFGR.4|GIFLHLSNQHEFGR.3|GIFLHLSNQHEFGR.2|LTHYHEGLPTTWGTR.4|LTHYHEGLPTTWGTR.3|VIAPMLSR.2|AVMNFVVR.2|AVM[Oxi]NFVVR.2|LSLNLDHK.2|DKGIFLHLSNQHEFGR.4|DKGIFLHLSNQHEFGR.3|LYLDPGLR.2|NVAYDTLPIVVHGNGPTK.4|NVAYDTLPIVVHGNGPTK.3|NVAYDTLPIVVHGNGPTK.2|GWALLHPGR.2|DMAMDLC[CAM]R.2|GRDPVNPEK.2|TLPGGQPPPR.2|TLGLGEEWR.2|YRPDEQPSLRPHHDSSTFTLNVALNHK.6|YRPDEQPSLRPHHDSSTFTLNVALNHK.5|YRPDEQPSLRPHHDSSTFTLNVALNHK.4|TLGLGEEWRGGDVAR.3|GLDYEGGGC[CAM]R.2|IRNVAYDTLPIVVHGNGPTK.4|YDC[CAM]VISSPR.2|IFQNLNGALDEVVLK.3|IFQNLNGALDEVVLK.2|YKDDDDDQLFYTR.3|YKDDDDDQLFYTR.2|LLVITVATAETEGYLR.3|LLVITVATAETEGYLR.2|DVFSGSDTDPDMAFC[CAM]K.3|DVFSGSDTDPDMAFC[CAM]K.2|DVFSGSDTDPDM[Oxi]AFC[CAM]K.2|LLLLDYPPDR.2|VTLFLHNNEVFHEPHIADSWPQLQDHFSAVK.6|VTLFLHNNEVFHEPHIADSWPQLQDHFSAVK.5|VTLFLHNNEVFHEPHIADSWPQLQDHFSAVK.4|TYVGPMTESLFPGYHTK.3|TYVGPM[Oxi]TESLFPGYHTK.3|TYVGPM[Oxi]TESLFPGYHTK.2|YDTEHLHPDLWQIFDNPVDWK.4|YDTEHLHPDLWQIFDNPVDWK.3|RVGVWNVPYISQAYVIR.3|GRDPVNPEKLLVITVATAETEGYLR.4|LWSNFWGALSPDEYYAR.3|LWSNFWGALSPDEYYAR.2|IFQNLNGALDEVVLKFDR.3|LVGPEEALSPGEAR.2|RFLNSGGFIGFATTIHQIVR.3|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGK.4|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGK.3|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGKR.4|LLFSAESFC[CAM]WPEWGLAEQYPEVGTGKR.3|LQLNYLGNYVPNGWTPEGGC[CAM]GFC[CAM]NQDRR.3
SEN / CTL,P63104,14-3-3 protein zeta/delta,YWHAZ,1.25,1.21,3.06E-07,1.94E-07,6.71E+00,"protein targeting,signal transduction,platelet activation,negative regulation of apoptotic process,regulation of mRNA stability,establishment of Golgi localization,membrane organization,Golgi reassembly,cell-cell adhesion,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway","protein binding,transcription factor binding,protein kinase binding,protein domain specific binding,ubiquitin protein ligase binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","extracellular space,nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,focal adhesion,cytoplasmic vesicle membrane,melanosome,extracellular exosome,blood microparticle",24,22,53,IETELRDIC[CAM]NDVLSLLEK.3|IETELRDIC[CAM]NDVLSLLEK.4|IETELRDIC[CAM]NDVLSLLEK.2|DIC[CAM]NDVLSLLEK.2|DIC[CAM]NDVLSLLEK.3|EKIETELRDIC[CAM]NDVLSLLEK.4|EKIETELRDIC[CAM]NDVLSLLEK.3|GIVDQSQQAYQEAFEISKK.3|GIVDQSQQAYQEAFEISKK.4|GIVDQSQQAYQEAFEISKK.2|SVTEQGAELSNEER.2|SVTEQGAELSNEER.3|LAEQAERYDDMAAC[CAM]MK.3|LAEQAERYDDM[Oxi]AAC[CAM]MK.3|LAEQAERYDDMAAC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]AAC[CAM]M[Oxi]K.3|LAEQAERYDDM[Oxi]AAC[CAM]MK.2|LAEQAERYDDMAAC[CAM]M[Oxi]K.2|LAEQAERYDDMAAC[CAM]MK.2|FLIPNASQAESK.2|FLIPNASQAESK.3|VVSSIEQKTEGAEKK.4|VVSSIEQKTEGAEKK.3|VVSSIEQKTEGAEKK.2|YLAEVAAGDDKK.3|YLAEVAAGDDKK.2|VVSSIEQK.2|VVSSIEQKTEGAEK.3|VVSSIEQKTEGAEK.2|AKLAEQAERYDDMAAC[CAM]MK.4|AKLAEQAERYDDM[Oxi]AAC[CAM]MK.3|AKLAEQAERYDDMAAC[CAM]M[Oxi]K.3|AKLAEQAERYDDMAAC[CAM]MK.3|KGIVDQSQQAYQEAFEISK.4|KGIVDQSQQAYQEAFEISK.3|KGIVDQSQQAYQEAFEISK.2|YDDMAAC[CAM]MK.2|YDDM[Oxi]AAC[CAM]MK.2|YDDMAAC[CAM]M[Oxi]K.2|YDDM[Oxi]AAC[CAM]M[Oxi]K.2|KGIVDQSQQAYQEAFEISKK.4|KGIVDQSQQAYQEAFEISKK.3|YLAEVAAGDDK.2|GIVDQSQQAYQEAFEISK.3|GIVDQSQQAYQEAFEISK.2|TAFDEAIAELDTLSEESYK.3|TAFDEAIAELDTLSEESYK.2|SVTEQGAELSNEERNLLSVAYKNVVGAR.4|SVTEQGAELSNEERNLLSVAYKNVVGAR.3|DNLTLWTSDTQGDEAEAGEGGEN.3|SVTEQGAELSNEERNLLSVAYK.3|YLAEVAAGDDKKGIVDQSQQAYQEAFEISK.4|YLAEVAAGDDKKGIVDQSQQAYQEAFEISK.3
SEN / CTL,Q99497,Protein deglycase DJ-1,PARK7,1.24,0.96,4.76E-04,1.87E-04,3.73E+00,"negative regulation of protein phosphorylation,negative regulation of protein kinase activity,proteolysis,protein deglycosylation,autophagy,inflammatory response,mitochondrion organization,Ras protein signal transduction,single fertilization,adult locomotory behavior,methylglyoxal metabolic process,detoxification of copper ion,positive regulation of gene expression,negative regulation of gene expression,enzyme active site formation via L-cysteine sulfinic acid,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,lactate biosynthetic process,negative regulation of protein ubiquitination,negative regulation of protein binding,activation of protein kinase B activity,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,positive regulation of interleukin-8 production,positive regulation of peptidyl-serine phosphorylation,negative regulation of protein sumoylation,cellular response to oxidative stress,cellular response to glyoxal,peptidyl-cysteine deglycation,peptidyl-arginine deglycation,peptidyl-lysine deglycation,protein deglycation, glyoxal removal,protein deglycation, methylglyoxal removal,glutathione deglycation,hydrogen peroxide metabolic process,negative regulation of apoptotic process,regulation of neuron apoptotic process,negative regulation of neuron apoptotic process,positive regulation of transcription from RNA polymerase II promoter,glycolate biosynthetic process,negative regulation of protein export from nucleus,regulation of inflammatory response,detoxification of mercury ion,protein stabilization,positive regulation of sequence-specific DNA binding transcription factor activity,negative regulation of ubiquitin-protein transferase activity,dopamine uptake involved in synaptic transmission,regulation of mitochondrial membrane potential,positive regulation of protein kinase B signaling,membrane depolarization,membrane hyperpolarization,negative regulation of cell death,regulation of androgen receptor signaling pathway,cellular response to hydrogen peroxide,positive regulation of protein homodimerization activity,cell-cell adhesion,cellular oxidant detoxification,positive regulation of protein localization to nucleus,negative regulation of neuron death,positive regulation of superoxide dismutase activity,negative regulation of protein acetylation,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,regulation of fibril organization,positive regulation of mitochondrial electron transport, NADH to ubiquinone,negative regulation of death-inducing signaling complex assembly,negative regulation of protein K48-linked deubiquitination,negative regulation of TRAIL-activated apoptotic signaling pathway,positive regulation of pyrroline-5-carboxylate reductase activity,positive regulation of tyrosine 3-monooxygenase activity,positive regulation of dopamine biosynthetic process,glyoxal metabolic process,glyoxal catabolic process,positive regulation of L-dopa biosynthetic process,positive regulation of L-dopa decarboxylase activity,negative regulation of oxidative stress-induced cell death,negative regulation of hydrogen peroxide-induced cell death,negative regulation of hydrogen peroxide-induced neuron death,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,positive regulation of reactive oxygen species biosynthetic process,positive regulation of mitophagy,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,negative regulation of ubiquitin-specific protease activity,positive regulation of oxidative phosphorylation uncoupler activity,positive regulation of transcription regulatory region DNA binding,positive regulation of androgen receptor activity,negative regulation of extrinsic apoptotic signaling pathway,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,regulation of TRAIL receptor biosynthetic process","transcription coactivator activity,mRNA binding,receptor binding,copper ion binding,protein binding,transcription factor binding,peptidase activity,superoxide dismutase copper chaperone activity,oxidoreductase activity, acting on peroxide as acceptor,glyoxalase III activity,enzyme binding,kinase binding,cytokine binding,tyrosine 3-monooxygenase activator activity,L-dopa decarboxylase activator activity,protein deglycase activity,identical protein binding,protein homodimerization activity,small protein activating enzyme binding,ubiquitin-like protein conjugating enzyme binding,mercury ion binding,androgen receptor binding,peroxiredoxin activity,repressing transcription factor binding,scaffold protein binding,cadherin binding involved in cell-cell adhesion,cupric ion binding,cuprous ion binding,ubiquitin-specific protease binding,glyoxalase (glycolic acid-forming) activity,core promoter binding,double-stranded DNA binding,single-stranded DNA binding","chromatin,nucleus,cytoplasm,mitochondrion,mitochondrial intermembrane space,mitochondrial matrix,endoplasmic reticulum,cytosol,plasma membrane,cell-cell adherens junction,PML body,axon,cell body,membrane raft,perinuclear region of cytoplasm,extracellular exosome,presynapse,mitochondrial respiratory chain complex I",12,27,55,GAEEMETVIPVDVMR.2|GAEEMETVIPVDVMR.3|GAEEMETVIPVDVM[Oxi]R.3|GAEEM[Oxi]ETVIPVDVMR.2|GAEEMETVIPVDVM[Oxi]R.2|GAEEM[Oxi]ETVIPVDVM[Oxi]R.2|AGIKVTVAGLAGKDPVQC[CAM]SR.4|AGIKVTVAGLAGKDPVQC[CAM]SR.3|GLIAAIC[CAM]AGPTALLAHEIGFGSK.3|GLIAAIC[CAM]AGPTALLAHEIGFGSK.4|GLIAAIC[CAM]AGPTALLAHEIGFGSK.2|VTVAGLAGK.2|VTVAGLAGKDPVQC[CAM]SR.4|VTVAGLAGKDPVQC[CAM]SR.3|VTVAGLAGKDPVQC[CAM]SR.2|DVVIC[CAM]PDASLEDAKK.4|DVVIC[CAM]PDASLEDAKK.3|DVVIC[CAM]PDASLEDAKK.2|DPVQC[CAM]SR.2|VTTHPLAK.2|DGLILTSR.2|RALVILAK.2|DKMMNGGHYTYSENR.4|DKMMNGGHYTYSENR.3|M[Oxi]MNGGHYTYSENRVEK.4|MMNGGHYTYSENRVEK.3|M[Oxi]MNGGHYTYSENRVEK.3|MM[Oxi]NGGHYTYSENRVEK.3|DVVIC[CAM]PDASLEDAK.3|DVVIC[CAM]PDASLEDAK.2|MMNGGHYTYSENR.3|M[Oxi]M[Oxi]NGGHYTYSENR.3|M[Oxi]MNGGHYTYSENR.3|MM[Oxi]NGGHYTYSENR.3|M[Oxi]MNGGHYTYSENR.2|MMNGGHYTYSENR.2|EILKEQENR.2|KGLIAAIC[CAM]AGPTALLAHEIGFGSK.4|KGLIAAIC[CAM]AGPTALLAHEIGFGSK.3|GAEEMETVIPVDVMRR.3|GAEEM[Oxi]ETVIPVDVM[Oxi]RR.3|GAEEMETVIPVDVM[Oxi]RR.3|VEKDGLILTSR.2|EGPYDVVVLPGGNLGAQNLSESAAVK.4|EGPYDVVVLPGGNLGAQNLSESAAVK.3|GPGTSFEFALAIVEALNGK.3|GPGTSFEFALAIVEALNGK.2|GPGTSFEFALAIVEALNGKEVAAQVK.4|GPGTSFEFALAIVEALNGKEVAAQVK.3|MMNGGHYTYSENRVEKDGLILTSR.4|DGLILTSRGPGTSFEFALAIVEALNGKEVAAQVK.4|KEGPYDVVVLPGGNLGAQNLSESAAVK.3|EGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENR.4|EGPYDVVVLPGGNLGAQNLSESAAVKEILK.3|DVVIC[CAM]PDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVK.4
SEN / CTL,P07711,Cathepsin L1,CTSL,1.23,0.78,1.84E-02,4.74E-03,2.32E+00,"toll-like receptor signaling pathway,adaptive immune response,proteolysis,antigen processing and presentation,antigen processing and presentation of exogenous peptide antigen via MHC class II,extracellular matrix disassembly,collagen catabolic process,proteolysis involved in cellular protein catabolic process,macrophage apoptotic process,cellular response to thyroid hormone stimulus","fibronectin binding,cysteine-type endopeptidase activity,serine-type endopeptidase activity,protein binding,collagen binding,cysteine-type peptidase activity,histone binding,proteoglycan binding,serpin family protein binding","extracellular region,extracellular space,nucleus,lysosome,endolysosome lumen,lysosomal lumen,extracellular exosome",6,9,13,VFQEPLFYEAPR.2|VFQEPLFYEAPR.3|NSWGEEWGMGGYVK.2|NSWGEEWGM[Oxi]GGYVK.2|MIELHNQEYR.3|MIELHNQEYR.2|RNHC[CAM]GIASAASYPTV.3|LYGMNEEGWR.2|NHC[CAM]GIASAASYPTV.2|AVATVGPISVAIDAGHESFLFYK.3|AVATVGPISVAIDAGHESFLFYK.2|NQGQC[CAM]GSC[CAM]WAFSATGALEGQMFR.3|NQGQC[CAM]GSC[CAM]WAFSATGALEGQMFRK.3
SEN / CTL,P55072,Transitional endoplasmic reticulum ATPase,VCP,1.22,1.68,1.20E-10,1.31E-10,9.88E+00,"DNA repair,double-strand break repair,NADH metabolic process,ER to Golgi vesicle-mediated transport,autophagy,activation of cysteine-type endopeptidase activity involved in apoptotic process,cellular response to DNA damage stimulus,positive regulation of mitochondrial membrane potential,protein ubiquitination,protein N-linked glycosylation via asparagine,viral genome replication,translesion synthesis,ER-associated ubiquitin-dependent protein catabolic process,endoplasmic reticulum unfolded protein response,retrograde protein transport, ER to cytosol,positive regulation of protein complex assembly,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,protein hexamerization,ERAD pathway,regulation of apoptotic process,proteasome-mediated ubiquitin-dependent protein catabolic process,establishment of protein localization,positive regulation of protein catabolic process,ATP metabolic process,protein homooligomerization,aggresome assembly,error-free translesion synthesis,ER-associated misfolded protein catabolic process,flavin adenine dinucleotide catabolic process,autophagosome maturation,positive regulation of protein K63-linked deubiquitination,positive regulation of Lys63-specific deubiquitinase activity,regulation of aerobic respiration,positive regulation of oxidative phosphorylation,positive regulation of ubiquitin-specific protease activity,positive regulation of ATP biosynthetic process","protein binding,ATP binding,lipid binding,ATPase activity,protein phosphatase binding,protein domain specific binding,polyubiquitin binding,ubiquitin protein ligase binding,deubiquitinase activator activity,K48-linked polyubiquitin binding,MHC class I protein binding,identical protein binding,ADP binding,ubiquitin-like protein ligase binding,poly(A) RNA binding,BAT3 complex binding,ubiquitin-specific protease binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,endoplasmic reticulum,endoplasmic reticulum membrane,lipid particle,cytosol,VCP-NPL4-UFD1 AAA ATPase complex,site of double-strand break,Derlin-1 retrotranslocation complex,myelin sheath,intracellular membrane-bounded organelle,perinuclear region of cytoplasm,extracellular exosome,VCP-NSFL1C complex",42,94,187,LGDVISIQPC[CAM]PDVK.2|LGDVISIQPC[CAM]PDVK.3|LIVDEAINEDNSVVSLSQPK.3|LIVDEAINEDNSVVSLSQPK.2|QAAPC[CAM]VLFFDELDSIAK.3|QAAPC[CAM]VLFFDELDSIAK.2|MDELQLFR.2|M[Oxi]DELQLFR.2|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.4|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIR.6|IVSQLLTLMDGLK.2|IVSQLLTLMDGLK.3|IVSQLLTLM[Oxi]DGLK.2|RIVSQLLTLMDGLK.3|RIVSQLLTLM[Oxi]DGLK.2|RIVSQLLTLMDGLK.2|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.5|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.6|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.4|ETVVEVPQVTWEDIGGLEDVKR.3|ETVVEVPQVTWEDIGGLEDVKR.4|VRLGDVISIQPC[CAM]PDVK.3|VRLGDVISIQPC[CAM]PDVK.2|KNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.6|KNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.5|ELQELVQYPVEHPDKFLK.4|ELQELVQYPVEHPDKFLK.3|LAGESESNLRK.3|LAGESESNLRK.2|RDHFEEAM[Oxi]R.3|RDHFEEAMR.2|AFEEAEK.2|GDIFLVR.2|AIGVKPPR.2|EMVELPLRHPALFK.4|EM[Oxi]VELPLRHPALFK.4|EMVELPLRHPALFK.3|EM[Oxi]VELPLRHPALFK.3|EM[Oxi]VELPLRHPALFK.2|EMVELPLRHPALFK.2|GVLFYGPPGC[CAM]GK.3|GVLFYGPPGC[CAM]GK.2|WALSQSNPSALR.3|WALSQSNPSALR.2|ARGGNIGDGGGAADR.3|ARGGNIGDGGGAADR.2|ELQELVQYPVEHPDK.4|ELQELVQYPVEHPDK.3|ELQELVQYPVEHPDK.2|SVSDNDIR.2|AHVIVM[Oxi]AATNRPNSIDPALRR.5|AHVIVMAATNRPNSIDPALRR.5|AHVIVMAATNRPNSIDPALRR.4|AHVIVMAATNRPNSIDPALRR.3|KGDIFLVR.2|PYFLEAYRPIR.3|ESIESEIR.2|EMVELPLR.2|RELQELVQYPVEHPDK.4|RELQELVQYPVEHPDK.3|RELQELVQYPVEHPDK.2|FGRFDREVDIGIPDATGR.4|NVFIIGATNRPDIIDPAILRPGR.5|NVFIIGATNRPDIIDPAILRPGR.4|NVFIIGATNRPDIIDPAILRPGR.3|GDDLSTAILK.2|SPVAKDVDLEFLAK.3|DHFEEAMR.2|DHFEEAM[Oxi]R.2|AIANEC[CAM]QANFISIK.3|AIANEC[CAM]QANFISIK.2|DVDLEFLAK.2|KNVFIIGATNRPDIIDPAILRPGR.5|KNVFIIGATNRPDIIDPAILRPGR.4|RSVSDNDIR.2|AHVIVMAATNRPNSIDPALR.4|AHVIVM[Oxi]AATNRPNSIDPALR.4|AHVIVM[Oxi]AATNRPNSIDPALR.3|AHVIVMAATNRPNSIDPALR.3|LAGESESNLR.2|KYEMFAQTLQQSR.3|KYEM[Oxi]FAQTLQQSR.3|KYEMFAQTLQQSR.2|KYEM[Oxi]FAQTLQQSR.2|FDREVDIGIPDATGRLEILQIHTK.5|FDREVDIGIPDATGRLEILQIHTK.4|FDREVDIGIPDATGRLEILQIHTK.3|LEILQIHTK.2|ESIESEIRR.2|FDREVDIGIPDATGR.3|FDREVDIGIPDATGR.2|GGNIGDGGGAADR.2|VINQILTEMDGMSTK.3|VINQILTEMDGM[Oxi]STK.3|VINQILTEM[Oxi]DGMSTK.2|VINQILTEMDGM[Oxi]STK.2|VINQILTEMDGMSTK.2|VINQILTEM[Oxi]DGM[Oxi]STK.2|IVSQLLTLMDGLKQR.3|EVDIGIPDATGRLEILQIHTK.4|EVDIGIPDATGRLEILQIHTK.3|QTNPSAMEVEEDDPVPEIRR.4|QTNPSAMEVEEDDPVPEIRR.3|GILLYGPPGTGK.2|MDELQLFRGDTVLLK.3|M[Oxi]DELQLFRGDTVLLK.3|M[Oxi]DELQLFRGDTVLLK.2|MDELQLFRGDTVLLK.2|LDQLIYIPLPDEKSR.3|MTNGFSGADLTEIC[CAM]QR.3|M[Oxi]TNGFSGADLTEIC[CAM]QR.3|M[Oxi]TNGFSGADLTEIC[CAM]QR.2|MTNGFSGADLTEIC[CAM]QR.2|NAPAIIFIDELDAIAPK.3|NAPAIIFIDELDAIAPK.2|VINQILTEMDGMSTKK.3|VINQILTEMDGM[Oxi]STKK.3|VINQILTEMDGMSTKK.2|EAVC[CAM]IVLSDDTC[CAM]SDEK.3|EAVC[CAM]IVLSDDTC[CAM]SDEK.2|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.7|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.6|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSR.5|EVDIGIPDATGR.2|REDEEESLNEVGYDDIGGC[CAM]RK.4|REDEEESLNEVGYDDIGGC[CAM]RK.3|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.6|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.5|LADDVDLEQVANETHGHVGADLAALC[CAM]SEAALQAIRK.4|GPELLTMWFGESEANVR.3|GPELLTM[Oxi]WFGESEANVR.3|GPELLTMWFGESEANVR.2|GPELLTM[Oxi]WFGESEANVR.2|IHVLPIDDTVEGITGNLFEVYLK.4|IHVLPIDDTVEGITGNLFEVYLK.3|ERQTNPSAMEVEEDDPVPEIRR.4|ERQTNPSAMEVEEDDPVPEIRR.3|NAPAIIFIDELDAIAPKR.3|NAPAIIFIDELDAIAPKR.2|REAVC[CAM]IVLSDDTC[CAM]SDEK.3|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.6|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.5|NVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEK.4|KAFEEAEKNAPAIIFIDELDAIAPK.4|KAFEEAEKNAPAIIFIDELDAIAPK.3|RIHVLPIDDTVEGITGNLFEVYLK.4|RIHVLPIDDTVEGITGNLFEVYLK.3|AFEEAEKNAPAIIFIDELDAIAPKR.4|AFEEAEKNAPAIIFIDELDAIAPKR.3|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRK.6|IHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRK.5|RIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.6|RIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIR.5|EAVC[CAM]IVLSDDTC[CAM]SDEKIR.3|NRPNRLIVDEAINEDNSVVSLSQPK.4|ARQAAPC[CAM]VLFFDELDSIAK.3|QTNPSAM[Oxi]EVEEDDPVPEIR.3|QTNPSAMEVEEDDPVPEIR.3|QTNPSAMEVEEDDPVPEIR.2|EDEEESLNEVGYDDIGGC[CAM]R.3|EDEEESLNEVGYDDIGGC[CAM]R.2|GGNIGDGGGAADRVINQILTEMDGMSTKK.4|ARGGNIGDGGGAADRVINQILTEMDGM[Oxi]STK.4|ARGGNIGDGGGAADRVINQILTEMDGMSTK.4|AVANETGAFFFLINGPEIMSK.3|AVANETGAFFFLINGPEIM[Oxi]SK.3|AVANETGAFFFLINGPEIM[Oxi]SK.2|AVANETGAFFFLINGPEIMSK.2|YEMFAQTLQQSR.2|EDEEESLNEVGYDDIGGC[CAM]RK.3|EDEEESLNEVGYDDIGGC[CAM]RK.2|LDQLIYIPLPDEK.2|VVETDPSPYC[CAM]IVAPDTVIHC[CAM]EGEPIKR.4|ETVVEVPQVTWEDIGGLEDVK.3|ETVVEVPQVTWEDIGGLEDVK.2|REDEEESLNEVGYDDIGGC[CAM]R.3|REDEEESLNEVGYDDIGGC[CAM]R.2|ERQTNPSAMEVEEDDPVPEIR.3|ERQTNPSAM[Oxi]EVEEDDPVPEIR.3|GPELLTM[Oxi]WFGESEANVREIFDK.3|AFEEAEKNAPAIIFIDELDAIAPK.3|GGNIGDGGGAADRVINQILTEMDGMSTK.3|WALSQSNPSALRETVVEVPQVTWEDIGGLEDVKR.4|VVETDPSPYC[CAM]IVAPDTVIHC[CAM]EGEPIK.3|FPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG.3|AIANEC[CAM]QANFISIKGPELLTM[Oxi]WFGESEANVR.3
SEN / CTL,P14543,Nidogen-1,NID1,1.22,1.68,2.56E-08,2.07E-08,7.68E+00,"cell-matrix adhesion,positive regulation of cell-substrate adhesion,extracellular matrix disassembly,extracellular matrix organization,glomerular basement membrane development,basement membrane organization","calcium ion binding,collagen binding,laminin binding,laminin-1 binding,proteoglycan binding","extracellular region,basement membrane,basal lamina,extracellular matrix,extracellular exosome,cell periphery",51,38,50,VYYREDLSPSITQR.3|VLFETDLVNPR.2|ALEGLQYPFAVTSYGK.2|ALEGLQYPFAVTSYGK.3|EGSPDALQNPC[CAM]YIGTHGC[CAM]DTNAAC[CAM]RPGPR.4|RVLFETDLVNPR.3|RVLFETDLVNPR.2|KALEGLQYPFAVTSYGK.3|KALEGLQYPFAVTSYGK.2|IFVGSSQVPIVFENTDLHSYVVMNHGR.4|IFVGSSQVPIVFENTDLHSYVVM[Oxi]NHGR.4|TQFTC[CAM]EC[CAM]SIGFR.2|MVYWTDITEPSIGR.2|M[Oxi]VYWTDITEPSIGR.2|QAEVTFVGHPGNLVIK.3|QAEVTFVGHPGNLVIK.2|NIFWTDSNLDRIEVAK.3|NIFWTDSNLDRIEVAK.2|VIIGLAFDC[CAM]VDK.2|GFPEISFQPSSAVVVTWESVAPYQGPSRDPDQK.4|QDLGSPEGIAVDHLGR.3|QDLGSPEGIAVDHLGR.2|ASLHGGEPTTIIRQDLGSPEGIAVDHLGR.4|ASLHGGEPTTIIRQDLGSPEGIAVDHLGR.5|GIVTDSVR.2|HQC[CAM]SVHAEC[CAM]R.3|ASLHGGEPTTIIR.3|ASLHGGEPTTIIR.2|ETDAFQPHK.2|RGGADTYSVPSVLSPR.3|EYTVTEPER.2|QC[CAM]VAEGSPQR.2|GNLYWTDWNRDNPK.3|GNLYWTDWNRDNPK.2|YALSNSIGPVR.2|EYTVTEPERDGASPSR.3|AEC[CAM]LNPSQPSR.2|IETSYMDGTNR.2|NGFSITGGEFTR.2|MNSVVALDLAISK.2|M[Oxi]NSVVALDLAISK.2|NIFWTDSNLDR.2|FSGIDEHGHLTIDTELEGR.3|SNGAYNIFANDRESVENLAK.3|KENNQVPAVVAFSQGSVGFLWK.3|C[CAM]PDNTLGVDC[CAM]IEQK.2|VPQIPFGSSVHIEPYTELYHYSTSVITSSSTR.4|ESHPGLFPPTFGAVAPFLADLDTTDGLGK.3|LYGITTALSQC[CAM]PQGHNYC[CAM]SVNNGGC[CAM]THLC[CAM]LATPGSR.4|QELFPFGPGQGDLELEDGDDFVSPALELSGALR.3
SEN / CTL,P98160,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,1.21,1.10,4.48E-66,8.50E-65,6.41E+01,"retinoid metabolic process,angiogenesis,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,extracellular matrix disassembly,extracellular matrix organization,glycosaminoglycan metabolic process,lipoprotein metabolic process,cellular protein metabolic process","calcium ion binding,protein binding,protein C-terminus binding","extracellular region,basement membrane,extracellular space,Golgi lumen,plasma membrane,focal adhesion,extracellular matrix,lysosomal lumen,extracellular exosome",291,163,239,AGLSSGFIGC[CAM]VR.2|FSSGITGC[CAM]VK.2|C[CAM]LIHDGAAPISLEWK.3|LRSPVISIDPPSSTVQQGQDASFK.3|FLVHDSFWALPEQFLGNKVDSYGGSLR.4|TPSGLYLGTC[CAM]ER.2|LPAVEPTDQAQYLC[CAM]R.2|LPAVEPTDQAQYLC[CAM]R.3|VISSGSVASYVTSPQGFQFR.3|VISSGSVASYVTSPQGFQFR.2|HLISTHFAPGDFQGFALVNPQR.4|HLISTHFAPGDFQGFALVNPQR.3|FLGDKVTSYGGELR.3|FLGDKVTSYGGELR.2|LYIFQASPADAGQYVC[CAM]R.2|LYIFQASPADAGQYVC[CAM]R.3|IQNLDQSC[CAM]QGTYIC[CAM]QAHGPWGK.3|AVTLEC[CAM]VSAGEPR.2|LVSEDPINDGEWHR.3|LHLVSPADSGEYVC[CAM]R.3|LHLVSPADSGEYVC[CAM]R.2|LLSGPYFWSLPSR.2|LLSGPYFWSLPSR.3|YELGSGLAVLR.2|EFREVSEAVVDTLESEYLK.3|LEGDTLIIPR.2|IPGDQVVSVVFIK.2|IAHVELADAGQYR.3|IAHVELADAGQYR.2|HQGSELHFPSVQPSDAGVYIC[CAM]TC[CAM]R.4|HQGSELHFPSVQPSDAGVYIC[CAM]TC[CAM]R.3|LLQVTPADSGEYVC[CAM]R.2|LLQVTPADSGEYVC[CAM]R.3|AAGVPSATITWR.2|SQSVRPGADVTFIC[CAM]TAK.3|SQSVRPGADVTFIC[CAM]TAK.2|VAEGQTLDLK.2|RGSIQVDGEELVSGR.2|QPQAIITWYK.2|VPAGSAAVFPC[CAM]IASGYPTPDISWSK.3|SIGASVEFHC[CAM]AVPSDR.3|SIGASVEFHC[CAM]AVPSDR.2|RFLVHDSFWALPEQFLGNKVDSYGGSLR.5|RFLVHDSFWALPEQFLGNKVDSYGGSLR.4|LC[CAM]NEC[CAM]ADGSFHLSTR.3|LC[CAM]NEC[CAM]ADGSFHLSTR.2|C[CAM]VASNAYGVAQSVVNLSVHGPPTVSVLPEGPVWVK.4|C[CAM]VASNAYGVAQSVVNLSVHGPPTVSVLPEGPVWVK.5|AHSVEEC[CAM]RC[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.4|AHSVEEC[CAM]RC[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.5|LRLPQVSPADSGEYVC[CAM]R.3|LRLPQVSPADSGEYVC[CAM]R.2|LDVEFKPLAPDGVLLFSGGK.3|LDVEFKPLAPDGVLLFSGGK.2|VGGHLRPGIVQSGGVVR.4|VGGHLRPGIVQSGGVVR.3|EHLLMALADLDELLIR.3|EHLLMALADLDELLIR.2|EHLLM[Oxi]ALADLDELLIR.3|LHQMSVADSGEYVC[CAM]R.3|LHQMSVADSGEYVC[CAM]R.2|LHQM[Oxi]SVADSGEYVC[CAM]R.2|MASVGLSDIAMDTTVTHATSHGR.4|M[Oxi]ASVGLSDIAMDTTVTHATSHGR.4|M[Oxi]ASVGLSDIAM[Oxi]DTTVTHATSHGR.4|VVPYFTQTPYSFLPLPTIK.3|VVPYFTQTPYSFLPLPTIK.2|EHLLMALAGIDTLLIR.3|EHLLMALAGIDTLLIR.2|EHLLM[Oxi]ALAGIDTLLIR.3|TYGLMDSHAVLQISSAKPSDAGTYVC[CAM]LAQNALGTAQK.4|ALEVEEC[CAM]RC[CAM]PPGYIGLSC[CAM]QDC[CAM]APGYTR.3|HPTPLALGHFHTVTLLR.4|FLVHDSFWALPEQFLGNK.3|C[CAM]PIGYSGLSC[CAM]ESC[CAM]DAHFTR.3|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.6|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.5|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.7|AQLHGASEEPGHFSLTNAASTHTTNEGIFSPTPGELGFSSFHR.4|GMVFGIPDGVLELVPQR.3|GMVFGIPDGVLELVPQR.2|GM[Oxi]VFGIPDGVLELVPQR.3|GM[Oxi]VFGIPDGVLELVPQR.2|SIGASVEFHC[CAM]AVPSDRGTQLR.4|SIGASVEFHC[CAM]AVPSDRGTQLR.3|SGPVEDFVSLAMVGGHLEFR.3|LRLPQVSPADSGEYVC[CAM]RVENGSGPK.4|LENNMLMLPSVRPQDAGTYVC[CAM]TATNR.3|SPLPWQHRLEGDTLIIPR.4|AQASAQLVIQALPSVLINIR.3|AQASAQLVIQALPSVLINIR.2|AMDFNGILTIR.2|AM[Oxi]DFNGILTIR.2|ITFRPDSADGMLLYNGQK.3|ITFRPDSADGM[Oxi]LLYNGQK.3|C[CAM]SATGSPTPTLEWTGGPGGQLPAK.3|C[CAM]SATGSPTPTLEWTGGPGGQLPAK.2|SIEYSPQLEDAGSR.2|SIEYSPQLEDAGSR.3|FDAGSGMATIR.2|FDAGSGM[Oxi]ATIR.2|RVPGSPTNLANRQPDFISFGLVGGRPEFR.5|RVPGSPTNLANRQPDFISFGLVGGRPEFR.4|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.6|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.5|SQPGSTPLHGQPLVVLQGNNIILEHHVAQEPSPGQPSTFIVPFR.4|VVPYFTQTPYSFLPLPTIKDAYR.3|C[CAM]QVSGSPPHYFYWSR.3|C[CAM]QVSGSPPHYFYWSR.2|QPDFISFGLVGGRPEFR.3|EVSEAVVDTLESEYLK.3|EVSEAVVDTLESEYLK.2|IESSSASLANGHTLDLNC[CAM]LVASQAPHTITWYK.4|LYQASPADSGEYVC[CAM]R.3|LYQASPADSGEYVC[CAM]R.2|QVQFSEEHWVHESGRPVQR.4|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.4|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.5|C[CAM]TATNAAGTTQSHVLLLVQALPQISMPQEVR.3|ATFSSVPLAASISAVSLEVAQPGPSNRPR.4|ATFSSVPLAASISAVSLEVAQPGPSNRPR.3|AAGVPSATITWRK.3|AAGVPSATITWRK.2|LRLHHVSPADSGEYVC[CAM]R.5|LRLHHVSPADSGEYVC[CAM]R.4|LRLHHVSPADSGEYVC[CAM]R.3|RGGSLPAR.2|ISSTPAKLEQR.3|ISSTPAKLEQR.2|SIVPQGGSHSLR.3|VQVSPER.2|C[CAM]RPVNQEIVR.3|RVPGSPTNLANR.3|RVPGSPTNLANR.2|LHHVSPADSGEYVC[CAM]R.4|LHHVSPADSGEYVC[CAM]R.3|LNWGHIPSHPR.3|RGGSLPSHHQTR.3|SAEPLALGR.2|VTVTSEGGR.2|GHTPTQPGALNQR.3|GHTPTQPGALNQR.2|VKAFAHLQVPER.3|RGGSLPVRHQTHGSLLR.4|SKSPAYTLVWTR.3|SKSPAYTLVWTR.2|EDGRPVPSGTQQR.3|VDSYGGSLR.2|AGFFGDAM[Oxi]K.2|AQIHGGILR.2|GGSLPSRHQIVGSR.3|LRSPLPWQHRLEGDTLIIPR.5|LSGSHSQGVAYPVR.3|LSGSHSQGVAYPVR.2|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHKR.6|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHKR.4|RPEEVC[CAM]GPTQFR.3|VTSYGGELR.2|ALEVEEC[CAM]R.2|RPDGQPATR.2|C[CAM]FC[CAM]MGVSR.2|EGGSLPPQAR.2|LGTVPQFPR.2|PGAPPPQPLDLQHR.3|HQTHGSLLR.2|LDGSLPPDSR.2|RGGSLPPHTQVHGSR.3|C[CAM]SATGSPAPTIHWSK.3|C[CAM]SATGSPAPTIHWSK.2|EQAWQRPDGQPATR.3|GC[CAM]VGEVSVNGK.2|WFKEGGQLPPGHSVQDGVLR.4|AHSSAGQQVAR.2|HC[CAM]TSSSWSR.2|VAEGQTLDLKC[CAM]VVPGQAHAQVTWHK.5|GSM[Oxi]GTSGEAC[CAM]R.2|DFISLGLQDGHLVFR.3|GGSLPVRHQTHGSLLR.3|IQVVVLSASDASPPPVK.3|IQVVVLSASDASPPPVK.2|RPDGQPATREHLLM[Oxi]ALADLDELLIR.5|RPDGQPATREHLLMALADLDELLIR.4|RPDGQPATREHLLM[Oxi]ALADLDELLIR.4|SYEIM[Oxi]FREEFWR.3|VISSGSVASYVTSPQGFQFRR.4|VISSGSVASYVTSPQGFQFRR.3|AELLVTEAPSK.2|AELLVTEAPSKPITVTVEEQR.4|AELLVTEAPSKPITVTVEEQR.3|AELLVTEAPSKPITVTVEEQR.2|AVLHVHGGGGPR.2|RFLVHDSFWALPEQFLGNK.4|RFLVHDSFWALPEQFLGNK.3|AFAHLQVPER.2|EGGQLPPGHSVQDGVLR.3|TC[CAM]ESLGAGGYR.2|SPAYTLVWTR.2|ASYAQQPAESR.2|EASITVSVLHGTHSGPSYTPVPGSTRPIR.5|AQAGANTRPC[CAM]PS.2|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHKR.6|C[CAM]LC[CAM]LPGFSGPR.2|LRFDQPDDFK.2|VVGSSGTQEASVLVTIQQR.3|VVGSSGTQEASVLVTIQQR.2|LRLLQVTPADSGEYVC[CAM]R.3|LRIPQVTPADSGEYVC[CAM]HVSNGAGSR.4|LRIPQVTPADSGEYVC[CAM]HVSNGAGSR.3|AQIHGGILRLPAVEPTDQAQYLC[CAM]R.4|AQIHGGILRLPAVEPTDQAQYLC[CAM]R.3|ATATSC[CAM]RPC[CAM]PC[CAM]PYIDASR.3|RC[CAM]ESC[CAM]APGYEGNPIQPGGK.3|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHK.5|IEPSSSHVAEGQTLDLNC[CAM]VVPGQAHAQVTWHK.4|VVPYFTQTPYSFLPLPTIKDAYRK.4|ATARNELLHFER.2|FLGDKVTSYGGELRFTVTQR.3|GPSC[CAM]QDC[CAM]DTGYTR.2|SPVISIDPPSSTVQQGQDASFK.3|SPVISIDPPSSTVQQGQDASFK.2|VPGSPTNLANRQPDFISFGLVGGRPEFR.4|AFAHLQVPERVVPYFTQTPYSFLPLPTIKDAYR.5|GQTVTFTC[CAM]VAIGVPTPIINWR.3|GQTVTFTC[CAM]VAIGVPTPIINWR.2|RFSDTC[CAM]FLDTDGQATC[CAM]DAC[CAM]APGYTGRR.4|IESSSPTVVEGQTLDLNC[CAM]VVAR.3|IESSSPTVVEGQTLDLNC[CAM]VVAR.2|VLGSSVPLEASVLVTIEPAGSVPALGVTPTVR.4|VLGSSVPLEASVLVTIEPAGSVPALGVTPTVR.3|ETSLIVTIQGSGSSHVPSVSPPIR.3|TSVQTVVVGHAVEFEC[CAM]LALGDPKPQVTWSK.4|ESDQGAYTC[CAM]EAMNAR.2|FQGLDLNEELYLGGYPDYGAIPK.3|AASGPGPEQEASFTVTVPPSEGSSYR.3|C[CAM]EQC[CAM]QPGYYGDAQR.2|GPC[CAM]PDGHFYLEHSAAC[CAM]LPC[CAM]FC[CAM]FGITSVC[CAM]QSTR.4|C[CAM]APGYYGNPSQGQPC[CAM]QR.2|RFSDTC[CAM]FLDTDGQATC[CAM]DAC[CAM]APGYTGR.3|LTGEFTVEPVPEGAQLSFGNFAQLGHESFYWQLPETYQGDK.4
SEN / CTL,P21291,Cysteine and glycine-rich protein 1,CSRP1,1.21,0.92,6.24E-04,2.37E-04,3.62E+00,platelet aggregation,"zinc ion binding,poly(A) RNA binding","nucleus,focal adhesion,extracellular exosome",9,16,31,GLESTTLADKDGEIYC[CAM]K.3|GLESTTLADKDGEIYC[CAM]K.2|GFGFGQGAGALVHSE.2|GFGFGQGAGALVHSE.3|TVYFAEEVQC[CAM]EGNSFHK.3|TVYFAEEVQC[CAM]EGNSFHK.4|TVYFAEEVQC[CAM]EGNSFHK.2|DGEIYC[CAM]K.2|HEEAPGHRPTTNPNASK.4|HEEAPGHRPTTNPNASK.3|HEEAPGHRPTTNPNASK.2|GESLGIKHEEAPGHRPTTNPNASK.5|GESLGIKHEEAPGHRPTTNPNASK.4|GESLGIKHEEAPGHRPTTNPNASK.3|GLESTTLADK.2|C[CAM]SQAVYAAEKVIGAGK.3|C[CAM]SQAVYAAEK.2|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.7|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.6|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.5|GYGYGQGAGTLSTDKGESLGIKHEEAPGHRPTTNPNASK.4|SC[CAM]FLC[CAM]MVC[CAM]K.2|SC[CAM]FLC[CAM]M[Oxi]VC[CAM]K.2|GLESTTLADKDGEIYC[CAM]KGC[CAM]YAK.4|GLESTTLADKDGEIYC[CAM]KGC[CAM]YAK.3|NLDSTTVAVHGEEIYC[CAM]K.3|NLDSTTVAVHGEEIYC[CAM]K.2|KNLDSTTVAVHGEEIYC[CAM]K.3|GYGYGQGAGTLSTDKGESLGIK.3|GYGYGQGAGTLSTDKGESLGIK.2|GYGYGQGAGTLSTDK.2
SEN / CTL,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,1.20,0.36,3.68E-02,8.95E-03,2.05E+00,"cellular protein modification process,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase","zinc ion binding,glutaminyl-peptide cyclotransferase activity",extracellular exosome,3,7,8,VFVGATDSAVPC[CAM]AMMLELAR.3|VFVGATDSAVPC[CAM]AMMLELAR.2|HLVLAC[CAM]HYDSK.3|YPGSPGSYAAR.2|SFSNIISTLNPTAK.2|YFQNYSYGGVIQDDHIPFLR.3|QIAEGTSISEMWQNDLQPLLIER.3|GVPVLHLIPSPFPEVWHTMDDNEENLDESTIDNLNK.4
SEN / CTL,O75083,WD repeat-containing protein 1,WDR1,1.19,0.83,6.47E-08,4.77E-08,7.32E+00,"platelet degranulation,sensory perception of sound,regulation of actin filament depolymerization,positive regulation of actin filament depolymerization,apical junction assembly,maintenance of epithelial cell apical/basal polarity,sarcomere organization,regulation of oligodendrocyte differentiation,regulation of ventricular cardiac muscle cell membrane repolarization",actin filament binding,"podosome,extracellular region,cytoplasm,cytosol,actin filament,cell-cell junction,cell projection,myelin sheath,extracellular exosome",21,47,76,LYSILGTTLKDEGK.3|LYSILGTTLKDEGK.2|YAPSGFYIASGDVSGK.2|YAPSGFYIASGDVSGK.3|AHDGGIYAISWSPDSTHLLSASGDKTSK.5|AHDGGIYAISWSPDSTHLLSASGDKTSK.4|AHDGGIYAISWSPDSTHLLSASGDKTSK.3|NIDNPALADIYTEHAHQVVVAK.4|NIDNPALADIYTEHAHQVVVAK.3|IAVVGEGR.2|TGEKVC[CAM]ALGGSK.3|KVFASLPQVER.3|KVFASLPQVER.2|IKDIAWTEDSK.3|IKDIAWTEDSK.2|VINSVDIK.2|YTSLMLR.2|IWDTTQK.2|LHHVSSLAWLDEHTLVTTSHDASVK.6|LHHVSSLAWLDEHTLVTTSHDASVK.5|LHHVSSLAWLDEHTLVTTSHDASVK.4|LHHVSSLAWLDEHTLVTTSHDASVK.3|FTIGDHSR.2|DYSGQGVVK.2|PYEIKKVFASLPQVER.4|RIAVVGEGR.2|IKDIAWTEDSKR.3|IKDIAWTEDSKR.2|IWDTTQKEHLLK.3|VVTVFSVADGYSENNVFYGHHAK.5|VVTVFSVADGYSENNVFYGHHAK.4|VVTVFSVADGYSENNVFYGHHAK.3|IWDTTQKEHLLKYEYQPFAGK.5|IWDTTQKEHLLKYEYQPFAGK.4|DIAWTEDSK.2|DHLLSVSLSGYINYLDRNNPSKPLHVIK.6|DHLLSVSLSGYINYLDRNNPSKPLHVIK.5|SIQC[CAM]LTVHK.2|YEYQPFAGK.2|LYSILGTTLK.2|GNNFLYTNGK.2|EHLLKYEYQPFAGK.3|EHLLKYEYQPFAGK.2|GPVTDVAYSHDGAFLAVC[CAM]DASK.4|GPVTDVAYSHDGAFLAVC[CAM]DASK.3|GPVTDVAYSHDGAFLAVC[CAM]DASK.2|VFASLPQVER.2|DIAWTEDSKR.2|EKFGAVFLWDSGSSVGEITGHNK.4|NNPSKPLHVIK.2|DHLLSVSLSGYINYLDRNNPSK.4|YAPSGFYIASGDVSGKLR.3|AHDGGIYAISWSPDSTHLLSASGDK.4|AHDGGIYAISWSPDSTHLLSASGDK.3|DHLLSVSLSGYINYLDR.3|LATGSDDNC[CAM]AAFFEGPPFK.3|LATGSDDNC[CAM]AAFFEGPPFK.2|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLKDQRK.4|MTVDESGQLISC[CAM]SMDDTVR.3|M[Oxi]TVDESGQLISC[CAM]SMDDTVR.3|MTVDESGQLISC[CAM]SM[Oxi]DDTVR.3|MTVDESGQLISC[CAM]SMDDTVR.2|LHHVSSLAWLDEHTLVTTSHDASVKEWTITY.5|FGAVFLWDSGSSVGEITGHNK.3|FGAVFLWDSGSSVGEITGHNK.2|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLK.3|C[CAM]VAVGPGGYAVVVC[CAM]IGQIVLLK.2|SYIYSGSHDGHINYWDSETGENDSFAGK.4|SYIYSGSHDGHINYWDSETGENDSFAGK.3|C[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.4|C[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.3|FATASADGQIYIYDGK.2|IWDVSVNSVVSTFPMGSTVLDQQLGC[CAM]LWQK.4|IWDVSVNSVVSTFPMGSTVLDQQLGC[CAM]LWQK.3|KC[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.4|KC[CAM]FSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVR.3
SEN / CTL,P18206,Vinculin,VCL,1.17,1.35,8.46E-11,9.59E-11,1.00E+01,"morphogenesis of an epithelium,platelet degranulation,movement of cell or subcellular component,muscle contraction,cell adhesion,cell-matrix adhesion,lamellipodium assembly,negative regulation of cell migration,adherens junction assembly,protein localization to cell surface,apical junction assembly,axon extension,platelet aggregation,epithelial cell-cell adhesion","dystroglycan binding,actin binding,structural molecule activity,protein binding,beta-catenin binding,ubiquitin protein ligase binding,alpha-catenin binding,cadherin binding,cadherin binding involved in cell-cell adhesion","extracellular region,cytosol,cytoskeleton,plasma membrane,cell-cell junction,adherens junction,cell-cell adherens junction,fascia adherens,focal adhesion,actin cytoskeleton,cell-substrate junction,costamere,protein complex,extracellular exosome,extracellular vesicle",72,102,192,AIPDLTAPVAAVQAAVSNLVR.3|AIPDLTAPVAAVQAAVSNLVR.2|WIDNPTVDDRGVGQAAIR.3|MSAEINEIIR.2|M[Oxi]SAEINEIIR.2|VLQLTSWDEDAWASKDTEAMKR.4|STVEGIQASVK.2|ELLPVLISAMK.2|ELLPVLISAM[Oxi]K.2|GILSGTSDLLLTFDEAEVRK.3|GILSGTSDLLLTFDEAEVRK.4|GILSGTSDLLLTFDEAEVRK.2|ALASQLQDSLKDLK.3|ALASQLQDSLKDLK.2|C[CAM]DRVDQLTAQLADLAARGEGESPQAR.4|C[CAM]DRVDQLTAQLADLAARGEGESPQAR.3|VGKETVQTTEDQILKR.4|VGKETVQTTEDQILKR.3|VGKETVQTTEDQILKR.2|MLGQMTDQVADLR.2|MLGQMTDQVADLR.3|M[Oxi]LGQM[Oxi]TDQVADLR.2|M[Oxi]LGQMTDQVADLR.2|MLGQM[Oxi]TDQVADLR.2|LLAVAATAPPDAPNREEVFDER.3|LLAVAATAPPDAPNREEVFDER.4|LLAVAATAPPDAPNREEVFDER.2|MTGLVDEAIDTK.2|MTGLVDEAIDTK.3|M[Oxi]TGLVDEAIDTK.2|ILLRNPGNQAAYEHFETMK.4|MALLMAEMSR.2|M[Oxi]ALLMAEMSR.2|MALLM[Oxi]AEMSR.2|MQEAMTQEVSDVFSDTTTPIK.3|M[Oxi]QEAMTQEVSDVFSDTTTPIK.3|M[Oxi]QEAMTQEVSDVFSDTTTPIK.2|MQEAM[Oxi]TQEVSDVFSDTTTPIK.2|MQEAMTQEVSDVFSDTTTPIK.2|C[CAM]DRVDQLTAQLADLAAR.3|C[CAM]DRVDQLTAQLADLAAR.4|C[CAM]DRVDQLTAQLADLAAR.2|QILDEAGKVGELC[CAM]AGK.3|QILDEAGKVGELC[CAM]AGK.2|AQQVSQGLDVLTAK.2|AQQVSQGLDVLTAK.3|VAMANIQPQMLVAGATSIAR.2|VAM[Oxi]ANIQPQMLVAGATSIAR.3|VAMANIQPQM[Oxi]LVAGATSIAR.3|VAMANIQPQMLVAGATSIAR.3|VAM[Oxi]ANIQPQM[Oxi]LVAGATSIAR.3|VAM[Oxi]ANIQPQM[Oxi]LVAGATSIAR.2|VAM[Oxi]ANIQPQMLVAGATSIAR.2|VAMANIQPQM[Oxi]LVAGATSIAR.2|TNISDEESEQATEMLVHNAQNLMQSVK.3|TNISDEESEQATEMLVHNAQNLMQSVK.4|TNISDEESEQATEM[Oxi]LVHNAQNLMQSVK.3|TNISDEESEQATEMLVHNAQNLM[Oxi]QSVK.3|AAAVGTANK.2|ALASIDSK.2|ALIQC[CAM]AK.2|REVENSEDPK.3|REVENSEDPK.2|AAVHLEGK.2|ALIQC[CAM]AKDIAK.3|NLGPGMTK.2|GLVAEGHR.2|VGELC[CAM]AGK.2|AVAGNISDPGLQK.3|AVAGNISDPGLQK.2|NQGIEEALKNR.3|NQGIEEALKNR.2|ETVREAEAASIK.3|ETVREAEAASIK.2|GNDIIAAAK.2|QQELTHQEHR.3|QQELTHQEHR.2|SLLDASEEAIKK.3|SLLDASEEAIKK.2|AANFENHSGKLGATAEK.4|AANFENHSGKLGATAEK.3|ALASQLQDSLKDLKAR.4|ALASQLQDSLKDLKAR.3|RMALLMAEMSR.3|RMALLMAEMSR.2|TDAGFTLR.2|EVENSEDPKFR.3|EVENSEDPKFR.2|IAELC[CAM]DDPKER.3|IAELC[CAM]DDPKER.2|ALASIDSKLNQAK.3|ALASIDSKLNQAK.2|EEVFDER.2|GEGESPQAR.2|DYLIDGSR.2|SFLDSGYR.2|RALASIDSK.2|RALIQC[CAM]AK.2|IAELC[CAM]DDPKERDDILR.4|IAELC[CAM]DDPKERDDILR.3|MIDERQQELTHQEHR.4|DPSASPGDAGEQAIR.3|DPSASPGDAGEQAIR.2|KIAELC[CAM]DDPKER.3|KIAELC[CAM]DDPKER.2|LLAVAATAPPDAPNR.3|LLAVAATAPPDAPNR.2|LVQAAQMLQSDPYSVPAR.4|LVQAAQMLQSDPYSVPAR.3|LVQAAQM[Oxi]LQSDPYSVPAR.3|LVQAAQM[Oxi]LQSDPYSVPAR.2|LVQAAQMLQSDPYSVPAR.2|QILDEAGKVGELC[CAM]AGKER.4|QILDEAGKVGELC[CAM]AGKER.3|VDQLTAQLADLAAR.3|VDQLTAQLADLAAR.2|IPTISTQLK.2|NQGIEEALK.2|AGEVINQPMMMAAR.3|AGEVINQPMMMAAR.2|AGEVINQPM[Oxi]MMAAR.2|AGEVINQPMM[Oxi]MAAR.2|AGEVINQPMMM[Oxi]AAR.2|AGEVINQPM[Oxi]M[Oxi]M[Oxi]AAR.2|AAVHLEGKIEQAQR.3|DEEFPEQK.2|KLEAMTNSK.2|ETVQTTEDQILKR.3|ETVQTTEDQILKR.2|EVENSEDPK.2|IAELC[CAM]DDPK.2|AANFENHSGK.2|GQGSSPVAMQK.2|GQGSSPVAM[Oxi]QK.2|SLGEISALTSK.2|TISPMVMDAK.2|TNLLQVC[CAM]ER.2|NQWIDNVEK.2|IRTDAGFTLR.2|LANVMMGPYR.2|LANVM[Oxi]MGPYR.2|LANVMM[Oxi]GPYR.2|NPGNQAAYEHFETMK.3|NPGNQAAYEHFETM[Oxi]K.3|NPGNQAAYEHFETMK.2|ALASQLQDSLK.2|ELTPQVVSAAR.2|VLQLTSWDEDAWASK.3|VLQLTSWDEDAWASK.2|KIAELC[CAM]DDPK.2|SLLDASEEAIK.2|SLLDASEEAIKKDLDK.3|LANVMMGPYRQDLLAK.3|LANVM[Oxi]MGPYRQDLLAK.3|LANVMM[Oxi]GPYRQDLLAK.3|LANVMMGPYRQDLLAK.2|WIDNPTVDDR.2|VMLVNSMNTVK.2|VM[Oxi]LVNSMNTVK.2|VMLVNSM[Oxi]NTVK.2|VM[Oxi]LVNSM[Oxi]NTVK.2|KIDAAQNWLADPNGGPEGEEQIR.4|KIDAAQNWLADPNGGPEGEEQIR.3|AAAVGTANKSTVEGIQASVK.3|QVATALQNLQTK.2|GWLRDPSASPGDAGEQAIR.3|GWLRDPSASPGDAGEQAIR.2|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.6|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.5|LTDELAPPKPPLPEGEVPPPRPPPPEEKDEEFPEQK.4|VREAFQPQEPDFPPPPPDLEQLR.4|VREAFQPQEPDFPPPPPDLEQLR.3|GILSGTSDLLLTFDEAEVR.3|GILSGTSDLLLTFDEAEVR.2|LLAVAATAPPDAPNREEVFDERAANFENHSGK.5|AQQVSQGLDVLTAKVENAAR.3|AQQVSQGLDVLTAKVENAAR.2|ETVQTTEDQILK.2|TNLLQVC[CAM]ERIPTISTQLK.3|LVQAAQMLQSDPYSVPARDYLIDGSR.4|LVQAAQM[Oxi]LQSDPYSVPARDYLIDGSR.3|LVQAAQMLQSDPYSVPARDYLIDGSR.3|LTDELAPPKPPLPEGEVPPPRPPPPEEK.4|LTDELAPPKPPLPEGEVPPPRPPPPEEK.3|TIESILEPVAQQISHLVIMHEEGEVDGK.4|TIESILEPVAQQISHLVIM[Oxi]HEEGEVDGK.4|TIESILEPVAQQISHLVIMHEEGEVDGK.3|IDAAQNWLADPNGGPEGEEQIR.3|IDAAQNWLADPNGGPEGEEQIR.2|KIDAAQNWLADPNGGPEGEEQIRGALAEAR.4|EAFQPQEPDFPPPPPDLEQLR.3|VLQLTSWDEDAWASKDTEAMK.3
SEN / CTL,Q32P28,Prolyl 3-hydroxylase 1,LEPRE1,1.17,0.08,1.51E-03,5.04E-04,3.30E+00,"protein folding,negative regulation of cell proliferation,protein hydroxylation,peptidyl-proline hydroxylation,collagen metabolic process,regulation of protein secretion,protein stabilization,oxidation-reduction process,bone development,chaperone-mediated protein folding,negative regulation of post-translational protein modification","molecular_function,iron ion binding,procollagen-proline 3-dioxygenase activity,L-ascorbic acid binding,protein complex binding,collagen binding","proteinaceous extracellular matrix,endoplasmic reticulum,endoplasmic reticulum lumen,membrane,macromolecular complex,extracellular exosome",3,29,36,GDWPGVVLSMER.2|TAIEEVQAERK.3|LTNVAATSGDGYR.3|LTNVAATSGDGYR.2|VQADDLVK.2|FYGVTVFK.2|AVGFSSGTENPHGVK.3|QNC[CAM]VTELASHPSR.3|QNC[CAM]VTELASHPSR.2|DLETQPHMQEFR.3|EADFKDLETQPHMQEFR.4|EIETLVEEK.2|RSPYNYLQVAYFK.3|RSPYNYLQVAYFK.2|DLSFFGGLLR.2|ISQEIGNLMK.2|TAIEEVQAER.2|C[CAM]LGPPAAHSLSEEMELEFRK.4|GQTSPHTPNEK.2|LDTPLYFSYSHLVC[CAM]R.3|LDTPLYFSYSHLVC[CAM]R.2|LTNVAATSGDGYRGQTSPHTPNEK.4|KDDSHPVHVDNC[CAM]ILNAETLVC[CAM]VK.4|KDDSHPVHVDNC[CAM]ILNAETLVC[CAM]VK.3|TVTAEVQPQC[CAM]GR.2|VVMDGVISDHEC[CAM]QELQR.3|C[CAM]LGPPAAHSLSEEMELEFR.3|ISQEIGNLMKEIETLVEEK.3|SPYNYLQVAYFK.2|TYLLFFPNDEVMNQNLAYYAAMLGEEHTR.4|TYLLFFPNDEVMNQNLAYYAAMLGEEHTR.3|LYSEEQPQEAVPHLEAALQEYFVAYEEC[CAM]R.4|LYSEEQPQEAVPHLEAALQEYFVAYEEC[CAM]R.3|AVAAAHTFFVGNPEHMEMQQNLDYYQTMSGVK.4|EGGPLLYEGISLTMNSK.2|TQC[CAM]AADFPWELDPDWSPSPAQASGAAALR.3
SEN / CTL,Q96CG8,Collagen triple helix repeat-containing protein 1,CTHRC1,1.16,2.63,5.60E-02,1.30E-02,1.89E+00,"cell migration,positive regulation of protein binding,positive regulation of osteoblast proliferation,ossification involved in bone remodeling,positive regulation of osteoblast differentiation,Wnt signaling pathway, planar cell polarity pathway,inner ear receptor stereocilium organization,negative regulation of canonical Wnt signaling pathway,cochlea morphogenesis,establishment of planar polarity involved in neural tube closure","frizzled binding,Wnt-protein binding","proteinaceous extracellular matrix,collagen trimer,extracellular space,cytoplasm",6,3,3,IIIEELPK.2|QC[CAM]SWSSLNYGIDLGK.2|GDASTGWNSVSR.2
SEN / CTL,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,1.14,1.70,2.83E-04,1.18E-04,3.93E+00,"retinoid metabolic process,receptor-mediated endocytosis,protein kinase C-activating G-protein coupled receptor signaling pathway,aging,cell proliferation,regulation of extracellular matrix disassembly,positive regulation of cholesterol efflux,negative regulation of neuron projection development,negative regulation of smooth muscle cell migration,cerebral cortex development,negative regulation of Wnt signaling pathway,positive regulation of lipid transport,regulation of cholesterol transport,regulation of phospholipase A2 activity,regulation of actin cytoskeleton organization,aorta morphogenesis,lipoprotein metabolic process,lipoprotein transport,apoptotic cell clearance,negative regulation of neuron apoptotic process,positive regulation of protein transport,beta-amyloid clearance,negative regulation of platelet-derived growth factor receptor-beta signaling pathway","protease binding,receptor activity,low-density lipoprotein receptor activity,calcium ion binding,protein binding,protein complex binding,apolipoprotein binding,lipoprotein transporter activity,poly(A) RNA binding,lipoprotein particle receptor binding","nucleolus,cytoplasm,lysosomal membrane,endosome,plasma membrane,integral component of plasma membrane,clathrin-coated pit,focal adhesion,clathrin-coated vesicle,dendrite,endocytic vesicle membrane,neuronal cell body,receptor complex",18,65,72,AALSGANVLTLIEKDIR.3|LDGLC[CAM]IPLR.2|VFFTDYGQIPK.2|IVFPHGITLDLVSR.3|AVTDEEPFLIFANR.2|SGFHTVPGQPGC[CAM]QDINEC[CAM]LR.3|SERPPIFEIR.3|YDGSGHMEVLR.3|TTLLAGDIEHPR.3|TTLLAGDIEHPR.2|IDLHKGDYSVLVPGLR.4|IDLHKGDYSVLVPGLR.3|YVVISQGLDKPR.3|SGFSLGSDGK.2|ADGSGSVVLR.2|C[CAM]PTGFTGPK.2|ETVITMSGDDHPR.3|GIALDPAMGK.2|KPEHELFLVYGK.3|KPEHELFLVYGK.2|ATALAIMGDK.2|TAC[CAM]GVGEFR.2|RITIVENVGSVEGLAYHR.4|RITIVENVGSVEGLAYHR.3|KLSGC[CAM]SQDC[CAM]EDLK.3|NAVVQGLEQPHGLVVHPLR.4|NAVVQGLEQPHGLVVHPLR.3|LYFSDATLDKIER.3|IEAASMSGAGR.2|C[CAM]TAYFEGSR.2|YTGDKC[CAM]ELDQC[CAM]WEHC[CAM]R.4|YTGDKC[CAM]ELDQC[CAM]WEHC[CAM]R.3|TPNGLAIDHR.2|SLDPFKPFIIFSNR.3|C[CAM]LEGAC[CAM]VVNK.2|SHAC[CAM]ENDQYGKPGGC[CAM]SDIC[CAM]LLANSHK.5|SHAC[CAM]ENDQYGKPGGC[CAM]SDIC[CAM]LLANSHK.4|GDYSVLVPGLR.2|IETAAMDGTLR.2|TNTQPFDLQVYHPSR.3|C[CAM]LC[CAM]VEGYAPR.2|MMPEC[CAM]QC[CAM]PPHMTGPR.3|GC[CAM]HINEC[CAM]LSR.2|GVGGAPPTVTLLR.2|ITIVENVGSVEGLAYHR.3|NLNAPVQPFEDPEHMK.3|VPDEHMIPIENLMNPR.3|AITVHPEKGYLFWTEWGQYPR.4|SC[CAM]MC[CAM]TAGYSLR.2|GPVGLAIDFPESK.2|EYAGYLLYSER.2|SEPVHPFGLAVYGEHIFWTDWVR.4|AALSGANVLTLIEK.2|LSGC[CAM]SQDC[CAM]EDLK.2|TC[CAM]GPSSFSC[CAM]PGTHVC[CAM]VPER.3|C[CAM]PLNYFAC[CAM]PSGR.2|LC[CAM]NGVQDC[CAM]MDGSDEGPHC[CAM]R.3|MYDAQQQQVGTNK.2|NLFWTSYDTNKK.2|NLNAPVQPFEDPEHMKNVIALAFDYR.4|SC[CAM]EGVTHVC[CAM]DPSVK.2|SGQQAC[CAM]EGVGSFLLYSVHEGIR.3|C[CAM]AC[CAM]PTNFYLGSDGR.2|EDYIEFASLDGSNR.2|AIALDPRDGILFWTDWDASLPR.3|ELLGRGPEDEIGDPLA.2|GYLFWTEWGQYPR.2|TVLWPNGLSLDIPAGR.2|ITWPNGLTLDYVTER.2|C[CAM]DNDNDC[CAM]GDNSDEAGC[CAM]SHSC[CAM]SSTQFK.3|NEPVDRPPVLLIANSQNILATYLSGAQVSTITPTSTR.4|AKNEPVDRPPVLLIANSQNILATYLSGAQVSTITPTSTR.4
SEN / CTL,P68363,Tubulin alpha-1B chain,TUBA1B,1.13,1.02,3.18E-12,4.64E-12,1.13E+01,"microtubule cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division,cellular response to interleukin-4","double-stranded RNA binding,GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,ubiquitin protein ligase binding","microtubule,cytoplasmic microtubule,myelin sheath,extracellular exosome",48,11,28,AVFVDLEPTVIDEVR.2|AVFVDLEPTVIDEVR.3|LISQIVSSITASLR.2|LISQIVSSITASLR.3|VGINYQPPTVVPGGDLAK.2|VGINYQPPTVVPGGDLAK.3|VGINYQPPTVVPGGDLAK.4|EIIDLVLDR.2|SIQFVDWC[CAM]PTGFK.2|SIQFVDWC[CAM]PTGFK.3|AVC[CAM]MLSNTTAIAEAWAR.3|AVC[CAM]MLSNTTAIAEAWAR.2|AVC[CAM]M[Oxi]LSNTTAIAEAWAR.3|AVC[CAM]M[Oxi]LSNTTAIAEAWAR.2|FDGALNVDLTEFQTNLVPYPR.3|FDGALNVDLTEFQTNLVPYPR.4|IHFPLATYAPVISAEK.3|IHFPLATYAPVISAEK.4|IHFPLATYAPVISAEK.2|NLDIERPTYTNLNR.3|NLDIERPTYTNLNR.4|NLDIERPTYTNLNR.2|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.4|KLADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.3|GHYTIGKEIIDLVLDR.3|GHYTIGKEIIDLVLDR.4|GHYTIGKEIIDLVLDR.2
SEN / CTL,P08123,Collagen alpha-2(I) chain,COL1A2,1.13,1.28,1.57E-20,5.97E-20,1.92E+01,"skeletal system development,blood vessel development,transforming growth factor beta receptor signaling pathway,Rho protein signal transduction,blood coagulation,regulation of blood pressure,platelet activation,extracellular matrix organization,collagen fibril organization,collagen catabolic process,odontogenesis,skin morphogenesis,regulation of immune response,leukocyte migration,protein heterotrimerization,cellular response to amino acid stimulus","extracellular matrix structural constituent,protein binding,protein binding, bridging,identical protein binding,SMAD binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type I trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome",96,44,57,SLNNQIETLLTPEGSR.2|SLNNQIETLLTPEGSR.3|DYEVDATLK.2|EMATQLAFMR.2|FTYTVLVDGC[CAM]SK.2|LSHPEWSSGYYWIDPNQGC[CAM]TMDAIK.3|VYC[CAM]DFSTGETC[CAM]IR.2|FTYTVLVDGC[CAM]SKK.3|GLPGVAGAVGEPGPLGIAGPPGAR.3|GYPGNIGPVGAAGAPGPHGPVGPAGK.3|GPSGPPGPDGNKGEPGVVGAVGTAGPSGPSGLPGER.3|GIPGPVGAAGATGAR.2|GAPGAVGAPGPAGATGDRGEAGAAGPAGPAGPR.4|GAPGAVGAPGPAGATGDRGEAGAAGPAGPAGPR.3|KAVILQGSNDVELVAEGNSR.3|NSIAYMDEETGNLKK.3|NSIAYMDEETGNLKK.2|NSIAYM[Oxi]DEETGNLKK.3|GLHGEFGLPGPAGPRGER.4|AVILQGSNDVELVAEGNSR.2|GAAGLPGVAGAPGLPGPR.2|SLNNQIETLLTPEGSRK.3|GLPGSPGNIGPAGK.2|GPPGESGAAGPTGPIGSR.2|GHNGLQGLPGIAGHHGDQGAPGSVGPAGPR.4|HGNRGETGPSGPVGPAGAVGPR.4|HGNRGETGPSGPVGPAGAVGPR.3|HGNRGETGPSGPVGPAGAVGPR.5|HGNRGETGPSGPVGPAGAVGPR.2|GLHGEFGLPGPAGPR.3|GVGLGPGPMGLMGPR.2|GVGLGPGPMGLMGPR.3|GVGLGPGPM[Oxi]GLMGPR.2|GVGLGPGPMGLM[Oxi]GPR.2|GVGLGPGPM[Oxi]GLM[Oxi]GPR.2|GDGGPPGMTGFPGAAGR.2|GDGGPPGM[Oxi]TGFPGAAGR.2|GEPGNIGFPGPK.2|GERGPPGESGAAGPTGPIGSR.3|AGEDGHPGKPGRPGER.4|AGEDGHPGKPGRPGER.3|GHAGLAGAR.2|GVVGPQGAR.2|VGAPGPAGAR.2|GPSGPQGIR.2|GPAGPSGPAGK.2|GHNGLDGLK.2|AGVMGPPGSR.2|DGNPGNDGPPGRDGQPGHKGER.4|DGNPGNDGPPGR.2|GPAGPSGPAGKDGR.2|TGHPGTVGPAGIR.2|GEAGAAGPAGPAGPR.2|GEVGPAGPNGFAGPAGAAGQPGAK.3|GEIGAVGNAGPAGPAGPR.2|GETGPSGPVGPAGAVGPR.2|GPSGEAGTAGPPGTPGPQGLLGAPGILGLPGSR.3
SEN / CTL,P13639,Elongation factor 2,EEF2,1.13,1.27,3.78E-10,3.83E-10,9.42E+00,"hematopoietic progenitor cell differentiation,response to ischemia,skeletal muscle contraction,translational elongation,aging,glial cell proliferation,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,response to estradiol,response to endoplasmic reticulum stress,skeletal muscle cell differentiation,response to hydrogen peroxide,response to ethanol,positive regulation of translation,response to folic acid,cell-cell adhesion,cellular response to brain-derived neurotrophic factor stimulus,positive regulation of cytoplasmic translation","p53 binding,translation elongation factor activity,GTPase activity,protein binding,GTP binding,5S rRNA binding,protein kinase binding,ribosome binding,poly(A) RNA binding,actin filament binding,cadherin binding involved in cell-cell adhesion","nucleus,cytoplasm,cytosol,plasma membrane,cell-cell adherens junction,membrane,aggresome,intracellular ribonucleoprotein complex,extracellular matrix,polysomal ribosome,membrane raft,extracellular exosome",48,83,182,VFSGLVSTGLK.2|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNR.3|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNR.3|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNR.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNR.4|EGIPALDNFLDKL.2|KIWC[CAM]FGPDGTGPNILTDITK.3|KIWC[CAM]FGPDGTGPNILTDITK.2|ALLELQLEPEELYQTFQR.3|ALLELQLEPEELYQTFQR.2|YLAEKYEWDVAEAR.3|YLAEKYEWDVAEAR.2|YVEPIEDVPC[CAM]GNIVGLVGVDQFLVK.3|YVEPIEDVPC[CAM]GNIVGLVGVDQFLVK.4|YRC[CAM]ELLYEGPPDDEAAMGIK.3|YRC[CAM]ELLYEGPPDDEAAMGIK.4|YRC[CAM]ELLYEGPPDDEAAM[Oxi]GIK.3|YRC[CAM]ELLYEGPPDDEAAM[Oxi]GIK.2|YRC[CAM]ELLYEGPPDDEAAMGIK.2|GHVFEESQVAGTPMFVVK.3|GHVFEESQVAGTPMFVVK.4|GHVFEESQVAGTPM[Oxi]FVVK.3|GHVFEESQVAGTPM[Oxi]FVVK.2|GHVFEESQVAGTPMFVVK.2|TFC[CAM]QLILDPIFK.2|TFC[CAM]QLILDPIFK.3|STAISLFYELSENDLNFIK.3|STAISLFYELSENDLNFIK.4|STAISLFYELSENDLNFIK.2|C[CAM]LYASVLTAQPR.2|C[CAM]LYASVLTAQPR.3|C[CAM]ELLYEGPPDDEAAMGIK.2|C[CAM]ELLYEGPPDDEAAM[Oxi]GIK.3|C[CAM]ELLYEGPPDDEAAMGIK.3|C[CAM]ELLYEGPPDDEAAM[Oxi]GIK.2|WLPAGDALLQMITIHLPSPVTAQK.3|WLPAGDALLQMITIHLPSPVTAQK.4|WLPAGDALLQM[Oxi]ITIHLPSPVTAQK.4|WLPAGDALLQM[Oxi]ITIHLPSPVTAQK.3|IMGPNYTPGKK.3|IMGPNYTPGKK.2|IM[Oxi]GPNYTPGKK.2|TGTITTFEHAHNMR.4|TGTITTFEHAHNM[Oxi]R.4|TGTITTFEHAHNMR.3|TGTITTFEHAHNM[Oxi]R.3|TGTITTFEHAHNM[Oxi]R.2|TGTITTFEHAHNMR.2|VFDAIMNFKK.3|VFDAIM[Oxi]NFKK.3|VFDAIMNFKK.2|TILMMGR.2|TILM[Oxi]MGR.2|TILMM[Oxi]GR.2|KLWGDRYFDPANGK.4|KLWGDRYFDPANGK.3|EDLYLKPIQR.3|EDLYLKPIQR.2|YEWDVAEARK.3|YEWDVAEARK.2|LDSEDKDKEGKPLLK.4|LDSEDKDKEGKPLLK.3|NMSVIAHVDHGK.3|NM[Oxi]SVIAHVDHGK.3|NMSVIAHVDHGK.2|NM[Oxi]SVIAHVDHGK.2|DSVVAGFQWATK.3|DSVVAGFQWATK.2|FDVHDVTLHADAIHR.4|FDVHDVTLHADAIHR.3|FDVHDVTLHADAIHR.2|KVEDMMK.2|KVEDM[Oxi]MK.2|KVEDMM[Oxi]K.2|VFDAIMNFKKEETAK.4|VFDAIMNFKKEETAK.3|VFDAIMNFKKEETAK.2|FSVSPVVR.2|KRGHVFEESQVAGTPMFVVK.5|KRGHVFEESQVAGTPMFVVK.4|KRGHVFEESQVAGTPMFVVK.3|VAVEAKNPADLPK.3|VAVEAKNPADLPK.2|VFSGLVSTGLKVR.3|SDPVVSYR.2|KEDLYLKPIQR.3|KEDLYLKPIQR.2|YLAEKYEWDVAEARK.4|YLAEKYEWDVAEARK.3|FAAKGEGQLGPAER.3|FAAKGEGQLGPAER.2|FTDTRKDEQER.3|FTDTRKDEQER.2|LDIKLDSEDKDK.3|LDIKLDSEDKDK.2|DLEEDHAC[CAM]IPIK.3|DLEEDHAC[CAM]IPIK.2|IMGPNYTPGKKEDLYLK.4|IMGPNYTPGKKEDLYLK.3|IM[Oxi]GPNYTPGKKEDLYLKPIQR.5|IMGPNYTPGKKEDLYLKPIQR.5|IMGPNYTPGKKEDLYLKPIQR.4|IM[Oxi]GPNYTPGKKEDLYLKPIQR.4|IMGPNYTPGKKEDLYLKPIQR.3|PSQVVAETR.2|GEGQLGPAER.2|KVEDMMKK.2|ARPFPDGLAEDIDK.3|ARPFPDGLAEDIDK.2|LWGDRYFDPANGK.3|RC[CAM]LYASVLTAQPR.3|RC[CAM]LYASVLTAQPR.2|DLEEDHAC[CAM]IPIKK.3|DLEEDHAC[CAM]IPIKK.2|GPLMMYISK.2|GPLM[Oxi]MYISK.2|GPLMM[Oxi]YISK.2|GPLM[Oxi]M[Oxi]YISK.2|ARPFPDGLAEDIDKGEVSARQELK.5|ARPFPDGLAEDIDKGEVSARQELK.4|ETVSEESNVLC[CAM]LSK.3|ETVSEESNVLC[CAM]LSK.2|GVQYLNEIK.2|KSDPVVSYR.2|RGHVFEESQVAGTPMFVVK.4|RGHVFEESQVAGTPM[Oxi]FVVK.4|RGHVFEESQVAGTPM[Oxi]FVVK.3|RGHVFEESQVAGTPMFVVK.3|RGHVFEESQVAGTPM[Oxi]FVVK.2|RGHVFEESQVAGTPMFVVK.2|ARPFPDGLAEDIDKGEVSAR.4|ARPFPDGLAEDIDKGEVSAR.3|ARPFPDGLAEDIDKGEVSAR.2|IMGPNYTPGK.2|IM[Oxi]GPNYTPGK.2|QFAEMYVAK.2|QFAEM[Oxi]YVAK.2|VFDAIMNFK.2|VFDAIM[Oxi]NFK.2|VNFTVDQIR.2|STLTDSLVC[CAM]K.2|YEWDVAEAR.2|GLKEGIPALDNFLDKL.3|GLKEGIPALDNFLDKL.2|GVQYLNEIKDSVVAGFQWATK.4|GVQYLNEIKDSVVAGFQWATK.3|GVQYLNEIKDSVVAGFQWATK.2|LDIKLDSEDK.2|AYLPVNESFGFTADLR.3|AYLPVNESFGFTADLR.2|EGALC[CAM]EENMR.2|EGALC[CAM]EENM[Oxi]R.2|NMSVIAHVDHGKSTLTDSLVC[CAM]K.4|MVNFTVDQIR.2|PFPDGLAEDIDKGEVSAR.3|VTDGALVVVDC[CAM]VSGVC[CAM]VQTETVLR.4|VTDGALVVVDC[CAM]VSGVC[CAM]VQTETVLR.3|KSDPVVSYRETVSEESNVLC[CAM]LSK.4|KSDPVVSYRETVSEESNVLC[CAM]LSK.3|PFPDGLAEDIDK.2|EGIPALDNFLDK.2|RWLPAGDALLQM[Oxi]ITIHLPSPVTAQK.4|RWLPAGDALLQMITIHLPSPVTAQK.4|RWLPAGDALLQMITIHLPSPVTAQK.3|DGAGFLINLIDSPGHVDFSSEVTAALR.4|DGAGFLINLIDSPGHVDFSSEVTAALR.3|IWC[CAM]FGPDGTGPNILTDITK.3|IWC[CAM]FGPDGTGPNILTDITK.2|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.6|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.5|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETRK.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.4|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.4|LM[Oxi]EPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.3|LMEPIYLVEIQC[CAM]PEQVVGGIYGVLNRK.3|QSKDGAGFLINLIDSPGHVDFSSEVTAALR.4|SDPVVSYRETVSEESNVLC[CAM]LSK.3|SDPMVQC[CAM]IIEESGEHIIAGAGELHLEIC[CAM]LK.4|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETR.5|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSRPSQVVAETR.4|STAISLFYELSENDLNFIKQSK.3|SNTGGQAFPQC[CAM]VFDHWQILPGDPFDNSSR.3
SEN / CTL,Q13361,Microfibrillar-associated protein 5,MFAP5,1.11,1.87,2.18E-01,4.50E-02,1.35E+00,"extracellular matrix organization,extracellular fibril organization,definitive hemopoiesis",extracellular matrix structural constituent,"microfibril,extracellular region",3,2,2,QC[CAM]IHQLC[CAM]FTSLR.3|EHEAMKDELC[CAM]R.3
SEN / CTL,Q16270,Insulin-like growth factor-binding protein 7,IGFBP7,1.11,1.27,7.70E-07,4.76E-07,6.32E+00,"regulation of cell growth,cell adhesion,embryo implantation,negative regulation of cell proliferation,response to heat,response to retinoic acid,cellular response to hormone stimulus,regulation of steroid biosynthetic process,response to cortisol","protein binding,insulin-like growth factor binding","extracellular region,extracellular space,extracellular exosome,extracellular matrix",33,12,15,TELLPGDRDNLAIQTR.3|TELLPGDRDNLAIQTR.2|SRYPVC[CAM]GSDGTTYPSGC[CAM]QLR.3|ITVVDALHEIPVK.3|GGPEKHEVTGWVLVSPLSK.4|AGAAAGGPGVSGVC[CAM]VC[CAM]K.2|AGAAAGGPGVSGVC[CAM]VC[CAM]K.3|GYC[CAM]APGMEC[CAM]VK.2|DAC[CAM]GC[CAM]C[CAM]PMC[CAM]AR.2|HEVTGWVLVSPLSKEDAGEYEC[CAM]HASNSQGQASASAK.5|HEVTGWVLVSPLSK.3|HEVTGWVLVSPLSK.2|GEGEPC[CAM]GGGGAGR.2|GTC[CAM]EQGPSIVTPPK.2|EDAGEYEC[CAM]HASNSQGQASASAK.3
SEN / CTL,P04083,Annexin A1,ANXA1,1.11,1.49,8.66E-07,5.26E-07,6.28E+00,"DNA strand renaturation,neutrophil homeostasis,adaptive immune response,monocyte chemotaxis,regulation of leukocyte migration,phagocytosis,inflammatory response,signal transduction,cell surface receptor signaling pathway,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,regulation of cell shape,response to X-ray,myoblast migration involved in skeletal muscle regeneration,peptide cross-linking,insulin secretion,keratinocyte differentiation,prostate gland development,endocrine pancreas development,positive regulation of vesicle fusion,positive regulation of prostaglandin biosynthetic process,actin cytoskeleton reorganization,response to estradiol,DNA duplex unwinding,regulation of interleukin-1 production,positive regulation of interleukin-2 production,positive regulation of neutrophil apoptotic process,DNA rewinding,gliogenesis,positive regulation of T cell proliferation,response to drug,negative regulation of apoptotic process,response to peptide hormone,estrous cycle,innate immune response,positive regulation of T-helper 1 cell differentiation,negative regulation of T-helper 2 cell differentiation,negative regulation of exocytosis,alpha-beta T cell differentiation,regulation of hormone secretion,arachidonic acid secretion,regulation of inflammatory response,cellular response to hydrogen peroxide,hepatocyte differentiation,prolactin secretion,response to interleukin-1,cellular response to glucocorticoid stimulus,granulocyte chemotaxis,positive regulation of wound healing,neutrophil clearance,positive regulation of G1/S transition of mitotic cell cycle,negative regulation of phospholipase A2 activity,negative regulation of interleukin-8 secretion","single-stranded DNA binding,single-stranded RNA binding,helicase activity,receptor binding,structural molecule activity,calcium ion binding,protein binding,phospholipid binding,calcium-dependent phospholipid binding,phospholipase A2 inhibitor activity,protein binding, bridging,double-stranded DNA-dependent ATPase activity,annealing helicase activity,protein homodimerization activity,calcium-dependent protein binding,cadherin binding involved in cell-cell adhesion","cornified envelope,phagocytic cup,extracellular region,extracellular space,nucleus,nucleoplasm,cytoplasm,endosome,plasma membrane,cell-cell adherens junction,focal adhesion,cell surface,basolateral plasma membrane,apical plasma membrane,lateral plasma membrane,extrinsic component of membrane,cytoplasmic vesicle membrane,extrinsic component of external side of plasma membrane,extrinsic component of endosome membrane,motile cilium,early endosome membrane,mitochondrial membrane,vesicle,sarcolemma,mast cell granule,protein complex,extracellular exosome",42,38,69,GLGTDEDTLIEILASR.2|GLGTDEDTLIEILASR.3|DLAKDITSDTSGDFR.2|DLAKDITSDTSGDFR.3|GDRSEDFGVNEDLADSDAR.3|GDRSEDFGVNEDLADSDAR.2|GVDEATIIDILTK.2|GVDEATIIDILTK.3|GVDEATIIDILTKR.3|RKGTDVNVFNTILTTR.4|RKGTDVNVFNTILTTR.3|RKGTDVNVFNTILTTR.2|KGTDVNVFNTILTTR.3|KGTDVNVFNTILTTR.2|ALTGHLEEVVLALLK.3|ALTGHLEEVVLALLK.4|ALTGHLEEVVLALLK.2|GTDVNVFNTILTTR.2|GTDVNVFNTILTTR.3|DITSDTSGDFR.2|DITSDTSGDFR.3|C[CAM]LTAIVK.2|PAFFAEK.2|NALLSLAK.2|VLDLELK.2|KALTGHLEEVVLALLK.4|KALTGHLEEVVLALLK.3|KALTGHLEEVVLALLK.2|ALYEAGER.2|C[CAM]ATSKPAFFAEK.3|C[CAM]ATSKPAFFAEK.2|VLDLELKGDIEK.3|VLDLELKGDIEK.2|ILVALC[CAM]GGN.2|ILVALC[CAM]GGN.1|PLDETLKK.2|AAYLQETGKPLDETLKK.4|AAYLQETGKPLDETLKK.3|AAYLQETGKPLDETLKK.2|AAYLQETGK.2|YSKHDMNK.2|ALYEAGERR.2|SEIDMNDIK.2|SEIDM[Oxi]NDIK.2|TPAQFDADELRAAM[Oxi]K.3|TPAQFDADELRAAMK.3|SEIDMNDIKAFYQK.3|MYGISLC[CAM]QAILDETK.3|M[Oxi]YGISLC[CAM]QAILDETK.2|MYGISLC[CAM]QAILDETK.2|SEDFGVNEDLADSDAR.3|SEDFGVNEDLADSDAR.2|AAYLQETGKPLDETLK.3|AAYLQETGKPLDETLK.2|GGPGSAVSPYPTFNPSSDVAALHK.4|GGPGSAVSPYPTFNPSSDVAALHK.3|GGPGSAVSPYPTFNPSSDVAALHK.2|DLAKDITSDTSGDFRNALLSLAK.4|TPAQFDADELR.2|SSKGGPGSAVSPYPTFNPSSDVAALHK.4|SSKGGPGSAVSPYPTFNPSSDVAALHK.3|DITSDTSGDFRNALLSLAK.3|DITSDTSGDFRNALLSLAK.2|ALTGHLEEVVLALLKTPAQFDADELR.4|QAWFIENEEQEYVQTVK.3|QAWFIENEEQEYVQTVK.2|MYGISLC[CAM]QAILDETKGDYEK.3|M[Oxi]YGISLC[CAM]QAILDETKGDYEK.3|MYGISLC[CAM]QAILDETKGDYEK.2
SEN / CTL,P30086,Phosphatidylethanolamine-binding protein 1,PEBP1,1.10,1.00,4.94E-04,1.93E-04,3.72E+00,"MAPK cascade,negative regulation of endopeptidase activity","serine-type endopeptidase inhibitor activity,protein binding,ATP binding,phosphatidylethanolamine binding,enzyme binding,protein kinase binding,poly(A) RNA binding","nucleus,cytosol,extracellular exosome",15,25,48,WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.4|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.5|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.3|YVWLVYEQDRPLKC[CAM]DEPILSNR.3|YVWLVYEQDRPLKC[CAM]DEPILSNR.4|GNDISSGTVLSDYVGSGPPK.3|GNDISSGTVLSDYVGSGPPK.2|GNDISSGTVLSDYVGSGPPKGTGLHR.4|GNDISSGTVLSDYVGSGPPKGTGLHR.3|VLTPTQVK.2|YREWHHFLVVNMK.4|YREWHHFLVVNM[Oxi]K.4|YREWHHFLVVNMK.3|YREWHHFLVVNM[Oxi]K.3|LYEQLSGK.2|EWHHFLVVNMK.3|EWHHFLVVNMK.2|LYTLVLTDPDAPSRKDPK.4|LYTLVLTDPDAPSRKDPK.3|LYTLVLTDPDAPSRKDPK.2|LYTLVLTDPDAPSR.3|LYTLVLTDPDAPSR.2|NRPTSISWDGLDSGK.3|NRPTSISWDGLDSGK.2|C[CAM]DEPILSNR.2|LYTLVLTDPDAPSRK.3|LYTLVLTDPDAPSRK.2|YVWLVYEQDRPLK.3|YVWLVYEQDRPLK.2|NRPTSISWDGLDSGKLYTLVLTDPDAPSRK.5|NRPTSISWDGLDSGKLYTLVLTDPDAPSRK.4|PTSISWDGLDSGK.2|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.6|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGK.5|YVWLVYEQDR.2|APVAGTC[CAM]YQAEWDDYVPK.3|APVAGTC[CAM]YQAEWDDYVPK.2|KYELRAPVAGTC[CAM]YQAEWDDYVPK.4|KYELRAPVAGTC[CAM]YQAEWDDYVPK.3|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.7|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.6|PVDLSKWSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.5|YREWHHFLVVNMKGNDISSGTVLSDYVGSGPPK.5|APVAGTC[CAM]YQAEWDDYVPKLYEQLSGK.4|APVAGTC[CAM]YQAEWDDYVPKLYEQLSGK.3|NRPTSISWDGLDSGKLYTLVLTDPDAPSR.4|NRPTSISWDGLDSGKLYTLVLTDPDAPSR.3|WSGPLSLQEVDEQPQHPLHVTYAGAAVDELGKVLTPTQVK.5
SEN / CTL,O00468,Agrin,AGRN,1.10,1.65,7.97E-05,3.72E-05,4.43E+00,"retinoid metabolic process,glycosaminoglycan biosynthetic process,glycosaminoglycan catabolic process,cytoskeleton organization,signal transduction,G-protein coupled acetylcholine receptor signaling pathway,extracellular matrix organization,glycosaminoglycan metabolic process,receptor clustering,positive regulation of GTPase activity,clustering of voltage-gated sodium channels,positive regulation of synaptic growth at neuromuscular junction,positive regulation of transcription from RNA polymerase II promoter,synapse organization,positive regulation of filopodium assembly","dystroglycan binding,structural constituent of cytoskeleton,calcium ion binding,protein binding,sialic acid binding,chondroitin sulfate binding,laminin binding,heparan sulfate proteoglycan binding","extracellular region,basal lamina,cytoplasm,Golgi lumen,plasma membrane,integral component of membrane,cell junction,extracellular matrix,lysosomal lumen,synapse,extracellular exosome",36,54,64,SIESTLDDLFR.2|SFLAFPTLR.2|GKDFLALALLDGR.3|TEATQGLVLWSGK.2|SAGDVDTLAFDGR.2|AYGTGFVGC[CAM]LR.2|AIVDVHFDPTTAFR.3|AIVDVHFDPTTAFR.2|GAPEGTVC[CAM]GSDGADYPGEC[CAM]QLLRR.3|EGSLQVGNEAPVTGSSPLGATQLDTDGALWLGGLPELPVGPALPK.4|EAAYVC[CAM]LC[CAM]PGGFSGPHC[CAM]EK.3|EAAYVC[CAM]LC[CAM]PGGFSGPHC[CAM]EK.2|VLGAPVPAFEGR.2|GLYVAAQGAC[CAM]R.2|QLLTPEHVLR.3|QLLTPEHVLR.2|TDGKGDFVSLALRDR.4|SREPVTLGAWTR.3|TDGKGDFVSLALR.3|ALQSNHFELSLR.3|LLDVNNQR.2|SELFGETAR.2|RPLQEHVR.2|DQC[CAM]PEPC[CAM]R.2|QVDVTSFAGHPC[CAM]TR.3|QVDVTSFAGHPC[CAM]TR.2|ALEPQGLLLYNGNAR.3|ALEPQGLLLYNGNAR.2|AIVDVHFDPTTAFRAPDVAR.4|EAAC[CAM]LQQTQIEEAR.3|EAAC[CAM]LQQTQIEEAR.2|TYDSDC[CAM]WR.2|LELGIGPGAATR.2|DFLALALLDGR.2|FGALC[CAM]EAETGR.2|HPLHLLEDAVTKPELRPC[CAM]PTP.4|AYGTGFVGC[CAM]LRDVVVGR.3|SGQC[CAM]QGRDQC[CAM]PEPC[CAM]R.3|VTC[CAM]DGAYRPVC[CAM]AQDGR.3|GPSGLLLYNGQK.2|AAAVSSGFDGAIQLVSLGGR.3|AAAVSSGFDGAIQLVSLGGR.2|IFFVNPAPPYLWPAHK.3|VGPTC[CAM]ADEKSPC[CAM]QPNPC[CAM]HGAAPC[CAM]R.4|KFDGPC[CAM]DPC[CAM]QGALPDPSR.3|KFDGPC[CAM]DPC[CAM]QGALPDPSR.2|EPLYVGGAPDFSK.2|SGQC[CAM]QGRDQC[CAM]PEPC[CAM]RFNAVC[CAM]LSR.4|LLDVNNQRLELGIGPGAATR.3|LLDVNNQRLELGIGPGAATR.2|FDTGSGPAVLTSAVPVEPGQWHRLELSR.4|TPSLDAEGSNC[CAM]PATK.2|GSGVGEC[CAM]GDHPC[CAM]LPNPC[CAM]HGGAPC[CAM]QNLEAGR.4|VVISGFGDPLIC[CAM]DNQVSTGDTR.3|VVISGFGDPLIC[CAM]DNQVSTGDTR.2|FDTGSGPAVLTSAVPVEPGQWHR.3|VLPEGGAQC[CAM]EC[CAM]PLGR.2|SADGLTASC[CAM]LC[CAM]PATC[CAM]R.2|VC[CAM]GSDGVTYGNEC[CAM]QLK.2|HQGPC[CAM]DQAPSPC[CAM]LGVQC[CAM]AFGATC[CAM]AVK.3|GMLC[CAM]GFGAVC[CAM]EPNAEGPGR.2|KSPC[CAM]PSVVAPVC[CAM]GSDASTYSNEC[CAM]ELQR.3|ASC[CAM]YNSALGC[CAM]C[CAM]SDGKTPSLDAEGSNC[CAM]PATK.3|ESLLDGGNKVVISGFGDPLIC[CAM]DNQVSTGDTR.3
SEN / CTL,P02751,Fibronectin,FN1,1.10,1.31,8.76E-83,3.33E-81,8.05E+01,"angiogenesis,regulation of protein phosphorylation,platelet degranulation,acute-phase response,cell-substrate junction assembly,cell adhesion,calcium-independent cell-matrix adhesion,positive regulation of cell proliferation,regulation of cell shape,response to wounding,positive regulation of gene expression,positive regulation of peptidase activity,peptide cross-linking,extracellular matrix disassembly,extracellular matrix organization,integrin activation,substrate adhesion-dependent cell spreading,endodermal cell differentiation,wound healing,positive regulation of axon extension,positive regulation of fibroblast proliferation,leukocyte migration,regulation of ERK1 and ERK2 cascade,positive regulation of substrate-dependent cell migration, cell attachment to substrate,negative regulation of transforming growth factor-beta secretion","protease binding,integrin binding,protein binding,collagen binding,heparin binding,peptidase activator activity","extracellular region,fibrinogen complex,basal lamina,extracellular space,endoplasmic reticulum-Golgi intermediate compartment,apical plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome,blood microparticle",402,126,209,FLATTPNSLLVSWQPPR.3|FLATTPNSLLVSWQPPR.2|VTWAPPPSIDLTNFLVR.2|VTWAPPPSIDLTNFLVR.3|SSPVVIDASTAIDAPSNLR.2|SSPVVIDASTAIDAPSNLR.3|TYLGNALVC[CAM]TC[CAM]YGGSR.2|TYLGNALVC[CAM]TC[CAM]YGGSR.3|LLC[CAM]QC[CAM]LGFGSGHFR.3|LLC[CAM]QC[CAM]LGFGSGHFR.2|NTFAEVTGLSPGVTYYFK.2|NTFAEVTGLSPGVTYYFK.3|GFNC[CAM]ESKPEAEETC[CAM]FDKYTGNTYR.4|GFNC[CAM]ESKPEAEETC[CAM]FDKYTGNTYR.3|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADREDSRE.3|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADREDSRE.4|EYLGAIC[CAM]SC[CAM]TC[CAM]FGGQR.2|EYLGAIC[CAM]SC[CAM]TC[CAM]FGGQR.3|WLPSSSPVTGYR.2|GLAFTDVDVDSIK.2|TKTETITGFQVDAVPANGQTPIQR.3|YSFC[CAM]TDHTVLVQTR.3|YSFC[CAM]TDHTVLVQTR.2|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.5|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.6|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]KPIAEK.4|WSRPQAPITGYR.3|DGQERDAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWER.5|DAPIVNKVVTPLSPPTNLHLEANPDTGVLTVSWER.4|TAGPDQTEMTIEGLQPTVEYVVSVYAQNPSGESQPLVQTAVTNIDRPK.5|QKTGLDSPTGIDFSDITANSFTVHWIAPR.4|STTPDITGYR.2|C[CAM]FDHAAGTSYVVGETWEKPYQGWMMVDC[CAM]TC[CAM]LGEGSGR.4|SYTITGLQPGTDYKIYLYTLNDNAR.3|C[CAM]TC[CAM]VGNGRGEWTC[CAM]IAYSQLR.3|NLQPASEYTVSLVAIKGNQESPK.3|NLQPASEYTVSLVAIKGNQESPK.4|HTSVQTTSSGSGPFTDVR.3|HTSVQTTSSGSGPFTDVR.2|FTQVTPTSLSAQWTPPNVQLTGYR.3|FTQVTPTSLSAQWTPPNVQLTGYR.4|VGDTYERPKDSMIWDC[CAM]TC[CAM]IGAGR.4|VGDTYERPKDSMIWDC[CAM]TC[CAM]IGAGR.3|VGDTYERPKDSM[Oxi]IWDC[CAM]TC[CAM]IGAGR.4|GEWTC[CAM]IAYSQLR.2|GEWTC[CAM]IAYSQLR.3|IYLYTLNDNAR.2|IYLYTLNDNAR.3|NLQPASEYTVSLVAIK.2|NLQPASEYTVSLVAIK.3|DLQFVEVTDVK.2|VVTPLSPPTNLHLEANPDTGVLTVSWER.3|VTIMWTPPESAVTGYRVDVIPVNLPGEHGQR.4|LGVRPSQGGEAPREVTSDSGSIVVSGLTPGVEYVYTIQVLR.4|QYNVGPSVSKYPLR.3|QYNVGPSVSKYPLR.2|IAWESPQGQVSR.2|FTNIGPDTMR.2|RPGGEPSPEGTTGQSYNQYSQR.3|YEKPGSPPREVVPRPRPGVTEATITGLEPGTEYTIYVIALK.6|VDVIPVNLPGEHGQR.3|VDVIPVNLPGEHGQR.2|WKEATIPGHLNSYTIK.4|WKEATIPGHLNSYTIK.3|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.5|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.6|KKTDELPQLVTLPHPNLHGPEILDVPSTVQK.4|VREEVVTVGNSVNEGLNQPTDDSC[CAM]FDPYTVSHYAVGDEWER.4|VDVIPVNLPGEHGQRLPISR.4|TFYSC[CAM]TTEGR.2|C[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.5|C[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.4|GNLLQC[CAM]IC[CAM]TGNGR.2|WC[CAM]GTTQNYDADQK.2|YQC[CAM]YC[CAM]YGR.2|VPGTSTSATLTGLTR.2|VPGTSTSATLTGLTR.3|GLKPGVVYEGQLISIQQYGHQEVTR.4|GLKPGVVYEGQLISIQQYGHQEVTR.3|ITGYIIKYEKPGSPPR.4|ITGYIIKYEKPGSPPR.3|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGMQWLK.4|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGMQWLK.5|AAVYQPQPHPQPPPYGHC[CAM]VTDSGVVYSVGM[Oxi]QWLK.4|SYTITGLQPGTDYK.2|SYTITGLQPGTDYK.3|C[CAM]DPVDQC[CAM]QDSETGTFYQIGDSWEK.3|NSITLTNLTPGTEYVVSIVALNGREESPLLIGQQSTVSDVPR.4|GNLLQC[CAM]IC[CAM]TGNGRGEWK.3|ISC[CAM]TIANR.2|DSMIWDC[CAM]TC[CAM]IGAGR.2|DSM[Oxi]IWDC[CAM]TC[CAM]IGAGR.2|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVMYR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVMYR.4|FGFC[CAM]PM[Oxi]AAHEEIC[CAM]TTNEGVMYR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVM[Oxi]YR.3|FGFC[CAM]PMAAHEEIC[CAM]TTNEGVM[Oxi]YR.4|FGFC[CAM]PM[Oxi]AAHEEIC[CAM]TTNEGVM[Oxi]YR.3|TEIDKPSQMQVTDVQDNSISVK.3|TEIDKPSQM[Oxi]QVTDVQDNSISVK.3|TEIDKPSQMQVTDVQDNSISVK.4|DDKESVPISDTIIPAVPPPTDLR.3|DDKESVPISDTIIPAVPPPTDLR.4|TETITGFQVDAVPANGQTPIQR.3|TETITGFQVDAVPANGQTPIQR.2|NSITLTNLTPGTEYVVSIVALNGR.3|YEVSVYALK.2|HYQINQQWER.3|HYQINQQWER.2|QGENGQMMSC[CAM]TC[CAM]LGNGKGEFK.3|VTIMWTPPESAVTGYR.2|VTIMWTPPESAVTGYR.3|VTIM[Oxi]WTPPESAVTGYR.3|VTIM[Oxi]WTPPESAVTGYR.2|EVVPRPRPGVTEATITGLEPGTEYTIYVIALK.4|EVVPRPRPGVTEATITGLEPGTEYTIYVIALK.3|IGDQWDKQHDMGHMMR.4|IGDQWDKQHDM[Oxi]GHMMR.4|ITYGETGGNSPVQEFTVPGSK.2|ITYGETGGNSPVQEFTVPGSK.3|STATISGLKPGVDYTITVYAVTGR.3|STATISGLKPGVDYTITVYAVTGR.4|NTFAEVTGLSPGVTYYFKVFAVSHGR.4|DTLTSRPAQGVVTTLENVSPPR.3|DTLTSRPAQGVVTTLENVSPPR.4|DTLTSRPAQGVVTTLENVSPPR.2|QDGHLWC[CAM]STTSNYEQDQK.3|QDGHLWC[CAM]STTSNYEQDQK.4|QDGHLWC[CAM]STTSNYEQDQK.2|VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGRK.4|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.4|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.3|RPHETGGYMLEC[CAM]VC[CAM]LGNGK.2|RPHETGGYM[Oxi]LEC[CAM]VC[CAM]LGNGK.3|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.5|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFRR.6|TGLDSPTGIDFSDITANSFTVHWIAPR.3|TGLDSPTGIDFSDITANSFTVHWIAPR.4|QAQQMVQPQSPVAVSQSKPGC[CAM]YDNGK.3|QAQQM[Oxi]VQPQSPVAVSQSKPGC[CAM]YDNGK.3|DLEVVAATPTSLLISWDAPAVTVR.3|GEFKC[CAM]DPHEATC[CAM]YDDGKTYHVGEQWQK.5|ITGYIIK.2|HRPRPYPPNVGEEIQIGHIPR.5|HRPRPYPPNVGEEIQIGHIPR.4|DTLTSRPAQGVVTTLENVSPPRR.4|DTLTSRPAQGVVTTLENVSPPRR.3|YEVSVYALKDTLTSRPAQGVVTTLENVSPPRR.5|GFNC[CAM]ESKPEAEETC[CAM]FDK.3|GFNC[CAM]ESKPEAEETC[CAM]FDK.2|PRPGVTEATITGLEPGTEYTIYVIALK.3|PRPGVTEATITGLEPGTEYTIYVIALK.4|EATIPGHLNSYTIK.3|EATIPGHLNSYTIK.2|PAQGVVTTLENVSPPR.4|PAQGVVTTLENVSPPR.3|PAQGVVTTLENVSPPR.2|TYHVGEQWQK.3|TYHVGEQWQK.2|IGDQWDK.2|SDTVPSPR.2|VFAVSHGR.2|WC[CAM]HDNGVNYK.3|WC[CAM]HDNGVNYK.2|GEWTC[CAM]KPIAEK.3|GEWTC[CAM]KPIAEK.2|LGVRPSQGGEAPR.3|LGVRPSQGGEAPR.2|YTGNTYR.2|DGQERDAPIVNK.3|DGQERDAPIVNK.2|ESKPLTAQQTTK.3|ESKPLTAQQTTK.2|PAQGVVTTLENVSPPRR.4|PAQGVVTTLENVSPPRR.3|PAQGVVTTLENVSPPRR.2|C[CAM]TC[CAM]VGNGR.2|PLTAQQTTK.2|C[CAM]DPHEATC[CAM]YDDGK.3|C[CAM]DPHEATC[CAM]YDDGK.2|GDSPASSKPISINYR.3|GDSPASSKPISINYR.2|VGDTYERPK.2|C[CAM]HEGGQSYK.2|QYNVGPSVSK.2|PRPYPPNVGEEIQIGHIPR.4|QHDMGHMMR.2|EESPLLIGQQSTVSDVPR.3|EESPLLIGQQSTVSDVPR.2|C[CAM]FDHAAGTSYVVGETWEK.3|EINLAPDSSSVVVSGLMVATK.3|EINLAPDSSSVVVSGLM[Oxi]VATK.3|EINLAPDSSSVVVSGLM[Oxi]VATK.2|EINLAPDSSSVVVSGLMVATK.2|ESVPISDTIIPAVPPPTDLR.3|ESVPISDTIIPAVPPPTDLR.2|PYQGWMMVDC[CAM]TC[CAM]LGEGSGR.3|PYQGWMMVDC[CAM]TC[CAM]LGEGSGR.2|RPHETGGYMLEC[CAM]VC[CAM]LGNGKGEWTC[CAM]K.4|RQAQQMVQPQSPVAVSQSKPGC[CAM]YDNGK.4|TDELPQLVTLPHPNLHGPEILDVPSTVQK.4|VTDATETTITISWR.2|TNTNVNC[CAM]PIEC[CAM]FMPLDVQADR.3|VEYELSEEGDEPQYLDLPSTATSVNIPDLLPGR.4|QGENGQMMSC[CAM]TC[CAM]LGNGK.2|EVTSDSGSIVVSGLTPGVEYVYTIQVLR.3|EEVVTVGNSVNEGLNQPTDDSC[CAM]FDPYTVSHYAVGDEWER.4|TPFVTHPGYDTGNGIQLPGTSGQQPSVGQQMIFEEHGFR.4|QMLC[CAM]TC[CAM]LGNGVSC[CAM]QETAVTQTYGGNSNGEPC[CAM]VLPFTYNGR.4
SEN / CTL,Q15063,Periostin,POSTN,1.10,1.37,1.15E-15,2.36E-15,1.46E+01,"skeletal system development,response to hypoxia,negative regulation of cell-matrix adhesion,regulation of systemic arterial blood pressure,cell adhesion,regulation of Notch signaling pathway,response to mechanical stimulus,response to muscle activity,positive regulation of smooth muscle cell migration,extracellular matrix organization,response to estradiol,cellular response to fibroblast growth factor stimulus,cellular response to vitamin K,cellular response to tumor necrosis factor,cellular response to transforming growth factor beta stimulus,negative regulation of substrate adhesion-dependent cell spreading,positive regulation of chemokine (C-C motif) ligand 2 secretion,neuron projection extension,bone regeneration","protein binding,heparin binding,metal ion binding,cell adhesion molecule binding","proteinaceous extracellular matrix,extracellular space,trans-Golgi network,extracellular matrix,neuromuscular junction",81,48,80,GC[CAM]PAVLPIDHVYGTLGIVGATTTQR.3|GC[CAM]PAVLPIDHVYGTLGIVGATTTQR.4|AAAITSDILEALGR.2|GSFTYFAPSNEAWDNLDSDIRR.3|IIDGVPVEITEKETR.3|DQGPNVC[CAM]ALQQILGTK.2|DQGPNVC[CAM]ALQQILGTK.3|VLTQIGTSIQDFIEAEDDLSSFR.3|VLTQIGTSIQDFIEAEDDLSSFR.4|DGHFTLFAPTNEAFEKLPR.4|DGHFTLFAPTNEAFEKLPR.3|DGHFTLFAPTNEAFEKLPR.2|GLESNVNVELLNALHSHMINKR.5|AAAITSDILEALGRDGHFTLFAPTNEAFEKLPR.5|AAAITSDILEALGRDGHFTLFAPTNEAFEKLPR.4|GFEPGVTNILK.2|IIDGVPVEITEK.2|DQGPNVC[CAM]ALQQILGTKK.3|IIHGNQIATNGVVHVIDR.3|IIHGNQIATNGVVHVIDR.4|IIHGNQIATNGVVHVIDR.2|DKNALQNIILYHLTPGVFIGK.4|DKNALQNIILYHLTPGVFIGK.3|TTVLYEC[CAM]C[CAM]PGYMR.2|TTVLYEC[CAM]C[CAM]PGYM[Oxi]R.2|DGHFTLFAPTNEAFEK.3|DGHFTLFAPTNEAFEK.2|GRDQGPNVC[CAM]ALQQILGTK.3|GRDQGPNVC[CAM]ALQQILGTK.2|NALQNIILYHLTPGVFIGK.3|NALQNIILYHLTPGVFIGK.4|NALQNIILYHLTPGVFIGK.2|DIVTNNGVIHLIDQVLIPDSAK.3|DIVTNNGVIHLIDQVLIPDSAK.4|DIVTNNGVIHLIDQVLIPDSAK.2|TAVC[CAM]IENSC[CAM]MEK.2|TAVC[CAM]IENSC[CAM]M[Oxi]EK.2|VGLNELYNGQILETIGGK.3|VGLNELYNGQILETIGGK.2|VASEALMK.2|IITGPEIK.2|IITGPEIKYTR.3|QVIELAGK.2|EIIKPAEK.2|NGAIHIFR.2|ISTGGGETEETLKK.3|ISTGGGETEETLKK.2|LLQEEVTK.2|LILQNHILK.2|IRGRDQGPNVC[CAM]ALQQILGTK.4|RFSTFLSLLEAADLK.3|RFSTFLSLLEAADLK.2|ESDIMTTNGVIHVVDK.3|ESDIMTTNGVIHVVDK.2|GLESNVNVELLNALHSHM[Oxi]INK.4|GLESNVNVELLNALHSHMINK.4|GLESNVNVELLNALHSHMINK.3|GLESNVNVELLNALHSHM[Oxi]INK.3|EGETITEVIHGEPIIK.3|FIEGGDGHLFEDEEIK.3|RGLESNVNVELLNALHSHMINK.4|EGETITEVIHGEPIIKK.3|KDIVTNNGVIHLIDQVLIPDSAK.4|KDIVTNNGVIHLIDQVLIPDSAK.3|AAAITSDILEALGRDGHFTLFAPTNEAFEK.5|AAAITSDILEALGRDGHFTLFAPTNEAFEK.3|SKESDIMTTNGVIHVVDK.3|ISTGGGETEETLK.2|IIDGVPVEITEKETREER.3|LLYPADTPVGNDQLLEILNK.3|LLYPADTPVGNDQLLEILNK.2|ELLTQPGDWTLFVPTNDAFK.3|ELLTQPGDWTLFVPTNDAFK.2|FSTFLSLLEAADLK.2|GSFTYFAPSNEAWDNLDSDIR.3|NGMIIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.4|NGM[Oxi]IIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.4|NGM[Oxi]IIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.3|NGMIIPSM[Oxi]YNNLGLFINHYPNGVVTVNC[CAM]AR.3|NGMIIPSMYNNLGLFINHYPNGVVTVNC[CAM]AR.3
SEN / CTL,P23528,Cofilin-1,CFL1,1.09,1.01,5.36E-11,6.57E-11,1.02E+01,"cytoskeleton organization,Rho protein signal transduction,response to virus,regulation of cell morphogenesis,actin cytoskeleton organization,actin filament depolymerization,negative regulation of apoptotic process,positive regulation by host of viral process,regulation of dendritic spine morphogenesis","protein binding,actin filament binding","extracellular space,nucleus,cytoplasm,focal adhesion,actin cytoskeleton,membrane,nuclear matrix,extracellular matrix,lamellipodium membrane,vesicle,ruffle membrane,extracellular exosome",42,24,46,ESKKEDLVFIFWAPESAPLK.4|ESKKEDLVFIFWAPESAPLK.3|ESKKEDLVFIFWAPESAPLK.2|NIILEEGKEILVGDVGQTVDDPYATFVK.4|NIILEEGKEILVGDVGQTVDDPYATFVK.3|NIILEEGKEILVGDVGQTVDDPYATFVK.5|LTGIKHELQANC[CAM]YEEVKDR.4|LTGIKHELQANC[CAM]YEEVKDR.5|LTGIKHELQANC[CAM]YEEVKDR.3|LGGSAVISLEGKPL.2|LGGSAVISLEGKPL.3|AVLFC[CAM]LSEDKK.3|AVLFC[CAM]LSEDKK.2|KEDLVFIFWAPESAPLK.3|KEDLVFIFWAPESAPLK.4|KEDLVFIFWAPESAPLK.2|KAVLFC[CAM]LSEDK.3|SSTPEEVK.2|HELQANC[CAM]YEEVKDR.4|HELQANC[CAM]YEEVKDR.3|HELQANC[CAM]YEEVKDR.2|NIILEEGK.2|KAVLFC[CAM]LSEDKK.3|KAVLFC[CAM]LSEDKK.2|DRC[CAM]TLAEK.2|KSSTPEEVK.2|SSTPEEVKK.2|HELQANC[CAM]YEEVK.3|HELQANC[CAM]YEEVK.2|LTGIKHELQANC[CAM]YEEVK.4|LTGIKHELQANC[CAM]YEEVK.3|LTGIKHELQANC[CAM]YEEVK.2|KNIILEEGK.2|MLPDKDC[CAM]R.2|M[Oxi]LPDKDC[CAM]R.2|EILVGDVGQTVDDPYATFVK.4|EILVGDVGQTVDDPYATFVK.3|EILVGDVGQTVDDPYATFVK.2|KLTGIKHELQANC[CAM]YEEVK.4|KLTGIKHELQANC[CAM]YEEVK.3|KLTGIKHELQANC[CAM]YEEVK.2|AVLFC[CAM]LSEDKKNIILEEGK.4|LGGSAVISLEGK.2|AVLFC[CAM]LSEDK.2|KNIILEEGKEILVGDVGQTVDDPYATFVK.4|KNIILEEGKEILVGDVGQTVDDPYATFVK.3
SEN / CTL,O00584,Ribonuclease T2,RNASET2,1.09,0.70,8.00E-04,2.96E-04,3.53E+00,"RNA catabolic process,RNA phosphodiester bond hydrolysis, endonucleolytic","RNA binding,ribonuclease activity,ribonuclease T2 activity","extracellular region,extracellular space,lysosome,endoplasmic reticulum lumen,lysosomal lumen,extracellular exosome",9,17,29,ELDLNSVLLK.2|SWPFNLEEIKDLLPEMR.3|LGIKPSINYYQVADFKDALAR.4|VC[CAM]EDGPVFYPPPKK.4|VC[CAM]EDGPVFYPPPKK.3|HGTC[CAM]AAQVDALNSQKK.4|HGTC[CAM]AAQVDALNSQKK.3|HGTC[CAM]AAQVDALNSQKK.2|LGIKPSINYYQVADFK.4|LGIKPSINYYQVADFK.3|LGIKPSINYYQVADFK.2|KLIMVQHWPETVC[CAM]EK.4|KLIMVQHWPETVC[CAM]EK.3|KLIMVQHWPETVC[CAM]EK.2|HGTC[CAM]AAQVDALNSQK.3|HGTC[CAM]AAQVDALNSQK.2|LIMVQHWPETVC[CAM]EK.3|LIM[Oxi]VQHWPETVC[CAM]EK.3|LIMVQHWPETVC[CAM]EK.2|DPPDYWTIHGLWPDK.3|DPPDYWTIHGLWPDK.2|SLELYRELDLNSVLLK.3|SWPFNLEEIK.2|IQNDC[CAM]RDPPDYWTIHGLWPDK.4|IQNDC[CAM]RDPPDYWTIHGLWPDK.3|PSINYYQVADFK.2|QEVWLANGAAESR.2|VC[CAM]EDGPVFYPPPK.2|IQC[CAM]LPPSQDEEVQTIGQIELC[CAM]LTK.3
SEN / CTL,P50395,Rab GDP dissociation inhibitor beta,GDI2,1.07,1.36,3.01E-07,1.92E-07,6.72E+00,"signal transduction,small GTPase mediated signal transduction,protein transport,vesicle-mediated transport,positive regulation of GTPase activity,regulation of small GTPase mediated signal transduction,oxidation-reduction process","Rab GDP-dissociation inhibitor activity,GTPase activator activity,protein binding,oxidoreductase activity,small GTPase binding,poly(A) RNA binding","cytoplasm,Golgi apparatus,cytosol,focal adhesion,membrane,vesicle,myelin sheath,extracellular exosome",36,56,113,KFDLGQDVIDFTGHALALYR.3|KFDLGQDVIDFTGHALALYR.4|KFDLGQDVIDFTGHALALYR.2|MLLYTEVTR.2|M[Oxi]LLYTEVTR.2|FVSISDLLVPK.2|FVSISDLLVPK.3|SPYLYPLYGLGELPQGFAR.3|SPYLYPLYGLGELPQGFAR.4|SPYLYPLYGLGELPQGFAR.2|TDDYLDQPC[CAM]YETINR.3|TDDYLDQPC[CAM]YETINR.2|DLGTESQIFISR.2|VLHMDRNPYYGGESASITPLEDLYKR.5|VLHM[Oxi]DRNPYYGGESASITPLEDLYKR.5|VLHMDRNPYYGGESASITPLEDLYKR.4|IYKVPSTEAEALASSLMGLFEK.3|IYKVPSTEAEALASSLM[Oxi]GLFEK.4|IYKVPSTEAEALASSLMGLFEK.4|IYKVPSTEAEALASSLM[Oxi]GLFEK.3|IYKVPSTEAEALASSLMGLFEK.2|FDLGQDVIDFTGHALALYR.3|FDLGQDVIDFTGHALALYR.4|FDLGQDVIDFTGHALALYR.2|KSDIYVC[CAM]MISFAHNVAAQGK.4|KSDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.4|KSDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.3|KSDIYVC[CAM]MISFAHNVAAQGK.3|KSDIYVC[CAM]MISFAHNVAAQGK.2|VTEGSFVYKGGK.3|GRDWNVDLIPK.3|GRDWNVDLIPK.2|TFEGIDPK.2|FKIPGSPPESMGR.3|LYSESLAR.2|KNDIYGED.2|QLIC[CAM]DPSYVKDR.3|VTEGSFVYK.2|TYDATTHFETTC[CAM]DDIKNIYKR.5|TYDATTHFETTC[CAM]DDIKNIYKR.4|MTGSEFDFEEMKR.3|M[Oxi]TGSEFDFEEMKR.3|MTGSEFDFEEM[Oxi]KR.3|MTGSEFDFEEMKR.2|RMTGSEFDFEEMK.3|RMTGSEFDFEEMK.2|KKNDIYGED.2|DWNVDLIPK.2|FLMANGQLVK.2|FLM[Oxi]ANGQLVK.2|EPEKEIRPALELLEPIEQK.4|EPEKEIRPALELLEPIEQK.3|IPGSPPESMGR.2|IPGSPPESM[Oxi]GR.2|YLDFKVTEGSFVYK.3|FLVYVANFDEKDPR.3|FLVYVANFDEKDPR.2|NTNDANSC[CAM]QIIIPQNQVNRK.4|NTNDANSC[CAM]QIIIPQNQVNRK.3|NTNDANSC[CAM]QIIIPQNQVNRK.2|RMTGSEFDFEEMKR.3|RM[Oxi]TGSEFDFEEMKR.3|RMTGSEFDFEEM[Oxi]KR.3|EIRPALELLEPIEQK.3|EIRPALELLEPIEQK.2|VIC[CAM]ILSHPIK.2|YIAIVSTTVETKEPEK.3|YIAIVSTTVETKEPEK.2|QLIC[CAM]DPSYVK.2|TYDATTHFETTC[CAM]DDIKNIYK.4|TYDATTHFETTC[CAM]DDIKNIYK.3|PIEEIIVQNGK.2|TYDATTHFETTC[CAM]DDIK.3|TYDATTHFETTC[CAM]DDIK.2|VPSTEAEALASSLMGLFEK.3|VPSTEAEALASSLM[Oxi]GLFEK.3|VPSTEAEALASSLM[Oxi]GLFEK.2|VPSTEAEALASSLMGLFEK.2|LSAIYGGTYMLNKPIEEIIVQNGK.4|LSAIYGGTYM[Oxi]LNKPIEEIIVQNGK.3|LSAIYGGTYMLNKPIEEIIVQNGK.3|YIAIVSTTVETK.2|FLVYVANFDEK.2|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.5|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.4|VIC[CAM]ILSHPIKNTNDANSC[CAM]QIIIPQNQVNR.3|PALELLEPIEQK.2|NPYYGGESASITPLEDLYK.3|NPYYGGESASITPLEDLYK.2|SDIYVC[CAM]MISFAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.3|SDIYVC[CAM]M[Oxi]ISFAHNVAAQGK.2|SDIYVC[CAM]MISFAHNVAAQGK.2|YIAIVSTTVETKEPEKEIRPALELLEPIEQK.5|YIAIVSTTVETKEPEKEIRPALELLEPIEQK.4|LSAIYGGTYMLNK.2|VLHM[Oxi]DRNPYYGGESASITPLEDLYK.4|VLHMDRNPYYGGESASITPLEDLYK.4|VLHM[Oxi]DRNPYYGGESASITPLEDLYK.3|VLHMDRNPYYGGESASITPLEDLYK.3|M[Oxi]TGSEFDFEEMK.2|MTGSEFDFEEM[Oxi]K.2|MTGSEFDFEEMK.2|NTNDANSC[CAM]QIIIPQNQVNR.3|NTNDANSC[CAM]QIIIPQNQVNR.2|EIRPALELLEPIEQKFVSISDLLVPK.4|KVLHMDRNPYYGGESASITPLEDLYK.4|NPYYGGESASITPLEDLYKR.3|NPYYGGESASITPLEDLYKR.2|KFDLGQDVIDFTGHALALYRTDDYLDQPC[CAM]YETINR.5|KFDLGQDVIDFTGHALALYRTDDYLDQPC[CAM]YETINR.4|YGKSPYLYPLYGLGELPQGFAR.3|FVSISDLLVPKDLGTESQIFISR.3
SEN / CTL,O00299,Chloride intracellular channel protein 1,CLIC1,1.07,1.63,6.02E-05,2.89E-05,4.54E+00,"chloride transport,signal transduction,regulation of ion transmembrane transport,positive regulation of osteoblast differentiation,regulation of cell cycle,regulation of mitochondrial membrane potential,platelet aggregation,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,cadherin binding involved in cell-cell adhesion,glutathione transferase activity","extracellular space,nucleus,nuclear envelope,cytoplasm,mitochondrion,plasma membrane,brush border,cell-cell adherens junction,membrane,nuclear membrane,vesicle,chloride channel complex,perinuclear region of cytoplasm,extracellular exosome,blood microparticle",24,24,42,LAALNPESNTAGLDIFAK.2|LAALNPESNTAGLDIFAK.3|GFTIPEAFR.2|YRGFTIPEAFR.3|YRGFTIPEAFR.2|LC[CAM]PGGQLPFLLYGTEVHTDTNKIEEFLEAVLC[CAM]PPRYPK.5|LC[CAM]PGGQLPFLLYGTEVHTDTNKIEEFLEAVLC[CAM]PPRYPK.4|GVTFNVTTVDTK.2|GVTFNVTTVDTK.3|EEFASTC[CAM]PDDEEIELAYEQVAK.3|EEFASTC[CAM]PDDEEIELAYEQVAK.4|LFMVLWLK.2|LFM[Oxi]VLWLK.2|LHIVQVVC[CAM]KK.3|LHIVQVVC[CAM]KK.2|GVTFNVTTVDTKR.3|GVTFNVTTVDTKR.2|YLSNAYAR.2|IEEFLEAVLC[CAM]PPRYPK.4|IEEFLEAVLC[CAM]PPRYPK.3|IEEFLEAVLC[CAM]PPRYPK.2|IEEFLEAVLC[CAM]PPR.3|IEEFLEAVLC[CAM]PPR.2|IGNC[CAM]PFSQR.2|LHIVQVVC[CAM]K.2|LC[CAM]PGGQLPFLLYGTEVHTDTNK.4|LC[CAM]PGGQLPFLLYGTEVHTDTNK.3|FLDGNELTLADC[CAM]NLLPK.3|FLDGNELTLADC[CAM]NLLPK.2|NSNPALNDNLEK.2|KFLDGNELTLADC[CAM]NLLPK.3|KFLDGNELTLADC[CAM]NLLPK.2|VLDNYLTSPLPEEVDETSAEDEGVSQR.4|VLDNYLTSPLPEEVDETSAEDEGVSQR.3|VLDNYLTSPLPEEVDETSAEDEGVSQRK.4|VLDNYLTSPLPEEVDETSAEDEGVSQRK.3|ALKVLDNYLTSPLPEEVDETSAEDEGVSQR.4|ALKVLDNYLTSPLPEEVDETSAEDEGVSQR.3|IGNC[CAM]PFSQRLFMVLWLKGVTFNVTTVDTK.4|NSNPALNDNLEKGLLK.2|YLSNAYAREEFASTC[CAM]PDDEEIELAYEQVAK.4|YLSNAYAREEFASTC[CAM]PDDEEIELAYEQVAK.3
SEN / CTL,P68032,"Actin, alpha cardiac muscle 1",ACTC1,1.05,1.12,1.04E-05,5.50E-06,5.26E+00,"apoptotic process,positive regulation of gene expression,actin filament-based movement,muscle filament sliding,skeletal muscle thin filament assembly,actomyosin structure organization,actin-myosin filament sliding,response to drug,negative regulation of apoptotic process,response to ethanol,cardiac myofibril assembly,cardiac muscle tissue morphogenesis,heart contraction,cardiac muscle contraction,mesenchyme migration","ATP binding,ATPase activity,myosin binding","extracellular space,cytoplasm,cytosol,actin filament,focal adhesion,membrane,sarcomere,lamellipodium,filopodium,I band,actomyosin, actin portion,cell body,extracellular exosome,blood microparticle",48,8,32,EKLC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.3|VAPEEHPTLLTEAPLNPK.3|VAPEEHPTLLTEAPLNPK.2|VAPEEHPTLLTEAPLNPK.4|YPIEHGIITNWDDMEKIWHHTFYNELR.5|YPIEHGIITNWDDMEKIWHHTFYNELR.6|YPIEHGIITNWDDMEKIWHHTFYNELR.4|YPIEHGIITNWDDMEKIWHHTFYNELR.3|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.6|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.5|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.4|YPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.3|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.6|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.5|GILTLKYPIEHGIITNWDDMEKIWHHTFYNELR.7|GILTLKYPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.7|GILTLKYPIEHGIITNWDDM[Oxi]EKIWHHTFYNELR.6|YPIEHGIITNWDDMEK.3|YPIEHGIITNWDDMEK.2|YPIEHGIITNWDDMEK.4|YPIEHGIITNWDDM[Oxi]EK.3|YPIEHGIITNWDDM[Oxi]EK.2|LC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.3|LC[CAM]YVALDFENEM[Oxi]ATAASSSSLEK.4|LC[CAM]YVALDFENEMATAASSSSLEK.4|LC[CAM]YVALDFENEMATAASSSSLEK.3|GYSFVTTAER.2|DLYANNVLSGGTTMYPGIADR.3|DLYANNVLSGGTTMYPGIADR.4|DLYANNVLSGGTTM[Oxi]YPGIADR.3|DLYANNVLSGGTTM[Oxi]YPGIADR.2|DLYANNVLSGGTTMYPGIADR.2
SEN / CTL,P60709;P63261,"Actin, cytoplasmic 1;Actin, cytoplasmic 2",ACTB;ACTG1,1.05,1.52,6.46E-16,1.36E-15,1.49E+01,"retina homeostasis,movement of cell or subcellular component,cytoskeleton organization,substantia nigra development,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,ATP-dependent chromatin remodeling,positive regulation of gene expression, epigenetic,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,platelet aggregation;retina homeostasis,movement of cell or subcellular component,cell junction assembly,Fc-gamma receptor signaling pathway involved in phagocytosis,sarcomere organization,vascular endothelial growth factor receptor signaling pathway,ephrin receptor signaling pathway,platelet aggregation","structural constituent of cytoskeleton,protein binding,ATP binding,kinesin binding,Tat protein binding,identical protein binding,nitric-oxide synthase binding,RNA polymerase II core promoter proximal region sequence-specific DNA binding,RNA polymerase II distal enhancer sequence-specific DNA binding,nucleosomal DNA binding;structural constituent of cytoskeleton,protein binding,ATP binding,ubiquitin protein ligase binding","nuclear chromatin,extracellular space,nucleoplasm,cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,intracellular ribonucleoprotein complex,cortical cytoskeleton,NuA4 histone acetyltransferase complex,cytoplasmic ribonucleoprotein granule,myelin sheath,protein complex,extracellular exosome,MLL5-L complex,blood microparticle,dense body;extracellular space,nucleus,cytosol,cytoskeleton,plasma membrane,focal adhesion,membrane,myofibril,extracellular matrix,filamentous actin,myelin sheath,extracellular exosome,blood microparticle,dense body",174,28,111,SYELPDGQVITIGNER.2|SYELPDGQVITIGNER.3|GYSFTTTAEREIVR.3|GYSFTTTAEREIVR.2|GYSFTTTAER.2|VAPEEHPVLLTEAPLNPK.3|VAPEEHPVLLTEAPLNPK.2|VAPEEHPVLLTEAPLNPK.4|DLTDYLMK.2|DLTDYLMK.1|DLTDYLM[Oxi]K.2|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.4|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.4|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.3|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.3|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.5|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.5|TTGIVMDSGDGVTHTVPIYEGYALPHAILR.6|TTGIVM[Oxi]DSGDGVTHTVPIYEGYALPHAILR.6|KDLYANTVLSGGTTMYPGIADR.3|KDLYANTVLSGGTTMYPGIADR.2|KDLYANTVLSGGTTMYPGIADR.4|KDLYANTVLSGGTTM[Oxi]YPGIADR.3|KDLYANTVLSGGTTM[Oxi]YPGIADR.2|LDLAGRDLTDYLMK.3|LDLAGRDLTDYLMK.2|LDLAGRDLTDYLM[Oxi]K.3|LDLAGRDLTDYLM[Oxi]K.2|AVFPSIVGRPR.3|AVFPSIVGRPR.2|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.3|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.4|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.4|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.3|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.4|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.6|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.6|FRC[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.5|FRC[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.3|EITALAPSTMK.2|EITALAPSTM[Oxi]K.2|IWHHTFYNELR.3|IWHHTFYNELR.2|AGFAGDDAPR.2|EKLC[CAM]YVALDFEQEMATAASSSSLEK.3|EKLC[CAM]YVALDFEQEMATAASSSSLEK.4|EKLC[CAM]YVALDFEQEM[Oxi]ATAASSSSLEK.3|C[CAM]DVDIRKDLYANTVLSGGTTMYPGIADR.4|C[CAM]DVDIRKDLYANTVLSGGTTMYPGIADR.3|C[CAM]DVDIRKDLYANTVLSGGTTM[Oxi]YPGIADR.4|C[CAM]DVDIRKDLYANTVLSGGTTM[Oxi]YPGIADR.3|LC[CAM]YVALDFEQEMATAASSSSLEK.3|LC[CAM]YVALDFEQEMATAASSSSLEK.4|LC[CAM]YVALDFEQEM[Oxi]ATAASSSSLEK.3|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.5|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.6|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK.4|DLYANTVLSGGTTMYPGIADR.3|DLYANTVLSGGTTMYPGIADR.2|DLYANTVLSGGTTM[Oxi]YPGIADR.4|DLYANTVLSGGTTMYPGIADR.4|DLYANTVLSGGTTM[Oxi]YPGIADR.3|DLYANTVLSGGTTM[Oxi]YPGIADR.2|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.3|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIMK.5|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.4|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.4|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIM[Oxi]K.3|C[CAM]PEALFQPSFLGM[Oxi]ESC[CAM]GIHETTFNSIMK.3|C[CAM]PEALFQPSFLGMESC[CAM]GIHETTFNSIM[Oxi]K.3|MQKEITALAPSTMK.3|MQKEITALAPSTMK.2|M[Oxi]QKEITALAPSTMK.3|MQKEITALAPSTM[Oxi]K.3|M[Oxi]QKEITALAPSTM[Oxi]K.3|M[Oxi]QKEITALAPSTM[Oxi]K.2|M[Oxi]QKEITALAPSTMK.2|MQKEITALAPSTM[Oxi]K.2|YPIEHGIVTNWDDMEKIWHHTFYNELR.5|YPIEHGIVTNWDDMEK.3|YPIEHGIVTNWDDM[Oxi]EK.3|YPIEHGIVTNWDDMEK.2|HQGVMVGMGQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.4|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.5|HQGVMVGMGQKDSYVGDEAQSKR.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSKR.5|HQGVMVGM[Oxi]GQKDSYVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDSYVGDEAQSKR.4|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSKR.3|GYSFTTTAEREIVRDIK.3|QEYDESGPSIVHR.3|QEYDESGPSIVHR.2|HQGVMVGMGQKDSYVGDEAQSK.4|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSK.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSK.4|HQGVMVGM[Oxi]GQKDSYVGDEAQSK.4|HQGVM[Oxi]VGMGQKDSYVGDEAQSK.3|HQGVMVGM[Oxi]GQKDSYVGDEAQSK.3|HQGVMVGMGQKDSYVGDEAQSK.3|HQGVM[Oxi]VGM[Oxi]GQKDSYVGDEAQSK.3|YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHR.4|YSVWIGGSILASLSTFQQM[Oxi]WISKQEYDESGPSIVHR.4|ILTERGYSFTTTAEREIVR.4|ILTERGYSFTTTAEREIVR.3
SEN / CTL,Q05682,Caldesmon,CALD1,1.04,1.82,2.58E-03,8.19E-04,3.09E+00,"movement of cell or subcellular component,muscle contraction,cell-cell adhesion","actin binding,calmodulin binding,tropomyosin binding,myosin binding,cadherin binding involved in cell-cell adhesion","cytosol,cytoskeleton,plasma membrane,cell-cell adherens junction,actin cytoskeleton,myofibril,actin cap",15,61,87,QKEFDPTITDASLSLPSRR.4|YEIEETETVTK.2|QERYEIEETETVTK.3|QERYEIEETETVTK.2|RGSIGENQVEVM[Oxi]VEEK.3|RGSIGENQVEVMVEEK.3|SAKPTKPAASDLPVPAEGVR.4|SAKPTKPAASDLPVPAEGVR.3|LKHTENTFSRPGGR.4|MPEDGLSDDKKPFK.4|MPEDGLSDDKKPFK.3|M[Oxi]PEDGLSDDKKPFK.3|PSDLRPGDVSSK.3|PSDLRPGDVSSK.2|LQEALER.2|SPAPKPSDLRPGDVSSK.4|SPAPKPSDLRPGDVSSK.3|REEMRLEAER.3|RKVLEEEEQR.3|EAEGAPQVEAGKR.3|EAEGAPQVEAGKR.2|QKQQEAALELEELKK.4|QKQQEAALELEELKK.3|RGETESEEFEK.3|RGETESEEFEK.2|HTENTFSRPGGR.3|HTENTFSRPGGR.2|INEWLTK.2|EKEEEEEEKPK.3|QQEAALELEELK.3|QQEAALELEELK.2|TPDGNKSPAPKPSDLRPGDVSSK.5|TPDGNKSPAPKPSDLRPGDVSSK.4|SPAPKPSDLRPGDVSSKR.4|GNVFSSPTAAGTPNK.3|GNVFSSPTAAGTPNK.2|NDDDEEEAARER.3|ASVDTKEAEGAPQVEAGKR.4|ASVDTKEAEGAPQVEAGKR.3|RRGETESEEFEK.3|TPDGNKSPAPKPSDLRPGDVSSKR.5|GSSLKIEER.2|QQEAALELEELKK.3|QQEAALELEELKK.2|RLQEALER.2|RMQNDTAENETTEKEEK.4|RMQNDTAENETTEKEEK.3|VLEEEEQR.2|IAYQRNDDDEEEAARER.4|STHQAAIVSK.2|RGETESEEFEKLK.3|LQEDKPTFK.2|MPEDGLSDDK.2|M[Oxi]PEDGLSDDK.2|RMQNDTAENETTEK.3|PTKPAASDLPVPAEGVR.3|PTKPAASDLPVPAEGVR.2|KVLEEEEQR.2|EFDPTITDASLSLPSR.3|EFDPTITDASLSLPSR.2|NDDDEEEAAR.2|EAEGAPQVEAGK.2|GETESEEFEK.2|MQNDTAENETTEKEEKSESR.4|SQNGEFMTHK.2|ASVDTKEAEGAPQVEAGK.3|IAYQRNDDDEEEAAR.3|IDSRLEQYTSAIEGTK.3|IDSRLEQYTSAIEGTK.2|EFDPTITDASLSLPSRR.3|M[Oxi]QNDTAENETTEKEEK.3|MQNDTAENETTEKEEK.3|MQNDTAENETTEKEEK.2|QSVDKVTSPTKV.2|QKEFDPTITDASLSLPSR.3|LEQYTSAIEGTK.2|GNVFSSPTAAGTPNKETAGLK.3|PAASDLPVPAEGVR.2|TTTTNTQVEGDDEAAFLER.3|TTTTNTQVEGDDEAAFLER.2|MQNDTAENETTEK.2|M[Oxi]QNDTAENETTEK.2|NGQISSEEPKQEEEREQGSDEISHHEK.4|TTESQEETVVMSLK.2|QKQEEESLGQVTDQVEVNAQNSVPDEEAK.4|QKQEEESLGQVTDQVEVNAQNSVPDEEAK.3|QEEESLGQVTDQVEVNAQNSVPDEEAK.3
SEN / CTL,Q9H173,Nucleotide exchange factor SIL1,SIL1,1.03,1.39,1.51E-02,4.01E-03,2.40E+00,"protein folding,intracellular protein transport",unfolded protein binding,"extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen",9,9,11,VVTLLYDLVTEK.2|VLQTLGVLLTTC[CAM]R.2|VLQTLGVLLTTC[CAM]R.3|RLDINTNTYTSQDLK.3|RLDINTNTYTSQDLK.2|LGGLQVLR.2|VLFALC[CAM]SLLR.2|VQVEAIEGGALQK.2|LLVILATEQPLTAK.2|LDINTNTYTSQDLK.2|QVHLLPGLWEQGWC[CAM]EITAHLLALPEHDAR.4
SEN / CTL,P04350,Tubulin beta-4A chain,TUBB4A,1.02,0.83,1.91E-03,6.32E-04,3.20E+00,"G2/M transition of mitotic cell cycle,cytoskeleton organization,microtubule-based process","GTPase activity,structural constituent of cytoskeleton,GTP binding","nucleus,cytosol,microtubule,cilium,internode region of axon,neuronal cell body,myelin sheath,extracellular exosome",12,7,19,MREIVHLQAGQC[CAM]GNQIGAK.4|MREIVHLQAGQC[CAM]GNQIGAK.3|M[Oxi]REIVHLQAGQC[CAM]GNQIGAK.4|M[Oxi]REIVHLQAGQC[CAM]GNQIGAK.3|MREIVHLQAGQC[CAM]GNQIGAK.2|FWEVISDEHGIDPTGTYHGDSDLQLER.4|FWEVISDEHGIDPTGTYHGDSDLQLER.5|FWEVISDEHGIDPTGTYHGDSDLQLER.3|AVLVDLEPGTMDSVR.3|AVLVDLEPGTM[Oxi]DSVR.3|AVLVDLEPGTMDSVR.2|AVLVDLEPGTM[Oxi]DSVR.2|M[Oxi]AATFIGNSTAIQELFK.3|M[Oxi]AATFIGNSTAIQELFK.2|MAATFIGNSTAIQELFK.2|MAATFIGNSTAIQELFKR.3|M[Oxi]AATFIGNSTAIQELFKR.3|EVDEQMLSVQSK.2|INVYYNEATGGNYVPR.2
SEN / CTL,Q9ULV4,Coronin-1C,CORO1C,1.01,0.53,6.92E-03,1.97E-03,2.71E+00,"neural crest cell migration,regulation of protein phosphorylation,negative regulation of protein phosphorylation,phagocytosis,signal transduction,regulation of epithelial cell migration,negative regulation of epithelial cell migration,regulation of fibroblast migration,actin cytoskeleton organization,negative regulation of protein kinase activity by regulation of protein phosphorylation,establishment of protein localization,regulation of focal adhesion assembly,negative regulation of focal adhesion assembly,activation of GTPase activity,regulation of substrate adhesion-dependent cell spreading,negative regulation of substrate adhesion-dependent cell spreading,regulation of ruffle assembly,positive regulation of lamellipodium morphogenesis","protein binding,Rac GTPase binding,actin filament binding","cytoplasm,focal adhesion,actin cytoskeleton,lateral plasma membrane,flotillin complex,lamellipodium,vesicle",6,36,54,VTWDSSFC[CAM]AVNPR.2|AIFLADGNVFTTGFSR.2|AIFLADGNVFTTGFSR.3|KQEIVAEKEK.3|KQEIVAEKEK.2|NDQC[CAM]YDDIR.3|NDQC[CAM]YDDIR.2|NILDSKPTANK.3|NILDSKPTANK.2|VGIVAWHPTAR.3|VGIVAWHPTAR.2|GLDVNKC[CAM]EIAR.3|GLDVNKC[CAM]EIAR.2|LEQQMAK.2|HVFGQAVK.2|NILDSKPTANKK.3|KC[CAM]EPIIMTVPR.3|KC[CAM]EPIIM[Oxi]TVPR.3|KC[CAM]EPIIMTVPR.2|KC[CAM]EPIIM[Oxi]TVPR.2|RVGIVAWHPTAR.3|KTTDTASVQNEAK.3|KTTDTASVQNEAK.2|KQEIVAEK.2|C[CAM]DLISIPK.2|RGLDVNKC[CAM]EIAR.3|QLALWNPK.2|SIKDTIC[CAM]NQDER.3|SIKDTIC[CAM]NQDER.2|HVFGQAVKNDQC[CAM]YDDIR.4|HVFGQAVKNDQC[CAM]YDDIR.3|KTTDTASVQNEAKLDEILK.4|KTTDTASVQNEAKLDEILK.3|NGSLIC[CAM]TASK.2|C[CAM]DLISIPKK.2|KC[CAM]DLISIPK.2|NADPILISLK.2|DTIC[CAM]NQDER.2|TTDTASVQNEAKLDEILKEIK.4|ISKLEQQMAK.2|C[CAM]EPIIMTVPR.2|YFEITDESPYVHYLNTFSSK.4|YFEITDESPYVHYLNTFSSK.3|TTDTASVQNEAK.2|NGSLIC[CAM]TASKDK.2|YFEITDESPYVHYLNTFSSKEPQR.4|YFEITDESPYVHYLNTFSSKEPQR.3|FRHVFGQAVKNDQC[CAM]YDDIR.3|SDLFQDDLYPDTAGPEAALEAEEWFEGK.4|SDLFQDDLYPDTAGPEAALEAEEWFEGK.3|KSDLFQDDLYPDTAGPEAALEAEEWFEGK.4|KSDLFQDDLYPDTAGPEAALEAEEWFEGK.3|NM[Oxi]QEPIALHEMDTSNGVLLPFYDPDTSIIYLC[CAM]GK.4|NMQEPIALHEMDTSNGVLLPFYDPDTSIIYLC[CAM]GK.4
SEN / CTL,P00352,Retinal dehydrogenase 1,ALDH1A1,1.00,1.18,2.25E-03,7.25E-04,3.14E+00,"ethanol oxidation,cellular aldehyde metabolic process,retinol metabolic process,positive regulation of GTPase activity,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate","retinal dehydrogenase activity,aldehyde dehydrogenase (NAD) activity,GTPase activator activity,androgen binding,benzaldehyde dehydrogenase (NAD+) activity","cytoplasm,cytosol,extracellular exosome",12,44,78,LYSNAYLNDLAGC[CAM]IK.2|LYSNAYLNDLAGC[CAM]IK.3|TIPIDGNFFTYTR.2|TIPIDGNFFTYTR.3|HEPIGVC[CAM]GQIIPWNFPLVMLIWK.3|HEPIGVC[CAM]GQIIPWNFPLVMLIWK.4|HEPIGVC[CAM]GQIIPWNFPLVM[Oxi]LIWK.3|FKSLDDVIKR.3|TMDASER.2|IFINNEWHDSVSGKK.4|IFINNEWHDSVSGKK.3|TLRYC[CAM]AGWADKIQGR.4|LLLATMESMNGGK.3|LLLATMESMNGGK.2|LLLATM[Oxi]ESMNGGK.2|LLLATMESM[Oxi]NGGK.2|SLDDVIKR.2|YC[CAM]AGWADKIQGR.3|YC[CAM]AGWADKIQGR.2|YC[CAM]AGWADK.2|ILDLIESGK.2|EGAKLEC[CAM]GGGPWGNK.3|EGAKLEC[CAM]GGGPWGNK.2|ANNTFYGLSAGVFTK.3|ANNTFYGLSAGVFTK.2|FKSLDDVIK.2|DRLLLATMESMNGGK.3|DRLLLATMESMNGGK.2|IFINNEWHDSVSGK.3|IFINNEWHDSVSGK.2|IFVEESIYDEFVR.3|IFVEESIYDEFVR.2|VAFTGSTEVGK.2|ILDLIESGKK.2|ELGEYGFHEYTEVK.3|ELGEYGFHEYTEVK.2|IAKEEIFGPVQQIMK.3|IAKEEIFGPVQQIM[Oxi]K.3|IAKEEIFGPVQQIMK.2|LEC[CAM]GGGPWGNK.2|RANNTFYGLSAGVFTK.3|RANNTFYGLSAGVFTK.2|PAEQTPLTALHVASLIK.3|PAEQTPLTALHVASLIK.2|QAFQIGSPWR.2|IFVEESIYDEFVRR.3|IFVEESIYDEFVRR.2|IGPALSC[CAM]GNTVVVKPAEQTPLTALHVASLIK.5|IGPALSC[CAM]GNTVVVKPAEQTPLTALHVASLIK.4|IGPALSC[CAM]GNTVVVKPAEQTPLTALHVASLIK.3|SPC[CAM]IVLADADLDNAVEFAHHGVFYHQGQC[CAM]C[CAM]IAASR.6|SPC[CAM]IVLADADLDNAVEFAHHGVFYHQGQC[CAM]C[CAM]IAASR.5|SPC[CAM]IVLADADLDNAVEFAHHGVFYHQGQC[CAM]C[CAM]IAASR.4|GYFVQPTVFSNVTDEMR.3|GYFVQPTVFSNVTDEM[Oxi]R.2|GYFVQPTVFSNVTDEMR.2|YILGNPLTPGVTQGPQIDK.3|YILGNPLTPGVTQGPQIDK.2|KYILGNPLTPGVTQGPQIDKEQYDK.4|KYILGNPLTPGVTQGPQIDKEQYDK.3|EEIFGPVQQIMK.2|EEIFGPVQQIM[Oxi]K.2|IGPALSC[CAM]GNTVVVK.2|KYILGNPLTPGVTQGPQIDK.3|KYILGNPLTPGVTQGPQIDK.2|FPVFNPATEEELC[CAM]QVEEGDKEDVDK.4|FPVFNPATEEELC[CAM]QVEEGDKEDVDK.3|KFPVFNPATEEELC[CAM]QVEEGDKEDVDK.4|KFPVFNPATEEELC[CAM]QVEEGDKEDVDK.3|EAGFPPGVVNIVPGYGPTAGAAISSHMDIDK.4|EAGFPPGVVNIVPGYGPTAGAAISSHMDIDK.3|FPVFNPATEEELC[CAM]QVEEGDKEDVDKAVK.4|RVTLELGGKSPC[CAM]IVLADADLDNAVEFAHHGVFYHQGQC[CAM]C[CAM]IAASR.6|AITISSALQAGTVWVNC[CAM]YGVVSAQC[CAM]PFGGFK.4|AITISSALQAGTVWVNC[CAM]YGVVSAQC[CAM]PFGGFK.3|EGAKLEC[CAM]GGGPWGNKGYFVQPTVFSNVTDEM[Oxi]R.4|YILGNPLTPGVTQGPQIDKEQYDK.3|EAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGK.4
SEN / CTL,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,BST1,1.00,0.37,1.50E-03,5.04E-04,3.30E+00,"humoral immune response,multicellular organism development,positive regulation of B cell proliferation","NAD+ nucleosidase activity,transferase activity,phosphorus-oxygen lyase activity,NAD(P)+ nucleosidase activity","plasma membrane,extrinsic component of membrane,anchored component of membrane,extracellular exosome",6,11,13,VADFLSWC[CAM]R.2|FMPLSDVLYGR.2|ALLSPEQR.2|GEGTSAHLR.2|LLQC[CAM]VDHSTHPDC[CAM]ALK.4|LLQC[CAM]VDHSTHPDC[CAM]ALK.3|DKSLFWENSHLLVNSFADNTRR.4|DMGFQYSC[CAM]INDYRPVK.3|SLFWENSHLLVNSFADNTR.3|SLFWENSHLLVNSFADNTR.2|GFFADYEIPNLQK.2|SLFWENSHLLVNSFADNTRR.3|IEIWVMHEIGGPNVESC[CAM]GEGSMK.3
SEN / CTL,Q9H299,SH3 domain-binding glutamic acid-rich-like protein 3,SH3BGRL3,0.99,0.89,3.93E-02,9.52E-03,2.02E+00,"regulation of actin filament depolymerization,regulation of actin cytoskeleton organization,regulation of blood vessel endothelial cell migration,positive regulation of GTPase activity,cell redox homeostasis,oxidation-reduction process","GTPase activator activity,electron carrier activity,protein disulfide oxidoreductase activity,semaphorin receptor binding","nucleus,cytoplasm,lamellipodium,extracellular exosome",6,7,15,IQYQLVDISQDNALRDEMR.3|IQYQLVDISQDNALRDEMR.4|IQYQLVDISQDNALRDEM[Oxi]R.3|IQYQLVDISQDNALRDEMR.2|ATPPQIVNGDQYC[CAM]GDYELFVEAVEQNTLQEFLK.4|SQQSEVTR.2|VYSTSVTGSR.2|IQYQLVDISQDNALR.3|IQYQLVDISQDNALR.2|RIQYQLVDISQDNALRDEM[Oxi]R.4|RIQYQLVDISQDNALRDEMR.4|RIQYQLVDISQDNALRDEM[Oxi]R.3|RIQYQLVDISQDNALRDEMR.3|RIQYQLVDISQDNALR.3|RIQYQLVDISQDNALR.2
SEN / CTL,Q92626,Peroxidasin homolog,PXDN,0.99,1.05,1.06E-05,5.57E-06,5.25E+00,"negative regulation of cytokine-mediated signaling pathway,immune response,response to oxidative stress,extracellular matrix organization,hydrogen peroxide catabolic process,oxidation-reduction process,cellular oxidant detoxification","peroxidase activity,interleukin-1 receptor antagonist activity,extracellular matrix structural constituent,heme binding,metal ion binding","proteinaceous extracellular matrix,extracellular space,endoplasmic reticulum,extracellular matrix,extracellular exosome",24,30,36,SPNDLLALFR.2|LYGSTLNIDLFPALVVEDLVPGSR.3|ISGVALHDQGQYEC[CAM]QAVNIIGSQK.3|LDSNTLHC[CAM]DC[CAM]EILWLADLLK.3|IVNEGGIDPLLR.2|C[CAM]MHLLLEAVPAVAPQTSILDLR.3|RLYGSTLNIDLFPALVVEDLVPGSR.3|LDENFQPIAQDHLPLHK.4|AGEIFER.2|AFFSPFR.2|ITHLVPGTFNHLESMK.4|ITHLVPGTFNHLESMK.3|FGHTLVNPLLYR.3|AEGNPKPEIIWLR.3|DGVQVTESGK.2|IVGAEIQHITYQHWLPK.4|IVGAEIQHITYQHWLPK.3|RIPSGAFEDLENLK.3|DAC[CAM]TIC[CAM]EC[CAM]K.2|ANEQLGLTSMHTLWFR.3|ANEQLGLTSMHTLWFR.2|NGDPFVATSIVEAIATVDR.3|LSTTEC[CAM]VDAGGESHANNTK.3|LFSMAHTVALDLAAINIQR.3|LFSM[Oxi]AHTVALDLAAINIQR.3|LFSMAHTVALDLAAINIQR.2|LWYENPGVFSPAQLTQIK.3|SSPVC[CAM]GSGMTSLLMNSVYPR.3|VWQDC[CAM]C[CAM]EDC[CAM]R.2|FHISPEGFLTINDVGPADAGR.3|NLNTLLLNNNQIK.2|VPSQLLNTELTER.2|LGPTLMC[CAM]LLSTQFK.2|LGPTLM[Oxi]C[CAM]LLSTQFK.2|EQINQLTSYIDASNVYGSTEHEAR.3|TLGEYHGYDPGINAGIFNAFATAAFR.3
SEN / CTL,Q14697,Neutral alpha-glucosidase AB,GANAB,0.99,1.71,2.77E-04,1.16E-04,3.93E+00,"carbohydrate metabolic process,protein folding","carbohydrate binding,glucan 1,3-alpha-glucosidase activity,poly(A) RNA binding","endoplasmic reticulum lumen,Golgi apparatus,membrane,glucosidase II complex,extracellular matrix,melanosome,extracellular exosome",27,70,141,YFTWDPSRFPQPR.3|SLLLSVNAR.2|LSFQHDPETSVLVLR.3|LSFQHDPETSVLVLR.4|LSFQHDPETSVLVLR.2|YSLLPFWYTLLYQAHR.3|YSLLPFWYTLLYQAHR.2|VVIIGAGKPAAVVLQTK.3|VVIIGAGKPAAVVLQTK.2|YRVPDVLVADPPIAR.3|YRVPDVLVADPPIAR.4|YRVPDVLVADPPIAR.2|VLLVLELQGLQK.2|VLLVLELQGLQK.3|LYNLDVFQYELYNPMALYGSVPVLLAHNPHR.4|LYNLDVFQYELYNPM[Oxi]ALYGSVPVLLAHNPHR.4|LYNLDVFQYELYNPM[Oxi]ALYGSVPVLLAHNPHR.6|LYNLDVFQYELYNPMALYGSVPVLLAHNPHR.6|LYNLDVFQYELYNPM[Oxi]ALYGSVPVLLAHNPHR.5|LYNLDVFQYELYNPMALYGSVPVLLAHNPHR.5|DGDKPEETQGK.3|DGDKPEETQGK.2|NLGLYVK.2|KLVAIVDPHIK.3|KLVAIVDPHIK.2|RYFTWDPSR.3|LKVTEGGEPYR.3|LKVTEGGEPYR.2|KPGINVASDWSIHLR.4|KPGINVASDWSIHLR.3|KPGINVASDWSIHLR.2|PFRLDLLEDR.3|IDELEPR.2|TC[CAM]EESSFC[CAM]KR.3|TC[CAM]EESSFC[CAM]KR.2|AFFAGSQR.2|LDLLEDR.2|SGGMERPFVLAR.3|SGGM[Oxi]ERPFVLAR.3|SGGMERPFVLAR.2|LVAIVDPHIKVDSGYR.4|DAQHYGGWEHR.3|DAQHYGGWEHR.2|PAAVVLQTK.2|RYFTWDPSRFPQPR.4|RYFTWDPSRFPQPR.3|LSFQHDPETSVLVLRK.4|REPWLLPSQHNDIIR.4|REPWLLPSQHNDIIR.3|REPWLLPSQHNDIIR.2|AHAHLDTGRREPWLLPSQHNDIIR.6|AHAHLDTGRREPWLLPSQHNDIIR.5|AHAHLDTGRREPWLLPSQHNDIIR.4|AHAHLDTGR.2|VDSGYRVHEELR.3|VTEGGEPYR.2|DPAEGDGAQPEETPR.3|DPAEGDGAQPEETPR.2|PGINVASDWSIHLR.3|WYQMGAYQPFFR.3|WYQM[Oxi]GAYQPFFR.3|WYQM[Oxi]GAYQPFFR.2|WYQMGAYQPFFR.2|DVHNIYGLYVHMATADGLR.4|DVHNIYGLYVHM[Oxi]ATADGLR.4|DVHNIYGLYVHM[Oxi]ATADGLR.3|DVHNIYGLYVHMATADGLR.3|DVHNIYGLYVHMATADGLR.2|NPEPELLVR.2|VSQGSKDPAEGDGAQPEETPR.4|VSQGSKDPAEGDGAQPEETPR.3|YFTWDPSR.2|AEKDEPGAWEETFK.3|AEKDEPGAWEETFK.2|LVAIVDPHIK.2|DENSVELTMAEGPYK.3|DENSVELTMAEGPYK.2|DENSVELTM[Oxi]AEGPYK.2|GLLEFEHQR.2|EPWLLPSQHNDIIR.3|EPWLLPSQHNDIIR.2|LSFQHDPETSVLVLRKPGINVASDWSIHLR.6|SIRPGLSPYR.2|TC[CAM]EESSFC[CAM]K.2|FRIDELEPR.2|EPWLLPSQHNDIIRDALGQR.4|HHGPQTLYLPVTLSSIPVFQR.4|HHGPQTLYLPVTLSSIPVFQR.3|HHGPQTLYLPVTLSSIPVFQR.2|ALLDSLQLGPDSLTVHLIHEVTK.4|ALLDSLQLGPDSLTVHLIHEVTK.3|REPWLLPSQHNDIIRDALGQR.4|QYASLTGTQALPPLFSLGYHQSR.4|QYASLTGTQALPPLFSLGYHQSR.3|RFSFSGNTLVSSSADPEGHFETPIWIER.5|RFSFSGNTLVSSSADPEGHFETPIWIER.4|RFSFSGNTLVSSSADPEGHFETPIWIER.3|MMDYLQGSGETPQTDVR.3|M[Oxi]M[Oxi]DYLQGSGETPQTDVR.3|M[Oxi]MDYLQGSGETPQTDVR.3|MM[Oxi]DYLQGSGETPQTDVR.3|MMDYLQGSGETPQTDVR.2|M[Oxi]MDYLQGSGETPQTDVR.2|MM[Oxi]DYLQGSGETPQTDVR.2|FGAVWTGDNTAEWDHLK.3|FGAVWTGDNTAEWDHLK.2|IILTARPFRLDLLEDR.3|DEPGAWEETFK.2|THSDSKPYGPMSVGLDFSLPGMEHVYGIPEHADNLR.6|THSDSKPYGPM[Oxi]SVGLDFSLPGMEHVYGIPEHADNLR.6|THSDSKPYGPMSVGLDFSLPGM[Oxi]EHVYGIPEHADNLR.6|THSDSKPYGPMSVGLDFSLPGMEHVYGIPEHADNLR.5|THSDSKPYGPM[Oxi]SVGLDFSLPGM[Oxi]EHVYGIPEHADNLR.5|THSDSKPYGPM[Oxi]SVGLDFSLPGMEHVYGIPEHADNLR.5|THSDSKPYGPMSVGLDFSLPGM[Oxi]EHVYGIPEHADNLR.5|THSDSKPYGPMSVGLDFSLPGMEHVYGIPEHADNLR.4|VSQGSKDPAEGDGAQPEETPRDGDKPEETQGK.5|VSQGSKDPAEGDGAQPEETPRDGDKPEETQGK.4|VSQGSKDPAEGDGAQPEETPRDGDKPEETQGK.3|VPDVLVADPPIAR.2|DPAEGDGAQPEETPRDGDKPEETQGK.4|DPAEGDGAQPEETPRDGDKPEETQGK.3|DAQHYGGWEHRDVHNIYGLYVHMATADGLR.5|DAQHYGGWEHRDVHNIYGLYVHMATADGLR.4|DGDKPEETQGKAEKDEPGAWEETFK.4|DGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.4|DGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.3|FSFSGNTLVSSSADPEGHFETPIWIER.4|FSFSGNTLVSSSADPEGHFETPIWIER.3|LSVSGRDENSVELTM[Oxi]AEGPYK.3|LSVSGRDENSVELTMAEGPYK.3|TRDGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.4|TRDGSDYEGWC[CAM]WPGSAGYPDFTNPTM[Oxi]R.3|TRDGSDYEGWC[CAM]WPGSAGYPDFTNPTMR.3|PYGPM[Oxi]SVGLDFSLPGMEHVYGIPEHADNLR.4|PYGPMSVGLDFSLPGMEHVYGIPEHADNLR.4|PYGPMSVGLDFSLPGMEHVYGIPEHADNLR.3|WNYRDEADVLEVDQGFDDHNLPC[CAM]DVIWLDIEHADGK.5|WNYRDEADVLEVDQGFDDHNLPC[CAM]DVIWLDIEHADGK.4|RSSEC[CAM]MKDDPITLFVALSPQGTAQGELFLDDGHTFNYQTR.5|SSEC[CAM]MKDDPITLFVALSPQGTAQGELFLDDGHTFNYQTR.4
SEN / CTL,P13611,Versican core protein,VCAN,0.98,1.30,3.27E-02,8.08E-03,2.09E+00,"skeletal system development,osteoblast differentiation,cell adhesion,multicellular organism development,central nervous system development,cell recognition,extracellular matrix organization,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process","extracellular matrix structural constituent,calcium ion binding,glycosaminoglycan binding,hyaluronic acid binding,carbohydrate binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi lumen,membrane,extracellular matrix,lysosomal lumen,intracellular membrane-bounded organelle",6,17,23,YTLNFEAAQK.2|LATVGELQAAWR.2|YEINSLIR.2|VGHDYQWIGLNDK.3|VGHDYQWIGLNDK.2|TQEEYEDK.2|GRVSVPTHPEAVGDASLTVVK.4|GRVSVPTHPEAVGDASLTVVK.3|LLASDAGLYR.2|AQC[CAM]GGGLLGVR.2|KGTVAC[CAM]GQPPVVENAK.3|AATSRYTLNFEAAQK.3|AATSRYTLNFEAAQK.2|LQGAHLTSILSHEEQMFVNR.4|LQGAHLTSILSHEEQM[Oxi]FVNR.3|LQGAHLTSILSHEEQMFVNR.3|LGEPNYGAEIR.2|SPQETYDVYC[CAM]YVDHLDGDVFHLTVPSK.5|SPQETYDVYC[CAM]YVDHLDGDVFHLTVPSK.4|VSVPTHPEAVGDASLTVVK.3|ETTVLVAQNGNIK.2|NGFDQC[CAM]DYGWLSDASVRHPVTVAR.4|GTVAC[CAM]GQPPVVENAK.2
SEN / CTL,Q562R1,Beta-actin-like protein 2,ACTBL2,0.98,0.37,4.41E-10,4.41E-10,9.36E+00,biological_process,"molecular_function,ATP binding","extracellular space,cytoplasm,cytoskeleton,extracellular exosome",18,9,17,KDLYANTVLSGGSTM[Oxi]YPGIADR.3|VAPDEHPILLTEAPLNPK.3|VAPDEHPILLTEAPLNPK.4|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.4|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.3|TTGIVM[Oxi]DSGDGVTHIVPIYEGYALPHAILR.5|DLYANTVLSGGSTM[Oxi]YPGIADR.3|DLYANTVLSGGSTM[Oxi]YPGIADR.2|HQGVMVGMGQKDC[CAM]YVGDEAQSKR.6|HQGVMVGMGQKDC[CAM]YVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSKR.5|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSKR.4|IWYHTFYNELR.3|HQGVMVGMGQKDC[CAM]YVGDEAQSK.4|HQGVM[Oxi]VGMGQKDC[CAM]YVGDEAQSK.4|FRC[CAM]PEAIFQPSFLGIESSGIHETTFNSIMK.4|C[CAM]PEAIFQPSFLGIESSGIHETTFNSIMK.3
SEN / CTL,P05090,Apolipoprotein D,APOD,0.98,2.96,5.57E-02,1.30E-02,1.89E+00,"response to reactive oxygen species,angiogenesis,glucose metabolic process,lipid metabolic process,lipid transport,brain development,aging,negative regulation of platelet-derived growth factor receptor signaling pathway,peripheral nervous system axon regeneration,tissue regeneration,negative regulation of protein import into nucleus,response to drug,negative regulation of smooth muscle cell proliferation,response to axon injury,negative regulation of focal adhesion assembly,negative regulation of lipoprotein lipid oxidation,negative regulation of monocyte chemotactic protein-1 production,negative regulation of cytokine production involved in inflammatory response,negative regulation of smooth muscle cell-matrix adhesion,negative regulation of T cell migration","lipid transporter activity,protein binding,cholesterol binding","extracellular region,extracellular space,endoplasmic reticulum,cytosolic ribosome,dendrite,neuronal cell body,perinuclear region of cytoplasm,extracellular exosome",6,11,13,C[CAM]PNPPVQENFDVNKYLGR.3|WYEIEKIPTTFENGR.3|VLNQELR.2|KMTVTDQVNC[CAM]PK.3|KMTVTDQVNC[CAM]PK.2|IPTTFENGR.2|NILTSNNIDVK.2|MTVTDQVNC[CAM]PK.2|M[Oxi]TVTDQVNC[CAM]PK.2|NILTSNNIDVKK.2|NPNLPPETVDSLKNILTSNNIDVKK.4|NPNLPPETVDSLK.2|C[CAM]PNPPVQENFDVNK.2
SEN / CTL,P02452,Collagen alpha-1(I) chain,COL1A1,0.96,1.35,2.32E-10,2.44E-10,9.61E+00,"skeletal system development,blood vessel development,osteoblast differentiation,intramembranous ossification,endochondral ossification,blood coagulation,visual perception,sensory perception of sound,positive regulation of epithelial to mesenchymal transition,negative regulation of cell-substrate adhesion,protein transport,platelet activation,extracellular matrix organization,collagen fibril organization,positive regulation of cell migration,collagen catabolic process,response to corticosteroid,response to estradiol,collagen biosynthetic process,protein localization to nucleus,tooth mineralization,response to drug,response to hydrogen peroxide,response to peptide hormone,skin morphogenesis,cellular response to fibroblast growth factor stimulus,tooth eruption,positive regulation of transcription, DNA-templated,embryonic skeletal system development,regulation of immune response,leukocyte migration,response to cAMP,response to hyperoxia,face morphogenesis,bone trabecula formation,cartilage development involved in endochondral bone morphogenesis,protein heterotrimerization,cellular response to amino acid stimulus,cellular response to mechanical stimulus,cellular response to retinoic acid,cellular response to vitamin E,cellular response to tumor necrosis factor,cellular response to epidermal growth factor stimulus,cellular response to transforming growth factor beta stimulus,positive regulation of canonical Wnt signaling pathway,cellular response to fluoride","extracellular matrix structural constituent,protein binding,identical protein binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type I trimer,extracellular space,endoplasmic reticulum lumen,Golgi apparatus,secretory granule,extracellular matrix",66,47,55,DRDLEVDTTLK.3|DRDLEVDTTLK.2|SGEYWIDPNQGC[CAM]NLDAIK.2|SGEYWIDPNQGC[CAM]NLDAIK.3|ALLLQGSNEIEIR.2|VFC[CAM]NMETGETC[CAM]VYPTQPSVAQK.3|FTYSVTVDGC[CAM]TSHTGAWGK.3|FTYSVTVDGC[CAM]TSHTGAWGK.2|VLC[CAM]DDVIC[CAM]DETK.2|SLSQQIENIRSPEGSR.3|SLSQQIENIR.2|NSVAYMDQQTGNLK.2|YHDRDVWKPEPC[CAM]R.4|GVPGPPGAVGPAGK.2|GFSGLQGPPGPPGSPGEQGPSGASGPAGPR.3|NSVAYMDQQTGNLKK.3|NSVAYMDQQTGNLKK.2|NSVAYM[Oxi]DQQTGNLKK.3|STGGISVPGPMGPSGPR.2|STGGISVPGPM[Oxi]GPSGPR.2|GQAGVM[Oxi]GFPGPK.2|GFPGLPGPSGEPGK.2|GLTGSPGSPGPDGK.2|TGPPGPAGQDGRPGPPGPPGAR.3|NGDDGEAGKPGRPGER.4|NGDDGEAGKPGRPGER.3|GPAGPQGPR.2|GFSGLDGAK.2|ADDANVVR.2|GEAGPQGPR.2|GSEGPQGVR.2|GVVGLPGQR.2|GPPGSAGAPGK.2|QGPSGASGER.2|IC[CAM]VC[CAM]DNGK.2|GPAGPQGPRGDKGETGEQGDR.4|GPAGPQGPRGDKGETGEQGDR.3|GRPGAPGPAGAR.2|GFPGADGVAGPK.2|EGAPGAEGSPGR.2|GVQGPPGPAGPR.2|GADGSPGKDGVR.2|GPSGPQGPGGPPGPK.2|GESGPSGPAGPTGAR.2|GEPGPVGVQGPPGPAGEEGKR.3|GEPGPTGLPGPPGER.2|GSAGPPGATGFPGAAGR.2|GETGPAGRPGEVGPPGPPGPAGEK.3|GANGAPGIAGAPGFPGAR.2|GDRGETGPAGPPGAPGAPGAPGPVGPAGK.3|DGEAGAQGPPGPAGPAGER.2|VGPPGPSGNAGPPGPPGPAGK.2|GPPGPMGPPGLAGPPGESGR.2|GLTGPIGPPGPAGAPGDKGESGPSGPAGPTGAR.3|GVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGER.3
SEN / CTL,Q3ZCM7,Tubulin beta-8 chain,TUBB8,0.95,0.87,1.83E-01,3.83E-02,1.42E+00,"oocyte maturation,spindle assembly involved in female meiosis,biological_process","molecular_function,GTPase activity,structural constituent of cytoskeleton,GTP binding","cytoplasm,microtubule,extracellular exosome,meiotic spindle",3,4,13,LPTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|ALTVAELTQQM[Oxi]FDAK.3|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.6|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.5|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.4|KEAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.5|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.4|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGM[Oxi]GTLLLSK.3|EAESC[CAM]DC[CAM]LQGFQLTHSLGGGTGSGMGTLLLSK.3
SEN / CTL,Q9Y696,Chloride intracellular channel protein 4,CLIC4,0.95,1.12,2.95E-04,1.22E-04,3.91E+00,"angiogenesis,endothelial cell morphogenesis,chloride transport,apoptotic process,vacuolar acidification,fertilization,cell differentiation,keratinocyte differentiation,negative regulation of cell migration,regulation of ion transmembrane transport,establishment or maintenance of apical/basal cell polarity,multicellular organism growth,branching morphogenesis of an epithelial tube,regulation of cytoskeleton organization,retina vasculature morphogenesis in camera-type eye,cellular response to calcium ion,chloride transmembrane transport,glutathione metabolic process","voltage-gated ion channel activity,chloride channel activity,protein binding,glutathione transferase activity","intracellular,cytoplasm,mitochondrion,centrosome,cytosol,plasma membrane,microvillus,cell-cell junction,cell surface,actin cytoskeleton,nuclear matrix,midbody,cytoplasmic vesicle membrane,chloride channel complex,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,microtubule cytoskeleton",15,25,45,YLTNAYSRDEFTNTC[CAM]PSDKEVEIAYSDVAK.4|TDVNKIEEFLEEVLC[CAM]PPK.3|TDVNKIEEFLEEVLC[CAM]PPK.4|TDVNKIEEFLEEVLC[CAM]PPK.2|LFMILWLK.2|LFM[Oxi]ILWLK.2|LSPKHPESNTAGMDIFAK.4|LSPKHPESNTAGM[Oxi]DIFAK.4|LSPKHPESNTAGMDIFAK.3|LSPKHPESNTAGMDIFAK.2|RKPADLQNLAPGTHPPFITFNSEVK.5|RKPADLQNLAPGTHPPFITFNSEVK.4|RKPADLQNLAPGTHPPFITFNSEVK.3|DEFTNTC[CAM]PSDK.3|DEFTNTC[CAM]PSDK.2|NSRPEANEALER.3|NSRPEANEALER.2|GVVFSVTTVDLKR.3|YLTNAYSR.2|HPESNTAGMDIFAK.3|HPESNTAGM[Oxi]DIFAK.3|HPESNTAGM[Oxi]DIFAK.2|HPESNTAGMDIFAK.2|EEDKEPLIELFVK.3|EEDKEPLIELFVK.2|IEEFLEEVLC[CAM]PPK.3|IEEFLEEVLC[CAM]PPK.2|NFDIPKEM[Oxi]TGIWR.3|AGSDGESIGNC[CAM]PFSQR.3|AGSDGESIGNC[CAM]PFSQR.2|EVEIAYSDVAK.2|GVVFSVTTVDLK.2|TDVNKIEEFLEEVLC[CAM]PPKYLK.4|FLDGNEMTLADC[CAM]NLLPK.3|FLDGNEMTLADC[CAM]NLLPK.2|KPADLQNLAPGTHPPFITFNSEVK.4|KPADLQNLAPGTHPPFITFNSEVK.3|KFLDGNEMTLADC[CAM]NLLPK.3|KFLDGNEM[Oxi]TLADC[CAM]NLLPK.3|KFLDGNEMTLADC[CAM]NLLPK.2|FSAYIKNSRPEANEALER.3|YLTNAYSRDEFTNTC[CAM]PSDK.3|KPADLQNLAPGTHPPFITFNSEVKTDVNKIEEFLEEVLC[CAM]PPK.6|DEFTNTC[CAM]PSDKEVEIAYSDVAK.3|LDEYLNSPLPDEIDENSMEDIK.3
SEN / CTL,Q92734,Protein TFG,TFG,0.95,1.00,2.23E-01,4.58E-02,1.34E+00,"signal transduction,positive regulation of I-kappaB kinase/NF-kappaB signaling,COPII vesicle coating","signal transducer activity,protein binding,identical protein binding","Golgi membrane,cytoplasm,cytosol,extracellular exosome",3,17,33,RIPIHNEDITYDELVLMMQR.4|RIPIHNEDITYDELVLM[Oxi]MQR.4|RIPIHNEDITYDELVLMM[Oxi]QR.4|RIPIHNEDITYDELVLMMQR.3|RIPIHNEDITYDELVLM[Oxi]MQR.3|NQDEINK.2|PLESSQVK.2|AQLGEDIR.2|LLSNDEVTIK.2|LTLFVNGQPR.2|IPIHNEDITYDELVLMMQR.4|IPIHNEDITYDELVLMMQR.3|IPIHNEDITYDELVLM[Oxi]M[Oxi]QR.3|IPIHNEDITYDELVLM[Oxi]MQR.3|IPIHNEDITYDELVLMM[Oxi]QR.3|IPIHNEDITYDELVLMMQR.2|QSTQVMAASMSAFDPLK.3|QSTQVM[Oxi]AASMSAFDPLK.2|QSTQVMAASMSAFDPLK.2|NVMSAFGLTDDQVSGPPSAPAEDR.4|NVM[Oxi]SAFGLTDDQVSGPPSAPAEDR.3|NVMSAFGLTDDQVSGPPSAPAEDR.3|NRPPFGQGYTQPGPGYR.3|GKLLSNDEVTIK.2|LTLFVNGQPRPLESSQVK.3|LTLFVNGQPRPLESSQVK.2|LLDSLEPPGEPGPSTNIPENDTVDGREEK.4|LLDSLEPPGEPGPSTNIPENDTVDGREEK.3|PGFTSLPGSTMTPPPSGPNPYAR.3|QSTQVMAASM[Oxi]SAFDPLKNQDEINK.3|QSTQVMAASMSAFDPLKNQDEINK.3|LLDSLEPPGEPGPSTNIPENDTVDGR.3|YKDEDGDLITIFDSSDLSFAIQC[CAM]SR.3
SEN / CTL,P37802,Transgelin-2,TAGLN2,0.93,1.62,2.41E-07,1.56E-07,6.81E+00,"epithelial cell differentiation,cell-cell adhesion",cadherin binding involved in cell-cell adhesion,"cell-cell adherens junction,vesicle,extracellular exosome",39,26,53,QMEQISQFLQAAER.2|QMEQISQFLQAAER.3|QM[Oxi]EQISQFLQAAER.2|YGINTTDIFQTVDLWEGK.3|YGINTTDIFQTVDLWEGK.2|QYDADLEQILIQWITTQC[CAM]R.3|QYDADLEQILIQWITTQC[CAM]R.2|IEKQYDADLEQILIQWITTQC[CAM]R.3|DDGLFSGDPNWFPK.2|DDGLFSGDPNWFPK.3|TLMNLGGLAVAR.2|TLMNLGGLAVAR.3|TLM[Oxi]NLGGLAVAR.3|TLM[Oxi]NLGGLAVAR.2|QYDADLEQILIQWITTQC[CAM]RK.3|TLMNLGGLAVARDDGLFSGDPNWFPKK.4|DGTVLC[CAM]ELINALYPEGQAPVK.3|DGTVLC[CAM]ELINALYPEGQAPVK.4|DGTVLC[CAM]ELINALYPEGQAPVK.2|DGTVLC[CAM]ELINALYPEGQAPVKK.3|DGTVLC[CAM]ELINALYPEGQAPVKK.5|DGTVLC[CAM]ELINALYPEGQAPVKK.4|NVIGLQMGTNR.3|NVIGLQMGTNR.2|NVIGLQM[Oxi]GTNR.2|GPAYGLSR.2|NFSDNQLQEGK.3|NFSDNQLQEGK.2|NMAC[CAM]VQR.2|NM[Oxi]AC[CAM]VQR.2|GASQAGMTGYGMPR.3|GASQAGM[Oxi]TGYGMPR.3|GASQAGMTGYGMPR.2|GASQAGM[Oxi]TGYGMPR.2|GASQAGMTGYGM[Oxi]PR.2|GASQAGM[Oxi]TGYGM[Oxi]PR.2|DVGRPQPGR.2|IQASTMAFK.2|IQASTM[Oxi]AFK.2|DVGRPQPGRENFQNWLK.4|DVGRPQPGRENFQNWLK.3|ENFQNWLK.2|KIQASTMAFK.2|KIQASTM[Oxi]AFK.2|DDGLFSGDPNWFPKK.3|DDGLFSGDPNWFPKK.2|ENPRNFSDNQLQEGK.3|TLMNLGGLAVARDDGLFSGDPNWFPK.4|TLMNLGGLAVARDDGLFSGDPNWFPK.3|NFSDNQLQEGKNVIGLQM[Oxi]GTNR.3|NFSDNQLQEGKNVIGLQMGTNR.3|NVIGLQM[Oxi]GTNRGASQAGMTGYGMPR.3|YGINTTDIFQTVDLWEGKNMAC[CAM]VQR.3
SEN / CTL,Q71U36,Tubulin alpha-1A chain,TUBA1A,0.93,1.23,1.83E-02,4.74E-03,2.32E+00,"G2/M transition of mitotic cell cycle,cytoskeleton organization,microtubule-based process,cytoskeleton-dependent intracellular transport,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,GTP binding,protein domain specific binding","nucleus,cytosol,microtubule,cytoplasmic microtubule,cytoplasmic ribonucleoprotein granule,myelin sheath,recycling endosome,extracellular exosome",6,36,88,TIQFVDWC[CAM]PTGFK.2|TIQFVDWC[CAM]PTGFK.3|RTIQFVDWC[CAM]PTGFK.3|RTIQFVDWC[CAM]PTGFK.2|YMAC[CAM]C[CAM]LLYR.3|YMAC[CAM]C[CAM]LLYR.2|YM[Oxi]AC[CAM]C[CAM]LLYR.2|FDLMYAK.2|FDLM[Oxi]YAK.2|EDMAALEK.2|EDM[Oxi]AALEK.2|LSVDYGKK.2|LDHKFDLMYAK.3|LDHKFDLM[Oxi]YAK.3|LDHKFDLMYAK.2|LDHKFDLM[Oxi]YAK.2|QLFHPEQLITGK.3|QLFHPEQLITGK.2|RNLDIERPTYTNLNR.4|RNLDIERPTYTNLNR.3|RNLDIERPTYTNLNR.2|LIGQIVSSITASLR.3|LIGQIVSSITASLR.2|DVNAAIATIK.2|EDAANNYAR.2|LDHKFDLMYAKR.3|LDHKFDLMYAKR.2|GHYTIGKEIIDLVLDRIR.4|GDVVPKDVNAAIATIK.3|GDVVPKDVNAAIATIK.2|AYHEQLSVAEITNAC[CAM]FEPANQMVK.5|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.5|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.4|AYHEQLSVAEITNAC[CAM]FEPANQMVK.4|AYHEQLSVAEITNAC[CAM]FEPANQMVK.3|AYHEQLSVAEITNAC[CAM]FEPANQM[Oxi]VK.3|AVFVDLEPTVIDEVRTGTYR.4|AVFVDLEPTVIDEVRTGTYR.3|TGTYRQLFHPEQLITGKEDAANNYAR.5|TGTYRQLFHPEQLITGKEDAANNYAR.4|TGTYRQLFHPEQLITGKEDAANNYAR.3|QLFHPEQLITGKEDAANNYAR.4|QLFHPEQLITGKEDAANNYAR.3|YMAC[CAM]C[CAM]LLYRGDVVPK.3|YM[Oxi]AC[CAM]C[CAM]LLYRGDVVPK.3|RAFVHWYVGEGMEEGEFSEAR.4|RAFVHWYVGEGM[Oxi]EEGEFSEAR.4|RAFVHWYVGEGMEEGEFSEAR.3|RAFVHWYVGEGM[Oxi]EEGEFSEAR.3|TIGGGDDSFNTFFSETGAGKHVPR.4|TIGGGDDSFNTFFSETGAGKHVPR.3|RAFVHWYVGEGMEEGEFSEAREDMAALEK.5|RAFVHWYVGEGM[Oxi]EEGEFSEAREDMAALEK.5|RAFVHWYVGEGMEEGEFSEAREDMAALEK.4|TIGGGDDSFNTFFSETGAGK.3|TIGGGDDSFNTFFSETGAGK.2|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.5|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.4|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.4|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLM[Oxi]ER.3|LADQC[CAM]TGLQGFLVFHSFGGGTGSGFTSLLMER.3|VGINYQPPTVVPGGDLAKVQR.3|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.6|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.6|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQM[Oxi]PSDK.5|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQM[Oxi]PSDK.5|M[Oxi]REC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQM[Oxi]PSDK.4|MREC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4|AFVHWYVGEGMEEGEFSEAR.3|AFVHWYVGEGM[Oxi]EEGEFSEAR.3|AFVHWYVGEGMEEGEFSEAR.2|DYEEVGVDSVEGEGEEEGEEY.3|DYEEVGVDSVEGEGEEEGEEY.2|LSVDYGK.1|AFVHWYVGEGMEEGEFSEAREDMAALEK.4|AFVHWYVGEGM[Oxi]EEGEFSEAREDMAALEK.4|AFVHWYVGEGMEEGEFSEAREDMAALEK.3|EC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.5|EC[CAM]ISIHVGQAGVQIGNAC[CAM]WELYC[CAM]LEHGIQPDGQMPSDK.4|SKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]RR.6|SKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]RR.5|EDM[Oxi]AALEKDYEEVGVDSVEGEGEEEGEEY.3|EDMAALEKDYEEVGVDSVEGEGEEEGEEY.3|LEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]RR.5|SKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDC[CAM]AFMVDNEAIYDIC[CAM]R.5
SEN / CTL,P60981,Destrin,DSTN,0.93,0.74,1.69E-02,4.45E-03,2.35E+00,"actin polymerization or depolymerization,actin filament depolymerization,positive regulation of actin filament depolymerization,actin filament severing","protein binding,actin filament binding","actin cytoskeleton,cortical actin cytoskeleton,extracellular exosome",6,22,34,YALYDASFETK.2|KEELMFFLWAPELAPLK.3|KEELM[Oxi]FFLWAPELAPLK.3|KEELMFFLWAPELAPLK.2|KC[CAM]STPEEIKK.3|AVIFC[CAM]LSADKK.3|AVIFC[CAM]LSADKK.2|C[CAM]STPEEIKKR.3|KAVIFC[CAM]LSADKK.3|C[CAM]IIVEEGK.2|C[CAM]STPEEIK.2|HFVGMLPEKDC[CAM]R.3|HFVGM[Oxi]LPEKDC[CAM]R.3|HFVGMLPEKDC[CAM]R.2|HEC[CAM]QANGPEDLNR.3|HEC[CAM]QANGPEDLNR.2|FQGIKHEC[CAM]QANGPEDLNR.4|FQGIKHEC[CAM]QANGPEDLNR.3|HFVGMLPEK.2|HFVGM[Oxi]LPEK.2|KC[CAM]IIVEEGK.2|C[CAM]STPEEIKK.2|KC[CAM]STPEEIK.2|KFQGIKHEC[CAM]QANGPEDLNR.4|KFQGIKHEC[CAM]QANGPEDLNR.3|AVIFC[CAM]LSADK.2|EILVGDVGVTITDPFK.3|EILVGDVGVTITDPFK.2|ESRKEELMFFLWAPELAPLK.4|ESRKEELMFFLWAPELAPLK.3|EELMFFLWAPELAPLK.3|EELMFFLWAPELAPLK.2|LGGSLIVAFEGC[CAM]PV.2|C[CAM]IIVEEGKEILVGDVGVTITDPFK.3
SEN / CTL,P50454,Serpin H1,SERPINH1,0.92,0.78,4.84E-15,9.43E-15,1.40E+01,"chondrocyte development involved in endochondral bone morphogenesis,response to unfolded protein,negative regulation of endopeptidase activity,collagen fibril organization,collagen biosynthetic process,protein maturation","serine-type endopeptidase inhibitor activity,collagen binding,poly(A) RNA binding,unfolded protein binding","endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum-Golgi intermediate compartment,membrane raft,extracellular exosome,extracellular space",48,33,71,LYGPSSVSFADDFVR.2|LYGPSSVSFADDFVR.3|AVLSAEQLRDEEVHAGLGELLR.4|AVLSAEQLRDEEVHAGLGELLR.3|DTQSGSLLFIGR.2|DQAVENILVSPVVVASSLGLVSLGGK.3|DQAVENILVSPVVVASSLGLVSLGGK.4|LFYADHPFIFLVR.3|LFYADHPFIFLVR.2|LFYADHPFIFLVR.4|HLAGLGLTEAIDKNKADLSR.4|HLAGLGLTEAIDKNKADLSR.3|SAGLAFSLYQAMAK.2|SAGLAFSLYQAMAK.3|SAGLAFSLYQAM[Oxi]AK.3|SAGLAFSLYQAM[Oxi]AK.2|TGLYNYYDDEKEKLQIVEMPLAHK.5|TGLYNYYDDEKEKLQIVEMPLAHK.4|SYTVGVMMMHR.3|SYTVGVMMMHR.2|SYTVGVM[Oxi]MMHR.3|SYTVGVMM[Oxi]MHR.3|SYTVGVM[Oxi]MMHR.2|HLAGLGLTEAIDKNK.3|HLAGLGLTEAIDKNK.2|LSSLIILMPHHVEPLER.4|LSSLIILM[Oxi]PHHVEPLER.4|LSSLIILM[Oxi]PHHVEPLER.3|LSSLIILMPHHVEPLER.3|LSSLIILM[Oxi]PHHVEPLER.2|LSSLIILMPHHVEPLER.2|AVAISLPK.2|GVVEVTHDLQK.3|GVVEVTHDLQK.2|LQIVEMPLAHK.3|LQIVEM[Oxi]PLAHK.3|LQIVEMPLAHK.2|LQIVEM[Oxi]PLAHK.2|HLAGLGLTEAIDK.3|HLAGLGLTEAIDK.2|KAVAISLPK.2|DEEVHAGLGELLR.3|DEEVHAGLGELLR.2|AVLSAEQLR.2|DVERTDGALLVNAMFFKPHWDEK.5|DVERTDGALLVNAM[Oxi]FFKPHWDEK.4|DVERTDGALLVNAMFFKPHWDEK.4|TGLYNYYDDEKEK.3|TGLYNYYDDEKEK.2|TDGALLVNAM[Oxi]FFKPHWDEK.4|TDGALLVNAMFFKPHWDEK.4|TDGALLVNAMFFKPHWDEK.3|TDGALLVNAMFFKPHWDEK.2|KPAAAAAPGTAEK.2|LSSLIILMPHHVEPLERLEK.4|SALQSINEWAAQTTDGK.3|SALQSINEWAAQTTDGK.2|SALQSINEWAAQTTDGKLPEVTK.4|SALQSINEWAAQTTDGKLPEVTK.3|RSALQSINEWAAQTTDGK.3|RSALQSINEWAAQTTDGK.2|RSALQSINEWAAQTTDGKLPEVTK.4|RSALQSINEWAAQTTDGKLPEVTK.3|LPEVTKDVERTDGALLVNAMFFKPHWDEK.5|TGLYNYYDDEK.2|TDGALLVNAMFFK.2|SALQSINEWAAQTTDGKLPEVTKDVER.4|SALQSINEWAAQTTDGKLPEVTKDVER.3|EKLQIVEMPLAHK.2|DLYLASVFHATAFELDTDGNPFDQDIYGREELRSPK.5|DLYLASVFHATAFELDTDGNPFDQDIYGREELRSPK.4
SEN / CTL,Q9Y490,Talin-1,TLN1,0.91,0.87,1.34E-18,3.93E-18,1.74E+01,"platelet degranulation,movement of cell or subcellular component,muscle contraction,cytoskeletal anchoring at plasma membrane,cell-cell junction assembly,cell-substrate junction assembly,viral process,cortical actin cytoskeleton organization,IRE1-mediated unfolded protein response,platelet aggregation","integrin binding,structural constituent of cytoskeleton,protein binding,vinculin binding,LIM domain binding,actin filament binding,cadherin binding involved in cell-cell adhesion","ruffle,extracellular region,cytoplasm,microtubule organizing center,cytosol,plasma membrane,cell-cell junction,cell-cell adherens junction,focal adhesion,cell surface,ruffle membrane,extracellular exosome",69,186,355,GLAGAVSELLR.2|AVASAAAALVLK.2|TLAESALQLLYTAK.2|TLAESALQLLYTAK.3|VMVTNVTSLLK.2|VM[Oxi]VTNVTSLLK.2|VGAIPANALDDGQWSQGLISAAR.3|VGAIPANALDDGQWSQGLISAAR.4|VGAIPANALDDGQWSQGLISAAR.2|LNEAAAGLNQAATELVQASR.3|LNEAAAGLNQAATELVQASR.4|LNEAAAGLNQAATELVQASR.2|AVAEQIPLLVQGVR.2|AVAEQIPLLVQGVR.3|AVSSAIAQLLGEVAQGNENYAGIAAR.3|AVSSAIAQLLGEVAQGNENYAGIAAR.4|LAQAAQSSVATITR.2|LAQAAQSSVATITR.3|VSQMAQYFEPLTLAAVGAASK.3|VSQMAQYFEPLTLAAVGAASK.4|VSQM[Oxi]AQYFEPLTLAAVGAASK.3|VSQM[Oxi]AQYFEPLTLAAVGAASK.2|VSQMAQYFEPLTLAAVGAASK.2|GVGAAATAVTQALNELLQHVK.3|GVGAAATAVTQALNELLQHVK.4|GVGAAATAVTQALNELLQHVK.2|VVAPTISSPVC[CAM]QEQLVEAGR.2|VVAPTISSPVC[CAM]QEQLVEAGR.4|VVAPTISSPVC[CAM]QEQLVEAGR.3|LASEAKPAAVAAENEEIGSHIK.4|LASEAKPAAVAAENEEIGSHIK.3|LASEAKPAAVAAENEEIGSHIK.2|VSHVLAALQAGNR.3|VSHVLAALQAGNR.2|SIAAATSALVK.2|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.4|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LR.2|LGAASLGAEDPETQVVLINAVK.3|LGAASLGAEDPETQVVLINAVK.4|LGAASLGAEDPETQVVLINAVK.2|ALEATTEHIRQELAVFC[CAM]SPEPPAK.4|ALEATTEHIRQELAVFC[CAM]SPEPPAK.3|ILAQATSDLVNAIKADAEGESDLENSR.4|ILAQATSDLVNAIKADAEGESDLENSR.3|QAAASATQTIAAAQHAASTPK.3|QAAASATQTIAAAQHAASTPK.2|ALSTDPAAPNLK.3|ALSTDPAAPNLK.2|DVDNALR.2|HTSALC[CAM]NSC[CAM]R.3|HTSALC[CAM]NSC[CAM]R.2|MATNAAAQNAIK.3|MATNAAAQNAIK.2|M[Oxi]ATNAAAQNAIK.2|VLVEDTK.2|FLPSELRDEH.3|FLPSELRDEH.2|ISIGNVVK.2|LKPLPGETMEK.3|LKPLPGETM[Oxi]EK.3|LKPLPGETMEK.2|VKADQDSEAM[Oxi]K.3|VKADQDSEAMK.3|VKADQDSEAMK.2|VLVQNAAGSQEK.3|VLVQNAAGSQEK.2|AC[CAM]KEAAYHPEVAPDVRLR.5|VGKVEHGSVALPAIMR.4|VGKVEHGSVALPAIMR.3|AQVVSNLK.2|AVEDEATK.2|AVTQALNR.2|GTPQDLAR.2|LHTDDELNWLDHGR.4|LHTDDELNWLDHGR.3|LHTDDELNWLDHGR.2|LQAAGNAVK.2|GIWLEAGK.2|QEDVIATANLSR.3|QEDVIATANLSR.2|AAGHPGDPESQQR.3|AAGHPGDPESQQR.2|HRVQELGHGC[CAM]AALVTK.4|MATNAAAQNAIKK.3|MATNAAAQNAIKK.2|AGFLDLKDFLPK.3|AGFLDLKDFLPK.2|AVAAGNSC[CAM]R.2|KSTVLQQQYNR.3|KSTVLQQQYNR.2|RASDNLVK.2|TIMVDDSK.2|TIM[Oxi]VDDSK.2|ADAEGESDLENSR.3|ADAEGESDLENSR.2|VEHGSVALPAIM[Oxi]R.3|VEHGSVALPAIMR.3|VEHGSVALPAIMR.2|VKADQDSEAMKR.3|VKADQDSEAMKR.2|AASAAQRELVAQGK.3|AASAAQRELVAQGK.2|AEASQLGHK.2|AGFLDLKDFLPKEYVK.4|AGFLDLKDFLPKEYVK.3|DPPSWSVLAGHSR.3|DPPSWSVLAGHSR.2|TKEVIQEWNLTNIKR.4|TVTDMLMTIC[CAM]AR.3|TVTDMLMTIC[CAM]AR.2|TVTDM[Oxi]LMTIC[CAM]AR.2|ASSLIEEAK.2|RAIADMLR.2|AHATGAGPAGR.2|RQFVQSAK.2|TLREQGVEEHETLLLR.4|TLREQGVEEHETLLLR.3|TMLESAGGLIQTAR.3|TMLESAGGLIQTAR.2|TM[Oxi]LESAGGLIQTAR.2|AGALQC[CAM]SPSDAYTK.3|AGALQC[CAM]SPSDAYTK.2|ASAGPQPLLVQSC[CAM]K.3|ASAGPQPLLVQSC[CAM]K.2|EAAYHPEVAPDVR.3|EAAYHPEVAPDVR.2|ILAQATSDLVNAIK.3|ILAQATSDLVNAIK.2|QVAASTAQLLVAC[CAM]K.3|QVAASTAQLLVAC[CAM]K.2|ALGDLISATK.2|EVIQEWNLTNIK.3|EVIQEWNLTNIK.2|KAAGHPGDPESQQR.3|KAAGHPGDPESQQR.2|NGDTMEYR.2|QKLHTDDELNWLDHGR.4|QKLHTDDELNWLDHGR.3|VQELGHGC[CAM]AALVTK.3|VQELGHGC[CAM]AALVTK.2|ADQDSEAMK.2|KFFYSDQNVDSR.3|KFFYSDQNVDSR.2|KGIWLEAGK.2|ADAEGESDLENSRK.3|ADAEGESDLENSRK.2|DPVQLNLLYVQAR.3|DPVQLNLLYVQAR.2|GAAAHPDSEEQQQR.3|GAAAHPDSEEQQQR.2|IGITNHDEYSLVR.3|IGITNHDEYSLVR.2|KLEQLKPR.2|LREAAEGLR.2|SAQPASAEPR.2|DDILNGSHPVSFDK.3|DDILNGSHPVSFDK.2|RLQAAGNAVK.2|ALDYYMLR.2|ALDYYM[Oxi]LR.2|EQGVEEHETLLLR.3|EQGVEEHETLLLR.2|KEEITGTLR.2|RQFVQSAKEVANSTANLVK.4|LLAALLEDEGGSGRPLLQAAK.4|LLAALLEDEGGSGRPLLQAAK.3|LLAALLEDEGGSGRPLLQAAK.2|NLGTALAELR.2|QELAVFC[CAM]SPEPPAK.3|QELAVFC[CAM]SPEPPAK.2|AGALQC[CAM]SPSDAYTKK.3|AGALQC[CAM]SPSDAYTKK.2|ALAVNPRDPPSWSVLAGHSR.4|ALAVNPRDPPSWSVLAGHSR.3|ASSLIEEAKK.2|C[CAM]VSC[CAM]LPGQR.2|EC[CAM]DNALRELETVR.3|TSTPEDFIR.2|ERIPEAPAGPPSDFGLFLSDDDPKK.5|ERIPEAPAGPPSDFGLFLSDDDPKK.4|ERIPEAPAGPPSDFGLFLSDDDPKK.3|NGNLPEFGDAISTASK.3|NGNLPEFGDAISTASK.2|PAAVAAENEEIGSHIK.3|PAAVAAENEEIGSHIK.2|VAGSVTELIQAAEAM[Oxi]K.3|VAGSVTELIQAAEAMK.3|VAGSVTELIQAAEAM[Oxi]K.2|VAGSVTELIQAAEAMK.2|EVIQEWNLTNIKR.3|EVIQEWNLTNIKR.2|AAAFEEQENETVVVK.3|AAAFEEQENETVVVK.2|EC[CAM]ANGYLELLDHVLLTLQK.4|EC[CAM]ANGYLELLDHVLLTLQK.3|EC[CAM]ANGYLELLDHVLLTLQK.2|AAMEPIVISAK.2|AAM[Oxi]EPIVISAK.2|C[CAM]TQDLGNSTK.2|ALEATTEHIR.2|EGTETFADHREGILK.3|EVANSTANLVK.2|TKEVIQEWNLTNIK.3|TKEVIQEWNLTNIK.2|TLSHPQQMALLDQTK.3|TLSHPQQM[Oxi]ALLDQTK.3|TLSHPQQM[Oxi]ALLDQTK.2|TLSHPQQMALLDQTK.2|ADQDSEAMKR.2|ALDGAFTEENRAQC[CAM]R.3|AVTDSINQLITMC[CAM]TQQAPGQK.4|AVTDSINQLITM[Oxi]C[CAM]TQQAPGQK.3|AVTDSINQLITMC[CAM]TQQAPGQK.3|AVTDSINQLITMC[CAM]TQQAPGQK.2|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.5|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.4|EC[CAM]ANGYLELLDHVLLTLQKPSPELK.3|EGTETFADHR.2|TYGVSFFLVK.2|AKPKEADESLNFEEQILEAAK.4|AVEDEATKGTR.2|DLDQASLAAVSQQLAPR.3|DLDQASLAAVSQQLAPR.2|RVAGSVTELIQAAEAMK.3|RVAGSVTELIQAAEAM[Oxi]K.3|RVAGSVTELIQAAEAMK.2|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.4|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.3|AC[CAM]EFAGFQC[CAM]QIQFGPHNEQK.2|AC[CAM]KEAAYHPEVAPDVR.3|IPEAPAGPPSDFGLFLSDDDPKK.4|IPEAPAGPPSDFGLFLSDDDPKK.3|ALDGAFTEENR.2|M[Oxi]VGGIAQIIAAQEEMLR.3|MVGGIAQIIAAQEEM[Oxi]LR.3|MVGGIAQIIAAQEEMLR.3|MVGGIAQIIAAQEEMLR.2|M[Oxi]VGGIAQIIAAQEEMLR.2|MVGGIAQIIAAQEEM[Oxi]LR.2|TMQFEPSTMVYDAC[CAM]R.3|TMQFEPSTMVYDAC[CAM]R.2|TM[Oxi]QFEPSTMVYDAC[CAM]R.2|VGDDPAVWQLK.2|AGALQC[CAM]SPSDAYTKKELIEC[CAM]AR.4|GVAALTSDPAVQAIVLDTASDVLDK.4|GVAALTSDPAVQAIVLDTASDVLDK.3|STVLQQQYNR.2|EC[CAM]ANGYLELLDHVLLTLQKPSPELKQQLTGHSK.6|MVAAATNNLC[CAM]EAANAAVQGHASQEK.4|M[Oxi]VAAATNNLC[CAM]EAANAAVQGHASQEK.3|MVAAATNNLC[CAM]EAANAAVQGHASQEK.3|NC[CAM]GQMSEIEAK.2|NC[CAM]GQM[Oxi]SEIEAK.2|SKDHFGLEGDEESTM[Oxi]LEDSVSPK.4|SKDHFGLEGDEESTMLEDSVSPK.4|SKDHFGLEGDEESTMLEDSVSPK.3|AAAFEEQENETVVVKEK.3|AIAVTVQEMVTK.2|AIAVTVQEM[Oxi]VTK.2|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.5|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.4|ANQAIQM[Oxi]AC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.3|ANQAIQMAC[CAM]QSLGEPGC[CAM]TQAQVLSAATIVAK.3|EADESLNFEEQILEAAK.3|EADESLNFEEQILEAAK.2|QFVQSAKEVANSTANLVK.3|LGAASLGAEDPETQVVLINAVKDVAK.4|LGAASLGAEDPETQVVLINAVKDVAK.3|MVGGIAQIIAAQEEMLRK.3|M[Oxi]VGGIAQIIAAQEEMLRK.3|MVGGIAQIIAAQEEM[Oxi]LRK.3|MVGGIAQIIAAQEEMLRK.2|ALSTDPAAPNLKSQLAAAAR.3|ALSTDPAAPNLKSQLAAAAR.2|EGISQEALHTQMLTAVQEISHLIEPLANAAR.5|EGISQEALHTQM[Oxi]LTAVQEISHLIEPLANAAR.4|EGISQEALHTQMLTAVQEISHLIEPLANAAR.4|EGISQEALHTQM[Oxi]LTAVQEISHLIEPLANAAR.3|EGISQEALHTQMLTAVQEISHLIEPLANAAR.3|VLVEDTKVLVQNAAGSQEK.3|FGQDFSTFLEAGVEMAGQAPSQEDR.4|FGQDFSTFLEAGVEM[Oxi]AGQAPSQEDR.3|FGQDFSTFLEAGVEMAGQAPSQEDR.3|LLSDSLPPSTGTFQEAQSR.3|LLSDSLPPSTGTFQEAQSR.2|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.5|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.4|AATAPLLEAVDNLSAFASNPEFSSIPAQISPEGR.3|APGQLEC[CAM]ETAIAALNSC[CAM]LR.3|APGQLEC[CAM]ETAIAALNSC[CAM]LR.2|AVEGC[CAM]VSASQAATEDGQLLR.3|AVEGC[CAM]VSASQAATEDGQLLR.2|FFYSDQNVDSR.2|GSQAQPDSPSAQLALIAASQSFLQPGGK.4|GSQAQPDSPSAQLALIAASQSFLQPGGK.3|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.6|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.5|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALM[Oxi]QLAK.4|QNLLQAAGNVGQASGELLQQIGESDTDPHFQDALMQLAK.4|LLAALLEDEGGSGR.2|ASVPTIQDQASAMQLSQC[CAM]AK.3|ASVPTIQDQASAM[Oxi]QLSQC[CAM]AK.3|ASVPTIQDQASAM[Oxi]QLSQC[CAM]AK.2|ASVPTIQDQASAMQLSQC[CAM]AK.2|VLGEAMTGISQNAK.2|VLGEAM[Oxi]TGISQNAK.2|FFYSDQNVDSRDPVQLNLLYVQAR.4|FFYSDQNVDSRDPVQLNLLYVQAR.3|AVAAGNSC[CAM]RQEDVIATANLSR.3|RLLSDSLPPSTGTFQEAQSR.3|SGASGPENFQVGSMPPAQQQITSGQM[Oxi]HR.4|SGASGPENFQVGSMPPAQQQITSGQMHR.4|SGASGPENFQVGSM[Oxi]PPAQQQITSGQMHR.3|SGASGPENFQVGSMPPAQQQITSGQM[Oxi]HR.3|SGASGPENFQVGSMPPAQQQITSGQMHR.3|TLAESALQLLYTAKEAGGNPK.3|ILAQATSDLVNAIKADAEGESDLENSRK.4|ILAQATSDLVNAIKADAEGESDLENSRK.3|KFFYSDQNVDSRDPVQLNLLYVQAR.4|SNTSPEELGPLANQLTSDYGR.3|SNTSPEELGPLANQLTSDYGR.2|IPEAPAGPPSDFGLFLSDDDPK.3|IPEAPAGPPSDFGLFLSDDDPK.2|TEDSGLQTQVIAAATQC[CAM]ALSTSQLVAC[CAM]TK.4|TEDSGLQTQVIAAATQC[CAM]ALSTSQLVAC[CAM]TK.3|AQEAC[CAM]GPLEMDSALSVVQNLEKDLQEVK.4|AQEAC[CAM]GPLEMDSALSVVQNLEKDLQEVK.3|DHFGLEGDEESTMLEDSVSPK.3|DHFGLEGDEESTM[Oxi]LEDSVSPK.3|DHFGLEGDEESTMLEDSVSPK.2|ALC[CAM]GFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFAR.5|ALC[CAM]GFTEAAAQAAYLVGVSDPNSQAGQQGLVEPTQFAR.4|ELLENPVQPINDMSYFGC[CAM]LDSVMENSK.4|ELLENPVQPINDM[Oxi]SYFGC[CAM]LDSVMENSK.3|ELLENPVQPINDMSYFGC[CAM]LDSVM[Oxi]ENSK.3|ELLENPVQPINDMSYFGC[CAM]LDSVMENSK.3|AQEAC[CAM]GPLEMDSALSVVQNLEK.3|AQEAC[CAM]GPLEMDSALSVVQNLEK.2|GHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASK.6|GHMPPLTSAQQALTGTINSSMQAVQAAQATLDDFDTLPPLGQDAASK.4|DHFGLEGDEESTMLEDSVSPKK.3|LADVVKLGAASLGAEDPETQVVLINAVKDVAK.4|ERIPEAPAGPPSDFGLFLSDDDPK.3|VLVEDTKVLVQNAAGSQEKLAQAAQSSVATITR.4|VLVQNAAGSQEKLAQAAQSSVATITR.3|ALEATTEHIRQELAVFC[CAM]SPEPPAKTSTPEDFIR.4|APGQLEC[CAM]ETAIAALNSC[CAM]LRDLDQASLAAVSQQLAPR.4|AHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEM[Oxi]VR.4|AHATGAGPAGRYDQATDTILTVTENIFSSMGDAGEMVR.4|YDQATDTILTVTENIFSSM[Oxi]GDAGEMVR.3|YDQATDTILTVTENIFSSMGDAGEM[Oxi]VR.3|DKAPGQLEC[CAM]ETAIAALNSC[CAM]LRDLDQASLAAVSQQLAPR.4|GTEWVDPEDPTVIAENELLGAAAAIEAAAK.3|LLSDSLPPSTGTFQEAQSRLNEAAAGLNQAATELVQASR.4
SEN / CTL,Q14847,LIM and SH3 domain protein 1,LASP1,0.91,1.06,2.12E-03,6.92E-04,3.16E+00,"ion transport,positive regulation of signal transduction,ion transmembrane transport,cell-cell adhesion","SH3/SH2 adaptor activity,protein binding,zinc ion binding,ion transmembrane transporter activity,actin filament binding,cadherin binding involved in cell-cell adhesion","cytoplasm,cell-cell adherens junction,focal adhesion,cortical actin cytoskeleton,extracellular exosome",12,20,35,QSFTMVADTPENLR.2|QSFTMVADTPENLR.3|QSFTM[Oxi]VADTPENLR.2|GFSVVADTPELQR.2|GFSVVADTPELQR.3|TGDTGMLPANYVEAI.2|TGDTGM[Oxi]LPANYVEAI.2|AC[CAM]FHC[CAM]ETC[CAM]K.3|AC[CAM]FHC[CAM]ETC[CAM]K.2|KPYC[CAM]NAHYPK.3|KPYC[CAM]NAHYPK.2|LKQQSELQSQVR.3|LKQQSELQSQVR.2|YKEEFEK.2|YHEEFEK.2|M[Oxi]GPSGGEGMEPERR.3|MGPSGGEGM[Oxi]EPERR.3|MGPSGGEGMEPERR.3|M[Oxi]GPSGGEGM[Oxi]EPERR.3|TQDQISNIKYHEEFEK.4|TQDQISNIKYHEEFEK.3|DSQDGSSYR.2|TQDQISNIK.2|EPAAPVSIQR.2|GKGFSVVADTPELQR.3|KTQDQISNIK.2|QQSELQSQVR.2|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.6|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.5|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.4|MGPSGGEGMEPER.2|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.7|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.6|RPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYKEPAAPVSIQR.5|DSQDGSSYRRPLEQQQPHHIPTSAPVYQQPQQQPVAQSYGGYK.6
SEN / CTL,P26038,Moesin,MSN,0.91,1.32,5.07E-08,3.81E-08,7.42E+00,"movement of cell or subcellular component,cytoskeleton organization,leukocyte cell-cell adhesion,regulation of cell shape,regulation of cell size,positive regulation of gene expression,gland morphogenesis,membrane to membrane docking,establishment of epithelial cell apical/basal polarity,leukocyte migration,establishment of endothelial barrier,cellular response to testosterone stimulus,positive regulation of podosome assembly,regulation of organelle assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,regulation of lymphocyte migration,positive regulation of early endosome to late endosome transport","double-stranded RNA binding,actin binding,receptor binding,structural constituent of cytoskeleton,protein binding,protein kinase binding,cell adhesion molecule binding","uropod,extracellular space,nucleus,cytoplasm,cytoskeleton,plasma membrane,microvillus,focal adhesion,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,pseudopodium,microvillus membrane,vesicle,myelin sheath,apical part of cell,perinuclear region of cytoplasm,extracellular exosome,cell periphery,blood microparticle",39,60,110,IGFPWSEIR.2|ERQEAEEAKEALLQASR.3|ERQEAEEAKEALLQASR.4|ERQEAEEAKEALLQASR.2|LFFLQVK.2|GMLREDAVLEYLK.3|GMLREDAVLEYLK.2|GM[Oxi]LREDAVLEYLK.3|GM[Oxi]LREDAVLEYLK.2|AKFYPEDVSEELIQDITQR.3|AKFYPEDVSEELIQDITQR.4|AKFYPEDVSEELIQDITQR.2|KTQEQLALEMAELTAR.3|KTQEQLALEMAELTAR.4|KTQEQLALEMAELTAR.2|KTQEQLALEM[Oxi]AELTAR.2|TQEQLALEMAELTAR.3|TQEQLALEMAELTAR.2|TQEQLALEM[Oxi]AELTAR.2|DQKKTQEQLALEMAELTAR.4|DQKKTQEQLALEMAELTAR.3|DQKKTQEQLALEMAELTAR.2|ESPLLFK.2|ESPLLFK.1|SGYLAGDK.2|ALTSELANARDESKK.4|ALTSELANARDESKK.3|ALTSELANARDESKK.2|AQQELEEQTR.3|AQQELEEQTR.2|IQVWHEEHR.3|IQVWHEEHR.2|YGDFNKEVHK.3|YGDFNKEVHK.2|AMLENEK.2|AM[Oxi]LENEK.2|LKQIEEQTKK.3|LKQIEEQTKK.2|EALLQASR.2|QIEEQTK.2|KAQQELEEQTR.3|KAQQELEEQTR.2|KESEAVEWQQK.3|KESEAVEWQQK.2|AQQELEEQTRR.3|AQQELEEQTRR.2|KVTAQDVR.2|TANDMIHAENMR.3|TANDM[Oxi]IHAENMR.3|TANDMIHAENM[Oxi]R.3|TANDMIHAENMR.2|AQM[Oxi]VQEDLEKTRAELK.4|AQMVQEDLEKTRAELK.3|AQM[Oxi]VQEDLEKTRAELK.3|ISQLEMAR.2|ISQLEM[Oxi]AR.2|SGYLAGDKLLPQR.3|SGYLAGDKLLPQR.2|AQMVQEDLEKTR.3|AQM[Oxi]VQEDLEKTR.3|KESPLLFK.2|VLEQHKLNKDQWEER.4|VLEQHKLNKDQWEER.3|ALELEQER.2|ALTSELANARDESK.3|ALTSELANARDESK.2|KAQQELEEQTRR.3|KAQQELEEQTRR.2|KTANDM[Oxi]IHAENMR.3|KTANDMIHAENM[Oxi]R.3|KTANDMIHAENMR.3|KTANDMIHAENMR.2|ALTSELANAR.2|KVTAQDVRK.2|DRSEEERTTEAEK.3|EDAVLEYLK.2|ALELEQERK.2|EVWFFGLQYQDTK.3|EVWFFGLQYQDTK.2|LKQIEEQTK.2|QEAEEAKEALLQASR.3|QEAEEAKEALLQASR.2|VLEQHKLNK.2|RALELEQER.2|SEEERTTEAEKNER.3|QRIDEFESM.2|AQMVQEDLEK.2|AQM[Oxi]VQEDLEK.2|LNKDQWEER.2|ESEAVEWQQK.2|IAQDLEMYGVNYFSIK.3|IAQDLEM[Oxi]YGVNYFSIK.2|IAQDLEMYGVNYFSIK.2|RALELEQERK.2|FYPEDVSEELIQDITQR.3|FYPEDVSEELIQDITQR.2|EGILNDDIYC[CAM]PPETAVLLASYAVQSK.4|EGILNDDIYC[CAM]PPETAVLLASYAVQSK.3|KGSELWLGVDALGLNIYEQNDRLTPK.4|KGSELWLGVDALGLNIYEQNDRLTPK.3|AKFYPEDVSEELIQDITQRLFFLQVK.4|GSELWLGVDALGLNIYEQNDR.3|GSELWLGVDALGLNIYEQNDR.2|KGSELWLGVDALGLNIYEQNDR.3|TAMSTPHVAEPAENEQDEQDENGAEASADLR.4|TAMSTPHVAEPAENEQDEQDENGAEASADLR.3|TAM[Oxi]STPHVAEPAENEQDEQDENGAEASADLR.3|GFSTWLK.1|GSELWLGVDALGLNIYEQNDRLTPK.3|TAMSTPHVAEPAENEQDEQDENGAEASADLRADAMAK.4
SEN / CTL,P81605,Dermcidin,DCD,0.89,1.16,1.73E-01,3.63E-02,1.44E+00,"proteolysis,killing of cells of other organism,defense response to bacterium,defense response to fungus","peptidase activity,poly(A) RNA binding","extracellular region,extracellular matrix,extracellular exosome",3,4,6,LGKDAVEDLESVGK.3|LGKDAVEDLESVGK.2|GAVHDVKDVLDSVL.3|GAVHDVKDVLDSVL.2|ENAGEDPGLAR.2|DAVEDLESVGK.2
SEN / CTL,P25788,Proteasome subunit alpha type-3,PSMA3,0.88,0.97,3.62E-02,8.85E-03,2.05E+00,"MAPK cascade,protein polyubiquitination,stimulatory C-type lectin receptor signaling pathway,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,regulation of cellular amino acid metabolic process,viral process,anaphase-promoting complex-dependent catabolic process,tumor necrosis factor-mediated signaling pathway,NIK/NF-kappaB signaling,Fc-epsilon receptor signaling pathway,proteasome-mediated ubiquitin-dependent protein catabolic process,regulation of mRNA stability,T cell receptor signaling pathway,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,regulation of endopeptidase activity,Wnt signaling pathway, planar cell polarity pathway,negative regulation of canonical Wnt signaling pathway,positive regulation of canonical Wnt signaling pathway","threonine-type endopeptidase activity,protein binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,cytosol,proteasome core complex,proteasome core complex, alpha-subunit complex,extracellular exosome",6,15,25,AVENSSTAIGIR.2|VFQVEYAMK.2|VFQVEYAM[Oxi]K.2|C[CAM]KDGVVFGVEK.3|C[CAM]KDGVVFGVEK.2|IIYIVHDEVK.3|IIYIVHDEVK.2|DIREEAEKYAK.3|DIREEAEKYAK.2|HVGMAVAGLLADAR.3|HVGM[Oxi]AVAGLLADAR.3|HVGMAVAGLLADAR.2|HVGM[Oxi]AVAGLLADAR.2|RLFNVDR.2|DGVVFGVEK.2|IIYIVHDEVKDK.3|IIYIVHDEVKDK.2|LFNVDRHVGMAVAGLLADAR.4|SLADIAREEASNFR.3|SLADIAREEASNFR.2|LYEEGSNKR.2|SNFGYNIPLK.2|AFELELSWVGELTNGRHEIVPK.4|AFELELSWVGELTNGRHEIVPK.3|AFELELSWVGELTNGR.2
SEN / CTL,P04075,Fructose-bisphosphate aldolase A,ALDOA,0.88,1.21,7.71E-19,2.44E-18,1.76E+01,"platelet degranulation,fructose metabolic process,gluconeogenesis,glycolytic process,ATP biosynthetic process,striated muscle contraction,actin filament organization,regulation of cell shape,fructose 1,6-bisphosphate metabolic process,muscle cell cellular homeostasis,protein homotetramerization,canonical glycolysis,cell-cell adhesion","actin binding,fructose-bisphosphate aldolase activity,cytoskeletal protein binding,tubulin binding,identical protein binding,poly(A) RNA binding,fructose binding,cadherin binding involved in cell-cell adhesion","extracellular region,extracellular space,nucleus,cytosol,cell-cell adherens junction,actin cytoskeleton,membrane,platelet alpha granule lumen,M band,I band,extracellular exosome",87,51,110,VDKGVVPLAGTNGETTTQGLDGLSER.3|VDKGVVPLAGTNGETTTQGLDGLSER.4|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.5|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.6|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.4|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.5|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.4|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.6|ALSDHHIYLEGTLLKPNM[Oxi]VTPGHAC[CAM]TQK.3|ALSDHHIYLEGTLLKPNMVTPGHAC[CAM]TQK.3|C[CAM]PLLKPWALTFSYGR.3|C[CAM]PLLKPWALTFSYGR.2|GILAADESTGSIAKR.3|GILAADESTGSIAKR.2|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.4|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.3|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.5|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLKR.6|GVVPLAGTNGETTTQGLDGLSER.3|GVVPLAGTNGETTTQGLDGLSER.2|GVVPLAGTNGETTTQGLDGLSER.4|GILAADESTGSIAK.2|GILAADESTGSIAK.3|IGEHTPSALAIMENANVLAR.3|IGEHTPSALAIMENANVLAR.4|IGEHTPSALAIMENANVLAR.2|IGEHTPSALAIM[Oxi]ENANVLAR.4|IGEHTPSALAIM[Oxi]ENANVLAR.3|IGEHTPSALAIM[Oxi]ENANVLAR.2|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.4|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.5|QLLLTADDRVNPC[CAM]IGGVILFHETLYQK.3|FSHEEIAMATVTALRR.4|FSHEEIAMATVTALRR.3|FSHEEIAM[Oxi]ATVTALRR.4|FSHEEIAM[Oxi]ATVTALRR.3|FSHEEIAMATVTALRR.2|IVAPGKGILAADESTGSIAK.3|IVAPGKGILAADESTGSIAK.4|IVAPGKGILAADESTGSIAK.2|FSHEEIAMATVTALR.3|FSHEEIAMATVTALR.4|FSHEEIAM[Oxi]ATVTALR.3|FSHEEIAM[Oxi]ATVTALR.2|FSHEEIAMATVTALR.2|VNPC[CAM]IGGVILFHETLYQK.3|VNPC[CAM]IGGVILFHETLYQK.4|VNPC[CAM]IGGVILFHETLYQK.2|TVPPAVTGITFLSGGQSEEEASINLNAINKC[CAM]PLLKPWALTFSYGR.6|TVPPAVTGITFLSGGQSEEEASINLNAINKC[CAM]PLLKPWALTFSYGR.5|GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSER.4|GGVVGIKVDKGVVPLAGTNGETTTQGLDGLSER.3|ADDGRPFPQVIK.3|ADDGRPFPQVIK.2|ALQASALK.2|ALSDHHIYLEGTLLK.4|ALSDHHIYLEGTLLK.3|ALSDHHIYLEGTLLK.2|KDGADFAK.2|ALQASALKAWGGK.3|ALQASALKAWGGK.2|RALANSLAC[CAM]QGK.3|RALANSLAC[CAM]QGK.2|RLQSIGTENTEENRR.4|RLQSIGTENTEENRR.3|RLQSIGTENTEENRR.2|C[CAM]QYVTEK.2|AAQEEYVK.2|ELSDIAHR.2|ALQASALKAWGGKK.3|ENLKAAQEEYVK.3|ENLKAAQEEYVK.2|PNMVTPGHAC[CAM]TQK.3|PNM[Oxi]VTPGHAC[CAM]TQK.3|PNMVTPGHAC[CAM]TQK.2|PYQYPALTPEQK.3|PYQYPALTPEQK.2|GGVVGIKVDK.2|LQSIGTENTEENR.3|LQSIGTENTEENR.2|PYQYPALTPEQKKELSDIAHR.5|PYQYPALTPEQKK.3|PYQYPALTPEQKK.2|QLLLTADDR.2|ENLKAAQEEYVKR.3|DGADFAKWR.2|KELSDIAHR.2|RC[CAM]QYVTEK.2|AAQEEYVKR.2|LQSIGTENTEENRR.3|LQSIGTENTEENRR.2|RLQSIGTENTEENR.3|RLQSIGTENTEENR.2|C[CAM]QYVTEKVLAAVYK.3|ALANSLAC[CAM]QGK.2|AWGGKKENLK.2|SKGGVVGIKVDK.2|PWALTFSYGR.2|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.5|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.4|YASIC[CAM]QQNGIVPIVEPEILPDGDHDLK.3|RTVPPAVTGITFLSGGQSEEEASINLNAINK.5|RTVPPAVTGITFLSGGQSEEEASINLNAINK.4|RTVPPAVTGITFLSGGQSEEEASINLNAINK.3|YTPSGQAGAAASESLFVSNHAY.3|YTPSGQAGAAASESLFVSNHAY.2|TVPPAVTGITFLSGGQSEEEASINLNAINK.4|TVPPAVTGITFLSGGQSEEEASINLNAINK.3|ALANSLAC[CAM]QGKYTPSGQAGAAASESLFVSNHAY.4|ALANSLAC[CAM]QGKYTPSGQAGAAASESLFVSNHAY.3
SEN / CTL,P52907,F-actin-capping protein subunit alpha-1,CAPZA1,0.86,1.15,2.54E-02,6.36E-03,2.20E+00,"protein complex assembly,movement of cell or subcellular component,blood coagulation,innate immune response,barbed-end actin filament capping,cell-cell adhesion","actin binding,cadherin binding involved in cell-cell adhesion","extracellular region,cytosol,cytoskeleton,cell-cell adherens junction,F-actin capping protein complex,actin cytoskeleton,extracellular exosome,WASH complex",9,20,42,FTITPPTAQVVGVLK.2|FTITPPTAQVVGVLK.3|LLLNNDNLLR.2|LLLNNDNLLR.3|DVQDSLTVSNEAQTAK.3|DVQDSLTVSNEAQTAK.2|SWRESC[CAM]DSALR.3|SWRESC[CAM]DSALR.2|ESC[CAM]DSALR.2|TKIDWNKILSYK.3|AYVKDHYSNGFC[CAM]TVYAK.4|AYVKDHYSNGFC[CAM]TVYAK.3|IQVHYYEDGNVQLVSHK.4|IQVHYYEDGNVQLVSHK.3|IQVHYYEDGNVQLVSHK.2|EASDPQPEEADGGLK.3|EASDPQPEEADGGLK.2|DHYSNGFC[CAM]TVYAK.3|DHYSNGFC[CAM]TVYAK.2|FITHAPPGEFNEVFNDVR.4|FITHAPPGEFNEVFNDVR.3|FITHAPPGEFNEVFNDVR.2|EGAAHAFAQYNMDQFTPVK.4|EGAAHAFAQYNM[Oxi]DQFTPVK.3|EGAAHAFAQYNMDQFTPVK.3|EGAAHAFAQYNMDQFTPVK.2|KEASDPQPEEADGGLK.3|IEGYEDQVLITEHGDLGNSR.4|IEGYEDQVLITEHGDLGNSR.3|IEGYEDQVLITEHGDLGNSR.2|TIDGQQTIIAC[CAM]IESHQFQPK.4|TIDGQQTIIAC[CAM]IESHQFQPK.3|TIDGQQTIIAC[CAM]IESHQFQPK.2|EASDPQPEEADGGLKSWR.3|IQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAK.5|IQVHYYEDGNVQLVSHKDVQDSLTVSNEAQTAK.4|IIENAENEYQTAISENYQTMSDTTFK.4|IIENAENEYQTAISENYQTM[Oxi]SDTTFK.3|IIENAENEYQTAISENYQTMSDTTFK.3|FITHAPPGEFNEVFNDVRLLLNNDNLLR.4|EGAAHAFAQYNMDQFTPVKIEGYEDQVLITEHGDLGNSR.5|EGAAHAFAQYNMDQFTPVKIEGYEDQVLITEHGDLGNSR.4
SEN / CTL,Q96D15,Reticulocalbin-3,RCN3,0.85,1.41,2.55E-04,1.09E-04,3.96E+00,,calcium ion binding,endoplasmic reticulum lumen,15,13,20,AGDGDGWVSLAELR.2|EVAKEFDQLTPEESQAR.3|EVAKEFDQLTPEESQAR.2|VHQAAPLSDAPHDDAHGNFQYDHEAFLGR.6|VHQAAPLSDAPHDDAHGNFQYDHEAFLGR.5|VHQAAPLSDAPHDDAHGNFQYDHEAFLGR.4|EELTAFLHPEEFPHMR.4|EELTAFLHPEEFPHMR.3|DIVIAETLEDLDR.3|DIVIAETLEDLDR.2|FRVADQDGDSMATR.3|AWIAHTQQR.2|DIVIAETLEDLDRNK.3|DIVIAETLEDLDRNK.2|VADQDGDSMATR.2|VADQDGDSM[Oxi]ATR.2|DSVSAAWDTYDTDRDGR.3|EFDQLTPEESQAR.2|DSVSAAWDTYDTDR.2|DGYVQVEEYIADLYSAEPGEEEPAWVQTER.3
SEN / CTL,Q6UVK1,Chondroitin sulfate proteoglycan 4,CSPG4,0.85,0.75,3.39E-03,1.05E-03,2.98E+00,"activation of MAPK activity,angiogenesis,transmembrane receptor protein tyrosine kinase signaling pathway,cell proliferation,glial cell migration,cell migration,glycosaminoglycan metabolic process,chondroitin sulfate biosynthetic process,chondroitin sulfate catabolic process,dermatan sulfate biosynthetic process,intracellular signal transduction,tissue remodeling,positive regulation of peptidyl-tyrosine phosphorylation","signal transducer activity,protein kinase binding","extracellular region,Golgi lumen,integral component of plasma membrane,focal adhesion,cell surface,apical plasma membrane,lamellipodium membrane,lysosomal lumen,extracellular exosome",9,46,56,GSLLLGGLDAEASR.2|ALLHVWAGGPWPQGATLR.3|ALLHVWAGGPWPQGATLR.2|GVLSYLEPR.2|MFTLLDVVNRK.3|TLSAFSWR.2|GNLQLQGTR.2|HGELELDIPGAQAR.3|SGDEVHYHVTAGPR.3|GQGTVLLHNSVPVADGQPHEVSVHINAHR.6|GQGTVLLHNSVPVADGQPHEVSVHINAHR.5|SSLSQQQLR.2|GGPAQDLTFR.2|LSDGEHTSPGHFFR.3|LVLGQEELR.2|FTQADVDSGR.2|VLFVHSGADR.2|ASEAVEDTFR.2|APLEVPQALGR.2|NGLAGDTETFR.2|SEHDVLFQVTQFPSR.3|SEHDVLFQVTQFPSR.2|MFTLLDVVNR.2|RGDFIYVDIFEGHLR.3|VAIQPVNDHAPVQTISR.3|APHNGFLSLVGGGLGPVTR.3|SFTQAQLDGGLVLFSHR.3|SFTQAQLDGGLVLFSHR.2|SLNSASYLYEVMERPR.3|VTGALQFGELQK.2|GQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFR.7|GQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFR.6|GQLLVSEEPLHAGQPHFLQSQLAAGQLVYAHGGGGTQQDGFHFR.5|ITVAALDASNLLASVPSPQR.3|ITVAALDASNLLASVPSPQR.2|ELEAGSLVYVHR.2|SPPSAGYLVMVSR.2|VSDGLQASPPATLK.2|IYVFQGEAAEIR.2|DLLFGSIVAVDEPTRPIYR.3|VSGPYFPTLLGLSLQVLEPPQHGALQK.4|VSGPYFPTLLGLSLQVLEPPQHGALQK.3|QGAGGVEGAEWWATQAFHQR.3|DQPGEPATEFSC[CAM]R.2|AQLSVVDPDSAPGEIEYEVQR.3|AQLSVVDPDSAPGEIEYEVQR.2|ASSSAGTDPQLLLYR.2|LEPLHTQNTQQETLTTAHLEATLEEAGPSPPTFHYEVVQAPR.6|LEPLHTQNTQQETLTTAHLEATLEEAGPSPPTFHYEVVQAPR.5|AHLQGPAGASVAGPQTSEAFAITVR.3|TTMVTSFTNEDLLR.2|GALADEPPSLDPVQSFSQEAVDTGR.3|LSDGQGFTQDDIQAGR.2|VSGPYFPTLLGLSLQVLEPPQHGALQKEDGPQAR.4|DQLEAAQEAVPPADIVFSVK.2|GSQTLTVC[CAM]PGSVQPLSSQTLR.2
SEN / CTL,P01344,Insulin-like growth factor II,IGF2,0.84,0.54,6.70E-03,1.91E-03,2.72E+00,"skeletal system development,ossification,positive regulation of protein phosphorylation,platelet degranulation,glucose metabolic process,regulation of gene expression by genetic imprinting,regulation of transcription, DNA-templated,multicellular organism development,positive regulation of cell proliferation,insulin receptor signaling pathway,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,positive regulation of activated T cell proliferation,positive regulation of catalytic activity,positive regulation of MAPK cascade,cellular protein metabolic process,positive regulation of glycogen biosynthetic process,positive regulation of mitotic nuclear division,positive regulation of insulin receptor signaling pathway,positive regulation of peptidyl-tyrosine phosphorylation,positive regulation of cell division,positive regulation of protein kinase B signaling,positive regulation of protein serine/threonine kinase activity,positive regulation of receptor activity,positive regulation of glycogen (starch) synthase activity","insulin receptor binding,insulin-like growth factor receptor binding,hormone activity,protein binding,growth factor activity,receptor activator activity,protein serine/threonine kinase activator activity","extracellular region,extracellular space,plasma membrane,platelet alpha granule lumen,extracellular exosome",6,2,3,GIVEEC[CAM]C[CAM]FR.2|SC[CAM]DLALLETYC[CAM]ATPAK.2|SC[CAM]DLALLETYC[CAM]ATPAK.3
SEN / CTL,P35555,Fibrillin-1,FBN1,0.83,0.84,1.34E-11,1.85E-11,1.07E+01,"skeletal system development,metanephros development,heart development,extracellular matrix disassembly,extracellular matrix organization,cell adhesion mediated by integrin,sequestering of BMP in extracellular matrix,sequestering of TGFbeta in extracellular matrix,camera-type eye development,negative regulation of osteoclast differentiation,embryonic eye morphogenesis,post-embryonic eye morphogenesis,cellular response to transforming growth factor beta stimulus,regulation of cellular response to growth factor stimulus,cellular response to insulin-like growth factor stimulus,negative regulation of osteoclast development","integrin binding,hormone activity,extracellular matrix structural constituent,calcium ion binding,protein binding,heparin binding,extracellular matrix constituent conferring elasticity,protein complex binding","microfibril,extracellular region,proteinaceous extracellular matrix,basement membrane,extracellular space,extracellular matrix,extracellular exosome",48,32,32,ILELLPALTTLTNHNR.3|TLPGGNQC[CAM]IVPIC[CAM]R.2|TC[CAM]VDINEC[CAM]LLEPR.2|C[CAM]LC[CAM]PEGFSLSSSGR.2|NLIGTYMC[CAM]IC[CAM]GPGYQR.2|C[CAM]EC[CAM]FPGLAVGLDGR.2|C[CAM]EC[CAM]PVGFFYNDK.2|C[CAM]IC[CAM]KPGFQLASDGR.3|RPDGEGC[CAM]VDENEC[CAM]QTKPGIC[CAM]ENGR.4|YEDEEC[CAM]TLPIAGR.2|GWGPHC[CAM]EIC[CAM]PFQGTVAFK.3|AC[CAM]EDIDEC[CAM]SLPNIC[CAM]VFGTC[CAM]HNLPGLFR.3|C[CAM]EC[CAM]EIGYELDR.2|C[CAM]QC[CAM]PSGMTLDATGR.2|TGC[CAM]TDINEC[CAM]EIGAHNC[CAM]GK.3|DINEC[CAM]ETPGIC[CAM]MNGR.2|C[CAM]VNLIGK.2|NGLC[CAM]VNTR.2|C[CAM]PVGYVLR.2|AWGHPC[CAM]EMC[CAM]PAQPHPC[CAM]R.4|PGFQLASDGR.2|GYILQEDGR.2|MC[CAM]KDEDEC[CAM]EEGKHDC[CAM]TEK.4|YQC[CAM]AC[CAM]NPGYHSTPDR.3|C[CAM]SNQLPQSITK.2|YNAYC[CAM]C[CAM]PGWK.2|GEC[CAM]IDVDEC[CAM]EK.2|NC[CAM]EDMDEC[CAM]SIR.2|C[CAM]SC[CAM]SPGWIGDGIK.2|C[CAM]PPGFYTSPDGTR.2|C[CAM]PTGYYLNEDTR.2|C[CAM]IC[CAM]NSGYEVDSTGK.2
SEN / CTL,Q15293,Reticulocalbin-1,RCN1,0.83,3.59,1.23E-01,2.65E-02,1.58E+00,"in utero embryonic development,camera-type eye development",calcium ion binding,"endoplasmic reticulum,endoplasmic reticulum lumen",15,29,48,AADLNGDLTATR.2|HWILPQDYDHAQAEAR.4|HWILPQDYDHAQAEAR.3|HWILPQDYDHAQAEAR.2|HLVYESDK.2|LTKEEILENWNMFVGSQATNYGEDLTKNHDEL.4|IVDRIDNDGDGFVTTEELK.2|IVDRIDNDGDGFVTTEELK.3|HLVYESDKNKDEK.4|HLVYESDKNKDEK.3|ISWEEYK.2|QATYGYYLGNPAEFHDSSDHHTFKK.6|QATYGYYLGNPAEFHDSSDHHTFKK.5|QATYGYYLGNPAEFHDSSDHHTFKK.4|QATYGYYLGNPAEFHDSSDHHTFKK.3|YIFDNVAK.2|FKAADLNGDLTATR.3|EEFTAFLHPEEFEHM[Oxi]K.4|EEFTAFLHPEEFEHMK.4|EEFTAFLHPEEFEHMK.3|EIVVLETLEDIDK.3|EIVVLETLEDIDK.2|TFDQLTPDESKER.3|TFDQLTPDESKER.2|QATYGYYLGNPAEFHDSSDHHTFK.5|QATYGYYLGNPAEFHDSSDHHTFK.4|QATYGYYLGNPAEFHDSSDHHTFK.3|RYIFDNVAK.2|DGKLDKDEIR.2|ERVVRPDSELGERPPEDNQSFQYDHEAFLGK.6|ERVVRPDSELGERPPEDNQSFQYDHEAFLGK.5|DEIRHWILPQDYDHAQAEAR.4|HLVYESDKNK.2|VVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.6|VVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.5|AADLNGDLTATREEFTAFLHPEEFEHMK.5|AADLNGDLTATREEFTAFLHPEEFEHM[Oxi]K.5|AADLNGDLTATREEFTAFLHPEEFEHMK.4|TFDQLTPDESK.2|VVRPDSELGERPPEDNQSFQYDHEAFLGK.5|VVRPDSELGERPPEDNQSFQYDHEAFLGK.4|ERVVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.6|ERVVRPDSELGERPPEDNQSFQYDHEAFLGKEDSK.5|EQFNEFRDLNK.2|IDNDGDGFVTTEELK.2|EEILENWNMFVGSQATNYGEDLTK.3|NGDGFVDQDEYIADMFSHEENGPEPDWVLSER.4|LTKEEILENWNMFVGSQATNYGEDLTK.3
SEN / CTL,Q14112,Nidogen-2,NID2,0.82,1.57,9.79E-02,2.15E-02,1.67E+00,"cell adhesion,cell-matrix adhesion,extracellular matrix organization,basement membrane organization","calcium ion binding,protein binding,collagen binding","extracellular region,basement membrane,extracellular matrix,extracellular exosome",27,46,60,VLYREDTSPAVLGLAAR.3|AIAVDPIRGNLYWTDWNR.3|AGLELGAEPETIVNSGLISPEGLAIDHIRR.4|FTPTHAFLATWEQVGAYEEVKR.4|SHLYGITAVYPYC[CAM]PTGR.3|GNLYWTDWNR.2|KVLFYTDLVNPR.3|KVLFYTDLVNPR.2|ITQTAEGLDPENYLSIK.2|ITQTAEGLDPENYLSIK.3|MVYWTDVAGR.2|M[Oxi]VYWTDVAGR.2|DGVVSVNK.2|AIAVDPIR.2|HAQAQYAYPGAR.3|HAQAQYAYPGAR.2|IETSSLDGENRR.3|VSGHLHVGHTPVHFTDVDLHAYIVGNDGR.6|VSGHLHVGHTPVHFTDVDLHAYIVGNDGR.5|VSGHLHVGHTPVHFTDVDLHAYIVGNDGR.4|VFALYNDEERVLR.3|VIQNNLKYPFSIVSYADHFYHTDWRR.6|HPSFPTTQQLNVDR.3|HPSFPTTQQLNVDR.2|SDFC[CAM]WC[CAM]VDKDGREVQGTR.4|LLC[CAM]WADAGTK.2|HSGQFTDEYLPEQR.3|HSGQFTDEYLPEQR.2|NC[CAM]VDENEC[CAM]ATGFHR.3|YPFSIVSYADHFYHTDWR.4|YPFSIVSYADHFYHTDWR.3|FAVTNQIGPVK.2|IESALLDGSER.2|ELYHYSDSTVTSTSSR.3|ELYHYSDSTVTSTSSR.2|IETSSLDGENR.2|SDFC[CAM]WC[CAM]VDK.2|DGVVSVNKHSGQFTDEYLPEQR.4|VFALYNDEER.2|AIAVDPIRGNLYWTDWNREAPK.4|AIAVDPIRGNLYWTDWNREAPK.3|EDTSPAVLGLAAR.2|HPSFPTTQQLNVDRVFALYNDEERVLR.5|VLFYTDLVNPR.2|KLEC[CAM]TLPDGTGR.2|EGTSLGEVGGPDLK.2|TMYWTDSVLDK.2|ESYNVQLQLPAR.2|FSNLYVGTNGIISTQDFPR.3|HPSFPTTQQLNVDRVFALYNDEER.4|ILINTDIGLPNGLTFDPFSK.3|ILINTDIGLPNGLTFDPFSK.2|AGLELGAEPETIVNSGLISPEGLAIDHIR.4|AGLELGAEPETIVNSGLISPEGLAIDHIR.3|C[CAM]VHHGGSTFSC[CAM]AC[CAM]LPGYAGDGHQC[CAM]TDVDEC[CAM]SENR.5|C[CAM]VHHGGSTFSC[CAM]AC[CAM]LPGYAGDGHQC[CAM]TDVDEC[CAM]SENR.4|SGYEFADDRHTC[CAM]ILITPPANPC[CAM]EDGSHTC[CAM]APAGQAR.5|C[CAM]HPGTGVDYTC[CAM]EC[CAM]ASGYQGDGR.3|C[CAM]GPNSVC[CAM]INLPGSYR.2|SEGPYFSLTSTEQSVK.2
SEN / CTL,P15144,Aminopeptidase N,ANPEP,0.80,1.38,1.86E-04,8.12E-05,4.09E+00,"angiogenesis,proteolysis,cell differentiation,peptide catabolic process,viral entry into host cell","virus receptor activity,aminopeptidase activity,receptor activity,metallopeptidase activity,zinc ion binding,peptide binding,metalloaminopeptidase activity","extracellular space,lysosomal membrane,endoplasmic reticulum-Golgi intermediate compartment,cytosol,integral component of plasma membrane,external side of plasma membrane,extracellular exosome",15,60,99,YLSYTLNPDLIR.2|YLSYTLNPDLIR.3|ENKEVVLQWFTENSK.3|ENKEVVLQWFTENSK.2|GVGGSQPPDIDKTELVEPTEYLVVHLK.4|GVGGSQPPDIDKTELVEPTEYLVVHLK.5|GVGGSQPPDIDKTELVEPTEYLVVHLK.3|QQQDYWLIDVR.2|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.5|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.6|VM[Oxi]AVDALASSHPLSTPASEINTPAQISELFDAISYSK.4|VMAVDALASSHPLSTPASEINTPAQISELFDAISYSK.4|AQIINDAFNLASAHK.4|AQIINDAFNLASAHK.3|AQIINDAFNLASAHK.2|YRLPNTLKPDSYR.4|YRLPNTLKPDSYR.3|EATDVIIIHSK.3|EATDVIIIHSK.2|QVTPLFIHFR.3|QVTPLFIHFR.2|LPNTLKPDSYR.3|IQTQLQR.2|ALEQALEK.2|SEVYGPMK.2|VNYDEENWRK.3|VNYDEENWRK.2|VVATTQMQAADAR.3|VVATTQMQAADAR.2|VVATTQM[Oxi]QAADAR.2|ELWILNR.2|KDNEETGFGSGTR.3|QASNGVLIR.2|VTLRPYLTPNDR.3|EVVLQWFTENSK.3|EVVLQWFTENSK.2|KVVATTQM[Oxi]QAADAR.3|KVVATTQMQAADAR.3|KVVATTQMQAADAR.2|KVVATTQM[Oxi]QAADAR.2|VVATTQMQAADARK.3|SIQLPTTVR.2|RFSTEYELQQLEQFKK.4|RFSTEYELQQLEQFKK.3|YLSYTLNPDLIRK.3|YLSYTLNPDLIRK.2|VTLRPYLTPNDRGLYVFK.4|KVVATTQM[Oxi]QAADARK.3|KVVATTQMQAADARK.3|SEYMEGNVR.2|SEYM[Oxi]EGNVR.2|AALAC[CAM]SKELWILNR.3|ALEQALEKTK.2|DHSAIPVINR.2|WVKENKEVVLQWFTENSK.4|ENSLLFDPLSSSSSNK.3|ENSLLFDPLSSSSSNK.2|GVGGSQPPDIDK.2|TELVEPTEYLVVHLK.3|TELVEPTEYLVVHLK.2|DGRQQQDYWLIDVR.3|DLTALSNMLPK.2|DLTALSNM[Oxi]LPK.2|VNYDEENWR.2|DLMVLNDVYR.2|DLM[Oxi]VLNDVYR.2|DNEETGFGSGTR.2|FSTEYELQQLEQFKK.3|FSTEYELQQLEQFKK.2|PSEFNYVWIVPITSIR.3|PSEFNYVWIVPITSIR.2|QYM[Oxi]PWEAALSSLSYFK.3|QYMPWEAALSSLSYFK.3|QYM[Oxi]PWEAALSSLSYFK.2|QYMPWEAALSSLSYFK.2|RFSTEYELQQLEQFK.3|RFSTEYELQQLEQFK.2|QWMENPNNNPIHPNLR.3|QWM[Oxi]ENPNNNPIHPNLR.3|SFPC[CAM]FDEPAMK.2|ENSLLFDPLSSSSSNKER.3|ENSLLFDPLSSSSSNKER.2|MLSSFLSEDVFK.2|M[Oxi]LSSFLSEDVFK.2|LFNDYGGGSFSFSNLIQAVTR.3|LFNDYGGGSFSFSNLIQAVTR.2|AALAC[CAM]SKELWILNRYLSYTLNPDLIR.4|AALAC[CAM]SKELWILNRYLSYTLNPDLIR.3|ELWILNRYLSYTLNPDLIR.3|FSTEYELQQLEQFKKDNEETGFGSGTR.4|KLFNDYGGGSFSFSNLIQAVTR.3|KQDATSTIISITNNVIGQGLVWDFVQSNWK.4|KQDATSTIISITNNVIGQGLVWDFVQSNWK.3|SDQIGLPDFNAGAMENWGLVTYR.3|KQDATSTIISITNNVIGQGLVWDFVQSNWKK.4|DSQYEMDSEFEGELADDLAGFYR.3|FSTEYELQQLEQFK.2|STVYC[CAM]NAIAQGGEEEWDFAWEQFR.3|EIPENLMDQYSEVNAISTAC[CAM]SNGVPEC[CAM]EEMVSGLFK.4
SEN / CTL,P28300,Protein-lysine 6-oxidase,LOX,0.80,0.70,3.46E-02,8.50E-03,2.07E+00,"cellular protein modification process,heart development,extracellular matrix organization,collagen fibril organization,lung development,aorta development,wound healing,response to drug,elastic fiber assembly,response to steroid hormone,oxidation-reduction process","protein-lysine 6-oxidase activity,copper ion binding,protein binding","extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,nucleus",6,2,3,YTGHHAYASGC[CAM]TISPY.3|YTGHHAYASGC[CAM]TISPY.2|NQGTSDFLPSRPR.3
SEN / CTL,P35442,Thrombospondin-2,THBS2,0.79,0.41,4.67E-06,2.59E-06,5.59E+00,"cell adhesion,negative regulation of angiogenesis,positive regulation of synapse assembly","calcium ion binding,heparin binding","extracellular region,basement membrane,platelet alpha granule",15,8,9,GTLLALEGPGLSQR.2|SC[CAM]DVTSNTC[CAM]LGPSIQTR.2|GLLQNVHLVFENSVEDILSK.3|VSNDNQFLWELIGGPPK.3|LGPHVTTEYVGPSSER.3|AC[CAM]VGDVQER.2|DDDYAGFVFGYQSSSR.3|DDDYAGFVFGYQSSSR.2|GNQPVGVGLEAAK.2
SEN / CTL,P08294,Extracellular superoxide dismutase [Cu-Zn],SOD3,0.79,1.28,1.44E-03,4.93E-04,3.31E+00,"response to reactive oxygen species,response to hypoxia,removal of superoxide radicals,response to copper ion,oxidation-reduction process","superoxide dismutase activity,copper ion binding,protein binding,heparin binding,zinc ion binding","extracellular region,extracellular space,nucleus,cytoplasm,Golgi lumen,trans-Golgi network,extracellular exosome,extracellular matrix",21,10,14,VTEIWQEVMQR.2|VTEIWQEVM[Oxi]QR.2|VTGVVLFR.2|LAC[CAM]C[CAM]VVGVC[CAM]GPGLWER.2|AGLAASLAGPHSIVGR.3|AGLAASLAGPHSIVGR.2|AIHVHQFGDLSQGC[CAM]ESTGPHYNPLAVPHPQHPGDFGNFAVR.6|AIHVHQFGDLSQGC[CAM]ESTGPHYNPLAVPHPQHPGDFGNFAVR.7|AIHVHQFGDLSQGC[CAM]ESTGPHYNPLAVPHPQHPGDFGNFAVR.5|AVVVHAGEDDLGRGGNQASVENGNAGR.4|AVVVHAGEDDLGR.3|GGNQASVENGNAGR.2|RLAC[CAM]C[CAM]VVGVC[CAM]GPGLWER.3|DDDGALHAAC[CAM]QVQPSATLDAAQPR.3
SEN / CTL,P05452,Tetranectin,CLEC3B,0.77,1.93,2.20E-03,7.10E-04,3.15E+00,"ossification,platelet degranulation,positive regulation of plasminogen activation,bone mineralization,cellular response to organic substance,cellular response to transforming growth factor beta stimulus","calcium ion binding,heparin binding,carbohydrate binding,kringle domain binding","granular component,extracellular region,extracellular space,cytoplasm,platelet dense granule lumen,extracellular exosome,extracellular matrix",21,11,14,LDTLAQEVALLK.2|GGTLGTPQTGSENDALYEYLR.3|GGTLGTPQTGSENDALYEYLR.2|EQQALQTVC[CAM]LK.2|C[CAM]RDQLPYIC[CAM]QFGIV.2|SRLDTLAQEVALLK.3|SRLDTLAQEVALLK.2|TFHEASEDC[CAM]ISR.3|NWETEITAQPDGGK.3|NWETEITAQPDGGK.2|C[CAM]FLAFTQTK.2|TENC[CAM]AVLSGAANGK.2|DQLPYIC[CAM]QFGIV.2|NWETEITAQPDGGKTENC[CAM]AVLSGAANGK.3
SEN / CTL,Q14315,Filamin-C,FLNC,0.77,1.22,6.29E-09,5.49E-09,8.26E+00,"cell junction assembly,muscle fiber development","protein binding,cytoskeletal protein binding,ankyrin binding,actin filament binding","cytoplasm,cytosol,cytoskeleton,plasma membrane,focal adhesion,sarcoplasm,Z disc,sarcolemma,costamere",51,146,209,LIALLEVLSQK.2|VAVGQEQAFSVNTR.2|YGGDEIPYSPFR.2|YWPTEPGEYAVHVIC[CAM]DDEDIRDSPFIAHILPAPPDC[CAM]FPDK.5|GAGTGGLGLAIEGPSEAK.2|GAGTGGLGLAIEGPSEAK.3|LYAQDADGC[CAM]PIDIK.2|GVAGVPAEFSIWTR.2|GVAGVPAEFSIWTR.3|AFGPGLEPTGC[CAM]IVDKPAEFTIDAR.3|AFGPGLEPTGC[CAM]IVDKPAEFTIDAR.4|SPFVVNVAPPLDLSK.2|SPFVVNVAPPLDLSK.3|EC[CAM]PEGHVVTYTPMAPGNYLIAIK.3|EC[CAM]PEGHVVTYTPM[Oxi]APGNYLIAIK.3|EAGAGGLSIAVEGPSKAEIAFEDRK.4|GELTGEVR.2|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.5|C[CAM]TYRPAM[Oxi]EGPHTVHVAFAGAPITR.5|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.4|C[CAM]TYRPAMEGPHTVHVAFAGAPITR.3|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.5|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.6|FGGEHIPNSPFHVLAC[CAM]DPLPHEEEPSEVPQLR.4|LIALLEVLSQKR.3|LIALLEVLSQKR.2|ITESDLSQLTASIR.2|ITESDLSQLTASIR.3|RDTVEVALEDKGDSTFR.4|RDTVEVALEDKGDSTFR.3|ATIRPVFDPSK.3|AKLDVQFAGTAK.3|LEPGGGAEAQAVR.3|LEPGGGAEAQAVR.2|SPFRVNVGEGSHPER.4|FNGAHIPGSPFK.3|FNGAHIPGSPFK.2|SLTATGGNHVTAR.3|SLTATGGNHVTAR.2|TGVEVGKPTHFTVLTK.4|TGVEVGKPTHFTVLTK.3|TGVEVGKPTHFTVLTK.2|VSGPGVEPHGVLR.3|VSGPGVEPHGVLR.2|GLHQMGIK.2|ITGDDSMR.2|ITGDDSM[Oxi]R.2|VHVQPAVDTSGVK.3|VHVQPAVDTSGVK.2|RLTDLQR.2|GDYILIVK.2|GSSYSSIPK.2|HVTNSPFK.2|YGGPQHIVGSPFK.3|YGGPQHIVGSPFK.2|LGSFGSITR.2|TARPNITDNKDGTITVR.4|TARPNITDNKDGTITVR.3|VLPAHDASK.2|AEIAFEDR.2|AGTNMMMVGVHGPK.3|AGTNMM[Oxi]MVGVHGPK.3|AGTNM[Oxi]M[Oxi]M[Oxi]VGVHGPK.3|RLTVTSLQETGLK.3|RLTVTSLQETGLK.2|VC[CAM]AYGPGLK.2|PATFTIVTK.2|YADQEVPR.2|APSGNEEPC[CAM]LLKR.3|HIGISFTPK.2|RPIPC[CAM]KLEPGGGAEAQAVR.4|RPIPC[CAM]KLEPGGGAEAQAVR.3|HTIIISWGGVNVPK.3|HTIIISWGGVNVPK.2|LENVSVALEFLER.3|LENVSVALEFLER.2|LENVSVALEFLEREHIK.4|C[CAM]SGPGLGAGVR.2|FVPQEMGPHTVAVK.3|FVPQEMGPHTVAVK.2|PAMEGPHTVHVAFAGAPITR.4|TYAVSYVPK.2|HVSAYGPGLSHGMVNKPATFTIVTK.5|HVSAYGPGLSHGMVNKPATFTIVTK.4|LSGGHSLHETSTVLVETVTK.4|LSGGHSLHETSTVLVETVTK.3|LSGGHSLHETSTVLVETVTK.2|VPQTFTVDC[CAM]SQAGR.3|VPQTFTVDC[CAM]SQAGR.2|VRAWGPGLETGQVGK.3|FIPHENGVHSIDVK.3|GAGGQGQLDVR.2|LDVQFAGTAK.2|NSFTVDC[CAM]SK.2|YRGQHVPGSPFQFTVGPLGEGGAHK.5|YRGQHVPGSPFQFTVGPLGEGGAHK.4|YRGQHVPGSPFQFTVGPLGEGGAHK.3|AEIAFEDRK.2|VIPNGDGTFR.2|VYNVTYTVK.2|HVSAYGPGLSHGMVNK.3|VHTPSGAVEEC[CAM]YVSELDSDKHTIR.5|VHTPSGAVEEC[CAM]YVSELDSDKHTIR.4|VVTRGPGLSQAFVGQK.3|VVTRGPGLSQAFVGQK.2|EVGEHVVSVR.2|IHALPTGDASK.2|IPGNWFQMVSAQER.3|IPGNWFQMVSAQER.2|TARPNITDNK.2|TPC[CAM]EEVYVK.2|YTIMVLFANQEIPASPFHIK.4|YTIMVLFANQEIPASPFHIK.3|YTIM[Oxi]VLFANQEIPASPFHIK.3|YTIMVLFANQEIPASPFHIK.2|DTVEVALEDKGDSTFR.3|DTVEVALEDKGDSTFR.2|EKGDYILIVK.2|GPGLSQAFVGQK.2|VNVGEGSHPER.2|ARVPQTFTVDC[CAM]SQAGR.3|ARVPQTFTVDC[CAM]SQAGR.2|C[CAM]SYVPTKPIK.2|QAPSIATIGSTC[CAM]DLNLK.3|QAPSIATIGSTC[CAM]DLNLK.2|VGVTEGC[CAM]DPTR.2|VEAAEIVEGEDSAYSVR.3|VEAAEIVEGEDSAYSVR.2|AFGPGLEGGLVNK.2|DNGDGTHTVHYTPATDGPYTVAVK.4|DNGDGTHTVHYTPATDGPYTVAVK.3|EVTTEFTVDAR.2|C[CAM]LVTVSIGGHGLGAC[CAM]LGPR.3|C[CAM]LVTVSIGGHGLGAC[CAM]LGPR.2|GLHQMGIKYDGNHIPGSPLQFYVDAINSR.5|ILVGPSEIGDASK.2|LTVTSLQETGLK.2|AWGPGLETGQVGK.2|DRTYAVSYVPK.2|RQAPSIATIGSTC[CAM]DLNLK.3|SPFPVHVSEAC[CAM]NPNAC[CAM]R.3|VPQLPITNFNR.2|WGDESVPGSPFK.2|APSGNEEPC[CAM]LLK.2|DAGEGLLTVQILDPEGKPK.3|DAGEGLLTVQILDPEGKPK.2|APLQVAVLGPTGVAEPVEVR.3|APLQVAVLGPTGVAEPVEVR.2|C[CAM]APGVVGPAEADIDFDIIK.3|GLSEGHTFQVAEFIVDTR.3|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.6|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.5|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.4|FNDEHIPDSPFVVPVASLSDDARR.4|VPQLPITNFNRDWQDGK.3|VTVLFAGQNIER.2|PFNLVIPFAVQK.2|VQYTAYEEGVHLVEVLYDEVAVPK.4|VQYTAYEEGVHLVEVLYDEVAVPK.3|ITESDLSQLTASIRAPSGNEEPC[CAM]LLK.4|ITESDLSQLTASIRAPSGNEEPC[CAM]LLK.3|QQEGEASSQDMTAQVTSPSGK.3|QQEGEASSQDMTAQVTSPSGK.2|DAGEGGLSLAVEGPSKAEITC[CAM]K.3|GGLVGTPAPFSIDTK.2|DAGEGGLSLAVEGPSK.2|VHTPSGAVEEC[CAM]YVSELDSDK.3|DGSC[CAM]GVSYVVQEPGDYEVSIK.3|DGSC[CAM]GVSYVVQEPGDYEVSIK.2|DGTC[CAM]TVSYLPTAPGDYSIIVR.3|DGTC[CAM]TVSYLPTAPGDYSIIVR.2|NAGYGGLGLSIEGPSK.2|VREAGDGVFEC[CAM]EYYPVVPGK.3|VREAGDGVFEC[CAM]EYYPVVPGK.2|TSQLNVGTSTDVSLK.2|VEESTQVGGDPFPAVFGDFLGR.3|VEESTQVGGDPFPAVFGDFLGR.2|ASGPGLNASGIPASLPVEFTIDAR.3|ASGPGLNASGIPASLPVEFTIDAR.2|FDDKHIPGSPFTAK.2|TDTYVTDNGDGTYR.2|VNQPASFAVQLNGAR.2|YDGNHIPGSPLQFYVDAINSR.3|SPFEVQVSPEAGVQK.2|YVVTITWGGYAIPR.2|AEVLIHNNADGTYHITYSPAFPGTYTITIK.4|AEVLIHNNADGTYHITYSPAFPGTYTITIK.3|QPYAPPRPGARPTHWATEEPVVPVEPMESMLRPFNLVIPFAVQK.6|SPFEVNVGMALGDANK.2|VQLDC[CAM]REC[CAM]PEGHVVTYTPMAPGNYLIAIK.4|ALGALVDNC[CAM]APGLC[CAM]PDWEAWDPNQPVENAR.4|ALGALVDNC[CAM]APGLC[CAM]PDWEAWDPNQPVENAR.3|FNDEHIPDSPFVVPVASLSDDAR.3|DNKDGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFRVPVK.5|DNKDGTC[CAM]TVSYLPTAPGDYSIIVR.3|VRASGPGLNASGIPASLPVEFTIDAR.3|APLQVAVLGPTGVAEPVEVRDNGDGTHTVHYTPATDGPYTVAVK.5|DGSC[CAM]TVEYIPFTPGDYDVNITFGGRPIPGSPFR.4|EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK.5|EAMQQADDWLGVPQVIAPEEIVDPNVDEHSVMTYLSQFPK.4|EVRVEESTQVGGDPFPAVFGDFLGR.3|VTYC[CAM]PTEPGTYIINIK.2|ARVPQTFTVDC[CAM]SQAGRAPLQVAVLGPTGVAEPVEVR.4|PTHWATEEPVVPVEPMESMLRPFNLVIPFAVQK.4|YMPPEEGPYKVDITYDGHPVPGSPFAVEGVLPPDPSK.4|AIAYGPGIEPQGNTVLQPAHFTVQTVDAGVGEVLVYIEDPEGHTEEAK.5|EAGDGVFEC[CAM]EYYPVVPGK.2|GPGLEPVGNVANKPTYFDIYTAGAGTGDVAVVIVDPQGRR.4|IEC[CAM]QDNGDGSC[CAM]AVSYLPTEPGEYTINILFAEAHIPGSPFK.4
SEN / CTL,Q01518,Adenylyl cyclase-associated protein 1,CAP1,0.75,0.37,3.76E-03,1.16E-03,2.94E+00,"cell morphogenesis,ameboidal-type cell migration,receptor-mediated endocytosis,establishment or maintenance of cell polarity,signal transduction,activation of adenylate cyclase activity,actin polymerization or depolymerization","actin binding,adenylate cyclase binding","plasma membrane,focal adhesion,cortical actin cytoskeleton,extracellular exosome",6,51,99,SSEMNVLIPTEGGDFNEFPVPEQFK.3|SSEMNVLIPTEGGDFNEFPVPEQFK.4|SSEM[Oxi]NVLIPTEGGDFNEFPVPEQFK.3|AGAAPYVQAFDSLLAGPVAEYLK.3|AGAAPYVQAFDSLLAGPVAEYLK.4|AGAAPYVQAFDSLLAGPVAEYLK.2|EPAVLELEGKK.3|KEPAVLELEGK.3|KEPAVLELEGK.2|GYADSPSK.2|HVSDDMK.2|EFHTTGLAWSK.3|EFHTTGLAWSK.2|EIGGDVQK.2|TLWNGQK.2|INSITVDNC[CAM]KK.3|INSITVDNC[CAM]KK.2|ALLVTASQC[CAM]QQPAENK.4|ALLVTASQC[CAM]QQPAENK.3|ALLVTASQC[CAM]QQPAENK.2|AVGRLEAVSHTSDMHR.4|AVGRLEAVSHTSDM[Oxi]HR.3|AVGRLEAVSHTSDMHR.3|QVAYIYK.2|GKINSITVDNC[CAM]K.3|GKINSITVDNC[CAM]K.2|KEPAVLELEGKK.3|KEPAVLELEGKK.2|KHVDWVK.2|LEAVSHTSDMHR.3|LEAVSHTSDM[Oxi]HR.3|LEAVSHTSDMHR.2|LEAVSHTSDM[Oxi]HR.2|SGPKPFSAPKPQTSPSPK.4|SGPKPFSAPKPQTSPSPK.3|LSDLLAPISEQIK.3|LSDLLAPISEQIK.2|EMNDAAMFYTNR.3|EM[Oxi]NDAAMFYTNR.3|EMNDAAM[Oxi]FYTNR.3|EMNDAAMFYTNR.2|EM[Oxi]NDAAMFYTNR.2|EMNDAAM[Oxi]FYTNR.2|EM[Oxi]NDAAM[Oxi]FYTNR.2|PFSAPKPQTSPSPK.3|GKINSITVDNC[CAM]KK.3|GKINSITVDNC[CAM]KK.2|LVTTVTEIAG.2|VPTISINKTDGC[CAM]HAYLSK.4|VPTISINKTDGC[CAM]HAYLSK.3|ATKKEPAVLELEGK.3|ATKKEPAVLELEGK.2|HAEMVHTGLKLER.3|KLGLVFDDVVGIVEIINSK.4|KLGLVFDDVVGIVEIINSK.3|KLGLVFDDVVGIVEIINSK.2|VENQENVSNLVIEDTELK.4|VENQENVSNLVIEDTELK.3|VENQENVSNLVIEDTELK.2|C[CAM]VNTTLQIK.2|EPAVLELEGK.2|HAEMVHTGLK.2|HAEM[Oxi]VHTGLK.2|TDGC[CAM]HAYLSK.2|INSITVDNC[CAM]K.2|ISKEIGGDVQK.2|KLGLVFDDVVGIVEIINSKDVK.4|KLGLVFDDVVGIVEIINSKDVK.3|LSDLLAPISEQIKEVITFREK.4|WRVENQENVSNLVIEDTELK.4|WRVENQENVSNLVIEDTELK.3|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.6|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.5|NRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APK.4|LFNHLSAVSESIQALGWVAMAPK.4|LFNHLSAVSESIQALGWVAM[Oxi]APK.3|LFNHLSAVSESIQALGWVAMAPK.3|LFNHLSAVSESIQALGWVAMAPKPGPYVK.5|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.5|LFNHLSAVSESIQALGWVAMAPKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.4|LFNHLSAVSESIQALGWVAM[Oxi]APKPGPYVK.3|LFNHLSAVSESIQALGWVAMAPKPGPYVK.3|NSLDC[CAM]EIVSAK.2|KWRVENQENVSNLVIEDTELK.4|KWRVENQENVSNLVIEDTELK.3|LGLVFDDVVGIVEIINSK.3|LGLVFDDVVGIVEIINSK.2|EIGGDVQKHAEMVHTGLK.3|SSLFAQINQGESITHALK.3|SSLFAQINQGESITHALK.2|LSDLLAPISEQIKEVITFR.3|LGLVFDDVVGIVEIINSKDVK.3|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIK.4|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIK.3|GSKLFNHLSAVSESIQALGWVAMAPKPGPYVK.4|AYLSIWTELQAYIK.2|ALLVTASQC[CAM]QQPAENKLSDLLAPISEQIKEVITFR.4
SEN / CTL,P10321,"HLA class I histocompatibility antigen, Cw-7 alpha chain",HLA-C,0.75,2.06,1.56E-06,9.25E-07,6.03E+00,,,,27,12,15,AYLEGTC[CAM]VEWLR.2|SWTAADTAAQITQR.2|SWTAADTAAQITQR.3|AYLEGTC[CAM]VEWLRR.3|DGEDQTQDTELVETRPAGDGTFQK.3|DGEDQTQDTELVETRPAGDGTFQK.4|C[CAM]WALGFYPAEITLTWQR.2|FISVGYVDDTQFVR.2|GYDQSAYDGKDYIALNEDLR.3|WAAVVVPSGQEQR.2|THVTHHPLSDHEATLR.4|THVTHHPLSDHEATLR.3|AEPPKTHVTHHPLSDHEATLR.5|GYDQSAYDGK.2|MSGC[CAM]DLGPDGR.2
SEN / CTL,P63241,Eukaryotic translation initiation factor 5A-1,EIF5A,0.75,1.60,1.03E-03,3.69E-04,3.43E+00,"mRNA export from nucleus,translational frameshifting,protein export from nucleus,nucleocytoplasmic transport,apoptotic process,positive regulation of cell proliferation,peptidyl-lysine modification to peptidyl-hypusine,positive regulation of translational elongation,positive regulation of translational termination","RNA binding,translation elongation factor activity,protein binding,U6 snRNA binding,ribosome binding,poly(A) RNA binding,protein N-terminus binding","nucleus,annulate lamellae,nuclear pore,cytoplasm,endoplasmic reticulum membrane,cytosol,membrane,extracellular exosome",15,19,41,VHLVGIDIFTGK.3|VHLVGIDIFTGK.2|RNDFQLIGIQDGYLSLLQDSGEVR.4|RNDFQLIGIQDGYLSLLQDSGEVR.3|KYEDIC[CAM]PSTHNMDVPNIKR.5|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.5|KYEDIC[CAM]PSTHNMDVPNIKR.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIKR.3|KYEDIC[CAM]PSTHNMDVPNIKR.3|KYEDIC[CAM]PSTHNMDVPNIK.4|KYEDIC[CAM]PSTHNM[Oxi]DVPNIK.4|KYEDIC[CAM]PSTHNMDVPNIK.3|KYEDIC[CAM]PSTHNM[Oxi]DVPNIK.3|KYEDIC[CAM]PSTHNMDVPNIK.2|LPEGDLGK.2|EDLRLPEGDLGK.3|EDLRLPEGDLGK.2|IVEMSTSK.2|KNGFVVLK.2|VHLVGIDIFTGKK.3|VHLVGIDIFTGKK.2|LPEGDLGKEIEQK.3|EDLRLPEGDLGKEIEQK.4|EDLRLPEGDLGKEIEQK.3|EDLRLPEGDLGKEIEQK.2|GRPC[CAM]KIVEM[Oxi]STSK.3|YEDIC[CAM]PSTHNMDVPNIK.4|YEDIC[CAM]PSTHNM[Oxi]DVPNIK.3|YEDIC[CAM]PSTHNMDVPNIK.3|YEDIC[CAM]PSTHNMDVPNIK.2|YEDIC[CAM]PSTHNM[Oxi]DVPNIKR.4|YEDIC[CAM]PSTHNMDVPNIKR.4|YEDIC[CAM]PSTHNMDVPNIKR.3|VHLVGIDIFTGKKYEDIC[CAM]PSTHNMDVPNIK.6|VHLVGIDIFTGKKYEDIC[CAM]PSTHNMDVPNIK.5|NDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGK.5|NDFQLIGIQDGYLSLLQDSGEVREDLRLPEGDLGK.4|RNDFQLIGIQDGYLSLLQDSGEVREDLR.4|NDFQLIGIQDGYLSLLQDSGEVR.3|YDC[CAM]GEEILITVLSAMTEEAAVAIK.3
SEN / CTL,Q92520,Protein FAM3C,FAM3C,0.73,1.03,3.97E-02,9.58E-03,2.02E+00,"platelet degranulation,multicellular organism development,biological_process",cytokine activity,"extracellular region,Golgi apparatus,platelet dense granule lumen,extracellular exosome",9,12,17,MDASLGNLFAR.2|IC[CAM]LEDNVLMSGVK.2|IC[CAM]LEDNVLM[Oxi]SGVK.2|LIADLGSTSITNLGFR.2|LIADLGSTSITNLGFR.3|TKSPFEQHIK.3|TGEVLDTK.2|GINVALANGK.2|SPFEQHIK.2|DNWVFC[CAM]GGK.2|MASGAANVVGPK.2|M[Oxi]ASGAANVVGPK.2|RLIADLGSTSITNLGFR.3|YFDM[Oxi]WGGDVAPFIEFLK.3|YFDMWGGDVAPFIEFLK.3|YFDMWGGDVAPFIEFLK.2|AIQDGTIVLMGTYDDGATK.2
SEN / CTL,O95967,EGF-containing fibulin-like extracellular matrix protein 2,EFEMP2,0.72,0.53,1.37E-04,6.12E-05,4.21E+00,,"extracellular matrix structural constituent,calcium ion binding,protein binding","extracellular region,basement membrane,extracellular exosome,extracellular vesicle",12,6,6,SC[CAM]VDVNEC[CAM]DMGAPC[CAM]EQR.2|C[CAM]INHYGGYLC[CAM]LPR.3|LC[CAM]QDIDEC[CAM]ESGAHQC[CAM]SEAQTC[CAM]VNFHGGYR.4|AGNSQGDFYIR.2|C[CAM]LC[CAM]PASNPLC[CAM]R.2|DVNEC[CAM]LTIPEAC[CAM]K.2
SEN / CTL,P06396,Gelsolin,GSN,0.72,1.08,2.42E-07,1.56E-07,6.81E+00,"phagocytosis, engulfment,positive regulation of gene expression,striated muscle atrophy,actin filament polymerization,protein destabilization,sequestering of actin monomers,cellular protein metabolic process,actin nucleation,negative regulation of viral entry into host cell,actin filament severing,barbed-end actin filament capping,positive regulation of actin nucleation,actin filament capping,cilium morphogenesis,regulation of podosome assembly,actin filament reorganization,renal protein absorption,hepatocyte apoptotic process,positive regulation of keratinocyte apoptotic process,regulation of wound healing, spreading of epidermal cells,regulation of establishment of T cell polarity,regulation of plasma membrane raft polarization,regulation of receptor clustering,positive regulation of protein processing in phagocytic vesicle,amyloid fibril formation,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,extracellular matrix disassembly","actin binding,calcium ion binding,protein binding,protein domain specific binding,myosin II binding","podosome,extracellular region,extracellular space,cytoplasm,cytosol,plasma membrane,focal adhesion,actin cytoskeleton,sarcoplasm,actin cap,cortical actin cytoskeleton,extracellular exosome,blood microparticle,nucleus",45,53,102,QTQVSVLPEGGETPLFK.2|QTQVSVLPEGGETPLFK.3|AGALNSNDAFVLK.2|AGALNSNDAFVLK.3|AQPVQVAEGSEPDGFWEALGGK.3|AQPVQVAEGSEPDGFWEALGGK.2|AQPVQVAEGSEPDGFWEALGGK.4|NWRDPDQTDGLGLSYLSSHIANVER.4|NWRDPDQTDGLGLSYLSSHIANVER.5|NWRDPDQTDGLGLSYLSSHIANVER.3|TPSAAYLWVGTGASEAEKTGAQELLR.4|TPSAAYLWVGTGASEAEKTGAQELLR.3|VEKFDLVPVPTNLYGDFFTGDAYVILK.3|VEKFDLVPVPTNLYGDFFTGDAYVILK.4|EVQGFESATFLGYFK.2|EVQGFESATFLGYFK.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.5|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.6|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANR.4|TPSAAYLWVGTGASEAEK.2|TPSAAYLWVGTGASEAEK.3|FDLVPVPTNLYGDFFTGDAYVILK.3|IEGSNKVPVDPATYGQFYGGDSYIILYNYR.4|IEGSNKVPVDPATYGQFYGGDSYIILYNYR.3|VPFDAATLHTSTAMAAQHGMDDDGTGQK.4|VPFDAATLHTSTAMAAQHGMDDDGTGQK.5|VPFDAATLHTSTAM[Oxi]AAQHGMDDDGTGQK.4|VPFDAATLHTSTAMAAQHGM[Oxi]DDDGTGQK.4|VPFDAATLHTSTAM[Oxi]AAQHGM[Oxi]DDDGTGQK.4|VPFDAATLHTSTAM[Oxi]AAQHGMDDDGTGQK.3|VPFDAATLHTSTAMAAQHGMDDDGTGQK.3|SEDC[CAM]FILDHGKDGK.4|SEDC[CAM]FILDHGKDGK.3|SEDC[CAM]FILDHGKDGK.2|RYIETDPANR.3|AGKEPGLQIWR.3|AGKEPGLQIWR.2|DSQEEEKTEALTSAK.4|DSQEEEKTEALTSAK.3|DSQEEEKTEALTSAK.2|HVVPNEVVVQR.3|HVVPNEVVVQR.2|KGGVASGFK.2|DSQEEEK.2|EPAHLM[Oxi]SLFGGK.3|EPAHLMSLFGGK.2|SEDC[CAM]FILDHGK.3|SEDC[CAM]FILDHGK.2|TASDFITK.2|TGAQELLR.2|VVQGKEPAHLMSLFGGK.4|VVQGKEPAHLMSLFGGK.3|RTPITVVK.2|KMDAHPPR.2|KM[Oxi]DAHPPR.2|PALPAGTEDTAKEDAANRK.4|PALPAGTEDTAKEDAANRK.3|EPGLQIWR.2|GASQAGAPQGR.2|RYIETDPANRDR.3|EPAHLMSLFGGKPMIIYK.4|EPAHLMSLFGGKPMIIYK.3|EPAHLMSLFGGKPMIIYK.2|PNSMVVEHPEFLK.3|PNSM[Oxi]VVEHPEFLK.3|PNSMVVEHPEFLK.2|VPEARPNSMVVEHPEFLK.4|VPEARPNSMVVEHPEFLK.3|EGGQTAPASTR.2|VHVSEEGTEPEAMLQVLGPK.4|VHVSEEGTEPEAM[Oxi]LQVLGPK.3|VHVSEEGTEPEAMLQVLGPK.3|VHVSEEGTEPEAMLQVLGPK.2|YIETDPANR.2|AVQHREVQGFESATFLGYFK.4|PALPAGTEDTAK.2|ARVHVSEEGTEPEAMLQVLGPK.4|ARVHVSEEGTEPEAMLQVLGPK.3|DPDQTDGLGLSYLSSHIANVER.4|DPDQTDGLGLSYLSSHIANVER.3|DPDQTDGLGLSYLSSHIANVER.2|PALPAGTEDTAKEDAANR.3|VSNGAGTMSVSLVADENPFAQGALK.4|VSNGAGTM[Oxi]SVSLVADENPFAQGALK.3|VSNGAGTMSVSLVADENPFAQGALK.3|GGVASGFKHVVPNEVVVQR.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.5|VHVSEEGTEPEAM[Oxi]LQVLGPKPALPAGTEDTAK.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.4|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.3|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRK.6|VHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRK.5|VPVDPATYGQFYGGDSYIILYNYR.4|VPVDPATYGQFYGGDSYIILYNYR.3|ARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.5|ARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAK.4|VSNGAGTMSVSLVADENPFAQGALKSEDC[CAM]FILDHGKDGK.5|MDYPKQTQVSVLPEGGETPLFK.3|NWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQK.6|ATEVPVSWESFNNGDC[CAM]FILDLGNNIHQWC[CAM]GSNSNR.4|QGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSR.4|ATEVPVSWESFNNGDC[CAM]FILDLGNNIHQWC[CAM]GSNSNRYER.4
SEN / CTL,Q06830,Peroxiredoxin-1,PRDX1,0.72,1.38,8.73E-06,4.67E-06,5.33E+00,"response to reactive oxygen species,skeletal system development,retina homeostasis,cell proliferation,removal of superoxide radicals,regulation of stress-activated MAPK cascade,erythrocyte homeostasis,natural killer cell mediated cytotoxicity,regulation of NF-kappaB import into nucleus,hydrogen peroxide catabolic process,cell redox homeostasis,oxidation-reduction process,cell-cell adhesion","peroxidase activity,protein binding,thioredoxin peroxidase activity,identical protein binding,poly(A) RNA binding,cadherin binding involved in cell-cell adhesion","extracellular space,nucleus,cytoplasm,mitochondrion,cytosol,cell-cell adherens junction,extracellular matrix,melanosome,myelin sheath,extracellular exosome",30,29,60,GLFIIDDKGILR.3|GLFIIDDKGILR.2|LVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.6|LVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.5|TIAQDYGVLKADEGISFR.3|TIAQDYGVLKADEGISFR.4|TIAQDYGVLKADEGISFR.2|QITVNDLPVGR.2|QITVNDLPVGR.3|LVQAFQFTDK.2|LVQAFQFTDK.3|KQGGLGPMNIPLVSDPKR.4|KQGGLGPMNIPLVSDPKR.3|KQGGLGPM[Oxi]NIPLVSDPKR.4|KQGGLGPM[Oxi]NIPLVSDPKR.3|ATAVMPDGQFKDISLSDYK.3|ATAVM[Oxi]PDGQFKDISLSDYK.3|SVDETLR.2|RTIAQDYGVLK.3|RTIAQDYGVLK.2|PGSDTIKPDVQK.3|PGSDTIKPDVQK.2|ADEGISFR.2|GLFIIDDK.2|GLFIIDDK.1|DISLSDYK.2|HGEVC[CAM]PAGWKPGSDTIKPDVQK.5|HGEVC[CAM]PAGWKPGSDTIKPDVQK.4|HGEVC[CAM]PAGWKPGSDTIKPDVQK.3|IGHPAPNFK.2|RTIAQDYGVLKADEGISFR.4|RTIAQDYGVLKADEGISFR.3|QGGLGPMNIPLVSDPK.3|QGGLGPMNIPLVSDPK.2|QGGLGPM[Oxi]NIPLVSDPK.2|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.5|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.4|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.3|TIAQDYGVLK.2|ATAVMPDGQFKDISLSDYKGK.4|HGEVC[CAM]PAGWK.2|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.5|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.4|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPK.3|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPKK.5|LNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPKK.4|ATAVMPDGQFK.2|ATAVM[Oxi]PDGQFK.2|KQGGLGPMNIPLVSDPK.3|KQGGLGPM[Oxi]NIPLVSDPK.3|KQGGLGPMNIPLVSDPK.2|KQGGLGPM[Oxi]NIPLVSDPK.2|QGGLGPMNIPLVSDPKR.3|QGGLGPM[Oxi]NIPLVSDPKR.3|QGGLGPMNIPLVSDPKR.2|KLNC[CAM]QVIGASVDSHFC[CAM]HLAWVNTPKK.5|SVDETLRLVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.7|SVDETLRLVQAFQFTDKHGEVC[CAM]PAGWKPGSDTIKPDVQK.5|GLFIIDDKGILRQITVNDLPVGR.4|GLFIIDDKGILRQITVNDLPVGR.3
SEN / CTL,P10599,Thioredoxin,TXN,0.72,1.58,6.06E-02,1.38E-02,1.86E+00,"sulfate assimilation,negative regulation of transcription from RNA polymerase II promoter,response to reactive oxygen species,transcription, DNA-templated,protein folding,glycerol ether metabolic process,movement of cell or subcellular component,signal transduction,cell-cell signaling,cell proliferation,response to radiation,nucleobase-containing small molecule interconversion,protein repair,activation of protein kinase B activity,positive regulation of peptidyl-serine phosphorylation,regulation of protein import into nucleus, translocation,positive regulation of DNA binding,cell redox homeostasis,negative regulation of protein export from nucleus,positive regulation of protein kinase B signaling,oxidation-reduction process,negative regulation of hydrogen peroxide-induced cell death","protein binding,protein disulfide oxidoreductase activity,peptide disulfide oxidoreductase activity,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,cytosol,extracellular exosome",12,12,20,C[CAM]MPTFQFFK.2|C[CAM]M[Oxi]PTFQFFK.2|VGEFSGANKEKLEATINELV.3|VGEFSGANKEKLEATINELV.2|EKLEATINELV.2|TAFQEALDAAGDKLVVVDFSATWC[CAM]GPC[CAM]K.4|TAFQEALDAAGDKLVVVDFSATWC[CAM]GPC[CAM]K.3|C[CAM]MPTFQFFKK.3|TAFQEALDAAGDK.3|TAFQEALDAAGDK.2|VGEFSGANK.2|MIKPFFHSLSEK.3|M[Oxi]IKPFFHSLSEK.3|MIKPFFHSLSEK.2|M[Oxi]IKPFFHSLSEK.2|LEATINELV.2|PFFHSLSEK.2|LVVVDFSATWC[CAM]GPC[CAM]K.3|LVVVDFSATWC[CAM]GPC[CAM]K.2|VGEFSGANKEK.2
SEN / CTL,P00747,Plasminogen,PLG,0.70,1.32,1.30E-02,3.53E-03,2.45E+00,"platelet degranulation,proteolysis,blood coagulation,negative regulation of cell proliferation,negative regulation of cell-substrate adhesion,extracellular matrix disassembly,fibrinolysis,cellular protein metabolic process,tissue remodeling,negative regulation of fibrinolysis,positive regulation of fibrinolysis,negative regulation of cell-cell adhesion mediated by cadherin","serine-type endopeptidase activity,receptor binding,protein binding,serine-type peptidase activity,protein domain specific binding,apolipoprotein binding","extracellular region,extracellular space,plasma membrane,cell surface,platelet alpha granule lumen,extrinsic component of external side of plasma membrane,extracellular exosome,blood microparticle",12,58,96,TPENYPNAGLTMNYC[CAM]R.3|TPENYPNAGLTMNYC[CAM]R.2|TPENYPNAGLTM[Oxi]NYC[CAM]R.3|TPENYPNAGLTM[Oxi]NYC[CAM]R.2|DKYILQGVTSWGLGC[CAM]ARPNKPGVYVR.5|YILQGVTSWGLGC[CAM]ARPNKPGVYVR.4|KDIALLK.2|RAPWC[CAM]HTTNSQVR.4|RAPWC[CAM]HTTNSQVR.3|RAPWC[CAM]HTTNSQVR.2|HSIFTPETNPR.3|HSIFTPETNPR.2|NLDENYC[CAM]RNPDGKR.4|VYLSEC[CAM]K.2|ELRPWC[CAM]FTTDPNKR.4|ELRPWC[CAM]FTTDPNKR.3|C[CAM]QSWSSMTPHR.3|GNVAVTVSGHTC[CAM]QHWSAQTPHTHNR.6|GNVAVTVSGHTC[CAM]QHWSAQTPHTHNR.5|APWC[CAM]HTTNSQVR.3|APWC[CAM]HTTNSQVR.2|KQLGAGSIEEC[CAM]AAK.3|KQLGAGSIEEC[CAM]AAK.2|TPENFPC[CAM]K.2|EQQC[CAM]VIMAENRK.3|KC[CAM]QSWSSMTPHR.3|VILGAHQEVNLEPHVQEIEVSR.5|VILGAHQEVNLEPHVQEIEVSR.4|VILGAHQEVNLEPHVQEIEVSR.3|WEYC[CAM]NLK.2|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.6|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.5|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.4|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.3|KVYLSEC[CAM]K.2|LSSPAVITDK.2|NPDADKGPWC[CAM]FTTDPSVR.4|NPDADKGPWC[CAM]FTTDPSVR.3|ATTVTGTPC[CAM]QDWAAQEPHR.4|ATTVTGTPC[CAM]QDWAAQEPHR.3|TMSGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.6|TM[Oxi]SGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.5|TMSGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.5|TMSGLEC[CAM]QAWDSQSPHAHGYIPSKFPNK.4|TMSGLEC[CAM]QAWDSQSPHAHGYIPSK.5|TM[Oxi]SGLEC[CAM]QAWDSQSPHAHGYIPSK.4|TMSGLEC[CAM]QAWDSQSPHAHGYIPSK.4|TMSGLEC[CAM]QAWDSQSPHAHGYIPSK.3|NLDENYC[CAM]R.2|VVGGC[CAM]VAHPHSWPWQVSLR.4|VVGGC[CAM]VAHPHSWPWQVSLR.3|WELC[CAM]DIPR.2|ELRPWC[CAM]FTTDPNK.3|YILQGVTSWGLGC[CAM]AR.3|YILQGVTSWGLGC[CAM]AR.2|EAQLPVIENK.2|NPDNDPQGPWC[CAM]YTTDPEKR.4|NPDNDPQGPWC[CAM]YTTDPEKR.3|RATTVTGTPC[CAM]QDWAAQEPHR.4|VIPAC[CAM]LPSPNYVVADR.3|VIPAC[CAM]LPSPNYVVADR.2|C[CAM]TTPPPSSGPTYQC[CAM]LK.3|C[CAM]TTPPPSSGPTYQC[CAM]LK.2|FVTWIEGVMR.2|FVTWIEGVM[Oxi]R.2|RWELC[CAM]DIPR.2|DKYILQGVTSWGLGC[CAM]AR.3|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEK.5|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEK.4|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEK.3|FSPATHPSEGLEENYC[CAM]R.3|FSPATHPSEGLEENYC[CAM]R.2|QLGAGSIEEC[CAM]AAK.2|SPRPSSYKVILGAHQEVNLEPHVQEIEVSR.5|C[CAM]EEDEEFTC[CAM]R.2|EQQC[CAM]VIMAENR.2|EQQC[CAM]VIM[Oxi]AENR.2|KQLGAGSIEEC[CAM]AAKC[CAM]EEDEEFTC[CAM]R.4|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEKDK.5|VQSTELC[CAM]AGHLAGGTDSC[CAM]QGDSGGPLVC[CAM]FEKDK.4|GPWC[CAM]FTTDPSVR.2|FGM[Oxi]HFC[CAM]GGTLISPEWVLTAAHC[CAM]LEK.4|FGMHFC[CAM]GGTLISPEWVLTAAHC[CAM]LEK.4|FGMHFC[CAM]GGTLISPEWVLTAAHC[CAM]LEK.3|LYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.4|LYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GKPQVEPK.3|TEC[CAM]FITGWGETQGTFGAGLLK.3|TEC[CAM]FITGWGETQGTFGAGLLK.2|KLYDYC[CAM]DVPQC[CAM]AAPSFDC[CAM]GK.3|NLDENYC[CAM]RNPDGK.2|FSPATHPSEGLEENYC[CAM]RNPDNDPQGPWC[CAM]YTTDPEKR.5|QLGAGSIEEC[CAM]AAKC[CAM]EEDEEFTC[CAM]R.3|NPDGDVGGPWC[CAM]YTTNPR.2|YDYC[CAM]DILEC[CAM]EEEC[CAM]MHC[CAM]SGENYDGK.3|NPDNDPQGPWC[CAM]YTTDPEK.2|C[CAM]SGTEASVVAPPPVVLLPDVETPSEEDC[CAM]MFGNGK.3
SEN / CTL,P12110,Collagen alpha-2(VI) chain,COL6A2,0.70,1.66,1.38E-12,2.14E-12,1.17E+01,"cell adhesion,response to glucose,extracellular matrix organization,collagen catabolic process,protein heterotrimerization",,"extracellular region,proteinaceous extracellular matrix,collagen trimer,extracellular space,endoplasmic reticulum lumen,extracellular matrix,sarcolemma,protein complex,extracellular exosome,extracellular vesicle",60,42,57,AAVFHEKDYDSLAQPGFFDR.4|AAVFHEKDYDSLAQPGFFDR.3|VFAVVITDGR.2|NFVINVVNR.2|NLEWIAGGTWTPSALK.3|NLEWIAGGTWTPSALK.2|VFAVVITDGRHDPRDDDLNLR.5|VFAVVITDGRHDPRDDDLNLR.4|NDYATMLPDSTEIDQDTINR.3|SKGTVHFAVVITDGHVTGSPC[CAM]GGIK.4|QFVPQFISQLQNEFYLDQVALSWR.3|QFVPQFISQLQNEFYLDQVALSWR.4|GTVHFAVVITDGHVTGSPC[CAM]GGIK.4|GTVHFAVVITDGHVTGSPC[CAM]GGIK.3|EQGLRDIASTPHELYRNDYATMLPDSTEIDQDTINR.5|LFAVAPNQNLK.2|LFAVAPNQNLKEQGLR.3|YGGLHFSDQVEVFSPPGSDR.3|YGGLHFSDQVEVFSPPGSDR.4|YGGLHFSDQVEVFSPPGSDR.2|DYDSLAQPGFFDR.2|VGVVQYSHEGTFEAIQLDDERIDSLSSFK.4|AAVFHEK.2|FVEQVAR.2|DIASTPHELYR.3|DIASTPHELYR.2|TRVFAVVITDGR.3|TRVFAVVITDGR.2|HDPRDDDLNLR.3|LGEQNFHK.2|ETC[CAM]GC[CAM]C[CAM]DC[CAM]EKR.3|RFVEQVAR.2|AREEGIRLFAVAPNQNLK.4|GPQGALGEPGK.2|NLQGISSFR.2|ASFIKNLQGISSFR.3|RDDDPLNAR.2|HESENLYSIAC[CAM]DKPQQVR.4|HESENLYSIAC[CAM]DKPQQVR.3|AAVFHEKDYDSLAQPGFFDRFIR.5|AAVFHEKDYDSLAQPGFFDRFIR.4|DVTVTAIGIGDMFHEK.3|HEAYGEC[CAM]YK.2|ALC[CAM]DRDVTVTAIGIGDMFHEK.4|ALC[CAM]DRDVTVTAIGIGDMFHEK.3|LFAVAPNQNLKEQGLRDIASTPHELYR.5|LFAVAPNQNLKEQGLRDIASTPHELYR.4|EQGLRDIASTPHELYR.3|ETC[CAM]GC[CAM]C[CAM]DC[CAM]EK.2|QNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.4|QNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.3|KQNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.4|KQNVVPTVLALGSDVDM[Oxi]DVLTTLSLGDR.3|VGVVQYSHEGTFEAIQLDDERIDSLSSFKEAVK.5|YGGLHFSDQVEVFSPPGSDRASFIKNLQGISSFR.5|HESENLYSIAC[CAM]DK.2|VGVVQYSHEGTFEAIQLDDER.3
SEN / CTL,Q6NZI2,Polymerase I and transcript release factor,PTRF,0.70,0.94,9.58E-04,3.50E-04,3.46E+00,"regulation of transcription, DNA-templated,transcription initiation from RNA polymerase I promoter,termination of RNA polymerase I transcription","protein binding,rRNA primary transcript binding,poly(A) RNA binding","nucleus,nucleoplasm,cytoplasm,mitochondrion,endoplasmic reticulum,cytosol,caveola,protein complex,membrane raft",15,15,23,QAEMEGAVQSIQGELSK.3|QAEMEGAVQSIQGELSK.2|QAEM[Oxi]EGAVQSIQGELSK.2|VMIYQDEVKLPAK.3|VM[Oxi]IYQDEVKLPAK.3|VMIYQDEVKLPAK.2|KLEVNEAELLR.3|KLEVNEAELLR.2|SFTPDHVVYAR.3|SFTPDHVVYAR.2|EGQVEVLK.2|KLEVNEAELLRR.3|AHATTSNTVSK.2|VMIYQDEVK.2|VM[Oxi]IYQDEVK.2|IREGQVEVLK.2|LEVNEAELLR.2|IIGAVDQIQLTQAQLEER.3|IIGAVDQIQLTQAQLEER.2|SDQVNGVLVLSLLDK.2|ATEMVEVGADDDEGGAERGEAGDLR.3|ATEMVEVGADDDEGGAER.2|IIGAVDQIQLTQAQLEERQAEMEGAVQSIQGELSK.4
SEN / CTL,P26599,Polypyrimidine tract-binding protein 1,PTBP1,0.69,1.81,4.18E-02,1.00E-02,2.00E+00,"alternative mRNA splicing, via spliceosome,regulation of alternative mRNA splicing, via spliceosome,mRNA splicing, via spliceosome,mRNA processing,RNA splicing,fibroblast growth factor receptor signaling pathway,gene expression,negative regulation of RNA splicing,negative regulation of mRNA splicing, via spliceosome,negative regulation of muscle cell differentiation,IRES-dependent viral translational initiation","nucleotide binding,RNA binding,protein binding,poly-pyrimidine tract binding,pre-mRNA binding,poly(A) RNA binding","nucleoplasm,nucleolus,membrane,extracellular exosome",6,35,87,KLPIDVTEGEVISLGLPFGK.3|KLPIDVTEGEVISLGLPFGK.4|KLPIDVTEGEVISLGLPFGK.2|KENALVQMADGNQAQLAM[Oxi]SHLNGHK.5|KENALVQMADGNQAQLAMSHLNGHK.5|KENALVQMADGNQAQLAMSHLNGHK.4|ELKTDSSPNQAR.3|ELKTDSSPNQAR.2|GQPIYIQFSNHKELK.4|VTNLLMLK.2|VTNLLM[Oxi]LK.2|GQPIYIQFSNHK.3|GQPIYIQFSNHK.2|TDSSPNQAR.2|HQNVQLPR.2|ENALVQMADGNQAQLAMSHLNGHK.5|ENALVQMADGNQAQLAMSHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAM[Oxi]SHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAMSHLNGHK.4|ENALVQMADGNQAQLAM[Oxi]SHLNGHK.4|ENALVQM[Oxi]ADGNQAQLAMSHLNGHK.3|ENALVQMADGNQAQLAM[Oxi]SHLNGHK.3|ENALVQMADGNQAQLAMSHLNGHK.3|ENALVQM[Oxi]ADGNQAQLAM[Oxi]SHLNGHK.3|HQNVQLPREGQEDQGLTK.4|HQNVQLPREGQEDQGLTK.3|DYGNSPLHR.2|EGQEDQGLTKDYGNSPLHR.4|EGQEDQGLTKDYGNSPLHR.3|EGQEDQGLTK.2|VLFSSNGGVVK.2|NNQFQALLQYADPVSAQHAK.4|NNQFQALLQYADPVSAQHAK.3|NNQFQALLQYADPVSAQHAK.2|IAIPGLAGAGNSVLLVSNLNPER.4|IAIPGLAGAGNSVLLVSNLNPER.3|IAIPGLAGAGNSVLLVSNLNPER.2|M[Oxi]ALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.6|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.6|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|M[Oxi]ALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.5|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.5|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|M[Oxi]ALIQMGSVEEAVQALIDLHNHDLGENHHLR.4|MALIQM[Oxi]GSVEEAVQALIDLHNHDLGENHHLR.4|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.4|MALIQMGSVEEAVQALIDLHNHDLGENHHLR.3|KMALIQMGSVEEAVQALIDLHNHDLGENHHLR.6|KMALIQMGSVEEAVQALIDLHNHDLGENHHLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.6|AQAALQAVNSVQSGNLALAASAAAVDAGM[Oxi]AMAGQSPVLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.5|AQAALQAVNSVQSGNLALAASAAAVDAGM[Oxi]AMAGQSPVLR.4|AQAALQAVNSVQSGNLALAASAAAVDAGMAM[Oxi]AGQSPVLR.4|AQAALQAVNSVQSGNLALAASAAAVDAGMAMAGQSPVLR.4|HQNVQLPREGQEDQGLTKDYGNSPLHR.5|LSLDGQNIYNAC[CAM]C[CAM]TLR.3|LSLDGQNIYNAC[CAM]C[CAM]TLR.2|LPIDVTEGEVISLGLPFGK.3|LPIDVTEGEVISLGLPFGK.2|IDFSKLTSLNVK.2|VTPQSLFILFGVYGDVQR.3|VTPQSLFILFGVYGDVQR.2|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.7|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.6|DYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|NFQNIFPPSATLHLSNIPPSVSEEDLK.4|NFQNIFPPSATLHLSNIPPSVSEEDLK.3|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.7|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.6|SRDYTRPDLPSGDSQPSLDQTM[Oxi]AAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|SRDYTRPDLPSGDSQPSLDQTMAAAFGLSVPNVHGALAPLAIPSAAAAAAAAGR.5|NQAFIEMNTEEAANTMVNYYTSVTPVLR.4|NQAFIEM[Oxi]NTEEAANTMVNYYTSVTPVLR.3|NQAFIEMNTEEAANTMVNYYTSVTPVLR.3|IIVENLFYPVTLDVLHQIFSK.3|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.4|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.3|GKNQAFIEMNTEEAANTMVNYYTSVTPVLR.4|GKNQAFIEM[Oxi]NTEEAANTMVNYYTSVTPVLR.3|GKNQAFIEMNTEEAANTMVNYYTSVTPVLR.3|RGSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSKK.4|GQPIYIQFSNHKELKTDSSPNQAR.3|GSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSK.3|GSDELFSTC[CAM]VTNGPFIMSSNSASAANGNDSKK.3
SEN / CTL,P08133,Annexin A6,ANXA6,0.68,0.81,9.63E-03,2.68E-03,2.57E+00,"calcium ion transport,regulation of muscle contraction,ion transmembrane transport,protein homooligomerization,mitochondrial calcium ion homeostasis,apoptotic signaling pathway","calcium ion binding,protein binding,GTP binding,calcium-dependent phospholipid binding,lipid binding,ligand-gated ion channel activity,cholesterol binding,protein homodimerization activity,calcium-dependent protein binding","mitochondrion,lysosomal membrane,focal adhesion,membrane,late endosome membrane,melanosome,perinuclear region of cytoplasm,extracellular exosome",15,72,121,GLGTDEDTIIDIITHR.3|GLGTDEDTIIDIITHR.2|GFGSDKEAILDIITSR.3|GFGSDKEAILDIITSR.2|ALIEILATR.2|VELKGTVRPANDFNPDADAK.4|VELKGTVRPANDFNPDADAK.3|DLMTDLKSEISGDLAR.3|DLM[Oxi]TDLKSEISGDLAR.3|DLMTDLKSEISGDLAR.2|SEIDLLNIRR.3|DLMTDLK.2|LILGLMMPPAHYDAK.4|LILGLMMPPAHYDAK.3|LILGLM[Oxi]MPPAHYDAK.3|LILGLMM[Oxi]PPAHYDAK.3|LILGLMMPPAHYDAK.2|PLFFADK.2|SLYSMIK.2|QRQEVC[CAM]QSYK.3|QRQEVC[CAM]QSYK.2|MTNYDVEHTIK.3|MTNYDVEHTIK.2|SLEDALSSDTSGHFRR.4|SLEDALSSDTSGHFRR.3|SLEDALSSDTSGHFRR.2|SLYGKDLIADLK.3|SLYGKDLIADLK.2|VFQEFIK.2|SEISGDLAR.2|AINEAYKEDYHK.3|DLIADLKYELTGK.3|DLIADLKYELTGK.2|EIKDAISGIGTDEK.3|EIKDAISGIGTDEK.2|GELSGDFEK.2|MTNYDVEHTIKK.3|M[Oxi]TNYDVEHTIKK.3|MTNYDVEHTIKK.2|M[Oxi]TNYDVEHTIKK.2|ALLALC[CAM]GGED.2|ALLALC[CAM]GGED.1|AMEGAGTDEK.2|SLYGKDLIADLKYELTGK.4|SLYGKDLIADLKYELTGK.3|LVFDEYLK.2|TNEQM[Oxi]HQLVAAYK.3|TNEQMHQLVAAYK.3|TNEQMHQLVAAYK.2|TNEQM[Oxi]HQLVAAYK.2|FMTILC[CAM]TR.2|FM[Oxi]TILC[CAM]TR.2|QEVC[CAM]QSYK.2|C[CAM]LIEILASR.2|RVFQEFIK.2|SEIDLLNIR.2|TTGKPIEASIRGELSGDFEK.4|TTGKPIEASIRGELSGDFEK.3|ILISLATGHR.2|NKPLFFADK.2|SELDMLDIR.2|SELDM[Oxi]LDIR.2|SELDMLDIREIFR.3|SELDM[Oxi]LDIREIFR.3|SLEDALSSDTSGHFR.3|SLEDALSSDTSGHFR.2|TNEQMHQLVAAYKDAYER.4|TNEQMHQLVAAYKDAYER.3|DAISGIGTDEK.2|STPEYFAER.2|EAILDIITSR.2|GTVRPANDFNPDADAK.3|GTVRPANDFNPDADAK.2|MLVVLLQGTR.2|M[Oxi]LVVLLQGTR.2|GAGTDEKTLTR.2|ILISLATGHREEGGENLDQAR.4|ILISLATGHREEGGENLDQAR.3|KAMEGAGTDEK.2|LIVGLM[Oxi]RPPAYC[CAM]DAK.3|LIVGLMRPPAYC[CAM]DAK.3|LIVGLM[Oxi]RPPAYC[CAM]DAK.2|SLHQAIEGDTSGDFLK.3|SLHQAIEGDTSGDFLK.2|TTGKPIEASIRGELSGDFEKLMLAVVK.5|DLEADIIGDTSGHFQK.3|DLEADIIGDTSGHFQK.2|TTGKPIEASIR.2|DAFVAIVQSVK.2|WGTDEAQFIYILGNR.3|WGTDEAQFIYILGNR.2|DAYERDLEADIIGDTSGHFQK.4|DAYERDLEADIIGDTSGHFQK.3|EEGGENLDQAR.2|DLIADLKYELTGKFER.3|EIKDAISGIGTDEKC[CAM]LIEILASR.4|EIKDAISGIGTDEKC[CAM]LIEILASR.3|GSIHDFPGFDPNQDAEALYTAMK.4|GSIHDFPGFDPNQDAEALYTAM[Oxi]K.3|GSIHDFPGFDPNQDAEALYTAMK.3|PANDFNPDADAK.2|EMSGDVRDAFVAIVQSVK.3|EM[Oxi]SGDVRDAFVAIVQSVK.3|TNEQMHQLVAAYKDAYERDLEADIIGDTSGHFQK.6|TNEQMHQLVAAYKDAYERDLEADIIGDTSGHFQK.4|AM[Oxi]EGAGTDEKALIEILATR.3|EDAQVAAEILEIADTPSGDK.3|EDAQVAAEILEIADTPSGDK.2|EDAQVAAEILEIADTPSGDKTSLETR.4|EDAQVAAEILEIADTPSGDKTSLETR.3|YRGSIHDFPGFDPNQDAEALYTAMK.4|YRGSIHDFPGFDPNQDAEALYTAM[Oxi]K.3|YRGSIHDFPGFDPNQDAEALYTAMK.3|DAISGIGTDEKC[CAM]LIEILASR.3|LSGGDDDAAGQFFPEAAQVAYQMWELSAVAR.4|LSGGDDDAAGQFFPEAAQVAYQMWELSAVAR.3|ILISLATGHREEGGENLDQAREDAQVAAEILEIADTPSGDK.5|EEDDVVSEDLVQQDVQDLYEAGELK.3|EEGGENLDQAREDAQVAAEILEIADTPSGDKTSLETR.4|M[Oxi]LVVLLQGTREEDDVVSEDLVQQDVQDLYEAGELK.4|EEGGENLDQAREDAQVAAEILEIADTPSGDK.3
SEN / CTL,O95084,Serine protease 23,PRSS23,0.67,0.74,1.09E-02,3.00E-03,2.52E+00,proteolysis,serine-type endopeptidase activity,"nucleus,extracellular exosome",6,5,6,YAQIC[CAM]YWIK.2|LSTGC[CAM]TGTLVAEK.2|LEVSSSC[CAM]GPQC[CAM]HK.3|LEVSSSC[CAM]GPQC[CAM]HK.2|FSIFGKDFLLNYPFSTSVK.3|DFLLNYPFSTSVK.2
SEN / CTL,P14625,Endoplasmin,HSP90B1,0.66,2.09,1.24E-04,5.65E-05,4.25E+00,"response to hypoxia,toll-like receptor signaling pathway,receptor-mediated endocytosis,protein transport,ER-associated ubiquitin-dependent protein catabolic process,retrograde protein transport, ER to cytosol,actin rod assembly,protein folding in endoplasmic reticulum,response to endoplasmic reticulum stress,ATF6-mediated unfolded protein response,negative regulation of apoptotic process,regulation of phosphoprotein phosphatase activity,sequestering of calcium ion,cellular response to ATP","RNA binding,calcium ion binding,protein binding,ATP binding,protein phosphatase binding,virion binding,low-density lipoprotein particle receptor binding,unfolded protein binding","extracellular region,nucleus,endoplasmic reticulum,endoplasmic reticulum lumen,endoplasmic reticulum membrane,cytosol,plasma membrane,focal adhesion,membrane,midbody,extracellular matrix,endoplasmic reticulum chaperone complex,melanosome,perinuclear region of cytoplasm,extracellular exosome,endocytic vesicle lumen",24,85,166,GVVDSDDLPLNVSR.2|GVVDSDDLPLNVSR.3|FAFQAEVNR.2|FQSSHHPTDITSLDQYVER.4|FQSSHHPTDITSLDQYVER.3|FQSSHHPTDITSLDQYVER.5|FQSSHHPTDITSLDQYVER.2|SILFVPTSAPR.2|GYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.3|GYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.4|EGSRTDDEVVQREEEAIQLDGLNASQIR.4|EGSRTDDEVVQREEEAIQLDGLNASQIR.5|EGSRTDDEVVQREEEAIQLDGLNASQIR.3|NLLHVTDTGVGMTREELVK.4|NLLHVTDTGVGM[Oxi]TREELVK.4|NLLHVTDTGVGMTREELVK.3|NLLHVTDTGVGM[Oxi]TREELVK.3|NLLHVTDTGVGMTREELVK.2|KIADDKYNDTFWK.4|KIADDKYNDTFWK.3|KEAESSPFVER.3|KEAESSPFVER.2|KTLDMIK.2|TLDMIKK.2|DISTNYYASQK.3|DISTNYYASQK.2|RFQNVAK.2|ETLQQHK.2|RVFITDDFHDMM[Oxi]PK.4|RVFITDDFHDMMPK.4|RVFITDDFHDMMPK.3|RVFITDDFHDM[Oxi]MPK.3|RVFITDDFHDMM[Oxi]PK.3|RVFITDDFHDMMPK.2|TFEINPR.2|EGSRTDDEVVQR.3|EGSRTDDEVVQR.2|EGVKFDESEKTK.3|EGVKFDESEKTK.2|LGVIEDHSNRTR.3|LIINSLYKNKEIFLR.4|QDKIYFMAGSSR.3|QDKIYFMAGSSR.2|DISTNYYASQKK.3|DISTNYYASQKK.2|GTTITLVLK.2|SEKFAFQAEVNR.3|SEKFAFQAEVNR.2|LIINSLYK.2|TDDEVVQR.2|KTLDMIKK.2|SGYLLPDTKAYGDRIER.4|YNDTFWK.2|SGTSEFLNK.2|KTFEINPR.2|KYSQFINFPIYVWSSK.4|KYSQFINFPIYVWSSK.3|KYSQFINFPIYVWSSK.2|SGYLLPDTK.2|EEASDYLELDTIK.3|EEASDYLELDTIK.2|GLFDEYGSK.2|IADDKYNDTFWK.3|IADDKYNDTFWK.2|NLLHVTDTGVGM[Oxi]TR.3|NLLHVTDTGVGMTR.3|NLLHVTDTGVGM[Oxi]TR.2|NLLHVTDTGVGMTR.2|PIWQRPSKEVEEDEYK.4|PIWQRPSKEVEEDEYK.3|ESTAEKDEL.2|EVEEDEYKAFYK.3|EVEEDEYKAFYK.2|IYFMAGSSR.2|IYFM[Oxi]AGSSR.2|TVWDWELMNDIK.3|TVWDWELMNDIK.2|TVWDWELM[Oxi]NDIK.2|EEKEESDDEAAVEEEEEEKKPK.5|EEKEESDDEAAVEEEEEEKKPK.4|EVEEDEYK.2|EAVEKEFEPLLNWMKDK.4|EAVEKEFEPLLNWMKDK.2|VFITDDFHDMMPK.3|VFITDDFHDM[Oxi]MPK.3|VFITDDFHDMM[Oxi]PK.3|VFITDDFHDM[Oxi]M[Oxi]PK.3|VFITDDFHDM[Oxi]MPK.2|VFITDDFHDMM[Oxi]PK.2|VFITDDFHDMMPK.2|VFITDDFHDM[Oxi]M[Oxi]PK.2|LSLNIDPDAK.2|SREGSRTDDEVVQR.3|IKEDEDDKTVLDLAVVLFETATLR.5|IKEDEDDKTVLDLAVVLFETATLR.4|IKEDEDDKTVLDLAVVLFETATLR.3|EESDDEAAVEEEEEEKKPK.4|EESDDEAAVEEEEEEKKPK.3|EESDDEAAVEEEEEEKKPK.2|AQAYQTGKDISTNYYASQKK.4|AQAYQTGKDISTNYYASQKK.3|GLFDEYGSKK.2|LGVIEDHSNR.2|TETVEEPMEEEEAAK.3|TETVEEPMEEEEAAK.2|TETVEEPM[Oxi]EEEEAAK.2|EAESSPFVER.2|IADDKYNDTFWKEFGTNIK.4|IADDKYNDTFWKEFGTNIK.3|IADDKYNDTFWKEFGTNIK.2|EGVKFDESEK.2|EKNLLHVTDTGVGMTR.3|EKNLLHVTDTGVGMTREELVK.4|LTESPC[CAM]ALVASQYGWSGNMER.4|LTESPC[CAM]ALVASQYGWSGNM[Oxi]ER.3|LTESPC[CAM]ALVASQYGWSGNMER.3|LTESPC[CAM]ALVASQYGWSGNM[Oxi]ER.2|LTESPC[CAM]ALVASQYGWSGNMER.2|EEEAIQLDGLNASQIR.3|EEEAIQLDGLNASQIR.2|GTTITLVLKEEASDYLELDTIK.4|GTTITLVLKEEASDYLELDTIK.3|EAVEKEFEPLLNWMK.3|EAVEKEFEPLLNWM[Oxi]K.3|EAVEKEFEPLLNWMK.2|EESDDEAAVEEEEEEK.3|EESDDEAAVEEEEEEK.2|YSQFINFPIYVWSSK.3|YSQFINFPIYVWSSK.2|TVWDWELMNDIKPIWQRPSK.4|TVWDWELM[Oxi]NDIKPIWQRPSK.4|TVWDWELMNDIKPIWQRPSK.3|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.5|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.4|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGKR.3|EFEPLLNWMK.2|EFEPLLNWM[Oxi]K.2|FDESEKTKESR.2|HNNDTQHIWESDSNEFSVIADPR.4|HNNDTQHIWESDSNEFSVIADPR.3|LISLTDENALSGNEELTVK.3|LISLTDENALSGNEELTVK.2|TDDEVVQREEEAIQLDGLNASQIR.4|TDDEVVQREEEAIQLDGLNASQIR.3|TVWDWELMNDIKPIWQRPSKEVEEDEYKAFYK.6|TVWDWELMNDIKPIWQRPSKEVEEDEYKAFYK.5|TETVEEPMEEEEAAKEEK.3|TETVEEPM[Oxi]EEEEAAKEEK.3|TETVEEPMEEEEAAKEEK.2|AQAYQTGKDISTNYYASQK.3|GTTITLVLKEEASDYLELDTIKNLVK.4|GYEVIYLTEPVDEYC[CAM]IQALPEFDGK.4|GYEVIYLTEPVDEYC[CAM]IQALPEFDGK.3|TVWDWELMNDIKPIWQR.3|TVWDWELMNDIKPIWQR.2|EEKEESDDEAAVEEEEEEK.3|ESDDPMAYIHFTAEGEVTFK.3|ESDDPM[Oxi]AYIHFTAEGEVTFK.3|ESDDPMAYIHFTAEGEVTFK.2|IRLISLTDENALSGNEELTVK.3|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGK.4|KGYEVIYLTEPVDEYC[CAM]IQALPEFDGK.3|TVLDLAVVLFETATLR.2|TETVEEPM[Oxi]EEEEAAKEEKEESDDEAAVEEEEEEK.4|TETVEEPMEEEEAAKEEKEESDDEAAVEEEEEEK.4|VEEEPEEEPEETAEDTTEDTEQDEDEEMDVGTDEEEETAK.4
SEN / CTL,Q15019,Septin-2,2-Sep,0.66,0.75,6.35E-03,1.85E-03,2.73E+00,"regulation of L-glutamate transport,mitotic nuclear division,smoothened signaling pathway,neuron projection development,regulation of protein localization,cilium assembly,regulation of catalytic activity,cell division,cell-cell adhesion","protein binding,GTP binding,enzyme regulator activity,protein complex scaffold,cadherin binding involved in cell-cell adhesion","exocyst,condensed chromosome kinetochore,nucleus,nucleolus,cytoplasm,spindle,cell-cell adherens junction,axoneme,actin cytoskeleton,midbody,septin complex,cleavage furrow,photoreceptor connecting cilium,myelin sheath,synapse,perinuclear region of cytoplasm,ciliary membrane,extracellular exosome,cell cortex",9,30,53,TIISYIDEQFER.2|ASIPFSVVGSNQLIEAK.2|ASIPFSVVGSNQLIEAK.3|LTVVDTPGYGDAINC[CAM]R.2|LTVVDTPGYGDAINC[CAM]R.3|YLHDESGLNR.3|YLHDESGLNR.2|DQILLEK.2|MQEMIAR.2|ILDEIEEHNIK.3|ILDEIEEHNIK.2|YLHDESGLNRR.3|YLHDESGLNRR.2|PLDVAFMK.2|VNIVPVIAK.2|KVENEDMNKDQILLEK.4|KVENEDMNKDQILLEK.3|VHC[CAM]C[CAM]FYFISPFGHGLK.4|VHC[CAM]C[CAM]FYFISPFGHGLK.3|RILDEIEEHNIK.3|AIHNKVNIVPVIAK.3|RMQEMIAR.2|TVQIEASTVEIEER.3|TVQIEASTVEIEER.2|KVENEDMNK.2|GRLYPWGVVEVENPEHNDFLKLR.5|LYPWGVVEVENPEHNDFLK.4|LYPWGVVEVENPEHNDFLK.3|LYPWGVVEVENPEHNDFLK.2|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFMK.5|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFM[Oxi]K.5|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFM[Oxi]K.4|VHC[CAM]C[CAM]FYFISPFGHGLKPLDVAFMK.4|QQPTQFINPETPGYVGFANLPNQVHR.5|QQPTQFINPETPGYVGFANLPNQVHR.4|QQPTQFINPETPGYVGFANLPNQVHR.3|KGFEFTLMVVGESGLGK.3|VENEDMNKDQILLEK.3|GRLYPWGVVEVENPEHNDFLK.4|GRLYPWGVVEVENPEHNDFLK.3|LRTMLITHMQDLQEVTQDLHYENFR.5|STLINSLFLTDLYPER.3|STLINSLFLTDLYPER.2|LRLTVVDTPGYGDAINC[CAM]R.3|TM[Oxi]LITHMQDLQEVTQDLHYENFR.4|TMLITHM[Oxi]QDLQEVTQDLHYENFR.4|TMLITHMQDLQEVTQDLHYENFR.4|TM[Oxi]LITHMQDLQEVTQDLHYENFR.3|TMLITHMQDLQEVTQDLHYENFR.3|QQPTQFINPETPGYVGFANLPNQVHRK.4|M[Oxi]QAQMQMQMQGGDGDGGALGHHV.3|MQAQM[Oxi]QMQMQGGDGDGGALGHHV.3|MQAQMQMQMQGGDGDGGALGHHV.3
SEN / CTL,P20908,Collagen alpha-1(V) chain,COL5A1,0.65,0.68,5.98E-07,3.75E-07,6.43E+00,"blood vessel development,heart morphogenesis,cell adhesion,cell migration,extracellular matrix organization,collagen fibril organization,collagen catabolic process,collagen biosynthetic process,wound healing, spreading of epidermal cells,tendon development,extracellular fibril organization,skin development,integrin biosynthetic process,eye morphogenesis,regulation of cellular component organization,negative regulation of endodermal cell differentiation","integrin binding,extracellular matrix structural constituent,heparin binding,proteoglycan binding,metal ion binding,platelet-derived growth factor binding","extracellular region,collagen type V trimer,basement membrane,endoplasmic reticulum lumen,extracellular matrix,extracellular exosome",33,15,18,SPVFLYEDHTGKPGPEDYPLFR.4|QLYPASAFPEDFSILTTVK.2|FLGSNDEEMSYDNNPYIR.2|VLDFHNLPDGITK.3|VLDFHNLPDGITK.2|TVLEIDTPKVEQVPIVDIMFNDFGEASQK.3|LLSYVDAEGNPVGVVQMTFLR.3|LLSYVDAEGNPVGVVQMTFLR.2|FGGGGDAGSKGPM[Oxi]VSAQESQAQAILQQAR.3|DLQLC[CAM]HPDFPDGEYWVDPNQGC[CAM]SR.3|FGFEVGPAC[CAM]FMG.2|RPLGTQQNPAR.3|DAQLSAPTK.2|GPAGPMGLTGR.2|TGPIGPQGAPGKPGPDGLR.3|GHPGPPGPPGEQGLPGLAGK.3|GPMVSAQESQAQAILQQAR.3|GPMVSAQESQAQAILQQAR.2
SEN / CTL,P13797,Plastin-3,PLS3,0.65,0.87,1.42E-02,3.82E-03,2.42E+00,"actin filament bundle assembly,actin filament network formation,actin crosslink formation,bone development","calcium ion binding,actin filament binding","cytoplasm,actin filament,actin filament bundle",15,45,74,VYALPEDLVEVKPK.3|VYALPEDLVEVKPK.2|MVMTVFAC[CAM]LMGR.2|M[Oxi]VMTVFAC[CAM]LMGR.2|MINLSVPDTIDER.2|MINLSVPDTIDER.3|M[Oxi]INLSVPDTIDER.2|HVIPMNPNTDDLFK.3|HVIPM[Oxi]NPNTDDLFK.3|HVIPMNPNTDDLFK.2|RYTLNVLEDLGDGQKANDDIIVNWVNR.4|RYTLNVLEDLGDGQKANDDIIVNWVNR.3|LMLDGDR.2|RAESMLQQADK.3|RAESMLQQADK.2|RAESM[Oxi]LQQADK.2|STSIQSFK.2|INNFSADIKDSK.3|INNFSADIKDSK.2|LENC[CAM]NYAVELGKHPAK.4|LENC[CAM]NYAVELGKHPAK.3|AYFHLLNQIAPK.3|AYFHLLNQIAPK.2|NEALAALLR.2|QFVTPADVVSGNPK.3|QFVTPADVVSGNPK.2|SGNLTEDDK.2|KLENC[CAM]NYAVELGKHPAK.4|KLENC[CAM]NYAVELGKHPAK.3|AVGDGIVLC[CAM]K.2|INNFSADIK.2|SGNLTEDDKHNNAK.3|AESMLQQADKLGC[CAM]R.3|WANFHLENSGWQK.3|WANFHLENSGWQK.2|AESMLQQADK.2|AESM[Oxi]LQQADK.2|EANMPLPGYK.2|EANM[Oxi]PLPGYK.2|IDINMSGFNETDDLK.3|IDINMSGFNETDDLK.2|RYTLNVLEDLGDGQK.3|RYTLNVLEDLGDGQK.2|DGETLEELMK.2|DGETLEELM[Oxi]K.2|ISFDEFVYIFQEVK.3|ISFDEFVYIFQEVK.2|AGKPHLVLGLLWQIIK.3|IDINMSGFNETDDLKR.3|IDINM[Oxi]SGFNETDDLKR.3|IDINMSGFNETDDLKR.2|LNLAFVANLFNK.2|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEK.4|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEK.3|NEALAALLRDGETLEELMK.3|TISSSLAVVDLIDAIQPGC[CAM]INYDLVK.4|TISSSLAVVDLIDAIQPGC[CAM]INYDLVK.3|ANDDIIVNWVNR.2|KLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.5|KLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|YPALTKPENQDIDWTLLEGETREER.4|KKLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.5|KKLTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|VDLNSNGFIC[CAM]DYELHELFK.3|VDLNSNGFIC[CAM]DYELHELFK.2|YTLNVLEDLGDGQK.2|YPALTKPENQDIDWTLLEGETR.3|LTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.4|LTPFIIQENLNLALNSASAIGC[CAM]HVVNIGAEDLR.3|NWMNSLGVNPHVNHLYADLQDALVILQLYER.4|PENQDIDWTLLEGETR.2|EGIC[CAM]ALGGTSELSSEGTQHSYSEEEKYAFVNWINK.4|YTLNVLEDLGDGQKANDDIIVNWVNR.3|DKTISSSLAVVDLIDAIQPGC[CAM]INYDLVK.3
SEN / CTL,P15311,Ezrin,EZR,0.64,1.25,2.37E-02,5.95E-03,2.23E+00,"negative regulation of transcription from RNA polymerase II promoter,intestinal D-glucose absorption,sphingosine-1-phosphate signaling pathway,cytoskeletal anchoring at plasma membrane,leukocyte cell-cell adhesion,axon guidance,regulation of cell shape,positive regulation of gene expression,protein kinase A signaling,membrane to membrane docking,microvillus assembly,astral microtubule organization,actin cytoskeleton reorganization,receptor internalization,regulation of microvillus length,cellular protein complex localization,positive regulation of multicellular organism growth,cortical microtubule organization,filopodium assembly,phosphatidylinositol-mediated signaling,positive regulation of protein secretion,negative regulation of T cell receptor signaling pathway,actin filament bundle assembly,establishment of centrosome localization,establishment of endothelial barrier,negative regulation of ERK1 and ERK2 cascade,cellular response to cAMP,protein localization to cell cortex,establishment of protein localization to plasma membrane,positive regulation of establishment of protein localization to plasma membrane,negative regulation of interleukin-2 secretion,regulation of organelle assembly,terminal web assembly,positive regulation of protein localization to early endosome,positive regulation of cellular protein catabolic process,negative regulation of p38MAPK cascade,positive regulation of early endosome to late endosome transport,regulation of cell size,gland morphogenesis,regulation of actin cytoskeleton organization,establishment of epithelial cell apical/basal polarity,regulation of NIK/NF-kappaB signaling","actin binding,protein binding,microtubule binding,protein domain specific binding,protein kinase A catalytic subunit binding,protein kinase A regulatory subunit binding,S100 protein binding,poly(A) RNA binding,cell adhesion molecule binding,actin filament binding,ATPase binding,cadherin binding involved in cell-cell adhesion","ruffle,immunological synapse,uropod,extracellular space,nucleolus,cytoplasm,endosome,cytosol,actin filament,plasma membrane,microvillus,brush border,cell-cell adherens junction,focal adhesion,actin cytoskeleton,membrane,basolateral plasma membrane,apical plasma membrane,extrinsic component of membrane,filopodium,T-tubule,cortical cytoskeleton,microvillus membrane,vesicle,ruffle membrane,ciliary basal body,cell projection,myelin sheath,cell body,microspike,plasma membrane raft,apical part of cell,perinuclear region of cytoplasm,cell tip,extracellular exosome,cell periphery,astrocyte projection,Schwann cell microvillus,cytoplasmic side of apical plasma membrane,TCR signalosome",12,50,90,QRIDEFEAL.2|SQEQLAAELAEYTAK.2|SQEQLAAELAEYTAK.3|GMLKDNAMLEYLK.3|GMLKDNAMLEYLK.2|QAVDQIKSQEQLAAELAEYTAK.3|QAVDQIKSQEQLAAELAEYTAK.4|LTRDQWEDR.3|QAVDQIK.2|AKEELERQAVDQIK.4|AKEELERQAVDQIK.3|RKEDEVEEWQHR.4|RKEDEVEEWQHR.3|RTHNDIIHNENMR.4|RTHNDIIHNENM[Oxi]R.4|RTHNDIIHNENMR.3|RTHNDIIHNENM[Oxi]R.3|RTHNDIIHNENMR.2|RITEAEKNER.3|RITEAEKNER.2|ALQLEEERKR.3|QQLETEK.2|SGYLSSER.2|AERELSEQIQR.3|AERELSEQIQR.2|EDEVEEWQHR.3|EDEVEEWQHR.2|IALLEEAR.2|KVSAQEVR.2|LQDYEEK.2|AQEEAERLEADR.3|AQEEAERLEADR.2|QLLTLSSELSQAR.3|QLLTLSSELSQAR.2|RILQLC[CAM]MGNHELYMR.4|RILQLC[CAM]M[Oxi]GNHELYMR.4|RILQLC[CAM]MGNHELYMR.3|RILQLC[CAM]M[Oxi]GNHELYMR.3|RILQLC[CAM]MGNHELYM[Oxi]R.3|AQEEAERLEADRMAALR.4|ALQLEEER.2|KAERELSEQIQR.3|KEDEVEEWQHR.3|KEDEVEEWQHR.2|DQWEDRIQVWHAEHR.4|DQWEDRIQVWHAEHR.3|ELSEQIQR.2|SGYLSSERLIPQR.3|THNDIIHNENMR.3|THNDIIHNENM[Oxi]R.3|THNDIIHNENM[Oxi]R.2|THNDIIHNENMR.2|QLLTLSSELSQARDENKR.4|RAQEEAERLEADR.3|IALLEEARR.2|ITEAEKNER.2|DNAMLEYLK.2|DNAM[Oxi]LEYLK.2|AKEAQDDLVK.2|AKFYPEDVAEELIQDITQK.4|AKFYPEDVAEELIQDITQK.3|AKFYPEDVAEELIQDITQK.2|ALQLEEERK.2|EVWYFGLHYVDNK.3|EVWYFGLHYVDNK.2|ILQLC[CAM]MGNHELYMR.3|ILQLC[CAM]M[Oxi]GNHELYMR.3|ILQLC[CAM]MGNHELYM[Oxi]R.3|ILQLC[CAM]M[Oxi]GNHELYMR.2|ILQLC[CAM]MGNHELYMR.2|IQVWHAEHR.2|FGDYNKEVHK.2|QLLTLSSELSQARDENK.3|IAQDLEMYGINYFEIK.3|IAQDLEM[Oxi]YGINYFEIK.3|IAQDLEM[Oxi]YGINYFEIK.2|IAQDLEMYGINYFEIK.2|GTDLWLGVDALGLNIYEK.3|GTDLWLGVDALGLNIYEK.2|FYPEDVAEELIQDITQK.3|FYPEDVAEELIQDITQK.2|GTDLWLGVDALGLNIYEKDDKLTPK.4|GTDLWLGVDALGLNIYEKDDKLTPK.3|KGTDLWLGVDALGLNIYEK.3|KGTDLWLGVDALGLNIYEK.2|EGILSDEIYC[CAM]PPETAVLLGSYAVQAK.4|EGILSDEIYC[CAM]PPETAVLLGSYAVQAK.3|GTDLWLGVDALGLNIYEKDDK.3|GTDLWLGVDALGLNIYEKDDK.2|KGTDLWLGVDALGLNIYEKDDK.3
SEN / CTL,Q13740,CD166 antigen,ALCAM,0.64,1.11,7.29E-02,1.63E-02,1.79E+00,"adaptive immune response,cell adhesion,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,signal transduction,motor neuron axon guidance,retinal ganglion cell axon guidance,axon extension involved in axon guidance,neuron projection extension","receptor binding,protein binding","immunological synapse,integral component of plasma membrane,focal adhesion,external side of plasma membrane,axon,dendrite,intrinsic component of plasma membrane,neuronal cell body,extracellular exosome,T cell receptor complex",9,30,45,EMDPVTQLYTMTSTLEYK.3|EMDPVTQLYTMTSTLEYK.2|VLHPLEGAVVIIFKK.4|VLHPLEGAVVIIFKK.3|TIIC[CAM]HVEGFPK.3|ALFLETEQLKK.3|ALFLETEQLKK.2|KTDPSGLSK.2|SSNTYTLTDVRR.3|WKYEKPDGSPVFIAFR.4|WKYEKPDGSPVFIAFR.3|VLHPLEGAVVIIFK.3|VLHPLEGAVVIIFK.2|ESLTLIVEGKPQIK.3|ESLTLIVEGKPQIK.2|DLGNMEENK.2|YEKPDGSPVFIAFR.3|YEKPDGSPVFIAFR.2|QIGDALPVSC[CAM]TISASR.3|QIGDALPVSC[CAM]TISASR.2|QPSKPEIVSK.2|KSVQYDDVPEYKDR.3|RFVC[CAM]MLVTEDNVFEAPTIVK.4|RFVC[CAM]MLVTEDNVFEAPTIVK.3|RFVC[CAM]M[Oxi]LVTEDNVFEAPTIVK.3|RFVC[CAM]MLVTEDNVFEAPTIVK.2|ALFLETEQLK.2|PDGSPVFIAFR.2|LDVPQNLMFGK.2|LDVPQNLM[Oxi]FGK.2|SSNTYTLTDVR.2|SVQYDDVPEYK.2|KSVQYDDVPEYK.2|FVC[CAM]MLVTEDNVFEAPTIVK.3|ADIQMPFTC[CAM]SVTYYGPSGQK.3|ADIQMPFTC[CAM]SVTYYGPSGQK.2|TIHSEQAVFDIYYPTEQVTIQVLPPK.4|TIHSEQAVFDIYYPTEQVTIQVLPPK.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLK.4|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLK.3|SVQYDDVPEYKDR.2|TTKADIQMPFTC[CAM]SVTYYGPSGQK.3|SMIASTAITVHYLDLSLNPSGEVTR.3|C[CAM]LGNGNPPPEEFLFYLPGQPEGIR.3|SSPSFSSLHYQDAGNYVC[CAM]ETALQEVEGLKK.3
SEN / CTL,O43852,Calumenin,CALU,0.64,0.80,7.54E-05,3.56E-05,4.45E+00,biological_process,"calcium ion binding,protein binding","extracellular region,endoplasmic reticulum,endoplasmic reticulum membrane,Golgi apparatus,membrane,sarcoplasmic reticulum lumen,melanosome",21,34,62,WIYEDVER.2|IDGDKDGFVTVDELKDWIK.4|IDGDKDGFVTVDELKDWIK.3|MDKEETKDWILPSDYDHAEAEAR.4|MDKEETKDWILPSDYDHAEAEAR.5|M[Oxi]DKEETKDWILPSDYDHAEAEAR.4|EEIVDKYDLFVGSQATDFGEALVRHDEF.4|EEIVDKYDLFVGSQATDFGEALVRHDEF.3|EQFVEFR.2|HLVYESDQNK.3|HLVYESDQNK.2|DGDLIATK.2|MADKDGDLIATK.3|M[Oxi]ADKDGDLIATK.3|MADKDGDLIATK.2|RWIYEDVER.3|RWIYEDVER.2|TEREQFVEFR.3|TEREQFVEFR.2|HLVYESDQNKDGKLTK.4|HLVYESDQNKDGKLTK.3|DRVHHEPQLSDK.3|DRVHHEPQLSDK.2|DIVVQETMEDIDK.3|DIVVQETM[Oxi]EDIDK.2|DIVVQETMEDIDK.2|HLVYESDQNKDGK.3|TEREQFVEFRDK.3|TFDQLTPEESKER.3|IDGDKDGFVTVDELK.3|IDGDKDGFVTVDELK.2|DGFVTVDELK.2|DGFVTVDELK.1|EETKDWILPSDYDHAEAEAR.4|VHHEPQLSDK.2|VHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.6|VHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.5|VHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.4|VHNDAQSFDYDHDAFLGAEEAK.4|VHNDAQSFDYDHDAFLGAEEAK.3|DWILPSDYDHAEAEAR.3|DWILPSDYDHAEAEAR.2|GHDLNEDGLVSWEEYK.3|GHDLNEDGLVSWEEYK.2|TFDQLTPEESK.2|DRVHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.6|DRVHHEPQLSDKVHNDAQSFDYDHDAFLGAEEAK.5|MADKDGDLIATKEEFTAFLHPEEYDYMK.5|MADKDGDLIATKEEFTAFLHPEEYDYMK.4|YDLFVGSQATDFGEALVR.3|YDLFVGSQATDFGEALVR.2|EEIVDKYDLFVGSQATDFGEALVR.4|EEIVDKYDLFVGSQATDFGEALVR.3|EEFTAFLHPEEYDYMK.3|EEFTAFLHPEEYDYM[Oxi]K.3|EEFTAFLHPEEYDYMK.2|DGDLIATKEEFTAFLHPEEYDYMK.4|LTKEEIVDKYDLFVGSQATDFGEALVR.4|LTKEEIVDKYDLFVGSQATDFGEALVR.3|NADGFIDLEEYIGDMYSHDGNTDEPEWVK.4|NADGFIDLEEYIGDMYSHDGNTDEPEWVK.3|YDLFVGSQATDFGEALVRHDEF.3
SEN / CTL,O60565;Q9H772,Gremlin-1;Gremlin-2,GREM1;GREM2,0.63,0.47,1.45E-01,3.09E-02,1.51E+00,"cell morphogenesis,branching involved in ureteric bud morphogenesis,cell migration involved in sprouting angiogenesis,positive regulation of receptor internalization,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,mesenchymal to epithelial transition involved in metanephros morphogenesis,apoptotic process,signal transduction,activation of transmembrane receptor protein tyrosine kinase activity,cell-cell signaling,positive regulation of cell proliferation,proximal/distal pattern formation,regulation of epithelial to mesenchymal transition,collagen fibril organization,negative regulation of cell growth,embryonic limb morphogenesis,negative regulation of bone mineralization,negative regulation of BMP signaling pathway,negative regulation of chondrocyte differentiation,negative regulation of osteoblast proliferation,positive regulation of NF-kappaB import into nucleus,negative regulation of apoptotic process,positive regulation of angiogenesis,negative regulation of transcription, DNA-templated,positive regulation of transcription from RNA polymerase II promoter,negative regulation of bone remodeling,determination of dorsal identity,positive regulation of NF-kappaB transcription factor activity,regulation of focal adhesion assembly,positive regulation of telomerase activity,limb development,negative regulation of pathway-restricted SMAD protein phosphorylation,ureteric bud formation,positive regulation of protein tyrosine kinase activity,negative regulation of monocyte chemotaxis,negative regulation of canonical Wnt signaling pathway,positive regulation of branching involved in ureteric bud morphogenesis,negative regulation of branching involved in ureteric bud morphogenesis,negative regulation of osteoclast proliferation,positive regulation of peptidyl-tyrosine autophosphorylation,negative regulation of bone trabecula formation,negative regulation of bone mineralization involved in bone maturation,positive regulation of receptor activity,positive regulation of cardiac muscle cell differentiation,regulation of stress-activated MAPK cascade,signal transduction by p53 class mediator;embryonic body morphogenesis,cytokine-mediated signaling pathway,BMP signaling pathway,sequestering of BMP from receptor via BMP binding,determination of dorsal identity,regulation of cytokine activity","cytokine activity,protein binding,morphogen activity,transmembrane receptor protein tyrosine kinase activator activity,BMP binding,vascular endothelial growth factor receptor 2 binding,receptor agonist activity;cytokine activity,heparin binding,BMP binding,protein homodimerization activity","extracellular space,cell surface;extracellular region,extracellular space",3,1,1,FC[CAM]YGQC[CAM]NSFYIPR.2
SEN / CTL,Q9Y4K0,Lysyl oxidase homolog 2,LOXL2,0.62,0.85,7.69E-06,4.20E-06,5.38E+00,"response to hypoxia,epithelial to mesenchymal transition,endothelial cell proliferation,sprouting angiogenesis,transcription, DNA-templated,cellular protein modification process,receptor-mediated endocytosis,cell adhesion,aging,histone modification,protein deamination,collagen fibril organization,positive regulation of chondrocyte differentiation,endothelial cell migration,negative regulation of transcription, DNA-templated,response to copper ion,oxidation-reduction process","chromatin binding,transcription corepressor activity,protein-lysine 6-oxidase activity,scavenger receptor activity,copper ion binding,protein binding,electron carrier activity,methylated histone binding,oligosaccharide binding","basement membrane,extracellular space,nucleus,nucleoplasm,chromosome,membrane,extracellular matrix",27,16,19,VVC[CAM]GMFGFPGER.2|LGQGIGPIHLNEIQC[CAM]TGNEK.3|NGEWGTVC[CAM]DDKWDLVSASVVC[CAM]R.3|ASFC[CAM]LEDTEC[CAM]EGDIQK.2|KFEHFSGLLNNQLSPQ.3|FNAESQGC[CAM]NHEEDAGVR.3|FDNSLINQIENLNIQVEDIR.3|FDNSLINQIENLNIQVEDIR.2|RTPVMEGYVEVK.2|IWMYNC[CAM]HIGGSFSEETEK.3|AYKPEQPLVR.3|C[CAM]SGTELSLAHC[CAM]R.3|C[CAM]SGTELSLAHC[CAM]R.2|HTEDVGVVC[CAM]SDKR.3|C[CAM]NTPAMGLQK.2|C[CAM]NTPAM[Oxi]GLQK.2|QRYWPFSMDC[CAM]TGTEAHISSC[CAM]K.4|HTEDVGVVC[CAM]SDK.2|HAWIWHDC[CAM]HR.2
SEN / CTL,Q14019,Coactosin-like protein,COTL1,0.62,0.66,4.97E-03,1.49E-03,2.83E+00,"biological_process,defense response to fungus","actin binding,enzyme binding","nucleus,cytoplasm,cytoskeleton,extracellular exosome",12,20,26,SKFALITWIGENVSGLQR.3|SKFALITWIGENVSGLQR.2|FALITWIGENVSGLQR.3|FALITWIGENVSGLQR.2|YDGSTIVPGEQGAEYQHFIQQC[CAM]TDDVR.3|YDGSTIVPGEQGAEYQHFIQQC[CAM]TDDVR.4|AAYNLVR.2|EFVISDR.2|EVVQNFAK.2|FTTGDAMSK.2|FTTGDAM[Oxi]SK.2|TGTDKTLVK.2|EFVISDRK.2|ELEEDFIK.2|ELEEDFIKSELKK.3|ELEEDFIKSELKK.2|AGGANYDAQTE.2|FTTGDAMSKR.2|KELEEDFIK.2|KAGGANYDAQTE.2|DDGSAVIWVTFK.2|TLVKEVVQNFAK.2|AAYNLVRDDGSAVIWVTFK.3|AAYNLVRDDGSAVIWVTFK.2|ELEEDFIKSELK.2|YDGSTIVPGEQGAEYQHFIQQC[CAM]TDDVRLFAFVR.4
SEN / CTL,P08758,Annexin A5,ANXA5,0.59,1.50,7.82E-09,6.75E-09,8.17E+00,"signal transduction,blood coagulation,response to organic substance,negative regulation of apoptotic process,negative regulation of catalytic activity,negative regulation of coagulation","phospholipase inhibitor activity,calcium ion binding,phospholipid binding,calcium-dependent phospholipid binding","intracellular,cytoplasm,focal adhesion,external side of plasma membrane,membrane,extracellular exosome,endothelial microparticle",36,45,70,GLGTDEESILTLLTSR.3|GLGTDEESILTLLTSR.2|SEIDLFNIR.2|GTVTDFPGFDERADAETLR.3|VLTEIIASR.2|WGTDEEKFITIFGTR.3|WGTDEEKFITIFGTR.2|SIPAYLAETLYYAMK.2|SIPAYLAETLYYAMK.3|SIPAYLAETLYYAM[Oxi]K.3|SIPAYLAETLYYAM[Oxi]K.2|DLLDDLK.2|NFATSLYSMIK.2|NFATSLYSMIK.3|NFATSLYSM[Oxi]IK.3|NFATSLYSM[Oxi]IK.2|GTVTDFPGFDERADAETLRK.4|GTVTDFPGFDERADAETLRK.3|DLLDDLKSELTGKFEK.3|DLLDDLKSELTGKFEK.4|DLLDDLKSELTGKFEK.2|SEIDLFNIRK.3|SEIDLFNIRK.2|WGTDEEK.2|GTVTDFPGFDER.3|GTVTDFPGFDER.2|QEISAAFK.2|ADAETLRK.2|KNFATSLYSMIK.3|KNFATSLYSMIK.2|FITIFGTR.2|DLLDDLKSELTGK.3|DLLDDLKSELTGK.2|SNAQRQEISAAFK.3|SNAQRQEISAAFK.2|LYDAYELKHALK.3|LYDAYELK.2|SELTGKFEK.2|LYDAYELKHALKGAGTNEK.4|LYDAYELKHALKGAGTNEK.3|ETSGNLEQLLLAVVK.3|ETSGNLEQLLLAVVK.2|GAGTNEKVLTEIIASR.3|GAGTNEKVLTEIIASR.2|ALLLLC[CAM]GEDD.2|NFATSLYSMIKGDTSGDYKK.4|HALKGAGTNEK.2|LIVALMKPSR.2|GAGTDDHTLIR.2|MLVVLLQANR.2|M[Oxi]LVVLLQANR.2|VLTEIIASRTPEELR.3|GAGTNEKVLTEIIASRTPEELR.4|YMTISGFQIEETIDR.3|YMTISGFQIEETIDR.2|KALLLLC[CAM]GEDD.2|DPDAGIDEAQVEQDAQALFQAGELK.4|DPDAGIDEAQVEQDAQALFQAGELK.3|TLFGRDLLDDLKSELTGK.3|AM[Oxi]KGLGTDEESILTLLTSR.3|TLFGRDLLDDLK.2|QVYEEEYGSSLEDDVVGDTSGYYQR.4|QVYEEEYGSSLEDDVVGDTSGYYQR.3|SIPAYLAETLYYAMKGAGTDDHTLIR.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.5|M[Oxi]LVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELK.4|MLVVLLQANRDPDAGIDEAQVEQDAQALFQAGELKWGTDEEK.5|VFDKYMTISGFQIEETIDRETSGNLEQLLLAVVK.4|AIKQVYEEEYGSSLEDDVVGDTSGYYQR.3
SEN / CTL,P09972,Fructose-bisphosphate aldolase C,ALDOC,0.59,1.11,1.31E-03,4.58E-04,3.34E+00,"fructose metabolic process,gluconeogenesis,fructose 1,6-bisphosphate metabolic process,epithelial cell differentiation,canonical glycolysis","fructose-bisphosphate aldolase activity,protein binding,cytoskeletal protein binding","mitochondrion,cytosol,cytoskeleton,extracellular exosome",12,27,42,VDKGVVPLAGTDGETTTQGLDGLSER.3|VDKGVVPLAGTDGETTTQGLDGLSER.4|GVVPLAGTDGETTTQGLDGLSER.3|GVVPLAGTDGETTTQGLDGLSER.2|GVVPLAGTDGETTTQGLDGLSER.4|PHSYPALSAEQK.3|PHSYPALSAEQK.2|RLSQIGVENTEENRR.4|RLSQIGVENTEENRR.3|ELSDIALR.2|PNMVTPGHAC[CAM]PIK.3|DDNGVPFVR.2|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.6|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.6|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.5|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.5|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIK.4|ALSDHHVYLEGTLLKPNM[Oxi]VTPGHAC[CAM]PIK.4|AEVNGLAAQGK.2|QVLFSADDR.2|LSQIGVENTEENRR.3|RLSQIGVENTEENR.3|TPSALAILENANVLAR.3|TPSALAILENANVLAR.2|YTPEEIAMATVTALR.3|YTPEEIAMATVTALR.2|ALSDHHVYLEGTLLK.3|ALQASALNAWR.2|C[CAM]IGGVIFFHETLYQK.3|C[CAM]IGGVIFFHETLYQK.2|C[CAM]PLPRPWALTFSYGR.3|RAEVNGLAAQGK.2|YTPEEIAMATVTALRR.3|DNAGAATEEFIK.2|GILAADESVGSMAK.2|GILAADESVGSM[Oxi]AK.2|DNAGAATEEFIKR.2|ISERTPSALAILENANVLAR.3|LSQIGVENTEENR.2|YEGSGEDGGAAAQSLYIANHAY.3|YEGSGEDGGAAAQSLYIANHAY.2|ALSDHHVYLEGTLLKPNMVTPGHAC[CAM]PIKYTPEEIAMATVTALR.6
SEN / CTL,Q04760,Lactoylglutathione lyase,GLO1,0.59,1.42,7.98E-02,1.77E-02,1.75E+00,"carbohydrate metabolic process,pyruvate metabolic process,regulation of transcription from RNA polymerase II promoter,glutathione metabolic process,methylglyoxal metabolic process,osteoclast differentiation,negative regulation of apoptotic process","lactoylglutathione lyase activity,zinc ion binding","cytoplasm,cytosol,extracellular exosome",6,16,31,GLAFIQDPDGYWIEILNPNK.3|GLAFIQDPDGYWIEILNPNK.2|GFGHIGIAVPDVYSAC[CAM]K.3|GFGHIGIAVPDVYSAC[CAM]K.4|GFGHIGIAVPDVYSAC[CAM]K.2|FEELGVK.2|IAWALSR.2|DFLLQQTMLR.3|DFLLQQTMLR.2|DFLLQQTM[Oxi]LR.2|C[CAM]DFPIMK.2|C[CAM]DFPIM[Oxi]K.2|SLDFYTR.2|GFGHIGIAVPDVYSAC[CAM]KR.4|GFGHIGIAVPDVYSAC[CAM]KR.3|GFGHIGIAVPDVYSAC[CAM]KR.2|RFEELGVK.2|VLGMTLIQK.2|VLGM[Oxi]TLIQK.2|FSLYFLAYEDKNDIPKEK.4|FSLYFLAYEDKNDIPKEK.3|ATLELTHNWGTEDDETQSYHNGNSDPR.5|ATLELTHNWGTEDDETQSYHNGNSDPR.4|ATLELTHNWGTEDDETQSYHNGNSDPR.3|KATLELTHNWGTEDDETQSYHNGNSDPR.5|KATLELTHNWGTEDDETQSYHNGNSDPR.4|KATLELTHNWGTEDDETQSYHNGNSDPR.3|FSLYFLAYEDKNDIPK.3|FSLYFLAYEDKNDIPK.2|GFGHIGIAVPDVYSAC[CAM]KRFEELGVK.4|FSLYFLAYEDK.2
SEN / CTL,P09486,SPARC,SPARC,0.56,0.98,6.64E-10,6.56E-10,9.18E+00,"ossification,negative regulation of endothelial cell proliferation,platelet degranulation,receptor-mediated endocytosis,signal transduction,heart development,response to gravity,response to lead ion,positive regulation of endothelial cell migration,negative regulation of angiogenesis,regulation of cell morphogenesis,extracellular matrix organization,lung development,response to lipopolysaccharide,response to L-ascorbic acid,response to cytokine,wound healing,response to peptide hormone,response to ethanol,response to cadmium ion,inner ear development,response to glucocorticoid,response to cAMP,response to calcium ion,bone development,cellular response to growth factor stimulus","calcium ion binding,protein binding,collagen binding,extracellular matrix binding","extracellular region,basement membrane,extracellular space,cytoplasm,cell surface,nuclear matrix,platelet alpha granule,platelet alpha granule membrane,platelet alpha granule lumen,endocytic vesicle lumen,mitochondrion,plasma membrane",48,14,22,YIPPC[CAM]LDSELTEFPLR.3|YIPPC[CAM]LDSELTEFPLR.2|FFETC[CAM]DLDNDKYIALDEWAGC[CAM]FGIK.3|NVLVTLYERDEDNNLLTEK.3|NYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLR.5|NYNMYIFPVHWQFGQLDQHPIDGYLSHTELAPLR.4|LHLDYIGPC[CAM]K.3|LHLDYIGPC[CAM]K.2|RLEAGDHPVELLAR.3|VC[CAM]ELDENNTPMC[CAM]VC[CAM]QDPTSC[CAM]PAPIGEFEK.3|VC[CAM]ELDENNTPMC[CAM]VC[CAM]QDPTSC[CAM]PAPIGEFEK.4|LEAGDHPVELLAR.3|LEAGDHPVELLAR.2|NVLVTLYER.2|TFDSSC[CAM]HFFATK.3|TFDSSC[CAM]HFFATK.2|APLIPMEHC[CAM]TTR.3|APLIPM[Oxi]EHC[CAM]TTR.3|APLIPMEHC[CAM]TTR.2|DEDNNLLTEK.2|FFETC[CAM]DLDNDK.2|YIALDEWAGC[CAM]FGIK.2
SEN / CTL,P02787,Serotransferrin,TF,0.54,0.66,5.96E-02,1.36E-02,1.86E+00,"retina homeostasis,platelet degranulation,cellular iron ion homeostasis,regulation of protein stability,transferrin transport,positive regulation of receptor-mediated endocytosis,iron ion homeostasis,cellular response to iron ion,ferrous iron import into cell","protein binding,ferrous iron binding,ferric iron binding,ferric iron transmembrane transporter activity,transferrin receptor binding","extracellular region,extracellular space,early endosome,late endosome,clathrin-coated pit,basal plasma membrane,cell surface,endosome membrane,cytoplasmic, membrane-bounded vesicle,apical plasma membrane,endocytic vesicle,extrinsic component of external side of plasma membrane,vesicle,secretory granule lumen,basal part of cell,perinuclear region of cytoplasm,recycling endosome,extracellular exosome,blood microparticle,HFE-transferrin receptor complex",6,86,160,C[CAM]LVEKGDVAFVK.3|C[CAM]LVEKGDVAFVK.2|NPDPWAK.2|DC[CAM]HLAQVPSHTVVAR.4|DC[CAM]HLAQVPSHTVVAR.3|EFQLFSSPHGK.3|EFQLFSSPHGK.2|HSTIFENLANK.3|HSTIFENLANK.2|KPVDEYKDC[CAM]HLAQVPSHTVVAR.6|KPVDEYKDC[CAM]HLAQVPSHTVVAR.5|KPVDEYKDC[CAM]HLAQVPSHTVVAR.4|KPVDEYKDC[CAM]HLAQVPSHTVVAR.3|DSAHGFLK.2|KDSGFQMNQLR.3|KDSGFQM[Oxi]NQLR.3|KDSGFQMNQLR.2|KDSGFQM[Oxi]NQLR.2|KPVDEYK.2|WC[CAM]AVSEHEATK.3|WC[CAM]AVSEHEATK.2|DYELLC[CAM]LDGTR.3|DYELLC[CAM]LDGTR.2|C[CAM]LKDGAGDVAFVK.3|C[CAM]LKDGAGDVAFVK.2|DDTVC[CAM]LAK.2|KSASDLTWDNLK.3|KSASDLTWDNLK.2|ADRDQYELLC[CAM]LDNTR.4|ADRDQYELLC[CAM]LDNTR.3|ADRDQYELLC[CAM]LDNTR.2|EFQLFSSPHGKDLLFK.4|APNHAVVTR.2|DGAGDVAFVK.2|HQTVPQNTGGKNPDPWAK.4|HQTVPQNTGGKNPDPWAK.3|MYLGYEYVTAIR.3|M[Oxi]YLGYEYVTAIR.3|MYLGYEYVTAIR.2|M[Oxi]YLGYEYVTAIR.2|ADRDQYELLC[CAM]LDNTRK.4|ASYLDC[CAM]IR.2|DLLFKDSAHGFLK.3|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.6|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.5|EGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.4|SETKDLLFRDDTVC[CAM]LAK.4|SETKDLLFRDDTVC[CAM]LAK.3|SKEFQLFSSPHGK.3|SKEFQLFSSPHGK.2|YLGEEYVK.2|LKC[CAM]DEWSVNSVGK.3|LKC[CAM]DEWSVNSVGK.2|SM[Oxi]GGKEDLIWELLNQAQEHFGK.5|SMGGKEDLIWELLNQAQEHFGK.5|SM[Oxi]GGKEDLIWELLNQAQEHFGK.4|SMGGKEDLIWELLNQAQEHFGK.4|SMGGKEDLIWELLNQAQEHFGK.3|C[CAM]STSSLLEAC[CAM]TFR.3|C[CAM]STSSLLEAC[CAM]TFR.2|DQYELLC[CAM]LDNTR.3|DQYELLC[CAM]LDNTR.2|SVIPSDGPSVAC[CAM]VKK.3|SVIPSDGPSVAC[CAM]VKK.2|DLLFRDDTVC[CAM]LAK.3|DLLFRDDTVC[CAM]LAK.2|EDLIWELLNQAQEHFGK.4|EDLIWELLNQAQEHFGK.3|EDLIWELLNQAQEHFGK.2|SASDLTWDNLKGKK.3|FDEFFSEGC[CAM]APGSK.3|FDEFFSEGC[CAM]APGSK.2|KPVEEYANC[CAM]HLAR.3|KPVEEYANC[CAM]HLAR.2|SKEFQLFSSPHGKDLLFK.4|TAGWNIPM[Oxi]GLLYNK.3|TAGWNIPMGLLYNK.3|TAGWNIPMGLLYNK.2|TAGWNIPM[Oxi]GLLYNK.2|GDVAFVKHQTVPQNTGGKNPDPWAK.5|HSTIFENLANKADR.3|EDPQTFYYAVAVVK.3|EDPQTFYYAVAVVK.2|SAGWNIPIGLLYC[CAM]DLPEPR.4|SAGWNIPIGLLYC[CAM]DLPEPR.3|SAGWNIPIGLLYC[CAM]DLPEPR.2|ADRDQYELLC[CAM]LDNTRKPVDEYK.5|ADRDQYELLC[CAM]LDNTRKPVDEYK.4|APNHAVVTRK.2|KC[CAM]STSSLLEAC[CAM]TFR.3|KC[CAM]STSSLLEAC[CAM]TFR.2|NLREGTC[CAM]PEAPTDEC[CAM]KPVK.4|NLREGTC[CAM]PEAPTDEC[CAM]KPVK.3|PVVAEFYGSK.2|SM[Oxi]GGKEDLIWELLNQAQEHFGKDK.5|SMGGKEDLIWELLNQAQEHFGKDK.5|SMGGKEDLIWELLNQAQEHFGKDK.4|SM[Oxi]GGKEDLIWELLNQAQEHFGKDK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSK.3|KASYLDC[CAM]IR.2|NLREGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.6|NLREGTC[CAM]PEAPTDEC[CAM]KPVKWC[CAM]ALSHHER.5|FDEFFSEGC[CAM]APGSKK.3|FDEFFSEGC[CAM]APGSKK.2|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNK.3|LC[CAM]MGSGLNLC[CAM]EPNNK.3|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNK.2|LC[CAM]MGSGLNLC[CAM]EPNNK.2|EDLIWELLNQAQEHFGKDK.4|IEC[CAM]VSAETTEDC[CAM]IAK.3|IEC[CAM]VSAETTEDC[CAM]IAK.2|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.5|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.4|DYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.3|EDPQTFYYAVAVVKK.3|EDPQTFYYAVAVVKK.2|HQTVPQNTGGK.2|LHDRNTYEK.2|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.6|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.5|NLNEKDYELLC[CAM]LDGTRKPVEEYANC[CAM]HLAR.4|DSGFQMNQLR.2|DSGFQM[Oxi]NQLR.2|INHC[CAM]RFDEFFSEGC[CAM]APGSKK.4|INHC[CAM]RFDEFFSEGC[CAM]APGSKK.3|WC[CAM]ALSHHER.2|EGTC[CAM]PEAPTDEC[CAM]KPVK.3|EGTC[CAM]PEAPTDEC[CAM]KPVK.2|C[CAM]LVEKGDVAFVKHQTVPQNTGGK.4|HSTIFENLANKADRDQYELLC[CAM]LDNTR.5|HSTIFENLANKADRDQYELLC[CAM]LDNTR.4|SASDLTWDNLK.2|C[CAM]DEWSVNSVGK.2|EGYYGYTGAFR.2|NLNEKDYELLC[CAM]LDGTR.3|NLNEKDYELLC[CAM]LDGTR.2|NLNEKDYELLC[CAM]LDGTRK.3|SVIPSDGPSVAC[CAM]VK.2|IMNGEADAMSLDGGFVYIAGK.3|IM[Oxi]NGEADAM[Oxi]SLDGGFVYIAGK.3|IMNGEADAM[Oxi]SLDGGFVYIAGK.2|IMNGEADAMSLDGGFVYIAGK.2|LHDRNTYEKYLGEEYVK.3|LHDRNTYEKYLGEEYVK.2|SASDLTWDNLKGK.2|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNKEGYYGYTGAFR.4|LC[CAM]M[Oxi]GSGLNLC[CAM]EPNNKEGYYGYTGAFR.3|LC[CAM]MGSGLNLC[CAM]EPNNKEGYYGYTGAFR.3|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.5|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSK.4|LKC[CAM]DEWSVNSVGKIEC[CAM]VSAETTEDC[CAM]IAK.4|NTYEKYLGEEYVK.2|AVANFFSGSC[CAM]APC[CAM]ADGTDFPQLC[CAM]QLC[CAM]PGC[CAM]GC[CAM]STLNQYFGYSGAFK.6|AVANFFSGSC[CAM]APC[CAM]ADGTDFPQLC[CAM]QLC[CAM]PGC[CAM]GC[CAM]STLNQYFGYSGAFK.5|QQQHLFGSNVTDC[CAM]SGNFC[CAM]LFR.3|PVVAEFYGSKEDPQTFYYAVAVVK.3|AIAANEADAVTLDAGLVYDAYLAPNNLK.3|C[CAM]DEWSVNSVGKIEC[CAM]VSAETTEDC[CAM]IAK.3|AIAANEADAVTLDAGLVYDAYLAPNNLKPVVAEFYGSKEDPQTFYYAVAVVK.5
SEN / CTL,P61224;P62834,Ras-related protein Rap-1b;Ras-related protein Rap-1A,RAP1B;RAP1A,0.54,1.54,1.73E-01,3.63E-02,1.44E+00,"cell proliferation,response to carbohydrate,Rap protein signal transduction,cellular response to drug,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to cAMP,cellular response to gonadotropin-releasing hormone,regulation of cell junction assembly,regulation of establishment of cell polarity,negative regulation of synaptic vesicle exocytosis,microvillus assembly;activation of MAPKK activity,signal transduction,positive regulation of neuron projection development,protein transport,Rap protein signal transduction,negative regulation of collagen biosynthetic process,cellular response to drug,nerve growth factor signaling pathway,positive regulation of GTPase activity,positive regulation of protein kinase activity,positive regulation of glucose import,positive regulation of phagocytosis,regulation of insulin secretion,establishment of endothelial barrier,positive regulation of ERK1 and ERK2 cascade,cellular response to cAMP,cellular response to glucose stimulus,response to antineoplastic agent,liver regeneration,regulation of cell junction assembly,cellular response to nerve growth factor stimulus,negative regulation of synaptic vesicle exocytosis,positive regulation of vasculogenesis,microvillus assembly","GTPase activity,protein binding,GTP binding,GDP binding,protein complex binding;GTPase activity,protein binding,GTP binding,protein transporter activity,Ras GTPase binding,Rap guanyl-nucleotide exchange factor activity,protein complex binding","intracellular,lipid particle,cytosol,plasma membrane,cell-cell junction,membrane,extracellular exosome,membrane raft;cytoplasm,early endosome,late endosome,cytosol,plasma membrane,cell junction,guanyl-nucleotide exchange factor complex,neuron projection,myelin sheath,perinuclear region of cytoplasm,extracellular exosome",6,2,3,SKINVNEIFYDLVR.3|SKINVNEIFYDLVR.2|LVVLGSGGVGK.2
SEN / CTL,P05121,Plasminogen activator inhibitor 1,SERPINE1,0.53,1.12,1.03E-03,3.69E-04,3.43E+00,"chronological cell aging,angiogenesis,platelet degranulation,circadian rhythm,regulation of receptor activity,negative regulation of plasminogen activation,negative regulation of endopeptidase activity,negative regulation of smooth muscle cell migration,positive regulation of blood coagulation,negative regulation of blood coagulation,extracellular matrix organization,negative regulation of cell migration,positive regulation of interleukin-8 production,negative regulation of cell adhesion mediated by integrin,positive regulation of leukotriene production involved in inflammatory response,fibrinolysis,positive regulation of angiogenesis,positive regulation of transcription from RNA polymerase II promoter,positive regulation of receptor-mediated endocytosis,positive regulation of inflammatory response,defense response to Gram-negative bacterium,negative regulation of fibrinolysis,negative regulation of vascular wound healing,negative regulation of wound healing,cellular response to lipopolysaccharide,positive regulation of monocyte chemotaxis,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of smooth muscle cell-matrix adhesion,negative regulation of endothelial cell apoptotic process","protease binding,serine-type endopeptidase inhibitor activity,receptor binding,protein binding","extracellular region,extracellular space,plasma membrane,extracellular matrix,platelet alpha granule lumen,extracellular exosome",18,9,10,MAPEEIIMDRPFLFVVR.3|HNPTGTVLFMGQVMEP.2|QFQADFTSLSDQEPLHVAQALQK.3|ELMGPWNKDEISTTDAIFVQR.3|EVPLSALTNILSAQLISHWK.3|EVPLSALTNILSAQLISHWK.2|LVQGFMPHFFR.3|VFQQVAQASK.2|TPFPDSSTHR.2|LVLVNALYFNGQWK.2
SEN / CTL,P17936,Insulin-like growth factor-binding protein 3,IGFBP3,0.53,1.15,5.97E-05,2.89E-05,4.54E+00,"regulation of cell growth,osteoblast differentiation,negative regulation of protein phosphorylation,protein phosphorylation,apoptotic process,negative regulation of cell proliferation,negative regulation of signal transduction,regulation of glucose metabolic process,negative regulation of smooth muscle cell migration,regulation of apoptotic process,positive regulation of apoptotic process,positive regulation of catalytic activity,positive regulation of MAPK cascade,regulation of insulin-like growth factor receptor signaling pathway,positive regulation of insulin-like growth factor receptor signaling pathway,cellular protein metabolic process,type B pancreatic cell proliferation,positive regulation of myoblast differentiation,negative regulation of smooth muscle cell proliferation","fibronectin binding,protein binding,insulin-like growth factor binding,protein tyrosine phosphatase activator activity,insulin-like growth factor I binding,insulin-like growth factor II binding,metal ion binding","extracellular region,extracellular space,nucleus,insulin-like growth factor binding protein complex,insulin-like growth factor ternary complex,extracellular exosome",24,10,13,C[CAM]QPSPDEARPLQALLDGR.3|FLNVLSPR.2|EPGC[CAM]GC[CAM]C[CAM]LTC[CAM]ALSEGQPC[CAM]GIYTER.3|ALAQC[CAM]APPPAVC[CAM]AELVR.2|ALAQC[CAM]APPPAVC[CAM]AELVR.3|GFC[CAM]WC[CAM]VDK.2|EMEDTLNHLK.3|EM[Oxi]EDTLNHLK.3|YGQPLPGYTTK.2|SAGSVESPSVSSTHR.3|SAGSVESPSVSSTHR.2|GKEDVHC[CAM]YSMQSK.3|YKVDYESQSTDTQNFSSESK.3
SEN / CTL,P32119,Peroxiredoxin-2,PRDX2,0.51,1.14,7.05E-03,2.00E-03,2.70E+00,"response to reactive oxygen species,response to oxidative stress,removal of superoxide radicals,cellular response to oxidative stress,hydrogen peroxide catabolic process,regulation of apoptotic process,negative regulation of apoptotic process,cell redox homeostasis,oxidation-reduction process","thioredoxin peroxidase activity,antioxidant activity","cytoplasm,cytosol,extracellular exosome",9,24,40,KEGGLGPLNIPLLADVTR.3|KEGGLGPLNIPLLADVTR.2|ATAVVDGAFKEVK.3|ATAVVDGAFKEVK.2|KLGC[CAM]EVLGVSVDSQFTHLAWINTPR.4|KLGC[CAM]EVLGVSVDSQFTHLAWINTPR.3|GLFIIDGK.2|GLFIIDGKGVLR.3|GLFIIDGKGVLR.2|IGKPAPDFKATAVVDGAFKEVK.5|TDEGIAYR.2|ATAVVDGAFK.2|ATAVVDGAFK.1|IGKPAPDFK.2|PGSDTIKPNVDDSK.3|PGSDTIKPNVDDSK.2|KEGGLGPLNIPLLADVTRR.4|KEGGLGPLNIPLLADVTRR.3|LSEDYGVLK.2|RLSEDYGVLKTDEGIAYR.4|RLSEDYGVLKTDEGIAYR.3|RLSEDYGVLKTDEGIAYR.2|EGGLGPLNIPLLADVTR.3|EGGLGPLNIPLLADVTR.2|RLSEDYGVLK.2|GLFIIDGKGVLRQITVNDLPVGR.4|EGGLGPLNIPLLADVTRR.3|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.6|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.5|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSK.4|LSEDYGVLKTDEGIAYR.3|LGC[CAM]EVLGVSVDSQFTHLAWINTPR.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPR.3|LGC[CAM]EVLGVSVDSQFTHLAWINTPRK.4|LGC[CAM]EVLGVSVDSQFTHLAWINTPRK.3|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.6|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.5|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIKPNVDDSKEYFSK.4|LVQAFQYTDEHGEVC[CAM]PAGWKPGSDTIK.4|LVQAFQYTDEHGEVC[CAM]PAGWK.3
SEN / CTL,P01023,Alpha-2-macroglobulin,A2M,0.50,1.34,1.43E-03,4.91E-04,3.31E+00,"negative regulation of complement activation, lectin pathway,platelet degranulation,blood coagulation, intrinsic pathway,negative regulation of endopeptidase activity,extracellular matrix disassembly,positive regulation of GTPase activity,stem cell differentiation,regulation of small GTPase mediated signal transduction","protease binding,serine-type endopeptidase inhibitor activity,GTPase activator activity,receptor binding,protein binding,growth factor binding,enzyme binding,interleukin-8 binding,interleukin-1 binding,tumor necrosis factor binding,calcium-dependent protein binding","extracellular region,cytosol,platelet alpha granule lumen,extracellular exosome,blood microparticle",33,89,144,QTVSWAVTPK.2|ATVLNYLPK.2|IAQWQSFQLEGGLKQFSFPLSSEPFQGSYK.4|MVSGFIPLKPTVK.3|M[Oxi]VSGFIPLKPTVK.2|AFQPFFVELTMPYSVIR.2|AFQPFFVELTMPYSVIR.3|AFQPFFVELTM[Oxi]PYSVIR.2|AFQPFFVELTM[Oxi]PYSVIR.3|DMYSFLEDMGLK.2|DM[Oxi]YSFLEDMGLK.2|VGFYESDVMGR.2|VGFYESDVM[Oxi]GR.2|GHFSISIPVKSDIAPVAR.4|GHFSISIPVKSDIAPVAR.3|LLLQQVSLPELPGEYSMK.3|LLLQQVSLPELPGEYSM[Oxi]K.3|LLLQQVSLPELPGEYSMK.2|GPTQEFK.2|LVHVEEPHTETVRK.4|VTAAPQSVC[CAM]ALR.3|VTAAPQSVC[CAM]ALR.2|DLKPAIVK.2|PVPGHVTVSIC[CAM]R.3|YGAATFTR.2|YNILPEK.2|SLNEEAVK.2|GVPIPNKVIFIR.3|ALLAYAFALAGNQDKRK.4|ALLAYAFALAGNQDKRK.3|NEDSLVFVQTDK.3|NEDSLVFVQTDK.2|TGTHGLLVK.2|EQAPHC[CAM]IC[CAM]ANGR.3|EQAPHC[CAM]IC[CAM]ANGR.2|LVDGKGVPIPNKVIFIR.4|HYDGSYSTFGER.3|HYDGSYSTFGER.2|KDTVIKPLLVEPEGLEK.4|KDTVIKPLLVEPEGLEK.3|VDSHFRQGIPFFGQVR.4|FQVDNNNR.2|SGGRTEHPFTVEEFVLPK.4|SGGRTEHPFTVEEFVLPK.3|SLNEEAVKK.2|TAQEGDHGSHVYTK.3|TAQEGDHGSHVYTK.2|LVHVEEPHTETVR.3|LVHVEEPHTETVR.2|VDLSFSPSQSLPASHAHLR.4|VDLSFSPSQSLPASHAHLR.3|VDLSFSPSQSLPASHAHLR.2|ALLAYAFALAGNQDK.3|ALLAYAFALAGNQDK.2|FEVQVTVPK.2|LHTEAQIQEEGTVVELTGR.4|LHTEAQIQEEGTVVELTGR.3|LHTEAQIQEEGTVVELTGR.2|IAQWQSFQLEGGLK.3|IAQWQSFQLEGGLK.2|DNSVHWERPQKPK.3|DNSVHWERPQKPK.2|GHFSISIPVK.2|KSGGRTEHPFTVEEFVLPK.4|TEVSSNHVLIYLDK.3|TEVSSNHVLIYLDK.2|SSGSLLNNAIK.2|KYSDASDC[CAM]HGEDSQAFC[CAM]EK.4|KYSDASDC[CAM]HGEDSQAFC[CAM]EK.3|SIYKPGQTVK.2|TEHPFTVEEFVLPK.3|TEHPFTVEEFVLPK.2|SASNMAIVDVK.2|SASNM[Oxi]AIVDVK.2|SSSNEEVMFLTVQVK.3|SSSNEEVM[Oxi]FLTVQVK.2|SSSNEEVMFLTVQVK.2|ALLAYAFALAGNQDKR.3|NALFC[CAM]LESAWKTAQEGDHGSHVYTK.5|QGIPFFGQVR.2|DTVIKPLLVEPEGLEK.3|DTVIKPLLVEPEGLEK.2|QQNAQGGFSSTQDTVVALHALSK.4|QQNAQGGFSSTQDTVVALHALSK.3|QQNAQGGFSSTQDTVVALHALSK.2|LPPNVVEESAR.2|LLIYAVLPTGDVIGDSAK.3|LLIYAVLPTGDVIGDSAK.2|PLLVEPEGLEK.2|SGGRTEHPFTVEEFVLPKFEVQVTVPK.5|YDVENC[CAM]LANK.2|QFSFPLSSEPFQGSYK.3|QFSFPLSSEPFQGSYK.2|SLFTDLEAENDVLHC[CAM]VAFAVPK.4|SLFTDLEAENDVLHC[CAM]VAFAVPK.3|AIGYLNTGYQR.2|LSFYYLIMAK.2|VSVQLEASPAFLAVPVEK.3|VSVQLEASPAFLAVPVEK.2|FSGQLNSHGC[CAM]FYQQVK.3|SFVHLEPM[Oxi]SHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.6|SFVHLEPMSHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.6|SFVHLEPMSHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.5|SFVHLEPMSHELPC[CAM]GHTQTVQAHYILNGGTLLGLK.4|YDVENC[CAM]LANKVDLSFSPSQSLPASHAHLR.5|SPC[CAM]YGYQWVSEEHEEAHHTAYLVFSPSK.5|SPC[CAM]YGYQWVSEEHEEAHHTAYLVFSPSK.4|NALFC[CAM]LESAWK.2|TEHPFTVEEFVLPKFEVQVTVPK.4|AGAFC[CAM]LSEDAGLGISSTASLR.3|AGAFC[CAM]LSEDAGLGISSTASLR.2|KLSFYYLIMAK.2|MC[CAM]PQLQQYEMHGPEGLR.3|M[Oxi]C[CAM]PQLQQYEMHGPEGLR.3|MC[CAM]PQLQQYEM[Oxi]HGPEGLR.3|PQYMVLVPSLLHTETTEK.3|PQYM[Oxi]VLVPSLLHTETTEK.3|VVSMDENFHPLNELIPLVYIQDPK.4|VVSMDENFHPLNELIPLVYIQDPK.3|VVSM[Oxi]DENFHPLNELIPLVYIQDPK.3|YSDASDC[CAM]HGEDSQAFC[CAM]EK.3|HNVYINGITYTPVSSTNEK.3|HNVYINGITYTPVSSTNEK.2|DRSPC[CAM]YGYQWVSEEHEEAHHTAYLVFSPSK.5|VSNQTLSLFFTVLQDVPVR.3|AVDQSVLLM[Oxi]KPDAELSASSVYNLLPEK.4|AVDQSVLLMKPDAELSASSVYNLLPEK.4|AVDQSVLLM[Oxi]KPDAELSASSVYNLLPEK.3|AVDQSVLLMKPDAELSASSVYNLLPEK.3|AAQVTIQSSGTFSSK.2|NQGNTWLTAFVLK.2|EEFPFALGVQTLPQTC[CAM]DEPK.3|VTGEGC[CAM]VYLQTSLK.2|FRVVSMDENFHPLNELIPLVYIQDPK.4|FRVVSMDENFHPLNELIPLVYIQDPK.3|AYIFIDEAHITQALIWLSQR.3|AYIFIDEAHITQALIWLSQR.2|ETTFNSLLC[CAM]PSGGEVSEELSLK.3|ETTFNSLLC[CAM]PSGGEVSEELSLK.2|GC[CAM]VLLSYLNETVTVSASLESVR.3|VYDYYETDEFAIAEYNAPC[CAM]SK.3|ETTFNSLLC[CAM]PSGGEVSEELSLKLPPNVVEESAR.4|APVGHFYEPQAPSAEVEMTSYVLLAYLTAQPAPTSEDLTSATNIVK.5|YNILPEKEEFPFALGVQTLPQTC[CAM]DEPK.3
SEN / CTL,P61158,Actin-related protein 3,ACTR3,0.49,1.48,1.01E-03,3.63E-04,3.44E+00,"movement of cell or subcellular component,establishment or maintenance of cell polarity,asymmetric cell division,meiotic chromosome movement towards spindle pole,meiotic cytokinesis,Arp2/3 complex-mediated actin nucleation,Fc-gamma receptor signaling pathway involved in phagocytosis,ephrin receptor signaling pathway,spindle localization,cilium morphogenesis","structural constituent of cytoskeleton,ATP binding,actin filament binding","cytosol,Arp2/3 protein complex,brush border,cell-cell junction,focal adhesion,actin cytoskeleton,membrane,lamellipodium,extracellular exosome",18,34,61,DITYFIQQLLR.2|DITYFIQQLLR.3|HGIVEDWDLMER.3|HGIVEDWDLMER.2|HGIVEDWDLM[Oxi]ER.2|FMEQVIFK.2|FM[Oxi]EQVIFK.2|NIVLSGGSTMFR.2|NIVLSGGSTMFR.3|NIVLSGGSTM[Oxi]FR.2|LKPKPIDVQVITHHMQR.4|LKPKPIDVQVITHHMQR.5|GVDDLDFFIGDEAIEKPTYATK.3|GVDDLDFFIGDEAIEKPTYATK.4|QYTGINAISKK.3|QYTGINAISKK.2|EFNKYDTDGSK.3|EFNKYDTDGSK.2|DYEEIGPSIC[CAM]R.3|DYEEIGPSIC[CAM]R.2|KEFSIDVGYER.3|KEFSIDVGYER.2|LSEELSGGR.2|KDYEEIGPSIC[CAM]R.3|KDYEEIGPSIC[CAM]R.2|HNPVFGVMS.2|HNPVFGVM[Oxi]S.2|ERYSYVC[CAM]PDLVK.3|ERYSYVC[CAM]PDLVK.2|LPAC[CAM]VVDC[CAM]GTGYTK.3|LPAC[CAM]VVDC[CAM]GTGYTK.2|WPIRHGIVEDWDLMER.4|PIDVQVITHHM[Oxi]QR.3|PIDVQVITHHMQR.3|PIDVQVITHHMQR.2|HIPIAGRDITYFIQQLLR.4|QYTGINAISK.2|DREVGIPPEQSLETAK.3|DREVGIPPEQSLETAK.2|LKLSEELSGGR.2|EFSIDVGYER.2|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.5|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.4|TLTGTVIDSGDGVTHVIPVAEGYVIGSC[CAM]IK.3|AEPEDHYFLLTEPPLNTPENR.4|AEPEDHYFLLTEPPLNTPENR.3|YSYVC[CAM]PDLVK.2|YSYVC[CAM]PDLVKEFNKYDTDGSK.4|YAVWFGGSMLASTPEFYQVC[CAM]HTK.4|YAVWFGGSM[Oxi]LASTPEFYQVC[CAM]HTK.3|YAVWFGGSMLASTPEFYQVC[CAM]HTK.3|YAVWFGGSMLASTPEFYQVC[CAM]HTKK.4|YAVWFGGSMLASTPEFYQVC[CAM]HTKK.3|LGYAGNTEPQFIIPSC[CAM]IAIK.3|LGYAGNTEPQFIIPSC[CAM]IAIK.2|YLRAEPEDHYFLLTEPPLNTPENR.4|YLRAEPEDHYFLLTEPPLNTPENR.3|EVGIPPEQSLETAK.2|GVDDLDFFIGDEAIEKPTYATKWPIR.4|LGYAGNTEPQFIIPSC[CAM]IAIKESAK.3|GVDDLDFFIGDEAIEK.2
SEN / CTL,P01008,Antithrombin-III,SERPINC1,0.49,0.90,8.29E-02,1.84E-02,1.74E+00,"acute inflammatory response to antigenic stimulus,response to nutrient,lactation,blood coagulation,negative regulation of endopeptidase activity,regulation of blood coagulation, intrinsic pathway","protease binding,serine-type endopeptidase inhibitor activity,protein binding,heparin binding","extracellular region,extracellular space,plasma membrane,extracellular exosome,blood microparticle",6,31,70,TSDQIHFFFAK.3|TSDQIHFFFAK.2|FRIEDGFSLK.3|FRIEDGFSLK.2|ANRPFLVFIR.3|ANRPFLVFIR.2|FDTISEK.2|GDDITMVLILPKPEK.4|GDDITMVLILPKPEK.3|GDDITM[Oxi]VLILPKPEK.3|GDDITM[Oxi]VLILPKPEK.2|GDDITMVLILPKPEK.2|LQPLDFK.2|DDLYVSDAFHK.3|DDLYVSDAFHK.2|IEDGFSLK.2|LPGIVAEGR.2|RVWELSK.2|ATEDEGSEQKIPEATNR.4|ATEDEGSEQKIPEATNR.3|DIPM[Oxi]NPMC[CAM]IYR.3|DIPMNPM[Oxi]C[CAM]IYR.3|DIPMNPMC[CAM]IYR.2|DIPM[Oxi]NPMC[CAM]IYR.2|DIPMNPM[Oxi]C[CAM]IYR.2|VAEGTQVLELPFK.3|VAEGTQVLELPFK.2|SKLPGIVAEGRDDLYVSDAFHK.5|SKLPGIVAEGRDDLYVSDAFHK.4|SKLPGIVAEGRDDLYVSDAFHK.3|KATEDEGSEQKIPEATNR.4|KATEDEGSEQKIPEATNR.3|ATEDEGSEQKIPEATNRR.4|ATEDEGSEQKIPEATNRR.3|FATTFYQHLADSK.3|FATTFYQHLADSK.2|RVAEGTQVLELPFK.3|LPGIVAEGRDDLYVSDAFHK.4|LQPLDFKENAEQSR.3|LQPLDFKENAEQSR.2|ADGESC[CAM]SASM[Oxi]M[Oxi]YQEGK.3|ADGESC[CAM]SASM[Oxi]MYQEGK.3|ADGESC[CAM]SASMM[Oxi]YQEGK.3|ADGESC[CAM]SASM[Oxi]MYQEGK.2|ADGESC[CAM]SASMM[Oxi]YQEGK.2|ADGESC[CAM]SASMMYQEGK.2|ADGESC[CAM]SASM[Oxi]M[Oxi]YQEGK.2|EQLQDM[Oxi]GLVDLFSPEK.3|EQLQDMGLVDLFSPEK.3|EQLQDM[Oxi]GLVDLFSPEK.2|EQLQDMGLVDLFSPEK.2|VAEGTQVLELPFKGDDITMVLILPKPEK.5|VAEGTQVLELPFKGDDITM[Oxi]VLILPKPEK.4|VAEGTQVLELPFKGDDITMVLILPKPEK.4|VAEGTQVLELPFKGDDITMVLILPKPEK.3|RVAEGTQVLELPFKGDDITMVLILPKPEK.5|RVAEGTQVLELPFKGDDITMVLILPKPEK.4|GDDITMVLILPK.2|ANRPFLVFIREVPLNTIIFMGRVANPC[CAM]VK.5|ADGESC[CAM]SASMMYQEGKFR.3|EVPLNTIIFMGR.2|EVPLNTIIFM[Oxi]GR.2|AFLEVNEEGSEAAASTAVVIAGR.3|AFLEVNEEGSEAAASTAVVIAGR.2|FATTFYQHLADSKNDNDNIFLSPLSISTAFAMTK.5|FATTFYQHLADSKNDNDNIFLSPLSISTAFAM[Oxi]TK.4|FATTFYQHLADSKNDNDNIFLSPLSISTAFAMTK.4|NDNDNIFLSPLSISTAFAMTK.3|NDNDNIFLSPLSISTAFAM[Oxi]TK.3|NDNDNIFLSPLSISTAFAMTK.2
SEN / CTL,P00734,Prothrombin,F2,0.48,0.63,7.29E-02,1.63E-02,1.79E+00,"positive regulation of protein phosphorylation,signal peptide processing,proteolysis,ER to Golgi vesicle-mediated transport,acute-phase response,cell surface receptor signaling pathway,multicellular organism development,blood coagulation,blood coagulation, intrinsic pathway,positive regulation of cell proliferation,regulation of cell shape,response to wounding,regulation of gene expression,negative regulation of platelet activation,positive regulation of phosphatidylinositol 3-kinase signaling,peptidyl-glutamic acid carboxylation,platelet activation,regulation of blood coagulation,positive regulation of blood coagulation,positive regulation of cell growth,positive regulation of collagen biosynthetic process,fibrinolysis,cellular protein metabolic process,negative regulation of proteolysis,negative regulation of astrocyte differentiation,leukocyte migration,positive regulation of release of sequestered calcium ion into cytosol,regulation of cytosolic calcium ion concentration,negative regulation of fibrinolysis,positive regulation of lipid kinase activity,positive regulation of protein localization to nucleus,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,positive regulation of reactive oxygen species metabolic process","serine-type endopeptidase activity,receptor binding,calcium ion binding,protein binding,growth factor activity,thrombospondin receptor activity","extracellular region,extracellular space,endoplasmic reticulum lumen,Golgi lumen,plasma membrane,extracellular exosome,blood microparticle",6,42,86,SPQELLC[CAM]GASLISDR.2|SPQELLC[CAM]GASLISDR.3|KSPQELLC[CAM]GASLISDR.3|KSPQELLC[CAM]GASLISDR.4|KSPQELLC[CAM]GASLISDR.2|VIDQFGE.2|ENLDRDIALMK.3|ENLDRDIALMK.2|VTGWGNLK.2|ITDNMFC[CAM]AGYKPDEGK.4|ITDNMFC[CAM]AGYKPDEGK.3|ITDNM[Oxi]FC[CAM]AGYKPDEGK.3|TFGSGEADC[CAM]GLRPLFEK.4|TFGSGEADC[CAM]GLRPLFEK.3|TFGSGEADC[CAM]GLRPLFEK.2|RQEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.5|RQEC[CAM]SIPVC[CAM]GQDQVTVAM[Oxi]TPR.3|RQEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.3|YTAC[CAM]ETAR.2|HQDFNSAVQLVENFC[CAM]R.4|HQDFNSAVQLVENFC[CAM]R.3|HQDFNSAVQLVENFC[CAM]R.2|ETWTANVGK.2|ITDNMFC[CAM]AGYKPDEGKR.4|ITDNM[Oxi]FC[CAM]AGYKPDEGKR.4|ITDNMFC[CAM]AGYKPDEGKR.3|ITDNM[Oxi]FC[CAM]AGYKPDEGKR.3|TFGSGEADC[CAM]GLRPLFEKK.4|TFGSGEADC[CAM]GLRPLFEKK.3|GDAC[CAM]EGDSGGPFVMK.3|GDAC[CAM]EGDSGGPFVMK.2|GDAC[CAM]EGDSGGPFVM[Oxi]K.2|KPVAFSDYIHPVC[CAM]LPDR.4|KPVAFSDYIHPVC[CAM]LPDR.3|SEGSSVNLSPPLEQC[CAM]VPDR.4|SEGSSVNLSPPLEQC[CAM]VPDR.3|SEGSSVNLSPPLEQC[CAM]VPDR.2|TATSEYQTFFNPR.3|TATSEYQTFFNPR.2|NPDSSTTGPWC[CAM]YTTDPTVR.4|NPDSSTTGPWC[CAM]YTTDPTVR.3|NPDSSTTGPWC[CAM]YTTDPTVR.2|SLEDKTERELLESYIDGR.4|SLEDKTERELLESYIDGR.3|DKLAAC[CAM]LEGNC[CAM]AEGLGTNYR.4|DKLAAC[CAM]LEGNC[CAM]AEGLGTNYR.3|DKLAAC[CAM]LEGNC[CAM]AEGLGTNYR.2|KSLEDKTER.2|GQPSVLQVVNLPIVERPVC[CAM]K.4|GQPSVLQVVNLPIVERPVC[CAM]K.3|GQPSVLQVVNLPIVERPVC[CAM]K.2|LKKPVAFSDYIHPVC[CAM]LPDR.4|LKKPVAFSDYIHPVC[CAM]LPDR.3|RGDAC[CAM]EGDSGGPFVM[Oxi]K.3|RGDAC[CAM]EGDSGGPFVMK.3|RGDAC[CAM]EGDSGGPFVMK.2|SGIEC[CAM]QLWR.2|GQPSVLQVVNLPIVER.3|GQPSVLQVVNLPIVER.2|YGFYTHVFR.2|ELLESYIDGR.2|WYQMGIVSWGEGC[CAM]DR.3|WYQMGIVSWGEGC[CAM]DR.2|VTGWGNLKETWTANVGK.3|ETAASLLQAGYK.2|PVAFSDYIHPVC[CAM]LPDR.3|KPVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.5|KPVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.4|LAAC[CAM]LEGNC[CAM]AEGLGTNYR.3|LAAC[CAM]LEGNC[CAM]AEGLGTNYR.2|WVLTAAHC[CAM]LLYPPWDK.3|WVLTAAHC[CAM]LLYPPWDK.2|LAVTTHGLPC[CAM]LAWASAQAK.3|LAVTTHGLPC[CAM]LAWASAQAK.2|LKKPVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.5|IVEGSDAEIGMSPWQVMLFR.3|IVEGSDAEIGM[Oxi]SPWQVMLFR.3|IVEGSDAEIGMSPWQVM[Oxi]LFR.3|IVEGSDAEIGM[Oxi]SPWQVMLFR.2|IVEGSDAEIGMSPWQVM[Oxi]LFR.2|IVEGSDAEIGMSPWQVMLFR.2|QEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.3|QEC[CAM]SIPVC[CAM]GQDQVTVAMTPR.2|PVAFSDYIHPVC[CAM]LPDRETAASLLQAGYK.4|NPDGDEEGVWC[CAM]YVAGK.2|SEGSSVNLSPPLEQC[CAM]VPDRGQQYQGR.3
SEN / CTL,O00622,Protein CYR61,CYR61,0.45,0.77,1.88E-02,4.83E-03,2.32E+00,"regulation of cell growth,osteoblast differentiation,positive regulation of protein phosphorylation,intussusceptive angiogenesis,atrioventricular valve morphogenesis,apoptotic process involved in heart morphogenesis,ventricular septum development,chemotaxis,cell adhesion,cell-cell signaling,cell proliferation,anatomical structure morphogenesis,positive regulation of phospholipase activity,positive regulation of cell-substrate adhesion,extracellular matrix organization,positive regulation of cell migration,positive regulation of BMP signaling pathway,positive regulation of osteoblast proliferation,negative regulation of apoptotic process,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,wound healing, spreading of cells,positive regulation of osteoblast differentiation,positive regulation of protein kinase activity,positive regulation of transcription from RNA polymerase II promoter,atrial septum morphogenesis,negative regulation of cell death,chondroblast differentiation,chorio-allantoic fusion,labyrinthine layer blood vessel development,positive regulation of cartilage development,regulation of ERK1 and ERK2 cascade,reactive oxygen species metabolic process,positive regulation of ceramide biosynthetic process","integrin binding,insulin-like growth factor binding,heparin binding,extracellular matrix binding","proteinaceous extracellular matrix,extracellular matrix",9,17,20,GLEC[CAM]NFGASSTALK.2|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.4|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.3|HQC[CAM]TC[CAM]IDGAVGC[CAM]IPLC[CAM]PQELSLPNLGC[CAM]PNPR.5|C[CAM]APGVGLVR.2|NNELIAVGK.2|AQSEGRPC[CAM]EYNSR.3|C[CAM]C[CAM]TPQLTR.2|C[CAM]EDGETFSK.2|YC[CAM]GSC[CAM]VDGR.2|VTNDNPEC[CAM]R.2|NVMMIQSC[CAM]K.2|NVMM[Oxi]IQSC[CAM]K.2|FTYAGC[CAM]LSVK.2|IC[CAM]EVRPC[CAM]GQPVYSSLK.3|FRC[CAM]EDGETFSK.2|C[CAM]NYNC[CAM]PHANEAAFPFYR.3|ELGFDASEVELTR.2|C[CAM]IVQTTSWSQC[CAM]SK.2|IYQNGESFQPNC[CAM]K.2
SEN / CTL,P20742,Pregnancy zone protein,PZP,0.43,0.84,1.27E-01,2.71E-02,1.57E+00,"female pregnancy,negative regulation of endopeptidase activity","endopeptidase inhibitor activity,serine-type endopeptidase inhibitor activity","extracellular region,extracellular exosome,blood microparticle",6,23,26,DLFHC[CAM]VSFTLPR.3|DLFHC[CAM]VSFTLPR.2|SGTHTLPVESGDMK.3|TLLVEAEGIEQEK.3|TLLVEAEGIEQEK.2|VVVQTESGGR.2|IREEGTDLEVTANR.3|ISEITNIVSK.2|IQHPFTVEEFVLPK.3|SLFTDLVAEK.2|YNILPEKEDSPFALK.3|ASPAFLASQNTK.2|AVGYLITGYQR.2|GSFALSFPVESDVAPIAR.3|GSFALSFPVESDVAPIAR.2|HQDGSYSTFGER.2|MLQITNTGFEMK.2|VFSLSGSYIHLEPVAGTLPC[CAM]GHTETITAHYTLNR.5|LEAGINQLSFPLSSEPIQGSYR.3|NELIPLIYLENPR.2|QQNAQGGFSSTQDTVVALHALSR.3|NALFC[CAM]LESAWNVAK.2|QGIPFFAQVLLVDGK.2|VDLSFSPAQSPPASHAHLQVAAAPQSLC[CAM]ALR.4|DLTNFPDNVDQQEEEQGHC[CAM]PR.3|PYVPQLGTYNVIPLNNEQSSGPVPETVR.3
SEN / CTL,Q9BRK5,45 kDa calcium-binding protein,SDF4,0.43,1.86,4.44E-02,1.05E-02,1.98E+00,"UV protection,calcium ion regulated exocytosis,cerebellum development,fat cell differentiation,response to ethanol,zymogen granule exocytosis","calcium ion binding,identical protein binding","cytoplasm,late endosome,Golgi apparatus,Golgi lumen,membrane,bleb,extracellular exosome,plasma membrane",9,20,30,WYQADSPPADLLLTEEEFLSFLHPEHSR.4|DLGGFDEDAEPR.2|AVDPDGDGHVSWDEYK.3|AVDPDGDGHVSWDEYK.2|GHSEKEVADAIR.3|GHSEKEVADAIR.2|VDVNTDRK.2|DLGGFDEDAEPRR.3|DLGGFDEDAEPRR.2|TAEHFQEAMEESK.3|TAEHFQEAM[Oxi]EESK.3|TAEHFQEAMEESK.2|VANREENEILPPDHLNGVK.4|VANREENEILPPDHLNGVK.3|VANREENEILPPDHLNGVKLEMDGHLNR.6|YSEFFTGSK.2|LEMDGHLNR.2|EENEILPPDHLNGVK.3|GFHQEVFLGK.2|VDEETQEVLENLKDR.3|QM[Oxi]IAVADENQNHHLEPEEVLK.4|QMIAVADENQNHHLEPEEVLK.4|QMIAVADENQNHHLEPEEVLK.3|LNEELKVDEETQEVLENLKDR.4|LNEELKVDEETQEVLENLKDR.3|EIVRDLDQDGDK.2|DRWYQADSPPADLLLTEEEFLSFLHPEHSR.5|DRWYQADSPPADLLLTEEEFLSFLHPEHSR.4|LNEELKVDEETQEVLENLK.3|VDEETQEVLENLK.2
SEN / CTL,P18065,Insulin-like growth factor-binding protein 2,IGFBP2,0.42,1.23,1.72E-02,4.50E-03,2.35E+00,"regulation of cell growth,signal transduction,female pregnancy,aging,response to nutrient,response to mechanical stimulus,response to lithium ion,response to estradiol,response to retinoic acid,cellular response to hormone stimulus,positive regulation of activated T cell proliferation,response to drug,regulation of insulin-like growth factor receptor signaling pathway,response to estrogen,cellular protein metabolic process,response to glucocorticoid,negative regulation of canonical Wnt signaling pathway","receptor binding,insulin-like growth factor I binding,insulin-like growth factor II binding","extracellular region,extracellular space,apical plasma membrane,cytoplasmic vesicle,extracellular exosome",15,11,14,TPC[CAM]QQELDQVLER.2|LEGEAC[CAM]GVYTPR.2|MPC[CAM]AELVREPGC[CAM]GC[CAM]C[CAM]SVC[CAM]AR.3|LAAC[CAM]GPPPVAPPAAVAAVAGGAR.2|LAAC[CAM]GPPPVAPPAAVAAVAGGAR.3|GPLEHLYSLHIPNC[CAM]DK.4|GPLEHLYSLHIPNC[CAM]DK.3|LPDERGPLEHLYSLHIPNC[CAM]DK.5|LPDERGPLEHLYSLHIPNC[CAM]DK.4|C[CAM]PPC[CAM]TPER.2|GDPEC[CAM]HLFYNEQQEAR.3|GEC[CAM]WC[CAM]VNPNTGK.2|LIQGAPTIRGDPEC[CAM]HLFYNEQQEAR.4|C[CAM]YPHPGSELPLQALVMGEGTC[CAM]EK.3
SEN / CTL,P35908,"Keratin, type II cytoskeletal 2 epidermal",KRT2,0.40,1.24,1.50E-07,1.02E-07,6.99E+00,"keratinocyte development,epidermis development,keratinization,keratinocyte activation,keratinocyte proliferation,intermediate filament organization,keratinocyte migration","structural constituent of cytoskeleton,protein binding,cytoskeletal protein binding","extracellular space,nucleus,cytoplasm,Golgi apparatus,intermediate filament,membrane,keratin filament,intermediate filament cytoskeleton,extracellular exosome",75,54,102,YEELQVTVGR.2|FLEQQNQVLQTK.2|FLEQQNQVLQTK.3|VDLLNQEIEFLK.2|VDLLNQEIEFLK.3|IEISELNR.2|GFSSGSAVVSGGSR.2|NKLNDLEEALQQAKEDLAR.4|NKLNDLEEALQQAKEDLAR.3|NKLNDLEEALQQAKEDLAR.2|LLRDYQELMNVK.3|LLRDYQELMNVK.2|LLRDYQELM[Oxi]NVK.3|HGDSLKEIKIEISELNR.4|HGDSLKEIKIEISELNR.3|HGDSLKEIKIEISELNR.2|NVQDAIADAEQRGEHALKDAR.4|NVQDAIADAEQRGEHALKDAR.3|NKLNDLEEALQQAK.3|NKLNDLEEALQQAK.2|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.4|WELLQQMNVGTRPINLEPIFQGYIDSLKR.4|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.3|WELLQQMNVGTRPINLEPIFQGYIDSLKR.3|YLDGLTAER.2|TSQNSELNNMQDLVEDYKK.3|TSQNSELNNMQDLVEDYKK.4|TSQNSELNNM[Oxi]QDLVEDYKK.3|TSQNSELNNM[Oxi]QDLVEDYKK.2|TSQNSELNNMQDLVEDYKK.2|SKEEAEALYHSKYEELQVTVGR.4|SKEEAEALYHSKYEELQVTVGR.3|VLYDAEISQIHQSVTDTNVILSM[Oxi]DNSR.4|VLYDAEISQIHQSVTDTNVILSMDNSR.4|VLYDAEISQIHQSVTDTNVILSM[Oxi]DNSR.3|VLYDAEISQIHQSVTDTNVILSMDNSR.3|SLVGLGGTK.2|RSTSSFSC[CAM]LSR.3|RSTSSFSC[CAM]LSR.2|HGGGGGGFGGGGFGSR.3|HGGGGGGFGGGGFGSR.2|NVQDAIADAEQR.3|NVQDAIADAEQR.2|TAAENDFVTLKK.3|TAAENDFVTLKK.2|LNDLEEALQQAK.3|LNDLEEALQQAK.2|SKEEAEALYHSK.3|SKEEAEALYHSK.2|GGSISGGGYGSGGGKHSSGGGSR.4|GGSISGGGYGSGGGKHSSGGGSR.3|NVQDAIADAEQRGEHALK.4|NVQDAIADAEQRGEHALK.3|GEHALKDAR.2|LQGEIAHVK.2|HGDSLKEIK.2|VDPEIQNVK.2|GGSSSGGGYGSGGGGSSSVK.3|GGSSSGGGYGSGGGGSSSVK.2|DVDNAYMIK.2|DVDNAYM[Oxi]IK.2|LQGEIAHVKK.2|STSSFSC[CAM]LSR.2|GGSGGGGSISGGGYGSGGGSGGR.3|GGSGGGGSISGGGYGSGGGSGGR.2|GSSSGGGYSSGSSSYGSGGR.3|GSSSGGGYSSGSSSYGSGGR.2|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.4|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.3|HSSGGGSRGGSSSGGGYGSGGGGSSSVK.2|EEAEALYHSK.2|GGSISGGGYGSGGGK.2|KDVDNAYMIK.2|KDVDNAYM[Oxi]IK.2|RYLDGLTAER.2|TSQNSELNNMQDLVEDYKKK.4|TSQNSELNNMQDLVEDYKKK.3|TAAENDFVTLK.2|PINLEPIFQGYIDSLK.3|SISISVAGGGGGFGAAGGFGGR.3|SISISVAGGGGGFGAAGGFGGR.2|YGSGGGSKGGSISGGGYGSGGGK.3|LNDLEEALQQAKEDLAR.3|LNDLEEALQQAKEDLAR.2|PINLEPIFQGYIDSLKR.3|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.6|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.5|FGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVK.4|TSQNSELNNM[Oxi]QDLVEDYK.3|TSQNSELNNMQDLVEDYK.3|TSQNSELNNM[Oxi]QDLVEDYK.2|TSQNSELNNMQDLVEDYK.2|QSGSRGGSGGGGSISGGGYGSGGGSGGR.3|QSGSRGGSGGGGSISGGGYGSGGGSGGR.2|GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR.3|GGGFGGGSSFGGGSGFSGGGFGGGGFGGGR.2|M[Oxi]SGDLSSNVTVSVTSSTISSNVASK.3|MSGDLSSNVTVSVTSSTISSNVASK.3|WELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLK.4|AAFGGSGGRGSSSGGGYSSGSSSYGSGGR.3|FLEQQNQVLQTKWELLQQM[Oxi]NVGTRPINLEPIFQGYIDSLKR.5|FLEQQNQVLQTKWELLQQMNVGTRPINLEPIFQGYIDSLKR.5
SEN / CTL,P13645,"Keratin, type I cytoskeletal 10",KRT10,0.37,1.44,5.45E-05,2.67E-05,4.57E+00,keratinocyte differentiation,structural constituent of epidermis,"extracellular space,nucleus,cytoplasm,intermediate filament,membrane,extracellular exosome",120,51,100,TIDDLKNQILNLTTDNANILLQIDNAR.4|TIDDLKNQILNLTTDNANILLQIDNAR.3|IRLENEIQTYR.3|IRLENEIQTYR.2|LKYENEVALR.3|LKYENEVALR.2|GSSGGGC[CAM]FGGSSGGYGGLGGFGGGSFR.2|GSSGGGC[CAM]FGGSSGGYGGLGGFGGGSFR.3|YC[CAM]VQLSQIQAQISALEEQLQQIR.3|YC[CAM]VQLSQIQAQISALEEQLQQIR.4|DAEAWFNEK.2|GSLGGGFSSGGFSGGSFSR.2|GSLGGGFSSGGFSGGSFSR.3|VLDELTLTKADLEM[Oxi]QIESLTEELAYLKK.4|VLDELTLTKADLEMQIESLTEELAYLKK.4|VLDELTLTKADLEM[Oxi]QIESLTEELAYLKK.5|VLDELTLTKADLEMQIESLTEELAYLKK.3|AETEC[CAM]QNTEYQQLLDIK.2|AETEC[CAM]QNTEYQQLLDIK.3|ALEESNYELEGK.2|ALEESNYELEGK.3|QSLEASLAETEGR.2|QSLEASLAETEGR.3|SQYEQLAEQNRKDAEAWFNEK.4|SQYEQLAEQNRKDAEAWFNEK.3|VLDELTLTK.2|NVSTGDVNVEMNAAPGVDLTQLLNNMR.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNMR.3|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNM[Oxi]R.3|NVSTGDVNVEMNAAPGVDLTQLLNNMR.4|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNMR.4|NVSTGDVNVEM[Oxi]NAAPGVDLTQLLNNM[Oxi]R.4|NVSTGDVNVEMNAAPGVDLTQLLNNM[Oxi]R.3|QSVEADINGLRR.3|QSVEADINGLRR.2|SKELTTEIDNNIEQISSYK.3|SKELTTEIDNNIEQISSYK.2|SLLEGEGSSGGGGR.2|SLLEGEGSSGGGGR.3|ADLEM[Oxi]QIESLTEELAYLK.3|ADLEMQIESLTEELAYLK.3|ADLEMQIESLTEELAYLK.2|ADLEM[Oxi]QIESLTEELAYLK.2|ADLEM[Oxi]QIESLTEELAYLKK.3|ADLEM[Oxi]QIESLTEELAYLKK.4|ADLEMQIESLTEELAYLKK.4|ADLEMQIESLTEELAYLKK.3|ADLEM[Oxi]QIESLTEELAYLKK.2|ADLEMQIESLTEELAYLKK.2|NQILNLTTDNANILLQIDNAR.3|NQILNLTTDNANILLQIDNAR.2|YYKTIDDLKNQILNLTTDNANILLQIDNAR.4|ELTTEIDNNIEQISSYKSEITELRR.4|ELTTEIDNNIEQISSYKSEITELRR.3|ISSSKGSLGGGFSSGGFSGGSFSR.3|SKELTTEIDNNIEQISSYKSEITELR.4|SKELTTEIDNNIEQISSYKSEITELR.3|QSVEADINGLR.3|QSVEADINGLR.2|KDAEAWFNEK.3|KDAEAWFNEK.2|SEITELR.2|NHEEEMKDLR.3|NHEEEM[Oxi]KDLR.3|NHEEEMKDLR.2|NHEEEM[Oxi]KDLR.2|YSSSKHYSSSR.3|SQYEQLAEQNR.3|SQYEQLAEQNR.2|NHEEEMK.2|KNHEEEMKDLR.3|KNHEEEM[Oxi]KDLR.3|KNHEEEMKDLR.2|IKEWYEK.2|SEITELRR.2|SQYEQLAEQNRK.3|SQYEQLAEQNRK.2|SSSSGSVGESSSKGPR.3|YENEVALR.2|SGGGGGGGGC[CAM]GGGGGVSSLR.3|SGGGGGGGGC[CAM]GGGGGVSSLR.2|IKEWYEKHGNSHQGEPR.4|IKEWYEKHGNSHQGEPR.3|KNHEEEMK.2|VRALEESNYELEGK.3|VRALEESNYELEGK.2|HGNSHQGEPR.2|HYSSSRSGGGGGGGGC[CAM]GGGGGVSSLR.4|HYSSSRSGGGGGGGGC[CAM]GGGGGVSSLR.3|LENEIQTYR.2|ALEESNYELEGKIKEWYEK.4|RVLDELTLTK.2|SSSSGSVGESSSK.2|NVQALEIELQSQLALK.3|NVQALEIELQSQLALK.2|ELTTEIDNNIEQISSYK.3|ELTTEIDNNIEQISSYK.2|ELTTEIDNNIEQISSYKSEITELR.4|ELTTEIDNNIEQISSYKSEITELR.3|NVQALEIELQSQLALKQSLEASLAETEGR.4
SEN / CTL,P54727,UV excision repair protein RAD23 homolog B,RAD23B,0.36,1.82,6.80E-02,1.54E-02,1.81E+00,"nucleotide-excision repair, DNA damage recognition,nucleotide-excision repair, DNA duplex unwinding,nucleotide-excision repair,nucleotide-excision repair, preincision complex assembly,spermatogenesis,regulation of proteasomal ubiquitin-dependent protein catabolic process,proteasome-mediated ubiquitin-dependent protein catabolic process,embryonic organ development,global genome nucleotide-excision repair","damaged DNA binding,single-stranded DNA binding,protein binding,polyubiquitin binding","proteasome complex,nucleus,nucleoplasm,cytoplasm,XPC complex",6,20,33,QIIQQNPSLLPALLQQIGR.3|QIIQQNPSLLPALLQQIGR.4|QIIQQNPSLLPALLQQIGR.2|ESQAVVDPPQAASTGAPQSSAVAAAAATTTATTTTTSSGGHPLEFLR.4|ESQAVVDPPQAASTGAPQSSAVAAAAATTTATTTTTSSGGHPLEFLR.5|NFVVVMVTKPK.3|NFVVVMVTKPK.2|EQVIAALR.2|ASFNNPDR.2|ILNDDTALKEYK.3|ILNDDTALKEYKIDEK.4|ILNDDTALKEYKIDEK.3|ILNDDTALK.2|GKDAFPVAGQK.2|IDIDPEETVK.2|NQPQFQQMR.2|NQPQFQQM[Oxi]R.2|PAEKPAETPVATSPTATDSTSGDSSR.4|PAEKPAETPVATSPTATDSTSGDSSR.3|NENLAANFLLQQNFDED.3|NENLAANFLLQQNFDED.2|ALGFPEGLVIQAYFAC[CAM]EK.3|ALGFPEGLVIQAYFAC[CAM]EK.2|PAETPVATSPTATDSTSGDSSR.3|PAETPVATSPTATDSTSGDSSR.2|TLQQQTFKIDIDPEETVK.3|TLQQQTFKIDIDPEETVK.2|AVEYLLM[Oxi]GIPGDR.2|AVEYLLMGIPGDR.2|QEKPAEKPAETPVATSPTATDSTSGDSSR.4|QEKPAEKPAETPVATSPTATDSTSGDSSR.3|ASFNNPDRAVEYLLMGIPGDR.3|IESEKGKDAFPVAGQK.2
SEN / CTL,P07437,Tubulin beta chain,TUBB,0.34,1.12,3.86E-13,6.38E-13,1.22E+01,"G2/M transition of mitotic cell cycle,movement of cell or subcellular component,microtubule-based process,cellular process,cytoskeleton-dependent intracellular transport,natural killer cell mediated cytotoxicity,spindle assembly,cell division","GTPase activity,structural molecule activity,structural constituent of cytoskeleton,protein binding,GTP binding,protein domain specific binding,ubiquitin protein ligase binding,protein complex binding,GTPase activating protein binding,MHC class I protein binding","extracellular region,nucleus,nuclear envelope lumen,cytoskeleton,microtubule,extracellular matrix,cytoplasmic ribonucleoprotein granule,protein complex,cell body,extracellular exosome",57,20,59,YLTVAAVFR.2|NSSYFVEWIPNNVK.2|NSSYFVEWIPNNVK.3|AILVDLEPGTMDSVR.2|AILVDLEPGTMDSVR.3|AILVDLEPGTM[Oxi]DSVR.3|AILVDLEPGTM[Oxi]DSVR.2|SGPFGQIFRPDNFVFGQSGAGNNWAK.3|SGPFGQIFRPDNFVFGQSGAGNNWAK.4|MREIVHIQAGQC[CAM]GNQIGAK.4|MREIVHIQAGQC[CAM]GNQIGAK.3|M[Oxi]REIVHIQAGQC[CAM]GNQIGAK.4|M[Oxi]REIVHIQAGQC[CAM]GNQIGAK.3|MREIVHIQAGQC[CAM]GNQIGAK.2|LHFFMPGFAPLTSR.3|LHFFMPGFAPLTSR.4|LHFFM[Oxi]PGFAPLTSR.3|LHFFM[Oxi]PGFAPLTSR.2|LHFFMPGFAPLTSR.2|LAVNMVPFPR.2|LAVNM[Oxi]VPFPR.2|LAVNMVPFPR.1|GHYTEGAELVDSVLDVVR.3|GHYTEGAELVDSVLDVVR.4|GHYTEGAELVDSVLDVVR.2|LTTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|LTTPTYGDLNHLVSATMSGVTTC[CAM]LR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.4|LTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.3|ISVYYNEATGGK.2|ISVYYNEATGGK.3|GHYTEGAELVDSVLDVVRK.4|GHYTEGAELVDSVLDVVRK.3|GHYTEGAELVDSVLDVVRK.2|FWEVISDEHGIDPTGTYHGDSDLQLDR.4|FWEVISDEHGIDPTGTYHGDSDLQLDR.5|FWEVISDEHGIDPTGTYHGDSDLQLDR.3|TLKLTTPTYGDLNHLVSATMSGVTTC[CAM]LR.4|TLKLTTPTYGDLNHLVSATM[Oxi]SGVTTC[CAM]LR.4|TLKLTTPTYGDLNHLVSATMSGVTTC[CAM]LR.3|KLAVNMVPFPR.3|KLAVNM[Oxi]VPFPR.3|KLAVNMVPFPR.2|MAVTFIGNSTAIQELFKR.3|MAVTFIGNSTAIQELFKR.4|M[Oxi]AVTFIGNSTAIQELFKR.3|M[Oxi]AVTFIGNSTAIQELFKR.2|MAVTFIGNSTAIQELFKR.2|ALTVPELTQQVFDAK.3|ALTVPELTQQVFDAK.2|ISVYYNEATGGKYVPR.3|MAVTFIGNSTAIQELFK.3|M[Oxi]AVTFIGNSTAIQELFK.3|MAVTFIGNSTAIQELFK.2|M[Oxi]AVTFIGNSTAIQELFK.2|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPR.7|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGKYVPR.5|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGK.5|FWEVISDEHGIDPTGTYHGDSDLQLDRISVYYNEATGGK.4
SEN / CTL,P09936,Ubiquitin carboxyl-terminal hydrolase isozyme L1,UCHL1,0.33,2.19,1.47E-02,3.91E-03,2.41E+00,"response to ischemia,axon target recognition,adult walking behavior,cell proliferation,regulation of macroautophagy,protein deubiquitination,sensory perception of pain,axonal transport of mitochondrion,eating behavior,proteasome-mediated ubiquitin-dependent protein catabolic process,negative regulation of MAP kinase activity,muscle fiber development,neuromuscular process","cysteine-type endopeptidase activity,thiol-dependent ubiquitin-specific protease activity,omega peptidase activity,ligase activity,ubiquitin protein ligase binding,alpha-2A adrenergic receptor binding,ubiquitin binding","nucleoplasm,cytoplasm,endoplasmic reticulum membrane,cytosol,neuronal cell body,myelin sheath,neuron projection terminus,extracellular exosome,axon cytoplasm,plasma membrane",30,20,39,C[CAM]FEKNEAIQAAHDAVAQEGQC[CAM]R.4|C[CAM]FEKNEAIQAAHDAVAQEGQC[CAM]R.3|MPFPVNHGASSEDTLLKDAAK.4|MPFPVNHGASSEDTLLKDAAK.3|M[Oxi]PFPVNHGASSEDTLLKDAAK.4|MQLKPMEINPEMLNK.3|MQLKPMEINPEMLNK.2|M[Oxi]QLKPMEINPEMLNK.3|MQLKPM[Oxi]EINPEMLNK.3|MQLKPMEINPEM[Oxi]LNK.3|MQLKPM[Oxi]EINPEMLNK.2|QTIGNSC[CAM]GTIGLIHAVANNQDKLGFEDGSVLK.4|QTIGNSC[CAM]GTIGLIHAVANNQDKLGFEDGSVLK.3|LGVAGQWR.2|EFTEREQGEVR.3|NEAIQAAHDAVAQEGQC[CAM]R.3|NEAIQAAHDAVAQEGQC[CAM]R.4|NEAIQAAHDAVAQEGQC[CAM]R.2|KQIEELKGQEVSPK.4|KQIEELKGQEVSPK.3|FSAVALC[CAM]K.2|VC[CAM]REFTEREQGEVR.4|VC[CAM]REFTEREQGEVR.3|QFLSETEK.2|QIEELKGQEVSPK.3|QIEELKGQEVSPK.2|LGFEDGSVLK.2|VDDKVNFHFILFNNVDGHLYELDGR.5|VDDKVNFHFILFNNVDGHLYELDGR.4|NEAIQAAHDAVAQEGQC[CAM]RVDDK.4|MPFPVNHGASSEDTLLK.3|M[Oxi]PFPVNHGASSEDTLLK.3|MPFPVNHGASSEDTLLK.2|VNFHFILFNNVDGHLYELDGR.4|VNFHFILFNNVDGHLYELDGR.3|PMEINPEMLNK.2|QTIGNSC[CAM]GTIGLIHAVANNQDK.3|QTIGNSC[CAM]GTIGLIHAVANNQDK.2|FVDVLGLEEESLGSVPAPAC[CAM]ALLLLFPLTAQHENFRK.4
SEN / CTL,O00469,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",PLOD2,0.31,1.64,2.40E-01,4.86E-02,1.31E+00,"response to hypoxia,cellular protein modification process,oxidation-reduction process","iron ion binding,procollagen-lysine 5-dioxygenase activity,L-ascorbic acid binding","endoplasmic reticulum,endoplasmic reticulum membrane,rough endoplasmic reticulum membrane,extracellular exosome",9,33,47,YLNSGGFIGYAPYVNR.2|AC[CAM]DELVEEMEHYGK.3|GFALLNFVVK.2|LTHLHEGLPVK.3|LTHLHEGLPVK.2|DKLDPDMALC[CAM]R.3|VFAGYYTK.2|LLVITVATK.2|VYIDPLKR.2|EFIAPVTLK.2|IVGPEENLSQAEAR.3|IVGPEENLSQAEAR.2|NMGMDFC[CAM]R.2|YIAVSFIDP.2|VVFAADGILWPDKR.3|VLGQGEEWR.2|IFQTLNGAVDEVVLK.3|IFQTLNGAVDEVVLK.2|QVDLENVWLHFIR.3|GGDGINSIGGGQK.2|ISGGYENVPTDDIHMK.3|ISGGYENVPTDDIHM[Oxi]K.3|ISGGYENVPTDDIHMK.2|VGVWNVPYMANVYLIK.3|VGVWNVPYM[Oxi]ANVYLIK.3|VGVWNVPYM[Oxi]ANVYLIK.2|VGVWNVPYMANVYLIK.2|C[CAM]KIFQTLNGAVDEVVLKFENGK.4|NTFYETLPVAINGNGPTK.3|NTFYETLPVAINGNGPTK.2|RYLNSGGFIGYAPYVNR.3|RYLNSGGFIGYAPYVNR.2|SLRPHHDASTFTINIALNNVGEDFQGGGC[CAM]K.5|SLRPHHDASTFTINIALNNVGEDFQGGGC[CAM]K.4|LWSNFWGALSPDGYYAR.3|LWSNFWGALSPDGYYAR.2|SEDYVDIVQGNR.2|AKNTFYETLPVAINGNGPTK.3|VVFAADGILWPDK.2|FLDILLTLDYPK.2|IFQTLNGAVDEVVLKFENGK.3|IFQTLNGAVDEVVLKFENGK.2|VLGQGEEWRGGDGINSIGGGQK.3|NMGMDFC[CAM]RQDEK.2|IVQQWNLQDNDDDQLFYTK.3|IVQQWNLQDNDDDQLFYTK.2|IFTENIVEQPC[CAM]PDVFWFPIFSEK.3
SEN / CTL,P01024,Complement C3,C3,0.31,1.57,5.90E-06,3.25E-06,5.49E+00,"positive regulation of type IIa hypersensitivity,positive regulation of protein phosphorylation,positive regulation of activation of membrane attack complex,proteolysis,fatty acid metabolic process,inflammatory response,immune response,complement activation,complement activation, alternative pathway,complement activation, classical pathway,signal transduction,G-protein coupled receptor signaling pathway,positive regulation of vascular endothelial growth factor production,positive regulation of glucose transport,regulation of triglyceride biosynthetic process,positive regulation of lipid storage,negative regulation of endopeptidase activity,regulation of complement activation,positive regulation of G-protein coupled receptor protein signaling pathway,positive regulation of angiogenesis,regulation of immune response,positive regulation of apoptotic cell clearance","serine-type endopeptidase activity,endopeptidase inhibitor activity,receptor binding,protein binding,C5L2 anaphylatoxin chemotactic receptor binding","extracellular region,extracellular space,plasma membrane,extracellular exosome,blood microparticle",39,130,202,YYGGGYGSTQATFMVFQALAQYQK.3|GYTQQLAFR.2|SGIPIVTSPYQIHFTK.3|SGIPIVTSPYQIHFTK.2|EPGQDLVVLPLSITTDFIPSFR.3|GQGTLSVVTMYHAK.3|TIYTPGSTVLYR.2|DFDFVPPVVR.2|SEETKENEGFTVTAEGK.3|SEETKENEGFTVTAEGK.2|ILLQGTPVAQMTEDAVDAER.3|ILLQGTPVAQM[Oxi]TEDAVDAER.3|ILLQGTPVAQM[Oxi]TEDAVDAER.2|ILLQGTPVAQMTEDAVDAER.2|AGDFLEANYMNLQR.2|AGDFLEANYM[Oxi]NLQR.3|AGDFLEANYMNLQR.3|AGDFLEANYM[Oxi]NLQR.2|VQLSNDFDEYIMAIEQTIK.3|VQLSNDFDEYIM[Oxi]AIEQTIK.3|VQLSNDFDEYIM[Oxi]AIEQTIK.2|VQLSNDFDEYIMAIEQTIK.2|LSINTHPSQKPLSITVR.4|LSINTHPSQKPLSITVR.3|LSINTHPSQKPLSITVR.2|VRVELLHNPAFC[CAM]SLATTK.4|VRVELLHNPAFC[CAM]SLATTK.3|AAVYHHFISDGVRK.4|AAVYHHFISDGVRK.3|FYHPEKEDGKLNK.4|FYHPEKEDGKLNK.3|IHWESASLLR.3|IHWESASLLR.2|KGYTQQLAFR.3|KGYTQQLAFR.2|SVQLTEK.2|TFISPIK.2|VTIKPAPETEK.3|VTIKPAPETEK.2|ASHLGLAR.2|KVLLDGVQNPR.3|KVLLDGVQNPR.2|FYHPEKEDGK.3|VVLVAVDK.2|TRFISLGEAC[CAM]K.3|QGALELIK.2|QLANGVDR.2|SGSDEVQVGQQR.3|SGSDEVQVGQQR.2|VVLVAVDKGVFVLNKK.4|VVLVAVDKGVFVLNKK.3|ISLPESLK.2|LMNIFLK.2|NEQVEIR.2|RIPIEDGSGEVVLSRK.4|RIPIEDGSGEVVLSRK.3|APSTWLTAYVVK.3|APSTWLTAYVVK.2|AVLYNYR.2|IWDVVEK.2|KLVLSSEK.2|KQELSEAEQATR.3|KQELSEAEQATR.2|VHQYFNVELIQPGAVK.4|VHQYFNVELIQPGAVK.3|VHQYFNVELIQPGAVK.2|SSLSVPYVIVPLK.3|SSLSVPYVIVPLK.2|TRFISLGEAC[CAM]KK.3|TRFISLGEAC[CAM]KK.2|VSHSEDDC[CAM]LAFK.3|VSHSEDDC[CAM]LAFK.2|VTIKPAPETEKRPQDAK.4|VTIKPAPETEKRPQDAK.3|EALKLEEK.2|GLEVTITAR.2|KVLLDGVQNPRAEDLVGK.4|KVLLDGVQNPRAEDLVGK.3|AAVYHHFISDGVR.3|AAVYHHFISDGVR.2|IPIEDGSGEVVLSR.3|IPIEDGSGEVVLSR.2|IRYYTYLIMNK.3|IRYYTYLIM[Oxi]NK.3|KVFLDC[CAM]C[CAM]NYITELRR.4|PNLSYIIGK.2|RAPSTWLTAYVVK.3|RAPSTWLTAYVVK.2|TGLQEVEVK.2|LVAYYTLIGASGQR.3|LVAYYTLIGASGQR.2|FISLGEAC[CAM]K.2|LKGPLLNKFLTTAK.3|RQGALELIK.2|ADIGC[CAM]TPGSGK.2|DSC[CAM]VGSLVVK.2|KC[CAM]C[CAM]EDGMR.2|IPIEDGSGEVVLSRK.3|VVLVAVDKGVFVLNK.3|RIPIEDGSGEVVLSR.3|RIPIEDGSGEVVLSR.2|TKKQELSEAEQATR.3|FVTVQATFGTQVVEK.3|FVTVQATFGTQVVEK.2|LDKAC[CAM]EPGVDYVYK.3|NTLIIYLDK.2|TVMVNIENPEGIPVK.3|TVM[Oxi]VNIENPEGIPVK.2|TVMVNIENPEGIPVK.2|SYTVAIAGYALAQMGR.3|SYTVAIAGYALAQM[Oxi]GR.3|SYTVAIAGYALAQM[Oxi]GR.2|SYTVAIAGYALAQMGR.2|VLLDGVQNPR.2|VYAYYNLEESC[CAM]TR.3|VYAYYNLEESC[CAM]TR.2|LESEETMVLEAHDAQGDVPVTVTVHDFPGKK.6|LESEETMVLEAHDAQGDVPVTVTVHDFPGKK.5|LSINTHPSQK.2|FYYIYNEK.2|VFLDC[CAM]C[CAM]NYITELR.3|VFLDC[CAM]C[CAM]NYITELR.2|QPSSAFAAFVK.2|KGYTQQLAFRQPSSAFAAFVK.4|GYTQQLAFRQPSSAFAAFVKR.4|DIC[CAM]EEQVNSLPGSITK.3|DIC[CAM]EEQVNSLPGSITK.2|SDDKVTLEER.2|VELLHNPAFC[CAM]SLATTK.3|VELLHNPAFC[CAM]SLATTK.2|SNLDEDIIAEENIVSR.3|SNLDEDIIAEENIVSR.2|VLLDGVQNPRAEDLVGK.3|YYTYLIMNK.2|YYTYLIM[Oxi]NK.2|KVFLDC[CAM]C[CAM]NYITELR.3|HYLMWGLSSDFWGEK.3|VFLDC[CAM]C[CAM]NYITELRR.3|EYVLPSFEVIVEPTEK.3|EYVLPSFEVIVEPTEK.2|NTMILEIC[CAM]TR.2|NTM[Oxi]ILEIC[CAM]TR.2|QELSEAEQATR.2|TELRPGETLNVNFLLR.3|TELRPGETLNVNFLLR.2|SYTVAIAGYALAQMGRLKGPLLNK.4|DSITTWEILAVSMSDKK.3|ENEGFTVTAEGK.2|QKPDGVFQEDAPVIHQEM[Oxi]IGGLR.4|QKPDGVFQEDAPVIHQEMIGGLR.4|QKPDGVFQEDAPVIHQEMIGGLR.3|TMQALPYSTVGNSNNYLHLSVLR.4|TM[Oxi]QALPYSTVGNSNNYLHLSVLR.4|TM[Oxi]QALPYSTVGNSNNYLHLSVLR.3|TMQALPYSTVGNSNNYLHLSVLR.3|AC[CAM]EPGVDYVYK.2|C[CAM]AEENC[CAM]FIQK.2|LESEETMVLEAHDAQGDVPVTVTVHDFPGK.5|LESEETMVLEAHDAQGDVPVTVTVHDFPGK.4|KVEGTAFVIFGIQDGEQR.3|KVEGTAFVIFGIQDGEQR.2|SGQSEDRQPVPGQQMTLK.3|EVVADSVWVDVK.2|EGVQKEDIPPADLSDQVPDTESETR.4|EGVQKEDIPPADLSDQVPDTESETR.3|QVREPGQDLVVLPLSITTDFIPSFR.4|QVREPGQDLVVLPLSITTDFIPSFR.3|AYYENSPQQVFSTEFEVK.3|AYYENSPQQVFSTEFEVK.2|DAPDHQELNLDVSLQLPSR.3|QLYNVEATSYALLALLQLK.3|QLYNVEATSYALLALLQLK.2|SEFPESWLWNVEDLKEPPKNGISTK.4|VPVAVQGEDTVQSLTQGDGVAK.3|VPVAVQGEDTVQSLTQGDGVAK.2|AEDLVGKSLYVSATVILHSGSDMVQAER.4|EDIPPADLSDQVPDTESETR.3|EDIPPADLSDQVPDTESETR.2|GYTQQLAFRQPSSAFAAFVK.3|KHYLMWGLSSDFWGEKPNLSYIIGK.4|VFSLAVNLIAIDSQVLC[CAM]GAVK.3|VFSLAVNLIAIDSQVLC[CAM]GAVK.2|SLYVSATVILHSGSDMVQAER.3|PGMPFDLMVFVTNPDGSPAYR.3|SEFPESWLWNVEDLKEPPK.3|NNNEKDMALTAFVLISLQEAK.3|ILLQGTPVAQM[Oxi]TEDAVDAERLK.3|ILLQGTPVAQMTEDAVDAERLK.3|SSLSVPYVIVPLKTGLQEVEVK.3|IRAYYENSPQQVFSTEFEVK.3|DYAGVFSDAGLTFTSSSGQQTAQR.3|DMALTAFVLISLQEAK.2|DTWVEHWPEEDEC[CAM]QDEENQK.3|YFKPGMPFDLMVFVTNPDGSPAYR.3|SEFPESWLWNVEDLK.2|VVLVSLQSGYLFIQTDK.2|HLIVTPSGC[CAM]GEQNMIGM[Oxi]TPTVIAVHYLDETEQWEK.4|HLIVTPSGC[CAM]GEQNMIGMTPTVIAVHYLDETEQWEK.4|NNNEKDM[Oxi]ALTAFVLISLQEAKDIC[CAM]EEQVNSLPGSITK.4|NNNEKDMALTAFVLISLQEAKDIC[CAM]EEQVNSLPGSITK.4|QDSLSSQNQLGVLPLSWDIPELVNM[Oxi]GQWK.3|QDSLSSQNQLGVLPLSWDIPELVNMGQWK.3
SEN / CTL,P12107,Collagen alpha-1(XI) chain,COL11A1,0.31,0.36,2.47E-01,4.99E-02,1.30E+00,"cartilage condensation,ossification,chondrocyte development,proteoglycan metabolic process,visual perception,sensory perception of sound,extracellular matrix organization,collagen fibril organization,collagen catabolic process,endodermal cell differentiation,tendon development,inner ear morphogenesis,embryonic skeletal system morphogenesis,detection of mechanical stimulus involved in sensory perception of sound,ventricular cardiac muscle tissue morphogenesis","extracellular matrix structural constituent,protein binding, bridging,metal ion binding,extracellular matrix binding","extracellular region,collagen type XI trimer,endoplasmic reticulum lumen",3,8,8,SPVFLFEDHTGKPAPEDYPLFR.4|ALDFHNSPEGISK.3|DGLPGHPGQR.2|TLYDGC[CAM]ASR.2|LGVPGLPGYPGR.2|TGPVGPQGPAGKPGPEGLR.3|AIVDTNGITVFGTR.2|GPTISAQEAQAQAILQQAR.2
SEN / CTL,P08572,Collagen alpha-2(IV) chain,COL4A2,0.30,1.08,4.23E-02,1.01E-02,2.00E+00,"angiogenesis,transcription, DNA-templated,negative regulation of angiogenesis,extracellular matrix organization,collagen catabolic process,endodermal cell differentiation,cellular response to transforming growth factor beta stimulus",extracellular matrix structural constituent,"extracellular region,collagen type IV trimer,endoplasmic reticulum lumen,extracellular matrix,intracellular membrane-bounded organelle,extracellular exosome",15,15,19,SVSIGYLLVK.2|FSTMPFLYC[CAM]NPGDVC[CAM]YYASR.3|RGPPGAPGEMGPQGPPGEPGFR.3|GGVSAVPGFRGDEGPIGHQGPIGQEGAPGRPGSPGLPGMPGR.5|GVSGFPGADGIPGHPGQGGPR.3|AHNQDLGLAGSC[CAM]LAR.3|AHNQDLGLAGSC[CAM]LAR.2|AGFPGLPGSPGAR.2|LWSGYSLLYFEGQEK.3|LWSGYSLLYFEGQEK.2|ATPFIEC[CAM]NGGR.2|GLDGYQGPDGPR.2|HSQTDQEPMC[CAM]PVGMNK.3|HSQTDQEPM[Oxi]C[CAM]PVGMNK.3|IAVQPGTVGPQGR.2|GEQGFMGNTGPTGAVGDRGPK.3|C[CAM]SVC[CAM]EAPAIAIAVHSQDVSIPHC[CAM]PAGWR.4|SYWLSTTAPLPMMPVAEDEIKPYISR.3|SYWLSTTAPLPM[Oxi]M[Oxi]PVAEDEIKPYISR.3
SEN / CTL,P04114,Apolipoprotein B-100,APOB,0.29,0.77,7.98E-02,1.77E-02,1.75E+00,"retinoid metabolic process,in utero embryonic development,triglyceride mobilization,receptor-mediated endocytosis,spermatogenesis,nervous system development,cholesterol metabolic process,fertilization,response to virus,response to carbohydrate,post-embryonic development,response to selenium ion,positive regulation of gene expression,positive regulation of macrophage derived foam cell differentiation,positive regulation of lipid storage,positive regulation of cholesterol storage,triglyceride catabolic process,cholesterol transport,flagellated sperm motility,response to lipopolysaccharide,cholesterol efflux,low-density lipoprotein particle remodeling,very-low-density lipoprotein particle assembly,low-density lipoprotein particle clearance,lipoprotein metabolic process,lipoprotein biosynthetic process,lipoprotein catabolic process,cholesterol homeostasis,lipoprotein transport,cellular protein catabolic process,regulation of cholesterol biosynthetic process,artery morphogenesis,leukocyte migration,cellular response to tumor necrosis factor,cellular response to prostaglandin stimulus","protein binding,phospholipid binding,heparin binding,cholesterol transporter activity,lipase binding,low-density lipoprotein particle receptor binding","extracellular region,extracellular space,cytoplasm,early endosome,endoplasmic reticulum lumen,endoplasmic reticulum membrane,Golgi apparatus,cytosol,plasma membrane,endosome membrane,actin cytoskeleton,clathrin-coated endocytic vesicle membrane,endosome lumen,mature chylomicron,chylomicron remnant,very-low-density lipoprotein particle,low-density lipoprotein particle,intermediate-density lipoprotein particle,chylomicron,neuronal cell body,intracellular membrane-bounded organelle,extracellular exosome,endoplasmic reticulum exit site,endocytic vesicle lumen",15,186,272,IEGNLIFDPNNYLPK.2|GFEPTLEALFGK.2|ENFAGEATLQR.2|TEVIPPLIENR.2|KYTYNYEAESSSGVPGTADSR.3|KYTYNYEAESSSGVPGTADSR.2|SEILAHWSPAK.3|SEILAHWSPAK.2|IYSLWEHSTK.3|IYSLWEHSTK.2|ATLYALSHAVNNYHK.4|ATLYALSHAVNNYHK.3|DLKVEDIPLAR.3|DLKVEDIPLAR.2|SHDELPR.2|IISDYHQQFR.3|KGNVATEISTER.3|KGNVATEISTER.2|KLTISEQNIQR.3|KLTISEQNIQR.2|LKQHIEAIDVR.3|VLADKFIIPGLK.3|VRESDEETQIK.3|VRESDEETQIK.2|YGMVAQVTQTLK.3|YGMVAQVTQTLK.2|HVAEAIC[CAM]K.2|IAELSATAQEIIK.3|IAELSATAQEIIK.2|QSFDLSVK.2|EQHLFLPFSYK.3|EQHLFLPFSYK.2|FQFPGKPGIYTR.3|IEDGTLASK.2|YHWEHTGLTLR.3|YHWEHTGLTLR.2|FVTQAEGAK.2|KIISDYHQQFR.3|KIISDYHQQFR.2|LDVTTSIGR.2|SPSQADINK.2|TKNSEEFAAAMSR.3|TKNSEEFAAAMSR.2|QIDDIDVR.2|AHLDIAGSLEGHLR.3|HIQNIDIQHLAGK.3|MGLAFESTK.2|TIHDLHLFIENIDFNK.4|SVGFHLPSR.2|AEPLAFTFSHDYK.3|AEPLAFTFSHDYK.2|LATALSLSNK.2|TGISPLALIK.2|VSTAFVYTK.2|ATVAVYLESLQDTK.3|ATVAVYLESLQDTK.2|LLSGGNTLHLVSTTK.3|LSNVLQQVK.2|NNALDFVTK.2|AVSMPSFSILGSDVR.3|AVSM[Oxi]PSFSILGSDVR.3|AVSM[Oxi]PSFSILGSDVR.2|AVSMPSFSILGSDVR.2|DNVFDGLVR.2|FPEVDVLTK.2|IPSVQINFK.2|LAPGELTIIL.2|NHLQLEGLFFTNGEHTSK.4|NHLQLEGLFFTNGEHTSK.3|DDKHEQDMVNGIM[Oxi]LSVEK.4|DDKHEQDMVNGIM[Oxi]LSVEK.3|DDKHEQDMVNGIMLSVEK.3|DDKHEQDMVNGIMLSVEK.2|HIYAISSAALSASYK.3|HIYAISSAALSASYK.2|KHVAEAIC[CAM]K.2|LDNIYSSDK.2|QTEATMTFK.2|QTEATM[Oxi]TFK.2|ESDEETQIK.2|IEIPLPFGGK.2|LALWGEHTGQLYSK.3|LALWGEHTGQLYSK.2|NIILPVYDK.2|TSSFALNLPTLPEVK.3|TSSFALNLPTLPEVK.2|ALYWVNGQVPDGVSK.3|ALYWVNGQVPDGVSK.2|LAAYLMLMR.2|LEIQSQVDSQHVGHSVLTAK.4|LEIQSQVDSQHVGHSVLTAK.3|AASGTTGTYQEWKDK.3|DSYDLHDLK.2|SVSDGIAALDLNAVANK.3|SVSDGIAALDLNAVANK.2|VPQTDMTFR.2|VPQTDM[Oxi]TFR.2|GIISALLVPPETEEAK.3|GIISALLVPPETEEAK.2|ITEVALMGHLSC[CAM]DTK.3|KITEVALMGHLSC[CAM]DTKEER.4|KMGLAFESTK.2|LIDVISMYR.2|VELEVPQLC[CAM]SFILK.3|VELEVPQLC[CAM]SFILK.2|ALVDTLKFVTQAEGAK.3|HLIDSLIDFLNFPR.3|NKYGMVAQVTQTLKLEDTPK.4|NKYGMVAQVTQTLKLEDTPK.3|VPSYTLILPSLELPVLHVPR.4|VPSYTLILPSLELPVLHVPR.3|EVYGFNPEGK.2|HINIDQFVR.2|NIQEYLSILTDPDGK.3|NIQEYLSILTDPDGK.2|QGFFPDSVNK.2|SVGFHLPSREFQVPTFTIPK.4|IVQILPWEQNEQVK.3|IVQILPWEQNEQVK.2|KMTSNFPVDLSDYPK.3|KM[Oxi]TSNFPVDLSDYPK.3|SPAFTDLHLR.2|SFDYHQFVDETNDK.3|SFDYHQFVDETNDK.2|VNWEEEAASGLLTSLK.3|VNWEEEAASGLLTSLK.2|WNFYYSPQSSPDKK.3|WNFYYSPQSSPDKK.2|YENYELTLK.2|GNVATEISTER.2|NLQNNAEWVYQGAIR.3|NLQNNAEWVYQGAIR.2|NMEVSVATTTK.2|NM[Oxi]EVSVATTTK.2|QVFLYPEKDEPTYILNIKR.4|VLVDHFGYTK.2|DKDQEVLLQTFLDDASPGDKR.4|DKDQEVLLQTFLDDASPGDKR.3|EELC[CAM]TMFIR.2|VNQNLVYESGSLNFSK.3|VNQNLVYESGSLNFSK.2|DAVEKPQEFTIVAFVK.3|DAVEKPQEFTIVAFVK.2|KITEVALMGHLSC[CAM]DTK.3|LTISEQNIQR.2|NSEEFAAAMSR.2|RGIISALLVPPETEEAK.3|RGIISALLVPPETEEAK.2|SGVQMNTNFFHESGLEAHVALK.4|SGVQM[Oxi]NTNFFHESGLEAHVALK.4|SGVQMNTNFFHESGLEAHVALK.3|SGVQM[Oxi]NTNFFHESGLEAHVALK.3|ATFQTPDFIVPLTDLR.3|ATFQTPDFIVPLTDLR.2|ATGVLYDYVNK.2|IADFELPTIIVPEQTIEIPSIK.4|IADFELPTIIVPEQTIEIPSIK.3|IDDIWNLEVK.2|TEHGSEMLFFGNAIEGK.3|TEHGSEM[Oxi]LFFGNAIEGK.3|ADSVVDLLSYNVQGSGETTYDHK.4|ADSVVDLLSYNVQGSGETTYDHK.3|FSVPAGIVIPSFQALTAR.3|FSVPAGIVIPSFQALTAR.2|VIGNMGQTMEQLTPELK.3|VIGNM[Oxi]GQTMEQLTPELK.3|VIGNM[Oxi]GQTMEQLTPELK.2|VIGNMGQTM[Oxi]EQLTPELK.2|VIGNMGQTMEQLTPELK.2|GMTRPLSTLISSSQSC[CAM]QYTLDAK.4|GM[Oxi]TRPLSTLISSSQSC[CAM]QYTLDAK.4|GMTRPLSTLISSSQSC[CAM]QYTLDAK.3|GM[Oxi]TRPLSTLISSSQSC[CAM]QYTLDAK.3|LIVAMSSWLQK.2|LIVAM[Oxi]SSWLQK.2|SVSLPSLDPASAK.2|NTLELSNGVIVK.2|RNLQNNAEWVYQGAIR.3|EFQVPTFTIPK.2|NFVASHIANILNSEELDIQDLKK.4|NFVASHIANILNSEELDIQDLKK.3|TILGTMPAFEVSLQALQK.3|TILGTM[Oxi]PAFEVSLQALQK.3|TILGTM[Oxi]PAFEVSLQALQK.2|TSQC[CAM]TLKEVYGFNPEGK.3|EVGTVLSQVYSK.2|LNGEIQALELPQKAEALK.3|ESQLPTVMDFR.2|LPQQANDYLNSFNWER.3|LPQQANDYLNSFNWER.2|NPNGYSFSIPVK.2|GNVATEISTERDLGQC[CAM]DR.3|IHSGSFQSQVELSNDQEK.3|IHSGSFQSQVELSNDQEK.2|ILGEELGFASLHDLQLLGK.3|ILGEELGFASLHDLQLLGK.2|INNQLTLDSNTK.2|LPYTIITTPPLK.2|SEYQADYESLR.2|VPLLLSEPINIIDALEM[Oxi]R.3|ASGSLPYTQTLQDHLNSLK.3|ASGSLPYTQTLQDHLNSLK.2|FDHTNSLNIAGLSLDFSSK.3|AASGTTGTYQEWK.2|PLSTLISSSQSC[CAM]QYTLDAK.3|PLSTLISSSQSC[CAM]QYTLDAK.2|TLADLTLLDSPIK.2|LELELRPTGEIEQYSVSATYELQR.4|LELELRPTGEIEQYSVSATYELQR.3|LEVANMQAELVAK.2|LEVANM[Oxi]QAELVAK.2|QTIIVVLENVQR.2|ALVEQGFTVPEIK.2|HSITNPLAVLC[CAM]EFISQSIK.3|YTYNYEAESSSGVPGTADSR.3|YTYNYEAESSSGVPGTADSR.2|IAIANIIDEIIEK.2|LNGEIQALELPQK.2|NKADYVETVLDSTC[CAM]SSTVQFLEYELNVLGTHK.5|NKADYVETVLDSTC[CAM]SSTVQFLEYELNVLGTHK.4|DKDQEVLLQTFLDDASPGDK.3|DKDQEVLLQTFLDDASPGDK.2|LNDLNSVLVMPTFHVPFTDLQVPSC[CAM]K.4|LSNDMMGSYAEMK.2|LSNDM[Oxi]MGSYAEM[Oxi]K.2|LSNDM[Oxi]MGSYAEMK.2|LSNDMMGSYAEM[Oxi]K.2|QVFLYPEKDEPTYILNIK.3|IGQDGISTSATTNLK.2|LPYTIITTPPLKDFSLWEK.3|VNWEEEAASGLLTSLKDNVPK.3|YDKNQDVHSINLPFFETLQEYFER.4|TLQGIPQMIGEVIR.2|TLQGIPQM[Oxi]IGEVIR.2|AQNLYQELLTQEGQASFQGLK.3|ITENDIQIALDDAK.2|ITLIINWLQEALSSASLAHM[Oxi]K.3|MYQMDIQQELQR.2|MYQM[Oxi]DIQQELQR.2|M[Oxi]YQM[Oxi]DIQQELQR.2|NKYGMVAQVTQTLK.2|SGSSTASWIQNVDTK.2|LKTQFNNNEYSQDLDAYNTK.3|QTVNLQLQPYSLVTTLNSDLK.3|TQFNNNEYSQDLDAYNTKDK.3|VLLDQLGTTISFER.2|VSALLTPAEQTGTWK.2|AALGKLPQQANDYLNSFNWER.3|M[Oxi]TSNFPVDLSDYPK.2|MTSNFPVDLSDYPK.2|WNFYYSPQSSPDK.2|NFVASHIANILNSEELDIQDLK.3|DFSAEYEEDGKYEGLQEWEGK.3|EFNLQNMGLPDFHIPENLFLK.3|DKAQNLYQELLTQEGQASFQGLK.3|GISTSAASPAVGTVGM[Oxi]DM[Oxi]DEDDDFSK.3|GISTSAASPAVGTVGMDM[Oxi]DEDDDFSK.3|GISTSAASPAVGTVGMDMDEDDDFSK.3|LQDFSDQLSDYYEK.2|NQDVHSINLPFFETLQEYFER.3|TSSFALNLPTLPEVKFPEVDVLTK.3|NTASLKYENYELTLK.2|KGISTSAASPAVGTVGMDM[Oxi]DEDDDFSK.3|KGISTSAASPAVGTVGMDMDEDDDFSK.3|NKADYVETVLDSTC[CAM]SSTVQFLEYELNVLGTHKIEDGTLASK.5|EYSGTIASEANTYLNSK.2|LLLQMDSSATAYGSTVSK.2|LSLESLTSYFSIESSTK.2|NLTDFAEQYSIQDWAK.2|TQFNNNEYSQDLDAYNTK.2|YEDGTLSLTSTSDLQSGIIK.2|YSQPEDSLIPFFEITVPESQLTVSQFTLPK.3
SEN / CTL,Q00610,Clathrin heavy chain 1,CLTC,0.29,1.95,3.37E-05,1.70E-05,4.77E+00,"osteoblast differentiation,intracellular protein transport,receptor-mediated endocytosis,mitotic nuclear division,antigen processing and presentation of exogenous peptide antigen via MHC class II,receptor internalization,transferrin transport,retrograde transport, endosome to Golgi,Wnt signaling pathway, planar cell polarity pathway,regulation of mitotic spindle organization,negative regulation of hyaluronan biosynthetic process,negative regulation of protein localization to plasma membrane","double-stranded RNA binding,structural molecule activity,protein binding,protein kinase binding,clathrin light chain binding,poly(A) RNA binding","spindle,cytosol,plasma membrane,focal adhesion,membrane,clathrin coat,clathrin coat of trans-Golgi network vesicle,clathrin coat of coated pit,clathrin-coated vesicle,clathrin-coated endocytic vesicle membrane,extracellular matrix,trans-Golgi network membrane,endolysosome membrane,melanosome,intracellular membrane-bounded organelle,protein complex,extracellular exosome,clathrin complex,extracellular vesicle,mitotic spindle microtubule",30,154,302,LLLPWLEAR.2|SVDPTLALSVYLR.2|VANVELYYR.2|SVNESLNNLFITEEDYQALR.3|SVNESLNNLFITEEDYQALR.2|TLQIFNIEMK.2|TLQIFNIEM[Oxi]K.2|GQFSTDELVAEVEKR.3|GQFSTDELVAEVEKR.2|LHIIEVGTPPTGNQPFPK.3|LHIIEVGTPPTGNQPFPK.4|LHIIEVGTPPTGNQPFPK.2|NLQNLLILTAIK.2|NLQNLLILTAIK.3|HSSLAGC[CAM]QIINYR.3|HSSLAGC[CAM]QIINYR.2|KFNALFAQGNYSEAAK.3|KFNALFAQGNYSEAAK.2|ALEHFTDLYDIKR.4|ALEHFTDLYDIKR.3|ALEHFTDLYDIKR.2|EHLELFWSR.3|EHLELFWSR.2|AVNYFSK.2|IAAYLFK.2|NLILVVR.2|QLPLVKPYLR.3|QLPLVKPYLR.2|VDKLDASESLR.3|VDKLDASESLR.2|YC[CAM]EKRDPHLAC[CAM]VAYER.5|YC[CAM]EKRDPHLAC[CAM]VAYER.4|YC[CAM]EKRDPHLAC[CAM]VAYER.3|IAAYLFKGNNR.3|YIQAAC[CAM]K.2|NNLAGAEELFAR.3|NNLAGAEELFAR.2|AMLSANIR.2|AM[Oxi]LSANIR.2|AYEFAER.2|DPHLAC[CAM]VAYER.3|DPHLAC[CAM]VAYER.2|LEKHELIEFR.3|LEKHELIEFR.2|IHEGC[CAM]EEPATHNALAK.4|IHEGC[CAM]EEPATHNALAK.3|IHEGC[CAM]EEPATHNALAK.2|IYIDSNNNPER.3|IYIDSNNNPER.2|LDASESLR.2|LKLLLPWLEAR.3|LKLLLPWLEAR.2|NNRPSEGPLQTR.3|NNRPSEGPLQTR.2|VDKLDASESLRK.3|VDKLDASESLRK.2|FLRENPYYDSRVVGK.4|KVSQPIEGHAASFAQFK.4|KVSQPIEGHAASFAQFK.3|VMEYINR.2|VM[Oxi]EYINR.2|EAIDSYIK.2|HELIEFR.2|IVLDNSVFSEHR.3|IVLDNSVFSEHR.2|AHTMTDDVTFWK.3|AHTM[Oxi]TDDVTFWK.3|AHTM[Oxi]TDDVTFWK.2|AHTMTDDVTFWK.2|NNLAGAEELFARK.3|NNLAGAEELFARK.2|ALEHFTDLYDIK.3|ALEHFTDLYDIK.2|FLRENPYYDSR.3|FLRENPYYDSR.2|VKQLPLVKPYLR.3|VVGAMQLYSVDRK.3|VVGAM[Oxi]QLYSVDRK.3|VVGAMQLYSVDRK.2|HNIMDFAMPYFIQVMK.4|HNIM[Oxi]DFAMPYFIQVMK.3|HNIMDFAM[Oxi]PYFIQVMK.3|HNIMDFAMPYFIQVM[Oxi]K.3|HNIMDFAMPYFIQVMK.3|HNIM[Oxi]DFAM[Oxi]PYFIQVMK.3|HNIM[Oxi]DFAMPYFIQVMK.2|HNIMDFAM[Oxi]PYFIQVMK.2|HNIMDFAMPYFIQVM[Oxi]K.2|HNIMDFAMPYFIQVMK.2|ISGETIFVTAPHEATAGIIGVNRK.5|ISGETIFVTAPHEATAGIIGVNRK.4|ISGETIFVTAPHEATAGIIGVNRK.3|LASTLVHLGEYQAAVDGAR.4|LASTLVHLGEYQAAVDGAR.3|LASTLVHLGEYQAAVDGAR.2|QSVELC[CAM]KK.2|RDPHLAC[CAM]VAYER.3|RDPHLAC[CAM]VAYER.2|MREHLELFWSR.3|M[Oxi]REHLELFWSR.3|VIQC[CAM]FAETGQVQK.3|VIQC[CAM]FAETGQVQK.2|WLLLTGISAQQNR.3|WLLLTGISAQQNR.2|LDASESLRK.2|TWKEVC[CAM]FAC[CAM]VDGKEFR.4|ENPYYDSR.2|GQFSTDELVAEVEK.3|GQFSTDELVAEVEK.2|LHIIEVGTPPTGNQPFPKK.4|LHIIEVGTPPTGNQPFPKK.3|LTDQLPLIIVC[CAM]DR.3|LTDQLPLIIVC[CAM]DR.2|MFDRHSSLAGC[CAM]QIINYR.4|RPISADSAIMNPASK.3|RPISADSAIM[Oxi]NPASK.3|RPISADSAIM[Oxi]NPASK.2|RPISADSAIMNPASK.2|PLLLNDLLMVLSPR.3|PLLLNDLLM[Oxi]VLSPR.3|PLLLNDLLM[Oxi]VLSPR.2|PLLLNDLLMVLSPR.2|TGQIKEVER.2|YIEIYVQK.2|AHIAQLC[CAM]EK.2|ESYVETELIFALAK.3|ESYVETELIFALAK.2|HDVVFLITK.2|KVGYTPDWIFLLR.3|KVGYTPDWIFLLR.2|TWKEVC[CAM]FAC[CAM]VDGK.3|TWKEVC[CAM]FAC[CAM]VDGK.2|YESLELC[CAM]R.2|FNALFAQGNYSEAAK.3|FNALFAQGNYSEAAK.2|KDPELWGSVLLESNPYRR.4|RKDPELWGSVLLESNPYR.4|RKDPELWGSVLLESNPYR.3|RKDPELWGSVLLESNPYR.2|WLKEDKLEC[CAM]SEELGDLVK.4|WLKEDKLEC[CAM]SEELGDLVK.3|WLKEDKLEC[CAM]SEELGDLVK.2|YHEQLSTQSLIELFESFK.4|YHEQLSTQSLIELFESFK.3|YHEQLSTQSLIELFESFK.2|DAMQYASESK.2|DAM[Oxi]QYASESK.2|FDFVHDLVLYLYR.3|FDFVHDLVLYLYR.2|NLQNLLILTAIKADR.3|NLQNLLILTAIKADR.2|AHMGMFTELAILYSK.3|AHM[Oxi]GMFTELAILYSK.3|AHMGM[Oxi]FTELAILYSK.3|AHM[Oxi]GM[Oxi]FTELAILYSK.3|AHM[Oxi]GMFTELAILYSK.2|AHMGM[Oxi]FTELAILYSK.2|AHMGMFTELAILYSK.2|AHM[Oxi]GM[Oxi]FTELAILYSK.2|DTELAEELLQWFLQEEKR.4|DTELAEELLQWFLQEEKR.3|MKAHTMTDDVTFWK.3|MKAHTMTDDVTFWK.2|VSQPIEGHAASFAQFK.3|VSQPIEGHAASFAQFK.2|RPLIDQVVQTALSETQDPEEVSVTVK.5|RPLIDQVVQTALSETQDPEEVSVTVK.4|RPLIDQVVQTALSETQDPEEVSVTVK.3|ESNC[CAM]YDPER.2|QKWLLLTGISAQQNR.3|EDKLEC[CAM]SEELGDLVK.3|EDKLEC[CAM]SEELGDLVK.2|EVC[CAM]FAC[CAM]VDGK.2|ISGETIFVTAPHEATAGIIGVNR.4|ISGETIFVTAPHEATAGIIGVNR.3|ISGETIFVTAPHEATAGIIGVNR.2|KFDVNTSAVQVLIEHIGNLDR.4|KFDVNTSAVQVLIEHIGNLDR.3|KFDVNTSAVQVLIEHIGNLDR.2|ARESYVETELIFALAK.3|ARESYVETELIFALAK.2|GQAGGKLHIIEVGTPPTGNQPFPK.4|GQAGGKLHIIEVGTPPTGNQPFPK.3|LAELEEFINGPNNAHIQQVGDR.4|LAELEEFINGPNNAHIQQVGDR.3|MEGNAEESTLFC[CAM]FAVR.3|M[Oxi]EGNAEESTLFC[CAM]FAVR.2|MEGNAEESTLFC[CAM]FAVR.2|YESLELC[CAM]RPVLQQGR.3|YESLELC[CAM]RPVLQQGR.2|DPELWGSVLLESNPYR.3|DPELWGSVLLESNPYR.2|LLEMNLMHAPQVADAILGNQMFTHYDR.5|LLEM[Oxi]NLM[Oxi]HAPQVADAILGNQMFTHYDR.4|LLEM[Oxi]NLMHAPQVADAILGNQM[Oxi]FTHYDR.4|LLEM[Oxi]NLMHAPQVADAILGNQMFTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQMFTHYDR.4|LLEMNLMHAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLMHAPQVADAILGNQMFTHYDR.4|LLEM[Oxi]NLM[Oxi]HAPQVADAILGNQM[Oxi]FTHYDR.4|LLEMNLM[Oxi]HAPQVADAILGNQMFTHYDR.3|LLEMNLMHAPQVADAILGNQM[Oxi]FTHYDR.3|LLEMNLMHAPQVADAILGNQMFTHYDR.3|AFMTADLPNELIELLEK.3|AFM[Oxi]TADLPNELIELLEK.3|AFM[Oxi]TADLPNELIELLEK.2|AFMTADLPNELIELLEK.2|KFDVNTSAVQVLIEHIGNLDRAYEFAER.5|KFDVNTSAVQVLIEHIGNLDRAYEFAER.4|LLYNNVSNFGR.2|TSIDAYDNFDNISLAQR.3|TSIDAYDNFDNISLAQR.2|VNPSRLPVVIGGLLDVDC[CAM]SEDVIK.4|VNPSRLPVVIGGLLDVDC[CAM]SEDVIK.3|AAEQAHLWAELVFLYDK.3|KDPELWGSVLLESNPYR.3|KDPELWGSVLLESNPYR.2|VVGAMQLYSVDR.2|VVGAM[Oxi]QLYSVDR.2|GMVKEAIDSYIK.2|LPVVIGGLLDVDC[CAM]SEDVIK.3|LPVVIGGLLDVDC[CAM]SEDVIK.2|PLIDQVVQTALSETQDPEEVSVTVK.4|PLIDQVVQTALSETQDPEEVSVTVK.3|IVLDNSVFSEHRNLQNLLILTAIK.4|IVLDNSVFSEHRNLQNLLILTAIK.3|LEC[CAM]SEELGDLVK.2|QNLQIC[CAM]VQVASK.2|C[CAM]NEPAVWSQLAK.2|ESNC[CAM]YDPERVK.2|PISADSAIMNPASK.2|ANVPNKVIQC[CAM]FAETGQVQK.3|DTELAEELLQWFLQEEK.3|LPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.4|LPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.3|TNRLAELEEFINGPNNAHIQQVGDR.4|TNRLAELEEFINGPNNAHIQQVGDR.3|TNRLAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.5|GQC[CAM]DLELINVC[CAM]NENSLFK.3|GQC[CAM]DLELINVC[CAM]NENSLFK.2|VGEQAQVVIIDMNDPSNPIR.3|VGEQAQVVIIDM[Oxi]NDPSNPIR.3|VGEQAQVVIIDM[Oxi]NDPSNPIR.2|VGEQAQVVIIDMNDPSNPIR.2|VGYTPDWIFLLR.2|FDVNTSAVQVLIEHIGNLDR.3|FDVNTSAVQVLIEHIGNLDR.2|KAVDVFFPPEAQNDFPVAMQISEKHDVVFLITK.5|KAVDVFFPPEAQNDFPVAMQISEKHDVVFLITK.4|FDVNTSAVQVLIEHIGNLDRAYEFAER.4|TSIDAYDNFDNISLAQRLEK.3|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDK.4|FQEHLQLQNLGINPANIGFSTLTMESDK.4|FQEHLQLQNLGINPANIGFSTLTMESDK.3|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDK.3|LAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.4|LAELEEFINGPNNAHIQQVGDRC[CAM]YDEK.3|LAQMC[CAM]GLHIVVHADELEELINYYQDR.4|LAQMC[CAM]GLHIVVHADELEELINYYQDR.3|EKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASK.5|FQSVPAQPGQTSPLLQYFGILLDQGQLNK.4|FQSVPAQPGQTSPLLQYFGILLDQGQLNK.3|WISLNTVALVTDNAVYHWSMEGESQPVK.4|WISLNTVALVTDNAVYHWSMEGESQPVK.3|YGYIHLYDLETGTC[CAM]IYM[Oxi]NR.3|YGYIHLYDLETGTC[CAM]IYMNR.3|YGYIHLYDLETGTC[CAM]IYMNR.2|EKVGEQAQVVIIDMNDPSNPIR.3|EKVGEQAQVVIIDM[Oxi]NDPSNPIR.3|LLYNNVSNFGRLASTLVHLGEYQAAVDGAR.4|REC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.4|REC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.3|YEEYDNAIITMMNHPTDAWK.3|GQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.4|GQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.3|SVQNHNNKSVNESLNNLFITEEDYQALR.4|DAMQYASESKDTELAEELLQWFLQEEKR.4|RFQSVPAQPGQTSPLLQYFGILLDQGQLNK.4|RFQSVPAQPGQTSPLLQYFGILLDQGQLNK.3|AVDVFFPPEAQNDFPVAMQISEK.3|KGQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.4|KGQVLSVC[CAM]VEEENIIPYITNVLQNPDLALR.3|VNPSRLPVVIGGLLDVDC[CAM]SEDVIKNLILVVR.4|AVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.4|AVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.3|DSLYKDAMQYASESK.2|AAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWK.5|AAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWK.4|ADDPSSYMEVVQAANTSGNWEELVK.3|ADDPSSYM[Oxi]EVVQAANTSGNWEELVK.3|EAIDSYIKADDPSSYMEVVQAANTSGNWEELVK.4|KAVDVFFPPEAQNDFPVAMQISEK.3|RAVVHTHLLNPEWLVNYFGSLSVEDSLEC[CAM]LR.4|VGEQAQVVIIDM[Oxi]NDPSNPIRRPISADSAIMNPASK.4|VGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASK.4|FQEHLQLQNLGINPANIGFSTLTM[Oxi]ESDKFIC[CAM]IR.4|FQEHLQLQNLGINPANIGFSTLTMESDKFIC[CAM]IR.4|FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELC[CAM]RPVLQQGR.5|EC[CAM]FGAC[CAM]LFTC[CAM]YDLLRPDVVLETAWR.3|FQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELC[CAM]RPVLQQGRK.5|DPELWGSVLLESNPYRRPLIDQVVQTALSETQDPEEVSVTVK.4
SEN / CTL,P07996,Thrombospondin-1,THBS1,0.27,1.45,1.92E-09,1.75E-09,8.76E+00,"activation of MAPK activity,response to hypoxia,negative regulation of endothelial cell proliferation,negative regulation of cell-matrix adhesion,sprouting angiogenesis,chronic inflammatory response,platelet degranulation,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,negative regulation of dendritic cell antigen processing and presentation,inflammatory response,immune response,response to unfolded protein,cell cycle arrest,cell adhesion,positive regulation of cell proliferation,response to mechanical stimulus,response to glucose,positive regulation of endothelial cell migration,negative regulation of endothelial cell migration,negative regulation of plasma membrane long-chain fatty acid transport,negative regulation of nitric oxide mediated signal transduction,negative regulation of cGMP-mediated signaling,negative regulation of plasminogen activation,positive regulation of macrophage chemotaxis,positive regulation of fibroblast migration,cell migration,negative regulation of angiogenesis,peptide cross-linking,positive regulation of blood coagulation,extracellular matrix organization,positive regulation of cell migration,positive regulation of transforming growth factor beta receptor signaling pathway,regulation of cGMP metabolic process,response to magnesium ion,response to progesterone,negative regulation of interleukin-12 production,positive regulation of transforming growth factor beta1 production,response to testosterone,cellular response to heat,response to endoplasmic reticulum stress,protein O-linked fucosylation,negative regulation of fibroblast growth factor receptor signaling pathway,positive regulation of phosphorylation,response to drug,positive regulation of tumor necrosis factor biosynthetic process,positive regulation of macrophage activation,negative regulation of apoptotic process,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,positive regulation of blood vessel endothelial cell migration,negative regulation of blood vessel endothelial cell migration,engulfment of apoptotic cell,positive regulation of translation,positive regulation of angiogenesis,behavioral response to pain,positive regulation of smooth muscle cell proliferation,positive regulation of chemotaxis,response to calcium ion,negative regulation of focal adhesion assembly,positive regulation of protein kinase B signaling,negative regulation of fibrinolysis,cellular response to tumor necrosis factor,cellular response to growth factor stimulus,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,positive regulation of endothelial cell apoptotic process,positive regulation of reactive oxygen species metabolic process,negative regulation of endothelial cell chemotaxis,negative regulation of extrinsic apoptotic signaling pathway","phosphatidylserine binding,glycoprotein binding,fibronectin binding,integrin binding,calcium ion binding,protein binding,heparin binding,fibroblast growth factor binding,low-density lipoprotein particle binding,identical protein binding,laminin binding,proteoglycan binding,transforming growth factor beta binding,fibrinogen binding,collagen V binding","extracellular region,fibrinogen complex,extracellular space,endoplasmic reticulum,endoplasmic reticulum lumen,external side of plasma membrane,cell surface,sarcoplasmic reticulum,secretory granule,extracellular matrix,platelet alpha granule,platelet alpha granule lumen,extracellular exosome",126,63,89,FVFGTTPEDILR.2|GFLLLASLR.2|TIVTTLQDSIR.2|GGVNDNFQGVLQNVR.2|SITLFVQEDR.2|IEDANLIPPVPDDKFQDLVDAVR.3|IEDANLIPPVPDDKFQDLVDAVR.4|FYVVMWK.2|TKDLQAIC[CAM]GISC[CAM]DELSSMVLELR.3|AGTLDLSLTVQGK.2|FQMIPLDPK.2|AQGYSGLSVK.2|QVTQSYWDTNPTR.2|TIVTTLQDSIRK.3|QHVVSVEEALLATGQWK.3|QHVVSVEEALLATGQWK.2|QHVVSVEEALLATGQWK.4|GPDPSSPAFRIEDANLIPPVPDDKFQDLVDAVR.4|AQLYIDC[CAM]EK.2|LVKGPDPSSPAFR.3|C[CAM]ENTDPGYNC[CAM]LPC[CAM]PPR.2|C[CAM]ENTDPGYNC[CAM]LPC[CAM]PPR.3|DNC[CAM]QYVYNVDQR.2|MENAELDVPIQSVFTR.2|MENAELDVPIQSVFTR.3|M[Oxi]ENAELDVPIQSVFTR.2|C[CAM]NYLGHYSDPMYR.3|C[CAM]NYLGHYSDPMYR.2|C[CAM]NYLGHYSDPM[Oxi]YR.3|DLQAIC[CAM]GISC[CAM]DELSSMVLELR.3|DTDMDGVGDQC[CAM]DNC[CAM]PLEHNPDQLDSDSDR.3|DTDMDGVGDQC[CAM]DNC[CAM]PLEHNPDQLDSDSDR.4|GTSQNDPNWVVR.2|FTGSQPFGQGVEHATANK.3|FTGSQPFGQGVEHATANK.2|NALWHTGNTPGQVR.3|NALWHTGNTPGQVR.2|IPESGGDNSVFDIFELTGAAR.3|IPESGGDNSVFDIFELTGAAR.2|KVTEENKELANELR.3|KVTEENKELANELR.4|KVTEENKELANELR.2|VTEENKELANELR.3|VTEENKELANELR.2|DHSGQVFSVVSNGK.3|DHSGQVFSVVSNGK.2|LC[CAM]NSPSPQMNGKPC[CAM]EGEAR.3|LC[CAM]NSPSPQMNGKPC[CAM]EGEAR.2|GTLLALER.2|NNEEWTVDSC[CAM]TEC[CAM]HC[CAM]QNSVTIC[CAM]K.3|DSDGDGRGDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.5|DSDGDGRGDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.4|KIMADSGPIYDK.3|KIMADSGPIYDK.2|TC[CAM]HIQEC[CAM]DKR.3|TC[CAM]HIQEC[CAM]DKR.2|LVPNPDQK.2|NPC[CAM]TDGTHDC[CAM]NK.3|NPC[CAM]TDGTHDC[CAM]NK.2|SC[CAM]DSLNNR.2|C[CAM]EGSSVQTR.2|GPDPSSPAFR.2|FQDLVDAVR.2|KDHSGQVFSVVSNGK.3|KDHSGQVFSVVSNGK.2|RPPLC[CAM]YHNGVQYR.3|RPPLC[CAM]YHNGVQYR.2|EVPDAC[CAM]FNHNGEHR.3|PRNPC[CAM]TDGTHDC[CAM]NK.3|C[CAM]TSYPDGSWK.2|TC[CAM]HIQEC[CAM]DK.2|GDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.4|GDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.3|IMADSGPIYDK.2|SC[CAM]DSLNNRC[CAM]EGSSVQTR.3|FTGSQPFGQGVEHATANKQVC[CAM]KPR.4|LC[CAM]NNPTPQFGGK.2|DGKGDAC[CAM]DHDDDNDGIPDDKDNC[CAM]R.4|DNC[CAM]PFHYNPAQYDYDRDDVGDR.4|GDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.5|GDAC[CAM]KDDFDHDSVPDIDDIC[CAM]PENVDISETDFR.4|IEDANLIPPVPDDK.2|DC[CAM]VGDVTENQIC[CAM]NK.2|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDKDGK.5|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDKDGK.4|DNC[CAM]PNLPNSGQEDYDK.2|C[CAM]DNC[CAM]PYNHNPDQADTDNNGEGDAC[CAM]AADIDGDGILNER.4|IGDTC[CAM]DNNQDIDEDGHQNNLDNC[CAM]PYVPNANQADHDK.4|DDFDHDSVPDIDDIC[CAM]PENVDISETDFR.3
SEN / CTL,P05997,Collagen alpha-2(V) chain,COL5A2,0.27,0.88,1.68E-01,3.55E-02,1.45E+00,"skeletal system development,ossification,extracellular matrix organization,collagen fibril organization,collagen catabolic process,skin development,eye morphogenesis,cellular response to amino acid stimulus,negative regulation of endodermal cell differentiation","molecular_function,extracellular matrix structural constituent,SMAD binding,metal ion binding","extracellular region,collagen type V trimer,endoplasmic reticulum lumen,extracellular matrix",12,14,15,GSQFAYGDHQSPNTAITQMTFLR.3|SPDNKPVWYGLDMNR.3|QSGEYWIDPNQGSVEDAIK.2|SGLGSQVGLMPGSVGPVGPR.2|SGLGSQVGLM[Oxi]PGSVGPVGPR.2|GPEGPQGQR.2|LGPQGAPGQR.2|GMAGGHGPDGPK.2|NSVGYMDDQAK.2|YIVLQDTC[CAM]SK.2|GEPGPHGIQGPIGPPGEEGK.3|GLTGNPGVQGPEGK.2|PAPC[CAM]QIC[CAM]VC[CAM]DNGAILC[CAM]DK.3|GTQGPPGATGFPGSAGR.2|GPQGIDGEPGVPGQPGAPGPPGHPSHPGPDGLSRPFSAQMAGLDEK.5
SEN / CTL,P02545,Prelamin-A/C,LMNA,0.11,2.08,3.04E-11,3.92E-11,1.04E+01,"mitotic nuclear envelope disassembly,mitotic nuclear envelope reassembly,regulation of cell migration,establishment or maintenance of microtubule cytoskeleton polarity,protein localization to nucleus,sterol regulatory element binding protein import into nucleus,IRE1-mediated unfolded protein response,ventricular cardiac muscle cell development,cellular response to hypoxia,negative regulation of mesenchymal cell proliferation,negative regulation of release of cytochrome c from mitochondria,positive regulation of cell aging,regulation of protein localization to nucleus,negative regulation of extrinsic apoptotic signaling pathway","structural molecule activity,protein binding","nucleus,nuclear envelope,lamin filament,nucleoplasm,cytoplasm,cytosol,nuclear speck,extracellular matrix,nuclear membrane",57,85,142,VAVEEVDEEGKFVR.3|VAVEEVDEEGKFVR.2|LQLELSK.2|IRIDSLSAQLSQLQK.3|IRIDSLSAQLSQLQK.2|IRIDSLSAQLSQLQK.4|NSNLVGAAHEELQQSR.3|NSNLVGAAHEELQQSR.2|NSNLVGAAHEELQQSR.4|LQEKEDLQELNDR.3|LQEKEDLQELNDR.2|MQQQLDEYQELLDIK.2|MQQQLDEYQELLDIK.3|M[Oxi]QQQLDEYQELLDIK.3|M[Oxi]QQQLDEYQELLDIK.2|TALINSTGEEVAMR.2|TALINSTGEEVAMR.3|TALINSTGEEVAM[Oxi]R.2|LAVYIDR.2|LAVYIDR.1|LRITESEEVVSR.3|LRITESEEVVSR.2|EGDLIAAQAR.2|LRDLEDSLAR.2|LQTMKEELDFQK.3|LQTM[Oxi]KEELDFQK.3|LQTMKEELDFQK.2|LQTM[Oxi]KEELDFQK.2|TLEGELHDLRGQVAK.3|TLEGELHDLRGQVAK.4|TLEGELHDLRGQVAK.2|EAALSTALSEKR.3|EAALSTALSEKR.2|LKDLEALLNSK.3|LKDLEALLNSK.2|ASSHSSQTQGGGSVTKK.4|AAYEAELGDARK.3|AAYEAELGDARK.2|GRASSHSSQTQGGGSVTK.4|GRASSHSSQTQGGGSVTK.3|LVEIDNGK.2|LALDM[Oxi]EIHAYR.3|LALDMEIHAYR.3|LALDMEIHAYR.2|RTLEGELHDLR.3|RTLEGELHDLR.2|AQNTWGC[CAM]GNSLR.3|AQNTWGC[CAM]GNSLR.2|LEAALGEAK.2|RTLEGELHDLRGQVAK.4|RTLEGELHDLRGQVAK.3|RTLEGELHDLRGQVAK.2|SGAQASSTPLSPTR.3|SGAQASSTPLSPTR.2|AQHEDQVEQYK.3|AQHEDQVEQYK.2|DLEDSLAR.2|NIYSEELRETK.3|NIYSEELRETK.2|SSFSQHAR.2|VAVEEVDEEGKFVRLR.4|IDSLSAQLSQLQK.3|IDSLSAQLSQLQK.2|KLESTESR.2|QREFESR.2|NKSNEDQSMGNWQIKR.4|NKSNEDQSM[Oxi]GNWQIKR.4|NKSNEDQSMGNWQIKR.3|NKSNEDQSM[Oxi]GNWQIKR.3|RQNGDDPLLTYR.3|RQNGDDPLLTYR.2|RQNGDDPLLTYRFPPK.4|RQNGDDPLLTYRFPPK.3|LALDMEIHAYRK.3|LALDM[Oxi]EIHAYRK.3|LALDMEIHAYRK.2|LSPSPTSQR.2|AQHEDQVEQYKK.3|AQHEDQVEQYKK.2|AQHEDQVEQYKKELEK.4|AQHEDQVEQYKKELEK.3|DLEALLNSK.2|LADALQELRAQHEDQVEQYKK.5|LADALQELRAQHEDQVEQYKK.4|LADALQELRAQHEDQVEQYKK.3|TSGRVAVEEVDEEGKFVR.4|TSGRVAVEEVDEEGKFVR.3|ASSHSSQTQGGGSVTK.3|ASSHSSQTQGGGSVTK.2|LRITESEEVVSREVSGIK.4|NTKKEGDLIAAQAR.3|TLDSVAKER.2|LADALQELR.2|LEAALGEAKK.2|NIYSEELR.2|QLQDEMLR.2|SNEDQSMGNWQIK.3|SNEDQSM[Oxi]GNWQIK.2|SNEDQSMGNWQIK.2|SVGGSGGGSFGDNLVTR.3|SVGGSGGGSFGDNLVTR.2|EREMAEMR.2|SLETENAGLR.2|TALINSTGEEVAM[Oxi]RK.3|TALINSTGEEVAMRK.3|TALINSTGEEVAMRK.2|IRIDSLSAQLSQLQKQLAAK.4|SRTVLC[CAM]GTC[CAM]GQPADK.3|SYLLGNSSPR.2|EAALSTALSEK.2|EDLQELNDR.2|SNEDQSMGNWQIKR.3|SNEDQSM[Oxi]GNWQIKR.3|ITESEEVVSR.2|KQLQDEMLR.2|AAYEAELGDAR.2|ITESEEVVSREVSGIK.3|KEGDLIAAQAR.2|LKDLEALLNSKEAALSTALSEK.4|ASASGSGAQVGGPISSGSSASSVTVTR.4|ASASGSGAQVGGPISSGSSASSVTVTR.3|ASASGSGAQVGGPISSGSSASSVTVTR.2|TLEGELHDLR.2|LVEIDNGKQREFESR.3|VAVEEVDEEGK.2|LQEKEDLQELNDRLAVYIDR.4|LQTMKEELDFQKNIYSEELR.4|LQTMKEELDFQKNIYSEELR.3|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.6|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.5|TVLC[CAM]GTC[CAM]GQPADKASASGSGAQVGGPISSGSSASSVTVTR.4|AGQVVTIWAAGAGATHSPPTDLVWK.4|AGQVVTIWAAGAGATHSPPTDLVWK.3|TLEGELHDLRGQVAKLEAALGEAK.4|QNGDDPLLTYR.2|EDLQELNDRLAVYIDR.3|KLLEGEEERLR.2|GQVAKLEAALGEAK.2|SVTVVEDDEDEDGDDLLHHHHGSHC[CAM]SSSGDPAEYNLR.6|TVLC[CAM]GTC[CAM]GQPADK.2|VDAENRLQTMKEELDFQK.3|NKSNEDQSMGNWQIK.2
SEN / CTL,P36955,Pigment epithelium-derived factor,SERPINF1,0.04,1.80,9.62E-05,4.43E-05,4.35E+00,"kidney development,multicellular organism development,aging,short-term memory,cell proliferation,response to acidic pH,negative regulation of endothelial cell migration,negative regulation of gene expression,negative regulation of endopeptidase activity,positive regulation of neuron projection development,negative regulation of angiogenesis,ovulation cycle,response to arsenic-containing substance,negative regulation of inflammatory response,positive regulation of neurogenesis,retina development in camera-type eye,negative regulation of epithelial cell proliferation involved in prostate gland development,cellular response to cobalt ion,cellular response to retinoic acid,cellular response to glucose stimulus,cellular response to dexamethasone stimulus,negative regulation of neuron death","serine-type endopeptidase inhibitor activity,protein binding","extracellular region,basement membrane,extracellular space,melanosome,axon hillock,perinuclear region of cytoplasm,extracellular exosome,extracellular matrix",39,20,26,DTDTGALLFIGK.2|LAAAVSNFGYDLYR.2|LAAAVSNFGYDLYR.3|SSTSPTTNVLLSPLSVATALSALSLGAEQR.3|KTSLEDFYLDEER.2|KTSLEDFYLDEER.3|TSLEDFYLDEER.2|LQSLFDSPDFSK.2|LDLQEINNWVQAQMK.2|LDLQEINNWVQAQMK.3|YGLDSDLSC[CAM]K.2|TVQAVLTVPK.2|IAQLPLTGSMSIIFFLPLK.3|IAQLPLTGSMSIIFFLPLK.2|LKLSYEGEVTK.3|TESIIHR.2|SSFVAPLEK.2|LSYEGEVTK.2|ELLDTVTAPQK.2|EIPDEISILLLGVAHFK.3|ALYYDLISSPDIHGTYK.3|ALYYDLISSPDIHGTYK.2|ALYYDLISSPDIHGTYKELLDTVTAPQK.4|AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.5|AGFEWNEDGAGTTPSPGLQPAHLTFPLDYHLNQPFIFVLR.4|SSTSPTTNVLLSPLSVATALSALSLGAEQRTESIIHR.4
SEN / CTL,P04259,"Keratin, type II cytoskeletal 6B",KRT6B,0.03,1.52,9.50E-02,2.09E-02,1.68E+00,"cytoskeleton organization,ectoderm development","structural constituent of cytoskeleton,protein binding","keratin filament,extracellular exosome",21,9,14,YEELQITAGR.2|YEELQITAGR.1|SGFSSISVSR.2|VLDTKWTLLQEQGTK.3|VLDTKWTLLQEQGTK.2|ATGGGLSSVGGGSSTIK.2|ATGGGLSSVGGGSSTIK.3|ATGGGLSSVGGGSSTIKYTTTSSSSR.3|QLDNIVGER.2|NMQDLVEDLK.2|NM[Oxi]QDLVEDLK.2|SRAEAESWYQTKYEELQITAGR.4|SRAEAESWYQTKYEELQITAGR.3|FLEQQNKVLDTKWTLLQEQGTK.3
SEN / CTL,Q9NR12,PDZ and LIM domain protein 7,PDLIM7,-0.01,2.36,2.01E-01,4.17E-02,1.38E+00,"ossification,receptor-mediated endocytosis,multicellular organism development,actin cytoskeleton organization,cell differentiation,positive regulation of osteoblast differentiation","protein binding,zinc ion binding","stress fiber,ruffle,nucleus,cytoplasm,cell-cell junction,focal adhesion,actin cytoskeleton",9,23,36,VVLEGPAPWGFR.2|VVLEGPAPWGFR.3|VLEEGGFFEEK.2|LQGGKDFNVPLSISR.3|LQGGKDFNVPLSISR.2|KITGEIMHALK.3|YAPDKTSTVLTR.3|YAPDKTSTVLTR.2|ASAPAADPPR.2|HSQPATPTPLQSR.3|HSQPATPTPLQSR.2|ILAHLTGTEFMQDPDEEHLKK.5|ILAHLTGTEFMQDPDEEHLKK.4|ILAHLTGTEFMQDPDEEHLKK.3|LMENTEDWRPRPGTGQSR.4|LMENTEDWRPRPGTGQSR.3|ITGEIMHALK.2|DFNVPLSISR.2|ILAHLTGTEFMQDPDEEHLK.4|ILAHLTGTEFMQDPDEEHLK.3|TSIVQAAAGGVPGGGSNNGK.3|TSIVQAAAGGVPGGGSNNGK.2|MTWHVHC[CAM]FTC[CAM]AAC[CAM]K.3|YTFAPSVSLNK.2|YLVALGHAYHPEEFVC[CAM]SQC[CAM]GK.4|YLVALGHAYHPEEFVC[CAM]SQC[CAM]GK.3|TARPFGAPPPADSAPQQNGQPLRPLVPDASK.5|TARPFGAPPPADSAPQQNGQPLRPLVPDASK.4|TARPFGAPPPADSAPQQNGQPLRPLVPDASK.3|GRYLVALGHAYHPEEFVC[CAM]SQC[CAM]GK.4|AFYMEEGVPYC[CAM]ERDYEK.3|GAIFC[CAM]PPC[CAM]YDVR.2|AAQAGVAVGDWVLSIDGENAGSLTHIEAQNK.4|AAQAGVAVGDWVLSIDGENAGSLTHIEAQNK.3|AFYMEEGVPYC[CAM]ER.2|TEAPAPASSTPQEPWPGPTAPSPTSRPPWAVDPAFAER.4
SEN / CTL,P08729,"Keratin, type II cytoskeletal 7",KRT7,-0.09,0.77,1.95E-01,4.06E-02,1.39E+00,viral process,"structural molecule activity,protein binding","nucleus,cytoplasm,intermediate filament,keratin filament,extracellular exosome",12,52,77,LALDIEIATYR.2|VDALNDEINFLR.2|SSRLPDIFEAQIAGLR.3|SSRLPDIFEAQIAGLR.2|LPDIFEAQIAGLR.2|LPDIFEAQIAGLR.3|VRQEESEQIK.3|VRQEESEQIK.2|SLDLDGIIAEVK.3|SLDLDGIIAEVK.2|NKYEDEINHR.3|NKYEDEINHR.2|FETLQAQAGKHGDDLR.4|TAAENEFVVLKK.3|TAAENEFVVLKK.2|NTRNEISEMNR.3|NTRNEISEMNR.2|NTRNEISEM[Oxi]NR.2|VRQEESEQIKTLNNK.4|VRQEESEQIKTLNNK.3|AKQEELEAALQR.3|AKQEELEAALQR.2|AKLEAAIAEAEER.3|AKLEAAIAEAEER.2|LALDIEIATYRK.3|LALDIEIATYRK.2|LQAEIDNIKNQR.3|LQAEIDNIKNQR.2|AQYEEMAK.2|EVTINQSLLAPLR.3|EVTINQSLLAPLR.2|NEISEMNR.2|AKLEAAIAEAEERGELALK.4|AKLEAAIAEAEERGELALK.3|DVDAAYMSK.2|DVDAAYM[Oxi]SK.2|LDADPSLQR.2|QLREYQELMSVK.3|QLREYQELMSVK.2|LQAEIDNIK.2|WTLLQEQK.2|LEAAIAEAEERGELALKDAR.4|LEAAIAEAEERGELALKDAR.3|FETLQAQAGK.2|SAYGGPVGAGIR.2|KDVDAAYMSK.2|LSSARPGGLGSSSLYGLGASRPR.4|EYQELMSVK.2|PGGLGSSSLYGLGASRPR.3|QEELEAALQR.2|AEAEAWYQTK.2|SMQDVVEDFK.2|SM[Oxi]QDVVEDFK.2|LEAAIAEAEER.2|LEAAIAEAEERGELALK.3|EVTINQSLLAPLRLDADPSLQR.4|EVTINQSLLAPLRLDADPSLQR.3|TAAENEFVVLK.2|GQLEALQVDGGR.2|FLEQQNKLLETKWTLLQEQK.4|FLEQQNKLLETKWTLLQEQK.3|SMQDVVEDFKNKYEDEINHR.4|SMQDVVEDFKNKYEDEINHR.3|AIQRLQAEIDNIKNQR.3|GQLEALQVDGGRLEAELR.3|LSSARPGGLGSSSLYGLGASR.3|VELEAKVDALNDEINFLR.3|VELEAKVDALNDEINFLR.2|SMQDVVEDFKNK.2|PGGLGSSSLYGLGASR.2|SLDLDGIIAEVKAQYEEMAK.3|TLNETELTELQSQISDTSVVLSMDNSR.4|TLNETELTELQSQISDTSVVLSMDNSR.3|TLNETELTELQSQISDTSVVLSM[Oxi]DNSR.3|AEAEAWYQTKFETLQAQAGK.3|C[CAM]SRAEAEAWYQTK.2|SAYGGPVGAGIREVTINQSLLAPLRLDADPSLQR.4
SEN / CTL,P02042;P02100;P68871;P69891;P69892,Hemoglobin subunit delta;Hemoglobin subunit epsilon;Hemoglobin subunit beta;Hemoglobin subunit gamma-1;Hemoglobin subunit gamma-2,HBD;HBE1;HBB;HBG1;HBG2,-0.28,0.53,1.12E-01,2.42E-02,1.62E+00,"blood coagulation,oxygen transport;blood coagulation,oxygen transport,protein heterooligomerization;receptor-mediated endocytosis,blood coagulation,regulation of blood pressure,positive regulation of cell death,oxygen transport,bicarbonate transport,nitric oxide transport,response to hydrogen peroxide,hydrogen peroxide catabolic process,positive regulation of nitric oxide biosynthetic process,regulation of blood vessel size,protein heterooligomerization,renal absorption,platelet aggregation,cellular oxidant detoxification;blood coagulation,oxygen transport;blood coagulation,oxygen transport","oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding;oxygen transporter activity,iron ion binding,oxygen binding,heme binding,hemoglobin alpha binding;oxygen transporter activity,iron ion binding,protein binding,oxygen binding,heme binding,hemoglobin binding,peroxidase activity,haptoglobin binding;oxygen transporter activity,iron ion binding,oxygen binding,heme binding;oxygen transporter activity,iron ion binding,oxygen binding,heme binding","cytosol,hemoglobin complex,blood microparticle;cytosol,hemoglobin complex,blood microparticle;extracellular region,cytosol,hemoglobin complex,haptoglobin-hemoglobin complex,extracellular exosome,endocytic vesicle lumen,blood microparticle;cytosol,hemoglobin complex;cytosol,hemoglobin complex,blood microparticle",6,1,2,LLVVYPWTQR.2|LLVVYPWTQR.3
SEN / CTL,Q02413,Desmoglein-1,DSG1,-0.41,1.23,2.26E-01,4.64E-02,1.33E+00,"cell-cell junction assembly,homophilic cell adhesion via plasma membrane adhesion molecules,single organismal cell-cell adhesion,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,response to progesterone,protein stabilization,maternal process involved in female pregnancy","calcium ion binding,protein binding,toxic substance binding,gamma-catenin binding","cytosol,plasma membrane,cytoplasmic side of plasma membrane,integral component of membrane,apical plasma membrane,lateral plasma membrane,desmosome,extracellular matrix,extracellular exosome,cell-cell junction",15,21,32,IIRQEPSDSPMFIINR.3|VIAPSSSLPTSLTIHHPR.4|VIAPSSSLPTSLTIHHPR.3|YVMGNNPADLLAVDSR.2|YVM[Oxi]GNNPADLLAVDSR.3|YVM[Oxi]GNNPADLLAVDSR.2|ALNSM[Oxi]GQDLERPLELR.3|ALNSMGQDLERPLELR.3|TM[Oxi]NNFLDREQYGQYALAVR.3|TMNNFLDREQYGQYALAVR.3|EQYNM[Oxi]LGGK.2|DGSNVIVTER.2|EMQDLGGGER.2|EM[Oxi]QDLGGGER.2|ESSNVVVTER.2|IHSDC[CAM]AANQQVTYR.3|IHSDC[CAM]AANQQVTYR.2|MTGFELTEGVK.2|M[Oxi]TGFELTEGVK.2|EQYGQYALAVR.2|VGDFVATDLDTGRPSTTVR.3|ISGVGIDQPPYGIFVINQK.3|ISGVGIDQPPYGIFVINQK.2|TYVVTGNMGSNDK.2|TYVVTGNM[Oxi]GSNDK.2|VVGPISGADLHGMLEMPDLR.3|EVTPFFIIYC[CAM]R.2|QEPSDSPMFIINR.2|QEPSDSPM[Oxi]FIINR.2|YQGTILSIDDNLQR.2|TYVVTGNM[Oxi]GSNDKVGDFVATDLDTGRPSTTVR.4|TSGM[Oxi]PEIC[CAM]QEYSGTLR.2
SEN / CTL,P50995,Annexin A11,ANXA11,-0.47,1.14,5.68E-02,1.32E-02,1.88E+00,"phagocytosis,cell cycle,cell division,response to calcium ion","calcium ion binding,protein binding,calcium-dependent phospholipid binding,phosphatidylethanolamine binding,MHC class II protein complex binding,S100 protein binding,poly(A) RNA binding,calcium-dependent protein binding","nuclear envelope,nucleoplasm,cytoplasm,spindle,membrane,midbody,melanosome,specific granule,azurophil granule,phagocytic vesicle,extracellular exosome",6,29,45,NTPAFFAER.2|GVGTDEAC[CAM]LIEILASR.3|GVGTDEAC[CAM]LIEILASR.2|TLEEAIR.2|SRAHLVAVFNEYQR.4|SRAHLVAVFNEYQR.3|DAQELYAAGENR.3|DAQELYAAGENR.2|TPVLFDIYEIK.3|TPVLFDIYEIK.2|SLYHDISGDTSGDYRK.4|SLYHDISGDTSGDYRK.3|SLYHDISGDTSGDYRK.2|TLEEAIRSDTSGHFQR.4|TLEEAIRSDTSGHFQR.3|AHLVAVFNEYQR.3|AHLVAVFNEYQR.2|FNAVLC[CAM]SR.2|AYKAEFKK.2|SDTSGHFQR.2|SETDLLDIRSEYK.3|SETDLLDIR.2|GTITDAPGFDPLRDAEVLRK.4|GTITDAPGFDPLRDAEVLRK.3|LLISLSQGNR.2|LGTDESKFNAVLC[CAM]SR.3|LGTDESKFNAVLC[CAM]SR.2|SLYHDISGDTSGDYR.3|SLYHDISGDTSGDYR.2|GFGTDEQAIIDC[CAM]LGSR.3|GFGTDEQAIIDC[CAM]LGSR.2|TPVLFDIYEIKEAIK.3|LLISLSQGNRDESTNVDMSLAQR.4|LLISLSQGNRDESTNVDM[Oxi]SLAQR.3|LLISLSQGNRDESTNVDMSLAQR.3|DLKSELSGNFEK.2|GTITDAPGFDPLR.2|GTITDAPGFDPLRDAEVLR.3|DAQELYAAGENRLGTDESK.3|EAIKGVGTDEAC[CAM]LIEILASR.3|DESTNVDMSLAQR.2|EMSGDLEEGMLAVVK.2|EM[Oxi]SGDLEEGMLAVVK.2|EMSGDLEEGM[Oxi]LAVVK.2|TPVLFDIYEIKEAIKGVGTDEAC[CAM]LIEILASR.4
SEN / CTL,P29279,Connective tissue growth factor,CTGF,-0.55,0.85,2.69E-02,6.73E-03,2.17E+00,"cartilage condensation,ossification,angiogenesis,regulation of cell growth,tissue homeostasis,transcription initiation from RNA polymerase II promoter,cell adhesion,cell-matrix adhesion,integrin-mediated signaling pathway,cell-cell signaling,aging,positive regulation of cell proliferation,fibroblast growth factor receptor signaling pathway,epidermis development,response to wounding,response to glucose,positive regulation of gene expression,negative regulation of gene expression,cell migration,cell differentiation,lung development,regulation of chondrocyte differentiation,response to estradiol,positive regulation of collagen biosynthetic process,response to anoxia,intracellular signal transduction,chondrocyte proliferation,response to amino acid,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,response to peptide hormone,positive regulation of cell differentiation,positive regulation of JNK cascade,positive regulation of cell activation,response to mineralocorticoid,positive regulation of stress fiber assembly,cytosolic calcium ion transport,positive regulation of cardiac muscle contraction,negative regulation of cell death,extracellular matrix constituent secretion,positive regulation of G0 to G1 transition,positive regulation of ERK1 and ERK2 cascade,response to fatty acid,DNA biosynthetic process,reactive oxygen species metabolic process","fibronectin binding,integrin binding,protein binding,insulin-like growth factor binding,protein C-terminus binding,growth factor activity,heparin binding","extracellular region,proteinaceous extracellular matrix,extracellular space,Golgi apparatus,cis-Golgi network,cytosol,plasma membrane,cell cortex,intracellular membrane-bounded organelle,perinuclear region of cytoplasm",9,8,8,DGAPC[CAM]IFGGTVYR.2|C[CAM]PAGVSLVLDGC[CAM]GC[CAM]C[CAM]R.2|LEDTFGPDPTMIR.2|C[CAM]PDEPAPR.2|TTTLPVEFK.2|FC[CAM]GVC[CAM]TDGR.2|SGESFQSSC[CAM]K.2|ANC[CAM]LVQTTEWSAC[CAM]SK.2
SEN / CTL,P67936,Tropomyosin alpha-4 chain,TPM4,-0.85,2.41,1.02E-01,2.22E-02,1.65E+00,"osteoblast differentiation,movement of cell or subcellular component,muscle contraction,muscle filament sliding","actin binding,calcium ion binding,protein binding,structural constituent of muscle","stress fiber,podosome,cytosol,cytoskeleton,muscle thin filament tropomyosin,focal adhesion,membrane,cortical cytoskeleton,filamentous actin,extracellular exosome",18,25,42,KIQALQQQADEAEDRAQGLQR.4|KIQALQQQADEAEDRAQGLQR.3|KIQALQQQADEAEDRAQGLQR.5|IQALQQQADEAEDRAQGLQR.3|IQALQQQADEAEDRAQGLQR.4|IQALQQQADEAEDRAQGLQR.2|KLVILEGELERAEER.4|KLVILEGELERAEER.3|C[CAM]GDLEEELKNVTNNLK.3|C[CAM]GDLEEELKNVTNNLK.2|AEERAEVSELK.3|SLEAASEK.2|EKAEGDVAALNR.3|EKAEGDVAALNR.2|YSEKEDKYEEEIK.4|YSEKEDKYEEEIK.3|YSEKEDKYEEEIK.2|LLSDKLKEAETR.3|REKAEGDVAALNR.3|RKIQALQQQADEAEDR.4|RKIQALQQQADEAEDR.3|TIDDLEEK.2|AEGDVAALNR.2|IQALQQQADEAEDR.3|IQALQQQADEAEDR.2|LVILEGELERAEER.3|LVILEGELERAEER.2|KIQALQQQADEAEDR.3|KIQALQQQADEAEDR.2|MEIQEMQLK.2|M[Oxi]EIQEMQLK.2|MEIQEM[Oxi]QLK.2|AEGDVAALNRR.2|AEVSELKC[CAM]GDLEEELKNVTNNLK.4|AEVSELKC[CAM]GDLEEELKNVTNNLK.3|SLEAASEKYSEK.2|TIDDLEEKLAQAK.2|EENVGLHQTLDQTLNELNC[CAM]I.3|EENVGLHQTLDQTLNELNC[CAM]I.2|AEVSELKC[CAM]GDLEEELK.2|LAQAKEENVGLHQTLDQTLNELNC[CAM]I.3|TIDDLEEKLAQAKEENVGLHQTLDQTLNELNC[CAM]I.4
SEN / CTL,P02533,"Keratin, type I cytoskeletal 14",KRT14,-1.14,1.68,1.39E-02,3.74E-03,2.43E+00,"aging,epidermis development,response to zinc ion,response to ionizing radiation,epithelial cell differentiation,hemidesmosome assembly,hair cycle,intermediate filament bundle assembly","structural constituent of cytoskeleton,protein binding,keratin filament binding","nucleus,cytoplasm,cytosol,intermediate filament,keratin filament,extracellular exosome,cell periphery",135,50,89,VLDELTLAR.2|ILTATVDNANVLLQIDNAR.3|ILTATVDNANVLLQIDNAR.2|APSTYGGGLSVSSSR.2|APSTYGGGLSVSSSR.3|LAADDFR.2|DAEEWFFTKTEELNREVATNSELVQSGK.4|TRLEQEIATYR.3|TRLEQEIATYR.2|RLLEGEDAHLSSSQFSSGSQSSR.4|RLLEGEDAHLSSSQFSSGSQSSR.3|LLEGEDAHLSSSQFSSGSQSSR.3|LLEGEDAHLSSSQFSSGSQSSR.4|LLEGEDAHLSSSQFSSGSQSSR.2|TKYETELNLR.3|TKYETELNLR.2|ALEEANADLEVK.2|ALEEANADLEVK.3|GSC[CAM]GIGGGIGGGSSR.2|TRLEQEIATYRR.3|VTMQNLNDRLASYLDKVR.4|VTMQNLNDRLASYLDKVR.3|VTM[Oxi]QNLNDRLASYLDKVR.4|VTM[Oxi]QNLNDRLASYLDKVR.3|DAEEWFFTK.2|ISSVLAGGSC[CAM]R.2|ADLEM[Oxi]QIESLKEELAYLKK.4|ADLEMQIESLKEELAYLKK.4|ADLEMQIESLKEELAYLKK.3|DAEEWFFTKTEELNR.2|DAEEWFFTKTEELNR.3|TEELNREVATNSELVQSGK.3|TEELNREVATNSELVQSGK.2|ASLENSLEETKGR.3|ASLENSLEETKGR.2|NKILTATVDNANVLLQIDNAR.3|ADLEMQIESLKEELAYLK.3|ADLEM[Oxi]QIESLKEELAYLK.3|ASLENSLEETK.2|EVATNSELVQSGK.2|EVATNSELVQSGK.3|GQVGGDVNVEMDAAPGVDLSR.2|GQVGGDVNVEM[Oxi]DAAPGVDLSR.2|GQVGGDVNVEM[Oxi]DAAPGVDLSR.3|TIEDLRNKILTATVDNANVLLQIDNAR.3|M[Oxi]SVEADINGLRR.3|MSVEADINGLRR.3|MSVEADINGLRR.2|MSVEADINGLR.2|M[Oxi]SVEADINGLR.2|LLEGEDAHLSSSQFSSGSQSSRDVTSSSR.4|VTMQNLNDR.2|VTM[Oxi]QNLNDR.2|EVATNSELVQSGKSEISELRR.4|EVATNSELVQSGKSEISELRR.3|LASYLDK.2|NHEEEMNALR.3|NHEEEM[Oxi]NALR.3|NHEEEMNALR.2|NHEEEM[Oxi]NALR.2|VM[Oxi]DVHDGKVVSTHEQVLR.5|VM[Oxi]DVHDGKVVSTHEQVLR.4|EELAYLK.2|KDAEEWFFTK.3|KDAEEWFFTK.2|QRPAEIKDYSPYFK.4|QRPAEIKDYSPYFK.3|KNHEEEMNALR.3|KNHEEEMNALR.2|DYSPYFK.2|TKVM[Oxi]DVHDGKVVSTHEQVLR.5|TKVM[Oxi]DVHDGKVVSTHEQVLR.4|EELAYLKK.2|QFTSSSSMK.2|QFTSSSSM[Oxi]K.2|IRDWYQR.2|LASYLDKVR.2|LEQEIATYR.2|ALEEANADLEVKIRDWYQR.4|VVSTHEQVLR.2|RVLDELTLAR.2|TMQNLEIELQSQLSM[Oxi]K.3|TM[Oxi]QNLEIELQSQLSM[Oxi]K.2|TMQNLEIELQSQLSM[Oxi]K.2|TMQNLEIELQSQLSMK.2|ILNEMRDQYEK.2|ILNEM[Oxi]RDQYEK.2|C[CAM]EMEQQNQEYK.2|C[CAM]EM[Oxi]EQQNQEYK.2
SEN / CTL,Q93084,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3,ATP2A3,-1.23,1.98,1.01E-01,2.21E-02,1.66E+00,"transport,calcium ion transport,cellular calcium ion homeostasis,ion transmembrane transport,calcium ion transmembrane transport,regulation of cardiac conduction","calcium-transporting ATPase activity,ATP binding,metal ion binding","endoplasmic reticulum,endoplasmic reticulum membrane,integral component of plasma membrane,sarcoplasmic reticulum,platelet dense tubular network membrane,nuclear membrane,sarcoplasmic reticulum membrane",9,26,35,SLPSVETLGC[CAM]TSVIC[CAM]SDK.2|SLPSVETLGC[CAM]TSVIC[CAM]SDK.3|DIVPGDIVEVAVGDKVPADLR.3|DIVPGDIVEVAVGDKVPADLR.2|KAEIGIAMGSGTAVAK.3|KAEIGIAM[Oxi]GSGTAVAK.3|KAEIGIAMGSGTAVAK.2|IRDWGSGSDTLR.3|AGAC[CAM]NTVIK.2|TAPLTPTSR.2|VVMITGDNK.2|RLGIFGDTEDVAGK.3|RLGIFGDTEDVAGK.2|AVGVAVATGLHTELGK.3|AVGVAVATGLHTELGK.2|HTEAIPDPR.2|NAESAIEALK.2|SMSVYC[CAM]TPTRPHPTGQGSK.4|SQMAAVEPER.2|HFSVTAEGGLSPAQVTGAR.3|HFSVTAEGGLSPAQVTGAR.2|AYTGREFDDLSPEQQR.3|LGIFGDTEDVAGK.2|NAESAIEALKEYEPEMGK.3|EFDDLSPEQQR.2|KEDMELDDC[CAM]SK.2|NMLFSGTNITSGK.2|C[CAM]SEDNPLFAGIDC[CAM]EVFESR.3|C[CAM]SEDNPLFAGIDC[CAM]EVFESR.2|MNVFDTDLQALSR.2|VDQSILTGESVSVTK.2|SAAEMVLSDDNFASIVAAVEEGR.3|SAAEMVLSDDNFASIVAAVEEGR.2|IVENLQSFNEITAMTGDGVNDAPALK.3|C[CAM]GQFDGLVELATIC[CAM]ALC[CAM]NDSALDYNEAK.3
SEN / CTL,P02538,"Keratin, type II cytoskeletal 6A",KRT6A,-1.35,1.41,1.22E-07,8.40E-08,7.08E+00,"morphogenesis of an epithelium,cytoskeleton organization,positive regulation of cell proliferation,cell differentiation,wound healing","structural constituent of cytoskeleton,protein binding","nucleus,membrane,keratin filament,extracellular exosome",126,61,85,YEELQVTAGR.2|ADTLTDEINFLR.2|ADTLTDEINFLR.3|QNLEPLFEQYINNLRR.3|LALDVEIATYR.2|LLKEYQELMNVK.3|LLKEYQELMNVK.2|SRAEAESWYQTKYEELQVTAGR.4|SRAEAESWYQTKYEELQVTAGR.3|AEAESWYQTKYEELQVTAGR.3|RISIGGGSC[CAM]AISGGYGSR.3|NLDLDSIIAEVK.2|NLDLDSIIAEVK.3|AIGGGLSSVGGGSSTIK.2|AIGGGLSSVGGGSSTIK.3|QNLEPLFEQYINNLR.3|QNLEPLFEQYINNLR.2|TLNNKFASFIDKVR.3|TLNNKFASFIDKVR.4|WTLLQEQGTK.2|SGFSSVSVSR.2|NKLEGLEDALQK.3|NKLEGLEDALQK.2|QLDSIVGER.2|SRGSGGLGGAC[CAM]GGAGFGSR.3|SRGSGGLGGAC[CAM]GGAGFGSR.2|NLDLDSIIAEVKAQYEEIAQR.3|NLDLDSIIAEVKAQYEEIAQR.4|ISIGGGSC[CAM]AISGGYGSR.2|ISIGGGSC[CAM]AISGGYGSR.3|AQYEEIAQR.2|TVRQNLEPLFEQYINNLRR.4|TVRQNLEPLFEQYINNLRR.3|GSGGLGGAC[CAM]GGAGFGSR.2|GSGGLGGAC[CAM]GGAGFGSR.3|FLEQQNKVLETK.2|GMQDLVEDFK.2|GM[Oxi]QDLVEDFK.2|AIGGGLSSVGGGSSTIKYTTTSSSSRK.4|HGDDLRNTKQEIAEINR.4|HGDDLRNTKQEIAEINR.3|SRAEAESWYQTK.3|SRAEAESWYQTK.2|ALYDAELSQMQTHISDTSVVLSMDNNR.3|ALYDAELSQM[Oxi]QTHISDTSVVLSM[Oxi]DNNR.3|ALYDAELSQMQTHISDTSVVLSM[Oxi]DNNR.3|FLEQQNKVLETKWTLLQEQGTK.4|AIGGGLSSVGGGSSTIKYTTTSSSSR.3|FASFIDKVR.2|TAAENEFVTLKK.3|TAAENEFVTLKK.2|FASFIDK.2|NKYEDEINKR.3|NKYEDEINKR.2|NTKQEIAEINR.3|NTKQEIAEINR.2|SLYGLGGSK.2|FLEQQNK.2|YEDEINK.2|GRLDSELR.2|RGFSANSAR.2|QEIAEINR.2|LLEGEEC[CAM]R.2|DVDAAYMNK.2|DVDAAYM[Oxi]NK.2|SLYGLGGSKR.2|RGFSANSARLPGVSR.3|YEDEINKR.2|LEGLEDALQK.2|DVDAAYMNKVELQAK.3|DVDAAYMNKVELQAK.2|KLLEGEEC[CAM]R.2|EYQELMNVK.2|EYQELM[Oxi]NVK.2|KDVDAAYMNK.2|NKYEDEINK.2|VRFLEQQNK.2|RQLDSIVGER.2|KQC[CAM]ANLQAAIADAEQR.3|AEAESWYQTK.2|TAAENEFVTLK.2|LALDVEIATYRK.2|TLNNKFASFIDK.2|QC[CAM]ANLQAAIADAEQRGEMALK.3|QC[CAM]ANLQAAIADAEQR.2
SEN / CTL,P08779,"Keratin, type I cytoskeletal 16",KRT16,-1.57,1.40,2.14E-09,1.94E-09,8.71E+00,"morphogenesis of an epithelium,inflammatory response,cytoskeleton organization,aging,cell proliferation,epidermis development,keratinocyte differentiation,negative regulation of cell migration,keratinization,hair cycle,innate immune response,intermediate filament cytoskeleton organization,keratinocyte migration,establishment of skin barrier","structural constituent of cytoskeleton,protein binding","nucleus,cytoskeleton,intermediate filament,extracellular exosome",96,25,45,APSTYGGGLSVSSR.2|DAETWFLSK.2|LLEGEDAHLSSQQASGQSYSSR.3|IIAATIENAQPILQIDNAR.3|IIAATIENAQPILQIDNAR.2|IIAATIENAQPILQIDNAR.4|NKIIAATIENAQPILQIDNAR.3|ILNEMRDQYEQMAEK.3|ILNEMRDQYEQMAEK.2|RLLEGEDAHLSSQQASGQSYSSR.4|TEELNKEVASNSELVQSSR.3|TEELNKEVASNSELVQSSR.2|TEELNKEVASNSELVQSSR.4|TDLEMQIEGLKEELAYLR.3|TDLEM[Oxi]QIEGLKEELAYLR.3|TDLEMQIEGLKEELAYLR.2|DAETWFLSKTEELNKEVASNSELVQSSR.3|VLQGLEIELQSQLSM[Oxi]K.2|TDLEM[Oxi]QIEGLKEELAYLRK.4|TDLEMQIEGLKEELAYLRK.4|TDLEM[Oxi]QIEGLKEELAYLRK.3|TDLEMQIEGLKEELAYLRK.3|QRPSEIKDYSPYFK.3|QRPSEIKDYSPYFK.4|QRPSEIKDYSPYFK.2|GQTGGDVNVEM[Oxi]DAAPGVDLSR.2|GQTGGDVNVEMDAAPGVDLSR.2|GQTGGDVNVEM[Oxi]DAAPGVDLSR.3|QTVEADVNGLRR.3|QTRPILKEQSSSSFSQGQSS.3|QTVEADVNGLR.2|TIEDLRNKIIAATIENAQPILQIDNAR.4|TIEDLRNKIIAATIENAQPILQIDNAR.5|TIEDLRNKIIAATIENAQPILQIDNAR.3|TKYEHELALR.3|TKYEHELALR.2|KNHEEEMLALR.3|KNHEEEMLALR.2|DQYEQMAEK.2|DQYEQM[Oxi]AEK.2|NHEEEMLALR.2|NHEEEM[Oxi]LALR.2|EVFTSSSSSSSR.2|EQSSSSFSQGQSS.2|EVASNSELVQSSR.2
SEN / CTL,P11055;P12882;Q9UKX2,Myosin-3;Myosin-1;Myosin-2,MYH3;MYH1;MYH2,-1.63,2.06,1.03E-02,2.85E-03,2.55E+00,"skeletal muscle contraction,protein dephosphorylation,muscle organ development,actin filament-based movement,muscle filament sliding,embryonic limb morphogenesis,sarcomere organization,ATP metabolic process,face morphogenesis;muscle contraction;plasma membrane repair,muscle contraction,response to activity,muscle filament sliding,Fc-gamma receptor signaling pathway involved in phagocytosis","microfilament motor activity,calmodulin binding,ATP binding,myosin phosphatase activity,ATPase activity, coupled,actin filament binding;motor activity,actin binding,calmodulin binding,ATP binding;microfilament motor activity,actin binding,protein binding,calmodulin binding,ATP binding","cytosol,muscle myosin complex,sarcomere,myosin filament,extracellular exosome;muscle myosin complex,intercalated disc,A band,myosin filament,cytoplasmic ribonucleoprotein granule;Golgi apparatus,actomyosin contractile ring,cytosol,muscle myosin complex,cell-cell junction,myofibril,sarcomere,A band,myosin filament,protein complex",9,3,3,HADSVAELGEQIDNLQR.3|GSSFQTVSALFR.2|LASADIETYLLEK.2
SEN / CTL,P12883;P13533,Myosin-7;Myosin-6,MYH7;MYH6,-1.68,1.58,2.31E-01,4.72E-02,1.33E+00,"regulation of the force of heart contraction,regulation of heart rate,skeletal muscle contraction,muscle contraction,striated muscle contraction,adult heart development,regulation of the force of skeletal muscle contraction,transition between fast and slow fiber,cardiac muscle hypertrophy in response to stress,muscle filament sliding,regulation of slow-twitch skeletal muscle fiber contraction,ATP metabolic process,ventricular cardiac muscle tissue morphogenesis,cardiac muscle contraction;in utero embryonic development,regulation of the force of heart contraction,regulation of heart rate,protein dephosphorylation,muscle contraction,striated muscle contraction,adult heart development,visceral muscle development,regulation of heart contraction,regulation of blood pressure,cardiac muscle hypertrophy in response to stress,muscle filament sliding,myofibril assembly,BMP signaling pathway,regulation of ATPase activity,sarcomere organization,ATP metabolic process,cardiac muscle fiber development,atrial cardiac muscle tissue morphogenesis,ventricular cardiac muscle tissue morphogenesis,cardiac muscle contraction,canonical Wnt signaling pathway,regulation of heart growth","microfilament motor activity,actin binding,protein binding,calmodulin binding,ATP binding,ATPase activity,actin-dependent ATPase activity;microfilament motor activity,actin binding,calmodulin binding,ATP binding,ATPase activity,myosin phosphatase activity,protein kinase binding,actin-dependent ATPase activity","stress fiber,muscle myosin complex,myosin complex,sarcomere,Z disc,myosin filament;stress fiber,cytosol,muscle myosin complex,myosin complex,myofibril,sarcomere,Z disc,myosin filament",3,1,1,IEELEEELEAER.2
SEN / CTL,Q04695,"Keratin, type I cytoskeletal 17",KRT17,-1.75,1.86,6.19E-03,1.81E-03,2.74E+00,"signal transduction,epidermis development,positive regulation of cell growth,hair follicle morphogenesis,keratinization,intermediate filament organization,positive regulation of translation,positive regulation of hair follicle development","structural constituent of cytoskeleton,MHC class II receptor activity,MHC class II protein binding","cytoplasm,intermediate filament,extracellular exosome,cell periphery",30,28,43,ALEEANTELEVK.2|LSVEADINGLRR.3|LSVEADINGLRR.2|ILTATVDNANILLQIDNAR.2|ILTATVDNANILLQIDNAR.3|ADLEM[Oxi]QIENLKEELAYLKK.4|ADLEMQIENLKEELAYLKK.4|ADLEMQIENLKEELAYLKK.3|TIEELQNKILTATVDNANILLQIDNAR.4|TKFETEQALR.3|TKFETEQALR.2|DYSQYYR.2|ADLEM[Oxi]QIENLKEELAYLK.3|ADLEMQIENLKEELAYLK.3|ADLEMQIENLKEELAYLK.2|LLEGEDAHLTQYKK.4|LLEGEDAHLTQYKK.3|RLLEGEDAHLTQYKK.4|RLLEGEDAHLTQYKK.3|GSSGLGGGSSR.2|ASLEGNLAETENR.3|ASLEGNLAETENR.2|TIEELQNK.2|QFTSSSSIK.2|LLEGEDAHLTQYK.3|LLEGEDAHLTQYK.2|LSGGLGAGSC[CAM]R.2|ATMQNLNDR.2|ATM[Oxi]QNLNDR.2|VRALEEANTELEVK.3|TIVEEVQDGKVISSR.3|RLLEGEDAHLTQYK.3|TIVEEVQDGK.2|DAEDWFFSK.2|DAEDWFFSK.1|LLEGEDAHLTQYKKEPVTTR.4|LSVEADINGLR.2|ATMQNLNDRLASYLDK.3|TMQALEIELQSQLSMK.3|TMQALEIELQSQLSMK.2|ADLEMQIENLK.2|ADLEM[Oxi]QIENLK.2|LGSAGGLGSTLGGSSYSSC[CAM]YSFGSGGGYGSSFGGVDGLLAGGEK.4